<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40620172</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-6971</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Current opinion in pulmonary medicine</Title><ISOAbbreviation>Curr Opin Pulm Med</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence in cardiac sarcoidosis: ECG, Echo, CPET and MRI.</ArticleTitle><Pagination><StartPage>534</StartPage><EndPage>539</EndPage><MedlinePgn>534-539</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MCP.0000000000001193</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Cardiac sarcoidosis is a form of inflammatory cardiomyopathy that varies in its clinical presentation. It is associated with significant clinical complications such as high-degree atrioventricular block, ventricular tachycardia, heart failure and sudden cardiac death. It is challenging to diagnose clinically, and its increasing detection rate may represent increasing awareness of the disease by clinicians as well as a rising incidence. Prompt diagnosis and risk stratification reduces morbidity and mortality from cardiac sarcoidosis. Noninvasive diagnostic modalities such as ECG, echocardiography, PET/computed tomography (PET/CT) and cardiac MRI (cMRI) are increasingly playing important roles in cardiac sarcoidosis diagnosis. Artificial intelligence driven applications are increasingly being applied to these diagnostic modalities to improve the detection of cardiac sarcoidosis.</AbstractText><AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Review of the recent literature suggests artificial intelligence based algorithms in PET/CT and cMRIs can predict cardiac sarcoidosis as accurately as trained experts, however, there are few published studies on artificial intelligence based algorithms in ECG and echocardiography.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">The impressive advances in artificial intelligence have the potential to transform patient screening in cardiac sarcoidosis, aid prompt diagnosis and appropriate risk stratification and change clinical practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Umeojiako</LastName><ForeName>Wilfred Ifeanyi</ForeName><Initials>WI</Initials><AffiliationInfo><Affiliation>Royal Brompton and Harefield Hospitals, part of Guy's and St Thomas' NHS Foundation Trust.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xfc;scher</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Royal Brompton and Harefield Hospitals, part of Guy's and St Thomas' NHS Foundation Trust.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London School of Cardiovascular Medicine and Sciences.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Royal Brompton and Harefield Hospitals, part of Guy's and St Thomas' NHS Foundation Trust.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London School of Cardiovascular Medicine and Sciences.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Opin Pulm Med</MedlineTA><NlmUniqueID>9503765</NlmUniqueID><ISSNLinking>1070-5287</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012507" MajorTopicYN="Y">Sarcoidosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072078" MajorTopicYN="N">Positron Emission Tomography Computed Tomography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmias</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiac sarcoidosis</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">imaging</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>7</Day><Hour>4</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40620172</ArticleId><ArticleId IdType="doi">10.1097/MCP.0000000000001193</ArticleId><ArticleId IdType="pii">00063198-990000000-00258</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sharma R, Kouranos V, Cooper LT, et al. Management of cardiac sarcoidosis. A clinical consensus statement of the Heart Failure Association. The European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial &amp; Pericardial Diseases, and the European Heart Rhythm Association of the ESC. Eur Heart J 2024; 45:1&#x2013;30.</Citation></Reference><Reference><Citation>Kandolin R, Lehtonen J, Airaksinen J, et al. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25&#x200a;years in a nationwide study. Circulation 2015; 131:624&#x2013;632.</Citation></Reference><Reference><Citation>Kouranos V, Khattar RS, Okafor J, et al. Predictors of outcome in a contemporary cardiac sarcoidosis population: role of brain natriuretic peptide, left ventricular function and myocardial inflammation. Eur J Heart Fail 2023; 25:2287&#x2013;2298.</Citation></Reference><Reference><Citation>Ekstr&#xf6;m K, Lehtonen J, Nordenswan HK, et al. Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries. Eur Heart J 2019; 40:3121&#x2013;3128.</Citation></Reference><Reference><Citation>Jamilloux Y, Maucort-Boulch D, Kerever S, et al. Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis. Eur Respir J 2016; 48:1700&#x2013;1709.</Citation></Reference><Reference><Citation>Kouranos V, Sharma R. Cardiac sarcoidosis: state-of-the-art review. Heart 2021; 107:1591&#x2013;1599.</Citation></Reference><Reference><Citation>Judson MA, Costabel U, Drent M, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis. Vasc Diffuse Lung Dis 2014; 31:19&#x2013;27.</Citation></Reference><Reference><Citation>Ribeiro Neto ML, Jellis C, Hachamovitch R, et al. Performance of diagnostic criteria in patients clinically judged to have cardiac sarcoidosis: is it time to e to regroup? Am Heart J 2020; 223:106&#x2013;109.</Citation></Reference><Reference><Citation>Mehta D, Lubitz SA, Frankel Z, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 2008; 133:1426&#x2013;1435.</Citation></Reference><Reference><Citation>Kouranos V, Tzelepis GE, Rapti A, et al. Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis. JACC Cardiovasc Imaging 2017; 10:1437&#x2013;1447.</Citation></Reference><Reference><Citation>Duvall C, Pavlovic N, Rosen NS, et al. Sex and race differences in cardiac sarcoidosis presentation, treatment and outcomes. J Card Fail 2023; 29:1135&#x2013;1145.</Citation></Reference><Reference><Citation>Martusewicz-Boros MM, Boros PW, Wiatr E, et al. Prevalence of cardiac sarcoidosis in white population: a case- control study: proposal for a novel risk index based on commonly available tests. Medicine (Baltimore) 2016; 95:e4518.</Citation></Reference><Reference><Citation>Kalra R, Malik S, Chen KA, et al. Sex differences in patients with suspected cardiac sarcoidosis assessed by cardiovascular magnetic resonance imaging. Circ Arrhythm Electrophysiol 2021; 14:e009966.</Citation></Reference><Reference><Citation>Iso T, Maeda D, Matsue Y, et al. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis. Heart 2023; 109:1387&#x2013;1393.</Citation></Reference><Reference><Citation>Zhou Y, Gerke AK, Lower EE, et al. The impact of demographic disparities in the presentation of sarcoidosis: a multicenter prospective study. Respir Med 2021; 187:106564.</Citation></Reference><Reference><Citation>Wazid M, Das AK, Chamola V, Park Y. Uniting cyber security and ma- chine learning: advantages, challenges and future research. ICT Express 2022; 8:313&#x2013;321.</Citation></Reference><Reference><Citation>What is artificial intelligence (AI)? | IBM. https://www.ibm.com/topics/artificial-intelligence . [Accessed 19 March 2025].</Citation></Reference><Reference><Citation>Emadi M, Tanha J, Shiri ME, Aghdam MH. A Selection Metric for semi-supervised learning based on neighborhood construction. Inf Process Manag 2021; 58:102444.</Citation></Reference><Reference><Citation>What is unsupervised learning? |IBM. https://www.ibm.com/topics/unsupervised-learning . [Accessed 19 March 2025].</Citation></Reference><Reference><Citation>Lecun Y, Bengio Y, Hinton G. Deep learning. Nature 2015; 521:436&#x2013;444.</Citation></Reference><Reference><Citation>Manafi-Farid R, Askari E, Shiri I, et al. 18F-FDG-PET/CT radiomics and artificial intelligence in lung cancer: technical aspects and potential clinical applications. Semin Nucl Med 2022; 52:759&#x2013;780.</Citation></Reference><Reference><Citation>Brownlee J. 4 types of classification tasks in machine learning. Python Machine Learning 2020; https://machinelearningmastery.com/types-of-classification-in-machine-learning . [Accessed 19 March 2025].</Citation></Reference><Reference><Citation>Yamashita R, Nishio M, Do RKG, Togashi K. Convolutional neural networks: an overview and application in radiology. Insights Imaging 2018; 9:611&#x2013;629.</Citation></Reference><Reference><Citation>Gulshan V, Peng L, Coram M, et al. Development and vali- dation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs. JAMA 2016; 316:2402&#x2013;2410.</Citation></Reference><Reference><Citation>Esteva A, Kuprel B, Novoa RA, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 2017; 542:115&#x2013;118.</Citation></Reference><Reference><Citation>Bejnordi BE, Veta M, van Diest PJ, et al. Diagnostic assessment of deep learning algorithms for detection of lymph node metastases in women with breast cancer. JAMA 2017; 318:2199&#x2013;2210.</Citation></Reference><Reference><Citation>Androulakis E, Fielder C. Artificial intelligence in ECG diagnostics - where are we now? ESC 2024.</Citation></Reference><Reference><Citation>Attia ZI, Kapa S, Yao X, et al. Prospective validation of a deep learning electrocardiogram algorithm for the detection of left ventricular systolic dysfunction. J Cardiovasc Electrophysiol 2019; 30:668&#x2013;674.</Citation></Reference><Reference><Citation>Kwon JM, Kim KH, Jeon KH, et al. Development and validation of deep-learning algorithm for electrocardiography-based heart failure identification. Korean Circ J 2019; 49:629&#x2013;639.</Citation></Reference><Reference><Citation>Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11:1305&#x2013;1323.</Citation></Reference><Reference><Citation>Terasaki F, Azuma A, Anzai T, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis- digest version. Circ J 2019; 83:2329&#x2013;2388.</Citation></Reference><Reference><Citation>de Melo JF, Mangold KE, Debertin J, et al. Detection of cardiac sarcoidosis with the artificial intelligence&#x2013;enhanced electrocardiogram. Heart Rhythm 2025; 22:859&#x2013;861.</Citation></Reference><Reference><Citation>Hanneman K, Playford D, Dey D, et al. Value creation through artificial intel- ligence and cardiovascular imaging: a scientific statement from the American Heart Association. Circulation 2024; 149:e296&#x2013;e311.</Citation></Reference><Reference><Citation>Zhang J, Gajjala S, Agrawal P, et al. Fully automated echocardiogram interpretation in clinical practice: feasibility and diagnostic accuracy. Circulation 2018; 138:1623&#x2013;1635.</Citation></Reference><Reference><Citation>Ouyang D, He B, Ghorbani A, et al. Video-based AI for beat-to-beat assessment of cardiac function. Nature 2020; 580:252&#x2013;256.</Citation></Reference><Reference><Citation>Luo X, Fang F, So H, et al. Automated left heart chamber volumetric assessment using three-dimensional echocardiography in Chinese adolescents. Echo Res Pract 2017; 4:53&#x2013;61.</Citation></Reference><Reference><Citation>Ghesu FC, Krubasik E, Georgescu B, et al. Marginal space deep learning: efficient architecture for volumetric image parsing. IEEE Trans Med Imaging 2016; 35:1217&#x2013;1228.</Citation></Reference><Reference><Citation>Dezaki FT, Liao Z, Luong C, et al. Cardiac phase detection in echocardiograms with densely gated recurrent neural networks and global extrema loss. IEEE Trans Med Imaging 2019; 38:1821&#x2013;1832.</Citation></Reference><Reference><Citation>Zhang S, Tong X, Zhang T, et al. Prevalence of sarcoidosis- associated pulmonary hypertension: a systematic review and meta-analysis. Front Cardiovasc Med 2022; 8:809594.</Citation></Reference><Reference><Citation>Di Stefano C, Bruno G, Arciniegas MC, et al. Diagnostic and predictive value of speckle tracking echocardiography in cardiac sarcoidosis. BMC Cardiovasc Disord 2020; 20:21.</Citation></Reference><Reference><Citation>Murtagh G, Laffin LJ, Patel KV, et al. Improved detection of myocardial damage in sarcoidosis using longitudinal strain in patients with preserved left ventricular ejection fraction. Echocardiography 2016; 33:1344&#x2013;1352.</Citation></Reference><Reference><Citation>Katsushika S, Kodera S, Nakamoto M, et al. Deep learning algorithm to detect cardiac sarcoidosis from echocardiographic movies. Circ J 2022; 86:87&#x2013;95.</Citation></Reference><Reference><Citation>Arabi H, AkhavanAllaf A, Sanaat A, et al. The promise of artificial intelligence and deep learning in PET and SPECT imaging. Phys Med 2021; 83:122&#x2013;137.</Citation></Reference><Reference><Citation>Wang T, Lei Y, Fu Y, et al. A review on medical imaging synthesis using deep learning and its clinical applications. J Appl Clin Med Phys 2021; 22:11&#x2013;36.</Citation></Reference><Reference><Citation>Matsubara K, Ibaraki M, Nemoto M, et al. A review on AI in PET imaging. Ann Nucl Med 2022; 36:133&#x2013;143.</Citation></Reference><Reference><Citation>Ahmadian A, Brogan A, Berman J, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol 2014; 21:925&#x2013;939.</Citation></Reference><Reference><Citation>Miller RJH, Shanbhag A, Marcinkiewicz AM, et al. AI-enabled CT-guided end-to-end quantification of total cardiac activity in 18FDG cardiac PET/CT for detection of cardiac sarcoidosis. J Nucl Cardiol 2025; 48:102195.</Citation></Reference><Reference><Citation>Poitrasson-Rivi&#xe8;re A, Vanderver MD, Tomoe T, et al. Automated deep learning segmentation of cardiac inflammatory FDG PET. J Nucl Cardiol 2024; 42:102052.</Citation></Reference><Reference><Citation>Zhang Q, Burrage MK, Shanmuganathan M, et al. Oxford Acute Myocardial Infarction (OxAMI) Study. Artificial intelligence for contrast-free MRI: scar assessment in myocardial infarction using deep learning-based virtual native enhancement. Circulation 2022; 146:1492&#x2013;1503.</Citation></Reference><Reference><Citation>Zhang Q, Burrage MK, Lukaschuk E, et al. Hypertrophic Cardiomyopathy Registry (HCMR) Investigators. Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium- free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy. Circulation 2021; 144:589&#x2013;599.</Citation></Reference><Reference><Citation>Gr&#xf6;schel J, Kuhnt J, Viezzer D, et al. Comparison of manual and artificial intel- ligence based quantification of myocardial strain by feature tracking-a cardio- vascular MR study in health and disease. Eur Radiol 2024; 34:1003&#x2013;1015.</Citation></Reference><Reference><Citation>Kwon DH, Asamoto L, Popovic ZB, et al. Infarct characterization and quantification by delayed enhancement cardiac magnetic resonance imaging is a powerful independent and incremental predictor of mortality in patients with advanced ischemic cardiomyopathy. Circ Cardiovasc Imaging 2014; 7:796&#x2013;804.</Citation></Reference><Reference><Citation>Scott PA, Morgan JM, Carroll N, et al. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2011; 4:324&#x2013;330.</Citation></Reference><Reference><Citation>Zegard A, Okafor O, de Bono J, et al. Myocardial fibrosis as a predictor of sudden death in patients with coronary artery disease. J Am Coll Cardiol 2021; 77:29&#x2013;41.</Citation></Reference><Reference><Citation>Fahmy AS, Neisius U, Chan RH, et al. Three-dimensional deep convolutional neural networks for automated myocardial scar quantification in hypertrophic cardiomyopathy: a multicenter multivendor study. Radiology 2020; 294:52&#x2013;60.</Citation></Reference><Reference><Citation>Ghanbari F, Joyce T, Lorenzoni V, et al. AI cardiac MRI Scar analysis aids pre diction of major arrhythmic events in the multicenter DERIVATE Registry. Radiology 2023; 307:e222239.</Citation></Reference><Reference><Citation>Eckstein J, Moghadasi N, K&#xf6;rperich H, et al. A machine learning challenge: detection of cardiac amyloidosis based on bi-atrial and right ventricular strain and cardiac function. Diagnostics 2022; 12:2693.</Citation></Reference><Reference><Citation>Coleman GC, Shaw PW, Balfour PC, et al. Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis. JACC Cardiovasc Imaging 2017; 10:411&#x2013;420.</Citation></Reference><Reference><Citation>Patel AR. Detection of cardiac sarcoidosis: a balancing act between symptoms and imaging findings. JACC Cardiovasc Imaging 2017; 10:1448&#x2013;1450.</Citation></Reference><Reference><Citation>Eckstein J, Moghadasi N, K&#xf6;rperich H, et al. Machine-learning-based diagnostics of cardiac sarcoidosis using multi-chamber wall motion analyses. Diagnostics 2023; 13:2426.</Citation></Reference><Reference><Citation>Norori N, Hu Q, Aellen FM, et al. Addressing bias in big data and AI for healthcare: a call for open science. Patterns 2021; 2:100347.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40544443</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1788-6120</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><Issue>25</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>22</Day></PubDate></JournalIssue><Title>Orvosi hetilap</Title><ISOAbbreviation>Orv Hetil</ISOAbbreviation></Journal><ArticleTitle>[Prevalence of ECG abnormalities in hypertrophic cardiomyopathy: who seeks will find].</ArticleTitle><Pagination><StartPage>970</StartPage><EndPage>981</EndPage><MedlinePgn>970-981</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1556/650.2025.33289</ELocationID><Abstract><AbstractText>Introduction: The 2023 European Society of Cardiology Cardiomyopathy Guidelines emphasize the crucial role of a multiparametric approach in diagnosing. During the diagnostic workup of hypertrophic cardiomyopathy, besides echocardiography and cardiac magnetic resonance, ECG plays an important role. Based on literature data, only 4&#x2013;18% of patients with hypertrophic cardiomyopathy have normal ECG, however, ECG deviations are often non-specific. Objective: To evaluate the ECG characteristics in a hypertrophic cardiomyopathy patient cohort followed-up at the Heart Failure Outpatient Clinic of Gottsegen National Cardiovascular Center. Method: We retrospectively analyzed the data and the first ECGs registered of patients with hypertrophic cardiomyopathy, diagnosed by cardiac magnetic resonance and/or genetic testing, followed-up between 01. 11. 2023 and 30. 09. 2024 at our Heart Failure Outpatient Clinic. Results: Data from 72 patients were evaluated, male: 58%, age: 49 (34&#x2013;62) years, left ventricular ejection fraction: 63 (47&#x2013;72)%, NYHA functional class: 2 (1&#x2013;2), ICD/CRT-D: 47%. Based on the left ventricular outflow tract obstruction of &#x2265;30 mmHg, 31% of the patients belonged to hypertrophic obstructive cardiomyopathy subgroup. Based on the ECGs analyzed, atrial fibrillation occurred in 6%. Interatrial conduction disturbances affected 29% of the patients. Atrioventricular and intraventricular conduction disturbances occurred in 50% (AV block: 20% [grade I: 18%, grade II: 2%, grade III: 0%], right bundle branch block: 14%, left bundle branch block: 16%, left anterior hemiblock: 13%, left posterior hemiblock: 3%, non-specific intraventricular conduction disturbance: 8%). The sensitivity of the Cornell, Sokolow&#x2013;Lyon, and Peguero&#x2013;Lo Presti &#x201c;high voltage&#x201d; criteria were low (23&#x2013;14&#x2013;25%). Pathological Q wave occurred in 42% of the patients, QRS fragmentation in 43% and corrected QT interval prolongation in 44%. T wave inversion was present in 94%, significant ST elevation in 21%, ST depression in 48%, while only 3% of patients had negative ECG. The only difference between hypertrophic obstructive cardiomyopathy and non-obstructive hypertrophic cardiomyopathy patients was the fulfillment of the Cornell criterion (45% vs. 15%, p = 0.044). Conclusions: A multimodal approach is essential in the diagnosis of hypertrophic cardiomyopathy. Based on our results, hypertrophic cardiomyopathy is often associated with heterogeneous ECG abnormalities. However, the early recognition of the ECG variations may help in the further diagnostic steps, contributing to the initiation of disease-modifying treatment. Orv Hetil. 2025; 166(25): 970&#x2013;981.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Forrai</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe1;nfi-Bacs&#xe1;rdi</LastName><ForeName>Fanni</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-5024-2820</Identifier><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Szegedi Tudom&#xe1;nyegyetem, Szent-Gy&#xf6;rgyi Albert Orvostudom&#xe1;nyi Kar, Klinikai Orvostudom&#xe1;nyi Doktori Iskola Szeged Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pilecky</LastName><ForeName>D&#xe1;vid</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Szegedi Tudom&#xe1;nyegyetem, Szent-Gy&#xf6;rgyi Albert Orvostudom&#xe1;nyi Kar, Klinikai Orvostudom&#xe1;nyi Doktori Iskola Szeged Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gergely</LastName><ForeName>Tam&#xe1;s G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanuska</LastName><ForeName>Laura Fanni</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;ffer</LastName><ForeName>P&#xe1;l P&#xe9;ter</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazay</LastName><ForeName>&#xc1;d&#xe1;m</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe9;rtes</LastName><ForeName>Vivien</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;mos</LastName><ForeName>M&#xe1;t&#xe9;</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>2 Szegedi Tudom&#xe1;nyegyetem, Szent-Gy&#xf6;rgyi Albert Orvostudom&#xe1;nyi Kar, Klinikai Orvostudom&#xe1;nyi Doktori Iskola Szeged Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>3 Szegedi Tudom&#xe1;nyegyetem, Szent-Gy&#xf6;rgyi Albert Orvostudom&#xe1;nyi Kar, Belgy&#xf3;gy&#xe1;szati Klinika, Kardiol&#xf3;giai Centrum, Elektrofiziol&#xf3;giai R&#xe9;szleg Szeged Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andr&#xe9;ka</LastName><ForeName>P&#xe9;ter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 Semmelweis Egyetem Doktori Iskola, R&#xe1;cz K&#xe1;roly Konzervat&#xed;v Orvostudom&#xe1;nyi Tagozat Budapest Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pir&#xf3;th</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 Semmelweis Egyetem Doktori Iskola, R&#xe1;cz K&#xe1;roly Konzervat&#xed;v Orvostudom&#xe1;nyi Tagozat Budapest Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyolczas</LastName><ForeName>No&#xe9;mi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>2 Szegedi Tudom&#xe1;nyegyetem, Szent-Gy&#xf6;rgyi Albert Orvostudom&#xe1;nyi Kar, Klinikai Orvostudom&#xe1;nyi Doktori Iskola Szeged Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>4 &#xc9;szak-Pesti Centrumk&#xf3;rh&#xe1;z - Honv&#xe9;dk&#xf3;rh&#xe1;z, Kardiol&#xf3;giai Oszt&#xe1;ly Budapest Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muk</LastName><ForeName>Bal&#xe1;zs</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>1 Gottsegen Gy&#xf6;gy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet, Feln&#x151;tt Kardiol&#xf3;giai Oszt&#xe1;ly Budapest, Haller u. 29., 1096 Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Szegedi Tudom&#xe1;nyegyetem, Szent-Gy&#xf6;rgyi Albert Orvostudom&#xe1;nyi Kar, Klinikai Orvostudom&#xe1;nyi Doktori Iskola Szeged Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>5 Semmelweis Egyetem Doktori Iskola, R&#xe1;cz K&#xe1;roly Konzervat&#xed;v Orvostudom&#xe1;nyi Tagozat Budapest Magyarorsz&#xe1;g.</Affiliation></AffiliationInfo></Author></AuthorList><Language>hun</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>EKG-elt&#xe9;r&#xe9;sek gyakoris&#xe1;ga hypertrophi&#xe1;s cardiomyopathi&#xe1;ban: aki keres, az tal&#xe1;l.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Hungary</Country><MedlineTA>Orv Hetil</MedlineTA><NlmUniqueID>0376412</NlmUniqueID><ISSNLinking>0030-6002</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002312" MajorTopicYN="Y">Cardiomyopathy, Hypertrophic</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="hun"><AbstractText>Bevezet&#xe9;s: Az Eur&#xf3;pai Kardiol&#xf3;gus T&#xe1;rsas&#xe1;g 2023-ban publik&#xe1;lt, Cardiomyopathia Ir&#xe1;nyelve a cardiomyopathi&#xe1;k diagnosztik&#xe1;j&#xe1;ban a multiparametrikus megk&#xf6;zel&#xed;t&#xe9;s fontoss&#xe1;g&#xe1;t hangs&#xfa;lyozza. A hypertrophi&#xe1;s cardiomyopathia kivizsg&#xe1;l&#xe1;s&#xe1;ban az echokardiogr&#xe1;fia, a sz&#xed;v m&#xe1;gnesesrezonancia-vizsg&#xe1;lata mellett az EKG is fontos szerepet j&#xe1;tszik. Szakirodalmi adatok alapj&#xe1;n a hypertrophi&#xe1;s cardiomyopathi&#xe1;ban szenved&#x151; betegek mind&#xf6;ssze 4&#x2013;18%-a rendelkezik elt&#xe9;r&#xe9;s n&#xe9;lk&#xfc;li EKG-val, &#xe1;m a megfigyelt EKG-elt&#xe9;r&#xe9;sek gyakorta aspecifikusak. C&#xe9;lkit&#x171;z&#xe9;s: Tercier kardiol&#xf3;giai centrumunk, a Gottsegen Gy&#xf6;rgy Orsz&#xe1;gos Kardiovaszkul&#xe1;ris Int&#xe9;zet Sz&#xed;vel&#xe9;gtelens&#xe9;g Ambulanci&#xe1;j&#xe1;n gondozott, hypertrophi&#xe1;s cardiomyopathi&#xe1;ban szenved&#x151; betegpopul&#xe1;ci&#xf3; EKG-jellemz&#x151;inek &#xe9;rt&#xe9;kel&#xe9;se. M&#xf3;dszer: Int&#xe9;zet&#xfc;nk Sz&#xed;vel&#xe9;gtelens&#xe9;g Ambulanci&#xe1;j&#xe1;n 2023. 11. 01. &#xe9;s 2024. 09. 30. k&#xf6;z&#xf6;tt gondoz&#xe1;sba vett, a sz&#xed;v m&#xe1;gnesesrezonancia-vizsg&#xe1;lat&#xe1;val &#xe9;s/vagy genetikai vizsg&#xe1;lattal igazolt hypertrophi&#xe1;s cardiomyopathi&#xe1;ban szenved&#x151; betegek adatait, els&#x151; ambul&#xe1;ns EKG-param&#xe9;tereit elemezt&#xfc;k retrospekt&#xed;v m&#xf3;don. Eredm&#xe9;nyek: A vizsg&#xe1;lt betegek (n = 72 f&#x151;) 58%-a volt f&#xe9;rfi, medi&#xe1;n&#xe9;letkoruk 49 (34&#x2013;62) &#xe9;v, bal kamrai ejekci&#xf3;s frakci&#xf3;juk 63 (47&#x2013;72)%, NYHA funkcion&#xe1;lis oszt&#xe1;lyuk 2 (1&#x2013;2) volt, ICD-t/CRT-D-t 47%-uk viselt. A balkamraki&#xe1;raml&#xe1;si-p&#xe1;lyaobstrukci&#xf3;j&#xe1;nak &#x2265;30 Hgmm &#xe9;rt&#xe9;ke alapj&#xe1;n a betegek 31%-a tartozott a hypertrophi&#xe1;s obstrukt&#xed;v cardiomyopathia csoportba. Az elemzett EKG-kon a betegek 6%-a pitvarfibrill&#xe1;lt, az interatrialis vezet&#xe9;si zavarok a 29%-ukat &#xe9;rintett&#xe9;k. Atrioventricularis &#xe9;s intraventricularis vezet&#xe9;si zavarok a betegek 50%-&#xe1;ban jelentkeztek (AV blokk: 20% [PQ-szakasz-megny&#xfa;l&#xe1;s: 18%, II. fok&#xfa; AV blokk: 2%, III. fok&#xfa; AV blokk: 0%], jobb-Tawara-sz&#xe1;rblokk: 14%, bal-Tawara-sz&#xe1;r-blokk: 16%, bal anterior hemiblokk: 13%, bal posterior hemiblokk: 3%, aspecifikus intraventricularis vezet&#xe9;si zavar: 8%). A Cornell, a Sokolow&#x2013;Lyon-, illetve a Peguero&#x2013;Lo Presti &#x201e;high voltage&#x201d; krit&#xe9;riumok szenzitivit&#xe1;sa alacsonynak bizonyult (23&#x2013;14&#x2013;25%). Patol&#xf3;gi&#xe1;s Q-hull&#xe1;m 42%-ban, QRS-fragment&#xe1;ci&#xf3; 43%-ban, korrig&#xe1;lt QT-id&#x151;-megny&#xfa;l&#xe1;s 44%-ban fordult el&#x151;. Repolariz&#xe1;ci&#xf3;s elt&#xe9;r&#xe9;sek, mint a T-hull&#xe1;m-inverzi&#xf3;, a csoport 94%-&#xe1;ban, szignifik&#xe1;ns ST-elev&#xe1;ci&#xf3; a 21%-&#xe1;ban &#xe9;s ST-depresszi&#xf3; a 48%-&#xe1;ban volt megfigyelhet&#x151;, mind&#xf6;ssze a p&#xe1;ciensek 3%-a rendelkezett negat&#xed;v EKG-val. A hypertrophi&#xe1;s obstrukt&#xed;v cardiomyopathia &#xe9;s a nonobstrukt&#xed;v hypertrophi&#xe1;s cardiomyopathia alcsoportok k&#xf6;z&#xf6;tt egyed&#xfc;l a Cornell-krit&#xe9;rium gyakoris&#xe1;g&#xe1;ban ad&#xf3;dott k&#xfc;l&#xf6;nbs&#xe9;g (45% vs. 15%, p = 0,044). K&#xf6;vetkeztet&#xe9;s: A hypertrophi&#xe1;s cardiomyopathia diagnosztik&#xe1;j&#xe1;ban elengedhetetlen a multimod&#xe1;lis szeml&#xe9;let. Eredm&#xe9;nyeink alapj&#xe1;n hypertrophi&#xe1;s cardiomyopathi&#xe1;ban gyakorta azonos&#xed;that&#xf3;k heterog&#xe9;n EKG-elt&#xe9;r&#xe9;sek, &#xe1;m a gyan&#xfa;jelek id&#x151;beli felismer&#xe9;se a tov&#xe1;bbi diagnosztikus l&#xe9;p&#xe9;seket seg&#xed;theti, hozz&#xe1;j&#xe1;rulva a c&#xe9;lzott kezel&#xe9;s megkezd&#xe9;s&#xe9;hez, a progn&#xf3;zis jav&#xed;t&#xe1;s&#xe1;hoz. Orv Hetil. 2025; 166(25): 970&#x2013;981.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">EKG</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">hypertrophi&#xe1;s cardiomyopathia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>24</Day><Hour>13</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>22</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40544443</ArticleId><ArticleId IdType="doi">10.1556/650.2025.33289</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40684845</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-685X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>The Journal of thoracic and cardiovascular surgery</Title><ISOAbbreviation>J Thorac Cardiovasc Surg</ISOAbbreviation></Journal><ArticleTitle>Risk Stratification of CABG Patients Using an Artificial Intelligence ECG-Derived Age.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0022-5223(25)00569-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtcvs.2025.06.037</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the prognostic value of artificial intelligence electrocardiogram-derived (AI ECG) age in predicting outcomes following isolated CABG.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used preoperative ECGs (within 30 days from surgery) from 13,808 isolated CABG patients to calculate AI ECG-derived age using convolutional neural networks. The age gap was calculated as AI ECG-derived age minus chronological age. The associations of age gap with baseline comorbidities, operative outcomes, and long-term survival were analyzed using multivariable regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Median chronological age was 68 (60-74) years, and the AI ECG-derived age was 67 (61-72) years. Mean age gap was -1&#xb1;8 year (range -39 to +35 years). In 44% of patients, the AI ECG-derived age was older than the chronological age (positive age gap of 6(&#xb1;5) years), and in 21.4% this gap was greater than 5 years. Patients with age gap&gt;5 years were more likely to have renal failure, congestive heart failure, history of myocardial infarction, higher BMI, and lower ejection fraction. Postoperatively, they were at higher risk of atrial fibrillation (OR=1.15(95% confidence interval [95% CI] 1.05-1.30), p=0.042), prolonged ventilation (OR=1.2 (95% CI 1.1-1.5), p=0.047), blood transfusion (OR=1.15(95% CI 1.1-1.30), p=0.017), postoperative creatinine(B-coefficient=+0.15 units, p&lt;0.001), and hospital stay (B-coefficient=+0.7 days, p=0.001). Long-term survival was lower in patients with age gap&gt;5 years compared to those with gap&#x2264;5 (Hazard Ratio=1.4(95% CI 1.2-1.5), p&lt;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Higher age gap identifies a cohort of CABG patients with increased comorbidities and advanced physiological age. Advanced physiological age identified by AI ECG is independently associated with worse operative outcomes and long-term mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sawma</LastName><ForeName>Tedy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: sawma.tedy@mayo.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arghami</LastName><ForeName>Arman</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaff</LastName><ForeName>Hartzell V</ForeName><Initials>HV</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aslahishahri</LastName><ForeName>Masoomeh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangold</LastName><ForeName>Kathryn E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dearani</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stulak</LastName><ForeName>John M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagameri</LastName><ForeName>Gabor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villavicencio</LastName><ForeName>Mauricio A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greason</LastName><ForeName>Kevin L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopez-Jimenez</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Attia</LastName><ForeName>Zachi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crestanello</LastName><ForeName>Juan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: crestanello.juan@mayo.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Thorac Cardiovasc Surg</MedlineTA><NlmUniqueID>0376343</NlmUniqueID><ISSNLinking>0022-5223</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AI ECG</Keyword><Keyword MajorTopicYN="N">AI ECG age</Keyword><Keyword MajorTopicYN="N">CABG</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">artificial intelligence ECG-derived age</Keyword><Keyword MajorTopicYN="N">chronological age</Keyword><Keyword MajorTopicYN="N">physiological age</Keyword><Keyword MajorTopicYN="N">revascularization</Keyword><Keyword MajorTopicYN="N">risk stratification</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>20</Day><Hour>19</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40684845</ArticleId><ArticleId IdType="doi">10.1016/j.jtcvs.2025.06.037</ArticleId><ArticleId IdType="pii">S0022-5223(25)00569-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40569238</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2405-5018</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>JACC. Clinical electrophysiology</Title><ISOAbbreviation>JACC Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>New ECG Morphologic Criteria for the Identification of Left Bundle Branch Capture.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S2405-500X(25)00358-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacep.2025.05.006</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Identification of left bundle branch capture (LBBc) during left bundle branch area pacing remains challenging.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study sought to validate the utility of new simple morphologic criteria for the identification of LBBc.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with proven LBBc based on the presence of QRS transition during decremental output pacing were included. The paced V<sub>6</sub> QRS upstroke/downstroke was quantitatively and qualitatively evaluated, and classified as fast or slow, with fast upstroke patterns associated with LBBc and slow upstroke patterns with left ventricular septal capture (LVSc). Additionally, the appearance of a paced QRS downstroke slurring/notching in any lead not previously present during lead penetration and/or an "M" QRS pattern in inferior leads was also considered suggestive of LBBc. Accuracy of these criteria was tested by independent evaluators using exclusively qualitative electrocardiogram morphologic features.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">115 patients with proven LBBc were included. Mean V<sub>6</sub> QRS upstroke duration during LBBc was significantly shorter than during LVSc (34.6 &#xb1; 10.1 ms vs 63.2 &#xb1; 12.1 ms; P &lt; 0.001). A paced V<sub>6</sub> upstroke/downstroke ratio &lt;1 had a sensitivity and specificity of 0.97 and 0.95 for the identification of LBBc. A slurred/notched QRS downstroke or "M" pattern in inferior leads was present in 91.1% during LBBc in baseline narrow QRS patients with inferior paced QRS axis, with sensitivity and specificity being 0.91 and 0.87, respectively. Using exclusively qualitative criteria, independent evaluators were able to identify the correct capture pattern in 87% of LBBc and 89% of LVSc cases, with diagnostic accuracy being significantly lower among dilated cardiomyopathy patients: 70.4% vs 93%; P = 0.004.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Simple electrocardiogram morphologic criteria can accurately identify LBBc during left bundle branch area pacing in patients with baseline narrow QRS and/or without cardiomyopathy.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cano</LastName><ForeName>&#xd3;scar</ForeName><Initials>&#xd3;</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain; Instituto de Investigaci&#xf3;n Sanitaria La Fe, Valencia, Spain; Centro de Investigaciones Biom&#xe9;dicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain. Electronic address: cano_osc@gva.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arveras</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain; Instituto de Investigaci&#xf3;n Sanitaria La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarrete</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain; Instituto de Investigaci&#xf3;n Sanitaria La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jover</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain; Instituto de Investigaci&#xf3;n Sanitaria La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soriano</LastName><ForeName>Valero</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robles</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izquierdo</LastName><ForeName>Maite</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain; Instituto de Investigaci&#xf3;n Sanitaria La Fe, Valencia, Spain; Centro de Investigaciones Biom&#xe9;dicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osca</LastName><ForeName>Joaqu&#xed;n</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain; Instituto de Investigaci&#xf3;n Sanitaria La Fe, Valencia, Spain; Centro de Investigaciones Biom&#xe9;dicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Dolz</LastName><ForeName>Luis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Universitario i Polit&#xe9;cnico La Fe, Valencia, Spain; Instituto de Investigaci&#xf3;n Sanitaria La Fe, Valencia, Spain; Centro de Investigaciones Biom&#xe9;dicas en RED en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vijayaraman</LastName><ForeName>Pugazhendhi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Geisinger Heart Institute, Wilkes Barre, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Clin Electrophysiol</MedlineTA><NlmUniqueID>101656995</NlmUniqueID><ISSNLinking>2405-500X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">conduction system pacing</Keyword><Keyword MajorTopicYN="N">left bundle branch area pacing</Keyword><Keyword MajorTopicYN="N">left bundle branch capture</Keyword><Keyword MajorTopicYN="N">left ventricular septal capture</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures Dr Cano has received speaker honoraria and consultancy fees from Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort. Dr Vijayaraman has received honoraria from Medtronic, Biotronik, and Boston Scientific; has been a consultant for Medtronic and Abbott; has received research funding from Medtronic; has served on an advisory board for Abbott; and holds a patent for His bundle pacing delivery tool. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>26</Day><Hour>10</Hour><Minute>28</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40569238</ArticleId><ArticleId IdType="doi">10.1016/j.jacep.2025.05.006</ArticleId><ArticleId IdType="pii">S2405-500X(25)00358-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40637654</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1876-7591</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jun</Month><Day>26</Day></PubDate></JournalIssue><Title>JACC. Cardiovascular imaging</Title><ISOAbbreviation>JACC Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>Comparative Prognosis by Stress ECG and Stress Imaging: Results From the ISCHEMIA Trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1936-878X(25)00263-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcmg.2025.03.016</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Limited contemporary evidence exists on risk prediction by stress imaging and exercise electrocardiography (ECG) among patients with chronic coronary syndromes (CCS). Objectives From the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) study, prognosis was examined by core laboratory-defined stress imaging and exercise ECG findings in CCS patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 5,179 patients (qualifying by stress nuclear imaging [n = 2,567], echocardiography [n = 1,085], cardiac magnetic resonance [CMR] [n = 257], and ECG [n = 1,270]) were randomized. Cox models assessed associations between trial endpoints and the number of scarred and ischemic segments, rest/stress left ventricular ejection fraction (LVEF), and ST-segment depression. HRs and 95% CIs were calculated per millimeter, segment, or 5% of LVEF. We examined prognostic models for the following trial endpoints: 1) the trial's primary endpoint of cardiovascular (CV) death, myocardial infarction (MI), resuscitated cardiac arrest, or hospitalization for unstable angina or heart failure; 2) CV death; 3) spontaneous MI; 4) procedural MI; and 5) type 2 MI.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The number of scarred segments (HR: 1.07 [95% CI: 1.02-1.13]; P = 0.0209), rest LVEF (HR: 0.88 [95% CI: 0.83-0.93]; P &lt; 0.001), and stress LVEF (HR: 0.87 [95% CI: 0.83-0.91]; P &lt; 0.001) predicted the trial's primary endpoint of CV death, MI, resuscitated cardiac arrest, or hospitalization for unstable angina or heart failure. The extent of scar and rest/stress LVEF on echocardiography and nuclear imaging predicted several trial endpoints. The number of ischemic segments predicted spontaneous (HR: 1.08 [95% CI: 1.03-1.14]; P = 0.0104) and procedural MI (HR: 1.14 [95% CI: 1.03-1.25]; P = 0.0015) but was of borderline significance for the trial's primary endpoint (P = 0.0746). Ischemia extent by CMR predicted the trial's primary endpoint (P = 0.0068) and spontaneous MI (P = 0.0042).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ISCHEMIA trial findings from 320 worldwide centers revealed that stress imaging and exercise ECG measures exhibited a variable association with key trial endpoints delineating risk patterns for ischemia and infarction. Stress CMR ischemia predicted several trial endpoints, supporting an expanded role in the evaluation of patients with CCS (ISCHEMIA [International Study of Comparative Health Effectiveness With Medical and Invasive Approaches]; NCT01471522).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Leslee J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: leslee.shaw@mountsinai.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phillips</LastName><ForeName>Lawrence M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>New York University School of Medicine, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leipsic</LastName><ForeName>Jonathon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Broderick</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mieres</LastName><ForeName>Jennifer H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Northwell Health, Zucker School of Medicine at Hofstra University, Hempstead, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marwick</LastName><ForeName>Thomas H</ForeName><Initials>TH</Initials><AffiliationInfo><Affiliation>Baker Heart and Vascular Institute, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedrich</LastName><ForeName>Matthias G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>McGill University Health Centre, Montreal, Quebec, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Todd</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopes</LastName><ForeName>Renato D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>University of Ottawa Heart Institute, Ottawa, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerci</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Quanta Diagn&#xf3;stico por Imagem, Curitiba, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blankstein</LastName><ForeName>Ron</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>DiCarli</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maron</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hochman</LastName><ForeName>Judith S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>New York University School of Medicine, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Karen P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Gregg W</ForeName><Initials>GW</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Brien</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Duke University School of Medicine, Durham, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaitman</LastName><ForeName>Bernard R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>St Louis School of Medicine Center for Comprehensive Cardiovascular Care, St Louis, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwong</LastName><ForeName>Raymond Y</ForeName><Initials>RY</Initials><AffiliationInfo><Affiliation>Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picard</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Cedars-Sinai Medical Center, Log Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reynolds</LastName><ForeName>Harmony R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>New York University School of Medicine, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>ISCHEMIA Research Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01471522</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>U01 HL105462</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL105561</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL105565</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL105907</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Cardiovasc Imaging</MedlineTA><NlmUniqueID>101467978</NlmUniqueID><ISSNLinking>1876-7591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">chronic coronary syndromes</Keyword><Keyword MajorTopicYN="N">ischemia</Keyword><Keyword MajorTopicYN="N">multimodality imaging</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword></KeywordList><CoiStatement>Funding Support and Author Disclosures This work has been supported by National Institutes of Health (NIH) grants U01HL105907, U01HL105462, U01HL105561, and U01HL105565. Dr Shaw has received grants from the National Heart, Lung, and Blood Institute (NHLBI) during the conduct of the trial and currently. Dr Leipsic has received consulting fees and has stock options with HeartFlow and Circle CVI; and a research grant from GE Healthcare outside of the submitted work. Dr Maron has received grants from the NHLBI during the conduct of the trial. Dr Hochman is the primary investigator for the ISCHEMIA trial for which, in addition to support from the NHLBI, devices and medications were provided by Abbott Vascular, Medtronic Inc, Abbott Laboratories (formerly St. Jude Medical Inc), Royal Philips NV (formerly Volcano Corporation), Arbor Pharmaceuticals LLC, AstraZeneca Pharmaceuticals LP, Merck Sharp and Dohme Corp, Omron Healthcare Inc, Sunovion Pharmaceuticals Inc, Espero BioPharma, and Amgen Inc; and has received financial donations from Arbor Pharmaceuticals LLC and AstraZeneca Pharmaceuticals LP. Dr Stone has received grants from the NHLBI during the conduct of the study; personal fees from Terumo, Amaranth, Shockwave, Valfix, TherOx, Reva, Vascular Dynamics, Robocath, HeartFlow, Gore, Ablative Solutions, Vectorious, Matrizyme, Miracor, Neovasc, SpectraWave, Orchestra Biomed, V-wave, Abiomed, Claret, Sirtex, MAIA Pharmaceuticals, Ancora, and Qool Therapeutics; and other support from Cagent, Applied Therapeutics, Aria, Biostar family of funds, Cardiac Success, and MedFocus family of funds, outside of the submitted work. Dr O&#x2019;Brien has received grants from the NHLBI during the conduct of the trial. Dr Chaitman has received grants from the NHLBI during the conduct of the trial; and personal fees from Merck, NovoNordisk, Sanofi, Lilly, Johnson and Johnson, Daiichi Sankyo, Tricida, Relypsa, Imbria, and Xylocor outside of the conduct of the trial. Dr Kwong has received grants from the NHLBI during the conduct of the trial. Dr Berman has received software royalties from Cedars-Sinai Medical Center outside of the submitted work; and grants from the NHLBI during the conduct of the trial. Dr Picard has received grants from the NHLBI during the conduct of the trial. Dr Reynolds has received grants from the NHLBI during the conduct of the trial; and has also received in-kind support for unrelated research from Abbott Vascular, Philips, SHL Telemedicine, and Siemens. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>10</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40637654</ArticleId><ArticleId IdType="mid">NIHMS2085589</ArticleId><ArticleId IdType="pmc">PMC12252255</ArticleId><ArticleId IdType="doi">10.1016/j.jcmg.2025.03.016</ArticleId><ArticleId IdType="pii">S1936-878X(25)00263-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Writing Committee M, Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;78:e187&#x2013;e285. doi: 10.1016/j.jacc.2021.07.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.07.053</ArticleId><ArticleId IdType="pubmed">34756653</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini GBJ, Hartigan PM, Shaw LJ, Berman DS, Hayes SW, Bates ER, Maron DJ, Teo K, Sedlis SP, Chaitman BR, et al. Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. JACC Cardiovasc Interv. 2014;7:195&#x2013;201. doi: 10.1016/j.jcin.2013.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2013.10.017</ArticleId><ArticleId IdType="pubmed">24440015</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw LJ, Cerqueira MD, Brooks MM, Althouse AD, Sansing VV, Beller GA, Pop-Busui R, Taillefer R, Chaitman BR, Gibbons RJ, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. J Nucl Cardiol. 2012;19:658&#x2013;669. doi: 10.1007/s12350-012-9548-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12350-012-9548-3</ArticleId><ArticleId IdType="pmc">PMC4135719</ArticleId><ArticleId IdType="pubmed">22527794</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron DJ, Hochman JS. Invasive or Conservative Strategy for Stable Coronary Disease. Reply. N Engl J Med. 2020;383:e66. doi: 10.1056/NEJMc2024008</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2024008</ArticleId><ArticleId IdType="pubmed">32877596</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds HR, Shaw LJ, Min JK, Page CB, Berman DS, Chaitman BR, Picard MH, Kwong RY, O&#x2019;Brien SM, Huang Z, et al. Outcomes in the ISCHEMIA Trial Based on Coronary Artery Disease and Ischemia Severity. Circulation. 2021;144:1024&#x2013;1038. doi: 10.1161/CIRCULATIONAHA.120.049755</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.049755</ArticleId><ArticleId IdType="pmc">PMC8478888</ArticleId><ArticleId IdType="pubmed">34496632</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O&#x2019;Brien SM, Boden WE, Chaitman BR, Senior R, Lopez-Sendon J, Alexander KP, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020;382:1395&#x2013;1407. doi: 10.1056/NEJMoa1915922</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1915922</ArticleId><ArticleId IdType="pmc">PMC7263833</ArticleId><ArticleId IdType="pubmed">32227755</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochman JS, Reynolds HR, Bangalore S, O&#x2019;Brien SM, Alexander KP, Senior R, Boden WE, Stone GW, Goodman SG, Lopes RD, et al. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial. JAMA Cardiol. 2019;4:273&#x2013;286. doi: 10.1001/jamacardio.2019.0014</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2019.0014</ArticleId><ArticleId IdType="pmc">PMC6439551</ArticleId><ArticleId IdType="pubmed">30810700</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007;20:1021&#x2013;1041. doi: S0894-7317(07)00537-8 [pii] 10.1016/j.echo.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2007.07.003</ArticleId><ArticleId IdType="pubmed">17765820</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35. doi: 1532-429X-10-35 [pii] 10.1186/1532-429X-10-35</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1532-429X-10-35</ArticleId><ArticleId IdType="pmc">PMC2467420</ArticleId><ArticleId IdType="pubmed">18605997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilkemeier PL, Bourque J, Doukky R, Sanghani R, Weinberg RL. ASNC imaging guidelines for nuclear cardiology procedures : Standardized reporting of nuclear cardiology procedures. J Nucl Cardiol. 2017;24:2064&#x2013;2128. doi: 10.1007/s12350-017-1057-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12350-017-1057-y</ArticleId><ArticleId IdType="pubmed">28916938</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaitman BR, Alexander KP, Cyr DD, Berger JS, Reynolds HR, Bangalore S, Boden WE, Lopes RD, Demkow M, Perna GP, et al. Myocardial Infarction in the ISCHEMIA Trial: Impact of Different Definitions on Incidence, Prognosis, and Treatment Comparisons. Circulation. 2020. doi: 10.1161/CIRCULATIONAHA.120.047987</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.047987</ArticleId><ArticleId IdType="pmc">PMC7902479</ArticleId><ArticleId IdType="pubmed">33267610</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368&#x2013;e454. doi: 10.1161/CIR.0000000000001029</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001029</ArticleId><ArticleId IdType="pubmed">34709879</ArticleId></ArticleIdList></Reference><Reference><Citation>Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148:e9&#x2013;e119. doi: 10.1161/CIR.0000000000001168</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001168</ArticleId><ArticleId IdType="pubmed">37471501</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407&#x2013;477. doi: 10.1093/eurheartj/ehz425</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz425</ArticleId><ArticleId IdType="pubmed">31504439</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwong RY, Ge Y, Steel K, Bingham S, Abdullah S, Fujikura K, Wang W, Pandya A, Chen YY, Mikolich JR, et al. Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain. J Am Coll Cardiol. 2019;74:1741&#x2013;1755. doi: 10.1016/j.jacc.2019.07.074</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.07.074</ArticleId><ArticleId IdType="pmc">PMC8109181</ArticleId><ArticleId IdType="pubmed">31582133</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535&#x2013;543. doi: 10.1161/01.cir.97.6.535</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.97.6.535</ArticleId><ArticleId IdType="pubmed">9494023</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharir T, Germano G, Kang X, Lewin HC, Miranda R, Cohen I, Agafitei RD, Friedman JD, Berman DS. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42:831&#x2013;837.</Citation><ArticleIdList><ArticleId IdType="pubmed">11390544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, Shaw LJ, Berman DS, Callister TQ, Weinsaft JW, Wong FJ, Szulc M, Tandon V, Okin PM, Devereux RB, et al. Multidetector computed tomography coronary artery plaque predictors of stress-induced myocardial ischemia by SPECT. Atherosclerosis. 2008;197:700&#x2013;709. doi: 10.1016/j.atherosclerosis.2007.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2007.07.002</ArticleId><ArticleId IdType="pubmed">17720167</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozanski A, Gransar H, Wong ND, Shaw LJ, Miranda-Peats R, Polk D, Hayes SW, Friedman JD, Berman DS. Clinical outcomes after both coronary calcium scanning and exercise myocardial perfusion scintigraphy. J Am Coll Cardiol. 2007;49:1352&#x2013;1361. doi: 10.1016/j.jacc.2006.12.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2006.12.035</ArticleId><ArticleId IdType="pubmed">17394969</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw LJ, Hendel RC, Heller GV, Borges-Neto S, Cerqueira M, Berman DS. Prognostic estimation of coronary artery disease risk with resting perfusion abnormalities and stress ischemia on myocardial perfusion SPECT. J Nucl Cardiol. 2008;15:762&#x2013;773. doi: 10.1007/BF03007357</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03007357</ArticleId><ArticleId IdType="pubmed">18984451</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon SD, Anavekar N, Skali H, McMurray JJ, Swedberg K, Yusuf S, Granger CB, Michelson EL, Wang D, Pocock S, et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738&#x2013;3744. doi: 10.1161/CIRCULATIONAHA.105.561423</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.561423</ArticleId><ArticleId IdType="pubmed">16330684</ArticleId></ArticleIdList></Reference><Reference><Citation>Hachamovitch R, Soman P. ISCHEMIA Trial: Are We Still Fighting the Last War? Circ Cardiovasc Imaging. 2021;14:e012319. doi: 10.1161/CIRCIMAGING.120.012319</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.120.012319</ArticleId><ArticleId IdType="pubmed">33455407</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40705009</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1953</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>European journal of cardiovascular nursing</Title><ISOAbbreviation>Eur J Cardiovasc Nurs</ISOAbbreviation></Journal><ArticleTitle>Rapid 12-lead ECG for assessment of ST-elevation myocardial infarction: fast enough?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">zvaf123</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurjcn/zvaf123</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Titu</LastName><ForeName>Helen</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4336-4675</Identifier><AffiliationInfo><Affiliation>Cardiology Nurse Consultant Acute Care, Wrightington, Wigan and Leigh Teaching Hospitals NHS Foundation Trust, Wigan Lane, Lancashire WN1 2NN, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Advisor CVD Strategic Clinical Network, Clinical Associate for Stable Chest Pain, Greater Manchester and Eastern Cheshire Strategic Clinical Networks, Floor 4, 3 Piccadilly Place, Manchester M1 3BN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsyth</LastName><ForeName>Faye</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-2107-3690</Identifier><AffiliationInfo><Affiliation>Cardiovascular Research Unit, Luxembourg Institute of Health, 1 A-B Rue Thomas Edison, Strassen 1445, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 35 PB7001, Leuven 3000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>PACE Section (Perioperative, Acute, Critical Care and Emergency Medicine), Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Cardiovasc Nurs</MedlineTA><NlmUniqueID>101128793</NlmUniqueID><ISSNLinking>1474-5151</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CoiStatement>Conflict of interest: none declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>11</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40705009</ArticleId><ArticleId IdType="doi">10.1093/eurjcn/zvaf123</ArticleId><ArticleId IdType="pii">8211786</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40846582</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1444-2892</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Heart, lung &amp; circulation</Title><ISOAbbreviation>Heart Lung Circ</ISOAbbreviation></Journal><ArticleTitle>Subtle ECG, but Significant Angiographic Change: Aslanger's Pattern, a Newly Described STEMI - Equivalent.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1443-9506(25)00437-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hlc.2025.04.090</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barlow</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Orange Health Service, Orange, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>Harry C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Orange Health Service, Orange, NSW, Australia; Department of Cardiology, Concord Repatriation General Hospital, Concord, NSW, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. Electronic address: harry.lowe@health.nsw.gov.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Heart Lung Circ</MedlineTA><NlmUniqueID>100963739</NlmUniqueID><ISSNLinking>1443-9506</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Reperfusion</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword></KeywordList><CoiStatement>Declaration of Competing Interests The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>23</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>23</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>22</Day><Hour>21</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40846582</ArticleId><ArticleId IdType="doi">10.1016/j.hlc.2025.04.090</ArticleId><ArticleId IdType="pii">S1443-9506(25)00437-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40708205</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-726X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography &amp; Interventions</Title><ISOAbbreviation>Catheter Cardiovasc Interv</ISOAbbreviation></Journal><ArticleTitle>Convolutional Neural Network Fused With Recurrent Network for ECG-Based Detection of Hypertrophic Cardiomyopathy.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ccd.70041</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hypertrophic Cardiomyopathy (HCM) affects the left ventricle of the heart, leading to thickening of the ventricular wall and potentially life-threatening conditions, such as atrial fibrillation, cardiac failure, and sudden death. Early and accurate detection of HCM from Electrocardiogram (ECG) signals is critical for reducing mortality risk. However, most existing methods fail to simultaneously capture spatial and temporal patterns in ECG data, resulting in reduced diagnostic reliability.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">This paper proposes a hybrid Deep Learning (DL) network for detecting HCM using the ECG. Initially, input ECG signals are forwarded for pre-processing by Kalman filter. Then, processed signal is fed to feature extraction phase for extracting Empirical Mode Decomposition (EMD), statistical and medical features, which is followed by feature fusion, wherein the optimal feature is merged by Deep Belief Network (DBN) with Jensen-Shannon distance. Moreover, Convolutional Neural Network Fused with Recurrent Network (CNNFRN) performs HCM detection and final detected output is effectively achieved. The proposed CNNFRN combines Kalman Neural Network (CNN) and Recurrent Neural Network (RNN) based on regression modelling. Finally, the model is trained under a supervised framework using the Adam optimizer.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The proposed model is validated using the PTB Diagnostic ECG Database and Shaoxing and Ningbo Hospital ECG Database. The results show that the proposed CNNFRN model achieved an accuracy of 0.940, sensitivity of 1.000, specificity of 0.913, and an F1-score of 0.956. These findings confirm the model's effectiveness in robust and early detection of HCM, offering significant clinical value.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The proposed model accurately detects HCM by combining advanced feature extraction and a hybrid deep learning approach that captures both spatial and temporal ECG patterns. It also shows strong performance and reliability across multiple databases, making it valuable for early and effective clinical diagnosis.</AbstractText><CopyrightInformation>&#xa9; 2025 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>V</LastName><ForeName>Yogalakshmi</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2186-4241</Identifier><AffiliationInfo><Affiliation>Department of ECE, Rajalakshmi Engineering College, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T</LastName><ForeName>Manikandan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of ECE, Rajalakshmi Engineering College, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Catheter Cardiovasc Interv</MedlineTA><NlmUniqueID>100884139</NlmUniqueID><ISSNLinking>1522-1946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Convolutional Neural Network</Keyword><Keyword MajorTopicYN="N">Deep Belief Network</Keyword><Keyword MajorTopicYN="N">Electrocardiogram</Keyword><Keyword MajorTopicYN="N">Recurrent Neural Network</Keyword><Keyword MajorTopicYN="N">regression modeling</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40708205</ArticleId><ArticleId IdType="doi">10.1002/ccd.70041</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>C. Semsarian, J. Ingles, M. S. Maron, and B. J. Maron, &#x201c;New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy,&#x201d; Journal of the American College of Cardiology 65, no. 12 (2015): 1249&#x2013;1254.</Citation></Reference><Reference><Citation>A. Bernardelli, F. Dossi, M. Raccis, R. Maggi, M. Brignole, and G. Parodi, &#x201c;Brugada ECG Phenocopy in Hypertrophic Cardiomyopathy: The Time Matter,&#x201d; Journal of Electro Cardiology 77 (2023): 1&#x2013;3.</Citation></Reference><Reference><Citation>S. Goto, D. Solanki, J. E. John, et al., &#x201c;Multinational Federated Learning Approach to Train ECG and Echocardiogram Models for Hypertrophic Cardiomyopathy Detection,&#x201d; Circulation 146, no. 10 (2022): 755&#x2013;769.</Citation></Reference><Reference><Citation>A. Pelliccia, B. J. Maron, A. Spataro, M. A. Proschan, and P. Spirito, &#x201c;The Upper Limit of Physiologic Cardiac Hypertrophy in Highly Trained Elite Athletes,&#x201d; New England Journal of Medicine 324, no. 5 (1991): 295&#x2013;301.</Citation></Reference><Reference><Citation>S. Basavarajaiah, M. Wilson, G. Whyte, A. Shah, W. McKenna, and S. Sharma, &#x201c;Prevalence of Hypertrophic Cardiomyopathy in Highly Trained Athletes: Relevance to Pre&#x2010;Participation Screening,&#x201d; Journal of the American College of Cardiology 51, no. 10 (2008): 1033&#x2013;1039.</Citation></Reference><Reference><Citation>B. J. Maron, J. J. Doerer, T. S. Haas, D. M. Tierney, and F. O. Mueller, &#x201c;Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980&#x2013;2006,&#x201d; Circulation 119, no. 8 (2009): 1085&#x2013;1092.</Citation></Reference><Reference><Citation>K. G. Harmon, I. M. Asif, D. Klossner, and J. A. Drezner, &#x201c;Incidence of Sudden Cardiac Death in National Collegiate Athletic Association Athletes,&#x201d; Circulation 123, no. 15 (2011): 1594&#x2013;1600.</Citation></Reference><Reference><Citation>M. Denis, M. Bachoro, W. Gebreslassie, and T. Oladunni, &#x201c;Automatic Electrocardiogram Detection of Suspected Hypertrophic Cardiomyopathy: Application to Wearable Heart Monitors,&#x201d; IEEE Sensors Letters 5, no. 8 (2021): 1&#x2013;4.</Citation></Reference><Reference><Citation>T. Tsoutsman, L. Lam, and C. Semsarian, &#x201c;Genes, Calcium and Modifying Factors in Hypertrophic Cardiomyopathy,&#x201d; Clinical and Experimental Pharmacology and Physiology 33, no. 1&#x2013;2 (2006): 139.</Citation></Reference><Reference><Citation>A. Marian, &#x201c;Pathogenesis of Diverse Clinical and Pathological Phenotypes in Hypertrophic Cardiomyopathy,&#x201d; The Lancet 355, no. 9197 (2000): 58&#x2013;60.</Citation></Reference><Reference><Citation>B. J. Maron, P. D. Thompson, M. J. Ackerman, et al., &#x201c;Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation,&#x201d; Circulation 115, no. 12 (2007): 1643&#x2013;1655.</Citation></Reference><Reference><Citation>C. O'Mahony, F. Jichi, M. Pavlou, et al., &#x201c;A Novel Clinical Risk Prediction Model for Sudden Cardiac Death in Hypertrophic Cardiomyopathy (HCM Risk&#x2010;SCD),&#x201d; European Heart Journal 35, no. 30 (2014): 2010&#x2013;2020.</Citation></Reference><Reference><Citation>A. Gudigar, U. Raghavendra, J. Samanth, et al., &#x201c;Novel Hypertrophic Cardiomyopathy Diagnosis Index Using Deep Features and Local Directional Pattern Techniques,&#x201d; Journal of Imaging 8, no. 4 (2022): 102.</Citation></Reference><Reference><Citation>A. J. Marian and E. Braunwald, &#x201c;Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy,&#x201d; Circulation Research 121, no. 7 (2017): 749&#x2013;770.</Citation></Reference><Reference><Citation>B. J. Maron and M. S. Maron, &#x201c;Hypertrophic Cardiomyopathy,&#x201d; Lancet 381, no. 9862 (2013): 242&#x2013;255.</Citation></Reference><Reference><Citation>T. Thottakara, N. Lund, E. Kr&#xe4;mer, P. Kirchhof, L. Carrier, and M. Patten, &#x201c;A Novel miRNA Screen Identifies miRNA&#x2010;4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients With Hypertrophic Cardiomyopathy,&#x201d; Biomolecules 11, no. 11 (2021): 1718.</Citation></Reference><Reference><Citation>K. C. Siontis, A. B. Su&#xe1;rez, O. Sehrawat, et al., &#x201c;Saliency Maps Provide Insights Into Artificial Intelligence&#x2010;Based Electrocardiography Models for Detecting Hypertrophic Cardiomyopathy,&#x201d; Journal of Electro Cardiology 81 (2023): 286&#x2013;291.</Citation></Reference><Reference><Citation>K. C. Siontis, K. Liu, J. M. Bos, et al., &#x201c;Detection of Hypertrophic Cardiomyopathy by an Artificial Intelligence Electrocardiogram in Children and Adolescents,&#x201d; International Journal of Cardiology 340 (2021): 42&#x2013;47.</Citation></Reference><Reference><Citation>C. J. Zhang, Yuan&#x2010;Lu, F. Q. Tang, H. P. Cai, Y. F. Qian, and C. Chao&#x2010;Wang, &#x201c;Heart Failure Classification Using Deep Learning to Extract Spatiotemporal Features From ECG,&#x201d; BMC Medical Informatics and Decision Making 24 (2024): 17.</Citation></Reference><Reference><Citation>Y. Zhang, A. Gu, Z. Xiao, et al., &#x201c;An Effective Integrated Framework for Fetal QRS Complex Detection Based on Abdominal ECG Signal,&#x201d; Journal of Medical and Biological Engineering 44, no. 1 (2024): 99&#x2013;113.</Citation></Reference><Reference><Citation>A. Zhang, X. Yang, T. Li, M. Dou, and H. Yang, &#x201c;Classification Method of ECG Signals Based on Ranet,&#x201d; Cardiovascular Engineering and Technology 15 (2024): 561&#x2013;571.</Citation></Reference><Reference><Citation>J. A. Panza and B. J. Maron, &#x201c;Relation of Electrocardiographic Abnormalities to Evolving Left Ventricular Hypertrophy in Hypertrophic Cardiomyopathy During Childhood,&#x201d; American Journal of Cardiology 63, no. 17 (1989): 1258&#x2013;1265.</Citation></Reference><Reference><Citation>G. Finocchiaro, N. Sheikh, E. Biagini, et al., &#x201c;The Electrocardiogram in the Diagnosis and Management of Patients With Hypertrophic Cardiomyopathy,&#x201d; Heart Rhythm: The Official Journal of the Heart Rhythm Society 17, no. 1 (2020): 142&#x2013;151.</Citation></Reference><Reference><Citation>W. Y. Ko, K. C. Siontis, Z. I. Attia, et al., &#x201c;Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network&#x2010;Enabled Electrocardiogram,&#x201d; Journal of the American College of Cardiology 75, no. 7 (2020): 722&#x2013;733.</Citation></Reference><Reference><Citation>G. Hajianfar, M. Khorgami, Y. Rezaei, et al., &#x201c;Comparison of Machine Learning Algorithms Using Manual/Automated Features on 12&#x2010;Lead Signal Electrocardiogram Classification: A Large Cohort Study on Students Aged Between 6 to 18 Years Old,&#x201d; Cardiovascular Engineering and Technology 14, no. 6 (2023): 786&#x2013;800.</Citation></Reference><Reference><Citation>S. M. Kochav, Y. Raita, M. A. Fifer, et al., &#x201c;Predicting the Development of Adverse Cardiac Events in Patients With Hypertrophic Cardiomyopathy Using Machine Learning,&#x201d; International Journal of Cardiology 327 (2021): 117&#x2013;124.</Citation></Reference><Reference><Citation>M. Maanja, P. A. Noseworthy, J. B. Geske, et al., &#x201c;Tandem Deep Learning and Logistic Regression Models to Optimize Hypertrophic Cardiomyopathy Detection in Routine Clinical Practice,&#x201d; Cardiovascular Digital Health Journal 3, no. 6 (2022): 289&#x2013;296.</Citation></Reference><Reference><Citation>Y. Forghani, H. Behnam, and M. Shojaeifard, &#x201c;Hypertrophic Cardiomyopathy (HCM) and Hypertensive Heart Disease (HHD) Diagnosis Using Echocardiography and Electrocardiography,&#x201d; Computer Methods in Biomechanics and Biomedical Engineering: Imaging &amp;Visualization 9, no. 6 (2021): 565&#x2013;573.</Citation></Reference><Reference><Citation>J. P. Moreno, M. A. Sep&#xfa;lveda, and E. J. Pino, &#x201c;1D Convolutional Neural Network Impact on Heart Rate Metrics for ECG and BCG Signals,&#x201d; Journal of Medical and Biological Engineering 44 (2024): 437&#x2013;447.</Citation></Reference><Reference><Citation>N. Hirota, S. Suzuki, J. Motogi, et al., &#x201c;Identification of Patients With Dilated Phase of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network Applied to Multiple, Dual, and Single Lead Electrocardiograms,&#x201d; International Journal of Cardiology. Heart &amp; Vasculature 46 (2023): 101211.</Citation></Reference><Reference><Citation>V. Fox, J. Hightower, L. Liao, D. Schulz, and G. Borriello, &#x201c;Bayesian Filtering for Location Estimation,&#x201d; IEEE Pervasive Computing 2, no. 3 (2003): 24&#x2013;33.</Citation></Reference><Reference><Citation>T. Lee, &#x201c;EMD and LSTM Hybrid DL Model for Predicting Sunspot Number Time Series With a Cyclic Pattern,&#x201d; Solar Physics 295, no. 6 (2020): 82.</Citation></Reference><Reference><Citation>S. H. Cha, &#x201c;Comprehensive Survey on Distance/Similarity Measures Between Probability Density Functions,&#x201d; City 1, no. 2 (2007): 1.</Citation></Reference><Reference><Citation>L. R. Chilakala and G. N. Kishore, &#x201c;Optimal Deep Belief Network With Opposition&#x2010;Based Hybrid Grasshopper and Honeybee Optimization Algorithm for Lung Cancer Classification: A DBNGHHB Approach,&#x201d; International Journal of Imaging Systems and Technology 31, no. 3 (2021): 1404&#x2013;1423.</Citation></Reference><Reference><Citation>H. T. Nguyen, S. Li, and C. C. Cheah, &#x201c;A Layer&#x2010;Wise Theoretical Framework for Deep Learning of Convolutional Neural Networks,&#x201d; IEEE Access 10 (2022): 14270&#x2013;14287.</Citation></Reference><Reference><Citation>M. B. Gorji, M. Mozaffar, J. N. Heidenreich, J. Cao, and D. Mohr, &#x201c;On the Potential of Recurrent Neural Networks for Modeling Path Dependent Plasticity,&#x201d; Journal of the Mechanics and Physics of Solids 143 (2020): 103972.</Citation></Reference><Reference><Citation>PTB Diagnostic ECG Database Is Taken From, accessed on April, https://physionet.org/content/ptb-xl/1.0.3/ 2023.</Citation></Reference><Reference><Citation>V. Bhagyalakshmi, R. V. Pujeri, and G. D. Devanagavi, &#x201c;GB&#x2010;SVNN: Genetic BAT Assisted Support Vector Neural Network for Arrhythmia Classification Using ECG Signals,&#x201d; Journal of King Saud University&#x2010;Computer and Information Sciences 33, no. 1 (2021): 54&#x2013;67.</Citation></Reference><Reference><Citation>D. J. Hemanth, &#x201c;EEG Signal Based Modified Kohonen Neural Networks for Classification of Human Mental Emotions,&#x201d; Journal of Artificial Intelligence and Systems 2 (2020): 1&#x2013;13.</Citation></Reference><Reference><Citation>B. Gohel, U. S. Tiwary, and T. Lahiri, &#x201c;Relative Amplitude&#x2010;Based Features of Characteristic ECG&#x2010;Peaks for Identification of Coronary Artery Disease&#x201d;, In Proceedings of the First International Conference on Intelligent Human Computer Interaction, Springer, New Delhi, pp. 140&#x2013;146, 2009.</Citation></Reference><Reference><Citation>B. P. Nayak, S. Kar, A. Routray, and A. K. Padhi, &#x201c;A Biomedical Approach to Retrieve Information on Driver's Fatigue by Integrating EEG, ECG and Blood Biomarkers During Simulated Driving Session&#x201d;, In Proceedings of 2012 4th International Conference on Intelligent Human Computer Interaction (IHCI), IEEE, pp. 1&#x2013;6, December. 2012.</Citation></Reference><Reference><Citation>L. Ordine, G. Canciello, F. Borrelli, et al., &#x201c;Artificial Intelligence&#x2010;Driven Electrocardiography: Innovations in Hypertrophic Cardiomyopathy Management,&#x201d; Trends in Cardiovascular Medicine 35 (2024): 126&#x2013;134.</Citation></Reference><Reference><Citation>H. He, Y. Tan, and Y. Wang, &#x201c;Optimal Base Wavelet Selection for ECG Noise Reduction Using a Comprehensive Entropy Criterion,&#x201d; Entropy 17, no. 9 (2015): 6093&#x2013;6109.</Citation></Reference><Reference><Citation>P. R. Bhaladhare and D. C. Jinwala, &#x201c;A Clustering Approach for the l&#x2010;Diversity Model in Privacy Preserving Data Mining Using Fractional Calculus&#x2010;Bacterial Foraging Optimization Algorithm,&#x201d; Advances in Computer Engineering 2014 (2014): 1&#x2013;12.</Citation></Reference><Reference><Citation>Shaoxing and Ningbo Hospital ECG Database, accessed on June 2025 https://www.kaggle.com/datasets/bjoernjostein/shaoxing-and-ningbo-first-hospital-database.</Citation></Reference><Reference><Citation>I. C. Hwang, D. Choi, Y. J. Choi, et al., &#x201c;Differential Diagnosis of Common Etiologies of Left Ventricular Hypertrophy Using a Hybrid CNN&#x2010;LSTM Model,&#x201d; Scientific Reports 12 (2022): 20998.</Citation></Reference><Reference><Citation>A. Gudigar, U. Raghavendra, J. Samanth, et al., &#x201c;Novel Hypertrophic Cardiomyopathy Diagnosis Index Using Deep Features and Local Directional Pattern Techniques,&#x201d; Journal of Imaging 8, no. 4 (2022): 102.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40535683</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1943-8141</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>5</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>American journal of translational research</Title><ISOAbbreviation>Am J Transl Res</ISOAbbreviation></Journal><ArticleTitle>Development and validation of an ECG-based nomogram for early diagnosis of dilated cardiomyopathy.</ArticleTitle><Pagination><StartPage>3380</StartPage><EndPage>3391</EndPage><MedlinePgn>3380-3391</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.62347/QPZP2392</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To develop a nomogram based on electrocardiogram (ECG) parameters to predict the early diagnosis of dilated cardiomyopathy (DCM), enhancing diagnostic accuracy and enabling earlier clinical intervention.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective analysis was conducted on ECG data from 168 DCM patients and 130 healthy controls (N-DCM), diagnosed between October 2022 and August 2024. Lasso regression identified 11 significant ECG features (e.g., QTc interval, PR interval, QRS duration), and a nomogram model was constructed. Model performance was evaluated using ROC curves, calibration curves, decision curves, and clinical utility curves.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Significant differences in ECG parameters were observed between DCM and N-DCM groups, with DCM patients showing elevated values across multiple parameters. The nomogram demonstrated high predictive accuracy, achieving an AUC of 0.928 in the training group and 0.862 in the validation group. Calibration and decision curve analyses confirmed good calibration and clinical utility.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The ECG-based nomogram provides an effective tool for early DCM diagnosis, with strong predictive accuracy and clinical benefits. It shows promising applicability for large-scale screenings, contributing to earlier detection and improved patient outcomes.</AbstractText><CopyrightInformation>AJTR Copyright &#xa9; 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Tongping</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery, Lanzhou First People's Hospital No. 1 Wujiayuan West Street, Qilihe District, Lanzhou 730050, Gansu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Magnetic Resonance Room, Lanzhou First People's Hospital No. 1 Wujiayuan West Street, Qilihe District, Lanzhou 730050, Gansu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Surgery, Lanzhou First People's Hospital No. 1 Wujiayuan West Street, Qilihe District, Lanzhou 730050, Gansu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaojun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, Baoji Central Hospital No. 8 Jiangtan Road, Baoji 721008, Shaanxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Guidong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiovascular Surgery, Baoji Central Hospital No. 8 Jiangtan Road, Baoji 721008, Shaanxi, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Transl Res</MedlineTA><NlmUniqueID>101493030</NlmUniqueID><ISSNLinking>1943-8141</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dilated cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Lasso regression</Keyword><Keyword MajorTopicYN="N">early diagnosis</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">nomogram</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>19</Day><Hour>7</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>19</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>19</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40535683</ArticleId><ArticleId IdType="pmc">PMC12170394</ArticleId><ArticleId IdType="doi">10.62347/QPZP2392</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heymans S, Lakdawala NK, Tsch&#xf6;pe C, Klingel K. Dilated cardiomyopathy: causes, mechanisms, and current and future treatment approaches. Lancet. 2023;402:998&#x2013;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">37716772</ArticleId></ArticleIdList></Reference><Reference><Citation>Moeinafshar A, Yazdanpanah N, Rezaei N. Diagnostic biomarkers of dilated cardiomyopathy. Immunobiology. 2021;226:152153.</Citation><ArticleIdList><ArticleId IdType="pubmed">34784575</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdonschot JAJ, Heymans SRB. Dilated cardiomyopathy: second hits knock-down the heart. Eur Heart J. 2024;45:500&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">38085575</ArticleId></ArticleIdList></Reference><Reference><Citation>Polcwiartek C, Andersen MP, Christensen HC, Torp-Pedersen C, S&#xf8;rensen KK, Kragholm K, Graff C. The Danish nationwide electrocardiogram (ECG) cohort. Eur J Epidemiol. 2024;39:325&#x2013;333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10995054</ArticleId><ArticleId IdType="pubmed">38407726</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Zhang Q, Yang N, Wang X, Zhang Z. Simple screening model based on electrocardiogram for patients with dilated cardiomyopathy. Medicine (Baltimore) 2023;102:e32910.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9907988</ArticleId><ArticleId IdType="pubmed">36820535</ArticleId></ArticleIdList></Reference><Reference><Citation>Finocchiaro G, Merlo M, Sheikh N, De Angelis G, Papadakis M, Olivotto I, Rapezzi C, Carr-White G, Sharma S, Mestroni L, Sinagra G. The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy. Eur J Heart Fail. 2020;22:1097&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243666</ArticleId></ArticleIdList></Reference><Reference><Citation>Li HZ, Boulanger P. A survey of heart anomaly detection using ambulatory electrocardiogram (ECG) Sensors (Basel) 2020;20:1461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7085598</ArticleId><ArticleId IdType="pubmed">32155930</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Lin S, Wu J, Lai J, Li L. A study of the clinical application value of ultrasound and electrocardiogram in the differential diagnosis of cardiomyopathy. Am J Transl Res. 2021;13:5200&#x2013;5207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8205793</ArticleId><ArticleId IdType="pubmed">34150109</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzato A, Milandri A, Tortorici G, Sinagra G, Merlo M. Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role. Eur Heart J Suppl. 2023;25(Suppl C):C162&#x2013;C168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10132561</ArticleId><ArticleId IdType="pubmed">37125300</ArticleId></ArticleIdList></Reference><Reference><Citation>Crescenzi C, Silvetti E, Romeo F, Martino A, Bressi E, Panattoni G, Stefanini M, Stazi A, Danza ML, Rebecchi M, Canestrelli S, Fedele E, Lanza O, Lanzillo C, Fusco A, Golia P, De Ruvo E, Cal&#xf2; L. The electrocardiogram in non-ischaemic-dilated cardiomyopathy. Eur Heart J Suppl. 2023;25(Suppl C):C179&#x2013;C184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10132560</ArticleId><ArticleId IdType="pubmed">37125290</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J, Zhao X, Huang B, Wu Y, Wang J, Guan J, Huang L, Li X, Zhang Y, Zhang J. Prognostic value of QRS duration in patients with dilated cardiomyopathy according to left ventricular ejection fraction. Rev Cardiovasc Med. 2023;24:362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11272873</ArticleId><ArticleId IdType="pubmed">39077076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C, Yi XY, Chen Y, Wang SS, Ji Q, Li F, Zou RM, Wang YW, Wang C. Association of T-wave amplitude on electrocardiogram with left ventricular ejection fraction in children with dilated cardiomyopathy. Zhongguo Dang Dai Er Ke Za Zhi. 2020;22:374&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7389690</ArticleId><ArticleId IdType="pubmed">32312378</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Ding C, Yang S, Ge Y, Yin J, Zhao Y, Zhang J. Comparison of electrocardiogram between dilated cardiomyopathy and ischemic cardiomyopathy based on empirical mode decomposition and variational mode decomposition. Bioengineering (Basel) 2024;11:1012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11505311</ArticleId><ArticleId IdType="pubmed">39451388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose G, Healy BC, Lokhande HA, Sotiropoulos MG, Polgar-Turcsanyi M, Anderson M, Glanz BI, Guttman CRG, Bakshi R, Weiner HL, Chitnis T. Early predictors of clinical and MRI outcomes using least absolute shrinkage and selection operator (LASSO) in multiple sclerosis. Ann Neurol. 2022;92:87&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">35429009</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia SQ, Lv SY, Jin YH, Zhao Y, Tian LP, Chang MM, Yan CL, Qi XL. Cardiac MRI for clinical dilated cardiomyopathy: improved diagnostic power via combined T1, T2, and ECV. Radiography (Lond) 2024;30:926&#x2013;931.</Citation><ArticleIdList><ArticleId IdType="pubmed">38657385</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdonschot JAJ, Hazebroek MR, Krapels IPC, Henkens MTHM, Raafs A, Wang P, Merken JJ, Claes GRF, Vanhoutte EK, van den Wijngaard A, Heymans SRB, Brunner HG. Implications of genetic testing in dilated cardiomyopathy. Circ Genom Precis Med. 2020;13:476&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">32880476</ArticleId></ArticleIdList></Reference><Reference><Citation>Eldemire R, Mestroni L, Taylor MRG. Genetics of dilated cardiomyopathy. Annu Rev Med. 2024;75:417&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10842880</ArticleId><ArticleId IdType="pubmed">37788487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao H, Wang X, Chen Z, Wu M, Li J, Liu C. ECG-CL: a comprehensive electrocardiogram interpretation method based on continual learning. IEEE J Biomed Health Inform. 2023;27:5225&#x2013;5236.</Citation><ArticleIdList><ArticleId IdType="pubmed">37713232</ArticleId></ArticleIdList></Reference><Reference><Citation>Vidrio-Villase&#xf1;or R, Rodr&#xed;guez-Salazar EA, Hern&#xe1;ndez-Gonz&#xe1;lez MA, Luna-Montalb&#xe1;n R, Bernal-Ru&#xed;z EA, Solorio-Meza SE. Electrocardiographic interval as a predictor of life-threatening arrhythmias in dilated cardiomyopathy patients. Rev Med Inst Mex Seguro Soc. 2023;61(Suppl 2):S127&#x2013;S134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10764111</ArticleId><ArticleId IdType="pubmed">38011537</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo C, Casas G, Martin-Isla C, Campello VM, Guala A, Gkontra P, Rodr&#xed;guez-Palomares JF, Lekadir K. Radiomics-based classification of left ventricular non-compaction, hypertrophic cardiomyopathy, and dilated cardiomyopathy in cardiovascular magnetic resonance. Front Cardiovasc Med. 2021;8:764312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8586199</ArticleId><ArticleId IdType="pubmed">34778415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavadovskij KV, Saushkin VV, Varlamova YV, Mishkina AI, Shipulin VV, Lebedev DI, Popov SV. Mechanical dyssynchrony for prediction of the cardiac resynchronization therapy response in patients with dilated cardiomyopathy. Kardiologiia. 2021;61:14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">34397337</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez Retamales V, Lara Garcia OE, Ranjha S, Koester C, Labedi MR. Takotsubo cardiomyopathy and QTc prolongation with subsequent improvement of QTc interval and resolution of apical ballooning: a case report. Cureus. 2020;12:e9143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417186</ArticleId><ArticleId IdType="pubmed">32789081</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Wang N, Chang Q, Pan D. An interesting electrocardiogram caused by lead reversal. BMC Cardiovasc Disord. 2024;24:217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11031905</ArticleId><ArticleId IdType="pubmed">38643100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahraman E, Keles N, Parsova KE, Bastopcu M, Karatas M. Assessment of atrial conduction times in patients with frequent premature ventricular complex. J Arrhythm. 2023;39:34&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9885309</ArticleId><ArticleId IdType="pubmed">36733324</ArticleId></ArticleIdList></Reference><Reference><Citation>Chayanopparat P, Boonyasirinant T, Prapan N, Phoopattana S, Kaolawanich Y. Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy. Front Cardiovasc Med. 2023;10:1281563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10619146</ArticleId><ArticleId IdType="pubmed">37920176</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XL, Adi D, Zhao Q, Aizezi A, Keremu M, Li YP, Liu F, Ma X, Li XM, Azhati A, Ma YT. Development and validation of nomogram for unplanned ICU admission in patients with dilated cardiomyopathy. Front Cardiovasc Med. 2023;10:1043274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10060526</ArticleId><ArticleId IdType="pubmed">37008312</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M, Guo YY, Li D, Cen XF, Qiu HL, Ma YL, Huang SH, Tang QZ. Screening of lipid metabolism-related gene diagnostic signature for patients with dilated cardiomyopathy. Front Cardiovasc Med. 2022;9:853468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9010535</ArticleId><ArticleId IdType="pubmed">35433888</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40590619</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1932-8737</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Clinical cardiology</Title><ISOAbbreviation>Clin Cardiol</ISOAbbreviation></Journal><ArticleTitle>Primordial Symptoms and ECG Among Sudden Cardiac Death Victims Due to Primary Myocardial Fibrosis.</ArticleTitle><Pagination><StartPage>e70057</StartPage><MedlinePgn>e70057</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70057</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/clc.70057</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sudden cardiac death (SCD) remains a major cause of death despite progress in prevention and intervention of cardiac diseases. The most common cause of nonischemic SCD in young individuals in Northern Finland is primary myocardial fibrosis (PMF).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Fingesture study consists of 5869 prospectively collected subjects with SCD from Northern Finland collected from 1998 to 2017. Nonischemic etiology was the cause of SCD in 1477 (25%) subjects out of which primary myocardial fibrosis was the cause of SCD in 184 (12%) subjects (65% men, median age 55&#x2009;&#xb1;&#x2009;16 years). We examined the ante mortem ECG and medical history of the subjects to discover preceding symptoms and ECG changes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Prior health care contact in electronic health record system (EHR) was found for 89 (48%) subjects and ECG was available for 52 (28%) subjects. Both medical history and ECG were available for 20 subjects (11%). We observed that transient loss of consciousness (TLOC) was the most common symptom recorded and was reported by 33 (37%) subjects. ECG was abnormal in 38 (73%) subjects. Fragmented QRS (fQRS) complex was found in 26 (50%) subjects. Vast majority, 87% of subjects had either TLOC or abnormal ECG. Only seven subjects with ECG or EHR history available had normal ECG and did not have TLOC.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Many SCD victims with primary myocardial fibrosis had abnormal ECG or history of TLOC. The results suggest that the combination should generate careful cardiovascular examination to detect underlying myocardial disease and possibly prevent SCD.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Clinical Cardiology published by Wiley Periodicals, LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silvola</LastName><ForeName>H</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-3217-6070</Identifier><AffiliationInfo><Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pakanen</LastName><ForeName>L</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3494-7652</Identifier><AffiliationInfo><Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Forensic Medicine Unit, Finnish Institute for Health and Welfare, Oulu, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Forensic Medicine, Research Unit of Internal Medicine, Medical Research Center Oulu, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holmstr&#xf6;m</LastName><ForeName>L</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-6166-5589</Identifier><AffiliationInfo><Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perki&#xf6;m&#xe4;ki</LastName><ForeName>J S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-1157-3985</Identifier><AffiliationInfo><Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eskuri</LastName><ForeName>M A E</ForeName><Initials>MAE</Initials><Identifier Source="ORCID">0009-0009-8933-1386</Identifier><AffiliationInfo><Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huikuri</LastName><ForeName>H V</ForeName><Initials>HV</Initials><Identifier Source="ORCID">0000-0001-8800-963X</Identifier><AffiliationInfo><Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Junttila</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-8896-1281</Identifier><AffiliationInfo><Affiliation>Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>The authors received no specific funding for this work.</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Cardiol</MedlineTA><NlmUniqueID>7903272</NlmUniqueID><ISSNLinking>0160-9289</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016757" MajorTopicYN="Y">Death, Sudden, Cardiac</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005387" MajorTopicYN="N" Type="Geographic">Finland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="Y">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="Y">Cardiomyopathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>21</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>21</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40590619</ArticleId><ArticleId IdType="pmc">PMC12210387</ArticleId><ArticleId IdType="doi">10.1002/clc.70057</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huikuri H. V., Castellanos A., and Myerburg R. J., &#x201c;Sudden Death Due to Cardiac Arrhythmias,&#x201d; New England Journal of Medicine 345, no. 20 (2001): 1473&#x2013;1482.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794197</ArticleId></ArticleIdList></Reference><Reference><Citation>Junttila M. J., Hookana E., Kaikkonen K. S., Kortelainen M. L., Myerburg R. J., and Huikuri H. V., &#x201c;Temporal Trends in the Clinical and Pathological Characteristics of Victims of Sudden Cardiac Death in the Absence of Previously Identified Heart Disease,&#x201d; Circulation: Arrhythmia and Electrophysiology 9, no. 6 (2016): e003723.</Citation><ArticleIdList><ArticleId IdType="pubmed">27301265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hookana E., Junttila M. J., Puurunen V. P., et al., &#x201c;Causes of Nonischemic Sudden Cardiac Death in the Current Era,&#x201d; Heart Rhythm: The Official Journal of the Heart Rhythm Society 8, no. 10 (2011): 1570&#x2013;1575.</Citation><ArticleIdList><ArticleId IdType="pubmed">21740887</ArticleId></ArticleIdList></Reference><Reference><Citation>Junttila M. J., Holmstr&#xf6;m L., Pylk&#xe4;s K., et al., &#x201c;Primary Myocardial Fibrosis as an Alternative Phenotype Pathway of Inherited Cardiac Structural Disorders,&#x201d; Circulation 137, no. 25 (2018): 2716&#x2013;2726.</Citation><ArticleIdList><ArticleId IdType="pubmed">29915098</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmstr&#xf6;m L., Haukilahti A., V&#xe4;h&#xe4;talo J., et al., &#x201c;Electrocardiographic Associations With Myocardial Fibrosis Among Sudden Cardiac Death Victims,&#x201d; Heart 106, no. 13 (2020): 1001&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">32201371</ArticleId></ArticleIdList></Reference><Reference><Citation>Marijon E., Narayanan K., Smith K., et al., &#x201c;The Lancet Commission to Reduce the Global Burden of Sudden Cardiac Death: A Call for Multidisciplinary Action,&#x201d; The Lancet 402, no. 10405 (2023): 883&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">37647926</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40797464</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>104</Volume><Issue>32</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Acute occlusion of the LMCA without significant dynamic changes in the ECG: A case report.</ArticleTitle><Pagination><StartPage>e43809</StartPage><MedlinePgn>e43809</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e43809</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000043809</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Acute myocardial infarction caused by left main coronary artery (LMCA) occlusion is a critical condition with high mortality. However, when it presents with atypical symptoms and lacks dynamic electrocardiogram (ECG) changes, it poses a diagnostic challenge leading to delayed treatment and poor outcomes. This case report aims to highlight the importance of early recognition and intervention in such "double-negative" presentations to improve prognosis and reduce mortality.</AbstractText><AbstractText Label="PATIENT CONCERNS" NlmCategory="METHODS">A 49-year-old male with no cardiac history presented to the emergency department with abdominal distension for 4 hours after ingesting a large amount of alcohol.</AbstractText><AbstractText Label="DIAGNOSES" NlmCategory="METHODS">Acute complete occlusion of the LMCA.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Percutaneous coronary intervention.</AbstractText><AbstractText Label="OUTCOMES" NlmCategory="RESULTS">One Firebird 3.0&#x2009;&#xd7;&#x2009;33&#x2009;mm (MicroPort company, Shanghai China) stent was successfully implanted in the LMCA, and the stenosis disappeared and blood flow was smooth after the operation.</AbstractText><AbstractText Label="LESSONS" NlmCategory="CONCLUSIONS">A typical AMI without dynamic ECG changes requires aggressive diagnostic workup, including early angiography, to prevent fatal outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhai</LastName><ForeName>Huiqi</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0003-2859-4584</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, The First Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xinjun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Qingmin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Disease, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022A1515220138</GrantID><Agency>the Basic and Applied Basic Research Foundation and Enterprise Joint Foundation of Guangdong Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">case report</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">left main coronary artery occlusion</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40797464</ArticleId><ArticleId IdType="pmc">PMC12338140</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000043809</ArticleId><ArticleId IdType="pii">00005792-202508080-00084</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, et al. ; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72:2231&#x2013;64.</Citation></Reference><Reference><Citation>Khan IA, Karim HMR, Panda CK, Ahmed G, Nayak S. Atypical presentations of myocardial infarction: a systematic review of case reports. Cureus. 2023;15:e35492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10048062</ArticleId><ArticleId IdType="pubmed">36999116</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, et al. ; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Xenogiannis I, Kolokathis F, Alexopoulos D, Rallidis LS. Myocardial infarction due to left main coronary artery total occlusion: a unique electrocardiographic presentation. J Electrocardiol. 2023;76:26&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">36399954</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora NP, Joumaa M, Rosman H, Mehta R. Left main coronary artery thrombosis with acute myocardial infarction: a management dilemma. Am J Med Sci. 2017;353:597&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">28641723</ArticleId></ArticleIdList></Reference><Reference><Citation>Paraskevaidis S, Kazinakis G, Girasis C, et al. Primary percutaneous coronary intervention in an acute myocardial infarction due to the occlusion of the left main coronary artery. Hellenic J Cardiol. 2007;48:368&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">18196661</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Huang YS, Zhao YT, et al. Clinical and electrocardiographic features in acute total left main coronary artery occlusion without collateral circulation. J Electrocardiol. 2023;76:79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">36512934</ArticleId></ArticleIdList></Reference><Reference><Citation>Koerselman J, de Jaegere PP, Verhaar MC, Grobbee DE, van der Graaf Y; SMART Study Group. Coronary collateral circulation: the effects of smoking and alcohol. Atherosclerosis. 2007;191:191&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16696984</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40649092</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>13</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Advanced Diagnosis of Hypertrophic Cardiomyopathy with AI-ECG and Differences Based on Ethnicity and HCM Subtype.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4718</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm14134718</ELocationID><Abstract><AbstractText><b>Background/Objective:</b> Hypertrophic cardiomyopathy (HCM) often presents later in the disease course, with frequent misdiagnoses and population-level underdiagnoses. Underserved patients may have even greater diagnostic delays. We aimed to test the hypothesis in a retrospective cohort that artificial intelligence analysis of ECGs (AI-ECG) could have afforded the opportunity for earlier diagnosis of HCM in one health system. <b>Methods:</b> We collected all available ECGs from patients referred to an HCM Center of Excellence over 15 years, both before and after HCM diagnosis. We applied AI-ECG to each ECG in a blinded fashion to predict the probability of HCM. We calculated the time between each patient's AI-ECG diagnosis and clinical diagnosis. We examined the sensitivity and specificity of AI-ECG for all patients, and by septal subtype and genetic test result. <b>Results:</b> 3499 ECGs were analyzed in 404 patients (age 56 &#xb1; 18 years, 52% female). AI-ECG correctly identified HCM in 155 patients with a sensitivity of 67%, specificity of 95%, positive predictive value of 94%, and a negative predictive value of 69%. The AUC was similar using mean probability from all ECGs for each patient (AUC 0.91 [0.88, 0.94]) or using probability from the first ECG (AUC 0.91 [0.87,0.93]). AI-ECG diagnosed 27 patients over 1 year before clinical diagnosis, and up to 16.3 years early. Black patients were more likely than White patients to have an AI-ECG diagnosis before a clinical diagnosis (<i>p</i> = 0.005). <b>Conclusions:</b> AI-ECG offers the potential for advanced HCM diagnosis. Differences in identification timing between subgroups highlight inequities in current care and show the potential of AI-ECG for the greatest benefit in underserved ethnic groups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lewontin</LastName><ForeName>Myra</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilchick</LastName><ForeName>Kenneth C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barber</LastName><ForeName>Anita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bivona</LastName><ForeName>Derek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0003-2057-7731</Identifier><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrish</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClean</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7819-7988</Identifier><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perry</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amos</LastName><ForeName>Kaitlyn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayers</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Division, Department of Medicine, University of Virginia Health System, Charlottesville, VA 22903, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GR104884-CC1083-BU01-FD084-FN009</GrantID><Agency>Viz.ai</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>13</Day><Hour>3</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>12</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40649092</ArticleId><ArticleId IdType="pmc">PMC12250434</ArticleId><ArticleId IdType="doi">10.3390/jcm14134718</ArticleId><ArticleId IdType="pii">jcm14134718</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785&#x2013;789. doi: 10.1161/01.CIR.92.4.785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.92.4.785</ArticleId><ArticleId IdType="pubmed">7641357</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron M.S., Hellawell J.L., Lucove J.C., Farzaneh-Far R., Olivotto I. Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States. Am. J. Cardiol. 2016;117:1651&#x2013;1654. doi: 10.1016/j.amjcard.2016.02.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2016.02.044</ArticleId><ArticleId IdType="pubmed">27006153</ArticleId></ArticleIdList></Reference><Reference><Citation>Semsarian C., Ingles J., Maron M.S., Maron B.J. New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy. J. Am. Coll. Cardiol. 2015;65:1249&#x2013;1254. doi: 10.1016/j.jacc.2015.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.01.019</ArticleId><ArticleId IdType="pubmed">25814232</ArticleId></ArticleIdList></Reference><Reference><Citation>Butzner M., Leslie D.L., Cuffee Y., Hollenbeak C.S., Sciamanna C., Abraham T. Stable Rates of Obstructive Hypertrophic Cardiomyopathy in a Contemporary Era. Front. Cardiovasc. Med. 2022;8:765876. doi: 10.3389/fcvm.2021.765876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.765876</ArticleId><ArticleId IdType="pmc">PMC8770922</ArticleId><ArticleId IdType="pubmed">35071348</ArticleId></ArticleIdList></Reference><Reference><Citation>Naidu S.S., Sutton M.B., Gao W., Fine J.T., Xie J., Desai N.R., Owens A.T. Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States. J. Med. Econ. 2023;26:682&#x2013;690. doi: 10.1080/13696998.2023.2208966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13696998.2023.2208966</ArticleId><ArticleId IdType="pubmed">37170479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zytnick D., Heard D., Ahmad F., Cresci S., Owens A.T., Shay C.M. Exploring experiences of hypertrophic cardiomyopathy diagnosis, treatment, and impacts on quality of life among middle-aged and older adults: An interview study. Heart Lung. 2021;50:788&#x2013;793. doi: 10.1016/j.hrtlng.2021.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrtlng.2021.06.004</ArticleId><ArticleId IdType="pubmed">34225089</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag A.S., Kuskowski M.A., Maron B.J. Determinants for Clinical Diagnosis of Hypertrophic Cardiomyopathy. Am. J. Cardiol. 2006;98:1507&#x2013;1511. doi: 10.1016/j.amjcard.2006.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2006.07.029</ArticleId><ArticleId IdType="pubmed">17126660</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., et al. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N. Engl. J. Med. 2000;342:365&#x2013;373. doi: 10.1056/NEJM200002103420601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200002103420601</ArticleId><ArticleId IdType="pubmed">10666426</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissler-Snir A., Saberi S., Wong T.C., Pantazis A., Owens A., Leunig A., Alvarez C., Rader F. Atrial Fibrillation in Hypertrophic Cardiomyopathy. JACC Adv. 2024;3:101210. doi: 10.1016/j.jacadv.2024.101210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2024.101210</ArticleId><ArticleId IdType="pmc">PMC11379995</ArticleId><ArticleId IdType="pubmed">39247675</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson P., M&#xf6;rner S. EvaLuation Using Cardiac Insertable Devices And TelephonE in Hypertrophic Cardiomyopathy (ELUCIDATE HCM): A prospective observational study on incidence of arrhythmias. J. Cardiovasc. Electrophysiol. 2021;32:129&#x2013;135. doi: 10.1111/jce.14792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.14792</ArticleId><ArticleId IdType="pmc">PMC7821320</ArticleId><ArticleId IdType="pubmed">33108031</ArticleId></ArticleIdList></Reference><Reference><Citation>Weissler-Snir A., Chan R.H., Adler A., Care M., Chauhan V., Gollob M.H., Ziv-Baran T., Fourey D., Hindieh W., Rakowski H., et al. Usefulness of 14-Day Holter for Detection of Nonsustained Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. Am. J. Cardiol. 2016;118:1258&#x2013;1263. doi: 10.1016/j.amjcard.2016.07.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2016.07.043</ArticleId><ArticleId IdType="pubmed">27567133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen S.R., Ho C.Y., Asif I.M., Balaji S., Burke M.A., Day S.M., Dearani J.A., Epps K.C., Evanovich L., Ferrari V.A., et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149:e1239&#x2013;e1311. doi: 10.1161/CIR.0000000000001250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001250</ArticleId><ArticleId IdType="pubmed">38718139</ArticleId></ArticleIdList></Reference><Reference><Citation>Finocchiaro G., Sheikh N., Biagini E., Papadakis M., Maurizi N., Sinagra G., Pelliccia A., Rapezzi C., Sharma S., Olivotto I. The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy. Heart Rhythm. 2020;17:142&#x2013;151. doi: 10.1016/j.hrthm.2019.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.07.019</ArticleId><ArticleId IdType="pubmed">31349064</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery J.V., Harris K.M., Casey S.A., Zenovich A.G., Maron B.J. Relation of Electrocardiographic Patterns to Phenotypic Expression and Clinical Outcome in Hypertrophic Cardiomyopathy. Am. J. Cardiol. 2005;96:270&#x2013;275. doi: 10.1016/j.amjcard.2005.03.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2005.03.058</ArticleId><ArticleId IdType="pubmed">16018856</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheikh N., Papadakis M., Panoulas V.F., Prakash K., Millar L., Adami P., Zaidi A., Gati S., Wilson M., Carr-White G., et al. Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK. Heart. 2016;102:1797&#x2013;1804. doi: 10.1136/heartjnl-2016-309843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2016-309843</ArticleId><ArticleId IdType="pubmed">27679836</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod C.J., Ackerman M.J., Nishimura R.A., Tajik A.J., Gersh B.J., Ommen S.R. Outcome of Patients With Hypertrophic Cardiomyopathy and a Normal Electrocardiogram. J. Am. Coll. Cardiol. 2009;54:229&#x2013;233. doi: 10.1016/j.jacc.2009.02.071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.02.071</ArticleId><ArticleId IdType="pubmed">19589435</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcr&#xe8; S.D.L., Di Donna P., Leuzzi S., Miceli S., Bisi M., Scaglione M., Caponi D., Conte M.R., Cecchi F., Olivotto I., et al. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: A cardiac magnetic resonance study. Int. J. Cardiol. 2013;167:1038&#x2013;1045. doi: 10.1016/j.ijcard.2012.03.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.03.074</ArticleId><ArticleId IdType="pubmed">22464482</ArticleId></ArticleIdList></Reference><Reference><Citation>Calore C., Melacini P., Pelliccia A., Cianfrocca C., Schiavon M., Di Paolo F.M., Bovolato F., Quattrini F.M., Basso C., Thiene G., et al. Prevalence and clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete&#x2019;s heart: Relevance to athletic screening. Int. J. Cardiol. 2013;168:4494&#x2013;4497. doi: 10.1016/j.ijcard.2013.06.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.06.123</ArticleId><ArticleId IdType="pubmed">23928341</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowin E.J., Maron B.J., Appelbaum E., Link M.S., Gibson C.M., Lesser J.R., Haas T.S., Udelson J.E., Manning W.J., Maron M.S. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am. J. Cardiol. 2012;110:1027&#x2013;1032. doi: 10.1016/j.amjcard.2012.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.05.035</ArticleId><ArticleId IdType="pubmed">22809754</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang N., Yamauchi K. Using a neural network to diagnose the hypertrophic portions of hypertrophic cardiomyopathy. MD Comput. 1998;15:106&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">9540323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko W.Y., Siontis K.C., Attia Z.I., Carter R.E., Kapa S., Ommen S.R., Demuth S.J., Ackerman M.J., Gersh B.J., Arruda-Olson A.M., et al. Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram. J. Am. Coll. Cardiol. 2020;75:722&#x2013;733. doi: 10.1016/j.jacc.2019.12.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.12.030</ArticleId><ArticleId IdType="pubmed">32081280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota N., Suzuki S., Motogi J., Umemoto T., Nakai H., Matsuzawa W., Takayanagi T., Hyodo A., Satoh K., Arita T., et al. Evaluating convolutional neural network-enhanced electrocardiography for hypertrophic cardiomyopathy detection in a specialized cardiovascular setting. Heart Vessels. 2024;39:524&#x2013;538. doi: 10.1007/s00380-024-02367-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-024-02367-9</ArticleId><ArticleId IdType="pubmed">38553520</ArticleId></ArticleIdList></Reference><Reference><Citation>Tison G.H., Zhang J., Delling F.N., Deo R.C. Automated and Interpretable Patient ECG Profiles for Disease Detection, Tracking, and Discovery. Circ. Cardiovasc. Qual. Outcomes. 2019;12:e005289. doi: 10.1161/CIRCOUTCOMES.118.005289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.118.005289</ArticleId><ArticleId IdType="pmc">PMC6951431</ArticleId><ArticleId IdType="pubmed">31525078</ArticleId></ArticleIdList></Reference><Reference><Citation>Maanja M., Noseworthy P.A., Geske J.B., Ackerman M.J., Arruda-Olson A.M., Ommen S.R., Attia Z.I., Friedman P.A., Siontis K.C. Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice. Cardiovasc. Digit. Health J. 2022;3:289&#x2013;296. doi: 10.1016/j.cvdhj.2022.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvdhj.2022.10.002</ArticleId><ArticleId IdType="pmc">PMC9795257</ArticleId><ArticleId IdType="pubmed">36589312</ArticleId></ArticleIdList></Reference><Reference><Citation>Harmon D.M., Sehrawat O., Maanja M., Wight J., Noseworthy P.A. Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation. Arrhythm. Electrophysiol. Rev. 2023;12:e12. doi: 10.15420/aer.2022.31.</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/aer.2022.31</ArticleId><ArticleId IdType="pmc">PMC10326669</ArticleId><ArticleId IdType="pubmed">37427304</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Zhang L., Sun W., Zhu Y., Zhang Z., Chen L., Xie M., Zhang L. Artificial Intelligence in Diagnosis of Heart Failure. J. Am. Heart Assoc. 2025;14:e039511. doi: 10.1161/JAHA.124.039511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.124.039511</ArticleId><ArticleId IdType="pmc">PMC12132872</ArticleId><ArticleId IdType="pubmed">40207505</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidi S.A.J., Ghafoor A., Kim J., Abbas Z., Lee S.W. HeartEnsembleNet: An Innovative Hybrid Ensemble Learning Approach for Cardiovascular Risk Prediction. Healthcare. 2025;13:507. doi: 10.3390/healthcare13050507.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare13050507</ArticleId><ArticleId IdType="pmc">PMC11898877</ArticleId><ArticleId IdType="pubmed">40077069</ArticleId></ArticleIdList></Reference><Reference><Citation>Petretto G., Porcheddu T., Isgender M., Merella P., Talanas G., Casu G., Navarese E.P., Bilotta F. An ensemble machine learning approach for predicting heart failure risk in acute coronary syndrome patients: Heartguardai. Eur. Heart J. 2024;45((Suppl. 1)):ehae666.1545. doi: 10.1093/eurheartj/ehae666.1545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae666.1545</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40783097</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1570</ISSN><JournalIssue CitedMedium="Internet"><Volume>215</Volume><PubDate><Year>2025</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Resuscitation</Title><ISOAbbreviation>Resuscitation</ISOAbbreviation></Journal><ArticleTitle>Beyond STEMI: High-risk ECG patterns as predictors of occlusive myocardial infarction in out-of-hospital cardiac arrest patients.</ArticleTitle><Pagination><StartPage>110763</StartPage><MedlinePgn>110763</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resuscitation.2025.110763</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0300-9572(25)00275-8</ELocationID><Abstract><AbstractText Label="BACKGROUND/AIM" NlmCategory="OBJECTIVE">Immediate coronary angiography (CAG) is recommended for patients with ST-elevation myocardial infarction (STEMI) after out-of-hospital cardiac arrest (OHCA). However, some occlusive myocardial infarctions (OMI) do not meet STEMI criteria. This study investigated whether additional ECG patterns beyond STEMI could more accurately identify OMI in OHCA patients, compared to using STEMI criteria alone.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study categorised patients based on their first post-resuscitation ECG into two groups: STEMI and non-STEMI with high-risk ECG criteria and compared them for OMI by CAG.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 97 patients OMI was identified in 55&#xa0;% (53/97) of patients, specifically in 25 of 31 with STEMI (81&#xa0;%), 24 of 29 with high-risk ECG (83&#xa0;%), and 4 of 37 patients with neither (11&#xa0;%). Combining STEMI and high-risk ECG criteria would have predicted OMI in 92&#xa0;% (49/53) of cases. Patients with high-risk ECG experienced significantly longer median delays until CAG (101.5 [IQR 63-336.75] vs. 47.5 [25.75-71.25] minutes; p&#xa0;=&#xa0;0.004) compared to those with STEMI on the ECG. Although 30-day mortality did not differ between STEMI and high-risk ECG patients (p&#xa0;=&#xa0;0.973), survival-differences could be observed between groups. Syntax-I-Score was significantly higher in the high-risk ECG group (29 [IQR 19-38] vs. 15 [IQR 3-24.5]; p&#xa0;=&#xa0;0.002).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Combining STEMI and high-risk ECG criteria improves OMI prediction compared to STEMI criteria alone, potentially enabling faster treatment and better OHCA survival.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Silwanis</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maier</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria; Clinical Research Institute for Cardiovascular and Metabolic Diseases, Medical Faculty, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria. Electronic address: julian.maier@kepleruniklinikum.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eder</LastName><ForeName>Johannes</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groche</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nahler</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fellner</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blessberger</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria; Clinical Research Institute for Cardiovascular and Metabolic Diseases, Medical Faculty, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellermair</LastName><ForeName>J&#xf6;rg</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria; Clinical Research Institute for Cardiovascular and Metabolic Diseases, Medical Faculty, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steinwender</LastName><ForeName>Clemens</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria; Clinical Research Institute for Cardiovascular and Metabolic Diseases, Medical Faculty, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lambert</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Kepler University Hospital Linz, Department of Cardiology and Medical Intensive Care, Medical Faculty, Johannes Kepler University, Linz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Resuscitation</MedlineTA><NlmUniqueID>0332173</NlmUniqueID><ISSNLinking>0300-9572</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronary angiogram</Keyword><Keyword MajorTopicYN="N">Coronary occlusion</Keyword><Keyword MajorTopicYN="N">Electrocardiogram</Keyword><Keyword MajorTopicYN="N">NSTEMI</Keyword><Keyword MajorTopicYN="N">Post-resuscitation care</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>9</Day><Hour>19</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40783097</ArticleId><ArticleId IdType="doi">10.1016/j.resuscitation.2025.110763</ArticleId><ArticleId IdType="pii">S0300-9572(25)00275-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40732503</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1424-8220</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>14</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>12</Day></PubDate></JournalIssue><Title>Sensors (Basel, Switzerland)</Title><ISOAbbreviation>Sensors (Basel)</ISOAbbreviation></Journal><ArticleTitle>ST Elevation Sonification of a 12-Lead ECG for the Assessment, Diagnosis, and Monitoring of ST Elevation Myocardial Infarction.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4373</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/s25144373</ELocationID><Abstract><AbstractText>We introduce a novel technique for the sonification/auditory representation of a 12-lead electrocardiogram (ECG), the standard diagnostic method for the detection of ST elevation myocardial infarction (STEMI). Our approach to ST elevation sonification conveys the detailed variation of the ST segment to enable differentiated, correct interpretation and severity without consulting a visual display. We present a variety of novel sonification designs and discuss their benefits and limitations. As part of an emergency training program, a cohort of 44 medical students (5th academic year) participated in a classification study in which the diagnostic accuracy of the participants was determined with regard to audibly presented ECG sequences of different STEMI severity levels. Regarding the classification of sonified ECG sequences, the discrimination of isoelectricity (IE, the healthy class) from all other (STEMI) classes combined yielded a perfect classification of all 660 classification instances (sensitivity = specificity = 1). With respect to the individual classification of all five classes (IE, inferior/anterior, and moderate/severe STEMI), an overall accuracy of 0.82 (0.79, 0.85) and an intraclass coefficient of &#x3ba;=0.77 were estimated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hermann</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-7975-4363</Identifier><AffiliationInfo><Affiliation>Ambient Intelligence Group, Faculty of Technology, Bielefeld University, 33619 Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grautoff</LastName><ForeName>Steffen</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3548-3271</Identifier><AffiliationInfo><Affiliation>Emergency Medical Services, District of Herford, Amtshausstr. 3, 32051 Herford, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Department, Herford Hospital, Ruhr-University Bochum, Campus OWL, Schwarzenmoorstr. 70, 32049 Herford, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tielking</LastName><ForeName>Friederike</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Medicine, MKK-Johannes Wesling Hospital Minden, Ruhr-University Bochum, Campus OWL, Hans-Nolte-Str. 1, 32429 Minden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Persson</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0009-0004-8465-6134</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Medicine, MKK-Johannes Wesling Hospital Minden, Ruhr-University Bochum, Campus OWL, Hans-Nolte-Str. 1, 32429 Minden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diebner</LastName><ForeName>Hans H</ForeName><Initials>HH</Initials><Identifier Source="ORCID">0000-0002-7138-6372</Identifier><AffiliationInfo><Affiliation>Department of Medical Informatics, Biometry, and Epidemiology, Ruhr-University Bochum, 44780 Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiesmeier</LastName><ForeName>Jens</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-8074-5085</Identifier><AffiliationInfo><Affiliation>Institute for Anesthesiology, Intensive Care- and Emergency Medicine, MKK-Hospital Luebbecke, Ruhr-University Bochum, Campus OWL, Virchowstr. 65, 32312 Luebbecke, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Sensors (Basel)</MedlineTA><NlmUniqueID>101204366</NlmUniqueID><ISSNLinking>1424-8220</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">auditory display</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">parameter mapping</Keyword><Keyword MajorTopicYN="N">process monitoring</Keyword><Keyword MajorTopicYN="N">sonification</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40732503</ArticleId><ArticleId IdType="pmc">PMC12299781</ArticleId><ArticleId IdType="doi">10.3390/s25144373</ArticleId><ArticleId IdType="pii">s25144373</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Widimsky P., Wijns W., Fajadet J., de Belder M., Knot J., Aaberge L., Andrikopoulos G., Baz J.A., Betriu A., Claeys M., et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: Description of the current situation in 30 countries. Eur. Heart J. 2010;31:943&#x2013;957. doi: 10.1093/eurheartj/ehp492.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehp492</ArticleId><ArticleId IdType="pmc">PMC2854523</ArticleId><ArticleId IdType="pubmed">19933242</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradi A., Dinh D.T., Brennan A., Stub D., Somaratne J., Palmer S., Nehme Z., Andrew E., Smith K., Liew D., et al. Prevalence and Predictors of Emergency Medical Service Use in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. Heart Lung Circ. 2024;33:990&#x2013;997. doi: 10.1016/j.hlc.2024.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2024.02.011</ArticleId><ArticleId IdType="pubmed">38570261</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne R.A., Rossello X., Coughlan J.J., Barbato E., Berry C., Chieffo A., Claeys M.J., Dan G.-A., Dweck M.R., Galbraith M., et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the man-agement of acute coronary syndromes of the European Society of Cardiology (ESC) Eur. Heart J. 2023;44:3720&#x2013;3826. doi: 10.1093/eurheartj/ehad191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad191</ArticleId><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldana Blanco A.L., Hermann T., Tiesmeier J., Persson J., Grautoff S. Sonification enables continuous surveillance of the ST segment in the electrocardiogram. Am. J. Emerg. Med. 2022;58:286&#x2013;297. doi: 10.1016/j.ajem.2022.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2022.05.016</ArticleId><ArticleId IdType="pubmed">35772373</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldana Blanco A.L., Grautoff S., Hermann T. ECG sonification to support the diagnosis and monitoring of myocardial infarction. J. Multimodal User Interfaces. 2020;14:207&#x2013;218. doi: 10.1007/s12193-020-00319-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12193-020-00319-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Badings E.A., Remkes W.S., The S.H., Dambrink J.H.E., Tjeerdsma G., Rasoul S., Timmer J.R., van der Wielen M.L., Lok D.J., Hermanides R., et al. Early or late intervention in patients with transient ST-segment elevation acute coronary syndrome: Subgroup analysis of the elisa-3 trial: Intervention in Transient ST-Segment Elevation ACS. Catheter. Cardiovasc. Interv. 2016;88:755&#x2013;764. doi: 10.1002/ccd.26719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.26719</ArticleId><ArticleId IdType="pubmed">27567144</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiesmeier J., Brandt F., Persson J., Hinkelbein J., Diebner H.H., Grautoff S., Hermann T. ST-Hebung-Sonifikation Unterst&#xfc;tzt Die Schnellere Detektion Eines STEMI&#x2014;Pr&#xe4;klinische Simulationsstudie Mit Humanmedizinstudierenden im 5. Studienjahr. Deutscher Interdiszipli&#xe4;rer Notfallmedizin Kongress (DINK) 2024, Proceeding Abstract Booklet, Abstract S100. 2024. S100.  [(accessed on 1 July 2025)].  Available online:  https://www.ai-online.info/images/ai-ausgabe/2024/03-2024/Supplement_05-2024_DINK.pdf.</Citation></Reference><Reference><Citation>V&#xe4;ljam&#xe4;e A., Steffert T., Holland S., Marimon X., Benitez R., Mealla S., Oliveira A., Jord&#xe0; S. A review of real-time EEG sonification research; Proceedings of the International Conference of Auditory Display 2013 (ICAD 2013); Lodz, Poland. 6&#x2013;10 July 2013; pp. 85&#x2013;93.</Citation></Reference><Reference><Citation>Pauletto S., Hunt A. The sonification of EMG data; Proceedings of the 12th International Conference on Auditory Display; London, UK. 19&#x2013;24 June 2006; pp. 152&#x2013;157.</Citation></Reference><Reference><Citation>Gionfrida L., Roginska A. A novel sonification approach to support the diagnosis of alzheimer&#x2019;s dementia. Front. Neurol. 2017;8:647. doi: 10.3389/fneur.2017.00647.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00647</ArticleId><ArticleId IdType="pmc">PMC5725407</ArticleId><ArticleId IdType="pubmed">29270150</ArticleId></ArticleIdList></Reference><Reference><Citation>Roginska A., Mohanraj H., Keary J., Friedman K. Sonification Method to Enhance the Diagnosis of Dementia. In International Conference on Auditory Display. 2014.  [(accessed on 1 July 2025)].  Available online:  https://api.semanticscholar.org/CorpusID:20280044.</Citation></Reference><Reference><Citation>Kanev I.K., Iliev I.T., Krasteva V.T. Sonification&#x2014;An Alternative Presentation of the Electrocardiogram: A Systematic Literature Review; Proceedings of the 2019 IEEE XXVIII International Scientific Conference Electronics (ET); Sozopol, Bulgaria. 12&#x2013;14 September 2019; pp. 1&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/ET.2019.8878650</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang J., An Q., Li B., Zhidong Z., Gao L., Xue C. A novel wearable device integrating ECG and PCG for cardiac health monitoring. Microsyst. Nanoeng. 2025;11:7. doi: 10.1038/s41378-024-00858-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41378-024-00858-3</ArticleId><ArticleId IdType="pmc">PMC11735617</ArticleId><ArticleId IdType="pubmed">39814701</ArticleId></ArticleIdList></Reference><Reference><Citation>Klum M., Urban M., Tigges T., Pielmus A.-G., Feldheiser A., Schmitt T., Orglmeister R. Wearable Cardiorespiratory Monitoring Employing a Multimodal Digital Patch Stethoscope: Estimation of ECG, PEP, LVET and Respiration Using a 55 mm Single-Lead ECG and Phonocardiogram. Sensors. 2020;20:2033. doi: 10.3390/s20072033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/s20072033</ArticleId><ArticleId IdType="pmc">PMC7180963</ArticleId><ArticleId IdType="pubmed">32260436</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl B., Thoshkahna B. Real-time heart rate sonification for athletes. In Proceedings of the 21st International Conference on Auditory Display. University of Music and Performing Arts Graz. Institute of Electronic Music and Acoustics; 2015.  [(accessed on 1 July 2025)].  Available online:  https://api.semanticscholar.org/CorpusID:114817490.</Citation></Reference><Reference><Citation>Aldana Blanco A.L., Grautoff S., Hermann T. CardioSounds: Real-time auditory assistance for supporting cardiac diagnostic and monitoring; Proceedings of the 12th International Audio Mostly Conference on Augmented and Participatory Sound and Music Experiences, AM &#x2019;17; London, UK. 23&#x2013;26 August 2017; New York, NY, USA: Association for Computing Machinery; 2017. pp. 1&#x2013;4.</Citation></Reference><Reference><Citation>Ballora M., Pennycook B., Ivanov P.C., Glass L., Goldberger A.L. Heart Rate Sonification: A New Approach to Medical Diagnosis. Leonardo. 2004;37:41&#x2013;46. doi: 10.1162/002409404772828094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1162/002409404772828094</ArticleId></ArticleIdList></Reference><Reference><Citation>Landry S., Sun Y., Slade D.L., Jeon M. Tempo-Fit Heart Rate App: Using Heart Rate Sonification as Exercise Performance Feedback; Proceedings of the International Conference on Auditory Display; Canberra, Australia. 2&#x2013;8 July 2015;  [(accessed on 1 July 2025)].  Available online:  https://digitalcommons.mtu.edu/cls-fp/40.</Citation></Reference><Reference><Citation>Aldana Blanco A.L., Grautoff S., Hermann T. Heart Alert: ECG Sonification for Supporting the Detection and Diagnosis of ST Segment Deviations; Proceedings of the Interactive Sonification Workshop (ISon); Bielefeld, Germany. 16 December 2016;  [(accessed on 20 May 2025)].  Available online:  https://core.ac.uk/download/pdf/211816842.pdf.</Citation></Reference><Reference><Citation>Kather J.N., Hermann T., Bukschat Y., Kramer T., Schad L.R., Z&#xf6;llner F.G. Polyphonic sonification of electrocardiography signals for diagnosis of cardiac pathologies. Sci. Rep. 2017;7:44549. doi: 10.1038/srep44549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44549</ArticleId><ArticleId IdType="pmc">PMC5357951</ArticleId><ArticleId IdType="pubmed">28317848</ArticleId></ArticleIdList></Reference><Reference><Citation>Grond F., Berger J.  Parameter Mapping Sonification. In: Hermann T., Hunt A., Neuhoff J.G., editors. The Sonification Handbook. Logos Publishing House; Berlin, Germany: 2011.  [(accessed on 1 July 2025)]. pp. 363&#x2013;397. Available online:  http://sonification.de/handbook/chapters/chapter15/</Citation></Reference><Reference><Citation>Hermann T., Hunt A., Neuhoff J.G., editors. The Sonification Handbook. Logos Publishing House; Berlin, Germany: 2011.  [(accessed on 1 July 2025)].  Available online:  http://sonification.de/handbook.</Citation></Reference><Reference><Citation>Kramer G. An Introduction to Auditory Display. In: Kramer G., editor. Auditory Display; ICAD. Addison-Wesley; Boston, MA, USA: 1994. pp. 1&#x2013;78.</Citation></Reference><Reference><Citation>Hildebrandt T., Hermann T., Rinderle-Ma S. Continuous sonification enhances adequacy of interactions in peripheral process monitoring. Int. J. Hum.-Comput. Stud. 2016;95:54&#x2013;65. doi: 10.1016/j.ijhcs.2016.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijhcs.2016.06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Grond F., Bovermann T., Hermann T. A SuperCollider Class for Vowel Synthesis and its Use for Sonification. In: Worall D., Wers&#xe9;nyi G., editors. Proceedings of the 17th Annual Conference on Auditory Display; Budapest, Hungary. 20&#x2013;24 June 2011; Budapest, Hungary: OPAKFI; 2011.  [(accessed on 1 July 2025)].  Proceedings. Available online:  https://pub.uni-bielefeld.de/record/2277122.</Citation></Reference><Reference><Citation>Walker B.N., Nees M.A. Theory of sonification. In: Hermann T., Hunt A., Neuhoff J.G., editors. The Sonification Handbook. Logos Verlag Berlin; Berlin, Germany: 2011. pp. 9&#x2013;39.</Citation></Reference><Reference><Citation>Reinsch D., Hermann T. Interacting with sonifications: The mesonic framework for interactive auditory data science. Psychoacoustics in the Loop. In: R&#xf6;nnberg N., Lenzi S., Ziemer T., Hermann T., Bresin R., editors. Proceedings of the 7th Interactive Sonification Workshop; Bremen, Germany. 22&#x2013;23 September 2022; Bielefeld, Germany: CITEC, Bielefeld University; 2022. pp. 65&#x2013;74.</Citation></Reference><Reference><Citation>Hermann T., Reinsch D. sc3nb: A Python-SuperCollider Interface for Auditory Data Science; Proceedings of the 16th International Audio Mostly Conference. AM &#x2019;21; Trento, Italy. 1&#x2013;3 September 2021; New York, NY, USA: Association for Computing Machinery; 2021. pp. 208&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1145/3478384.3478401</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson H.R., Borgen A.C., Christnacht R., Ng J., Weller J.G., Davison H.N., Noseworthy P.A., Olson R., O&#x2032;Laughlin D., Disrud L., et al. Stats on the desats: Alarm fatigue and the implications for patient safety. BMJ Open Qual. 2023;12:e002262. doi: 10.1136/bmjoq-2023-002262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjoq-2023-002262</ArticleId><ArticleId IdType="pmc">PMC10357676</ArticleId><ArticleId IdType="pubmed">37474134</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M. Building Predictive Models in R Using the caret Package. J. Stat. Softw. 2008;28:1&#x2013;26. doi: 10.18637/jss.v028.i05.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v028.i05</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro J.C., Bates D.M. Statistics and Computing. Springer; New York, NY, USA: 2006. Mixed-Effects Models in S and S-PLUS.</Citation></Reference><Reference><Citation>R Core Team  R: A Language and Environment for Statistical Computing. 2024.  [(accessed on 1 July 2025)].  Available online:  https://www.R-project.org/</Citation></Reference><Reference><Citation>Case A. Calm Technology: Principles and Patterns for Non-intrusive Design. O&#x2019;Reilly Media. 2016.  [(accessed on 1 July 2025)].  Available online:  https://books.google.de/books?id=wQaGjwEACAAJ.</Citation></Reference><Reference><Citation>Chen H., Zhou J., Cao H., Liang D., Chen L., Yang Y., Wang L., Xie J., Duan H., Fu Y. Thermo-responsive and phase-separated hydrogels for cardiac arrhythmia diagnosis with deep learning algorithms. Biosens. Bioelectron. 2025;276:117262. doi: 10.1016/j.bios.2025.117262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2025.117262</ArticleId><ArticleId IdType="pubmed">39965416</ArticleId></ArticleIdList></Reference><Reference><Citation>Darmawahyuni A., Nurmaini S., Rachmatullah M.N., Tutuko B., Sapitri A.I., Firdaus F., Fansyuri A., Predyansyah A. Deep learning-based electrocardiogram rhythm and beat features for heart abnormality classification. PeerJ Comput. Sci. 2022;8:e825. doi: 10.7717/peerj-cs.825.</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj-cs.825</ArticleId><ArticleId IdType="pmc">PMC8802771</ArticleId><ArticleId IdType="pubmed">35174263</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim S.R., Helseth H.C., Baker P.O., Keller G.A., Meyers H.P., Herman R., Smith S.W. Artificial Intelligence Detection of Occlusive Myocardial Infarction from Electrocardiograms Interpreted as &#x201c;Normal&#x201d; by Conventional Algorithms. J. Pers. Med. 2025;15:130. doi: 10.3390/jpm15040130.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm15040130</ArticleId><ArticleId IdType="pmc">PMC12028524</ArticleId><ArticleId IdType="pubmed">40278309</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkammash A., Ring L. The effectiveness of cardiology e-training in improving electrocardiogram interpretation skills in junior medical trainees; a pre-post mixed methods study. Future Healthc. J. 2023;10((Suppl. S3)):72&#x2013;73. doi: 10.7861/fhj.10-3-s72.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/fhj.10-3-s72</ArticleId><ArticleId IdType="pmc">PMC10884624</ArticleId><ArticleId IdType="pubmed">38406759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40535152</PMID><DateRevised><Year>2025</Year><Month>06</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Case Report: Stepwise noninvasive diagnosis of Takotsubo cardiomyopathy in an elderly patient-From ECG clues to echocardiographic and CTA confirmation.</ArticleTitle><Pagination><StartPage>1608992</StartPage><MedlinePgn>1608992</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1608992</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2025.1608992</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Takotsubo cardiomyopathy (TTC) is frequently misdiagnosed as acute coronary syndrome in elderly patients. This case demonstrates how ECG findings facilitate a noninvasive diagnostic algorithm for TTC, validated by echocardiography and coronary computed tomography angiography (CCTA).</AbstractText><AbstractText Label="CASE SUMMARY" NlmCategory="UNASSIGNED">An 88-year-old woman presented with chest tightness and dyspnea after emotional stress (bereavement). Initial ECGs showed the concurrent appearance of ST-segment elevations in anterior (V3-V5) and inferior leads (II, III, aVF), suggesting apical injury and the diagnosis of TTC. Bedside echocardiography revealed apical akinesis with preserved basal contraction (LVEF 35%), while CCTA ruled out obstructive disease. Supportive therapy led to symptom resolution. At 1-year follow-up, LVEF recovered to 61% with normalized ECG.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This case highlights ECG's pivotal role in suspecting TTC, enabling a Noninvasive diagnostic approach (echocardiography&#x2009;+&#x2009;CCTA) for elderly patients.</AbstractText><CopyrightInformation>&#xa9; 2025 Teng, Sun, Wang, Wang and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Teng</LastName><ForeName>Yanling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First People's Hospital of Lianyungang, The First Affiliated Hospital of Kangda College of Nanjing Medical University, Lianyungang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sun</LastName><ForeName>Xingxing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second People's Hospital of Lianyungang, Affiliated to Kangda College of Nanjing Medical University, Lianyungang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Minglang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second People's Hospital of Lianyungang, Affiliated to Kangda College of Nanjing Medical University, Lianyungang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ziyang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second People's Hospital of Lianyungang, Affiliated to Kangda College of Nanjing Medical University, Lianyungang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yilian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Second People's Hospital of Lianyungang, Affiliated to Kangda College of Nanjing Medical University, Lianyungang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">Takotsubo cardiomyopathy</Keyword><Keyword MajorTopicYN="N">coronary CTA</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">noninvasive diagnosis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>19</Day><Hour>7</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>19</Day><Hour>7</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>19</Day><Hour>5</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40535152</ArticleId><ArticleId IdType="pmc">PMC12174099</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2025.1608992</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases. J Cardiol. (1991) 21:203&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">1841907</ArticleId></ArticleIdList></Reference><Reference><Citation>Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. (2015) 373:929&#x2013;38. 10.1056/NEJMoa1406761</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1406761</ArticleId><ArticleId IdType="pubmed">26332547</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J. (2023) 44:3503&#x2013;626. 10.1093/eurheartj/ehad194</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad194</ArticleId><ArticleId IdType="pubmed">37622657</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai MY, Windecker S, Lancellotti P, Bax JJ, Griffin BP, Cahlon O, et al. Prevention, diagnosis, and management of radiation-associated cardiac disease. JACC scientific expert panel. J Am Coll Cardiol. (2019) 74:905&#x2013;27. 10.1016/j.jacc.2019.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.07.006</ArticleId><ArticleId IdType="pubmed">31416535</ArticleId></ArticleIdList></Reference><Reference><Citation>Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. (2004) 141:858&#x2013;65. 10.7326/0003-4819-141-11-200412070-00010</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-141-11-200412070-00010</ArticleId><ArticleId IdType="pubmed">15583228</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosuge M, Ebina T, Hibi K, Tsukahara K, Iwahashi N, Gohbara M, et al. Differences in negative T waves among acute coronary syndrome, acute pulmonary embolism, and takotsubo cardiomyopathy. Eur Heart J Acute Cardiovasc Care. (2012) 1:349&#x2013;57. 10.1177/2048872612466790</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872612466790</ArticleId><ArticleId IdType="pmc">PMC3760560</ArticleId><ArticleId IdType="pubmed">24062927</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. (2008) 155:408&#x2013;17. 10.1016/j.ahj.2007.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2007.11.008</ArticleId><ArticleId IdType="pubmed">18294473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management. Eur Heart J. (2018) 39:2047&#x2013;62. 10.1093/eurheartj/ehy077</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy077</ArticleId><ArticleId IdType="pmc">PMC5991205</ArticleId><ArticleId IdType="pubmed">29850820</ArticleId></ArticleIdList></Reference><Reference><Citation>Giusca S, Sch&#xfc;tz M, Kronbach F, Wolf D, Nunninger P, Korosoglou G. Coronary computer tomography angiography in 2021-acquisition protocols, tips and tricks and heading beyond the possible. Diagnostics (Basel). (2021) 11(6):1072. 10.3390/diagnostics11061072</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11061072</ArticleId><ArticleId IdType="pmc">PMC8230532</ArticleId><ArticleId IdType="pubmed">34200866</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MC, Moss AJ, Dweck M, Adamson PD, Alam S, Hunter A, et al. Coronary artery plaque characteristics associated with adverse outcomes in the SCOT-HEART study. J Am Coll Cardiol. (2019) 73:291&#x2013;301. 10.1016/j.jacc.2018.10.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.10.066</ArticleId><ArticleId IdType="pmc">PMC6342893</ArticleId><ArticleId IdType="pubmed">30678759</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen C, Abdulla J. Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging. (2016) 17:120&#x2013;9. 10.1093/ehjci/jev325</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jev325</ArticleId><ArticleId IdType="pmc">PMC4882896</ArticleId><ArticleId IdType="pubmed">26690951</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40735565</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1682-024X</ISSN><JournalIssue CitedMedium="Print"><Volume>41</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Pakistan journal of medical sciences</Title><ISOAbbreviation>Pak J Med Sci</ISOAbbreviation></Journal><ArticleTitle>Improving Door-to-ECG Time in Acute Myocardial Infarction: A Closed-Loop Audit from a Tertiary Care Center in Peshawar.</ArticleTitle><Pagination><StartPage>2160</StartPage><EndPage>2163</EndPage><MedlinePgn>2160-2163</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12669/pjms.41.7.11635</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; OBJECTIVE" NlmCategory="UNASSIGNED">Acute myocardial infarction is the leading cause of heart disease worldwide. Timely diagnosis and decision of management plan is paramount which is pinned on early electrocardiogram to minimize the door-to-electrocardiogram time. Our objective was to evaluate the current practice of timing of initial electrocardiogram of patients presenting with Acute myocardial infarction at our local cardiac hospital in Pakistan and implement changes with a complete closed loop audit.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Retrospective and prospective data collection for all patients who presented to the emergency room of Peshawar Institute of Cardiology from September 2022 till September 2023. The hospital management information system and electronic medical record of the hospital was used for data collection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 149 patients' data was collected and analyzed. The first cycle of the audit analyzed 29 patients, the second cycle of the audit analyzed 60 patients and the third cycle of the audit again analyzed 60 patients. In the first set of patients, 17.2 percent of patients had door-to-ECG time of less than 10 minutes which was far from ideal. Therefore different departmental meetings were conducted and it was decided to set up a designated triage for ACS patients. Therefore in the second cycle of the audit 43.3% of patients achieved this time showing improvement. During the third cycle when the initial registration and formal paperwork for admission to ER were removed then 75% of patients had their ECG done within 10 minutes of the presentation.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This audit successfully identified the modifiable factors responsible for the delay in the first ECG which included a lack of staff, non-viability of triage, and paperwork. After working on these factors our target Door to ECG time of 75% was achieved.</AbstractText><CopyrightInformation>Copyright: &#xa9; Pakistan Journal of Medical Sciences.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Muhammad Ishaq</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Muhammad Ishaq Khan, Fellow interventional cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abidullah</LastName><AffiliationInfo><Affiliation>Abidullah, Head of Department Cardiology Unit, Peshawar Institute of Cardiology, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mujtaba</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Muhammad Mujtaba, House Officer, Naseer Teaching Hospital, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waheed</LastName><ForeName>Nazia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Nazia Waheed, Resident Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Pakistan</Country><MedlineTA>Pak J Med Sci</MedlineTA><NlmUniqueID>100913117</NlmUniqueID><ISSNLinking>1681-715X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute myocardial infarction</Keyword><Keyword MajorTopicYN="N">Audit</Keyword><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">Electrocardiogram</Keyword><Keyword MajorTopicYN="N">ST-elevation myocardial infarction</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword></KeywordList><CoiStatement>Conflict of Intrest: None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>11</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40735565</ArticleId><ArticleId IdType="pmc">PMC12302104</ArticleId><ArticleId IdType="doi">10.12669/pjms.41.7.11635</ArticleId><ArticleId IdType="pii">PJMS-41-2160</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mensah GA, Fuster V, Murray CJL, Roth GA Global Burden of Cardiovascular Diseases and Risks Collaborators. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol. 2023;82(25):2350&#x2013;2473. doi:10.1016/j.jacc.2023.11.007.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615984</ArticleId><ArticleId IdType="pubmed">38092509</ArticleId></ArticleIdList></Reference><Reference><Citation>Siudak Z, Slawska A, Dziewierz A, Dudek D. P4617 Acute myocardial infarction as a first time presentation of coronary artery disease in Poland in 2014-2016. Eur Heart J. 2018;39(Suppl_1):ehy563.P4617. doi:10.1093/eurheartj/ehy563. P4617.</Citation></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720&#x2013;3826. doi:10.1093/eurheartj/ehad191. Erratum in:Eur Heart J. 2024;45(13):1145. doi:10.1093/eurheartj/ehad870.</Citation><ArticleIdList><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng L, Li M, Xie W, Zhang A, Lei L, Li X, et al. Prehospital and in-hospital delays to care and associated factors in patients with STEMI:an observational study in 101 non-PCI hospitals in China. BMJ Open. 2019;9(11):e031918. doi:10.1136/ bmjopen-2019-031918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858215</ArticleId><ArticleId IdType="pubmed">31712344</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne CJ, Testa N, Desai S, Lagrone J, Chang R, Zheng L, et al. Improving door-to-balloon time by decreasing door-to-ECG time for walk-in STEMI patients. West J Emerg Med. 2015;16(1):184&#x2013;189. doi:10.5811/westjem.2014.10.23277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4307715</ArticleId><ArticleId IdType="pubmed">25671039</ArticleId></ArticleIdList></Reference><Reference><Citation>Members WC, Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization:a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(2):e21&#x2013;e129. doi:10.1016/j.jacc.2021.09.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">34895950</ArticleId></ArticleIdList></Reference><Reference><Citation>Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction:a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">12517460</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley EH, Nallamothu BK, Herrin J, Ting HH, Stern AF, Nembhard IM, et al. National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. J Am Coll Cardiol. 2009;54(25):2423&#x2013;2429. doi:10.1016/j.jacc.2009.11.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">20082933</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2018;39(2):119&#x2013;177. doi:10.1093/eurheartj/ehx393.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Diercks DB, Peacock WF, Hiestand BC, Chen AY, Pollack CV, Jr, Kirk JD, et al. Frequency and consequences of recording an electrocardiogram &gt;10 minutes after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative) Am J Cardiol. 2006;97(4):437&#x2013;442. doi:10.1016/j.amjcard.2005.09.073.</Citation><ArticleIdList><ArticleId IdType="pubmed">16461033</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Choi KH, Lee JM, Kim HK, Hwang D, Rhee TM, et al. KAMIR-NIH (Korea Acute Myocardial Infarction Registry&#x2013;National Institutes of Health) Investigators. Prognostic Implications of Door-to-Balloon Time and Onset-to-Door Time on Mortality in Patients With ST -Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention. J Am Heart Assoc. 2019;8(9):e012188. doi:10.1161/JAHA.119.012188.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512115</ArticleId><ArticleId IdType="pubmed">31041869</ArticleId></ArticleIdList></Reference><Reference><Citation>Rokos IC, French WJ, Koenig WJ, Stratton SJ, Nighswonger B, Strunk B, et al. Integration of pre-hospital electrocardiograms and ST-elevation myocardial infarction receiving center (SRC) networks:impact on door-to-balloon times across 10 independent regions. JACC Cardiovasc Interv. 2009;2(4):339&#x2013;346. doi:10.1016/j.jcin.2008.11.013.</Citation><ArticleIdList><ArticleId IdType="pubmed">19463447</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A, Gersh BJ, Mehran R, Brodie BR, Brener SJ, Dizon JM, et al. Effect of ischemia duration and door-to-balloon time on myocardial perfusion in ST-segment elevation myocardial infarction:an analysis from HORIZONS-AMI Trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) JACC Cardiovasc Interv. 2015;8(15):1966&#x2013;1974. doi:10.1016/j.jcin.2015.08.031.</Citation><ArticleIdList><ArticleId IdType="pubmed">26738667</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz KH, Maier SK, Maier LS, Lengenfelder B, Jacobshagen C, Jung J, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability:results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39(13):1065&#x2013;1074. doi:10.1093/eurheartj/ehy004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6018916</ArticleId><ArticleId IdType="pubmed">29452351</ArticleId></ArticleIdList></Reference><Reference><Citation>Su H-Y, Tsai J-L, Hsu Y-C, Lee K-H, Chang C-S, Sun C-K, et al. A modified cardiac triage strategy reduces door to ECG time in patients with ST elevation myocardial infarction. Sci Rep. 2021;11(1):1&#x2013;9. doi:10.1038/s41598-021-86013-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7973784</ArticleId><ArticleId IdType="pubmed">33737723</ArticleId></ArticleIdList></Reference><Reference><Citation>Khursheed M, Fayyaz J, Feroze A, Shakeel N, Bhatti JA. Time to treatment in patients of suspected acute coronary syndrome in Pakistan:A clinical audit. Heart Lung. 2015;44(1):63&#x2013;67. doi:10.1016/j.hrtlng.2014.08.007.</Citation><ArticleIdList><ArticleId IdType="pubmed">25281530</ArticleId></ArticleIdList></Reference><Reference><Citation>Sami A, Maqsood S, Iqbal U, Safdar H, Khalil H, Yasir SB, et al. Recording the Door-To-ECG Time for Patients Presenting with Acute Chest Pain to a Cardiac Emergency Unit:A Clinical Audit and Quality Improvement Project. Pak Armed Forces Med J. 2022:72. doi:10.51253/pafmj.v72iSUPPL-3.9577.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40626266</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2047-2501</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Health information science and systems</Title><ISOAbbreviation>Health Inf Sci Syst</ISOAbbreviation></Journal><ArticleTitle>CnnBoost: a multilevel explainable stacked ensemble framework for effective detection of Myocardial Infarction from 12-lead ECG images using a transformational approach.</ArticleTitle><Pagination><StartPage>40</StartPage><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">40</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13755-025-00357-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Electrocardiogram (ECG) is the most commonly used non-invasive diagnostic tool for cardiovascular diseases. However, its interpretation requires significant expertise, which may not be available across all medical specializations. Automated detection of heart abnormalities can assist clinicians in making accurate and efficient diagnoses. This study aims to develop an explainable machine-learning framework for classifying myocardial infarction (MI) and other heart abnormalities using ECG images.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Publicly available ECG images from health centers in South Asia were used for this study. The dataset consists of four classes: Normal, Abnormal, Myocardial Infarction (MI), and Previous History of MI. The ECG images were preprocessed and transformed into time-series signals for efficient computation. These signals were then used to train an ensemble model, XGBoost, and a deep learning model, Convolutional Neural Network (CNN). To enhance learning of both spatial and temporal features, we proposed CNNBoost, a Multilevel Explainable Stacked Ensemble model where CNN-extracted spatial features were concatenated with time-series data and processed by XGBoost. SHapley Additive Explanations (SHAP) were used to identify diagnostically significant ECG leads, validated by a senior cardiologist.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The proposed framework achieved 99% accuracy, 98.58% AUC, and 96.47% AUPRC, demonstrating effective MI classification. The explainability component identified critical ECG leads, reinforcing model trustworthiness.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">By integrating deep learning and ensemble learning, our approach enhances ECG classification while ensuring clinical relevance. CNNBoost's ability to learn spatial and temporal features improves interpretability and decision support. Cardiologist validation confirms its potential for real-world healthcare applications, reducing misdiagnoses and aiding clinical decision-making.</AbstractText><CopyrightInformation>&#xa9; The Author(s), under exclusive licence to Springer Nature Switzerland AG 2025. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashokan</LastName><ForeName>Pillai Lekshmi</ForeName><Initials>PL</Initials><Identifier Source="ORCID">0000-0002-9556-396X</Identifier><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathya</LastName><ForeName>S Siva</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantari Nagar, Puducherry, 605006 India.</Affiliation><Identifier Source="ROR">https://ror.org/02fq2px14</Identifier><Identifier Source="GRID">grid.414953.e</Identifier><Identifier Source="ISNI">0000000417678301</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satheesh</LastName><ForeName>Santhosh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computer Science, School of Engineering &amp; Technology, Pondicherry University, Kalapet, Puducherry, 605014 India.</Affiliation><Identifier Source="ROR">https://ror.org/01a3mef16</Identifier><Identifier Source="GRID">grid.412517.4</Identifier><Identifier Source="ISNI">0000 0001 2152 9956</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Inf Sci Syst</MedlineTA><NlmUniqueID>101638060</NlmUniqueID><ISSNLinking>2047-2501</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Convolutional neural network</Keyword><Keyword MajorTopicYN="N">ECG images</Keyword><Keyword MajorTopicYN="N">EXplainable AI (XAI)</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">SHAP</Keyword><Keyword MajorTopicYN="N">XGBoost</Keyword></KeywordList><CoiStatement>Conflict of interestThe authors have no Conflict of interest to declare that are relevant to the content of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>5</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40626266</ArticleId><ArticleId IdType="pmc">PMC12229351</ArticleId><ArticleId IdType="doi">10.1007/s13755-025-00357-3</ArticleId><ArticleId IdType="pii">357</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tr&#xe4;g&#xe5;rdh E, Engblom H, Pahlm O. How many ecg leads do we need? Cardiol Clin. 2006;24(3):317&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16939826</ArticleId></ArticleIdList></Reference><Reference><Citation>Macfarlane P, Devine B, Clark E. The university of glasgow (uni-g) ecg analysis program. In: Computers in Cardiology, pp&#xa0;451&#x2013; 454; 2005. IEEE</Citation></Reference><Reference><Citation>Ojha N, Dhamoon AS. Myocardial Infarction. In: StatPearls. StatPearls Publishing, Treasure Island (FL); 2024. http://www.ncbi.nlm.nih.gov/books/NBK537076/ Accessed 2024-03-04</Citation></Reference><Reference><Citation>Kwok CS, Bennett S, Azam Z, Welsh V, Potluri R, Loke YK, Mallen CD. Misdiagnosis of acute myocardial infarction: a systematic review of the literature. Crit Pathw Cardiol. 2021;20(3):155&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">33606411</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AH, Hussain M, Malik MK. Ecg images dataset of cardiac and covid-19 patients. Data Brief. 2021;34:106762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820911</ArticleId><ArticleId IdType="pubmed">33521183</ArticleId></ArticleIdList></Reference><Reference><Citation>Abubaker MB, Babayi&#x11f;it B. Detection of cardiovascular diseases in ecg images using machine learning and deep learning methods. IEEE Trans Artif Intell. 2022;4(2):373&#x2013;82.</Citation></Reference><Reference><Citation>Anand A, Kadian T, Shetty MK, Gupta A. Explainable ai decision model for ecg data of cardiac disorders. Biomed Signal Process Control. 2022;75:103584.</Citation></Reference><Reference><Citation>Goldberger AL, Goldberger ZD, Shvilkin A. ECG Leads. In: Goldberger&#x2019;s Clinical Electrocardiography, pp. 21&#x2013; 31. Elsevier, Amsterdam, 2018. 10.1016/B978-0-323-40169-2.00004-4. https://linkinghub.elsevier.com/retrieve/ pii/B9780323401692000044 Accessed 2024-03-01</Citation></Reference><Reference><Citation>Ashley EA, Niebauer J. Conquering the ecg. cardiology explained, 15&#x2013;33; 2004</Citation><ArticleIdList><ArticleId IdType="pubmed">20821845</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Qu Q, Wang M, Yu L, Wang J, Shen L, He K. Deep learning for digitizing highly noisy paper-based ecg records. Comput Biol Med. 2020;127:104077.</Citation><ArticleIdList><ArticleId IdType="pubmed">33171291</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra S, Khatwani G, Patil R, Sapariya D, Shah V, Parmar D, Dinesh S, Daphal P, Mehendale N. Ecg paper record digitization and diagnosis using deep learning. J Med Biol Eng. 2021;41(4):422&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8204064</ArticleId><ArticleId IdType="pubmed">34149335</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortune JD, Coppa NE, Haq KT, Patel H, Tereshchenko LG. Digitizing ecg image: a new method and open-source software code. Comput Methods Programs Biomed. 2022;221:106890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9286778</ArticleId><ArticleId IdType="pubmed">35598436</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu H, Patel KHK, Li X, Zhang B, Galazis C, Bajaj N, Sau A, Shi X, Sun L, Tao Y, et al. A fully-automated paper ecg digitisation algorithm using deep learning. Sci Rep. 2022;12(1):20963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9722713</ArticleId><ArticleId IdType="pubmed">36471089</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathail I, Bhagile VD. Ecg paper digitization and r peaks detection using fft. Appl Comput Intell Soft Comput. 2022;2022(1):1238864.</Citation></Reference><Reference><Citation>Hannun AY, Rajpurkar P, Haghpanahi M, Tison GH, Bourn C, Turakhia MP, Ng AY. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019;25(1):65&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6784839</ArticleId><ArticleId IdType="pubmed">30617320</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro AH, Ribeiro MH, Paix&#xe3;o GM, Oliveira DM, Gomes PR, Canazart JA, Ferreira MP, Andersson CR, Macfarlane PW, Meira W Jr, et al. Automatic diagnosis of the 12-lead ecg using a deep neural network. Nat Commun. 2020;11(1):1760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7145824</ArticleId><ArticleId IdType="pubmed">32273514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganeshkumar M, Ravi V, Sowmya V, Gopalakrishnan E, Soman K. Explainable deep learning-based approach for multilabel classification of electrocardiogram. IEEE Trans Eng Manag. 2021;70(8):2787&#x2013;99.</Citation></Reference><Reference><Citation>Sangha V, Mortazavi BJ, Haimovich AD, Ribeiro AH, Brandt CA, Jacoby DL, Schulz WL, Krumholz HM, Ribeiro ALP, Khera R. Automated multilabel diagnosis on electrocardiographic images and signals. Nat Commun. 2022;13(1):1583.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948243</ArticleId><ArticleId IdType="pubmed">35332137</ArticleId></ArticleIdList></Reference><Reference><Citation>Le KH, Pham HH, Nguyen TB, Nguyen TA, Thanh TN, Do CD. Lightx3ecg: a lightweight and explainable deep learning system for 3-lead electrocardiogram classification. Biomed Signal Process Control. 2023;85:104963.</Citation></Reference><Reference><Citation>Han C, Sun J, Bian Y, Que W, Shi L. Automated detection and localization of myocardial infarction with interpretability analysis based on deep learning. IEEE Trans Instrum Meas. 2023;72:1&#x2013;12.</Citation></Reference><Reference><Citation>Qiang Y, Dong X, Yang Y. Automatic detection and localisation of myocardial infarction using multi-channel dense attention neural network. Biomed Signal Process Control. 2024;89:105766.</Citation></Reference><Reference><Citation>Alamatsaz N, Tabatabaei L, Yazdchi M, Payan H, Alamatsaz N, Nasimi F. A lightweight hybrid cnn-lstm explainable model for ecg-based arrhythmia detection. Biomed Signal Process Control. 2024;90:105884.</Citation></Reference><Reference><Citation>Abagaro AM, Barki H, Ayana G, Dawud AA, Thamineni BL, Jemal T, Choe S-W. Automated ecg signals analysis for cardiac abnormality detection and classification. J Electr Eng Technol. 2024;19(5):3353&#x2013;71.</Citation></Reference><Reference><Citation>Saha A, Bristy EJ, Islam MR, Afzal R, Ridita SA et al. Lime-based explainable ai models for predicting disease from patient&#x2019;s symptoms. In: 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), pp. 1&#x2013;6; 2023. IEEE</Citation></Reference><Reference><Citation>Sanim MS, Hasan KM, et al. Identification of covid-19 from other upper respiratory tract infections using random undersampling and lime-based xai model. In: 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), pp. 1&#x2013; 6; 2023. IEEE</Citation></Reference><Reference><Citation>Akhtar M, Ahmed KA, et al. An improved prediction of polycystic ovary syndrome using smote-based oversampling and stacking classifier. In: 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), pp. 1&#x2013; 6; 2023. IEEE</Citation></Reference><Reference><Citation>Robbani R, Alam MM, Sanim MS, Hasan KM. Adaseml: Hospitalization period prediction of covid-19 patients using adasyn and stacking based ensemble learning. In: International Conference on Advanced Network Technologies and Intelligent Computing, pp&#xa0;3&#x2013;15; 2022. Springer</Citation></Reference><Reference><Citation>Xiong P, Lee SM-Y, Chan G. Deep learning for detecting and locating myocardial infarction by electrocardiogram: A literature review. Front Cardiovasc Med. 2022;9:860032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990170</ArticleId><ArticleId IdType="pubmed">35402563</ArticleId></ArticleIdList></Reference><Reference><Citation>Denysyuk HV, Pinto RJ, Silva PM, Duarte RP, Marinho FA, Pimenta L, Gouveia AJ, Gon&#xe7;alves NJ, Coelho PJ, Zdravevski E, et al. Algorithms for automated diagnosis of cardiovascular diseases based on ecg data: a comprehensive systematic review. Heliyon. 2023;9(2):e13601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9958295</ArticleId><ArticleId IdType="pubmed">36852052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodner E, Simon M, Fisher RB, Denzler J. Fine-grained recognition in the noisy wild: Sensitivity analysis of convolutional neural networks approaches; 2016. arXiv preprint arXiv:1610.06756</Citation></Reference><Reference><Citation>Grinsztajn L, Oyallon E, Varoquaux G. Why do tree-based models still outperform deep learning on typical tabular data? Adv Neural Inf Process Syst. 2022;35:507&#x2013;20.</Citation></Reference><Reference><Citation>Ashokan PL, Sathya SS. Comparing tree-based ensemble machine learning models and convolutional neural network for automatic classification of heart abnormalities from ecg images. In: 2023 14th International Conference on Computing Communication and Networking Technologies (ICCCNT), pp. 1&#x2013; 6; 2023. IEEE</Citation></Reference><Reference><Citation>Anwar T, Zakir S. Effect of image augmentation on ecg image classification using deep learning. In: 2021 International Conference on Artificial Intelligence (ICAI), pp. 182&#x2013;186; 2021. IEEE</Citation></Reference><Reference><Citation>Meek S, Morris F. Introduction. i&#x2013;leads, rate, rhythm, and cardiac axis. BMJ. 2002;324(7334):415&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1122339</ArticleId><ArticleId IdType="pubmed">11850377</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AH, Hussain M, Malik MK. Cardiac disorder classification by electrocardiogram sensing using deep neural network. Complexity. 2021;2021:1&#x2013;8.</Citation></Reference><Reference><Citation>Goldberger AL, Goldberger ZD, Shvilkin A. Chapter 4&#x2014;ecg leads. In: Goldberger AL, Goldberger ZD, Shvilkin A (eds) Goldberger&#x2019;s clinical electrocardiography, 9th Edn, pp. 21&#x2013; 31. Elsevier, Amsterdam (2018). 10.1016/B978-0-323-40169-2.00004-4 . https://www.sciencedirect.com/science/article/pii/B9780323401692000044</Citation></Reference><Reference><Citation>Leong LH, Yap YC, Lo ZZ. Importance of lead avl in the diagnosis of inferior wall myocardial infarction: A case report. Malaysn Fam Phys. 2023;18:38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10337600</ArticleId><ArticleId IdType="pubmed">37449275</ArticleId></ArticleIdList></Reference><Reference><Citation>George A, Arumugham PS, Figueredo VM. avr-the forgotten lead. Exp Clin Cardiol. 2010;15(2):36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2898534</ArticleId><ArticleId IdType="pubmed">20631863</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40809617</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Hypotensive Patient Presenting With Abnormal Pre-hospital Ischemic Electrocardiogram: A Case of Pulmonary Embolism Diagnosed by Point-of-Care Ultrasound (POCUS).</ArticleTitle><Pagination><StartPage>e87909</StartPage><MedlinePgn>e87909</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e87909</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.87909</ELocationID><Abstract><AbstractText>Electrocardiograms (ECGs) are widely utilized to identify a variety of emergent and life-threatening conditions and are routinely used in the pre-hospital setting.&#xa0;Early and accurate identification of cardiac conditions such as ischemia or arrhythmia can facilitate accurate and prompt medical management by the pre-hospital team and the emergency department providers.&#xa0;This case describes&#xa0;a 65-year-old male with a pre-hospital presentation of chest pressure and a syncopal event. A pre-hospital ECG was concerning for ST-segment elevation myocardial infarction (STEMI), but the patient was&#xa0;ultimately&#xa0;found to have an alternative diagnosis of pulmonary embolism (PE)&#xa0;with an intraventricular thrombus identified on&#xa0;cardiac point-of-care ultrasound (POCUS). ECGs and&#xa0;POCUS&#xa0;should be jointly utilized in the patient assessment to consider a broad differential diagnosis as there are alternative pathologies that can mimic STEMI-like ECG changes.&#xa0;Treatment of the underlying pulmonary emboli with thrombolytic therapy led to stabilization of this patient&#xa0;and ultimately led to the patient being discharged home from the hospital. At a four-month follow-up appointment, the patient remained on oral anticoagulation, and a routine echocardiogram demonstrated normal ventricular size and function.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Ellis et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ellis</LastName><ForeName>Caleb</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Wright State University, Dayton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wenn</LastName><ForeName>Jared</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Wright State University, Dayton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunswick</LastName><ForeName>Jordan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Wright State University, Dayton, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Medicine, Miami Valley Emergency Specialists, Dayton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>Justin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Miami Valley Emergency Specialists, Dayton, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKinley</LastName><ForeName>Hillary</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Wright State University, Dayton, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Medicine, Miami Valley Emergency Specialists, Dayton, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">emergency medicine</Keyword><Keyword MajorTopicYN="N">pocus</Keyword><Keyword MajorTopicYN="N">pulmonary emboli</Keyword><Keyword MajorTopicYN="N">stemi</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>19</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>19</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40809617</ArticleId><ArticleId IdType="pmc">PMC12349743</ArticleId><ArticleId IdType="doi">10.7759/cureus.87909</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rui P, Kang K. National Center for Health Statistics; 2015. National Hospital Ambulatory Medical Care Survey: 2015 Emergency Department Summary Tables.</Citation></Reference><Reference><Citation>A case of ST-elevation myocardial infarction with right bundle branch block, an ominous sign of critical coronary occlusion. Basit H, Kahn A, Zaidi S, Chadow H, Khan A. Cureus. 2022;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8840869</ArticleId><ArticleId IdType="pubmed">35174024</ArticleId></ArticleIdList></Reference><Reference><Citation>Swift and safe high-sensitive troPonin evaluation in the emergency department with a 30-min protocol: the SPEED-30 cohort study. Kucukardali AE, Boraci Z, Kudu E, Karacabey S, Sanri E, Denizbasi A. Am J Emerg Med. 2025;89:30&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">39689630</ArticleId></ArticleIdList></Reference><Reference><Citation>2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Gulati M, Levy PD, Mukherjee D, et al. J Cardiovasc Comput Tomogr. 2022;16:54&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pubmed">34955448</ArticleId></ArticleIdList></Reference><Reference><Citation>Appearance of right bundle branch block in electrocardiograms of patients with pulmonary embolism as a marker for obstruction of the main pulmonary trunk. Petrov DB. J Electrocardiol. 2001;34:185&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">11455507</ArticleId></ArticleIdList></Reference><Reference><Citation>WAMAMI: emergency physicians can accurately identify wall motion abnormalities in acute myocardial infarction. Croft PE, Strout TD, Kring RM, Director L, Vasaiwala SC, Mackenzie DC. Am J Emerg Med. 2019;37:2224&#x2013;2228.</Citation><ArticleIdList><ArticleId IdType="pubmed">30987914</ArticleId></ArticleIdList></Reference><Reference><Citation>Discerning STEMI mimics in the field. Brown A, Slovis CM, McKinney J, Brywczynski J. https://www.jems.com/patient-care/discerning-stemi-mimics-field/ JEMS. 2013</Citation><ArticleIdList><ArticleId IdType="pubmed">24592567</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical value of ultrasonography in diagnosis of pulmonary embolism in critically ill patients. Zhu R, Ma XC. J Transl Int Med. 2017;5:200&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5767709</ArticleId><ArticleId IdType="pubmed">29340276</ArticleId></ArticleIdList></Reference><Reference><Citation>Management of massive pulmonary embolism. Kucher N, Goldhaber SZ. Circulation. 2005;112:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">16009801</ArticleId></ArticleIdList></Reference><Reference><Citation>ECG diagnosis: pulmonary embolism. Levis JT. Perm J. 2011;15:75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3267566</ArticleId><ArticleId IdType="pubmed">22319421</ArticleId></ArticleIdList></Reference><Reference><Citation>Posterior occlusive myocardial infarction on chronic right bundle branch block. Sanchez A, El-Charif O. Brown Hosp Med. 2025;4:15&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11966757</ArticleId><ArticleId IdType="pubmed">40191704</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyas V, Sankari A, Goyal A. In: StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2025. Acute pulmonary embolism.</Citation><ArticleIdList><ArticleId IdType="pubmed">32809386</ArticleId></ArticleIdList></Reference><Reference><Citation>Accuracy of point-of-care multiorgan ultrasonography for the diagnosis of pulmonary embolism. Nazerian P, Vanni S, Volpicelli G, et al. Chest. 2014;145:950&#x2013;957.</Citation><ArticleIdList><ArticleId IdType="pubmed">24092475</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40808528</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2149-2271</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>14</Day></PubDate></JournalIssue><Title>Anatolian journal of cardiology</Title><ISOAbbreviation>Anatol J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Results of a Screening Program for Diagnosis of Amyloid Cardiomyopathy Among Patients with Left Ventricular Hypertrophy: PAPCAT Cardiac Amyloidosis T&#xfc;rkiye Survey.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.14744/AnatolJCardiol.2025.4942</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac amyloidosis (CA) is an increasingly recognized disease. Several recent advanced imaging techniques and parameters have been introduced into the diagnosis of CA. However, the first step in using those techniques is clinical suspicion. Left ventricular hypertrophy (LVH) is the main entity in rising the suspicion of CA in routine echocardiography, although it is not a diagnosis for CA. The aim of this study is to investigate the prevalence of CA and its subtypes and predictive value of clinical and echocardiographic red flags of CA among consecutive adult patients with LVH identified during routine echocardiographic examination in 25 tertiary institutions in T&#xfc;rkiye.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective observational multicenter, national registration study. Patients with LVH (interventricular septum thickness &#x2265;13 mm or &gt;15 mm in those with hypertension) were screened for CA stepwise. The first step was a clinical questionnaire for the red flags of CA. Those having &#x2265;2 red flags were further analyzed by detailed echocardiography, blood tests, Tc-pyrophosphate (PYP) bone scintigraphy, and histopathological examination if needed. Parameters associated with CA were evaluated via univariate and multivariate analyses. Wild-type transthyretin (wTTR) vs. mutant-type TTR (mTTR), CA discriminators were also evaluated in the same manner.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 420 patients meeting these criteria were included in the study. With a standardized algorithmic approach, 27.1% (114) of patients received a CA diagnosis. Among these patients with CA, 50.8% (58) were diagnosed with immunoglobulin free chain (AL) CA, 38.6% (44) with wTTR CA, and 7% (8) with mTTR CA. Left ventricular apical sparing pattern and restrictive type LV filling on echocardiography, low QRS voltage on ECG, bilateral carpal tunnel syndrome, low blood pressure, right ventricular diameter, and an increased basal heart rate (HR) were independent predictors for CA diagnosis. When it comes to diagnosis of wTTR CA; advanced age (age &gt;75), lower troponin values, absence of pericardial effusion and absence of proteinuria were the independent predictors.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Cardiac amyloidosis is highly prevalent in a patient population with LVH and 2 red flags who underwent a standardized algorithmic approach, in which apical sparing, restrictive filling pattern, low QRS voltage, carpal tunnel syndrome, low blood pressure, and increased HR are the highly suggestive signs of CA. Among this pool of newly diagnosed CA patients in T&#xfc;rkiye, AL-CA constituted 50.8%, wTTR CA 38.6%, and mTTR CA 7%, emphasizing that approximately 1 in 2 patients diagnosed with CA may have TTR CA.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#xd6;zpelit</LastName><ForeName>Ebru</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dokuz Eyl&#xfc;l University, Faculty of Medicine, &#x130;zmir, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;avu&#x15f;o&#x11f;lu</LastName><ForeName>Y&#xfc;ksel</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Eski&#x15f;ehir Osmangazi University Faculty of Medicine, Eski&#x15f;ehir, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babur G&#xfc;ler</LastName><ForeName>Gamze</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xdc;nl&#xfc;</LastName><ForeName>Serkan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Gazi University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Y&#x131;ld&#x131;r&#x131;mt&#xfc;rk</LastName><ForeName>&#xd6;zlem</ForeName><Initials>&#xd6;</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;i&#xe7;ek Y&#x131;lmaz</LastName><ForeName>Dilek</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Mersin University Faculty of Medicine, Mersin, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;rem</LastName><ForeName>Cihan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Karadeniz Technical University Farabi Hospital, Trabzon, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ba&#x15f;ar&#x131;c&#x131;</LastName><ForeName>&#x130;brahim</ForeName><Initials>&#x130;</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Akdeniz University Faculty of Medicine, Antalya, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xfc;fek&#xe7;io&#x11f;lu</LastName><ForeName>Oma&#xe7;</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ankara Bilkent City Hospital, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokg&#xf6;zo&#x11f;lu</LastName><ForeName>Lale</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karakulak</LastName><ForeName>U&#x11f;ur Nadir</ForeName><Initials>UN</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Din&#xe7;er</LastName><ForeName>&#x130;rem</ForeName><Initials>&#x130;</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ankara University Faculty of Medicine, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;apa Kaya</LastName><ForeName>Gamze</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Dokuz Eyl&#xfc;l University, Faculty of Medicine, &#x130;zmir, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ak Sivri&#xf6;z</LastName><ForeName>&#x130;lknur</ForeName><Initials>&#x130;</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Eski&#x15f;ehir Osmangazi University Faculty of Medicine, Eski&#x15f;ehir, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murat</LastName><ForeName>Selda</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Eski&#x15f;ehir Osmangazi University Faculty of Medicine, Eski&#x15f;ehir, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;ler</LastName><ForeName>Arda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc7;olak</LastName><ForeName>Ay&#x15f;e</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dokuz Eyl&#xfc;l University, Faculty of Medicine, &#x130;zmir, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x15e;ahin</LastName><ForeName>M&#xfc;rsel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Karadeniz Technical University Farabi Hospital, Trabzon, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaplan</LastName><ForeName>Elmas</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ankara Bilkent City Hospital, Ankara, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akaslan</LastName><ForeName>Dursun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Marmara University Faculty of Medicine, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xfc;rer Cabbar</LastName><ForeName>Ay&#xe7;e</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Yeditepe University Faculty of Medicine, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xfc;nb&#xfc;l</LastName><ForeName>Murat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Marmara University Faculty of Medicine, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaya</LastName><ForeName>Y&#xfc;ksel</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Van Y&#xfc;z&#xfc;nc&#xfc; Y&#x131;l University Faculty of Medicine, Van, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zorkun</LastName><ForeName>Cafer Sad&#x131;k</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, &#x130;stanbul University &#x130;stanbul Medical Faculty, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vatansever A&#x11f;ca</LastName><ForeName>Fahriye</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University of Health Sciences Bursa Y&#xfc;ksek &#x130;htisas Training and Research Hospital, Bursa, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x130;kitimur</LastName><ForeName>Bar&#x131;&#x15f;</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology, &#x130;stanbul University-Cerrahpa&#x15f;a, Cerrahpa&#x15f;a Medical Faculty, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Onba&#x15f;&#x131;l&#x131;</LastName><ForeName>Alper</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ayd&#x131;n Adnan Menderes University Faculty of Medicine, Ayd&#x131;n, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#x131;l&#x131;&#xe7;gedik</LastName><ForeName>Alev</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ba&#x15f;ak&#x15f;ehir &#xc7;am and Sakura City Hospital, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altay</LastName><ForeName>Hakan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ba&#x15f;kent University &#x130;stanbul Hospital, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ero&#x11f;lu B&#xfc;y&#xfc;k&#xf6;ner</LastName><ForeName>Elif</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Ac&#x131;badem Mehmet Ali Aydinlar University Faculty of Medicine, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De&#x11f;ertekin</LastName><ForeName>Muzaffer</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Yeditepe University Faculty of Medicine, &#x130;stanbul, T&#xfc;rkiye.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Turkey</Country><MedlineTA>Anatol J Cardiol</MedlineTA><NlmUniqueID>101652981</NlmUniqueID><ISSNLinking>2149-2263</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>3</Hour><Minute>44</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40808528</ArticleId><ArticleId IdType="doi">10.14744/AnatolJCardiol.2025.4942</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40809637</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence in Hypertrophic Cardiomyopathy: Advances, Challenges, and Future Directions for Personalized Risk Prediction and Management.</ArticleTitle><Pagination><StartPage>e87907</StartPage><MedlinePgn>e87907</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e87907</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.87907</ELocationID><Abstract><AbstractText>Hypertrophic cardiomyopathy (HCM) is a complex genetic cardiovascular disease,&#xa0;with current risk stratification strategies showing limited accuracy in predicting sudden cardiac death and clinical outcomes. This review examines how artificial intelligence (AI) is transforming personalized risk prediction and management in HCM, with particular focus on validated clinical applications. We conducted a comprehensive literature search across PubMed, IEEE Xplore, Web of Science, and Scopus databases from January 2015 to January 2025. Search terms included "artificial intelligence", "machine learning", "deep learning", "hypertrophic cardiomyopathy", and "risk prediction". Inclusion criteria comprised peer-reviewed studies reporting AI applications in HCM with validated performance metrics. We excluded case reports, editorials, and studies without clinical validation. Of 487 identified articles, 84 met inclusion criteria and were analyzed for AI techniques, clinical applications, performance metrics, and implementation challenges. Machine learning algorithms have achieved significant breakthroughs in HCM care. Random forest models identifying ventricular arrhythmias demonstrated 83% accuracy (area under the curve (AUC): 0.83), discovering 12 novel predictors, including left atrial volume index. Deep learning ECG analysis using convolutional neural networks achieved 85-87% accuracy in sudden cardiac death prediction, substantially outperforming traditional risk scores (AUC: 0.87 vs. 0.62). AI-enhanced genetic testing has shown 96% accuracy in reclassifying variants of uncertain significance, while automated cardiac MRI analysis provides objective disease progression monitoring with reduced inter-observer variability. Real-time applications include automated ECG screening tools currently in pilot programs at major cardiac centers, and decision support systems for therapy selection showing &gt;90% accuracy in predicting response to cardiac resynchronization therapy. Multi-center collaborations such as the SHaRe Registry are developing standardized AI models across institutions. Implementation faces specific barriers, including data bias from underrepresented populations, lack of standardized electronic health record formats across centers, regulatory approval pathways for AI-based clinical tools, and "black box" interpretability issues requiring explainable AI solutions. Integration requires addressing these challenges through prospective validation studies, development of regulatory frameworks, and clinician training programs. AI demonstrates transformative potential in HCM management, but realizing clinical benefits requires addressing technical, ethical, and implementation challenges through coordinated multidisciplinary efforts.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Mohyeldin et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohyeldin</LastName><ForeName>Moiud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, BronxCare Health System, Bronx, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Physiology, University of Medical Sciences and Technology (UMST), Khartoum, SDN.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research, California Institute of Behavioral Neurosciences and Psychology, Fairfield, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohamed</LastName><ForeName>Feras O</ForeName><Initials>FO</Initials><AffiliationInfo><Affiliation>Diagnostic and Interventional Radiology, Texas Medical Center Memorial Hermann Hospital, Houston, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molina</LastName><ForeName>Marcos</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, BronxCare Health System, Bronx, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Towfig</LastName><ForeName>Muhanned Faisal</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Geriatrics, Montefiore Medical Center, Wakefield Campus, Bronx, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mustafa</LastName><ForeName>Ahmed M G</ForeName><Initials>AMG</Initials><AffiliationInfo><Affiliation>Cardiology, Salaam Clinic, Cleveland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology, Mercy University Hospital, Cork, IRL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elhussein</LastName><ForeName>Ahmed H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Internal Medicine, The National Ribat University, Khartoum, SDN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alamin</LastName><ForeName>Faris</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Internal Medicine, University of Medical Sciences and Technology (UMST), Khartoum, SDN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaja</LastName><ForeName>Misbahuddin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, BronxCare Health System, Bronx, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jadhav</LastName><ForeName>Preeti</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Cardiology, BronxCare Health System, Bronx, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ai and machine learning</Keyword><Keyword MajorTopicYN="N">artificial intelligence (ai)</Keyword><Keyword MajorTopicYN="N">convolutional neural networks</Keyword><Keyword MajorTopicYN="N">deep learning artificial intelligence</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">hypertrophic obstructive cardiomyopathy (hocm)</Keyword><Keyword MajorTopicYN="N">natural language processing models</Keyword><Keyword MajorTopicYN="N">personalized management</Keyword><Keyword MajorTopicYN="N">risk prediction</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>5</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40809637</ArticleId><ArticleId IdType="pmc">PMC12348218</ArticleId><ArticleId IdType="doi">10.7759/cureus.87907</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hypertrophic cardiomyopathy. Maron BJ, Maron MS. Lancet. 2013;381:242&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">22874472</ArticleId></ArticleIdList></Reference><Reference><Citation>New perspectives on the prevalence of hypertrophic cardiomyopathy. Semsarian C, Ingles J, Maron MS, Maron BJ. J Am Coll Cardiol. 2015;65:1249&#x2013;1254.</Citation><ArticleIdList><ArticleId IdType="pubmed">25814232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies. Maron BJ, Rowin EJ, Casey SA, et al. J Am Coll Cardiol. 2015;65:1915&#x2013;1928.</Citation><ArticleIdList><ArticleId IdType="pubmed">25953744</ArticleId></ArticleIdList></Reference><Reference><Citation>How to image hypertrophic cardiomyopathy. Maron MS, Rowin EJ, Maron BJ. Circ Cardiovasc Imaging. 2017;10</Citation><ArticleIdList><ArticleId IdType="pubmed">28701526</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Olivotto I, Cecchi F, Poggesi C, Yacoub MH. Circ Heart Fail. 2012;5:535&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pubmed">22811549</ArticleId></ArticleIdList></Reference><Reference><Citation>Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe) Ho CY, Day SM, Ashley EA, et al. Circulation. 2018;138:1387&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6170149</ArticleId><ArticleId IdType="pubmed">30297972</ArticleId></ArticleIdList></Reference><Reference><Citation>A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD) O'Mahony C, Jichi F, Pavlou M, et al. Eur Heart J. 2014;35:2010&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pubmed">24126876</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in precision&#xa0;cardiovascular medicine. Krittanawong C, Zhang H, Wang Z, Aydar M, Kitai T. J Am Coll Cardiol. 2017;69:2657&#x2013;2664.</Citation><ArticleIdList><ArticleId IdType="pubmed">28545640</ArticleId></ArticleIdList></Reference><Reference><Citation>Identifying ventricular arrhythmias and their predictors by applying machine learning methods to electronic health records in patients with hypertrophic cardiomyopathy (HCM-VAR-risk model) Bhattacharya M, Lu DY, Kudchadkar SM, et al. Am J Cardiol. 2019;123:1681&#x2013;1689.</Citation><ArticleIdList><ArticleId IdType="pubmed">30952382</ArticleId></ArticleIdList></Reference><Reference><Citation>Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers. Lyon A, Ariga R, Minchol&#xe9; A, et al. Front Physiol. 2018;9:213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859357</ArticleId><ArticleId IdType="pubmed">29593570</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in cardiology. Johnson KW, Torres Soto J, Glicksberg BS, et al. J Am Coll Cardiol. 2018;71:2668&#x2013;2679.</Citation><ArticleIdList><ArticleId IdType="pubmed">29880128</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in cardiovascular medicine: are we there yet? Shameer K, Johnson KW, Glicksberg BS, Dudley JT, Sengupta PP. Heart. 2018;104:1156&#x2013;1164.</Citation><ArticleIdList><ArticleId IdType="pubmed">29352006</ArticleId></ArticleIdList></Reference><Reference><Citation>A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy. Smole T, &#x17d;unkovi&#x10d; B, Pi&#x10d;ulin M, et al. Comput Biol Med. 2021;135:104648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34280775</ArticleId></ArticleIdList></Reference><Reference><Citation>Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction. Aro AL, Reinier K, Phan D, et al. Europace. 2017;19:1146&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075451</ArticleId><ArticleId IdType="pubmed">27256423</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center. Mazzarotto F, Girolami F, Boschi B, et al. Genet Med. 2019;21:284&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6752309</ArticleId><ArticleId IdType="pubmed">29875424</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy. Cikes M, Sanchez-Martinez S, Claggett B, et al. Eur J Heart Fail. 2019;21:74&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">30328654</ArticleId></ArticleIdList></Reference><Reference><Citation>Global burden of hypertrophic&#xa0;cardiomyopathy. Maron BJ, Rowin EJ, Maron MS. JACC Heart Fail. 2018;6:376&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pubmed">29724362</ArticleId></ArticleIdList></Reference><Reference><Citation>Implementing machine learning in health care - addressing ethical challenges. Char DS, Shah NH, Magnus D. N Engl J Med. 2018;378:981&#x2013;983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5962261</ArticleId><ArticleId IdType="pubmed">29539284</ArticleId></ArticleIdList></Reference><Reference><Citation>High-performance medicine: the convergence of human and artificial intelligence. Topol EJ. Nat Med. 2019;25:44&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">30617339</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in medicine. Deo RC. Circulation. 2015;132:1920&#x2013;1930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5831252</ArticleId><ArticleId IdType="pubmed">26572668</ArticleId></ArticleIdList></Reference><Reference><Citation>A novel approach to predict sudden cardiac death (SCD) using nonlinear and time-frequency analyses from HRV signals. Ebrahimzadeh E, Pooyan M, Bijar A. PLoS One. 2014;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3913584</ArticleId><ArticleId IdType="pubmed">24504331</ArticleId></ArticleIdList></Reference><Reference><Citation>Predicting the development of adverse cardiac events in patients with hypertrophic cardiomyopathy using machine learning. Kochav SM, Raita Y, Fifer MA, et al. Int J Cardiol. 2021;327:117&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">33181159</ArticleId></ArticleIdList></Reference><Reference><Citation>Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry. Neubauer S, Kolm P, Ho CY, et al. J Am Coll Cardiol. 2019;74:2333&#x2013;2345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6905038</ArticleId><ArticleId IdType="pubmed">31699273</ArticleId></ArticleIdList></Reference><Reference><Citation>Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Bos JM, Will ML, Gersh BJ, Kruisselbrink TM, Ommen SR, Ackerman MJ. Mayo Clin Proc. 2014;89:727&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4234122</ArticleId><ArticleId IdType="pubmed">24793961</ArticleId></ArticleIdList></Reference><Reference><Citation>Deep learning. LeCun Y, Bengio Y, Hinton G. Nature. 2015;521:436&#x2013;444.</Citation><ArticleIdList><ArticleId IdType="pubmed">26017442</ArticleId></ArticleIdList></Reference><Reference><Citation>Predicting survival from large echocardiography and electronic health record datasets: optimization with machine learning. Samad MD, Ulloa A, Wehner GJ, et al. JACC Cardiovasc Imaging. 2019;12:681&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6286869</ArticleId><ArticleId IdType="pubmed">29909114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fully automated echocardiogram interpretation in clinical practice: feasibility and diagnostic accuracy. Zhang J, Gajjala S, Agrawal P, et al. Circulation. 2018;138:1623&#x2013;1635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6200386</ArticleId><ArticleId IdType="pubmed">30354459</ArticleId></ArticleIdList></Reference><Reference><Citation>Deep learning techniques for automatic MRI cardiac multi-structures segmentation and diagnosis: is the problem solved? Bernard O, Lalande A, Zotti C, et al. IEEE Trans Med Imaging. 2018;37:2514&#x2013;2525.</Citation><ArticleIdList><ArticleId IdType="pubmed">29994302</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in cardiovascular magnetic resonance: basic concepts and applications. Leiner T, Rueckert D, Suinesiaputra A, Bae&#xdf;ler B, Nezafat R, I&#x161;gum I, Young AA. J Cardiovasc Magn Reson. 2019;21:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778980</ArticleId><ArticleId IdType="pubmed">31590664</ArticleId></ArticleIdList></Reference><Reference><Citation>Computational techniques for ECG analysis and interpretation in light of their contribution to medical advances. Lyon A, Minchol&#xe9; A, Mart&#xed;nez JP, Laguna P, Rodriguez B. J R Soc Interface. 2018;15:20170821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5805987</ArticleId><ArticleId IdType="pubmed">29321268</ArticleId></ArticleIdList></Reference><Reference><Citation>Utilizing ECG-based heartbeat classification for hypertrophic cardiomyopathy identification. Rahman QA, Tereshchenko LG, Kongkatong M, Abraham T, Abraham MR, Shatkay H. IEEE Trans Nanobioscience. 2015;14:505&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658666</ArticleId><ArticleId IdType="pubmed">25915962</ArticleId></ArticleIdList></Reference><Reference><Citation>Natural language processing: an introduction. Nadkarni PM, Ohno-Machado L, Chapman WW. J Am Med Inform Assoc. 2011;18:544&#x2013;551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3168328</ArticleId><ArticleId IdType="pubmed">21846786</ArticleId></ArticleIdList></Reference><Reference><Citation>Natural language processing of clinical notes on chronic diseases: systematic review. Sheikhalishahi S, Miotto R, Dudley JT, Lavelli A, Rinaldi F, Osmani V. JMIR Med Inform. 2019;7:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6528438</ArticleId><ArticleId IdType="pubmed">31066697</ArticleId></ArticleIdList></Reference><Reference><Citation>Questions for artificial intelligence in health care. Maddox TM, Rumsfeld JS, Payne PR. JAMA. 2019;321:31&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">30535130</ArticleId></ArticleIdList></Reference><Reference><Citation>Maximising the impact of patient reported outcome assessment for patients and society. Calvert M, Kyte D, Price G, Valderas JM, Hjollund NH. BMJ. 2019;364:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">30679170</ArticleId></ArticleIdList></Reference><Reference><Citation>Social media use in healthcare: a systematic review of effects on patients and on their relationship with healthcare professionals. Smailhodzic E, Hooijsma W, Boonstra A, Langley DJ. BMC Health Serv Res. 2016;16:442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5000484</ArticleId><ArticleId IdType="pubmed">27562728</ArticleId></ArticleIdList></Reference><Reference><Citation>Correlation between liver volume and liver weight in a cohort with chronic liver disease: a semiautomated CT-volumetry study. Hagen F, Mair A, B&#xf6;sm&#xfc;ller H, Horger M. Quant Imaging Med Surg. 2022;12:376&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8666767</ArticleId><ArticleId IdType="pubmed">34993086</ArticleId></ArticleIdList></Reference><Reference><Citation>A multicenter, scan-rescan, human and machine learning CMR study to test generalizability and precision in imaging biomarker analysis. Bhuva AN, Bai W, Lau C, et al. Circ Cardiovasc Imaging. 2019;12:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">31547689</ArticleId></ArticleIdList></Reference><Reference><Citation>Deep learning for prediction of obstructive disease from fast myocardial perfusion SPECT: a multicenter study. Betancur J, Commandeur F, Motlagh M, et al. JACC Cardiovasc Imaging. 2018;11:1654&#x2013;1663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6135711</ArticleId><ArticleId IdType="pubmed">29550305</ArticleId></ArticleIdList></Reference><Reference><Citation>A deep-learning classifier identifies patients with clinical heart failure using whole-slide images of H&amp;E tissue. Nirschl JJ, Janowczyk A, Peyster EG, Frank R, Margulies KB, Feldman MD, Madabhushi A. PLoS One. 2018;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5882098</ArticleId><ArticleId IdType="pubmed">29614076</ArticleId></ArticleIdList></Reference><Reference><Citation>cMRI-BED: a novel informatics framework for cardiac MRI biomarker extraction and discovery applied to pediatric cardiomyopathy classification. Gopalakrishnan V, Menon PG, Madan S. Biomed Eng Online. 2015;14:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547147</ArticleId><ArticleId IdType="pubmed">26329721</ArticleId></ArticleIdList></Reference><Reference><Citation>Identifying facial phenotypes of genetic disorders using deep learning. Gurovich Y, Hanani Y, Bar O, et al. Nat Med. 2019;25:60&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">30617323</ArticleId></ArticleIdList></Reference><Reference><Citation>Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Poplin R, Varadarajan AV, Blumer K, et al. Nat Biomed Eng. 2018;2:158&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">31015713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertrophic cardiomyopathy detection with artificial intelligence electrocardiography in international cohorts: an external validation study. Siontis KC, Wieczorek MA, Maanja M, et al. Eur Heart J Digit Health. 2024;5:416&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11284003</ArticleId><ArticleId IdType="pubmed">39081936</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. Maron BJ, Ommen SR, Semsarian C, Spirito P, Olivotto I, Maron MS. https://pubmed.ncbi.nlm.nih.gov/24998133/ J Am Coll Cardiol. 2014;64:83&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">24998133</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. Heart Rhythm. Vol. 15. Heart Rhythm: 2018. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society; pp. 0&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">29097320</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence-enabled ECG algorithm to identify patients with left ventricular systolic dysfunction presenting to the emergency department with dyspnea. Adedinsewo D, Carter RE, Attia Z, et al. Circ Arrhythm Electrophysiol. 2020;13:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32986471</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in ventricular arrhythmias and sudden death. Holmstr&#xf6;m L, Zhang FZ, Ouyang D, Dey D, Slomka PJ, Chugh SS. Arrhythm Electrophysiol Rev. 2023;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10345967</ArticleId><ArticleId IdType="pubmed">37457439</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of the electrocardiographic phenotype in risk stratification for sudden cardiac death in childhood hypertrophic cardiomyopathy. Norrish G, Topriceanu C, Qu C, et al. Eur J Prev Cardiol. 2022;29:645&#x2013;653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8967480</ArticleId><ArticleId IdType="pubmed">33772274</ArticleId></ArticleIdList></Reference><Reference><Citation>Current and future use of artificial intelligence in electrocardiography. Mart&#xed;nez-Sell&#xe9;s M, Marina-Breysse M. J Cardiovasc Dev Dis. 2023;10:175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10145690</ArticleId><ArticleId IdType="pubmed">37103054</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetic advances in sarcomeric cardiomyopathies: state of the art. Ho CY, Charron P, Richard P, Girolami F, Van Spaendonck-Zwarts KY, Pinto Y. Cardiovasc Res. 2015;105:397&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4349164</ArticleId><ArticleId IdType="pubmed">25634555</ArticleId></ArticleIdList></Reference><Reference><Citation>The outcomes of coronary artery bypass surgery after 18 months&#x2014;is there an influence of the initial right ventricle diastolic dysfunction? Sumin AN, Shcheglova AV, Korok EV, Sergeeva TJ. J Cardiovasc Dev Dis. 2023;10:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9866549</ArticleId><ArticleId IdType="pubmed">36661913</ArticleId></ArticleIdList></Reference><Reference><Citation>Molecular diagnosis of hypertrophic cardiomyopathy (HCM): in the heart of cardiac disease. Melas M, Beltsios ET, Adamou A, Koumarelas K, McBride KL. J Clin Med. 2023;12:225.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9821215</ArticleId><ArticleId IdType="pubmed">36615026</ArticleId></ArticleIdList></Reference><Reference><Citation>2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC) Elliott PM, Anastasakis A, Borger MA, et al. Eur Heart J. 2014;35:2733&#x2013;2779.</Citation><ArticleIdList><ArticleId IdType="pubmed">25173338</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning for predicting heart failure progression in hypertrophic cardiomyopathy. Fahmy AS, Rowin EJ, Manning WJ, Maron MS, Nezafat R. Front Cardiovasc Med. 2021;8:647857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155292</ArticleId><ArticleId IdType="pubmed">34055932</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical trials in hypertrophic cardiomyopathy therapy: a comprehensive analysis of trials registered in global clinical databases. Zhang H, Yu C, Cheng Y, et al. Drug Des Devel Ther. 2023;17:1863&#x2013;1877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10291003</ArticleId><ArticleId IdType="pubmed">37377648</ArticleId></ArticleIdList></Reference><Reference><Citation>Advances in multi-modality imaging in hypertrophic cardiomyopathy. Goldie FC, Lee MM, Coats CJ, Nordin S. J Clin Med. 2024;13:842&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10856479</ArticleId><ArticleId IdType="pubmed">38337535</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in cardiac MRI: is clinical adoption forthcoming? Fotaki A, Puyol-Ant&#xf3;n E, Chiribiri A, Botnar R, Pushparajah K, Prieto C. Front Cardiovasc Med. 2021;8:818765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785419</ArticleId><ArticleId IdType="pubmed">35083303</ArticleId></ArticleIdList></Reference><Reference><Citation>Disease progression of hypertrophic cardiomyopathy: modeling using machine learning. Pi&#x10d;ulin M, Smole T, &#x17d;unkovi&#x10d; B, et al. JMIR Med Inform. 2022;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8851344</ArticleId><ArticleId IdType="pubmed">35107432</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in cardiovascular medicine: an updated review of the literature. Zargarzadeh A, Javanshir E, Ghaffari A, Mosharkesh E, Anari B. J Cardiovasc Thorac Res. 2023;15:204&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10862032</ArticleId><ArticleId IdType="pubmed">38357567</ArticleId></ArticleIdList></Reference><Reference><Citation>Global longitudinal strain and left atrial volume index provide incremental prognostic value in patients with hypertrophic cardiomyopathy. Hiemstra YL, Debonnaire P, Bootsma M, et al. Circ Cardiovasc Imaging. 2017;10</Citation><ArticleIdList><ArticleId IdType="pubmed">28679523</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of outcomes in patients with nonobstructive, labile-obstructive, and chronically obstructive hypertrophic cardiomyopathy. Pozios I, Corona-Villalobos C, Sorensen LL, et al. Am J Cardiol. 2015;116:938&#x2013;944.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4554842</ArticleId><ArticleId IdType="pubmed">26239580</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of arrhythmic events after alcohol septal ablation for hypertrophic cardiomyopathy using continuous implantable cardiac monitoring. Bleszynski PA, Goldenberg I, Fernandez G, et al. Heart Rhythm. 2021;18:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">32853778</ArticleId></ArticleIdList></Reference><Reference><Citation>Enhanced American College of Cardiology/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy. Maron MS, Rowin EJ, Wessler BS, et al. JAMA Cardiol. 2019;4:644&#x2013;657.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537832</ArticleId><ArticleId IdType="pubmed">31116360</ArticleId></ArticleIdList></Reference><Reference><Citation>Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) Hershberger RE, Givertz MM, Ho CY, et al.  https://pubmed.ncbi.nlm.nih.gov/29904160/ Genet Med. 2018;20:899&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">29904160</ArticleId></ArticleIdList></Reference><Reference><Citation>Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Rudin C. Nat Mach Intell. 2019;1:206&#x2013;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9122117</ArticleId><ArticleId IdType="pubmed">35603010</ArticleId></ArticleIdList></Reference><Reference><Citation>A survey on explainable artificial intelligence (XAI): toward medical XAI. Tjoa E, Guan C. IEEE Trans Neural Netw Learn Syst. 2021;32:4793&#x2013;4813.</Citation><ArticleIdList><ArticleId IdType="pubmed">33079674</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning in medicine: addressing ethical challenges. Vayena E, Blasimme A, Cohen IG. PLoS Med. 2018;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6219763</ArticleId><ArticleId IdType="pubmed">30399149</ArticleId></ArticleIdList></Reference><Reference><Citation>The legal and ethical concerns that arise from using complex predictive analytics in health care. Cohen IG, Amarasingham R, Shah A, Xie B, Lo B. Health Aff (Millwood) 2014;33:1139&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">25006139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ensuring fairness in machine learning to advance health equity. Rajkomar A, Hardt M, Howell MD, Corrado G, Chin MH. Ann Intern Med. 2018;169:866&#x2013;872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6594166</ArticleId><ArticleId IdType="pubmed">30508424</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical decision support in the era of artificial intelligence. Shortliffe EH, Sep&#xfa;lveda MJ. JAMA. 2018;320:2199&#x2013;2200.</Citation><ArticleIdList><ArticleId IdType="pubmed">30398550</ArticleId></ArticleIdList></Reference><Reference><Citation>Phenomapping for novel classification of heart failure with preserved ejection fraction. Shah SJ, Katz DH, Selvaraj S, et al. Circulation. 2015;131:269&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302027</ArticleId><ArticleId IdType="pubmed">25398313</ArticleId></ArticleIdList></Reference><Reference><Citation>Key challenges for delivering clinical impact with artificial intelligence. Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. BMC Med. 2019;17:195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6821018</ArticleId><ArticleId IdType="pubmed">31665002</ArticleId></ArticleIdList></Reference><Reference><Citation>2017 roadmap for innovation&#x2014;ACC health policy statement on healthcare transformation in the era of digital health, big data, and precision health: a report of the American College of Cardiology task force on health policy statements and systems of care. Bhavnani SP, Parakh K, Atreja A, et al. J Am Coll Cardiol. 2017;70:2696&#x2013;2718.</Citation><ArticleIdList><ArticleId IdType="pubmed">29169478</ArticleId></ArticleIdList></Reference><Reference><Citation>Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Hripcsak G, Duke JD, Shah NH, et al. Stud Health Technol Inform. 2015;216:574&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4815923</ArticleId><ArticleId IdType="pubmed">26262116</ArticleId></ArticleIdList></Reference><Reference><Citation>Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. Hemingway H, Asselbergs FW, Danesh J, et al. Eur Heart J. 2018;39:1481&#x2013;1495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6019015</ArticleId><ArticleId IdType="pubmed">29370377</ArticleId></ArticleIdList></Reference><Reference><Citation>UK phenomics platform for developing and validating electronic health record phenotypes: CALIBER. Denaxas S, Gonzalez-Izquierdo A, Direk K, et al. J Am Med Inform Assoc. 2019;26:1545&#x2013;1559.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857510</ArticleId><ArticleId IdType="pubmed">31329239</ArticleId></ArticleIdList></Reference><Reference><Citation>Integrative omics for health and disease. Karczewski KJ, Snyder MP. Nat Rev Genet. 2018;19:299&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5990367</ArticleId><ArticleId IdType="pubmed">29479082</ArticleId></ArticleIdList></Reference><Reference><Citation>Multi-omics approaches to disease. Hasin Y, Seldin M, Lusis A. Genome Biol. 2017;18:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5418815</ArticleId><ArticleId IdType="pubmed">28476144</ArticleId></ArticleIdList></Reference><Reference><Citation>More is better: recent progress in multi-omics data integration methods. Huang S, Chaudhary K, Garmire LX. Front Genet. 2017;8:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5472696</ArticleId><ArticleId IdType="pubmed">28670325</ArticleId></ArticleIdList></Reference><Reference><Citation>Machine learning and integrative analysis of biomedical big data. Mirza B, Wang W, Wang J, Choi H, Chung NC, Ping P. Genes (Basel) 2019;10:87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6410075</ArticleId><ArticleId IdType="pubmed">30696086</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence in healthcare: past, present and future. Jiang F, Jiang Y, Zhi H, et al. Stroke Vasc Neurol. 2017;2:230&#x2013;243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5829945</ArticleId><ArticleId IdType="pubmed">29507784</ArticleId></ArticleIdList></Reference><Reference><Citation>An overview of clinical decision support systems: benefits, risks, and strategies for success. Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. NPJ Digit Med. 2020;3:17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7005290</ArticleId><ArticleId IdType="pubmed">32047862</ArticleId></ArticleIdList></Reference><Reference><Citation>Health care robotics: qualitative exploration of key challenges and future directions. Cresswell K, Cunningham-Burley S, Sheikh A. J Med Internet Res. 2018;20:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053611</ArticleId><ArticleId IdType="pubmed">29973336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40796920</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Left ventricle strain and T1 mapping evaluation in a mouse model with myocardial infarction.</ArticleTitle><Pagination><StartPage>29579</StartPage><MedlinePgn>29579</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">29579</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-025-09699-0</ELocationID><Abstract><AbstractText>Myocardial strain and T1 mapping offer precise evaluation of cardiac function and tissue characteristics. The aim of this study is to provide normative myocardial strain and T1 values in mice model along with their changes after myocardial infarction (MI) using a tailored acquisition and analysis protocol. Healthy mice had MRI before and after MI. Imaging was performed to assess cardiac function and left ventricle (LV) strain. A Look-Locker Inversion-Recovery sequence was used for T1 maps reconstruction. Gadolinium doses and timing of image acquisitions were optimized. Radial and circumferential strain measurements were conducted using a custom software based on feature tracking. To address ECG signal interference, adjustments were made for accurate strain calculations. An LV dilation in MI compared to wild-type (WT) with a decrease in LV ejection fraction (p&#x2009;&lt;&#x2009;0.0001) were reported while stroke volume and cardiac output remained preserved (p&#x2009;&gt;&#x2009;0.21). Normative strain and T1 mapping data were provided revealing an increase in circumferential strain from base to apex (basal: -14&#x2009;&#xb1;&#x2009;1%, mid: -15&#x2009;&#xb1;&#x2009;2%, apical: - 21&#x2009;&#xb1;&#x2009;3%;&#xa0;p&#x2009;&lt;&#x2009;0.0001) and notable differences in native and post-contrast T1 values between mid-ventricular and apical LV segments. Circumferential strain differences between MI and WT mice were pronounced, with a significant drop in apical strain (p&#x2009;&lt;&#x2009;0.0001) in MI. Post-MI mice exhibited higher native T1 and lower post-contrast T1 compared to WT. Our methodological approach not only refines imaging sequences but also offers insights into cardiac function and tissue characteristics in mice. By describing normative values of strain and T1, our findings lay the groundwork for future research, particularly in drug therapy.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bouazizi</LastName><ForeName>Khaoula</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale (LIB), Sorbonne Universit&#xe9;, INSERM, CNRS, Paris, France. khaoula.bouazizi@inserm.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICAN Imaging, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France. khaoula.bouazizi@inserm.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoganathan</LastName><ForeName>Thulaciga</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM, PARCC, Paris, F-75015, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kober</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for Magnetic Resonance in Biology and Medicine (CRMBM), CNRS, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Autret</LastName><ForeName>Gwennhael</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM, PARCC, Paris, F-75015, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsac</LastName><ForeName>Perrine</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale (LIB), Sorbonne Universit&#xe9;, INSERM, CNRS, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delacroix</LastName><ForeName>Cl&#xe9;ment</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM, PARCC, Paris, F-75015, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soulez</LastName><ForeName>Shannon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale (LIB), Sorbonne Universit&#xe9;, INSERM, CNRS, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarai</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ICAN Imaging, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguyen</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale (LIB), Sorbonne Universit&#xe9;, INSERM, CNRS, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squalli</LastName><ForeName>Adil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM, PARCC, Paris, F-75015, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alayrac</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM, PARCC, Paris, F-75015, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robidel</LastName><ForeName>Estelle</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM, PARCC, Paris, F-75015, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavitian</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM, PARCC, Paris, F-75015, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redheuil</LastName><ForeName>Alban</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale (LIB), Sorbonne Universit&#xe9;, INSERM, CNRS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICAN Imaging, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Unit&#xe9; d'Imagerie Cardiovasculaire et Thoracique (ICT), Piti&#xe9;-Salp&#xea;tri&#xe8;re Hospital AP-HP, Sorbonne Universit&#xe9;, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulot</LastName><ForeName>Jean-S&#xe9;bastien</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Universit&#xe9; Paris Cit&#xe9;, INSERM, PARCC, Paris, F-75015, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kachenoura</LastName><ForeName>Nadjia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Laboratoire d'Imagerie Biom&#xe9;dicale (LIB), Sorbonne Universit&#xe9;, INSERM, CNRS, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ICAN Imaging, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>ANR-18-CE14-0032-01</GrantID><Agency>Agence Nationale de la Recherche</Agency><Country/></Grant><Grant><GrantID>Fellowship</GrantID><Agency>Soci&#xe9;t&#xe9; Fran&#xe7;aise de Cardiologie</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac MRI</Keyword><Keyword MajorTopicYN="N">Mice</Keyword><Keyword MajorTopicYN="N">Myocardial infarction.</Keyword><Keyword MajorTopicYN="N">Strain</Keyword><Keyword MajorTopicYN="N">T1 mapping</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Experiments were approved by the Animal Ethics Committee of the French Ministry of Research (agreement number 19064/21040). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40796920</ArticleId><ArticleId IdType="pmc">PMC12344140</ArticleId><ArticleId IdType="doi">10.1038/s41598-025-09699-0</ArticleId><ArticleId IdType="pii">10.1038/s41598-025-09699-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pattynama, P., De Roos, A., Ernst, E. &amp; Van der Wall, A. Evaluation of cardiac function with magnetic resonance imaging. <i>Am. Heart J.</i><b>128</b>, 595&#x2013;607 (1994).
</Citation><ArticleIdList><ArticleId IdType="pubmed">8074024</ArticleId></ArticleIdList></Reference><Reference><Citation>Auger, D. A. et al. Reproducibility of global and segmental myocardial strain using cine DENSE at 3 T: a multicenter cardiovascular magnetic resonance study in healthy subjects and patients with heart disease. <i>J. Cardiovasc. Magn. Reson.</i><b>24</b>, 1&#x2013;75(2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8978361</ArticleId><ArticleId IdType="pubmed">35369885</ArticleId></ArticleIdList></Reference><Reference><Citation>Korosoglou, G. et al. <i>Strain-encoded magnetic resonance: a method for the assessment of myocardial deformation</i> Vol. 6, 584&#x2013;602 (Wiley-Blackwell, 2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6676282</ArticleId><ArticleId IdType="pubmed">31021534</ArticleId></ArticleIdList></Reference><Reference><Citation>Muser, D., Castro, S. A., Santangeli, P. &amp; Nucifora, G. Clinical applications of feature-tracking cardiac magnetic resonance imaging. <i>World J. Cardiol.</i><b>10</b> (11), 210&#x2013;221 (2018).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259029</ArticleId><ArticleId IdType="pubmed">30510638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman, Z. U. et al. Feature tracking cardiac magnetic resonance imaging: A review of a novel non-invasive cardiac imaging technique. <i>World J. Cardiol.</i><b>9</b> (4), 312 (2017).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5411965</ArticleId><ArticleId IdType="pubmed">28515849</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, J., Park, J., Park, J. &amp; Cho, G. Global longitudinal strain to predict mortality in patients with acute heart failure. <i>J. Am. Coll. Cardiol.</i><b>71</b>, 1947&#x2013;1957 (2018).
</Citation><ArticleIdList><ArticleId IdType="pubmed">29724346</ArticleId></ArticleIdList></Reference><Reference><Citation>Piella, G. et al. Characterizing myocardial deformation in patients with left ventricular hypertrophy of different etiologies using the strain distribution obtained by magnetic resonance imaging. <i>Rev. Esp. Cardiol.</i><b>63</b>, 1281&#x2013;1291 (2010).
</Citation><ArticleIdList><ArticleId IdType="pubmed">21070724</ArticleId></ArticleIdList></Reference><Reference><Citation>Perea, R. J. et al. <i>T1 mapping: characterisation of myocardial interstitial space</i> Vol. 6, 189&#x2013;202 (Springer, 2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4376813</ArticleId><ArticleId IdType="pubmed">25424598</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, T. C. et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. <i>Circulation</i><b>126</b> (10), 1206&#x2013;1216 (2012).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3464491</ArticleId><ArticleId IdType="pubmed">22851543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira, V. M., Holloway, C. J., Piechnik, S. K., Karamitsos, T. D. &amp; Neubauer, S. Is it really fat? Ask a T1-map. <i>Eur. Heart. J. Cardiovasc. Imaging</i>. <b>14</b>, 1060 (2013).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3806581</ArticleId><ArticleId IdType="pubmed">23686674</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks, J., Kramer, C. M. &amp; Salerno, M. Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping. <i>J. Magn. Reson. Imaging</i>. <b>38</b> (6), 1591&#x2013;1595 (2013).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3855558</ArticleId><ArticleId IdType="pubmed">23450747</ArticleId></ArticleIdList></Reference><Reference><Citation>Karamitsos, T. D. et al. Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis [Internet]. (2013). Available from: http://imaging.onlinejacc.org</Citation><ArticleIdList><ArticleId IdType="pubmed">23498672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira, V. M. et al. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: A comparison to T2-weighted cardiovascular magnetic resonance. <i>J. Cardiovasc. Magn. Reson.</i><b>14</b>(1), 53 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3424120</ArticleId><ArticleId IdType="pubmed">22720998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinojar, R. et al. Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis A proposed diagnostic algorithm using CMR. <i>JACC Cardiovasc. Imaging</i>. <b>8</b>, 37&#x2013;46 (2015).
</Citation><ArticleIdList><ArticleId IdType="pubmed">25499131</ArticleId></ArticleIdList></Reference><Reference><Citation>Messroghli, D. R. et al. <i>Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)</i> Vol. 19 (BioMed Central Ltd., 2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633041</ArticleId><ArticleId IdType="pubmed">28992817</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor, A. J., Salerno, M., Dharmakumar, R. &amp; Jerosch-Herold, M. T1 Mapping Basic Techniques and Clinical Applications. (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26762877</ArticleId></ArticleIdList></Reference><Reference><Citation>Haaf, P. et al. Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: A comprehensive review. <i>J. Cardiovasc. Magn. Reson.</i><b>18</b>(1), 89 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5129251</ArticleId><ArticleId IdType="pubmed">27899132</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangion, K., McComb, C., Auger, D. A., Epstein, F. H. &amp; Berry, C. Magnetic resonance imaging of myocardial strain after acute st-segment-elevation myocardial infarction a systematic review. <i>Circ. Cardiovasc. Imaging</i>. <b>10</b>, e006498 (2017).
</Citation><ArticleIdList><ArticleId IdType="pubmed">28733364</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber, L. et al. Impact of myocardial injury on regional left ventricular function in the course of acute myocarditis with preserved ejection fraction: insights from segmental feature tracking strain analysis using cine cardiac MRI. <i>Int. J. Cardiovasc. Imaging</i>. <b>38</b> (8), 1851&#x2013;1861 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9797452</ArticleId><ArticleId IdType="pubmed">37726513</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, L. et al. T1 mapping and extracellular volume in cardiomyopathy showing left ventricular hypertrophy: differentiation between hypertrophic cardiomyopathy and hypertensive heart disease. <i>Int. J. Gen. Med.</i><b>15</b>, 4163&#x2013;4173 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9030388</ArticleId><ArticleId IdType="pubmed">35465304</ArticleId></ArticleIdList></Reference><Reference><Citation>Swoboda, P. P., McDiarmid, A. K., Page, S. P., Greenwood, J. P. &amp; Plein, S. Role of T1 mapping in inherited cardiomyopathies. <i>Eur. Cardiol. Rev.</i><b>11</b> (2), 96&#x2013;101 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5228763</ArticleId><ArticleId IdType="pubmed">28090218</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. et al. T1 mapping and extracellular volume fraction in dilated cardiomyopathy: A prognosis study. <i>JACC Cardiovasc. Imaging</i>. <b>15</b> (4), 578&#x2013;590 (2022).
</Citation><ArticleIdList><ArticleId IdType="pubmed">34538631</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber, A. T. et al. Non-invasive differentiation of idiopathic inflammatory myopathy with cardiac involvement from acute viral myocarditis using cardiovascular magnetic resonance imaging T1 and T2 mapping. <i>J. Cardiovasc. Magn. Reson.</i><b>20</b>(1), 11 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5808400</ArticleId><ArticleId IdType="pubmed">29429407</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, S., Simonetti, O., Carr, J., Kramer, U. &amp; Finn, J. MR imaging of the heart with cine true fast imaging with Steady-State precession: influence of Spatial and Temporal resolutions on left ventricular functional parameters. <i>Radiology</i><b>223</b>, 263&#x2013;269 (2002).
</Citation><ArticleIdList><ArticleId IdType="pubmed">11930076</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H. et al. Technical aspects of in vivo small animal CMR imaging. <i>Front. Phys.</i><b>8</b>, 183 (2020).</Citation></Reference><Reference><Citation>Sant&#x2019;anna, M. F. B. et al. Morbidity and mortality rate among men and women diagnosed with myocardial infarction. <i>Revista Enfermagem</i>. <b>29</b>, e53001 (2021).</Citation></Reference><Reference><Citation>Kober, F. et al. High-Resolution myocardial perfusion mapping in small animals in vivo by Spin-Labeling Gradient-Echo imaging. <i>Magn. Reson. Med.</i><b>51</b> (1), 62&#x2013;67 (2004).
</Citation><ArticleIdList><ArticleId IdType="pubmed">14705046</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamy, J. et al. Scan-rescan reproducibility of ventricular and atrial MRI feature tracking strain. <i>Comput. Biol. Med.</i><b>92</b>, 197&#x2013;203 (2018).
</Citation><ArticleIdList><ArticleId IdType="pubmed">29227821</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber, A. et al. Cardiac MR strain: A noninvasive biomarker of fibrofatty remodeling of the left atrial myocardium. <i>Radiology</i><b>286</b>, 83&#x2013;92 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28813234</ArticleId></ArticleIdList></Reference><Reference><Citation>Evin, M. et al. Left atrial aging: A cardiac magnetic resonance feature-tracking study. <i>Am. J. Physiol. Heart Circ. Physiol.</i><b>310</b> (5), H542&#x2013;H549 (2016).
</Citation><ArticleIdList><ArticleId IdType="pubmed">26747498</ArticleId></ArticleIdList></Reference><Reference><Citation>Evin, M. et al. Impact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis. <i>Cardiovasc. Diabetol.</i><b>15</b>(1), 64 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5178096</ArticleId><ArticleId IdType="pubmed">28007022</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoganathan, T. et al. Acute stress induces long-term metabolic, functional, and structural remodeling of the heart. <i>Nat. Commun.</i><b>14</b>(1), 3835 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10307856</ArticleId><ArticleId IdType="pubmed">37380648</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkenhans, B., Protti, A., Shah, A., Onthank, D. &amp; Botnar, R. Visualization of Elastin using cardiac magnetic resonance imaging after myocardial infarction as inflammatory response. <i>Sci. Rep.</i><b>11</b>(1), 11004 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155029</ArticleId><ArticleId IdType="pubmed">34040032</ArticleId></ArticleIdList></Reference><Reference><Citation>Santer, D. et al. In vivo and ex vivo functional characterization of left ventricular remodelling after myocardial infarction in mice. <i>ESC Heart Fail.</i><b>2</b> (3), 171&#x2013;177 (2015).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6410549</ArticleId><ArticleId IdType="pubmed">28834679</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe4;ty, I. et al. Ex vivo imaging of subacute myocardial infarction with ultra-short echo time 3D quantitative T1- and T1&#x3c1; -mapping magnetic resonance imaging in mice. European heart journal Imaging methods and practice [Internet]. 3(1):qyae131. (2025). Available from: http://www.ncbi.nlm.nih.gov/pubmed/39811012</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11726772</ArticleId><ArticleId IdType="pubmed">39811012</ArticleId></ArticleIdList></Reference><Reference><Citation>Coolen, B. et al. Three-dimensional T1 mapping of the mouse heart using variable flip angle steady-state MR imaging. <i>NMR Biomed.</i><b>24</b>, 154&#x2013;162 (2011).
</Citation><ArticleIdList><ArticleId IdType="pubmed">20960583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueda, J. &amp; Saito, S. Evaluation of cardiac function in young Mdx mice using MRI with feature tracking and Self-Gated magnetic resonance cine imaging. <i>Diagnostics</i><b>13</b>, 1472 (2023).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10137836</ArticleId><ArticleId IdType="pubmed">37189573</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilson, W. D. et al. Innovative methodology measurement of myocardial mechanics in mice before and after infarction using multislice displacement-encoded MRI with 3D motion encoding measurement of myocardial mechanics in mice before and after infarction using multislice displacement-encoded MRI with 3D motion encoding. <i>Am. J. Physiol. Heart Circ. Physiol.</i><b>288</b>, 1491&#x2013;1497 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15513963</ArticleId></ArticleIdList></Reference><Reference><Citation>Suever, J. D. et al. Simplified post processing of cine DENSE cardiovascular magnetic resonance for quantification of cardiac mechanics. <i>J. Cardiovasc. Magn. Reson.</i><b>16</b>, 94 (2014).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4246464</ArticleId><ArticleId IdType="pubmed">25430079</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, H. et al. Distribution pattern of left-ventricular myocardial strain analyzed by a cine MRI based deformation registration algorithm in healthy Chinese volunteers. <i>Sci. Rep.</i><b>7</b>, 45314 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5368608</ArticleId><ArticleId IdType="pubmed">28349989</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitman, M. et al. Circumferential and longitudinal strain in 3 myocardial layers in normal subjects and in patients with regional left ventricular dysfunction. <i>J. Am. Soc. Echocardiogr.</i><b>23</b>, 64&#x2013;70 (2010).
</Citation><ArticleIdList><ArticleId IdType="pubmed">20122496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuppinger, C. et al. Detection of myocardial fibrosis: where we stand. <i>Front. Cardiovasc. Med.</i><b>9</b>, 926378 (2022).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9557071</ArticleId><ArticleId IdType="pubmed">36247487</ArticleId></ArticleIdList></Reference><Reference><Citation>Nezafat, M. et al. Improved segmented modified Look-Locker inversion recovery T1 mapping sequence in mice. <i>PLoS One</i>. <b>12</b>, e0187621 (2017).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5679534</ArticleId><ArticleId IdType="pubmed">29121086</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitou&#x161;, J. et al. T1 mapping of myocardium in rats using self-gated golden-angle acquisition. <i>Magn. Reson. Med.</i><b>91</b> (1), 368&#x2013;380 (2024).
</Citation><ArticleIdList><ArticleId IdType="pubmed">37811699</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapon, C., Herlihy, A. H. &amp; Bhakoo, K. K. Assessment of myocardial infarction in mice by late gadolinium enhancement MR imaging using an inversion recovery pulse sequence at 9.4T. <i>J. Cardiovasc. Magn. Reson.</i><b>10</b>(1), 44 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2244610</ArticleId><ArticleId IdType="pubmed">18272007</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl, S. et al. Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI. <i>Am. J. Physiol. Heart Circ. Physiol.</i><b>296</b>, H1200&#x2013;H1208 (2009).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2670705</ArticleId><ArticleId IdType="pubmed">19218501</ArticleId></ArticleIdList></Reference><Reference><Citation>Sk&#xe5;rdal, K., Rolim, N. P. L., Haraldseth, O., Goa, P. E. &amp; Thuen, M. Late gadolinium enhancement in the assessment of the infarcted mouse heart: A longitudinal comparison with manganese-enhanced MRI. <i>J. Magn. Reson. Imaging</i>. <b>38</b> (6), 1388&#x2013;1394 (2013).
</Citation><ArticleIdList><ArticleId IdType="pubmed">23559475</ArticleId></ArticleIdList></Reference><Reference><Citation>Price, A. N. et al. Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T. <i>J. Cardiovasc. Magn. Reson.</i><b>13</b>(1). (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182945</ArticleId><ArticleId IdType="pubmed">21892953</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Z., Berr, S. S., Gilson, W. D., Toufektsian, M. C. &amp; French, B. A. Simultaneous evaluation of infarct size and cardiac function in intact mice by Contrast-Enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. <i>Circulation</i><b>109</b> (9), 1161&#x2013;1167 (2004).
</Citation><ArticleIdList><ArticleId IdType="pubmed">14967719</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaher, N., Lacerda S., Digilio G., Padovan S., Gao L., Lavin B., Stefania R., Velasco C., Cruz G., Prieto C., Botnar R., Phinikariou A. Imaging Non-invasive in vivo imaging of changes in Collagen III turnover in myocardial fibrosis. npj imaging 2, 33 (2024)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11408249</ArticleId><ArticleId IdType="pubmed">39301014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapinskas, T. et al. Cardiovascular magnetic resonance feature tracking in small animals - a preliminary study on reproducibility and sample size calculation. <i>BMC Med. Imaging</i>. <b>17</b>, 51 (2017).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5569535</ArticleId><ArticleId IdType="pubmed">28835220</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthuramu, I., Lox, M., Jacobs, F. &amp; De Geest, B. Permanent ligation of the left anterior descending coronary artery in mice: A model of post-myocardial infarction remodelling and heart failure. <i>J. Visualized Experiments</i> (2014) (94).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4354439</ArticleId><ArticleId IdType="pubmed">25489995</ArticleId></ArticleIdList></Reference><Reference><Citation>Johny, E. &amp; Dutta, P. Left coronary artery ligation: A surgical murine model of myocardial infarction. <i>J. Visualized Experiments</i>. <b>2022</b>, 186 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10444521</ArticleId><ArticleId IdType="pubmed">36036590</ArticleId></ArticleIdList></Reference><Reference><Citation>Degabriele, N. M. et al. Critical appraisal of the mouse model of myocardial infarction. <i>Exp. Physiol.</i><b>89</b> (4), 497&#x2013;505 (2004).
</Citation><ArticleIdList><ArticleId IdType="pubmed">15131069</ArticleId></ArticleIdList></Reference><Reference><Citation>Krug, J. W., Rose, G., Stucht, D., Clifford, G. &amp; Oster, J. Limitations of VCG based gating methods in ultra high field cardiac MRI. <i>J. Cardiovasc. Magn. Reson.</i><b>15</b>, W19 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4174900</ArticleId><ArticleId IdType="pubmed">24252594</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe4;b, D., Roessler, J., O&#x2019;Brien, K., Hamilton-Craig, C. &amp; Barth, M. ECG triggering in Ultra-High field cardiovascular MRI. <i>Tomography</i><b>2</b> (3), 167&#x2013;174 (2016).
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6024401</ArticleId><ArticleId IdType="pubmed">30042961</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40795835</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-2412</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>09</Day></PubDate></JournalIssue><Title>European heart journal. Cardiovascular Imaging</Title><ISOAbbreviation>Eur Heart J Cardiovasc Imaging</ISOAbbreviation></Journal><ArticleTitle>Cardiovascular magnetic resonance to differentiate veteran athlete's heart with cavity dilatation and mild dilated cardiomyopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">jeaf234</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjci/jeaf234</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To investigate the distribution of myocardial fibrosis and patterns of tissue characteristics on cardiovascular magnetic resonance (CMR) between athletes with LV dilatation and mild DCM patients.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">We prospectively recruited male cyclists/triathletes aged &#x2265;50y who undertook &#x2265;10h/week of exercise for &#x2265;15y along with age/sex-matched patients with non-ischaemic heart failure (HF). Participants underwent clinical assessment, 12-lead ECG, stress-perfusion CMR with fibrosis assessment and parametric tissue mapping.Following CMR, included participants in both groups had LVEF&gt;40% and LVEDVi&gt;110ml/m2 without ischaemic heart disease or significant cardiac pathology on CMR likely to cause HF.Of 113 participants (64 athletes, 49 mild DCM patients), athletes with fibrosis demonstrated a greater prevalence of inferolateral fibrosis (87.5% vs 50.0%, P=0.002) whereas inferoseptal fibrosis was more common in mild DCM patients (45.8% vs 9.4%, P=0.002).Native T1 (1249.0&#xb1;38.1 vs 1308.3&#xb1;47.1ms,P&lt;0.001) and extracellular volume (ECV) (22.0&#xb1;2.1 vs 25.9&#xb1;3.5%, P&lt;0.001) were lower in athletes. Athletes had greater right ventricular end-diastolic volume indexed to body surface area (RVEDVi) (121.0&#xb1;14.3 vs 97.6&#xb1;25.2%, P&lt;0.001), myocardial perfusion reserve (MPR) (3.65&#xb1;1.30 vs 2.76&#xb1;0.92,P&lt;0.001) and stress myocardial blood flow (MBF) (2.09&#xb1;0.70 vs 1.62&#xb1;0.66,P&lt;0.001) than mild DCM patients.On receiver-operator curve analysis, native T1 (area under curve (AUC) 0.89,P&lt;0.001), ECV (AUC 0.85,P&lt;0.001), RVEDVi (AUC 0.81, P&lt;0.001) and stress MBF (AUC 0.68,P=0.002) were able to differentiate between groups.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Septal fibrosis is rare amongst veteran athletes with LV dilation in contrast to mild DCM patients. Native T1, ECV and RVEDVi can also discriminate between these overlapping phenotypes which may be clinically useful.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Javed</LastName><ForeName>W</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-5677-5708</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomoaia</LastName><ForeName>R</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1944-4088</Identifier><AffiliationInfo><Affiliation>"Iuliu Ha&#x21b;ieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farooq</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chambers</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botis</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goh</LastName><ForeName>Z</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>L A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farley</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xue</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National Institutes for Health, National Heart, Lung, and Blood Institute, Bethesda, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levelt</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Baker Heart and Diabetes Institute &amp; University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dall'Armellina</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenwood</LastName><ForeName>J P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-2861-0914</Identifier><AffiliationInfo><Affiliation>Baker Heart and Diabetes Institute &amp; University of Melbourne, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kellman</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9875-6070</Identifier><AffiliationInfo><Affiliation>National Institutes for Health, National Heart, Lung, and Blood Institute, Bethesda, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plein</LastName><ForeName>S</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0997-4384</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Swoboda</LastName><ForeName>P P</ForeName><Initials>PP</Initials><AffiliationInfo><Affiliation>Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Cardiovasc Imaging</MedlineTA><NlmUniqueID>101573788</NlmUniqueID><ISSNLinking>2047-2404</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Athlete&#x2019;s Heart</Keyword><Keyword MajorTopicYN="N">Dilated Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Myocardial fibrosis</Keyword><Keyword MajorTopicYN="N">Parametric Tissue Characterisation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>18</Hour><Minute>40</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40795835</ArticleId><ArticleId IdType="doi">10.1093/ehjci/jeaf234</ArticleId><ArticleId IdType="pii">8229587</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40794966</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1936-9018</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>The western journal of emergency medicine</Title><ISOAbbreviation>West J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Mixed-Methods Investigation of Rural Emergency Medical Services ST-Elevation Myocardial Infarction Time to Percutaneous Coronary Intervention: High- vs Low-Performing Agencies.</ArticleTitle><Pagination><StartPage>924</StartPage><EndPage>935</EndPage><MedlinePgn>924-935</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5811/westjem.43536</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Patients with ST-elevation myocardial infarction (STEMI) cared for by rural emergency medical services (EMS) agencies commonly do not have first medical contact-to-percutaneous coronary intervention (PCI) time within the recommended goal of 90 minutes. In this study we identify factors associated with performance variation among rural EMS agencies in first medical contact-to-PCI time.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In this explanatory, sequential, mixed-methods study, we ranked eight rural county EMS agencies by continuous first medical contact-to-PCI time, accounting for loaded mileage, using data from a regional STEMI registry (2016-2019). A qualitative researcher conducted 28, one-hour, semi-structured interviews from January- March 2021 with the EMS director, training officer, medical director, and four paramedics at the top two high- and bottom two low-performing rural EMS agencies. Key informants were blinded to agency STEMI performance. Interviews were structured to identify positive deviance by exploring agencies' clinical approach to patients with chest pain, their organizational culture, structure, and quality improvement (QI) activities regarding STEMI care, and recommendations for improving STEMI performance. Interviews were digitally recorded and transcribed verbatim by a professional transcription service. We established a codebook and performed a thematic analysis using an inductive approach. We summarized and compared data across agencies to identify commonalities and differences between high- and low-performing agencies. Findings were reviewed and validated by an expert panel.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The top two highest-performing EMS agencies had a median first medical contact-to-PCI time of 79 minutes (interquartile range [IQR] 65-91) minutes vs 98 minutes (IQR 82-120) among the bottom two lowest-performing agencies, P&lt;.001. Both high- and low-performing agencies identified issues with electrocardiogram (ECG) transmitting technology and cumbersome hospital activation communications. However, top-performing agencies shared a culture that encourages early EMS activation of the cardiac catheterization lab after STEMI recognition. Top-performing agencies also placed a higher value on QI and training. These agencies prioritized mission and chain of command over staff relationships/interpersonal bonds; have stable, strong leadership; provide opportunities for career advancement; and collaborate with community leaders.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Top-performing rural EMS agencies for STEMI care promote early activation, have a strong chain of command, are mission focused, and have a greater focus on quality improvement and training.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Supples</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Emergency Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallagher</LastName><ForeName>McKenna E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Implementation Science, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashburn</LastName><ForeName>Nicklaus P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Emergency Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snavely</LastName><ForeName>Anna C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Emergency Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Biostatistics and Data Science, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strahley</LastName><ForeName>Ashley E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Social Sciences and Health Policy, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Chadwick D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Emergency Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahler</LastName><ForeName>Simon A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Emergency Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Epidemiology and Prevention, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Implementation Science, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stopyra</LastName><ForeName>Jason P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Emergency Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HS029017</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HL169929</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 HS029234</GrantID><Acronym>HS</Acronym><Agency>AHRQ HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR001421</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HL123027</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>West J Emerg Med</MedlineTA><NlmUniqueID>101476450</NlmUniqueID><ISSNLinking>1936-900X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="Y">Emergency Medical Services</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019035" MajorTopicYN="Y">Rural Health Services</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="Y">Time-to-Treatment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="N">Quality Improvement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><i>Conflicts of Interest</i>: By the <i>West</i>JEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. Dr. Supples receives funding from the National Foundation of Emergency Medicine and Health Resources and Services Administration (HRSA) (1H2ARH399760100). Dr. Ashburn receives funding from NHLBI (K23HL169929), AHRQ (R01HS029017), and the Emergency Medicine Foundation. Dr. Snavely receives funding from Abbott Laboratories and HRSA (1H2ARH399760100). Dr. Miller receives research funding from Siemens, Abbott Point of Care, Creavo Medical Technologies, Grifols, and National Heart, Lung, and Blood Institute (5U01HL123027). He has a US patent on cardiac biomarkers for coronary artery disease related to cholesterol esters. Dr Mahler has received funding/support from Roche Diagnostics, Abbott Laboratories, QuidelOrtho Clinical Diagnostics, Siemens, Grifols, Pathfast, Genetesis, Cytovale, Beckman Coulter, Brainbox, Bluejay Diagnostics, Agency for Healthcare Research and Quality (R01HS029017 and R21HS029234), the Duke Endowment, National Foundation of Emergency Medicine, and HRSA (1H2ARH399760100); is a consultant for Roche, Abbott, Siemens, QuidelOrtho, Genetesis, Inflammatix, and Radiometer; and is the chief medical officer for Impathiq Inc. Dr. Stopyra receives research funding from HRSA (H2ARH39976-01-00), Roche Diagnostics, Abbott Laboratories, Pathfast, Genetesis, Cytovale, Forest Devices, Vifor Pharma, and Chiesi Farmaceutici. Research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number KL2TR001421. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>18</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>18</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>14</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40794966</ArticleId><ArticleId IdType="pmc">PMC12342413</ArticleId><ArticleId IdType="doi">10.5811/westjem.43536</ArticleId><ArticleId IdType="pii">westjem.43536</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 Update: a report from the American Heart Association. Circulation. 2016;133(4):e38&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">26673558</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362&#x2013;425.</Citation><ArticleIdList><ArticleId IdType="pubmed">23247304</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong PW, Boden WE. Reperfusion paradox in ST-segment elevation myocardial infarction. Ann Intern Med. 2011;155(6):389&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">21930857</ArticleId></ArticleIdList></Reference><Reference><Citation>Bates ER, Nallamothu BK. Commentary: the role of percutaneous coronary intervention in ST-segment-elevation myocardial infarction. Circulation. 2008;118(5):567&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">18663104</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39(13):1065&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6018916</ArticleId><ArticleId IdType="pubmed">29452351</ArticleId></ArticleIdList></Reference><Reference><Citation>Terkelsen CJ, Jensen LO, Tilsted HH, et al. Health care system delay and heart failure in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: follow-up of population-based medical registry data. Ann Intern Med. 2011;155(6):361&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21930853</ArticleId></ArticleIdList></Reference><Reference><Citation>Terkelsen CJ, Sorensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA. 2010;304(7):763&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">20716739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert L, Brown K, Segal E, et al. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA. 2010;303(21):2148&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">20516415</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenship JC, Scott TD, Skelding KA, et al. Door-to-balloon times under 90 min can be routinely achieved for patients transferred for ST-segment elevation myocardial infarction percutaneous coronary intervention in a rural setting. J Am Coll Cardiol. 2011;57(3):272&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21232663</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen DK, Washington A, Dougherty J, et al. Door-to-balloon time for primary percutaneous coronary intervention: How does Northern West Virginia compare? J Emerg Med. 2012;43(3):413&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22032813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennin CK, Ibrahim S, Al-Saffar F, et al. Achieving timely percutaneous reperfusion for rural ST-elevation myocardial infarction patients by direct transport to an urban PCI-hospital. J Geriatr Cardiol. 2016;13(10):840&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131199</ArticleId><ArticleId IdType="pubmed">27928226</ArticleId></ArticleIdList></Reference><Reference><Citation>American Heart Association. Opportunities to Improve STEMI Systems of Care. 2018.  [Accessed June 20, 2024].  Available at:  https://www.heart.org/en/professional/quality-improvement/mission-lifeline/opportunities-to-improve-stemi-systems-of-care.</Citation></Reference><Reference><Citation>Hsia RY, Shen YC. Percutaneous coronary intervention in the United States: risk factors for untimely access. Health Serv Res. 2016;51(2):592&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4799910</ArticleId><ArticleId IdType="pubmed">26174998</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams TE, Vaughan-Sarrazin M, Kaboli PJ. Mortality and revascularization following admission for acute myocardial infarction: implication for rural veterans. J Rural Health. 2010;26(4):310&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21029165</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Medicare &amp; Medicaid Services. Rural Health Strategy. 2018.  [Accessed August 27, 2018].  Available at:  https://www.cms.gov/About-CMS/Agency-Information/OMH/Downloads/Rural-Strategy-2018.pdf.</Citation></Reference><Reference><Citation>US Department of Health and Human Services. Healthy People 2020: Objectives for Improving Health. Washington, DC: US Dept of Health and Human Services; ; 2010.  [Accessed July 2, 2024].  Available at:  https://www.healthypeople.gov/2020.</Citation></Reference><Reference><Citation>EMS Agenda 2050 Technical Expert Panel. EMS Agenda 2050: A People-Centered Vision for the Future of Emergency Medical Services (Report No. DOT HS 812, 664) 2019.  [Accessed June 20, 2024].  Available at:  https://www.ems.gov/resources/newsletters/may-2019/creating-a-people-centered-ems/</Citation></Reference><Reference><Citation>O&#x2019;Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013;82(1):E1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">23299937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauerman HL, Bates ER, Kontos MC, et al. Nationwide analysis of patients with ST-segment-elevation myocardial infarction transferred for primary percutaneous intervention: findings from the American Heart Association Mission: Lifeline Program. Circ Cardiovasc Interv. 2015;8(5):e002450.</Citation><ArticleIdList><ArticleId IdType="pubmed">25901044</ArticleId></ArticleIdList></Reference><Reference><Citation>Langabeer JR, 2nd, Prasad S, Seo M, et al. The effect of interhospital transfers, emergency medical services, and distance on ischemic time in a rural ST-elevation myocardial infarction system of care. Am J Emerg Med. 2015;33(7):913&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25910668</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhudy JP, Jr, Alexandrov AW, Hyrkas KE, et al. Geographic access to interventional cardiology services in one rural state. Heart Lung. 2016;45(5):434&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">27493022</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanguay A, Dallaire R, Hebert D, et al. Rural patient access to primary percutaneous coronary intervention centers is improved by a novel integrated telemedicine prehospital system. J Emerg Med. 2015;49(5):657&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">26215451</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopyra JP, Snavely AC, Ashburn NP, et al. Rural EMS STEMI patients - why the delay to PCI? Prehosp Emerg Care. 2024;28(7):947&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11255126</ArticleId><ArticleId IdType="pubmed">38235978</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravasi D, Schultz M. Responding to organizational identity threats: exploring the role of organizational culture. Acad Manage J. 2006;49(3):433&#x2013;58.</Citation></Reference><Reference><Citation>Bradley EH, Curry LA, Spatz ES, et al. Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann Intern Med. 2012;156(9):618&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3386642</ArticleId><ArticleId IdType="pubmed">22547471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley EH, Curry LA, Webster TR, et al. Achieving rapid door-to-balloon times: how top hospitals improve complex clinical systems. Circulation. 2006;113(8):1079&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">16490818</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley EH, Roumanis SA, Radford MJ, et al. Achieving door-to-balloon times that meet quality guidelines: How do successful hospitals do it? J Am Coll Cardiol. 2005;46(7):1236&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">16198837</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry LA, Spatz E, Cherlin E, et al. What distinguishes top-performing hospitals in acute myocardial infarction mortality rates? A qualitative study. Ann Intern Med. 2011;154(6):384&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4735872</ArticleId><ArticleId IdType="pubmed">21403074</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster TR, Curry L, Berg D, et al. Organizational resiliency: how top-performing hospitals respond to setbacks in improving quality of cardiac care. J Healthc Manag. 2008;53(3):169&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203950</ArticleId><ArticleId IdType="pubmed">18546919</ArticleId></ArticleIdList></Reference><Reference><Citation>Nam J, Caners K, Bowen JM, et al. Systematic review and meta-analysis of the benefits of out-of-hospital 12-lead ECG and advance notification in ST-segment elevation myocardial infarction patients. Ann Emerg Med. 2014;64(2):176&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">24368054</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage ML, Poon KK, Johnston EM, et al. Pre-hospital ambulance notification and initiation of treatment of ST-elevation myocardial infarction is associated with significant reduction in door-to-balloon time for primary PCI. Heart Lung Circ. 2014;23(5):435&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">24388497</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn T, Johnsen S, Gale CP, et al. Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project. Heart. 2014;100(12):944&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033209</ArticleId><ArticleId IdType="pubmed">24732676</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo CY, Bonsu KO, Nallamothu BK, et al. Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis. Heart. 2018;104(16):1362&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29437704</ArticleId></ArticleIdList></Reference><Reference><Citation>Studnek JR, Infinger A, Wilson H, et al. Decreased time from 9-1-1 call to PCI among patients experiencing STEMI results in a decreased one year mortality. Prehosp Emerg Care. 2018;22(6):669&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">29596009</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunetti ND, Dellegrottaglie G, Lopriore C, et al. Prehospital telemedicine electrocardiogram triage for a regional public emergency medical service: is it worth it? A preliminary cost analysis. Clin Cardiol. 2014;37(3):140&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6649415</ArticleId><ArticleId IdType="pubmed">24452666</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen MB, Frost L, Stengaard C, et al. Diagnostic performance and system delay using telemedicine for prehospital diagnosis in triaging and treatment of STEMI. Heart. 2014;100(9):711&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">24637516</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen JT, Terkelsen CJ, Norgaard BL, et al. Urban and rural implementation of pre-hospital diagnosis and direct referral for primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction. Eur Heart J. 2011;32(4):430&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">21138933</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Malley R, O&#x2019;Connor P, Madden C, et al. A systematic review of the use of positive deviance approaches in primary care. Fam Pract. 2022;39(3):493&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">34849733</ArticleId></ArticleIdList></Reference><Reference><Citation>Stopyra JP, Snavely AC, Ashburn NP, et al. Delayed first medical contact to reperfusion time increases mortality in rural emergency medical services patients with ST-elevation myocardial infarction. Acad Emerg Med. 2023;30(11):1101&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10830062</ArticleId><ArticleId IdType="pubmed">37567785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley EH, Curry LA, Ramanadhan S, et al. Research in action: using positive deviance to improve quality of health care. Implement Sci. 2009;4:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2690576</ArticleId><ArticleId IdType="pubmed">19426507</ArticleId></ArticleIdList></Reference><Reference><Citation>US Census Bureau. American Community Survey (ACS)  Washington, DC: US Census Bureau; 2014.  [Accessed January 30, 2022].  Available at:  https://www.census.gov/programs-surveys/acs.</Citation></Reference><Reference><Citation>Huber PJ, Ronchetti EM. Robust Statistics. New York, NY: John Wiley and Sons; 1981. Regression; pp. 153&#x2013;98.</Citation></Reference><Reference><Citation>ATLAS.ti, version 9.0 [computer software] Denver, CO: Lumivero; 2021.</Citation></Reference><Reference><Citation>Green J, Thorogood N. Qualitative Methods for Health Research. 4th ed. London, UK: Sage Publications; 2018.</Citation></Reference><Reference><Citation>National Highway Traffic Safety Administration. National Emergency Medical Services Education Standards 2021. 2021.  [Accessed July 10, 2024].  Available at:  https://www.ems.gov/pdf/EMS_Education_Standards_2021_v22.pdf.</Citation></Reference><Reference><Citation>D&#x2019;Arcy NT, Bosson N, Kaji AH, et al. Weekly checks improve real-time prehospital ECG transmission in suspected STEMI. Prehosp Disaster Med. 2018;33(3):245&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29708085</ArticleId></ArticleIdList></Reference><Reference><Citation>Roswell RO, Greet B, Parikh P, et al. From door-to-balloon time to contact-to-device time: predictors of achieving target times in patients with ST-elevation myocardial infarction. Clin Cardiol. 2014;37(7):389&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6649358</ArticleId><ArticleId IdType="pubmed">24700343</ArticleId></ArticleIdList></Reference><Reference><Citation>Tolles J, Bosson N, Kaji AH, et al. The effect of implementation of the American Heart Association Mission Lifeline PreAct Algorithm for Prehospital Cardiac Catheterization Laboratory Activation on the rate of &#x201c;false positive&#x201d; activations. Prehosp Disaster Med. 2020;35(4):388&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">32430085</ArticleId></ArticleIdList></Reference><Reference><Citation>Khot UN, Johnson ML, Ramsey C, et al. Emergency department physician activation of the catheterization laboratory and immediate transfer to an immediately available catheterization laboratory reduce door-to-balloon time in ST-elevation myocardial infarction. Circulation. 2007;116(1):67&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">17562960</ArticleId></ArticleIdList></Reference><Reference><Citation>Baran KW, Kamrowski KA, Westwater JJ, et al. Very rapid treatment of ST-segment-elevation myocardial infarction: utilizing prehospital electrocardiograms to bypass the emergency department. Circ Cardiovasc Qual Outcomes. 2010;3(4):431&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20647577</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheskes S, Turner L, Foggett R, et al. Paramedic contact to balloon in less than 90 minutes: a successful strategy for ST-segment elevation myocardial infarction bypass to primary percutaneous coronary intervention in a Canadian emergency medical system. Prehosp Emerg Care. 2011;15(4):490&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21830918</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagai A, Al-Khalidi HR, Mu&#xf1;oz D, et al. Bypassing the emergency department and time to reperfusion in patients with prehospital ST-segment-elevation: findings from the reperfusion in acute myocardial infarction in Carolina Emergency Departments project. Circ Cardiovasc Interv. 2013;6(4):399&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">23861465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontos MC, Gunderson MR, Zegre-Hemsey JK, et al. Prehospital Activation of Hospital Resources (PreAct) ST-Segment-Elevation Myocardial Infarction (STEMI): A standardized approach to prehospital activation and direct to the catheterization laboratory for STEMI: recommendations from the American Heart Association&#x2019;s Mission: Lifeline Program. J Am Heart Assoc. 2020;9(2):e011963.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7033830</ArticleId><ArticleId IdType="pubmed">31957530</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincoln EW, Reed-Schrader E, Jarvis JL. StatsPearls. Treasure Island, FL: StatsPearls Publishing.; 2023. EMS quality improvement programs.</Citation><ArticleIdList><ArticleId IdType="pubmed">30725667</ArticleId></ArticleIdList></Reference><Reference><Citation>Redlener M, Olivieri P, Loo GT, et al. National assessment of quality programs in emergency medical services. Prehosp Emerg Care. 2018;22(3):370&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29297735</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo V, Minutolo G, Battaglini A, et al. Leadership effectiveness in healthcare settings: a systematic review and meta-analysis of cross-sectional and before-after studies. Int J Environ Res Public Health. 2022;19(17)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9518077</ArticleId><ArticleId IdType="pubmed">36078706</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfantou DF, Laliotis A, Patelarou AE, et al. Importance of leadership style towards quality of care measures in healthcare settings: a systematic review. Healthcare (Basel) 2017;5(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5746707</ArticleId><ArticleId IdType="pubmed">29036901</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis Doverspike OnShift Inc-Avesta Systems Inc. 2022 EMS Employee Turnover Study. 2023.  [Accessed August 18, 2024].  Available at:  https://ambulance.org/sp_product/2022-ems-employee-turnover-study/</Citation></Reference><Reference><Citation>Cash RE, White-Mills K, Crowe RP, et al. Workplace incivility among nationally certified EMS professionals and associations with workforce-reducing factors and organizational culture. Prehosp Emerg Care. 2019;23(3):346&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">30118629</ArticleId></ArticleIdList></Reference><Reference><Citation>Hentschker C, Mennicken R. The volume&#x2013;outcome relationship revisited: Practice indeed makes perfect. Health Serv Res. 2018;53(1):15&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5785314</ArticleId><ArticleId IdType="pubmed">28868612</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker D, Rosenthal G, Cram P. Simultaneous relationships between procedure volume and mortality: Do they bias studies of mortality at specialty hospitals? Health Econ. 2011;20(5):505&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">21433215</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaynor M, Seider H, Vogt WB. The volume&#x2013;outcome effect, scale economies, and learning-by-doing. Am Econ Rev. 2005;95(2):243&#x2013;7.</Citation></Reference><Reference><Citation>Luft HS, Hunt SS, Maerki SC. The volume-outcome relationship: practice-makes-perfect or selective-referral patterns? Health Serv Res. 1987;22(2):157&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1065430</ArticleId><ArticleId IdType="pubmed">3112042</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40808578</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-8298</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>14</Day></PubDate></JournalIssue><Title>Future cardiology</Title><ISOAbbreviation>Future Cardiol</ISOAbbreviation></Journal><ArticleTitle>Acute myocardial infarction treatment delay in South Asia: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>15</EndPage><MedlinePgn>1-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14796678.2025.2541525</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Acute Myocardial Infarction (AMI) necessitates timely treatment to improve outcomes. Identifying treatment delays across different South Asian countries can aid in formulating policies to reduce these delays. Objectives: To estimate the average treatment delay in AMI patients in South Asia and identify contributing factors.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Using the CoCoPop framework (Condition, Context, Population), studies were reviewed on AMI treatment delays in South Asia from 2000 to 2022. Databases searched included PubMed Central, Embase and Google Scholar. Eligible studies were cross-sectional and analytical that reported exact delay times, excluding knowledge, attitude, practice studies, narrative reviews, and case reports.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The search yielded 2954 records, with 42 studies meeting the inclusion criteria. The pooled median prehospital delay was 531&#x2009;minutes (95% CI: 366-769&#x2009;minutes). The pooled mean door-to-ECG time was 9.18&#x2009;minutes (95% CI: 2.52-15.84&#x2009;minutes). The door-to-needle and door to balloon time among STEMI patients were 37.95 (95% CI: 30.11-45.78&#x2009;minutes) minutes and 62.92&#x2009;minutes (95% CI: 45.28-80.56&#x2009;minutes), respectively with significant heterogeneity. Factors associated with delays included old age, female gender, low literacy, ignorance, financial constraints, and rural location.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Significant treatment delays for AMI patients in South Asia are identified, with socio-economic and logistical barriers contributing to these delays.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ramamurthy</LastName><ForeName>Deepthi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, ESIC MC &amp; PGIMSR, Bengaluru, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panda</LastName><ForeName>Meely</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Medicine &amp; Family Medicine, AIIMS Bibinagar, Hyderabad, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rangappa</LastName><ForeName>Manjula</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, S Nijalingappa Medical College, Bagalkot, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannan</LastName><ForeName>Suthanthira</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, ESIC Medical College and Hospital, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kundapur</LastName><ForeName>Rashmi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Community Medicine &amp; Family Medicine, AIIMS Bibinagar, Hyderabad, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajeshwari</LastName><ForeName>Swetha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>All India Institute of Hygiene and Public Health, Bidhannaga, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subbiah</LastName><ForeName>Padmavathi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Community Medicine, ESIC Medical College and Hospital, Chennai, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Pradeep</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Community Medicine &amp; Family Medicine, AIIMS, Rishikesh, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Sumit</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Descriptive Research, Indian Council of Medical Research- Hqrs, New Delhi, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Future Cardiol</MedlineTA><NlmUniqueID>101239345</NlmUniqueID><ISSNLinking>1479-6678</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Acute Myocardial Infarction (AMI), also known as heart attack, needs timely treatment to save lives and improve recovery. Identifying treatment delays in South Asia guides policies to effectively reduce such delays. Studies published between 2000 and 2022 from countries in South Asia were reviewed. It was observed that patients had delays of an average of 531&#x2009;minutes (nearly 9&#x2009;hours) to reach the hospital after symptoms began. Once at the hospital, it took around 9&#x2009;minutes for patients to get an ECG. For patients with a serious heart artery blockage (STEMI) the average time taken from reaching the hospital to starting medicine to break the clot (medicine given through a drip to open blocked arteries) was about 38&#x2009;minutes. On average, the time taken to reach and start treatment with a heart balloon procedure was about 63&#x2009;minutes. These times varied widely between studies. Several factors caused delays in treatment, including older age, being female, low education levels, not knowing heart attack symptoms, financial problems, and living in rural areas. This study shows that many people in South Asia experience long delays before getting treatment for heart attacks. Reducing these delays through public awareness, improved transport, and hospital readiness could help save more lives.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">STROBE</Keyword><Keyword MajorTopicYN="N">South Asia</Keyword><Keyword MajorTopicYN="N">Time-to-treatment</Keyword><Keyword MajorTopicYN="N">acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">treatment delay</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>4</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40808578</ArticleId><ArticleId IdType="doi">10.1080/14796678.2025.2541525</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40821353</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Cannabis-Induced Wellens Syndrome: A Rising Cardiovascular Risk.</ArticleTitle><Pagination><StartPage>e88068</StartPage><MedlinePgn>e88068</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e88068</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.88068</ELocationID><Abstract><AbstractText>Wellens syndrome&#xa0;is a rare variant of acute coronary syndrome (ACS) that often heralds an impending large anterior wall myocardial infarction. We present the case of a young male with no traditional coronary artery disease (CAD) risk factors. Despite only minimally elevated troponin levels, the patient's smoking history, serial&#xa0;electrocardiogram (ECG) changes, and the emerging evidence linking cannabis use to cardiovascular risk contributed to the timely diagnosis of Wellens syndrome. Although cannabis is increasingly accepted for medical and recreational use, growing concerns have been raised about its potential adverse cardiovascular effects. This case highlights the importance of early identification and prompt intervention. In Wellens syndrome, a conservative approach is associated with poor outcomes, making the decision to proceed with an invasive strategy critical. Understanding the association between cannabis use and myocardial infarction may shape future medical management as cannabis consumption continues to rise.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Unal et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Unal</LastName><ForeName>Selin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rattan</LastName><ForeName>Keston</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Mir Sulayman</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Internal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Roy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Internal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amro</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Internal Medicine, State University of New York Downstate Health Sciences University, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bukharovich</LastName><ForeName>Inna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cardiology, Kings County Hospital Center, Brooklyn, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cad: coronary artery disease</Keyword><Keyword MajorTopicYN="N">cannabis use</Keyword><Keyword MajorTopicYN="N">critical care cardiology</Keyword><Keyword MajorTopicYN="N">ecg interpretation</Keyword><Keyword MajorTopicYN="N">wellens syndrome</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40821353</ArticleId><ArticleId IdType="pmc">PMC12357741</ArticleId><ArticleId IdType="doi">10.7759/cureus.88068</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Miner B, Grigg WS, Hart EH. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2025. Wellens syndrome.</Citation><ArticleIdList><ArticleId IdType="pubmed">29494097</ArticleId></ArticleIdList></Reference><Reference><Citation>Pseudo-Wellens' syndrome secondary to concurrent cannabis and phencyclidine intoxication. Inayat F, Riaz I, Ali NS, Figueredo VM. BMJ Case Rep. 2018;2018</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6040563</ArticleId><ArticleId IdType="pubmed">29960973</ArticleId></ArticleIdList></Reference><Reference><Citation>Angiographic and clinical characteristics of patients with unstable angina showing an ECG pattern indicating critical narrowing of the proximal LAD coronary artery. de Zwaan C, B&#xe4;r FW, Janssen JH, et al. Am Heart J. 1989;117:657&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pubmed">2784024</ArticleId></ArticleIdList></Reference><Reference><Citation>Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Thomas G, Kloner RA, Rezkalla S. Am J Cardiol. 2014;113:187&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pubmed">24176069</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Pacher P, Steffens S, Hask&#xf3; G, Schindler TH, Kunos G. Nat Rev Cardiol. 2018;15:151&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">28905873</ArticleId></ArticleIdList></Reference><Reference><Citation>World Drug Report 2022. World Drug Report. 2022. https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html https://www.unodc.org/unodc/en/data-and-analysis/world-drug-report-2022.html</Citation></Reference><Reference><Citation>Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction. de Zwaan C, B&#xe4;r FW, Wellens HJ. Am Heart J. 1982;104:730&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">6121481</ArticleId></ArticleIdList></Reference><Reference><Citation>Triggering myocardial infarction by marijuana. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Circulation. 2001;103:2805&#x2013;2809.</Citation><ArticleIdList><ArticleId IdType="pubmed">11401936</ArticleId></ArticleIdList></Reference><Reference><Citation>Recreational marijuana use and acute myocardial infarction: insights from nationwide inpatient sample in the United States. Desai R, Patel U, Sharma S, et al. Cureus. 2017;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5752226</ArticleId><ArticleId IdType="pubmed">29312837</ArticleId></ArticleIdList></Reference><Reference><Citation>Recent cannabis use and myocardial infarction in young adults: a cross-sectional study. Ladha KS, Mistry N, Wijeysundera DN, Clarke H, Verma S, Hare GM, Mazer CD. CMAJ. 2021;193:0&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443297</ArticleId><ArticleId IdType="pubmed">34493564</ArticleId></ArticleIdList></Reference><Reference><Citation>Myocardial infarction and cardiovascular risks associated with cannabis use: a multicenter retrospective study. Kamel I, Mahmoud AK, Twayana AR, Younes AM, Horn B, Dietzius H. JACC Adv. 2025;4:101698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12235408</ArticleId><ArticleId IdType="pubmed">40104933</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannabis use: signal of increasing risk of serious cardiovascular disorders. Jouanjus E, Lapeyre-Mestre M, Micallef J. J Am Heart Assoc. 2014;3:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4187498</ArticleId><ArticleId IdType="pubmed">24760961</ArticleId></ArticleIdList></Reference><Reference><Citation>Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? Malinowska B, Baranowska-Kuczko M, Schlicker E. Br J Pharmacol. 2012;165:2073&#x2013;2088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3413845</ArticleId><ArticleId IdType="pubmed">22022923</ArticleId></ArticleIdList></Reference><Reference><Citation>The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Deusch E, Kress HG, Kraft B, Kozek-Langenecker SA. Anesth Analg. 2004;99:1127&#x2013;1130.</Citation><ArticleIdList><ArticleId IdType="pubmed">15385362</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. Rajesh M, Mukhopadhyay P, B&#xe1;tkai S, et al. J Am Coll Cardiol. 2010;56:2115&#x2013;2125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3026637</ArticleId><ArticleId IdType="pubmed">21144973</ArticleId></ArticleIdList></Reference><Reference><Citation>2025 ACC/AHA/ACEP/NAEMSP/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Rao SV, O'Donoghue ML, Ruel M, et al. J Am Coll Cardiol. 2025;85:2135&#x2013;2237.</Citation><ArticleIdList><ArticleId IdType="pubmed">40013746</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical impact of optical coherence tomography findings on culprit plaque in acute coronary syndrome: the OCT-FORMIDABLE study registry. Iannaccone M, Souteyrand G, Niccoli G, et al. Catheter Cardiovasc Interv. 2018;92:0&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">29745476</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40821329</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>The Clinical and Angiographic Profile and Outcomes of Patients With Left Bundle Branch Block (LBBB): An Observational Study From a Tertiary Care Center in North India.</ArticleTitle><Pagination><StartPage>e87953</StartPage><MedlinePgn>e87953</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e87953</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.87953</ELocationID><Abstract><AbstractText>Background and objective Left bundle branch block (LBBB) is a common electrocardiographic abnormality resulting from impaired conduction in both the His-Purkinje system's anterior and posterior left fascicles. LBBB prevalence varies with age, gender, race, and underlying cardiovascular conditions. It affects 0.06-0.1% of the general population, rising to 6-7% in those over 80, and is often detected incidentally in older males. Although once considered a ST-segment-elevation myocardial infarction (STEMI) equivalent in chest pain, recent data indicate a low risk of myocardial infarction. Diagnosing coronary artery disease (CAD) in these patients is challenging due to limitations of noninvasive tests, often necessitating coronary angiography (CAG) for confirmation. CT angiography is typically the first-line test for patients under 65, while stress nuclear imaging or dobutamine stress echo is preferred in those 65 and older. Certain ECG changes, like ST elevation or depression, may suggest myocardial infarction in LBBB cases. This study aimed to examine various demographic and clinical features, as well as outcomes, in patients presenting with&#xa0;symptomatic LBBB Methods This non-randomized, prospective, single-center observational study aimed to evaluate the clinical characteristics, demographic profile, and outcomes of patients presenting with symptomatic LBBB. All enrolled patients underwent CAG, with or without subsequent revascularization, as part of their diagnostic workup. Results A total of 200 symptomatic LBBB patients, comprising 104 males (52%), with a mean age of 60.2 &#xb1; 11.4 years, were included in the study. Hypertension and diabetes mellitus were the most common comorbidities, observed in 98 (49%) and 68 (34%) patients, respectively. Additionally, 160 (80%) patients exhibited some degree of left ventricular (LV) systolic dysfunction. CAG showed normal findings in 100 patients (50%), obstructive CAD in 78 (39%), and non-obstructive CAD in 22 (11%). The left anterior descending (LAD) artery was the most involved vessel, affected in 70 patients (70%). Among the 78 patients with obstructive CAD, 72 (92.3%) had severe obstruction. The LAD artery was the most affected vessel, observed in 60 patients (76.9%). Percutaneous coronary intervention (PCI) was performed in 42 patients, eight were referred for coronary artery bypass grafting (CABG), and 28 were managed with guideline-directed medical therapy (GDMT). Age &#x2265;50 years (p=0.005), angina (p&lt;0.001), diabetes mellitus (p&lt;0.001), and LV ejection fraction (LVEF) &#x2264;50% (p=0.006) were significantly associated with obstructive CAD. Mortality was also significantly higher in this group (p=0.001). During the six-month follow-up, 12 patients (6%), all over 70 years, died, resulting in an overall survival rate of 94% despite the high-risk profile. Conclusions Older patients with LBBB who present with angina, cardiovascular risk factors, and LV systolic dysfunction should be evaluated for CAD by using CAG, especially when troponin markers are elevated (troponin I&#xa0;&gt;0.04 ng/mL).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Khanal et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khanal</LastName><ForeName>Suraj</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thakur</LastName><ForeName>Jitender</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Basant</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahiya</LastName><ForeName>Neelam</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">angiographic profile</Keyword><Keyword MajorTopicYN="N">cag</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">left bundle branch block</Keyword><Keyword MajorTopicYN="N">pci</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Ethics Committee issued approval IEC-INT/2022/DM-701. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40821329</ArticleId><ArticleId IdType="pmc">PMC12351135</ArticleId><ArticleId IdType="doi">10.7759/cureus.87953</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Scherbak D, Shams P, Hicks GJ. Treasure Island, FL: StatPearls Publishing; 2025. Left Bundle Branch Block.</Citation><ArticleIdList><ArticleId IdType="pubmed">29489192</ArticleId></ArticleIdList></Reference><Reference><Citation>Implications of left bundle branch block in patient treatment. Kumar V, Venkataraman R, Aljaroudi W, Osorio J, Heo J, Iskandrian AE, Hage FG. Am J Cardiol. 2013;111:291&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">23111137</ArticleId></ArticleIdList></Reference><Reference><Citation>Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Grines CL, Bashore TM, Boudoulas H, Olson S, Shafer P, Wooley CF. Circulation. 1989;79:845&#x2013;853.</Citation><ArticleIdList><ArticleId IdType="pubmed">2924415</ArticleId></ArticleIdList></Reference><Reference><Citation>Left bundle branch block: Epidemiology, etiology, anatomic features, electrovectorcardiography, and classification proposal. P&#xe9;rez-Riera AR, Barbosa-Barros R, de Rezende Barbosa MP, Daminello-Raimundo R, de Abreu LC, Nikus K. Ann Noninvasive Electrocardiol. 2019;24:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6931474</ArticleId><ArticleId IdType="pubmed">29932265</ArticleId></ArticleIdList></Reference><Reference><Citation>Racial and socioeconomic determinants of cardiovascular health: a comprehensive review. Borkowski P, Borkowska N, Mangeshkar S, Adal BH, Singh N. Cureus. 2024;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11143437</ArticleId><ArticleId IdType="pubmed">38826910</ArticleId></ArticleIdList></Reference><Reference><Citation>The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Mahmood SS, Levy D, Vasan RS, Wang TJ. Lancet. 2014;383:999&#x2013;1008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4159698</ArticleId><ArticleId IdType="pubmed">24084292</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis of the electrocardiogram (Article in German) Zur EH. Wien Klin Wochenschr. 1909;22:1091&#x2013;1098.</Citation></Reference><Reference><Citation>AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. Surawicz B, Childers R, Deal BJ, et al. Circulation. 2009;119:0&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">19228822</ArticleId></ArticleIdList></Reference><Reference><Citation>2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines, and the Heart Rhythm Society. Kusumoto FM, Schoenfeld MH, Barrett C, et al. Circulation. 2019;140:0&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">30586771</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining left bundle branch block patterns in cardiac resynchronisation therapy: a return to his bundle recordings. Tung R, Upadhyay GA. Arrhythm Electrophysiol Rev. 2020;9:28&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7330724</ArticleId><ArticleId IdType="pubmed">32637117</ArticleId></ArticleIdList></Reference><Reference><Citation>Defining left bundle branch block in the era of cardiac resynchronization therapy. Strauss DG, Selvester RH, Wagner GS. Am J Cardiol. 2011;107:927&#x2013;934.</Citation><ArticleIdList><ArticleId IdType="pubmed">21376930</ArticleId></ArticleIdList></Reference><Reference><Citation>Left bundle branch block: from cardiac mechanics to clinical and diagnostic challenges. Surkova E, Badano LP, Bellu R, et al. Europace. 2017;19:1251&#x2013;1271.</Citation><ArticleIdList><ArticleId IdType="pubmed">28444180</ArticleId></ArticleIdList></Reference><Reference><Citation>A novel pacing strategy with low and stable output: pacing the left bundle branch immediately beyond the conduction block. Huang W, Su L, Wu S, Xu L, Xiao F, Zhou X, Ellenbogen KA. Can J Cardiol. 2017;33:1736&#x2013;1733.</Citation><ArticleIdList><ArticleId IdType="pubmed">29173611</ArticleId></ArticleIdList></Reference><Reference><Citation>ECG characteristics of "true" left bundle branch block: Insights from transcatheter aortic valve-related LBBB and His-Purkinje conduction system pacing-correctable LBBB. Kawamura I, Batul SA, Vijayaraman P, et al. Heart Rhythm. 2023;20:1659&#x2013;1666.</Citation><ArticleIdList><ArticleId IdType="pubmed">37696443</ArticleId></ArticleIdList></Reference><Reference><Citation>Left bundle branch block, an old-new entity. Breithardt G, Breithardt OA. J Cardiovasc Transl Res. 2012;5:107&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3294212</ArticleId><ArticleId IdType="pubmed">22258866</ArticleId></ArticleIdList></Reference><Reference><Citation>Idiopathic/iatrogenic left bundle branch block-induced reversible left ventricle dysfunction: JACC state-of-the-art review. Auffret V, Martins RP, Daubert C, Leclercq C, Le Breton H, Mabo P, Donal E. J Am Coll Cardiol. 2018;72:3177&#x2013;3188.</Citation><ArticleIdList><ArticleId IdType="pubmed">30545456</ArticleId></ArticleIdList></Reference><Reference><Citation>Is the treadmill exercise test useful for evaluating coronary artery disease in patients with complete left bundle branch block? Orzan F, Garcia E, Mathur VS, Hall RJ. Am J Cardiol. 1978;42:36&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">677034</ArticleId></ArticleIdList></Reference><Reference><Citation>Left bundle branch block-Innocent bystander, silent menace, or both. Lau EW, Bonnemeier H, Baldauf B. Heart Rhythm. 2025;22:0&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">39742988</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostic and prognostic value of left bundle branch block and its correlation with left ventricular functions: a prospective observational study. Bharath M, Sunayana N, Channakeshava S. Int J Adv Med. 2017;4:713.</Citation></Reference><Reference><Citation>Asymptomatic left bundle branch block predicts new-onset congestive heart failure and death from cardiovascular diseases. Azadani PN, Soleimanirahbar A, Marcus GM, Haight TJ, Hollenberg M, Olgin JE, Lee BK. Cardiol Res. 2012;3:258&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5358299</ArticleId><ArticleId IdType="pubmed">28352414</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of left bundle branch block with obstructive coronary artery disease on coronary CT angiography: a case-control study. Clerc OF, Possner M, Maire R, et al. Eur Heart J Cardiovasc Imaging. 2016;17:765&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pubmed">26320169</ArticleId></ArticleIdList></Reference><Reference><Citation>A strain-based staging classification of left bundle branch block-induced cardiac remodeling. Calle S, Kamoen V, De Buyzere M, De Pooter J, Timmermans F. JACC Cardiovasc Imaging. 2021;14:1691&#x2013;1702.</Citation><ArticleIdList><ArticleId IdType="pubmed">33865764</ArticleId></ArticleIdList></Reference><Reference><Citation>Left bundle branch block-induced cardiomyopathy: insights from left bundle branch pacing. Ponnusamy SS, Vijayaraman P. JACC Clin Electrophysiol. 2021;7:1155&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">33812829</ArticleId></ArticleIdList></Reference><Reference><Citation>A revised definition of left bundle branch block using time to notch in lead I. Treger JS, Allaw AB, Razminia P, et al. JAMA Cardiol. 2024;9:449&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10974693</ArticleId><ArticleId IdType="pubmed">38536171</ArticleId></ArticleIdList></Reference><Reference><Citation>Left bundle branch block induces ventricular remodelling and functional septal hypoperfusion. Vernooy K, Verbeek XA, Peschar M, Crijns HJ, Arts T, Cornelussen RN, Prinzen FW. Eur Heart J. 2005;26:91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">15615805</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic significance of incident complete left bundle branch block observed over a 40-year period. Imanishi R, Seto S, Ichimaru S, Nakashima E, Yano K, Akahoshi M. Am J Cardiol. 2006;98:644&#x2013;648.</Citation><ArticleIdList><ArticleId IdType="pubmed">16923453</ArticleId></ArticleIdList></Reference><Reference><Citation>Usefulness of ECG criteria to rule out left ventricular hypertrophy in older individuals with true left bundle branch block: an observational study. Tavares CA, Samesima N, Lazar Neto F, et al. BMC Cardiovasc Disord. 2021;21:547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8600759</ArticleId><ArticleId IdType="pubmed">34789151</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical outcomes of permanent left bundle branch area pacing in patients with left bundle branch block and left ventricular ejection fraction &gt;35 vs. &#x2264;35. Jiang Z, Wu T, Wu Y, et al. Front Cardiovasc Med. 2022;9:838708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968131</ArticleId><ArticleId IdType="pubmed">35369330</ArticleId></ArticleIdList></Reference><Reference><Citation>Newly acquired left bundle-branch block: the Framingham study. Schneider JF, Thomas HE Jr, Kreger BE, McNamara PM, Kannel WB. Ann Intern Med. 1979;90:303&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">154870</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary angiographic profile in patients with left bundle branch block-an observational study. Karthikeyan S, Elamaran C, Swaminathan N. https://www.worldwidejournals.com/international-journal-of-scientific-research-(IJSR)/article/coronary-angiographic-profile-in-patients-with-left-bundle-branch-block-an-observational-study/MTU4OTE=/ Int J Sci Res. 2018;7:53&#x2013;54.</Citation></Reference><Reference><Citation>Risk factors and angiographic findings in patients with LBBB who underwent coronary angiography in Duhok Heart Center. Mutar M, Merza MA, Issa HA, Shaikhow SK. https://citeseerx.ist.psu.edu/document?repid=rep1&amp;type=pdf&amp;doi=4a5da9ebf60f9c8e7df43ebdd1e974e1f0ac007b JMSCR. 2016;4:14112&#x2013;14117.</Citation></Reference><Reference><Citation>Left bundle branch block. Boyle DM, Fenton SS. https://pmc.ncbi.nlm.nih.gov/articles/PMC2384928/ Ulster Med J. 1966;35:93&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2384928</ArticleId><ArticleId IdType="pubmed">5922878</ArticleId></ArticleIdList></Reference><Reference><Citation>Outcomes with left bundle branch block and mildly to moderately reduced left ventricular function. Witt CM, Wu G, Yang D, Hodge DO, Roger VL, Cha YM. JACC Heart Fail. 2016;4:897&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">27614941</ArticleId></ArticleIdList></Reference><Reference><Citation>Left bundle branch block: current and future perspectives. Tan NY, Witt CM, Oh JK, Cha YM. Circ Arrhythm Electrophysiol. 2020;13:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">32186936</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40817221</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6947</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>BMC medical informatics and decision making</Title><ISOAbbreviation>BMC Med Inform Decis Mak</ISOAbbreviation></Journal><ArticleTitle>Risk prediction of QTc prolongation occurrence in cancer patients treated with commonly used oral tyrosine kinase inhibitors: machine learning modeling or conventional statistical analysis better?</ArticleTitle><Pagination><StartPage>310</StartPage><MedlinePgn>310</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12911-025-03091-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cancer patients receiving targeted therapies need to prevent QTc prolongation and life-threatening cardiovascular (CV) events to maintain a balanced benefit-risk ratio. This study aimed to develop an optimal prediction model for QTc prolongation risk and estimate its risk probability in cancer patients treated with oral tyrosine kinase inhibitors (TKIs).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study analyzed electronic medical records (EMR) of cancer patients newly treated with commonly used oral TKIs at a medical center between January 2016 and December 2020. QTc prolongation was defined as&#x2009;&#x2265;&#x2009;450&#xa0;ms in males and&#x2009;&#x2265;&#x2009;470&#xa0;ms in females using Bazett's formula. The study followed four key steps: (1) Managing missing data, (2) Identifying important variables, (3) Training and testing the best prediction models, (4). Estimating risk probability and determining cut-off points. Both univariate logistic regression (LR) and supervised machine learning (ML) approaches were used for variable selection. The backward LR method and seven ML algorithms were applied to train and test the prediction models. The best model was identified based on model performance, fitting criteria, area under the receiver operating characteristic curve (AUROC), risk probability cut-off points, and clinical relevance.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The statistical 12-parameter model demonstrated excellent performance (AUROC&#x2009;=&#x2009;0.89, sensitivity&#x2009;=&#x2009;0.91, specificity&#x2009;=&#x2009;0.75) and strong discrimination ability for risk probability prediction (AUROC&#x2009;=&#x2009;0.78, cut-off&#x2009;=&#x2009;0.46), outperforming other ML models. In the final best model: the baseline risk probability of QTc prolongation was 0.13, even in the absence of other contributing factors. Baseline QTc prolongation and a history of cardiovascular disease (excluding arrhythmia, cardiomyopathy, etc.) contributed the most to incremental risk probability (0.471 and 0.282, respectively), after controlling for other factors. The remaining 10 factors each contributed to an increased probability of QTc prolongation for more than 0.14 probability.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A logistic regression model utilizing 12 easily accessible variables from EMRs outperformed ML models in predicting the risk probability of QTc prolongation in cancer patients newly treated with five oral TKIs. These findings serve as a valuable clinical reference for integrating digital monitoring into cardiovascular care for cancer survivors undergoing targeted therapy with TKIs. They also underscore the importance of screening baseline ECG before initiating TKIs to assess the risk of QTc prolongation, facilitating early intervention and prevention in the future.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Hsiang-Wen</ForeName><Initials>HW</Initials><Identifier Source="ORCID">0000-0002-6771-6746</Identifier><AffiliationInfo><Affiliation>School of Pharmacy and Graduate Institute, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy System, Outcomes and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Tien-Chao</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Chien-Ning</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; School of Nursing, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Tzu-Pei</ForeName><Initials>TP</Initials><Identifier Source="ORCID">0000-0002-2620-0591</Identifier><AffiliationInfo><Affiliation>School of Nursing, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yu-Chieh</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>School of Pharmacy and Graduate Institute, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liang-Chih</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Surgical Department, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chen-Yuan</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0002-1256-0959</Identifier><AffiliationInfo><Affiliation>School of Pharmacy and Graduate Institute, China Medical University, Taichung, Taiwan. jnynlin@mail.cmu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Hematology and Oncology, China Medical University Hospital, No. 100, Section 1, Jingmao Road, Beitun District, Taichung City, 406040, Taiwan. jnynlin@mail.cmu.edu.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med Inform Decis Mak</MedlineTA><NlmUniqueID>101088682</NlmUniqueID><ISSNLinking>1472-6947</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Algorithm</Keyword><Keyword MajorTopicYN="N">Logistic regression</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Oral</Keyword><Keyword MajorTopicYN="N">QTc prolongation</Keyword><Keyword MajorTopicYN="N">Tyrosine kinase inhibitors</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Written informed consent was waived for this retrospective EMR review. The study protocol was approved by the Research Ethics Committee (Institutional Review Board [IRB] of China Medical University Hospital (CMUH): CMUH109-REC2-122). This study meets the criteria of waving the inform consent because we used &#x201c;de-identified&#x201d; data, which were retrospectively collected and processed by the information technology (IT) center through formal application process in this specific hospital upon the request of the available reginal IRB. Specifically, the used data cannot be identified for the personal information after being processed by the IT center. In Taiwan, it is emphasized that &#x201c;as for the personal data regarding medical records, medical treatment, genetics, sexual life, health examinations and criminal records, which were prepared or collected by public agencies or medical/academic research institutes for medical, health or crime prevention purposes, only the data meet the following criteria can be used to fulfill the necessity of analysis purpose or academic research: data cannot be identified for the personal information after being processed by the providers or which were collected through deidentify the personal information based on the method of disclosure&#x201d;. Thus, the aforementioned data can be used without having inform consents from patients or individuals, upon the &#x201c;Personal Data Protection Law&#x201d; announced by the Committee of Personal Data Protection, Executive Yuan, Taiwan, and approved by CMUH IRB accordingly. Consent for publication: Not applicable. Clinical trial number: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>16</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>16</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>15</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40817221</ArticleId><ArticleId IdType="pmc">PMC12355842</ArticleId><ArticleId IdType="doi">10.1186/s12911-025-03091-8</ArticleId><ArticleId IdType="pii">10.1186/s12911-025-03091-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yang P, Zheng Y, Chen J, et al. Immediate risk of non-cancer deaths after a cancer diagnosis. BMC Cancer. 2021;21(1):963. 10.1186/s12885-021-08707-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394256</ArticleId><ArticleId IdType="pubmed">34452598</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoltzfus KC, Zhang Y, Sturgeon K, et al. Fatal heart disease among cancer patients. Nat Commun. 2020;11(1):2011. 10.1038/s41467-020-15639-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181822</ArticleId><ArticleId IdType="pubmed">32332714</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Fan Z, Yang L, et al. Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors. Fron Cardiovasc Med. 2023;10:1014400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9905625</ArticleId><ArticleId IdType="pubmed">36760569</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaorsky NG, Churilla TM, Egleston BL, et al. Causes of death among cancer patients. Ann Oncol. 2017;28(2):400&#x2013;07. 10.1093/annonc/mdw604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5834100</ArticleId><ArticleId IdType="pubmed">27831506</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamas MA, Matetic A. How common is pre-existing cardiovascular disease in cancer patients. JACC: CardioOncology. 2022;4(2):254&#x2013;57. 10.1016/j.jaccao.2022.05.001</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9270616</ArticleId><ArticleId IdType="pubmed">35818543</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta-S&#xe1;nchez A, Gilbert C, Spears D, et al. Incidence, Diagnosis, and Management of QT prolongation induced by cancer therapies: a systematic review. J Am Heart Assoc. 2017;6(12):e007724. 10.1161/JAHA.117.007724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5779062</ArticleId><ArticleId IdType="pubmed">29217664</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu Rmilah AA, Lin G, Begna KH, Friedman PA, Herrmann J. Risk of QTc prolongation among cancer patients treated with tyrosine kinase inhibitors. Int J Cancer. 2020;147(11):3160&#x2013;67. 10.1002/ijc.33119</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8772338</ArticleId><ArticleId IdType="pubmed">32449208</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora A, Scholar EM. Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther. 2005 Dec;315(3):971&#x2013;79. 10.1124/jpet.105.084145. Epub 2005 Jul 7. PMID: 16002463</Citation><ArticleIdList><ArticleId IdType="pubmed">16002463</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamore SD, Kohnken RA, Peters MF, Kolaja KL. Cardiovascular toxicity induced by kinase inhibitors: mechanisms and preclinical approaches. Chem Res Toxicol. 2020;33(1):125&#x2013;36. 10.1021/acs.chemrestox.9b00387</Citation><ArticleIdList><ArticleId IdType="pubmed">31840498</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim JV, Chun B, van Hasselt JGC, et al. Mechanistic systems modeling to improve understanding and prediction of cardiotoxicity caused by targeted cancer therapeutics. Front Physiol. 2017;8. 10.3389/fphys.2017.00651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5599787</ArticleId><ArticleId IdType="pubmed">28951721</ArticleId></ArticleIdList></Reference><Reference><Citation>Grela-Wojewoda A, Pacholczak-Madej R, Adamczyk A, Korman M, P&#xfc;sk&#xfc;ll&#xfc;o&#x11f;lu M. Cardiotoxicity induced by protein kinase inhibitors in patients with cancer. Int J Mol Sci. 2022;23(5):2815. 10.3390/ijms23052815</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8910876</ArticleId><ArticleId IdType="pubmed">35269958</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Noord C, Eijgelsheim M, Stricker BH. Drug-and non-drug-associated QT interval prolongation. Br J Clin Pharmacol. 2010;70(1):16&#x2013;23. 10.1111/j.1365-2125.2010.03660.x</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2909803</ArticleId><ArticleId IdType="pubmed">20642543</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisdale JE, Jaynes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6(4):479&#x2013;87. 10.1161/CIRCOUTCOMES.113.000152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788679</ArticleId><ArticleId IdType="pubmed">23716032</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandael E, Vandenberk B, Vandenberghe J, et al. A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ-PATH model. Br J Clin Pharmacol. 2018;84(12):2824&#x2013;35. 10.1111/bcp.13740.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6255989</ArticleId><ArticleId IdType="pubmed">30112769</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuel Y, Babu A, Karagkouni F, Ismail A, Choi S, Boussios S. Cardiac toxicities in oncology: elucidating the dark box in the era of precision medicine. Curr Issues Mol Biol. 2023;45(10):8337&#x2013;58. 10.3390/cimb45100526</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10605822</ArticleId><ArticleId IdType="pubmed">37886969</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Laere S, Muylle KM, Dupont AG, Cornu P. Machine learning techniques outperform conventional statistical methods in the prediction of high risk QTc prolongation related to a drug-drug interaction. J Med Syst. 2022;46(12):100. 10.1007/s10916-022-01890-4</Citation><ArticleIdList><ArticleId IdType="pubmed">36418746</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon ST, Mandair D, Tiwari P, Rosenberg MA. Prediction of drug-induced long QT syndrome using machine learning applied to harmonized electronic health record data. J Cardiovasc Pharmacol Ther. 2021;26(4):335&#x2013;40. 10.1177/1074248421995348</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8411414</ArticleId><ArticleId IdType="pubmed">33682475</ArticleId></ArticleIdList></Reference><Reference><Citation>Woosley RL, Black K, Heise CW, Romero K. CredibleMeds.org: what does it offer? Trends Cardiovasc Med. 2018;28(2):94&#x2013;99. 10.1016/j.tcm.2017.07.010</Citation><ArticleIdList><ArticleId IdType="pubmed">28801207</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandael E, Vandenberk B, Vandenberghe J, Spriet I, Willems R, Foulon V. Development of a risk score for QTc-prolongation: the RISQ-PATH study. Int J Clin Pharm. 2017;39(2):424&#x2013;32. 10.1007/s11096-017-0446-2</Citation><ArticleIdList><ArticleId IdType="pubmed">28281228</ArticleId></ArticleIdList></Reference><Reference><Citation>Remme CA, Bezzina CR. Genetic modulation of cardiac repolarization reserve. Heart Rhythm. 2007;4(5):608&#x2013;10. 10.1016/j.hrthm.2007.02.025</Citation><ArticleIdList><ArticleId IdType="pubmed">17467629</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart. 2003;89(11):1363&#x2013;72. 10.1136/heart.89.11.1363</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1767957</ArticleId><ArticleId IdType="pubmed">14594906</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandael E, Vandenberk B, Vandenberghe J, Willems R, Foulon V. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm. 2017;39(1):16&#x2013;25. 10.1007/s11096-016-0414-2</Citation><ArticleIdList><ArticleId IdType="pubmed">28012118</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisdale JE, Jaynes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6(4):479&#x2013;87. 10.1161/CIRCOUTCOMES.113.000152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3788679</ArticleId><ArticleId IdType="pubmed">23716032</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus SM, Sturkenboom MC, Bleumink GS, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005;26(19):2007&#x2013;12. 10.1093/eurheartj/ehi312.</Citation><ArticleIdList><ArticleId IdType="pubmed">15888497</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus SM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362&#x2013;67. 10.1016/j.jacc.2005.08.067.</Citation><ArticleIdList><ArticleId IdType="pubmed">16412861</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden DM. A current understanding of drug-induced QT prolongation and its implications for anticancer therapy. Cardiovasc Res. 2019;115(5):895&#x2013;903. 10.1093/cvr/cvz013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967705</ArticleId><ArticleId IdType="pubmed">30689740</ArticleId></ArticleIdList></Reference><Reference><Citation>Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350(10):1013&#x2013;22. 10.1056/NEJMra032426</Citation><ArticleIdList><ArticleId IdType="pubmed">14999113</ArticleId></ArticleIdList></Reference><Reference><Citation>Letsas KP, Efremidis M, Filippatos GS, Sideris AM. Drug-induced long QT syndrome. Hellenic J Cardiol. 2007;48(5):296&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">17966685</ArticleId></ArticleIdList></Reference><Reference><Citation>Haugaa KH, Bos JM, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ. Institution-Wide QT Alert system identifies patients with a high risk of mortality. Mayo Clin Proc. 2013;88(4):315&#x2013;25. 10.1016/j.mayocp.2013.01.013</Citation><ArticleIdList><ArticleId IdType="pubmed">23541006</ArticleId></ArticleIdList></Reference><Reference><Citation>Brana I, Tabernero J. Cardiotoxicity. Ann Oncol. 2010;Suppl 7:vii173-vii179. 10.1093/annonc/mdq295.</Citation><ArticleIdList><ArticleId IdType="pubmed">20943611</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Defined Daily Dose (DDD) https://www.who.int/tools/atc-ddd-toolkit/about-ddd Available By. July 30, 2024.</Citation></Reference><Reference><Citation>Bazett HC. An analysis of the time-relations of electrocardiograms. Ann Noninvasive Electrocardio. 1997;2(2):177&#x2013;94. 10.1111/j.1542-474X.1997.tb00325.x</Citation></Reference><Reference><Citation>Duan J, Tao J, Zhai M, et al. Anticancer drugs-related QTc prolongation, torsade de pointes and sudden death: current evidence and future research perspectives. Oncotarget. 2018;9(39):25738&#x2013;49. 10.18632/oncotarget.25008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5986642</ArticleId><ArticleId IdType="pubmed">29876021</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel D, Singh P, Katz W, et al. QT interval prolongation in end-stage liver disease cannot be explained by nonhepatic factors. Ann Noninvasive Electrocardiol. 2014;19(6):574&#x2013;81. 10.1111/anec.12161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6932090</ArticleId><ArticleId IdType="pubmed">24762117</ArticleId></ArticleIdList></Reference><Reference><Citation>Majeed CN, Ahmad MI, Ahsan I, et al. Relation of total bilirubin and QT interval prolongation (from the Third National Health and Nutrition Examination Survey). Ann Noninvasive Electrocardiol. 2020;25(2):e12696. 10.1111/anec.12696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358851</ArticleId><ArticleId IdType="pubmed">31498504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Chen Z, Huang S, et al. Machine learning in cardio-oncology: new insights from an emerging discipline. Rev Cardiovasc Med. 2023;24(10):296. 10.31083/j.rcm2410296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11273149</ArticleId><ArticleId IdType="pubmed">39077576</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinze G, Wallisch C, Dunkler D. Variable selection - A review and recommendations for the practicing statistician. Biom J. 2018;60(3):431&#x2013;49. 10.1002/bimj.201700067</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969114</ArticleId><ArticleId IdType="pubmed">29292533</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz &#xdc;, Kuvat &#xd6;. Invstigating the effect of feature selection methods on the success of overall equipment effectiveness prediction. Uludag &#xdc;niversitesi J Fac Eng. 2023;28(2):437&#x2013;52. 10.17482/uumfd.1296479</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40845836</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2817-1705</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2025</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>JMIR AI</Title><ISOAbbreviation>JMIR AI</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of the GPT-4o Model in Interpreting Electrocardiogram Images for Cardiac Diagnostics: Diagnostic Accuracy Study.</ArticleTitle><Pagination><StartPage>e74426</StartPage><MedlinePgn>e74426</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2196/74426</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Recent progress has demonstrated the potential of deep learning models in analyzing electrocardiogram (ECG) pathologies. However, this method is intricate, expensive to develop, and designed for specific purposes. Large language models show promise in medical image interpretation, and yet their effectiveness in ECG analysis remains understudied. Generative Pretrained Transformer 4 Omni (GPT-4o), a multimodal artificial intelligence model, capable of processing images and text without task-specific training, may offer an accessible alternative.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aimed to evaluate GPT-4o's effectiveness in interpreting 12-lead ECGs, assessing classification accuracy, and exploring methods to enhance its performance.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 6 common ECG diagnoses were evaluated: normal ECG, ST-segment elevation myocardial infarction, atrial fibrillation, right bundle branch block, left bundle branch block, and paced rhythm, with 30 normal ECGs and 10 of each abnormal pattern, totaling 80 cases. Deidentified ECGs were analyzed using OpenAI's GPT-4o. Our study used both zero-shot and few-shot learning methodologies to investigate three main scenarios: (1) ECG image recognition, (2) binary classification of normal versus abnormal ECGs, and (3) multiclass classification into 6 categories.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The model excelled in recognizing ECG images, achieving an accuracy of 100%. In the classification of normal or abnormal ECG cases, the few-shot learning approach improved GPT-4o's accuracy by 30% from the baseline, reaching 83% (95% CI 81.8%-84.6%). However, multiclass classification for a specific pathology remained limited, achieving only 41% accuracy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">GPT-4o effectively differentiates normal from abnormal ECGs, suggesting its potential as an accessible artificial intelligence-assisted triage tool. Although limited in diagnosing specific cardiac conditions, GPT-4o's capability to interpret ECG images without specialized training highlights its potential for preliminary ECG interpretation in clinical and remote settings.</AbstractText><CopyrightInformation>&#xa9; Haya Engelstein, Roni Ramon Gonen, Avi Sabbag, Eyal Klang, Karin Sudri, Michal Cohen-Shelly, Israel Barbash. Originally published in JMIR AI (https://ai.jmir.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Engelstein</LastName><ForeName>Haya</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0005-6721-5158</Identifier><AffiliationInfo><Affiliation>Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ramon-Gonen</LastName><ForeName>Roni</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2529-1567</Identifier><AffiliationInfo><Affiliation>The Graduate School of Business Administration, Information Systems Program, Bar-Ilan University, Max and Anna Webb St, Ramat Gan, 5290002, Israel, 972 3-531-8910.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabbag</LastName><ForeName>Avi</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-4295-6679</Identifier><AffiliationInfo><Affiliation>Davidai Arrhythmia Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klang</LastName><ForeName>Eyal</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-4567-3108</Identifier><AffiliationInfo><Affiliation>Division of Data-Driven and Digital Medicine (D3M), Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Charles Bronfman Institute of Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sudri</LastName><ForeName>Karin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-5118-8619</Identifier><AffiliationInfo><Affiliation>Sheba ARC, Sagol Big Data and AI Hub, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cohen-Shelly</LastName><ForeName>Michal</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0007-6532-9252</Identifier><AffiliationInfo><Affiliation>Sheba ARC, Sagol Big Data and AI Hub, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Barbash</LastName><ForeName>Israel</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-7416-5989</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interventional Cardiology Unit, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR AI</MedlineTA><NlmUniqueID>9918645789006676</NlmUniqueID><ISSNLinking>2817-1705</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LLMs</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">cardiology</Keyword><Keyword MajorTopicYN="N">decision support systems</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">large language models</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>23</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>23</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>22</Day><Hour>18</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40845836</ArticleId><ArticleId IdType="doi">10.2196/74426</ArticleId><ArticleId IdType="pii">v4i1e74426</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40837844</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2514-2119</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European heart journal. Case reports</Title><ISOAbbreviation>Eur Heart J Case Rep</ISOAbbreviation></Journal><ArticleTitle>'De Winter' electrocardiographic pattern in left bundle branch block and acute coronary occlusion: a case report.</ArticleTitle><Pagination><StartPage>ytaf354</StartPage><MedlinePgn>ytaf354</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ytaf354</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjcr/ytaf354</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">ST-segment elevation on electrocardiogram (ECG) is traditionally interpreted as acute coronary occlusion, with a sensitivity of approximately 75%. Electrocardiographic patterns such as 'Wellens' and 'De Winter' have been studied as ST-segment elevation myocardial infarction (STEMI) equivalents.</AbstractText><AbstractText Label="CASE SUMMARY" NlmCategory="UNASSIGNED">A 79-year-old hypertensive woman was admitted with chest pain radiating to the neck. The initial ECG showed a left bundle branch block with a 'De Winter' pattern. After initial care, she underwent cardiac catheterization that revealed thrombotic occlusion of the left anterior descending artery. She underwent angioplasty with angiographic success and clinical improvement, leading to hospital discharge.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Recognition of electrocardiographic patterns associated with acute coronary occlusion is crucial for diagnosis and prompt reperfusion, reducing morbidity and mortality. The 'De Winter' pattern is an equivalent to STEMI. Patients with pre-existing conditions that affect QRS amplitude and width, such as the left bundle branch block, pose an additional challenge.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baldisserotto</LastName><ForeName>Hugo Leonardi</ForeName><Initials>HL</Initials><Identifier Source="ORCID">0000-0003-3322-3086</Identifier><AffiliationInfo><Affiliation>Internal Medicine Department, Federal University of Rio Grande do Sul (UFRGS), Ramiro Barcelos, 2400, 90610-264 Porto Alegre/RS, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daga</LastName><ForeName>Andressa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital de Cl&#xed;nicas de Porto Alegre (HCPA), Ramiro Barcelos, 2350, 90035-003 Porto Alegre/RS, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heiden Telo</LastName><ForeName>Guilherme</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiology Department, Hospital de Cl&#xed;nicas de Porto Alegre (HCPA), Ramiro Barcelos, 2350, 90035-003 Porto Alegre/RS, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Case Rep</MedlineTA><NlmUniqueID>101730741</NlmUniqueID><ISSNLinking>2514-2119</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute coronary occlusion</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">De Winter pattern</Keyword><Keyword MajorTopicYN="N">Left bundle branch block</Keyword></KeywordList><CoiStatement>Conflict of interest. None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>5</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40837844</ArticleId><ArticleId IdType="pmc">PMC12361888</ArticleId><ArticleId IdType="doi">10.1093/ehjcr/ytaf354</ArticleId><ArticleId IdType="pii">ytaf354</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmitt &#xa0;C, Lehmann &#xa0;G, Schmieder &#xa0;S, Karch &#xa0;M, Neumann &#xa0;FJ, Sch&#xf6;mig &#xa0;A. Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel: limitations of ST-segment elevation in standard and extended ECG leads. Chest &#xa0;2001;120:1540&#x2013;1546.</Citation><ArticleIdList><ArticleId IdType="pubmed">11713132</ArticleId></ArticleIdList></Reference><Reference><Citation>Asatryan &#xa0;B, Vaisnora &#xa0;L, Manavifar &#xa0;N. Electrocardiographic diagnosis of life-threatening STEMI equivalents: when every minute counts. JACC Case Rep &#xa0;2019;1:666&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8288700</ArticleId><ArticleId IdType="pubmed">34316902</ArticleId></ArticleIdList></Reference><Reference><Citation>Knotts &#xa0;RJ, Wilson &#xa0;JM, Kim &#xa0;E, Huang &#xa0;HD, Birnbaum &#xa0;Y. Diffuse ST depression with ST elevation in aVR: is this pattern specific for global ischemia due to left main coronary artery disease?. J Electrocardiol &#xa0;2013;46:240&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">23312698</ArticleId></ArticleIdList></Reference><Reference><Citation>de Winter &#xa0;RJ, Verouden &#xa0;NJ, Wellens &#xa0;HJ, Wilde &#xa0;AA; Interventional Cardiology Group of the Academic Medical Center . A new ECG sign of proximal LAD occlusion. N Eng J Med &#xa0;2008;359:2071&#x2013;2073.</Citation><ArticleIdList><ArticleId IdType="pubmed">18987380</ArticleId></ArticleIdList></Reference><Reference><Citation>John &#xa0;T, Pecoraro &#xa0;A, Weich &#xa0;H, Joubert &#xa0;L, Griffiths &#xa0;B, Herbst &#xa0;P. The De Winter&#x2019;s pattern revisited: a case series. Eur Heart J Case Rep &#xa0;2020;4:1&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7793130</ArticleId><ArticleId IdType="pubmed">33442615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgarbossa &#xa0;EB, Pinski &#xa0;SL, Barbagelata &#xa0;A, Underwood &#xa0;MD, Gates &#xa0;KB, Topol &#xa0;EJ, et al. &#xa0;Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. N Engl J Med &#xa0;1996;334:481&#x2013;487.</Citation><ArticleIdList><ArticleId IdType="pubmed">8559200</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith &#xa0;SW, Dodd &#xa0;KW, Henry &#xa0;TD, Dvorak &#xa0;DM, Pearce &#xa0;LA. Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med &#xa0;2012;60:766&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">22939607</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40834883</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1361-6579</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>20</Day></PubDate></JournalIssue><Title>Physiological measurement</Title><ISOAbbreviation>Physiol Meas</ISOAbbreviation></Journal><ArticleTitle>Improved state refinement for LSTM determined 3D CAISR-LSTM model for automatic myocardial infarction detection.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1088/1361-6579/adfda9</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Electrocardiograms (ECGs) contain valuable information in the clinical diagnosis of myocardial infarction (MI). However, its interpretation process is dependent on cardiologists with extensive clinical experience and expertise. The issue not only causes a paucity of medical resources, but also restricts patients from receiving timely diagnoses. Thus, a novel approach for MI automatic detection is developed, based on 12-lead ECG and an improved state refinement for long short-term memory (LSTM) determined 3D convolution-attention (3D CAISR-LSTM) model.</AbstractText><AbstractText Label="APPROACH" NlmCategory="METHODS">The proposed 3D CAISR-LSTM model is trained in an end-to-end fashion. The input 12-lead ECG signals are preprocessed to eliminate power line interference, high-frequency noise and baseline wander. Then, the ECG signals are transformed into time-frequency images using continuous wavelet transform (CWT) and bilinear interpolation. The obtained images are constructed into three-dimensional spatiotemporal features, serving as input to the 3D CAISR-LSTM model. In the 3D CAISR-LSTM model, there are three main components: a convolutional module, four identical convolutional attention modules, and an improved state refinement for LSTM. Performance of the 3D CAISR-LSTM model in automatic detection of MI versus healthy controls (HC) is evaluated through ten-fold cross validation on the publicly available PTB diagnostic ECG database.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">Experimental results demonstrate that the 3D CAISR-LSTM model achieves an accuracy of 98.45%, sensitivity of 98.69%, specificity of 97.50%, and F1 score of 99.03%, outperforming various advanced 2D and 3D deep neural network architectures.</AbstractText><AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">The proposed approach is expected to provide an early warning before obvious MI symptoms appear. It also has the potential to be developed into a lightweight embedded MI detection equipment.</AbstractText><CopyrightInformation>&#xa9; 2025 Institute of Physics and Engineering in Medicine. All rights, including for text and data mining, AI training, and similar technologies, are reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Muqing</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guangdong University of Technology School of Automation, No.100 Waihuan West Road, Xiaoguwei Street, Guangzhou University Town, Panyu District, Guangzhou City, Guangdong Province, China, Guangzhou, Guangdong, 510006, CHINA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Boyan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Guangdong University of Technology School of Automation, No.100 Waihuan West Road, Xiaoguwei Street, Guangzhou University Town, Panyu District, Guangzhou City, Guangdong Province, China, Guangzhou, Guangdong, 510006, CHINA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Mingying</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Guangdong University of Technology School of Automation, No.100 Waihuan West Road, Xiaoguwei Street, Guangzhou University Town, Panyu District, Guangzhou City, Guangdong Province, China, Guangzhou, Guangdong, 510006, CHINA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Guangdong University of Technology School of Automation, No.100 Waihuan West Road, Xiaoguwei Street, Guangzhou University Town, Panyu District, Guangzhou City, Guangdong Province, China, Guangzhou, Guangdong, 510006, CHINA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Xinghui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Information, People's Hospital of Yangjiang, No. 42, Dongshan Road, Jiangcheng District, Yangjiang City, Guangdong Province,, Yangjiang, Guangdong, 529500, CHINA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanjiao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Guangdong University of Technology School of Automation, No.100 Waihuan West Road, Xiaoguwei Street, Guangzhou University Town, Panyu District, Guangzhou City, Guangdong Province, China, Guangzhou, Guangdong, 510006, CHINA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xiaoyu</ForeName><Initials>X</Initials><Identifier Source="ORCID">0009-0003-1552-0295</Identifier><AffiliationInfo><Affiliation>Center of Preventive Disease, People's Hospital of Yangjiang, No. 42, Dongshan Road, Jiangcheng District, Yangjiang City, Guangdong Province, China, Yangjiang, Guangdong, 529500, CHINA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Physiol Meas</MedlineTA><NlmUniqueID>9306921</NlmUniqueID><ISSNLinking>0967-3334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3D CAISR-LSTM model</Keyword><Keyword MajorTopicYN="N">Myocardial infarction detection</Keyword><Keyword MajorTopicYN="N">State refinement mechanism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>19</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40834883</ArticleId><ArticleId IdType="doi">10.1088/1361-6579/adfda9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40838531</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1540-8159</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>21</Day></PubDate></JournalIssue><Title>Pacing and clinical electrophysiology : PACE</Title><ISOAbbreviation>Pacing Clin Electrophysiol</ISOAbbreviation></Journal><ArticleTitle>High-Precision Hemodynamic and Echocardiographic Assessment of Pacing in Obstructive Hypertrophic Cardiomyopathy.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/pace.70024</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Left ventricular outflow obstruction drives symptoms and outcomes in obstructive hypertrophic cardiomyopathy (oHCM). Right ventricular pacing (RVP) can desynchronize the left ventricle to relieve this and allows control of atrioventricular delay (AVD) but may impair ventricular function. We used high-precision assessment to quantify the hemodynamic and echocardiographic effects of RVP in oHCM.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with oHCM and implanted dual-chamber pacing devices underwent continuous recording of ECG, beat-by-beat outflow tract continuous wave Doppler, and beat-by-beat, noninvasive finger-cuff blood pressure while pacing was alternated between atrium-only pacing and AV-sequential RVP at a range of AVDs at 5&#xa0;bpm above resting heart rate and 100&#xa0;bpm. Changes in systolic blood pressure (&#x2206;SBP) and left ventricular outflow tract gradient (&#x2206;LVOTg) were fitted to parabolas to produce reproducible, narrow confidence interval estimates of effects.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty two patients were recruited (60% male, mean resting LVOTg 53&#xa0;mmHg). At just above resting heart rate (mean 75&#xa0;bpm), RVP produced mean peak &#x2206;SBP from AAI to DDD of 2.47&#xa0;mmHg (95% confidence interval: 0.19-4.76, p = 0.04). The mean AVD for peak &#x2206;SBP was 173.2&#xa0;ms. Mean LVOTg reduction at this AVD was 8.31&#xa0;mmHg (2.43-14.18, p &lt; 0.001). Apart from the hemodynamically optimum AVD, no other AVDs produced statistically significant increases in SBP. At 100&#xa0;bpm, greater increases in SBP and reductions in LVOTg were seen at hemodynamically optimal AVD.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Multiple alternation assessment allows precise, reproducible, narrow confidence interval quantification of hemodynamic and echocardiographic pacing effects. RVP can reduce LVOTg while preserving or improving cardiac output, but AVD is a key modifier of this relationship.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Pacing and Clinical Electrophysiology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohal</LastName><ForeName>Jagdeep S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-0442-4033</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shun-Shin</LastName><ForeName>Matthew J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiew</LastName><ForeName>Kayla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyazawa</LastName><ForeName>Alejandra A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simader</LastName><ForeName>Florentina</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tangkongpanich</LastName><ForeName>Pannathorn</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahl</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Ji-Jian</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naraen</LastName><ForeName>Akriti</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saleh</LastName><ForeName>Keenan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samways</LastName><ForeName>Jack W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keene</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sohaib</LastName><ForeName>S M Afzal</ForeName><Initials>SMA</Initials><AffiliationInfo><Affiliation>Barts Heart Centre, St Bartholomew's Hospital, West Smithfield, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanner</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leong</LastName><ForeName>Kevin M W</ForeName><Initials>KMW</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National University Heart Centre, National University Hospital, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Norman A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefroy</LastName><ForeName>David C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanagaratnam</LastName><ForeName>Prapa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francis</LastName><ForeName>Darrel P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varnava</LastName><ForeName>Amanda</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whinnett</LastName><ForeName>Zachary I</ForeName><Initials>ZI</Initials><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnold</LastName><ForeName>Ahran D</ForeName><Initials>AD</Initials><Identifier Source="ORCID">0000-0002-7597-0170</Identifier><AffiliationInfo><Affiliation>National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Coronary Flow Trust</Agency><Country/></Grant><Grant><GrantID>MR/X502959/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>IAA 2023/1</GrantID><Agency>Rosetrees Trust</Agency><Country/></Grant><Grant><Agency>NIHR Imperial Biomedical Research Centre</Agency><Country/></Grant><Grant><GrantID>FS/CRTF/21/24171</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pacing Clin Electrophysiol</MedlineTA><NlmUniqueID>7803944</NlmUniqueID><ISSNLinking>0147-8389</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hemodynamics</Keyword><Keyword MajorTopicYN="N">hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">obstructive hypertrophic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">right ventricular pacing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>12</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>7</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40838531</ArticleId><ArticleId IdType="doi">10.1111/pace.70024</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>M. S. Maron, I. Olivotto, S. Betocchi, et&#xa0;al., &#x201c;Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy,&#x201d; New England Journal of Medicine 348 (2003): 295&#x2013;303, https://doi.org/10.1056/NEJMoa021332.</Citation></Reference><Reference><Citation>L. Kappenberger, C. Linde, C. Daubert, et&#xa0;al., &#x201c;Pacing in Hypertrophic Obstructive Cardiomyopathy. A Randomized Crossover Study. PIC Study Group,&#x201d; European Heart Journal 18 (1997): 1249&#x2013;1256, https://doi.org/10.1093/oxfordjournals.eurheartj.a015435.</Citation></Reference><Reference><Citation>B. J. Maron, W. J. McKenna, G. K. Danielson, et&#xa0;al., &#x201c;American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines,&#x201d; Journal of American College of Cardiology 42 (2003): 1687&#x2013;1713, https://doi.org/10.1016/s0735&#x2010;1097(03)00941&#x2010;0.</Citation></Reference><Reference><Citation>Z. I. Whinnett, M. J. Shun&#x2010;Shin, M. Tanner, et&#xa0;al., &#x201c;Effects of Haemodynamically Atrio&#x2010;Ventricular Optimized His Bundle Pacing on Heart Failure Symptoms and Exercise Capacity: The His Optimized Pacing Evaluated for Heart Failure (HOPE&#x2010;HF) Randomized, Double&#x2010;blind, Cross&#x2010;Over Trial,&#x201d; European Journal of Heart Failure 25 (2023): 274&#x2013;283, https://doi.org/10.1002/ejhf.2736.</Citation></Reference><Reference><Citation>D. R. Ludwig, H. Tanaka, M. Friehling, J. Gorcsan 3rd, and D. Schwartzman, &#x201c;Further Deterioration of LV Ejection Fraction and Mechanical Synchrony During RV Apical Pacing in Patients With Heart Failure and LBBB,&#x201d; Journal of Cardiovascular Translational Research 6 (2013): 425&#x2013;429, https://doi.org/10.1007/s12265&#x2010;013&#x2010;9457&#x2010;0.</Citation></Reference><Reference><Citation>A. A. Miyazawa, D. P. Francis, and Z. I. Whinnett, &#x201c;Basic Principles of Hemodynamics in Pacing,&#x201d; Cardiac Electrophysiology Clinics 14 (2022): 133&#x2013;140, https://doi.org/10.1016/j.ccep.2021.12.001.</Citation></Reference><Reference><Citation>P. A. Pabari, K. Willson, B. Stegemann, et&#xa0;al., &#x201c;When Is an Optimization Not an Optimization? Evaluation of Clinical Implications of Information Content (Signal&#x2010;to&#x2010;Noise Ratio) in Optimization of Cardiac Resynchronization Therapy, and How to Measure and Maximize It,&#x201d; Heart Failure Reviews 16 (2011): 277&#x2013;290, https://doi.org/10.1007/s10741&#x2010;010&#x2010;9203&#x2010;5.</Citation></Reference><Reference><Citation>B. J. Maron, R. A. Nishimura, W. J. McKenna, H. Rakowski, M. E. Josephson, and R. S. Kieval, &#x201c;Assessment of Permanent Dual&#x2010;Chamber Pacing as a Treatment for Drug&#x2010;Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. A Randomized, Double&#x2010;Blind, Crossover Study (M&#x2010;PATHY),&#x201d; Circulation 99 (1999): 2927&#x2013;2933, https://doi.org/10.1161/01.cir.99.22.2927.</Citation></Reference><Reference><Citation>A. J. Sharp, S. M. A. Sohaib, M. J. Shun&#x2010;Shin, et&#xa0;al., &#x201c;Improving Haemodynamic Optimization of Cardiac Resynchronization Therapy for Heart Failure,&#x201d; Physiological Measurement 40 (2019): 04NT01, https://doi.org/10.1088/1361&#x2010;6579/ab152c.</Citation></Reference><Reference><Citation>Z. I. Whinnett, S. M. A. Sohaib, M. Mason, et&#xa0;al., &#x201c;Multicenter Randomized Controlled Crossover Trial Comparing Hemodynamic Optimization Against Echocardiographic Optimization of AV and VV Delay of Cardiac Resynchronization Therapy: The BRAVO Trial,&#x201d; JACC: Cardiovascular Imaging 12 (2019): 1407&#x2013;1416, https://doi.org/10.1016/j.jcmg.2018.02.014.</Citation></Reference><Reference><Citation>C. H. Manisty, A. Al&#x2010;Hussaini, B. Unsworth, et&#xa0;al., &#x201c;The Acute Effects of Changes to AV Delay on BP and Stroke Volume: Potential Implications for Design of Pacemaker Optimization Protocols,&#x201d; Circulation: Arrhythmia and Electrophysiology 5 (2012): 122&#x2013;130, https://doi.org/10.1161/circep.111.964205.</Citation></Reference><Reference><Citation>Z. I. Whinnett, J. E. Davies, K. Willson, et&#xa0;al., &#x201c;Determination of Optimal Atrioventricular Delay for Cardiac Resynchronization Therapy Using Acute Non&#x2010;Invasive Blood Pressure,&#x201d; Europace 8 (2006): 358&#x2013;366, https://doi.org/10.1093/europace/eul017.</Citation></Reference><Reference><Citation>M. J. Shun&#x2010;Shin, A. A. Miyazawa, D. Keene, et&#xa0;al., &#x201c;How to Deliver Personalized Cardiac Resynchronization Therapy Through the Precise Measurement of the Acute Hemodynamic Response: Insights From the iSpot Trial,&#x201d; Journal of Cardiovascular Electrophysiology 30 (2019): 1610&#x2013;1619, https://doi.org/10.1111/jce.14001.</Citation></Reference><Reference><Citation>P. P. Dimitrow, J. Grodecki, B. Bacior, et&#xa0;al., &#x201c;The Importance of Ventricular Septal Morphology in the Effectiveness of Dual Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy,&#x201d; Pacing and Clinical Electrophysiology 23 (2000): 1324&#x2013;1329, https://doi.org/10.1111/j.1540&#x2010;8159.2000.tb00958.x.</Citation></Reference><Reference><Citation>I. Topilski, J. Sherez, G. Keren, and I. Copperman, &#x201c;Long&#x2010;Term Effects of Dual&#x2010;Chamber Pacing With Periodic Echocardiographic Evaluation of Optimal Atrioventricular Delay in Patients With Hypertrophic Cardiomyopathy &gt;50 Years of Age,&#x201d; American Journal of Cardiology 97 (2006): 1769&#x2013;1775, https://doi.org/10.1016/j.amjcard.2006.01.040.</Citation></Reference><Reference><Citation>D. Javidgonbadi, N. J. Abdon, B. Andersson, M. Schaufelberger, and I. &#xd6;stman&#x2010;Smith, &#x201c;Short Atrioventricular Delay Pacing Therapy in Young and Old Patients With Hypertrophic Obstructive Cardiomyopathy: Good Long&#x2010;Term Results and a Low Need for Reinterventions,&#x201d; Europace 20 (2018): 1683&#x2013;1691, https://doi.org/10.1093/europace/eux331.</Citation></Reference><Reference><Citation>D. Gras, C. Daubert, and P. Mabo, &#x201c;Value of Cardiac Pacing in Hypertrophic Obstructive Cardiomyopathy Refractory to Medical Treatment [in French],&#x201d; Archives Des Maladies Du Coeur Et Des Vaisseaux 88 (1995): 577&#x2013;583.</Citation></Reference><Reference><Citation>N. Inoue, T. Ishikawa, S. Sumita, et&#xa0;al., &#x201c;Long&#x2010;Term Follow&#x2010;Up of Atrioventricular Delay Optimization in Patients With Biventricular Pacing,&#x201d; Circulation Journal 69 (2005): 201&#x2013;204, https://doi.org/10.1253/circj.69.201.</Citation></Reference><Reference><Citation>Team RC, &#x201c;R: A Language and Environment for Statistical Computing,&#x201d; MSOR Connections 1 (2014).</Citation></Reference><Reference><Citation>K. McDonald, E. McWilliams, B. O'Keeffe, and B. Maurer, &#x201c;Functional Assessment of Patients Treated With Permanent Dual Chamber Pacing as a Primary Treatment for Hypertrophic Cardiomyopathy,&#x201d; European Heart Journal 9 (1988): 893&#x2013;898, https://doi.org/10.1093/oxfordjournals.eurheartj.a062584.</Citation></Reference><Reference><Citation>S. Seitler, S. De Zoysa Anthony, C. C. C. Obianyo, et&#xa0;al., &#x201c;Systolic Anterior Motion of the Anterior Mitral Valve Leaflet Begins in Subclinical Hypertrophic Cardiomyopathy,&#x201d; European Heart Journal &#x2010; Cardiovascular Imaging 25 (2023): 86&#x2013;94, https://doi.org/10.1093/ehjci/jead186.</Citation></Reference><Reference><Citation>A. J. Bank, R. M. Gage, and K. V. Burns, &#x201c;Right Ventricular Pacing, Mechanical Dyssynchrony, and Heart Failure,&#x201d; Journal of Cardiovascular Translational Research 5 (2012): 219&#x2013;231, https://doi.org/10.1007/s12265&#x2010;011&#x2010;9341&#x2010;8.</Citation></Reference><Reference><Citation>X. Jeanrenaud, J. J. Goy, and L. Kappenberger, &#x201c;Effects of Dual&#x2010;Chamber Pacing in Hypertrophic Obstructive Cardiomyopathy,&#x201d; Lancet 339 (1992): 1318&#x2013;1323, https://doi.org/10.1016/0140&#x2010;6736(92)91961&#x2010;7.</Citation></Reference><Reference><Citation>J. M. Tolosana and E. Trucco, &#x201c;Cardiac Pacing in Patients With Hypertrophic Obstructive Cardiomyopathy,&#x201d; Global Cardiology Science and Practice 2018 (2018): 29, https://doi.org/10.21542/gcsp.2018.29.</Citation></Reference><Reference><Citation>R. A. Nishimura, J. M. Trusty, D. L. Hayes, et&#xa0;al., &#x201c;Dual&#x2010;Chamber Pacing for Hypertrophic Cardiomyopathy: A Randomized, Double&#x2010;Blind, Crossover Trial,&#x201d; Journal of American College of Cardiology 29 (1997): 435&#x2013;441, https://doi.org/10.1016/s0735&#x2010;1097(96)00473&#x2010;1.</Citation></Reference><Reference><Citation>A. D. Arnold, J. P. Howard, K. Chiew, et&#xa0;al., &#x201c;Right Ventricular Pacing for Hypertrophic Obstructive Cardiomyopathy: Meta&#x2010;Analysis and Meta&#x2010;Regression of Clinical Trials,&#x201d; European Heart Journal &#x2010; Quality of Care and Clinical Outcomes 5 (2019): 321&#x2013;333, https://doi.org/10.1093/ehjqcco/qcz006.</Citation></Reference><Reference><Citation>P. M. Elliott, A. Anastasakis, M. A. Borger, et&#xa0;al., &#x201c;2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC),&#x201d; European Heart Journal 35 (2014): 2733&#x2013;2779, https://doi.org/10.1093/eurheartj/ehu284.</Citation></Reference><Reference><Citation>S. R. Ommen, S. Mital, M. A. Burke, et&#xa0;al., &#x201c;2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,&#x201d; Journal of American College of Cardiology 76 (2020): e159&#x2013;e240, https://doi.org/10.1016/j.jacc.2020.08.045.</Citation></Reference><Reference><Citation>S. Riaz, S. R. McMahon, K. Stockey, M. Meyer, and A. Weissler&#x2010;Snir, &#x201c;Effect of Personalized Accelerated Pacing in Patients With Nonobstructive Hypertrophic Cardiomyopathy,&#x201d; Journal of American College of Cardiology 83 (2024): 1492&#x2013;1493, https://doi.org/10.1016/j.jacc.2024.01.036.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40837922</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Cardiac Complications in Cancer Patients Following Chemotherapy and Radiotherapy.</ArticleTitle><Pagination><StartPage>e88372</StartPage><MedlinePgn>e88372</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e88372</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.88372</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac complications are critical concerns in the management of cancer patients, particularly following chemotherapy and radiotherapy. These treatments, while effective against cancer, pose&#xa0;significant risks to cardiovascular health, potentially leading to conditions such as cardiomyopathy, arrhythmias, and coronary artery disease.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study investigates the prevalence and nature of cardiac complications among cancer patients in Bangladesh who have undergone chemotherapy, radiotherapy, or both.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="METHODS">This prospective cross-sectional observational study was conducted from April 2023 to May 2024 at the Bangladesh Medical University (BMU) in Dhaka, Bangladesh. A total of 339 cancer patients, aged over 18, who received chemotherapy, radiotherapy, or both, were included. Patients were evaluated for cardiac complications during and after treatment using clinical assessments and diagnostic tests, while&#xa0;the&#xa0;clinical indicators were measured (e.g., ECG, ECHO, biomarkers). Data were analyzed using IBM&#xa0;SPSS&#xa0;Statistics for Windows, Version 23 (Released 2015; IBM Corp., Armonk, New York, United States), with statistical significance set at a <i>P-</i>value &lt;0.05. Clinical features and cardiac complications were observed among the patients undergoing chemotherapy and radiotherapy.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean age of participants was 52.4 years. Cardiac complications were observed in a significant proportion of patients. Statistically significant increases in hypertension, diabetes, and levels of cardiac biomarkers (Troponin-I, NT-proBNP, CK-MB) were noted post-treatment compared to pre-treatment values (<i>P</i> &lt; 0.001). Specifically, 83 (24.5%) patients developed hypertension, 70 (20.6%) diabetes, and notable elevations in cardiac biomarkers were recorded, indicating heightened cardiac risk.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study highlights a substantial burden of cardiac complications in cancer patients receiving chemotherapy and/or radiotherapy in Bangladesh. These findings underscore the need for integrated oncologic and cardiac care to monitor and manage cardiovascular health in cancer patients. Further research is necessary to develop targeted interventions to mitigate these risks in the Bangladeshi population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Bhuiyan et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhuiyan</LastName><ForeName>Md Zillur Rahman</ForeName><Initials>MZR</Initials><AffiliationInfo><Affiliation>Department of Clinical Oncology, Bangladesh Medical University, Dhaka, BGD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoque</LastName><ForeName>Harisul</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Bangabandhu Sheikh Mujib Medical University Hospital, Dhaka, BGD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alam</LastName><ForeName>Sarwar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Oncology, Bangladesh Medical University, Dhaka, BGD.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cancer radiotherapy</Keyword><Keyword MajorTopicYN="N">cardiac complications</Keyword><Keyword MajorTopicYN="N">chemotherapy-related toxicity</Keyword><Keyword MajorTopicYN="N">critical care cardiology</Keyword><Keyword MajorTopicYN="N">radiation and clinical oncology</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Review Board of Bangladesh Medical University Formerly Bangabandhu Sheikh Mujib Medical University issued approval Memo No. BSMMU/2024/3325. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>21</Day><Hour>5</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40837922</ArticleId><ArticleId IdType="pmc">PMC12364381</ArticleId><ArticleId IdType="doi">10.7759/cureus.88372</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Surgical complications and their impact on patients' psychosocial well-being: a systematic review and meta-analysis. Pinto A, Faiz O, Davis R, Almoudaris A, Vincent C. BMJ Open. 2016;6:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4762142</ArticleId><ArticleId IdType="pubmed">26883234</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis and management of noncardiac complications in adults with congenital heart disease: a scientific statement from the American Heart Association. Lui GK, Saidi A, Bhatt AB, et al. Circulation. 2017;136:0&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">28993401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lung Cancer in Bangladesh. Islam MR, Siddiqua SM, Islam R, et al. J Thorac Oncol. 2023;18:972&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">37479327</ArticleId></ArticleIdList></Reference><Reference><Citation>Access to public health facilities in Bangladesh: a study on facility utilisation and burden of treatment. Mannan MA. https://www.jstor.org/stable/44730025 Bangladesh Dev Stud. 2013;36:25&#x2013;80.</Citation></Reference><Reference><Citation>Unequal access to health care facilities and its impact on achieving Sustainable Development Goals: Bangladesh perspective. Ahmed M. https://www.researchgate.net/publication/362057733_UNEQUAL_ACCESS_TO_HEALTH_CARE_FACILITIES_AND_ITS_IMPACT_ON_ACHIEVING_SUSTAINABLE_DEVELOPMENT_GOALS_BANGLADESH_PERSPECTIVE J Community Posit Pract. 2022;22:120&#x2013;144.</Citation></Reference><Reference><Citation>Ansar A. Victoria: La Trobe University; 2021. Exploring the Timeliness of Care for Patients with Lung Cancer in Bangladesh.</Citation></Reference><Reference><Citation>Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019. EClinicalMedicine. 2023;59:101936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614570</ArticleId><ArticleId IdType="pubmed">37229504</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigating Bangladeshi rural women&#x2019;s awareness and knowledge of cervical cancer and attitude towards HPV vaccination: a community-based cross-sectional analysis. Banik R, Naher S, Rahman M, Gozal D. J Cancer Educ. 2022;37:449&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">32734448</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiotoxicity of cancer treatments: focus on anthracycline cardiomyopathy. Nishi M, Wang PY, Hwang PM. Arterioscler Thromb Vasc Biol. 2021;41:2648&#x2013;2660.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8551037</ArticleId><ArticleId IdType="pubmed">34587760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar N, Chatterjee S, Solanki B. Cardiovascular Toxicity and Therapeutic Modalities Targeting Cardio-Oncology. 2022. Cardiovascular complication from cancer therapy; pp. 165&#x2013;193.</Citation></Reference><Reference><Citation>de Andrade Martins W, Renni MJ, Issa AF. Nuclear Cardiology: Basic and Advanced Concepts in Clinical Practice. Cham: Springer ; 2021. The clinical aspects of heart damage by chemotherapy and radiotherapy; pp. 675&#x2013;689.</Citation></Reference><Reference><Citation>Cardiotoxicity of radiation therapy: mechanisms, management, and mitigation. Ell P, Martin JM, Cehic DA, Ngo DT, Sverdlov AL. Curr Treat Options Oncol. 2021;22:70.</Citation><ArticleIdList><ArticleId IdType="pubmed">34110500</ArticleId></ArticleIdList></Reference><Reference><Citation>Radiation oncologists' perspectives on reducing radiation-induced heart disease in early breast cancer. Mahdavi H. Curr Probl Cancer. 2020;44:100509.</Citation><ArticleIdList><ArticleId IdType="pubmed">31748146</ArticleId></ArticleIdList></Reference><Reference><Citation>What should laypersons know about cancer? Towards an operational definition of cancer literacy. Diviani N, Schulz PJ. Patient Educ Couns. 2011;85:487&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pubmed">20926225</ArticleId></ArticleIdList></Reference><Reference><Citation>Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study. Schroeder MC, Chapman CG, Nattinger MC, Halfdanarson TR, Abu-Hejleh T, Tien YY, Brooks JM. BMC Health Serv Res. 2016;16:274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4950719</ArticleId><ArticleId IdType="pubmed">27430623</ArticleId></ArticleIdList></Reference><Reference><Citation>2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Cosentino F, Grant PJ, Aboyans V, et al. Eur Heart J. 2020;41:255&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">31497854</ArticleId></ArticleIdList></Reference><Reference><Citation>Biomarkers-a general review. Aronson JK, Ferner RE. Curr Protoc Pharmacol. 2017;76:9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28306150</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Mehta LS, Watson KE, Barac A, et al. Circulation. 2018;137:0&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6722327</ArticleId><ArticleId IdType="pubmed">29437116</ArticleId></ArticleIdList></Reference><Reference><Citation>Anthracycline-induced cardiotoxicity: prospective cohort study from Pakistan. Shaikh AS, Saleem AF, Mohsin SS, Alam MM, Ahmed MA. BMJ Open. 2013;3:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3840341</ArticleId><ArticleId IdType="pubmed">24259388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma in Taiwan: a multicenter prospective Phase II trial. Hsieh JC, Hsu CL, Ng SH, et al. Jpn J Clin Oncol. 2015;45:819&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pubmed">26056323</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart failure in relation to anthracyclines and other chemotherapies. Agunbiade TA, Zaghlol RY, Barac A. Methodist Debakey Cardiovasc J. 2019;15:243&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6977567</ArticleId><ArticleId IdType="pubmed">31988684</ArticleId></ArticleIdList></Reference><Reference><Citation>Analysis of risk factors associated with breast cancer in women: a systematic review and meta-analysis. Liu H, Shi S, Gao J, Guo J, Li M, Wang L. Transl Cancer Res. 2022;11:1344&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189186</ArticleId><ArticleId IdType="pubmed">35706783</ArticleId></ArticleIdList></Reference><Reference><Citation>TLR4-a pertinent player in radiation-induced heart disease? Gawali B, Sridharan V, Krager KJ, Boerma M, Pawar SA. Genes (Basel) 2023;14:1002.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10218711</ArticleId><ArticleId IdType="pubmed">37239362</ArticleId></ArticleIdList></Reference><Reference><Citation>Subclinical cardiac damage in cancer patients before chemotherapy. Fabiani I, Panichella G, Aimo A, et al. Heart Fail Rev. 2022;27:1091&#x2013;1104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9197815</ArticleId><ArticleId IdType="pubmed">34318387</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk of ischemic heart disease in women after radiotherapy for breast cancer. Darby SC, Ewertz M, McGale P, et al. N Engl J Med. 2013;368:987&#x2013;998.</Citation><ArticleIdList><ArticleId IdType="pubmed">23484825</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissue Reactions and Mechanism in Cardiovascular Diseases Induced by Radiation. Liu XC, Zhou PK. Int J Mol Sci. 2022;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9738833</ArticleId><ArticleId IdType="pubmed">36499111</ArticleId></ArticleIdList></Reference><Reference><Citation>Postoperative complications and long-term survival after complex cancer resection. Nathan H, Yin H, Wong SL. Ann Surg Oncol. 2017;24:638&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">27619939</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300 000 women in US SEER cancer registries. Darby SC, McGale P, Taylor CW, Peto R. Lancet Oncol. 2005;6:557&#x2013;565.</Citation><ArticleIdList><ArticleId IdType="pubmed">16054566</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40755592</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Unmasking Myopericarditis Behind an ST-Segment Elevation Myocardial Infarction (STEMI) Presentation.</ArticleTitle><Pagination><StartPage>e87226</StartPage><MedlinePgn>e87226</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e87226</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.87226</ELocationID><Abstract><AbstractText>Myopericarditis is an inflammatory cardiac condition that can closely mimic ST-elevation myocardial infarction (STEMI), presenting with chest pain, elevated troponin levels, and ST-segment changes on electrocardiogram (ECG). We present the case of a 46-year-old man with a history of hypertension who presented to the emergency department with sudden-onset, substernal chest pain that awoke him from sleep. The pain was described as crushing in nature, associated with diaphoresis, and was initially attributed to anxiety. Electrocardiography revealed ST-segment elevations in leads II, III, and aVF, with reciprocal changes and an incomplete right bundle branch block (IRBBB). Initial troponin I was markedly elevated at 16.9 ng/mL. Given these concerning findings, the patient underwent emergent cardiac catheterization. Coronary angiography revealed no obstructive coronary artery disease, and left ventriculography demonstrated preserved systolic function. Further evaluation uncovered a recent viral upper respiratory infection, and transthoracic echocardiography showed diastolic dysfunction with a trivial pericardial effusion.&#xa0;The combination of clinical presentation, elevated cardiac markers, ST-segment changes, and absence of coronary pathology led to the diagnosis of myopericarditis. This case highlights the importance of maintaining a broad differential diagnosis in patients presenting with apparent acute coronary syndromes and underscores the need for comprehensive assessment to avoid unnecessary interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Basart et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Basart</LastName><ForeName>Lazaro</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Internal Medicine, Palmetto General Hospital, Hialeah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Fort Lauderdale, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhandal</LastName><ForeName>Jasmandeep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Internal Medicine, Palmetto General Hospital, Hialeah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohana</LastName><ForeName>Montadar</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, Palmetto General Hospital, Hialeah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sande</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Internal Medicine, Palmetto General Hospital, Hialeah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Razzeto</LastName><ForeName>Mariano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, Palmetto General Hospital, Hialeah, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac cath</Keyword><Keyword MajorTopicYN="N">internal medicine-cardiology</Keyword><Keyword MajorTopicYN="N">myopericarditis</Keyword><Keyword MajorTopicYN="N">right bundle branch block</Keyword><Keyword MajorTopicYN="N">st-elevation myocardial infarction (stemi)</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>4</Day><Hour>12</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>4</Day><Hour>12</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40755592</ArticleId><ArticleId IdType="pmc">PMC12318142</ArticleId><ArticleId IdType="doi">10.7759/cureus.87226</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS appropriate utilization of cardiovascular imaging in emergency department patients with chest pain: a joint document of the American College of Radiology Appropriateness Criteria Committee and the American College&#xa0;of Cardiology Appropriate Use Criteria Task Force. Rybicki FJ, Udelson JE, Peacock WF, et al. J Am Coll Cardiol. 2016;67:853&#x2013;879.</Citation><ArticleIdList><ArticleId IdType="pubmed">26809772</ArticleId></ArticleIdList></Reference><Reference><Citation>ST segment elevations: always a marker of acute myocardial infarction? Coppola G, Carit&#xe0; P, Corrado E, et al. Indian Heart J. 2013;65:412&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3860734</ArticleId><ArticleId IdType="pubmed">23993002</ArticleId></ArticleIdList></Reference><Reference><Citation>Case report: ST-segment elevation in a man with acute pericarditis. Li YM, Jia YH, Tsauo JY, Wang S, Peng Y. Front Cardiovasc Med. 2020;7:609691.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7793765</ArticleId><ArticleId IdType="pubmed">33426006</ArticleId></ArticleIdList></Reference><Reference><Citation>Influenza myopericarditis and pericarditis: a literature review. Radovanovic M, Petrovic M, Barsoum MK, et al. J Clin Med. 2022;11:4123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9316162</ArticleId><ArticleId IdType="pubmed">35887887</ArticleId></ArticleIdList></Reference><Reference><Citation>The utility of troponin dynamics in influenza myopericarditis: a literature review. Rafa O, Basile EJ. Cureus. 2024;16:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11186441</ArticleId><ArticleId IdType="pubmed">38899234</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovascular disease and COVID-19 vaccines: a systematic review and analysis of published cases. Khaity A, Rababah AA, Abdelwahab OA, et al. Eur Cardiol. 2023;18:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10512119</ArticleId><ArticleId IdType="pubmed">37745168</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40763602</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8171</ISSN><JournalIssue CitedMedium="Internet"><Volume>97</Volume><PubDate><Year>2025</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>The American journal of emergency medicine</Title><ISOAbbreviation>Am J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Accuracy of cath lab activation decisions for STEMI-equivalent and mimic ECGs: Physicians vs. AI (Queen of Hearts by PMcardio).</ArticleTitle><Pagination><StartPage>193</StartPage><EndPage>199</EndPage><MedlinePgn>193-199</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajem.2025.07.061</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-6757(25)00523-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Accurate ECG interpretation is crucial to identify occlusive myocardial infarction (OMI) to determine the need for immediate catheterization laboratory activation (CLA). STEMI-equivalent and STEMI-mimic ECG patterns deviate from conventional STEMI criteria, risking misclassification of OMI cases. The diagnostic accuracy for these complex ECGs is unknown.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to measure physician accuracy for interpreting STEMI-equivalent and STEMI-mimic ECGs for catheterization laboratory activation (CLA) and compare their performance to a machine learning-based artificial intelligence algorithm, Queen of Hearts AI (QoH AI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-three EPs and 42 cardiologists interpreted 18 ECGs (eight STEMI-equivalents, eight STEMI-mimics, with one STEMI, and a normal ECG as controls) to determine the presence of OMI requiring immediate CLA. The same ECGs were analyzed by QoH AI. Interpretations were compared against a reference standard based on angiography, troponin, echocardiography, and clinical follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Interpretation accuracies were similar between EPs and cardiologists (65.6&#xa0;%, 95&#xa0;% CI [51, 78]; 65.5&#xa0;%, 95&#xa0;% CI [51, 77], respectively; p&#xa0;=&#xa0;0.969), and significantly lower than QoH AI (88.9&#xa0;%, 95&#xa0;% CI [82, 93]) vs. physicians overall, 65.6&#xa0;%, 95&#xa0;% CI [52, 77]; p&#xa0;&lt;&#xa0;0.001). Physicians most frequently misclassified de Winter, Transient STEMI, Hyperacute T-wave OMI, and bundle branch block ECGs. QoH AI only misclassified left bundle branch block with OMI and left ventricular aneurysm without OMI.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Physicians frequently misinterpret STEMI-equivalent and STEMI-mimic ECGs, potentially impacting CLA decisions. QoH AI demonstrated superior accuracy, suggesting a potential to reduce missed OMIs and unnecessary catheterization laboratory activations. Prospective studies are needed to validate these findings in clinical practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shroyer</LastName><ForeName>Steven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Greater San Antonio Emergency Physicians, Methodist Hospital System, San Antonio, TX, USA. Electronic address: stevenshroyerMD@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Sumeru</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Greater San Antonio Emergency Physicians, Methodist Hospital System, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thukral</LastName><ForeName>Nandish</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Cardiology Clinic of San Antonio, Methodist Hospital System, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smiley</LastName><ForeName>Kyle</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Brooke Army Medical Center, San Antonio, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercaldo</LastName><ForeName>Nathaniel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyers</LastName><ForeName>H Pendell</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephen W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Hennepin County Medical Center, and Department of Emergency Medicine, University of Minnesota School of Medicine, Minneapolis, MN, USA. Electronic address: smith253@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Emerg Med</MedlineTA><NlmUniqueID>8309942</NlmUniqueID><ISSNLinking>0735-6757</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cath lab activation</Keyword><Keyword MajorTopicYN="N">ECG accuracy</Keyword><Keyword MajorTopicYN="N">Myocardical infarction</Keyword><Keyword MajorTopicYN="N">PCI</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">STEMI equivalent</Keyword><Keyword MajorTopicYN="N">STEMI mimic</Keyword></KeywordList><CoiStatement>Declaration of competing interest Authors SRS, SM, KS, NM and NT report no conflicts of interest, including financial support from the PMcardio&#x2014;Queen of Hearts App developer, Powerful Medical. SWS reports stock ownership in Powerful Medical and has consulted with Rapid AI; HPM reports stock ownership in Powerful Medical and has consulted with Rapid AI.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>18</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40763602</ArticleId><ArticleId IdType="doi">10.1016/j.ajem.2025.07.061</ArticleId><ArticleId IdType="pii">S0735-6757(25)00523-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40763660</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0736-4679</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>The Journal of emergency medicine</Title><ISOAbbreviation>J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Impact of Education for Paramedic-Performed Point-of-Care Ultrasound for Cardiac Function Evaluation: A Pilot Study Assessing Imaging Quality and Interpretation.</ArticleTitle><Pagination><StartPage>33</StartPage><EndPage>40</EndPage><MedlinePgn>33-40</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jemermed.2025.07.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0736-4679(25)00267-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac point-of-care ultrasound (cPoCUS) can detect occlusive myocardial infarction (OMI) in the absence of diagnostic electrocardiogram (ECG) by assessment of left ventricle (LV) function. The feasibility of cPoCUS to assess LV function in the prehospital setting is unknown.</AbstractText><AbstractText Label="STUDY OBJECTIVE" NlmCategory="OBJECTIVE">To determine image adequacy and interpretation accuracy of paramedics performing cPoCUS for assessment of LV function and wall motion abnormality (WMA).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a prospective observation pilot study of ultrasound-na&#xef;ve paramedics who participated in a clinical education program to identify OMI and performed cPoCUS during transport of adult patients. Primary outcomes were proportion of patients with 12-lead ECG who received cPoCUS, quality of images obtained, and paramedic interpretations (overall LV function and presence of a WMA). Sensitivity and specificity for LV function and WMA were calculated along with Cohen's kappa (&#x3ba;) comparing paramedic interpretation to ultrasound fellowship-trained emergency physicians.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of paramedics who passed a clinical evaluation (n = 14) and written test (n = 10), six opted to participate. Of the 201 eligible cases, 88.6% received cPoCUS during their transport to the hospital. Adequate views for LV function and WMA were obtained among 61.2% and 38.8% of patients, respectively. Accurate paramedic interpretations for LV function and WMA were made among 83/94 (88.3%) and 54/56 (96.4%) patients, respectively. There was moderate agreement between paramedics and physicians on LV function (&#x3ba; = 0.41), with 41.7% sensitivity and 95.1% specificity. No patients presented with WMA.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">With brief training, paramedics were able to acquire adequate cPoCUS images for LV function assessment, and interpretations were largely accurate.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thorne</LastName><ForeName>Jaelle L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Medicine, Department of Emergency Medicine, Farmington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>LaRese</LastName><ForeName>Taylor</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Baystate Medical Center, Department of Emergency Medicine, Springfield, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Katie</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Medicine, Department of Emergency Medicine, Farmington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thorne</LastName><ForeName>Catriana R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Medicine, Department of Emergency Medicine, Farmington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adelson</LastName><ForeName>Lindsay</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Medicine, Department of Emergency Medicine, Farmington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonowicz</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Charlotte Hungerford Hospital, Department of Emergency Medical Services, Torrington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latosek</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Medicine, Department of Emergency Medicine, Farmington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostyun</LastName><ForeName>Regina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Medicine, Department of Emergency Medicine, Farmington, Connecticut.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herbst</LastName><ForeName>Meghan Kelly</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>University of Connecticut School of Medicine, Department of Emergency Medicine, Farmington, Connecticut. Electronic address: meherbst@uchc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Emerg Med</MedlineTA><NlmUniqueID>8412174</NlmUniqueID><ISSNLinking>0736-4679</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">emergency medical services</Keyword><Keyword MajorTopicYN="N">paramedic</Keyword><Keyword MajorTopicYN="N">point-of-care ultrasound</Keyword><Keyword MajorTopicYN="N">prehospital medicine</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>18</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40763660</ArticleId><ArticleId IdType="doi">10.1016/j.jemermed.2025.07.015</ArticleId><ArticleId IdType="pii">S0736-4679(25)00267-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40773304</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1680-0745</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Cardiovascular journal of Africa</Title><ISOAbbreviation>Cardiovasc J Afr</ISOAbbreviation></Journal><ArticleTitle>Effect of percutaneous coronary intervention with prolonged balloon pre-dilation on coronary flow in ST-segment elevation myocardial infarction.</ArticleTitle><Pagination><StartPage>82</StartPage><EndPage>88</EndPage><MedlinePgn>82-88</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5830/CVJA-2025-004</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Coronary artery disease is the leading cause of death worldwide. Prompt revascularisation is crucial once a diagnosis of ST-segment elevation myocardial infarction (STEMI) is established. It is well-known that improved coronary flow and perfusion result in better long-term outcomes. In our study, we aimed to compare the effects of balloon angioplasty with prolonged and brief balloon inflation on coronary flow in primary percutaneous coronary intervention (PCI) in STEMI patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We included 62 patients who presented to our clinic diagnosed with STEMI and underwent primary PCI in our study. Pre-dilation was performed briefly, under 30 seconds (s), in 31 patients, while prolonged balloon dilation exceeding 30 s was conducted in the remaining 31 patients. ST-segment resolutions, laboratory parameters, troponin monitoring, and troponin peak times were collected for both groups before and after the procedure. After revascularisation of the responsible vessel, coronary flow parameters like thrombolysis in myocardial infarction (TIMI) score, TIMI frame count (TIMIfc), and myocardial blush grade (MBG) were evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants in both groups were similar in characteristics aside from the investigated parameters (<i>p</i> &gt;0.05). The troponin peak occurred earlier in those with prolonged balloon inflation times. Electrocardiography (ECG) improvement percentages at 1, 3, and 6 hours were higher in the prolonged balloon group (78.71&#xb1;21, 92.26&#xb1;1, 96.77&#xb1;1) compared to the brief balloon group (60.97&#xb1;2, 81.94&#xb1;1, 92.90&#xb1;1) (<i>p</i> &lt;0.05). Logistic regression showed that increasing age negatively affected TIMI flow grade and myocardial blush grade, while prolonged balloon times had a positive impact (<i>p</i> &lt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The current study demonstrated that prolonged balloon pre-dilation yielded superior outcomes compared to brief balloon pre-dilation in primary PCI performed on STEMI patients. These outcomes included enhanced TIMI, TIMIfc, and MBG parameters, along with faster and improved ST-segment resolution, allowing for a more rapid attainment of the troponin peak value. If similar findings are demonstrated in larger studies, standardising the balloon duration could be beneficial in primary PCI of STEMI patients. Thus, improved coronary flow would be associated with better long-term outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ta&#x15f;demir</LastName><ForeName>M&#xfc;cahit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Canakkale Biga State Hospital, Clinic of Cardiology, Ministry of Health, Canakkale, Turkey. Email: mucahit_tsdmr@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emet</LastName><ForeName>Samim</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Cardiology, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>South Africa</Country><MedlineTA>Cardiovasc J Afr</MedlineTA><NlmUniqueID>101313864</NlmUniqueID><ISSNLinking>1015-9657</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014336">Troponin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003326" MajorTopicYN="Y">Coronary Circulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015906" MajorTopicYN="Y">Angioplasty, Balloon, Coronary</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014336" MajorTopicYN="N">Troponin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronary flow</Keyword><Keyword MajorTopicYN="N">No&#x2010;reflow</Keyword><Keyword MajorTopicYN="N">Prolonged pre&#x2010;dilation</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">TIMIfc</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>7</Day><Hour>12</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40773304</ArticleId><ArticleId IdType="doi">10.5830/CVJA-2025-004</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40782970</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1874-1754</ISSN><JournalIssue CitedMedium="Internet"><Volume>440</Volume><PubDate><Year>2025</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>International journal of cardiology</Title><ISOAbbreviation>Int J Cardiol</ISOAbbreviation></Journal><ArticleTitle>Identifying low-risk patients within the observation zone of a 0/2-h high-sensitivity troponin diagnostic protocol for chest pain evaluation.</ArticleTitle><Pagination><StartPage>133730</StartPage><MedlinePgn>133730</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijcard.2025.133730</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-5273(25)00773-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">High-sensitivity cardiac troponin (hs-cTn) based accelerated diagnostic protocols for suspected acute coronary syndrome (ACS) in the emergency department (ED) can classify up to 40&#xa0;% of patients as intermediate-risk (the "observation zone"). Expert consensus pathways recommend further risk stratification with additional hs-cTn testing and clinical risk scores.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study of adult encounters for chest pain across 21 community EDs from January 1, 2023, to June 30, 2024. We assessed the test characteristics and efficacy (proportion identified as low risk) of two clinical risk strategies [History, ECG, Age, Risk Factors, and Troponin (HEART) pathway or the ED Assessment of Chest Pain Score Accelerated Diagnostic Pathway (EDACS-ADP)] in excluding 30-day myocardial infarction (MI) or death among patients classified as intermediate-risk by a 0/2-h hs-cTnI diagnostic protocol (Beckman Access hsTnI).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 11,178 intermediate-risk encounters, of which 789 (7.1&#xa0;%) had 30-day MI or death. Both clinical risk strategies had high negative predictive value (NPV; EDACS-ADP 99.1&#xa0;%, 95&#xa0;% CI 98.5-99.4&#xa0;%; HEART pathway 99.0&#xa0;%, 95&#xa0;% CI 98.1-99.5&#xa0;%) but also low efficacy (14&#xa0;% and 8&#xa0;%, respectively). In contrast, objective testing alone (hs-cTnI &lt;99th percentile and non-ischemic ECG) and ED discharge disposition had higher efficacy (31&#xa0;% and 57&#xa0;%) with slightly lower NPV (98.2&#xa0;% and 98.1&#xa0;%, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Both EDACS-ADP and the HEART pathway identified intermediate-risk patients with &#x2264;1&#xa0;% risk of 30-day MI or death, but with low efficacy. Objective testing or ED discharge disposition had notably higher efficacy, but require an acceptable "miss-rate" of &#x2264;2&#xa0;%.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DiLena</LastName><ForeName>Daniel D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northern California Division of Research, Pleasanton, CA, United States of America. Electronic address: Daniel.d.dilena@kp.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northern California Division of Research, Pleasanton, CA, United States of America. Electronic address: Jie.huang@kp.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauchwerger</LastName><ForeName>Adina S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northern California Division of Research, Pleasanton, CA, United States of America. Electronic address: Adina.s.rauchwerger@kp.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reed</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northern California Division of Research, Pleasanton, CA, United States of America. Electronic address: Mary.e.Reed@kp.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mark</LastName><ForeName>Dustin G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Northern California Division of Research, Pleasanton, CA, United States of America; Kaiser Permanente Oakland Medical Center, Departments of Critical Care and Emergency Medicine, Oakland, CA, United States of America. Electronic address: Dustin.g.mark@kp.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Cardiol</MedlineTA><NlmUniqueID>8200291</NlmUniqueID><ISSNLinking>0167-5273</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chest pain</Keyword><Keyword MajorTopicYN="N">Risk assessment</Keyword><Keyword MajorTopicYN="N">Troponin</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors report no relationships that could be construed as a conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>9</Day><Hour>19</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40782970</ArticleId><ArticleId IdType="doi">10.1016/j.ijcard.2025.133730</ArticleId><ArticleId IdType="pii">S0167-5273(25)00773-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40746702</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2836-9386</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>16</Day></PubDate></JournalIssue><Title>NEJM AI</Title><ISOAbbreviation>NEJM AI</ISOAbbreviation></Journal><ArticleTitle>AI Opportunistic Coronary Calcium Screening at Veterans Affairs Hospitals.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1056/aioa2400937</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronary artery calcium (CAC) is highly predictive of cardiovascular events. Although millions of chest computed tomography (CT) scans are performed annually in the United States, CAC is not routinely quantified from scans done for noncardiac purposes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We developed a deep learning algorithm, AI-CAC, using 446 expert segmentations to automatically quantify CAC on noncontrast, nongated CT scans. Our study differs from prior works by utilizing imaging data from 98 medical centers across the Veterans Affairs national health care system, capturing extensive heterogeneity in imaging protocols, scanners, and patients. AI-CAC performance on nongated scans was compared against clinical standard electrocardiogram (ECG)-gated CAC scoring in 795 patients with paired gated scans within 1 year of their nongated scan. In addition, the model was tested on 8052 low-dose CTs (LDCTs) to simulate opportunistic CAC screening.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nongated AI-CAC differentiated zero versus nonzero and less than 100 versus 100 or greater Agatston scores with accuracies of 89.4% (F1 0.93) and 87.3% (F1 0.89), respectively. Nongated AI-CAC was predictive of 10-year all-cause mortality (CAC 0 vs. &gt;400 group: 25.4% vs. 60.2%, Cox hazard ratio 3.49; P&lt;0.005), and composite first-time stroke, myocardial infarction, or death (CAC 0 vs. &gt;400 group: 33.5% vs. 63.8%, Cox hazard ratio 3.00; P&lt;0.005). In the LDCT dataset, 3091 out of 8052 (38.4%) individuals had AI-CAC scores &gt;400. Four cardiologists qualitatively reviewed a random sample of the &gt;400 AI-CAC LDCT patients and verified that 527 of the 531 (99.2%) would benefit from lipid-lowering therapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This nongated CT CAC algorithm was developed across a national health care system and shows strong performance in evaluation against paired gated CT scans. The model code and weights are available at https://github.com/Raffi-Hagopian/AI-CAC/. (Funded by the Veterans Affairs health care system.).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hagopian</LastName><ForeName>Raffi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0004-6118-4832</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Applied Innovations and Medical Informatics (AIMI), Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strebel</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0003-3962-5366</Identifier><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernatz</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-7758-8100</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology and Nuclear Medicine, GROW &amp; CARIM Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myers</LastName><ForeName>Gregory A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0009-0008-8904-3467</Identifier><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Offerman</LastName><ForeName>Erik</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-8196-8675</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zuniga</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0004-5482-343X</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Cy Y</ForeName><Initials>CY</Initials><Identifier Source="ORCID">0000-0002-5514-1244</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Angie T</ForeName><Initials>AT</Initials><Identifier Source="ORCID">0009-0002-0573-3644</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwaz</LastName><ForeName>James A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0009-0008-1073-8777</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xfc;rnberg</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-6544-4268</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology and Nuclear Medicine, GROW &amp; CARIM Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sunny P</ForeName><Initials>SP</Initials><Identifier Source="ORCID">0009-0006-7853-8443</Identifier><AffiliationInfo><Affiliation>Applied Innovations and Medical Informatics (AIMI), Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carey</LastName><ForeName>Evan P</ForeName><Initials>EP</Initials><Identifier Source="ORCID">0000-0001-7963-6818</Identifier><AffiliationInfo><Affiliation>Applied Innovations and Medical Informatics (AIMI), Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics and Informatics, University of Colorado School of Public Health, Denver.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0009-0001-9266-7229</Identifier><AffiliationInfo><Affiliation>Applied Innovations and Medical Informatics (AIMI), Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Office of Research and Development, Veterans Health Administration, Washington, DC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schaefer</LastName><ForeName>R Spencer</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0009-0006-6824-1056</Identifier><AffiliationInfo><Affiliation>Medical Informatics Data Science and Emerging Technology (MinDSET), Veterans Affairs Kansas City Healthcare System, Kansas City, MO.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jeannie</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9043-8791</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Veterans Affairs Long Beach Healthcare System, Long Beach, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Cardiology, University of California, Irvine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gentili</LastName><ForeName>Amilcare</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5623-7512</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Veterans Affairs San Diego Healthcare System, San Diego, CA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, University of California, San Diego, San Diego.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aerts</LastName><ForeName>Hugo J W L</ForeName><Initials>HJWL</Initials><Identifier Source="ORCID">0000-0002-2122-2003</Identifier><AffiliationInfo><Affiliation>Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Radiology and Nuclear Medicine, GROW &amp; CARIM Maastricht University, Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>VA999999</GrantID><Acronym>ImVA</Acronym><Agency>Intramural VA</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>NEJM AI</MedlineTA><NlmUniqueID>9918752186406676</NlmUniqueID><ISSNLinking>2836-9386</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>5</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40746702</ArticleId><ArticleId IdType="mid">NIHMS2096765</ArticleId><ArticleId IdType="pmc">PMC12311810</ArticleId><ArticleId IdType="doi">10.1056/aioa2400937</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McEvoy JW, Blaha MJ, DeFilippis AP, et al. Coronary artery calcium progression: an important clinical measurement? A review of published reports. J Am Coll Cardiol 2010;56:1613&#x2013;1622. DOI: 10.1016/j.jacc.2010.06.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.06.038</ArticleId><ArticleId IdType="pubmed">21050970</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortensen MB, Nordestgaard BG. Statin use in primary prevention of atherosclerotic cardiovascular disease according to 5 major guidelines for sensitivity, specificity, and number needed to treat. JAMA Cardiol 2019;4:1131&#x2013;1138. DOI: 10.1001/jamacardio.2019.3665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2019.3665</ArticleId><ArticleId IdType="pmc">PMC6777225</ArticleId><ArticleId IdType="pubmed">31577339</ArticleId></ArticleIdList></Reference><Reference><Citation>Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827&#x2013;832. DOI: 10.1016/0735-1097(90)90282-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(90)90282-T</ArticleId><ArticleId IdType="pubmed">2407762</ArticleId></ArticleIdList></Reference><Reference><Citation>Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008;358:1336&#x2013;1345. DOI: 10.1056/NEJMoa072100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa072100</ArticleId><ArticleId IdType="pubmed">18367736</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140:e596&#x2013;e646. DOI: 10.1161/CIR.0000000000000678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000678</ArticleId><ArticleId IdType="pmc">PMC7734661</ArticleId><ArticleId IdType="pubmed">30879355</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X, Zhao Y, de Bock GH, et al. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: systematic review and meta-analysis. Circ Cardiovasc Imaging 2013;6:514&#x2013;521. DOI: 10.1161/CIRCIMAGING.113.000092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.113.000092</ArticleId><ArticleId IdType="pubmed">23756678</ArticleId></ArticleIdList></Reference><Reference><Citation>Takx RAP, de Jong PA, Leiner T, et al. Automated coronary artery calcification scoring in non-gated chest CT: agreement and reliability. PLoS One 2014;9:e91239. DOI: 10.1371/journal.pone.0091239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0091239</ArticleId><ArticleId IdType="pmc">PMC3953377</ArticleId><ArticleId IdType="pubmed">24625525</ArticleId></ArticleIdList></Reference><Reference><Citation>Cano-Espinosa C, Gonz&#xe1;lez G, Washko GR, Cazorla M, Est&#xe9;par RS. Automated Agatston score computation in non-ECG gated CT scans using deep learning. Proc SPIE Int Soc Opt Eng 2018;10574:105742K. DOI: 10.1117/12.2293681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/12.2293681</ArticleId><ArticleId IdType="pmc">PMC6095680</ArticleId><ArticleId IdType="pubmed">30122801</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeleznik R, Foldyna B, Eslami P, et al. Deep convolutional neural networks to predict cardiovascular risk from computed tomography. Nat Commun 2021;12:715. DOI: 10.1038/s41467-021-20966-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-20966-2</ArticleId><ArticleId IdType="pmc">PMC7846726</ArticleId><ArticleId IdType="pubmed">33514711</ArticleId></ArticleIdList></Reference><Reference><Citation>Eng D, Chute C, Khandwala N, et al. Automated coronary calcium scoring using deep learning with multicenter external validation. NPJ Digit Medi 2021;4:88. DOI: 10.1038/s41746-021-00460-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-021-00460-1</ArticleId><ArticleId IdType="pmc">PMC8169744</ArticleId><ArticleId IdType="pubmed">34075194</ArticleId></ArticleIdList></Reference><Reference><Citation>Pieszko K, Shanbhag A, Killekar A, et al. Deep learning of coronary calcium scores from PET/CT attenuation maps accurately predicts adverse cardiovascular events. Cardiovasc Imaging 2023;16:675&#x2013;687. DOI: 10.1016/j.jcmg.2022.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2022.06.006</ArticleId><ArticleId IdType="pubmed">36284402</ArticleId></ArticleIdList></Reference><Reference><Citation>van Velzen SGM, Lessmann N, Velthuis BK, et al. Deep learning for automatic calcium scoring in CT: validation using multiple cardiac CT and chest CT protocols. Radiology 2020;295:66&#x2013;79. DOI: 10.1148/radiol.2020191621.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020191621</ArticleId><ArticleId IdType="pmc">PMC7106943</ArticleId><ArticleId IdType="pubmed">32043947</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelrahman K, Shiyovich A, Huck DM, et al. Artificial intelligence in coronary artery calcium scoring detection and quantification. Diagnostics 2024;14:125. DOI: 10.3390/diagnostics14020125.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics14020125</ArticleId><ArticleId IdType="pmc">PMC10814920</ArticleId><ArticleId IdType="pubmed">38248002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandhu AT, Rodriguez F, Ngo S, et al. Incidental coronary artery calcium: opportunistic screening of previous nongated chest computed tomography scans to improve statin rates (NOTIFY-1 project). Circulation 2023;147:703&#x2013;714. DOI: 10.1161/CIRCULATIONAHA.122.062746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062746</ArticleId><ArticleId IdType="pmc">PMC10108579</ArticleId><ArticleId IdType="pubmed">36342823</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Department of Veterans Affairs. Veterans Health Administration. About VHA. January
20, 2025.  (https://www.va.gov/health/aboutvha.asp).</Citation></Reference><Reference><Citation>Gassett AJ, Sheppard L, McClelland RL, et al. Risk factors for long-term coronary artery calcium progression in the multi-ethnic study of atherosclerosis. J Am Heart Assoc 2015;4:e001726. DOI: 10.1161/JAHA.114.001726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.114.001726</ArticleId><ArticleId IdType="pmc">PMC4599452</ArticleId><ArticleId IdType="pubmed">26251281</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging 2012;30:1323&#x2013;1341. DOI: 10.1016/j.mri.2012.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2012.05.001</ArticleId><ArticleId IdType="pmc">PMC3466397</ArticleId><ArticleId IdType="pubmed">22770690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatamizadeh A, Nath V, Tang Y, Yang D, Roth HR, Xu D. Swin UNETR: swin transformers for semantic segmentation of brain tumors in MRI images. In: International MICCAI Brainlesion Workshop, September 22&#x2013;27, 2021. Cham: Springer International Publishing, 2021:272&#x2013;284.</Citation></Reference><Reference><Citation>Ronneberger O, Fischer P, Brox T. U-net: convolutional networks for biomedical image segmentation. In Medical Image Computing and Computer-Assisted Intervention &#x2014; MICCAI 2015: 18th International Conference, Munich, Germany, October 5&#x2013;9, 2015, Proceedings, Part III. Cham: Springer International Publishing, 2015:234&#x2013;241.</Citation></Reference><Reference><Citation>Paszke A, Gross S, Massa F, et al. PyTorch: an imperative style, high-performance deep learning library. December 3, 2019. ( 10.48550/arXiv.1912.01703). Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1912.01703</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso MJ, Li W, Brown R, et al. Monai: an open-source framework for deep learning in healthcare. November 4, 2022 ( 10.48550/arXiv.2211.02701). Preprint.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2211.02701</ArticleId></ArticleIdList></Reference><Reference><Citation>van Assen M, Martin SS, Varga-Szemes A, et al. Automatic coronary calcium scoring in chest CT using a deep neural network in direct comparison with non-contrast cardiac CT: a validation study. Eur J Radiol 2021;134:109428. DOI: 10.1016/j.ejrad.2020.109428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.109428</ArticleId><ArticleId IdType="pubmed">33285350</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Liu J, Guo N, et al. Performance of artificial intelligence-based coronary artery calcium scoring in non-gated chest CT. Eur J Radiol 2021;145:110034. DOI: 10.1016/j.ejrad.2021.110034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2021.110034</ArticleId><ArticleId IdType="pubmed">34837795</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu C, Guo H, Xu M, et al. Automatic coronary artery calcium scoring on routine chest computed tomography (CT): comparison of a deep learning algorithm and a dedicated calcium scoring CT. Quant Imaging Med Surg 2022;12:2684&#x2013;2695. DOI: 10.21037/qims-21-1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/qims-21-1017</ArticleId><ArticleId IdType="pmc">PMC9014138</ArticleId><ArticleId IdType="pubmed">35502379</ArticleId></ArticleIdList></Reference><Reference><Citation>Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of lipids on cardiovascular health: JACC health promotion series. J Am Coll Cardiol 2018;72:1141&#x2013;1156. DOI: 10.1016/j.jacc.2018.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.06.046</ArticleId><ArticleId IdType="pubmed">30165986</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40750283</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Association between ultra-short-term heart rate variability and atrial fibrillation in heart failure population: a protocol for a prospective observational cohort study.</ArticleTitle><Pagination><StartPage>e101170</StartPage><MedlinePgn>e101170</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e101170</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2025-101170</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Patients with heart failure with reduced ejection fraction (HFrEF) and heart failure with mildly reduced ejection fraction (HFmrEF) are at high risk for developing atrial fibrillation (AF) due to significantly impaired cardiac pump function, heightened sympathetic nervous system activity and the frequent coexistence of cardiovascular comorbidities such as hypertension and coronary artery disease. Reduced heart rate variability (HRV), a key marker of autonomic nervous system balance, is an independent predictor of AF. Recently, ultra-short-term HRV (usHRV) has emerged as a promising method for rapid HRV assessment. UsHRV, operationally defined through &#x2264;10&#x2009;s ECG analyses, represents a methodological divergence from conventional short-term HRV measurements requiring &#x2265;5&#x2009;min recordings. This paradigm shift permits continuous autonomic surveillance while specifically capturing parasympathetic modulation indices as opposed to composite sympathetic-parasympathetic metrics. Such temporal optimisation establishes a novel framework for expedited autonomic evaluation in time-sensitive clinical environments. Evidence on the link between usHRV and AF in heart failure patients remains limited. This study aims to investigate the association between usHRV and AF risk in this population.</AbstractText><AbstractText Label="METHOD AND ANALYSIS" NlmCategory="METHODS">This is a prospective, single-centre cohort study in patients with heart failure and reduced left ventricular ejection fraction (LVEF&lt;50%). Eligible patients will be enrolled based on predefined inclusion and exclusion criteria. The primary endpoints are AF, atrial flutter and subclinical AF. Secondary outcomes include all-cause mortality and first major cardiovascular events. Kansas City Cardiomyopathy Questionnaire (KCCQ-12) scores at baseline, 6 and 12 months as patient-centred secondary outcomes. LVEF will be assessed via standard transthoracic ECG, and AF will be identified through 12-lead ECG or long-term wearable ECG monitoring. Patient enrolment began on 1 January 2025, and is expected to conclude by 31 March 2026.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="BACKGROUND">The study protocol received approval from the Ethics Committee of Beijing Tsinghua Changgung Hospital on 14 November 2024 (review no. 24674-4-01). The findings will be submitted for publication in a peer-reviewed journal. Additionally, this protocol has been registered with the Chinese Clinical Trial Registry.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">ChiCTR2400092516).</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xiaodi</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-5071-498X</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Rong</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China dr_herong@sina.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ping</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-5843-1108</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001281" MajorTopicYN="Y">Atrial Fibrillation</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="Y">Heart Failure</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="N">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular Disease</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Pacing &amp; electrophysiology</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>21</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40750283</ArticleId><ArticleId IdType="pmc">PMC12314973</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2025-101170</ArticleId><ArticleId IdType="pii">bmjopen-2025-101170</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moses JC, Adibi S, Angelova M, et al. Time-domain heart rate variability features for automatic congestive heart failure prediction. ESC Heart Fail. 2024;11:378&#x2013;89. doi: 10.1002/ehf2.14593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.14593</ArticleId><ArticleId IdType="pmc">PMC10804149</ArticleId><ArticleId IdType="pubmed">38009405</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshi B, Geurts S, Tilly MJ, et al. Heart rate variability is associated with left ventricular systolic, diastolic function and incident heart failure in the general population. BMC Med. 2022;20:91. doi: 10.1186/s12916-022-02273-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02273-9</ArticleId><ArticleId IdType="pmc">PMC8862241</ArticleId><ArticleId IdType="pubmed">35189879</ArticleId></ArticleIdList></Reference><Reference><Citation>Y&#x131;ld&#x131;z BS, &#xd6;zkan E, Esin F, et al. Evaluation of heart rate variability in patients with coronary artery ectasia and coronary artery disease. Turk Kardiyol Dern Ars. 2016;44:306&#x2013;14. doi: 10.5543/tkda.2015.84899.</Citation><ArticleIdList><ArticleId IdType="doi">10.5543/tkda.2015.84899</ArticleId><ArticleId IdType="pubmed">27372615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P-S, Chen LS, Fishbein MC, et al. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114:1500&#x2013;15. doi: 10.1161/CIRCRESAHA.114.303772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.114.303772</ArticleId><ArticleId IdType="pmc">PMC4043633</ArticleId><ArticleId IdType="pubmed">24763467</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal SK, Norby FL, Whitsel EA, et al. Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation: Results From 20 Years Follow-Up. J Am Coll Cardiol. 2017;69:291&#x2013;9. doi: 10.1016/j.jacc.2016.10.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.10.059</ArticleId><ArticleId IdType="pmc">PMC5260487</ArticleId><ArticleId IdType="pubmed">28104071</ArticleId></ArticleIdList></Reference><Reference><Citation>Koduri H, Ng J, Cokic I, et al. Contribution of fibrosis and the autonomic nervous system to atrial fibrillation electrograms in heart failure. Circ Arrhythm Electrophysiol. 2012;5:640&#x2013;9. doi: 10.1161/CIRCEP.111.970095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.111.970095</ArticleId><ArticleId IdType="pmc">PMC3607299</ArticleId><ArticleId IdType="pubmed">22722658</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamson PB, Smith AL, Abraham WT, et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004;110:2389&#x2013;94. doi: 10.1161/01.CIR.0000139841.42454.78.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000139841.42454.78</ArticleId><ArticleId IdType="pubmed">15313946</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin M, Zeng C, Liu X. The cardiac autonomic nervous system: A target for modulation of atrial fibrillation. Clin Cardiol. 2019;42:644&#x2013;52. doi: 10.1002/clc.23190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.23190</ArticleId><ArticleId IdType="pmc">PMC6553352</ArticleId><ArticleId IdType="pubmed">31038759</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017;5:258. doi: 10.3389/fpubh.2017.00258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2017.00258</ArticleId><ArticleId IdType="pmc">PMC5624990</ArticleId><ArticleId IdType="pubmed">29034226</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaffer F, Meehan ZM, Zerr CL. A Critical Review of Ultra-Short-Term Heart Rate Variability Norms Research. Front Neurosci. 2020;14:594880. doi: 10.3389/fnins.2020.594880.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.594880</ArticleId><ArticleId IdType="pmc">PMC7710683</ArticleId><ArticleId IdType="pubmed">33328866</ArticleId></ArticleIdList></Reference><Reference><Citation>Orini M, van Duijvenboden S, Young WJ, et al. Long-term association of ultra-short heart rate variability with cardiovascular events. Sci Rep. 2023;13:18966. doi: 10.1038/s41598-023-45988-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-45988-2</ArticleId><ArticleId IdType="pmc">PMC10624663</ArticleId><ArticleId IdType="pubmed">37923787</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz ML, van Roon A, Riese H, et al. Validity of (Ultra-)Short Recordings for Heart Rate Variability Measurements. PLoS One. 2015;10:e0138921. doi: 10.1371/journal.pone.0138921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138921</ArticleId><ArticleId IdType="pmc">PMC4586373</ArticleId><ArticleId IdType="pubmed">26414314</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek HJ, Cho C-H, Cho J, et al. Reliability of ultra-short-term analysis as a surrogate of standard 5-min analysis of heart rate variability. Telemed J E Health. 2015;21:404&#x2013;14. doi: 10.1089/tmj.2014.0104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/tmj.2014.0104</ArticleId><ArticleId IdType="pubmed">25807067</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder EB, Whitsel EA, Evans GW, et al. Repeatability of heart rate variability measures. J Electrocardiol. 2004;37:163&#x2013;72. doi: 10.1016/j.jelectrocard.2004.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2004.04.004</ArticleId><ArticleId IdType="pubmed">15286929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Lim KR, Seo J-H, et al. Higher heart rate variability as a predictor of atrial fibrillation in patients with hypertension. Sci Rep. 2022;12:3702. doi: 10.1038/s41598-022-07783-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07783-3</ArticleId><ArticleId IdType="pmc">PMC8904557</ArticleId><ArticleId IdType="pubmed">35260686</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauchier L, Babuty D, Melin A, et al. Heart rate variability in severe right or left heart failure: the role of pulmonary hypertension and resistances. Eur J Heart Fail. 2004;6:181&#x2013;5. doi: 10.1016/j.ejheart.2003.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejheart.2003.09.007</ArticleId><ArticleId IdType="pubmed">14984725</ArticleId></ArticleIdList></Reference><Reference><Citation>Thanh NV, Hien NS, Son PN, et al. Heart Rate Variability and Its Role in Predicting Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft. Int J Gen Med. 2023;16:4919&#x2013;30. doi: 10.2147/IJGM.S435901.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S435901</ArticleId><ArticleId IdType="pmc">PMC10625374</ArticleId><ArticleId IdType="pubmed">37928958</ArticleId></ArticleIdList></Reference><Reference><Citation>Perek S, Nussinovitch U, Cohen R, et al. Ultra Short Heart Rate Variability Predicts Clinical Outcomes in Patients with a Clinical Presentation Consistent with Myocarditis: A Derivation Cohort Analysis. J Clin Med. 2022;12:89. doi: 10.3390/jcm12010089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010089</ArticleId><ArticleId IdType="pmc">PMC9821232</ArticleId><ArticleId IdType="pubmed">36614887</ArticleId></ArticleIdList></Reference><Reference><Citation>Habibi M, Chahal H, Greenland P, et al. Resting Heart Rate, Short-Term Heart Rate Variability and Incident Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis (MESA)) Am J Cardiol. 2019;124:1684&#x2013;9. doi: 10.1016/j.amjcard.2019.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2019.08.025</ArticleId><ArticleId IdType="pmc">PMC6939867</ArticleId><ArticleId IdType="pubmed">31575421</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2024;45:3314&#x2013;414. doi: 10.1093/eurheartj/ehae176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae176</ArticleId><ArticleId IdType="pubmed">39210723</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandenberk B, Haemers P, Morillo C. The autonomic nervous system in atrial fibrillation&#x2014;pathophysiology and non-invasive assessment. Front Cardiovasc Med. 2024;10 doi: 10.3389/fcvm.2023.1327387.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1327387</ArticleId><ArticleId IdType="pmc">PMC10794613</ArticleId><ArticleId IdType="pubmed">38239878</ArticleId></ArticleIdList></Reference><Reference><Citation>Geurts S, Tilly MJ, Arshi B, et al. Heart rate variability and atrial fibrillation in the general population: a longitudinal and Mendelian randomization study. Clin Res Cardiol. 2023;112:747&#x2013;58. doi: 10.1007/s00392-022-02072-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-022-02072-5</ArticleId><ArticleId IdType="pmc">PMC10241681</ArticleId><ArticleId IdType="pubmed">35962833</ArticleId></ArticleIdList></Reference><Reference><Citation>Puglisi A, Gasparini M, Lunati M, et al. Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients. J Cardiovasc Electrophysiol. 2008;19:693&#x2013;701. doi: 10.1111/j.1540-8167.2007.01093.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2007.01093.x</ArticleId><ArticleId IdType="pubmed">18328039</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40749988</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6795</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography</Title><ISOAbbreviation>J Am Soc Echocardiogr</ISOAbbreviation></Journal><ArticleTitle>Multiparametric approach to arrhythmic mitral valve prolapse: novel and recognized markers of increased sudden cardiac arrest risk.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0894-7317(25)00404-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.echo.2025.07.011</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Mitral valve prolapse (MVP) in some cases may predispose to life-threatening ventricular arrhythmias. This study was aimed to evaluate determinants of arrhythmic MVP (AMVP) in a large population and to identify variables associated with sudden cardiac arrest (SCA) or sudden cardiac death (SCD).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This ambispective cohort study included patients with MVP at the age of 18-70 years with preserved ejection fraction, no coronary artery disease, cardiomyopathies, or channelopathies. AMVP was defined according to the European Heart Rhythm Association / Heart Rhythm Society consensus: MVP associated with ventricular tachycardia (VT), at least 5% of premature ventricular complexes in Holter ECG monitoring or SCA in the mechanism of ventricular fibrillation or VT. All available clinical data, results of electrocardiography, echocardiography and cardiac magnetic resonance were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The studied population comprised 574 out of 3325 patients with MVP treated in our center between 2009-2024, mean age 38.5&#xb1;14.3 years, females 65%. True mitral annular disjunction (true-MAD) and pseudo-MAD were observed more frequently in patients with AMVP (8.0% vs. 3.3%, P=.013 and 59.4% vs. 24.0%, P&lt;.001, respectively), as were "double" and "triple" e' (70.4% vs. 31.3% and 43.9% vs. 18.2%, respectively, P&lt;.001). Patients with AMVP had higher values of longitudinal strain and myocardial work indices in basal and mid segments of left ventricular inferolateral and anterolateral walls. Independent echocardiographic variables associated with AMVP were: MAD/pseudo-MAD distance, double-peak strain, "double" e' pattern and peak strain dispersion. Peak mitral annular lateral velocity, T-wave abnormalities in ECG and VT burden in Holter ECG monitoring were markers of malignant MVP.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Assessment of MAD, longitudinal strain, myocardial work and early diastolic pattern in TDI may be useful in the evaluation of arrhythmogenic MVP phenotype. The stratification of SCA/SCD risk requires multiparametric approach including clinical data, results of ECG, Holter ECG monitoring and comprehensive cardiac imaging.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jaworski</LastName><ForeName>Krzysztof</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, Warsaw, Poland. Electronic address: kjaworski@ikard.pl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalik</LastName><ForeName>Ilona</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Clinical Research Support Center, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Firek</LastName><ForeName>Bohdan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marczak</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Magnetic Resonance Unit, Department of Radiology, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiewak</LastName><ForeName>Mateusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Magnetic Resonance Unit, Department of Radiology, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baranowski</LastName><ForeName>Rafal</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>First Department of Cardiac Arrhythmias, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazarczyk</LastName><ForeName>Hubert</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Digital Medicine, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bilinska</LastName><ForeName>Zofia</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Unit for Screening Studies in Inherited Cardiovascular Diseases, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chmielewski</LastName><ForeName>Przemyslaw</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit for Screening Studies in Inherited Cardiovascular Diseases, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biernacka</LastName><ForeName>Elzbieta Katarzyna</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Congenital Heart Diseases, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kowalik</LastName><ForeName>Ewa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Congenital Heart Diseases, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakrzewski</LastName><ForeName>Dariusz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Valvular Heart Diseases, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoklosa</LastName><ForeName>Patrycjusz</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewandowski</LastName><ForeName>Michal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Second Department of Cardiac Arrhythmias, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syska</LastName><ForeName>Pawel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Second Department of Cardiac Arrhythmias, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pytkowski</LastName><ForeName>Mariusz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Second Department of Cardiac Arrhythmias, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterlinski</LastName><ForeName>Maciej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>First Department of Cardiac Arrhythmias, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dabrowski</LastName><ForeName>Rafal</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Coronary Artery Disease and Cardiac Rehabilitation, National Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Am Soc Echocardiogr</MedlineTA><NlmUniqueID>8801388</NlmUniqueID><ISSNLinking>0894-7317</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">mitral annular disjunction</Keyword><Keyword MajorTopicYN="N">mitral valve prolapse</Keyword><Keyword MajorTopicYN="N">sudden cardiac arrest</Keyword><Keyword MajorTopicYN="N">sudden cardiac death</Keyword><Keyword MajorTopicYN="N">ventricular arrhythmia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>19</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40749988</ArticleId><ArticleId IdType="doi">10.1016/j.echo.2025.07.011</ArticleId><ArticleId IdType="pii">S0894-7317(25)00404-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40735762</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0972-3919</ISSN><JournalIssue CitedMedium="Print"><Volume>40</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India</Title><ISOAbbreviation>Indian J Nucl Med</ISOAbbreviation></Journal><ArticleTitle>Assessment of ATTR Cardiac Amyloidosis in Patients with Left Ventricular Hypertrophy Using Tc-99m Pyrophosphate Scintigraphy.</ArticleTitle><Pagination><StartPage>79</StartPage><EndPage>87</EndPage><MedlinePgn>79-87</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/ijnm.ijnm_156_24</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Amyloidosis is characterized by the extracellular deposition of fibrillar proteins, leading to tissue damage and dysfunction. Cardiac amyloidosis (CA) occurs when these fibrils accumulate in the heart's extracellular matrix, causing infiltrative cardiomyopathy, heart failure, and potentially death. Early diagnosis is imperative in accurate management. Transthyretin amyloidosis, either hereditary or age-related, is a common cause of CA, often presenting with left ventricular hypertrophy (LVH) and heart failure with preserved ejection fraction (HFpEF). This study investigates the utility of Tc-99 m Pyrophosphate (Tc-99 m PYP) imaging in diagnosing Transthyretin Amyloidosis ((ATTR)-CA) in patients with unexplained LVH.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">This prospective observational study, conducted between January 2023 and June 2024, involved 52 patients with clinical suspicion of CA and left ventricular wall thickness &gt;12 mm. Patients underwent Tc-99 m PYP scintigraphy, and the results were categorized as positive, negative, or equivocal.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The study population's mean age was 64.6 years, with a male predominance (69%). Of the 52 patients, 9 (17.3%) had positive, 28 (53.8%) negative, and 15 (28.8%) equivocal Tc-99 m PYP scan results. Echocardiographic features, such as septal hypertrophy and granular speckled appearance, were significantly associated with positive scan findings. Comorbidities such as coronary artery disease and dyslipidemia were also common. Cardiac biomarkers NT-proBNP and troponin I showed elevated levels in patients with positive scan results.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Tc-99 m PYP imaging is an effective noninvasive tool for diagnosing ATTR CA, particularly in patients with unexplained LVH. The presence of HFpEF, abnormal ECG, and restrictive features on echocardiography should prompt further investigation for CA. Early diagnosis allows for timely management, improving patient outcomes.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Indian Journal of Nuclear Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Priyadharshini</LastName><ForeName>V M Vimala</ForeName><Initials>VMV</Initials><AffiliationInfo><Affiliation>Department of Nuclear medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muthukrishnan</LastName><ForeName>Indirani</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Nuclear medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Shelley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nuclear medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Indian J Nucl Med</MedlineTA><NlmUniqueID>8901274</NlmUniqueID><ISSNLinking>0974-0244</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ATTR-cardiac amyloidosis</Keyword><Keyword MajorTopicYN="N">Tc-99 m pyrophosphate scintigraphy</Keyword><Keyword MajorTopicYN="N">left ventricular hypertrophy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>5</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40735762</ArticleId><ArticleId IdType="pmc">PMC12303218</ArticleId><ArticleId IdType="doi">10.4103/ijnm.ijnm_156_24</ArticleId><ArticleId IdType="pii">IJNM-40-79</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bokhari S, Gupta R. Aging, aortic stenosis, and transthyretin cardiac amyloidosis: A perfect cardiac storm? JACC CardioOncol. 2021;3:577&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8543125</ArticleId><ArticleId IdType="pubmed">34729529</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer MS, Hanna M, Grogan M, Dispenzieri A, Witteles R, Drachman B, et al. Genotype and phenotype of transthyretin cardiac amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey) J Am Coll Cardiol. 2016;68:161&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4940135</ArticleId><ArticleId IdType="pubmed">27386769</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. Circulation. 2017;135:1357&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5392416</ArticleId><ArticleId IdType="pubmed">28373528</ArticleId></ArticleIdList></Reference><Reference><Citation>Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379:1007&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">30145929</ArticleId></ArticleIdList></Reference><Reference><Citation>From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardial biopsy. Mayo Clin Proc. 2011;86:1095&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3203000</ArticleId><ArticleId IdType="pubmed">22033254</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">27143678</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, Murata H, Takano H, Kiriyama T, Kunugi S, Hachisuka M, et al. External validation of the kumamoto criteria in transthyretin amyloid cardiomyopathy screening &#x2013; A retrospective cohort study. Circ Rep. 2022;4:579&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9727327</ArticleId><ArticleId IdType="pubmed">36530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakao Y, Saito M, Inoue K, Higaki R, Yokomoto Y, Ogimoto A, et al. Cardiac amyloidosis screening using a relative apical sparing pattern in patients with left ventricular hypertrophy. Cardiovasc Ultrasound. 2021;19:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8383373</ArticleId><ArticleId IdType="pubmed">34425846</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokhari S, Casta&#xf1;o A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m) Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6:195&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3727049</ArticleId><ArticleId IdType="pubmed">23400849</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain A, Oomman A, Sathyamurthy I, Pandurangan P, Mao R, Mahilmaran A, et al. Cardiac amyloidosis in South India: A tertiary care centre experience. Heart Fail J India. 2023;1:145.</Citation></Reference><Reference><Citation>Gonz&#xe1;lez-L&#xf3;pez E, Gagliardi C, Dominguez F, Quarta CC, de Haro-Del Moral FJ, Milandri A, et al. Clinical characteristics of wild-type transthyretin cardiac amyloidosis: Disproving myths. Eur Heart J. 2017;38:1895&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pubmed">28329248</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal H, Ghosh T, Arava S, Ray R, Seth S. Cardiac amyloidosis in India: A clinicopathological study. J Pract Cardiovasc Sci. 2021;7:121&#x2013;7.</Citation></Reference><Reference><Citation>Raut N, Potdar A, Sharma S. Cardiac amyloidosis: A case series from India. J Assoc Physicians India. 2019;67:35&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31562714</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Suwaidi J, Velianou JL, Gertz MA, Cannon RO, 3rd, Higano ST, Holmes DR, Jr., et al. Systemic amyloidosis presenting with angina pectoris. Ann Intern Med. 1999;131:838&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">10610629</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorbala S, Vangala D, Bruyere J, Jr., Quarta C, Kruger J, Padera R, et al. Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart Fail. 2014;2:358&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4127145</ArticleId><ArticleId IdType="pubmed">25023822</ArticleId></ArticleIdList></Reference><Reference><Citation>Dower J, Dima D, Lalla M, Patel AR, Comenzo RL, Varga C. The use of PYP scan for evaluation of ATTR cardiac amyloidosis at a tertiary medical centre. Br J Cardiol. 2022;29:19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9534106</ArticleId><ArticleId IdType="pubmed">36212788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogasawara K, Shiraishi S, Tsuda N, Sakamoto F, Oda S, Takashio S, et al. Usefulness of quantitative (99m) Tc-pyrophosphate SPECT/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis. Jpn J Radiol. 2022;40:508&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9068718</ArticleId><ArticleId IdType="pubmed">34973114</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: A position statement of the ESC Working Group on myocardial and pericardial diseases. Eur Heart J. 2021;42:1554&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8060056</ArticleId><ArticleId IdType="pubmed">33825853</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen CP, Vanichsarn CT, Pandey AC, Billick K, Rubenson DS, Mohan RC, et al. Wild type cardiac amyloidosis: Is it time to order a nuclear technetium pyrophosphate SPECT imaging study? Int J Cardiovasc Imaging. 2023;39:201&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9813141</ArticleId><ArticleId IdType="pubmed">36598681</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleem M, Sadat B, Van Harn M, Ananthasubramaniam K. Towards a diagnosis of cardiac amyloidosis: Single center experience with (99m) technetium pyrophosphate planar imaging and opportunities for standardization of diagnostic workflow. Medicina (Kaunas) 2023;59:378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9959230</ArticleId><ArticleId IdType="pubmed">36837580</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigoratos C, Aimo A, Rapezzi C, Genovesi D, Barison A, Aquaro GD, et al. Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis. Int J Cardiol. 2020;307:187&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">32081469</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan D, Collier P, Thavendiranathan P, Popovi&#x107; ZB, Hanna M, Plana JC, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98:1442&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22865865</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidiqi MH, McPhail ED, Theis JD, Dasari S, Vrana JA, Drosou ME, et al. Two types of amyloidosis presenting in a single patient: A case series. Blood Cancer J. 2019;9:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6401104</ArticleId><ArticleId IdType="pubmed">30837451</ArticleId></ArticleIdList></Reference><Reference><Citation>Vergaro G, Castiglione V, Poletti R, Buda G, Pucci A, Musetti V, et al. Biopsy evidence of sequential transthyretin and immunoglobulin light-chain cardiac amyloidosis in the same patient. JACC Case Rep. 2021;3:450&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8311035</ArticleId><ArticleId IdType="pubmed">34317556</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarta CC, Zheng J, Hutt D, Grigore SF, Manwani R, Sachchithanantham S, et al. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. Eur Heart J Cardiovasc Imaging. 2021;22:1304&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8527328</ArticleId><ArticleId IdType="pubmed">34254119</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40737341</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>7</Issue><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Role of rosuvastatin and pitavastatin in alleviating diabetic cardiomyopathy in rats: Targeting of RISK, NF-&#x3ba;B/ NLRP3 inflammasome and TLR4/ NF-&#x3ba;B signaling cascades.</ArticleTitle><Pagination><StartPage>e0325767</StartPage><MedlinePgn>e0325767</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0325767</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0325767</ELocationID><Abstract><AbstractText>Diabetic cardiomyopathy (DCM) is a serious outcome of type II diabetes mellitus (T2DM) and a key contributor to high morbidity and death in diabetic individuals. The current research is intended to elucidate and compare the therapeutic benefits of rosuvastatin (RVS) and pitavastatin (PTS) in mitigating DMC-induced in rats and exploring the possible underlying molecular signaling pathways. DCM was prompted by feeding rats a high-fat/fructose (F/Fr) diet for eight weeks with a sub-diabetogenic dose of streptozotocin (35&#x2009;mg/kg; i.p) injection at week seven. All rats were allocated into four groups: a normal control group, a DCM-induced positive control group, the RVS group of DCM-induced rats that were treated once daily with 10&#x2009;mg/kg of RVS, and the PTS group of DCM rats that were treated with 0.8&#x2009;mg/kg of PTS. Rats were given the treatments orally for four consecutive weeks. The outcome of the existing work discovered that RVS and PTS significantly improved T2DM-associated DCM, as evidenced by the amelioration of glucose, lipids, cardiac markers, ECG parameters, and redox status. Considering the relationship between oxidative stress and inflammation, this attenuation was evidenced by the downregulation of redox, inflammatory, and cellular fibrotic cascades, namely RISK, NF-&#x3ba;B/NLRP3 inflammasome, and TLR4/NF-&#x3ba;B signaling pathways. Additionally, the histopathological examinations confirmed these structural alterations in the myocardium. Besides, RVS and PTS diminished the expression of caspase-1 assessed by immunochemical staining. In summary, the present study demonstrated that RVS and PTS mitigated the metabolic abnormalities associated with T2DM-induced DCM.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Saleh et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saleh</LastName><ForeName>Dalia O</ForeName><Initials>DO</Initials><AffiliationInfo><Affiliation>Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abo El Nasr</LastName><ForeName>Nesma M E</ForeName><Initials>NME</Initials><AffiliationInfo><Affiliation>Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elbaset</LastName><ForeName>Marawan A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Pharmacology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shabana</LastName><ForeName>Marwa E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Pathology Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esatbeyoglu</LastName><ForeName>Tuba</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-2413-6925</Identifier><AffiliationInfo><Affiliation>Department of Molecular Food Chemistry and Food Development, Institute of Food and One Health, Gottfried Wilhelm Leibniz University Hannover, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afifi</LastName><ForeName>Sherif M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department for Life Quality Studies, Rimini Campus, University of Bologna, Rimini, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashad</LastName><ForeName>Ingy M</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>Biochemistry Department, Faculty of Phamacy and Biotechnology, German Universty in Cairo, Cairo, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>M5681Q5F9P</RegistryNumber><NameOfSubstance UI="C108475">pitavastatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071199">NLR Family, Pyrin Domain-Containing 3 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>83MVU38M7Q</RegistryNumber><NameOfSubstance UI="D000068718">Rosuvastatin Calcium</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011804">Quinolines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C573346">Nlrp3 protein, rat</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495347">Tlr4 protein, rat</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058065" MajorTopicYN="Y">Diabetic Cardiomyopathies</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071199" MajorTopicYN="N">NLR Family, Pyrin Domain-Containing 3 Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000068718" MajorTopicYN="Y">Rosuvastatin Calcium</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011804" MajorTopicYN="Y">Quinolines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="Y">Inflammasomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003921" MajorTopicYN="N">Diabetes Mellitus, Experimental</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="N">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>18</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40737341</ArticleId><ArticleId IdType="pmc">PMC12310044</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0325767</ArticleId><ArticleId IdType="pii">PONE-D-24-48775</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Grubi&#x107; Rotkvi&#x107; P, Planini&#x107; Z, Liberati Pr&#x161;o A-M, &#x160;iki&#x107; J, Gali&#x107; E, Rotkvi&#x107; L. The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities. Int J Mol Sci. 2021;22(11):5973. doi: 10.3390/ijms22115973</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115973</ArticleId><ArticleId IdType="pmc">PMC8198766</ArticleId><ArticleId IdType="pubmed">34205870</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W, Li D, Gao X, Zhang W, Robinson BO. Carvedilol alleviates diabetic cardiomyopathy in diabetic rats. Exp Ther Med. 2019;17(1):479&#x2013;87. doi: 10.3892/etm.2018.6954</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6954</ArticleId><ArticleId IdType="pmc">PMC6307467</ArticleId><ArticleId IdType="pubmed">30651825</ArticleId></ArticleIdList></Reference><Reference><Citation>Macvanin MT, Gluvic Z, Radovanovic J, Essack M, Gao X, Isenovic ER. Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs. Front Endocrinol (Lausanne). 2023;14:1124613. doi: 10.3389/fendo.2023.1124613</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2023.1124613</ArticleId><ArticleId IdType="pmc">PMC10025540</ArticleId><ArticleId IdType="pubmed">36950696</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu W, Wu J, Cai F, Xiang J, Zha W, Fan D, et al. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One. 2012;7(12):e52013. doi: 10.1371/journal.pone.0052013</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052013</ArticleId><ArticleId IdType="pmc">PMC3522633</ArticleId><ArticleId IdType="pubmed">23251674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou J, Zheng D, Fung G, Deng H, Chen L, Liang J, et al. Mangiferin suppressed advanced glycation end products (AGEs) through NF-&#x3ba;B deactivation and displayed anti-inflammatory effects in streptozotocin and high fat diet-diabetic cardiomyopathy rats. Can J Physiol Pharmacol. 2016;94(3):332&#x2013;40. doi: 10.1139/cjpp-2015-0073</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2015-0073</ArticleId><ArticleId IdType="pubmed">26751764</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuentes-Antr&#xe1;s J, Ioan AM, Tu&#xf1;&#xf3;n J, Egido J, Lorenzo O. Activation of toll-like receptors and inflammasome complexes in the diabetic cardiomyopathy-associated inflammation. Int J Endocrinol. 2014;2014:1&#x2013;10. doi: 10.1155/2014/847827</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/847827</ArticleId><ArticleId IdType="pmc">PMC3972909</ArticleId><ArticleId IdType="pubmed">24744784</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur N, Guan Y, Raja R, Ruiz-Velasco A, Liu W. Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response. Front Physiol. 2021;12. doi: 10.3389/fphys.2021.694864</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.694864</ArticleId><ArticleId IdType="pmc">PMC8257042</ArticleId><ArticleId IdType="pubmed">34234695</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo B, Huang F, Liu Y, Liang Y, Wei Z, Ke H, et al. NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy. Front Physiol. 2017;8. doi: 10.3389/fphys.2017.00519</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2017.00519</ArticleId><ArticleId IdType="pmc">PMC5524816</ArticleId><ArticleId IdType="pubmed">28790925</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossello X, Yellon DM. The RISK pathway and beyond. Basic Res Cardiol. 2017;113(1):2. doi: 10.1007/s00395-017-0662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00395-017-0662-x</ArticleId><ArticleId IdType="pmc">PMC5688212</ArticleId><ArticleId IdType="pubmed">29143177</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares ROS, Losada DM, Jordani MC, &#xc9;vora P, Castro-E-Silva O. Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies. Int J Mol Sci. 2019;20(20):5034. doi: 10.3390/ijms20205034</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205034</ArticleId><ArticleId IdType="pmc">PMC6834141</ArticleId><ArticleId IdType="pubmed">31614478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Chen Q, Ke D, Li G, Deng W. Emodin protects against diabetic cardiomyopathy by regulating the AKT/GSK-3&#x3b2; signaling pathway in the rat model. Molecules. 2014;19(9):14782&#x2013;93. doi: 10.3390/molecules190914782</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules190914782</ArticleId><ArticleId IdType="pmc">PMC6271268</ArticleId><ArticleId IdType="pubmed">25232702</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Damry NT, Attia HA, Al-Rasheed NM, Al-Rasheed NM, Mohamad RA, Al-Amin MA, et al. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3&#x3b2; and p38&#x3b1;/MAPK in a rat model of diabetic cardiomyopathy. Biomed Pharmacother. 2018;107:347&#x2013;58. doi: 10.1016/j.biopha.2018.07.126</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.07.126</ArticleId><ArticleId IdType="pubmed">30099338</ArticleId></ArticleIdList></Reference><Reference><Citation>Markowska A, Antoszczak M, Markowska J, Huczy&#x144;ski A. Statins: HMG-CoA Reductase Inhibitors as Potential Anticancer Agents against Malignant Neoplasms in Women. Pharmaceuticals (Basel). 2020;13(12):422. doi: 10.3390/ph13120422</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph13120422</ArticleId><ArticleId IdType="pmc">PMC7760915</ArticleId><ArticleId IdType="pubmed">33255609</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadat S, Boskabady MH. Anti-inflammatory and Antioxidant Effects of Rosuvastatin on Asthmatic, Hyperlipidemic, and Asthmatic-Hyperlipidemic Rat Models. Inflammation. 2021;44(6):2279&#x2013;90. doi: 10.1007/s10753-021-01499-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-021-01499-8</ArticleId><ArticleId IdType="pubmed">34226988</ArticleId></ArticleIdList></Reference><Reference><Citation>Potential protective effect of pitavastatin against doxorubicin-induced cardiotoxicity in male rats. JPTCP. 2023;30(8). doi: 10.47750/jptcp.2023.30.08.037</Citation><ArticleIdList><ArticleId IdType="doi">10.47750/jptcp.2023.30.08.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, et al. Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways. Clin Rev Allergy Immunol. 2021;60(2):175&#x2013;99. doi: 10.1007/s12016-020-08791-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08791-9</ArticleId><ArticleId IdType="pmc">PMC7985098</ArticleId><ArticleId IdType="pubmed">32378144</ArticleId></ArticleIdList></Reference><Reference><Citation>Morofuji Y, Nakagawa S, Ujifuku K, Fujimoto T, Otsuka K, Niwa M, et al. Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer. Pharmaceuticals (Basel). 2022;15(2):151. doi: 10.3390/ph15020151</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15020151</ArticleId><ArticleId IdType="pmc">PMC8877351</ArticleId><ArticleId IdType="pubmed">35215263</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo El-Nasr NME, Saleh DO, Hashad IM. Role of olmesartan in ameliorating diabetic nephropathy in rats by targeting the AGE/PKC, TLR4/P38-MAPK and SIRT-1 autophagic signaling pathways. Eur J Pharmacol. 2022;928:175117. doi: 10.1016/j.ejphar.2022.175117</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2022.175117</ArticleId><ArticleId IdType="pubmed">35752350</ArticleId></ArticleIdList></Reference><Reference><Citation>Abo El-Nasr NME, Saleh DO, Mahmoud SS, Nofal SM, Abdelsalam RM, Safar MM, et al. Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways. Eur J Pharmacol. 2020;874:173010. doi: 10.1016/j.ejphar.2020.173010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2020.173010</ArticleId><ArticleId IdType="pubmed">32067934</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Rahman RF, Fayed HM, Mohamed MA, Hessin AF, Asaad GF, AbdelRahman SS, et al. Apigenin role against thioacetamide-triggered liver fibrosis: Deciphering the PPAR&#x3b3;/TGF-&#x3b2;1/NF-&#x3ba;B and the HIF/FAK/AKT pathways. J Herbmed Pharmacol. 2023;12(2):202&#x2013;13. doi: 10.34172/jhp.2023.21</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/jhp.2023.21</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelkader NF, Elbaset MA, Moustafa PE, Ibrahim SM. Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling. Arch Pharm Res. 2022;45(7):475&#x2013;93. doi: 10.1007/s12272-022-01391-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12272-022-01391-5</ArticleId><ArticleId IdType="pmc">PMC9325846</ArticleId><ArticleId IdType="pubmed">35767208</ArticleId></ArticleIdList></Reference><Reference><Citation>ElBaset MA, Salem RS, Ayman F, Ayman N, Shaban N, Afifi SM, et al. Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1&#x3b1; Pathway in Halting Liver Fibrosis. Antioxidants (Basel). 2022;11(11):2152. doi: 10.3390/antiox11112152</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11112152</ArticleId><ArticleId IdType="pmc">PMC9686640</ArticleId><ArticleId IdType="pubmed">36358524</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbaset MA, Nasr M, Ibrahim BMM, Ahmed-Farid OAH, Bakeer RM, Hassan NS, et al. Curcumin nanoemulsion counteracts hepatic and cardiac complications associated with high-fat/high-fructose diet in rats. J Food Biochem. 2022;46(12):e14442. doi: 10.1111/jfbc.14442</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfbc.14442</ArticleId><ArticleId IdType="pubmed">36165438</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanna M, Seddiek H, Aboulhoda BE, Morcos GNB, Akabawy AMA, Elbaset MA, et al. Synergistic cardioprotective effects of melatonin and deferoxamine through the improvement of ferritinophagy in doxorubicin-induced acute cardiotoxicity. Front Physiol. 2022;13:1050598. doi: 10.3389/fphys.2022.1050598</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.1050598</ArticleId><ArticleId IdType="pmc">PMC9748574</ArticleId><ArticleId IdType="pubmed">36531171</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh D, Abdelbaset M, Hassan A, Sharaf O, Mahmoud S, Hegazy R. Omega-3 fatty acids ameliorate doxorubicin-induced cardiorenal toxicity: In-vivo regulation of oxidative stress, apoptosis and renal Nox4, and in-vitro preservation of the cytotoxic efficacy. PLoS One. 2020;15(11):e0242175. doi: 10.1371/journal.pone.0242175</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0242175</ArticleId><ArticleId IdType="pmc">PMC7660507</ArticleId><ArticleId IdType="pubmed">33180794</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Long M-Y, Chen Z-Q, Huang J-W, Qin Z-B, Li L. Downregulation of miR-181a-5p alleviates oxidative stress and inflammation in coronary microembolization-induced myocardial damage by directly targeting XIAP. J Geriatr Cardiol. 2021;18(6):426&#x2013;39. doi: 10.11909/j.issn.1671-5411.2021.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.11909/j.issn.1671-5411.2021.06.007</ArticleId><ArticleId IdType="pmc">PMC8220381</ArticleId><ArticleId IdType="pubmed">34220972</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng D, Wang Y, Liu Y, Wu L, Li X, Chen Y, et al. DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-&#x3ba;B activation in renal tubular epithelial cells during acute renal injury. Clin Exp Immunol. 2018;191(1):107&#x2013;15. doi: 10.1111/cei.13048</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13048</ArticleId><ArticleId IdType="pmc">PMC5721233</ArticleId><ArticleId IdType="pubmed">28898406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner EM. Monitoring Gene Expression: Quantitative Real-Time RT-PCR. Methods Mol Biol. Humana Press. 2013. p. 19&#x2013;45. doi: 10.1007/978-1-60327-369-5_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60327-369-5_2</ArticleId><ArticleId IdType="pubmed">23912981</ArticleId></ArticleIdList></Reference><Reference><Citation>Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010;38(Database issue):D792-9. doi: 10.1093/nar/gkp1005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkp1005</ArticleId><ArticleId IdType="pmc">PMC2808898</ArticleId><ArticleId IdType="pubmed">19906719</ArticleId></ArticleIdList></Reference><Reference><Citation>Galati G, Leone O, Pasquale F, Olivotto I, Biagini E, Grigioni F, et al. Histological and Histometric Characterization of Myocardial Fibrosis in End-Stage Hypertrophic Cardiomyopathy. Circ: Heart Failure. 2016;9(9). doi: 10.1161/circheartfailure.116.003090</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circheartfailure.116.003090</ArticleId><ArticleId IdType="pubmed">27618852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21&#x2013;8. doi: 10.1007/s00125-017-4390-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-017-4390-4</ArticleId><ArticleId IdType="pmc">PMC5720913</ArticleId><ArticleId IdType="pubmed">28776083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawada A, Machowiak A, Rychter AM, Ratajczak AE, Szymczak-Tomczak A, Dobrowolska A, et al. Accumulation of Advanced Glycation End-Products in the Body and Dietary Habits. Nutrients. 2022;14(19):3982. doi: 10.3390/nu14193982</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14193982</ArticleId><ArticleId IdType="pmc">PMC9572209</ArticleId><ArticleId IdType="pubmed">36235635</ArticleId></ArticleIdList></Reference><Reference><Citation>Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44(9):1834&#x2013;40. doi: 10.1016/j.jacc.2004.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2004.08.016</ArticleId><ArticleId IdType="pubmed">15519016</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinkley KE, Page RL 2nd, Lien H, Yamanouye K, Tisdale JE. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin. 2013;29(12):1719&#x2013;26. doi: 10.1185/03007995.2013.840568</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007995.2013.840568</ArticleId><ArticleId IdType="pubmed">24020938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bashandy SAE, El-Seidy AMA, Ibrahim FAA, Abdelrahman SS, Abdelmottaleb Moussa SA, ElBaset MA. Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload. Sci Rep. 2023;13(1):16010. doi: 10.1038/s41598-023-42550-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-42550-y</ArticleId><ArticleId IdType="pmc">PMC10519991</ArticleId><ArticleId IdType="pubmed">37749096</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Khatib SM, LaPointe NMA, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA. 2003;289(16):2120&#x2013;7. doi: 10.1001/jama.289.16.2120</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.289.16.2120</ArticleId><ArticleId IdType="pubmed">12709470</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Luo W, Han J, Khan ZA, Fang Q, Jin Y, et al. MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy. Nat Commun. 2020;11(1):2148. doi: 10.1038/s41467-020-15978-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-15978-3</ArticleId><ArticleId IdType="pmc">PMC7195432</ArticleId><ArticleId IdType="pubmed">32358497</ArticleId></ArticleIdList></Reference><Reference><Citation>Youssef ME, El-Azab MF, Abdel-Dayem MA, Yahya G, Alanazi IS, Saber S. Electrocardiographic and histopathological characterizations of diabetic cardiomyopathy in rats. Environ Sci Pollut Res. 2022;29(17):25723&#x2013;32. doi: 10.1007/s11356-021-17831-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11356-021-17831-6</ArticleId><ArticleId IdType="pubmed">34845640</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol. 2016;12(3):144&#x2013;53. doi: 10.1038/nrendo.2015.216</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrendo.2015.216</ArticleId><ArticleId IdType="pmc">PMC4753054</ArticleId><ArticleId IdType="pubmed">26678809</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa HN, Hegazy GA, Awdan SAE, AbdelBaset M. Protective role of CoQ10 or L-carnitine on the integrity of the myocardium in doxorubicin induced toxicity. Tissue Cell. 2017;49(3):410&#x2013;26. doi: 10.1016/j.tice.2017.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tice.2017.03.007</ArticleId><ArticleId IdType="pubmed">28410798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M, Gardin JM, Lynch JC, Smith VE, Tracy RP, Savage PJ, et al. Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study. Am Heart J. 1997;133(1):36&#x2013;43. doi: 10.1016/s0002-8703(97)70245-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-8703(97)70245-x</ArticleId><ArticleId IdType="pubmed">9006288</ArticleId></ArticleIdList></Reference><Reference><Citation>Assis FR, Krishnan A, Zhou X, James CA, Murray B, Tichnell C, et al. Cardiac sympathectomy for refractory ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2019;16(7):1003&#x2013;10. doi: 10.1016/j.hrthm.2019.01.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2019.01.019</ArticleId><ArticleId IdType="pubmed">30677492</ArticleId></ArticleIdList></Reference><Reference><Citation>Krejci J, Mlejnek D, Sochorova D, Nemec P. Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment. Biomed Res Int. 2016;2016:4087632. doi: 10.1155/2016/4087632</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/4087632</ArticleId><ArticleId IdType="pmc">PMC4921131</ArticleId><ArticleId IdType="pubmed">27382566</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117(6):1450&#x2013;88. doi: 10.1093/cvr/cvaa324</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvaa324</ArticleId><ArticleId IdType="pmc">PMC8152700</ArticleId><ArticleId IdType="pubmed">33135058</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. Int J Mol Sci. 2019;20(13):3328. doi: 10.3390/ijms20133328</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20133328</ArticleId><ArticleId IdType="pmc">PMC6651423</ArticleId><ArticleId IdType="pubmed">31284572</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu N, Liu S, Zhang Y, Chen Y, Zuo Y, Tan X, et al. Oxidative stress signaling in the pathogenesis of diabetic cardiomyopathy and the potential therapeutic role of antioxidant naringenin. Redox Rep. 2023;28(1):2246720. doi: 10.1080/13510002.2023.2246720</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13510002.2023.2246720</ArticleId><ArticleId IdType="pmc">PMC10538464</ArticleId><ArticleId IdType="pubmed">37747066</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng Y, Li Y, Jiang W, Hou N. Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy. Front Cardiovasc Med. 2024;11. doi: 10.3389/fcvm.2024.1375400</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2024.1375400</ArticleId><ArticleId IdType="pmc">PMC11003275</ArticleId><ArticleId IdType="pubmed">38596692</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M, Fu Y, Wu C, Zhang Y, Ren H, Zhou S. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy. Front Endocrinol. 2022;13. doi: 10.3389/fendo.2022.907757</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.907757</ArticleId><ArticleId IdType="pmc">PMC9240190</ArticleId><ArticleId IdType="pubmed">35784531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Kusaka S, Shimojo H, Fujikado T. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity. Ophthalmology. 2009;116(11):2165&#x2013;9. doi: 10.1016/j.ophtha.2009.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ophtha.2009.04.026</ArticleId><ArticleId IdType="pubmed">19700197</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel-Rahman RF, Hessin AF, Abdelbaset M, Ogaly HA, Abd-Elsalam RM, Hassan SM. Antihypertensive Effects of Roselle-Olive Combination in L-NAME-Induced Hypertensive Rats. Oxid Med Cell Longev. 2017;2017:9460653. doi: 10.1155/2017/9460653</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/9460653</ArticleId><ArticleId IdType="pmc">PMC5671754</ArticleId><ArticleId IdType="pubmed">29201276</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagan LU, Gomes MJ, Gatto M, Mota GAF, Okoshi K, Okoshi MP. The Role of Oxidative Stress in the Aging Heart. Antioxidants (Basel). 2022;11(2):336. doi: 10.3390/antiox11020336</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11020336</ArticleId><ArticleId IdType="pmc">PMC8868312</ArticleId><ArticleId IdType="pubmed">35204217</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M-L, Fu Y, Wu C-W, Zhang Y, Ren H, Zhou S-S. Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy. Front Endocrinol (Lausanne). 2022;13:907757. doi: 10.3389/fendo.2022.907757</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.907757</ArticleId><ArticleId IdType="pmc">PMC9240190</ArticleId><ArticleId IdType="pubmed">35784531</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo S, Gamba P, Testa G, Rossin D, Biasi F, Poli G, et al. Relation between TLR4/NF-&#x3ba;B signaling pathway activation by 27-hydroxycholesterol and 4-hydroxynonenal, and atherosclerotic plaque instability. Aging Cell. 2015;14(4):569&#x2013;81. doi: 10.1111/acel.12322</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.12322</ArticleId><ArticleId IdType="pmc">PMC4531071</ArticleId><ArticleId IdType="pubmed">25757594</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, Li L, Sun Y, Yang H, Ye Z, Zhao J. Effects of the TLR4/Myd88/NF-&#x3ba;B Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury. Cell Physiol Biochem. 2018;47(4):1497&#x2013;508. doi: 10.1159/000490866</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000490866</ArticleId><ArticleId IdType="pubmed">29940584</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandanmagsar B, Youm Y-H, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17(2):179&#x2013;88. doi: 10.1038/nm.2279</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2279</ArticleId><ArticleId IdType="pmc">PMC3076025</ArticleId><ArticleId IdType="pubmed">21217695</ArticleId></ArticleIdList></Reference><Reference><Citation>Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459&#x2013;72. doi: 10.1093/eurheartj/ehx144</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx144</ArticleId><ArticleId IdType="pmc">PMC5837225</ArticleId><ArticleId IdType="pubmed">28444290</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Yang F, Cheng S, Liu Y, Wan L, Cong H. Rosuvastatin postconditioning protects isolated hearts against ischemia&#x2013;reperfusion injury: The role of radical oxygen species, PI3K&#x2013;Akt&#x2013;GSK&#x2010;3&#x3b2; pathway, and mitochondrial permeability transition pore. Cardiovasc Ther. 2016;35(1):3&#x2013;9. doi: 10.1111/1755-5922.12225</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12225</ArticleId><ArticleId IdType="pubmed">27580017</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwakura K, Ito H, Kawano S, Okamura A, Kurotobi T, Date M, et al. Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction. Eur Heart J. 2006;27(5):534&#x2013;9. doi: 10.1093/eurheartj/ehi715</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehi715</ArticleId><ArticleId IdType="pubmed">16401674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Yang Y, Cui C, You S, Gao R. Pretreatment with simvastatin reduces myocardial no&#x2010;reflow by opening mitochondrial KATP channel. British J Pharmacology. 2006;149(3):243&#x2013;9. doi: 10.1038/sj.bjp.0706862</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjp.0706862</ArticleId><ArticleId IdType="pmc">PMC2014278</ArticleId><ArticleId IdType="pubmed">16921391</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelbaset M, Safar MM, Mahmoud SS, Negm SA, Agha AM. Red yeast rice and coenzyme Q10 as safe alternatives to surmount atorvastatin-induced myopathy in hyperlipidemic rats. Can J Physiol Pharmacol. 2014;92(6):481&#x2013;9. doi: 10.1139/cjpp-2013-0430</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2013-0430</ArticleId><ArticleId IdType="pubmed">24896301</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo B, Li B, Wang W, Liu X, Liu X, Xia Y, et al. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc Drugs Ther. 2014;28(1):33&#x2013;43. doi: 10.1007/s10557-013-6498-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10557-013-6498-1</ArticleId><ArticleId IdType="pubmed">24254031</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-W, Yang F, Cheng S-Z, Liu Y, Wan L-H, Cong H-L. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3&#x3b2; pathway, and mitochondrial permeability transition pore. Cardiovasc Ther. 2017;35(1):3&#x2013;9. doi: 10.1111/1755-5922.12225</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12225</ArticleId><ArticleId IdType="pubmed">27580017</ArticleId></ArticleIdList></Reference><Reference><Citation>Roudier E, Mistafa O, Stenius U. Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs. Mol Cancer Ther. 2006;5(11):2706&#x2013;15. doi: 10.1158/1535-7163.MCT-06-0352</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1535-7163.MCT-06-0352</ArticleId><ArticleId IdType="pubmed">17121917</ArticleId></ArticleIdList></Reference><Reference><Citation>Gollmer J, Zirlik A, Bugger H. Established and Emerging Mechanisms of Diabetic Cardiomyopathy. J Lipid Atheroscler. 2019;8(1):26&#x2013;47. doi: 10.12997/jla.2019.8.1.26</Citation><ArticleIdList><ArticleId IdType="doi">10.12997/jla.2019.8.1.26</ArticleId><ArticleId IdType="pmc">PMC7379081</ArticleId><ArticleId IdType="pubmed">32821697</ArticleId></ArticleIdList></Reference><Reference><Citation>Landa-Galvan HV, Rios-Castro E, Romero-Garcia T, Rueda A, Olivares-Reyes JA. Metabolic syndrome diminishes insulin-induced Akt activation and causes a redistribution of Akt-interacting proteins in cardiomyocytes. PLoS One. 2020;15(1):e0228115. doi: 10.1371/journal.pone.0228115</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0228115</ArticleId><ArticleId IdType="pmc">PMC6988918</ArticleId><ArticleId IdType="pubmed">31995605</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Hua Y, Nair S, Zhang Y, Ren J. Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation. J Mol Cell Biol. 2013;5(1):61&#x2013;3. doi: 10.1093/jmcb/mjs055</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjs055</ArticleId><ArticleId IdType="pmc">PMC3695604</ArticleId><ArticleId IdType="pubmed">23258696</ArticleId></ArticleIdList></Reference><Reference><Citation>Ota H, Eto M, Kano MR, Kahyo T, Setou M, Ogawa S, et al. Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. Arterioscler Thromb Vasc Biol. 2010;30(11):2205&#x2013;11. doi: 10.1161/ATVBAHA.110.210500</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.110.210500</ArticleId><ArticleId IdType="pubmed">20705918</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinellu A, Paliogiannis P, Usai MF, Carru C, Mangoni AA. Effect of statin treatment on circulating malondialdehyde concentrations: a systematic review and meta-analysis. Ther Adv Chronic Dis. 2019;10:2040622319862714. doi: 10.1177/2040622319862714</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2040622319862714</ArticleId><ArticleId IdType="pmc">PMC6643183</ArticleId><ArticleId IdType="pubmed">31367297</ArticleId></ArticleIdList></Reference><Reference><Citation>Schupp N, Schmid U, Heidland A, Stopper H. Rosuvastatin protects against oxidative stress and DNA damage in vitro via upregulation of glutathione synthesis. Atherosclerosis. 2008;199(2):278&#x2013;87. doi: 10.1016/j.atherosclerosis.2007.11.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2007.11.016</ArticleId><ArticleId IdType="pubmed">18154958</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren G, Zhou Q, Lu M, Wang H. Rosuvastatin corrects oxidative stress and inflammation induced by LPS to attenuate cardiac injury by inhibiting the NLRP3/TLR4 pathway. Can J Physiol Pharmacol. 2021;99(9):964&#x2013;73. doi: 10.1139/cjpp-2020-0321</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/cjpp-2020-0321</ArticleId><ArticleId IdType="pubmed">33641435</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacio A, Sanvee GM, Bouitbir J, Kr&#xe4;henb&#xfc;hl S. The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity. Biochim Biophys Acta. 2015;1853(8):1841&#x2013;9. doi: 10.1016/j.bbamcr.2015.04.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2015.04.010</ArticleId><ArticleId IdType="pubmed">25913013</ArticleId></ArticleIdList></Reference><Reference><Citation>Altaf A, Qu P, Zhao Y, Wang H, Lou D, Niu N. NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins. Coron Artery Dis. 2015;26(5):409&#x2013;21. doi: 10.1097/MCA.0000000000000255</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCA.0000000000000255</ArticleId><ArticleId IdType="pubmed">25946654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuijk LM, Mandey SH, Schellens I, Waterham HR, Rijkers GT, Coffer PJ, et al. Statin synergizes with LPS to induce IL-1beta release by THP-1 cells through activation of caspase-1. Mol Immunol. 2008;45(8):2158&#x2013;65. doi: 10.1016/j.molimm.2007.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2007.12.008</ArticleId><ArticleId IdType="pubmed">18242710</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosser N, Erdmann K, Hemmerle A, Berndt G, Hinkelmann U, Smith G, et al. Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1. Biochem Biophys Res Commun. 2004;325(3):871&#x2013;6. doi: 10.1016/j.bbrc.2004.10.123</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2004.10.123</ArticleId><ArticleId IdType="pubmed">15541371</ArticleId></ArticleIdList></Reference><Reference><Citation>Haendeler J, Hoffmann J, Zeiher AM, Dimmeler S. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. Circulation. 2004;110(7):856&#x2013;61. doi: 10.1161/01.CIR.0000138743.09012.93</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000138743.09012.93</ArticleId><ArticleId IdType="pubmed">15289372</ArticleId></ArticleIdList></Reference><Reference><Citation>Reilly SN, Jayaram R, Nahar K, Antoniades C, Verheule S, Channon KM, et al. Atrial Sources of Reactive Oxygen Species Vary With the Duration and Substrate of Atrial Fibrillation. Circulation. 2011;124(10):1107&#x2013;17. doi: 10.1161/circulationaha.111.029223</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/circulationaha.111.029223</ArticleId><ArticleId IdType="pubmed">21844076</ArticleId></ArticleIdList></Reference><Reference><Citation>Kameda Y, Hasegawa H, Kubota A, Tadokoro H, Kobayashi Y, Komuro I, et al. Effects of pitavastatin on pressure overload-induced heart failure in mice. Circ J. 2012;76(5):1159&#x2013;68. doi: 10.1253/circj.cj-11-1114</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.cj-11-1114</ArticleId><ArticleId IdType="pubmed">22361916</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40726694</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2249-4863</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Journal of family medicine and primary care</Title><ISOAbbreviation>J Family Med Prim Care</ISOAbbreviation></Journal><ArticleTitle>Association of QTc prolongation with liver function test and complications in patients with cirrhosis: An observational study.</ArticleTitle><Pagination><StartPage>2323</StartPage><EndPage>2329</EndPage><MedlinePgn>2323-2329</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/jfmpc.jfmpc_1814_24</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Cirrhotic cardiomyopathy is a cardiac abnormality due to hepatic cirrhosis, which presents as a serious electrocardiographic complication and often the patient is asymptomatic. The objective of our study was to find the ECG changes in patients with various aetiologies of cirrhosis and correlate them with their respective LFT parameters.</AbstractText><AbstractText Label="MATERIALS AND METHODOLOGY" NlmCategory="UNASSIGNED">We assessed the QTc interval in patients of various aetiologies of liver cirrhosis and correlated them with the prevalence of complication of cirrhosis, such as portal hypertension, splenomegaly, and ascites. Furthermore, we correlated the LFT parameters with their respective QTc interval.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our study evaluated 300 patients of multiple aetiologies of cirrhosis, such as ALD, NASH, DCLD, AIH, HCC, HA, Hep-B, and Wilson's disease. Prolonged QTc was observed in 194 (64.66%) patients. QTc prolongation was most prevalent in DCLD patients. The association of complication including portal hypertension, splenomegaly, and ascites with prolonged QTc were all statistically significant (<i>P</i> = &lt;0.001). QTc ms was significantly related to the Child-Pugh class (<i>P</i> = &lt;0.001). SGOT and SGPT parameters were significantly correlated with QTc intervals (<i>P</i> = &lt;0.001) in all aetiologies of liver disease. However, the correlation between ALP and indirect bilirubin levels with QTc interval was not statistically significant.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Prolonged QTc interval is frequently observed as the ECG abnormality in patients with cirrhosis. QT prolongation correlates with elevated LFTs and cirrhotic complications.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Journal of Family Medicine and Primary Care.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Relekar</LastName><ForeName>Rhythm Yogandh</ForeName><Initials>RY</Initials><AffiliationInfo><Affiliation>DY Patil Deemed to be University School of Medicine, Navi Mumbai, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mishra</LastName><ForeName>Priyavardhan</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>DY Patil Deemed to be University School of Medicine, Navi Mumbai, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabale</LastName><ForeName>Vishal Raghunath</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>Department of General Medicine, DY Patil Deemed to be University School of Medicine, Navi Mumbai, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Iqra Chandmiya</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>DY Patil Deemed to be University School of Medicine, Navi Mumbai, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Vijaykumar</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Physiology, Chirayu Medical College and Hospital, Bhopal, Madhya Pradesh, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Family Med Prim Care</MedlineTA><NlmUniqueID>101610082</NlmUniqueID><ISSNLinking>2249-4863</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Child&#x2013;Pugh score</Keyword><Keyword MajorTopicYN="N">QTc prolongation</Keyword><Keyword MajorTopicYN="N">cirrhotic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">complication of cirrhosis</Keyword><Keyword MajorTopicYN="N">electrocardiographic changes</Keyword><Keyword MajorTopicYN="N">liver cirrhosis</Keyword></KeywordList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>5</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40726694</ArticleId><ArticleId IdType="pmc">PMC12296311</ArticleId><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_1814_24</ArticleId><ArticleId IdType="pii">JFMPC-14-2323</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lyssy LA, Soos MP. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Cirrhotic cardiomyopathy 2024 Jul 1.</Citation><ArticleIdList><ArticleId IdType="pubmed">32310549</ArticleId></ArticleIdList></Reference><Reference><Citation>Izzy MJ, VanWagner LB. Current concepts of cirrhotic cardiomyopathy. Clin Liver Dis. 2021;25:471&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8856594</ArticleId><ArticleId IdType="pubmed">33838862</ArticleId></ArticleIdList></Reference><Reference><Citation>Chayanupatkul M, Liangpunsakul S. Cirrhotic cardiomyopathy: Review of pathophysiology and treatment. Hepatol Int. 2014;8:308&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4160726</ArticleId><ArticleId IdType="pubmed">25221635</ArticleId></ArticleIdList></Reference><Reference><Citation>Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Orphanet J Rare Dis. 2007;2:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1847677</ArticleId><ArticleId IdType="pubmed">17389039</ArticleId></ArticleIdList></Reference><Reference><Citation>Toma L, Stanciu AM, Zgura A, Bacalbasa N, Diaconu C, Iliescu L. Electrocardiographic changes in liver cirrhosis-clues for cirrhotic cardiomyopathy. Medicina (Kaunas) 2020;56:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7073951</ArticleId><ArticleId IdType="pubmed">32050594</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaskari SA, Honar H, Lee SS. Therapy insight: Cirrhotic cardiomyopathy. Nat Clin Pract Gastroenterol Hepatol. 2006;3:329&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741552</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho MVH, Kroll PC, Kroll RTM, Carvalho VN. Cirrhotic cardiomyopathy: The liver affects the heart. Braz J Med Biol Res. 2019;52:e7809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6376321</ArticleId><ArticleId IdType="pubmed">30785477</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahangiri S, Abdiardekani A, Jamshidi S, Askarinejad A, Mosalamiaghili S, Bazrafshan M, et al. Electrocardiographic characteristics of cirrhotic patients and their association with Child-Pugh score. Clin Cardiol. 2023;46:967&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10436787</ArticleId><ArticleId IdType="pubmed">37436825</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiese S, Hove JD, Bendtsen F, M&#xf8;ller S. Cirrhotic cardiomyopathy: Pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol. 2014;11:177&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">24217347</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi M, Maggioli C, Dibra V, Zaccherini G. QT interval prolongation in liver cirrhosis: Innocent bystander or serious threat? Expert Rev Gastroenterol Hepatol. 2012;6:57&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">22149582</ArticleId></ArticleIdList></Reference><Reference><Citation>Enache I, Oswald-Mammosser M, Woehl-Jaegle ML, Habersetzer F, Di Marco P, Charloux A, et al. Cirrhotic cardiomyopathy and hepatopulmonary syndrome: Prevalence and prognosis in a series of patients. Respir Med. 2013;107:1030&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23615223</ArticleId></ArticleIdList></Reference><Reference><Citation>Giudicessi JR, Noseworthy PA, Ackerman MJ. The QT interval. Circulation. 2019;139:2711&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">31180747</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovesi S, Prata Pizzala DM, Pozzi M, Ratti L, Milanese M, Pieruzzi F, et al. QT interval prolongation and decreased heart rate variability in cirrhotic patients: Relevance of hepatic venous pressure gradient and serum calcium. Clin Sci (Lond) 2009;116:851&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19076059</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj A, Joshi S, Sharma R, Bhardwaj S, Agrawal R, Gupta N. QTc prolongation in patients of cirrhosis and its relation with disease severity: An observational study from a rural teaching hospital. J Family Med Prim Care. 2020;9:3020&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491802</ArticleId><ArticleId IdType="pubmed">32984166</ArticleId></ArticleIdList></Reference><Reference><Citation>Day CP, James OF, Butler TJ, Campbell RW. QT prolongation and sudden cardiac death in patients with alcoholic liver disease. Lancet. 1993;341:1423&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8099138</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupari M, Koskinen P. Alcohol, cardiac arrhythmias and sudden death. Novartis Found Symp. 1998;216:68&#x2013;79. discussion 79-85.</Citation><ArticleIdList><ArticleId IdType="pubmed">9949788</ArticleId></ArticleIdList></Reference><Reference><Citation>Mozos I. Arrhythmia risk in liver cirrhosis. World J Hepatol. 2015;7:662&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4388994</ArticleId><ArticleId IdType="pubmed">25866603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardi M, Calandra S, Colantoni A, Trevisani F, Raimondo ML, Sica G, et al. Q-T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology. 1998;27:28&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9425913</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishberger SB, Pittman NS, Rossi AF. Prolongation of the QT interval in children with liver failure. Clin Cardiol. 1999;22:658&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6655423</ArticleId><ArticleId IdType="pubmed">10526691</ArticleId></ArticleIdList></Reference><Reference><Citation>Arikan C, Kilic M, Tumgor G, Levent E, Yuksekkaya HA, Yagci RV, et al. Impact of liver transplantation on rate-corrected QT interval and myocardial function in children with chronic liver disease*. Pediatr Transplant. 2009;13:300&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18537904</ArticleId></ArticleIdList></Reference><Reference><Citation>Marconi VC, Duncan MS, So-Armah K, Re VL, 3rd, Lim JK, Butt AA, et al. Bilirubin is inversely associated with cardiovascular disease among HIV-positive and HIV-negative individuals in VACS (Veterans Aging Cohort Study) J Am Heart Assoc. 2018;7:e007792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6015337</ArticleId><ArticleId IdType="pubmed">29720501</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40724593</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>New Perspectives of Underlying Cardiomyopathy in Pediatric SMA Patients-An Age Matched Control Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1091</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life15071091</ELocationID><Abstract><AbstractText>Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder primarily affecting motor neurons. Emerging evidence suggests it also involves multiple organs, including potential cardiac manifestations. This study aimed to evaluate cardiac abnormalities in pediatric SMA patients compared to age-matched healthy controls, providing insight into underlying cardiomyopathy in this population. A total of 126 children were included in the study, with 63 SMA patients and 63 age-matched controls. We conducted clinical examinations, standard electrocardiography (ECG), and cardiac ultrasound (CUS) in all patients. Electrocardiographic analysis revealed a higher prevalence of sinus tachycardia in the SMA group and significantly deeper Q waves, indicating possible myocardial involvement. Echocardiographic findings demonstrated a significant reduction in left ventricular mass and left ventricular mass index in SMA patients compared to controls, despite normal systolic function. Statistical analysis confirmed that SMA diagnosis was an independent predictor of reduced myocardial mass, suggesting a distinct cardiac phenotype in SMA patients. This study provides new evidence of subclinical cardiac involvement in SMA, characterized by reduced myocardial mass, altered electrocardiographic parameters, and increased sinus tachycardia. These findings suggest a previously unrecognized form of cardiomyopathy in SMA that differs from cardiac manifestations typically seen in other neuromuscular disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nicolae</LastName><ForeName>Georgiana</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6028-2407</Identifier><AffiliationInfo><Affiliation>Faculty of Midwifery and Nursing, "Carol Davila" University of Medicine and Pharmacy, 020021, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Dr. Nicolae Robanescu" Children's Rehabilitation Center, 041408, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Capitanescu</LastName><ForeName>Andrei</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, "M.S. Curie" Emergency Clinical Hospital for Children, 041451, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leanca</LastName><ForeName>Madalina Cristina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>"Dr. Nicolae Robanescu" Children's Rehabilitation Center, 041408, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neagu</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>"Dr. Nicolae Robanescu" Children's Rehabilitation Center, 041408, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasile</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>"Dr. Nicolae Robanescu" Children's Rehabilitation Center, 041408, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filip</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3824-1489</Identifier><AffiliationInfo><Affiliation>Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, "Marie Curie" Emergency Children's Hospital, 041451, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinteza</LastName><ForeName>Eliza</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 020021, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, "Marie Curie" Emergency Children's Hospital, 041451, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aria</LastName><ForeName>Amelia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, "Marie Curie" Emergency Children's Hospital, 041451, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavlov</LastName><ForeName>Bianka Maria</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, "Marie Curie" Emergency Children's Hospital, 041451, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uscoiu</LastName><ForeName>Gabriela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic Department, "Carol Davila" University of Medicine and Pharmacy, 021021, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raita</LastName><ForeName>Cristiana Ioana</ForeName><Initials>CI</Initials><AffiliationInfo><Affiliation>Department of Pediatric Cardiology, "Marie Curie" Emergency Children's Hospital, 041451, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mirea</LastName><ForeName>Andrada</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Midwifery and Nursing, "Carol Davila" University of Medicine and Pharmacy, 020021, Bucharest, Romania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>"Dr. Nicolae Robanescu" Children's Rehabilitation Center, 041408, Bucharest, Romania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac abnormalities</Keyword><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">left ventricular mass</Keyword><Keyword MajorTopicYN="N">neuromuscular disease</Keyword><Keyword MajorTopicYN="N">pediatric cardiology</Keyword><Keyword MajorTopicYN="N">sinus tachycardia</Keyword><Keyword MajorTopicYN="N">spinal muscular atrophy</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40724593</ArticleId><ArticleId IdType="pmc">PMC12298988</ArticleId><ArticleId IdType="doi">10.3390/life15071091</ArticleId><ArticleId IdType="pii">life15071091</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Prior T.W. Spinal Muscular Atrophy&#x2014;GeneReviews&#xae;&#x2014;NCBI Bookshelf.  [(accessed on 9 February 2025)];2024  Available online:  https://www.ncbi.nlm.nih.gov/books/NBK1352/</Citation></Reference><Reference><Citation>Hjartarson H.T., Nathorst-B&#xf6;&#xf6;s K., Sejersen T. Disease Modifying Therapies for the Management of Children with Spinal Muscular Atrophy (5q SMA): An Update on the Emerging Evidence. Drug Des. Devel. Ther. 2022;16:1865. doi: 10.2147/DDDT.S214174.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S214174</ArticleId><ArticleId IdType="pmc">PMC9208376</ArticleId><ArticleId IdType="pubmed">35734367</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Muscular Atrophy|National Institute of Neurological Disorders and Stroke.  [(accessed on 9 February 2025)]; Available online:  https://www.ninds.nih.gov/health-information/disorders/spinal-muscular-atrophy.</Citation></Reference><Reference><Citation>Dubowitz V. Very Severe Spinal Muscular Atrophy (SMA Type 0): An Expanding Clinical Phenotype. Eur. J. Paediatr. Neurol. 1999;3:49&#x2013;51. doi: 10.1016/S1090-3798(99)80012-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1090-3798(99)80012-9</ArticleId><ArticleId IdType="pubmed">10700538</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas N.H., Dubowitz V. The Natural History of Type I (Severe) Spinal Muscular Atrophy. Neuromuscul. Disord. 1994;4:497&#x2013;502. doi: 10.1016/0960-8966(94)90090-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0960-8966(94)90090-6</ArticleId><ArticleId IdType="pubmed">7881295</ArticleId></ArticleIdList></Reference><Reference><Citation>Pera M.C., Coratti G., Berti B., D&#x2019;Amico A., Sframeli M., Albamonte E., Frosini S., Mazzone E.S., Pane M., Bruno C., et al. Diagnostic Journey in Spinal Muscular Atrophy: Is It Still an Odyssey? PLoS ONE. 2020;15:e0230677. doi: 10.1371/journal.pone.0230677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0230677</ArticleId><ArticleId IdType="pmc">PMC7089564</ArticleId><ArticleId IdType="pubmed">32203538</ArticleId></ArticleIdList></Reference><Reference><Citation>Childhood Spinal Muscular Atrophy: Controversies and Challenges&#x2014;PubMed.  [(accessed on 9 February 2025)]; Available online:  https://pubmed.ncbi.nlm.nih.gov/22516079/</Citation></Reference><Reference><Citation>Kolb S.J., Coffey C.S., Yankey J.W., Krosschell K., Arnold W.D., Rutkove S.B., D&#x2019;Anjou G., Gooch C.L., Swoboda K.J., Reyna S.P., et al. Natural History of Infantile-Onset Spinal Muscular Atrophy. Ann. Neurol. 2017;82:883&#x2013;891. doi: 10.1002/ana.25101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25101</ArticleId><ArticleId IdType="pmc">PMC5776712</ArticleId><ArticleId IdType="pubmed">29149772</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendell J.R., Al-Zaidy S., Shell R., Arnold W.D., Rodino-Klapac L.R., Prior T.W., Lowes L., Alfano L., Berry K., Church K., et al. Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. N. Engl. J. Med. 2017;377:1713&#x2013;1722. doi: 10.1056/NEJMoa1706198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1706198</ArticleId><ArticleId IdType="pubmed">29091557</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel R.S., Mercuri E., Darras B.T., Connolly A.M., Kuntz N.L., Kirschner J., Chiriboga C.A., Saito K., Servais L., Tizzano E., et al. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. N. Engl. J. Med. 2017;377:1723&#x2013;1732. doi: 10.1056/NEJMoa1702752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1702752</ArticleId><ArticleId IdType="pubmed">29091570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiriboga C.A., Swoboda K.J., Darras B.T., Iannaccone S.T., Montes J., De Vivo D.C., Norris D.A., Bennett C.F., Bishop K.M. The Results from a Phase 1 Study of Nusinersen (ISIS-SMN(Rx)) in Children with Spinal Muscular Atrophy. Neurology. 2016;86:890&#x2013;897. doi: 10.1212/WNL.0000000000002445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002445</ArticleId><ArticleId IdType="pmc">PMC4782111</ArticleId><ArticleId IdType="pubmed">26865511</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo C.J.J., Darras B.T. Overturning the Paradigm of Spinal Muscular Atrophy as Just a Motor Neuron Disease. Pediatr Neurol. 2020;109:12&#x2013;19. doi: 10.1016/j.pediatrneurol.2020.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2020.01.003</ArticleId><ArticleId IdType="pubmed">32409122</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregoretti C., Ottonello G., Chiarini Testa M.B., Mastella C., Rav&#xe0; L., Bignamini E., Cutrera R., Fagioli F., Ferrero F., Biban P., et al. Survival of Patients with Spinal Muscular Atrophy Type 1. Pediatrics. 2013;131:e1509&#x2013;e1514. doi: 10.1542/peds.2012-2278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2012-2278</ArticleId><ArticleId IdType="pubmed">23610208</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijngaarde C.A., Blank A.C., Stam M., Wadman R.I., van den Berg L.H., van der Pol W.L. Cardiac Pathology in Spinal Muscular Atrophy: A Systematic Review. Orphanet. J. Rare Dis. 2017;12:67. doi: 10.1186/s13023-017-0613-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13023-017-0613-5</ArticleId><ArticleId IdType="pmc">PMC5387385</ArticleId><ArticleId IdType="pubmed">28399889</ArticleId></ArticleIdList></Reference><Reference><Citation>Macleod M.J., Taylor J.E., Lunt P.W., Mathew C.G., Robb S.A. Prenatal Onset Spinal Muscular Atrophy. Eur. J. Paediatr. Neurol. 1999;3:65&#x2013;72. doi: 10.1016/S1090-3798(99)80015-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1090-3798(99)80015-4</ArticleId><ArticleId IdType="pubmed">10700541</ArticleId></ArticleIdList></Reference><Reference><Citation>Devriendt K., Lammens M., Schollen E., Van Hole C., Dom R., Devlieger H., Matthijs G., Fryns J.P. Clinical and Molecular Genetic Features of Congenital Spinal Muscular Atrophy. Ann. Neurol. 1996;40:731&#x2013;738. doi: 10.1002/ana.410400509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410400509</ArticleId><ArticleId IdType="pubmed">8957014</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnik-Sch&#xf6;neborn S., Heller R., Berg C., Betzler C., Grimm T., Eggermann T., Wiegand G., Zerres K. Congenital Heart Disease Is a Feature of Severe Infantile Spinal Muscular Atrophy. J. Med. Genet. 2008;45:635&#x2013;638. doi: 10.1136/jmg.2008.057950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2008.057950</ArticleId><ArticleId IdType="pubmed">18662980</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawood A.A., Moosa A. Hand and ECG Tremor in Spinal Muscular Atrophy. Arch. Dis. Child. 1983;58:376&#x2013;378. doi: 10.1136/adc.58.5.376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.58.5.376</ArticleId><ArticleId IdType="pmc">PMC1627871</ArticleId><ArticleId IdType="pubmed">6859919</ArticleId></ArticleIdList></Reference><Reference><Citation>Russman B.S., Fredericks E.J. Use of the ECG in the Diagnosis of Childhood Spinal Muscular Atrophy. Arch. Neurol. 1979;36:317&#x2013;318. doi: 10.1001/archneur.1979.00500410095017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1979.00500410095017</ArticleId><ArticleId IdType="pubmed">444102</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianco F., Pane M., Vasco G., Tiziano D., Mongini T., Angelini C., Vita G., Bruno C., Bertini E., Mercuri E., et al. S.P.24 24-Hour Holter ECG in Type II and III SMA. Neuromuscul. Disord. 2012;22:894. doi: 10.1016/j.nmd.2012.06.299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2012.06.299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevan A.K., Hutchinson K.R., Foust K.D., Braun L., McGovern V.L., Schmelzer L., Ward J.G., Petruska J.C., Lucchesi P.A., Burghes A.H.M., et al. Early Heart Failure in the SMN&#x394;7 Model of Spinal Muscular Atrophy and Correction by Postnatal scAAV9-SMN Delivery. Hum. Mol. Genet. 2010;19:3895&#x2013;3905. doi: 10.1093/hmg/ddq300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq300</ArticleId><ArticleId IdType="pmc">PMC2947399</ArticleId><ArticleId IdType="pubmed">20639395</ArticleId></ArticleIdList></Reference><Reference><Citation>Shababi M., Habibi J., Yang H.T., Vale S.M., Sewell W.A., Lorson C.L. Cardiac Defects Contribute to the Pathology of Spinal Muscular Atrophy Models. Hum. Mol. Genet. 2010;19:4059&#x2013;4071. doi: 10.1093/hmg/ddq329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq329</ArticleId><ArticleId IdType="pubmed">20696672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng L., Wan B., Feng P., Sun J., Rigo F., Bennett C.F., Hua Y., Li H., Li Y., Luo H., et al. Downregulation of Survivin Contributes to Cell-Cycle Arrest during Postnatal Cardiac Development in a Severe Spinal Muscular Atrophy Mouse Model. Hum. Mol. Genet. 2018;27:486&#x2013;498. doi: 10.1093/hmg/ddx418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx418</ArticleId><ArticleId IdType="pmc">PMC5886172</ArticleId><ArticleId IdType="pubmed">29220503</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrogeni S., Markousis-Mavrogenis G., Papavasiliou A., Kolovou G. Cardiac Involvement in Duchenne and Becker Muscular Dystrophy. World J. Cardiol. 2015;7:410&#x2013;414. doi: 10.4330/wjc.v7.i7.410.</Citation><ArticleIdList><ArticleId IdType="doi">10.4330/wjc.v7.i7.410</ArticleId><ArticleId IdType="pmc">PMC4513493</ArticleId><ArticleId IdType="pubmed">26225202</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar P., Indorkar R., Dietrich M., Farzaneh-Far A. Cardiomyopathy in Friedreich&#x2019;s Ataxia. Eur. Heart J. 2018;39:631. doi: 10.1093/eurheartj/ehx607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx607</ArticleId><ArticleId IdType="pubmed">29059291</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers D.E., Basha H.I., Koenig M.K. Mitochondrial Cardiomyopathy. Tex. Heart Inst. J. 2013;40:385&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3783139</ArticleId><ArticleId IdType="pubmed">24082366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sixtus R.P., Dyson R.M., Gray C.L. Impact of Prematurity on Lifelong Cardiovascular Health: Structural and Functional Considerations. NPJ Cardiovasc. Health. 2024;1:2. doi: 10.1038/s44325-024-00002-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44325-024-00002-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrselja A., Pillow J.J., Black M.J. Effect of Preterm Birth on Cardiac and Cardiomyocyte Growth and the Consequences of Antenatal and Postnatal Glucocorticoid Treatment. J. Clin. Med. 2021;10:3896. doi: 10.3390/jcm10173896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10173896</ArticleId><ArticleId IdType="pmc">PMC8432182</ArticleId><ArticleId IdType="pubmed">34501343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohlkert L., Hallberg J., Broberg O., Rydberg A., Halvorsen C.P., Liuba P., &#xc5;str&#xf6;m-Olsson K., Persson P.B., Norman M., Brodin L.-&#xc5;., et al. The Preterm Heart in Childhood: Left Ventricular Structure, Geometry, and Function Assessed by Echocardiography in 6-Year-Old Survivors of Periviable Births. J. Am. Heart Assoc. 2018;7:e007742. doi: 10.1161/JAHA.117.007742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.007742</ArticleId><ArticleId IdType="pmc">PMC5850168</ArticleId><ArticleId IdType="pubmed">29353231</ArticleId></ArticleIdList></Reference><Reference><Citation>Robel-Tillig E., Kn&#xfc;pfer M., Pulzer F., Vogtmann C. Blood Flow Parameters of the Superior Mesenteric Artery as an Early Predictor of Intestinal Dysmotility in Preterm Infants. Pediatr. Radiol. 2004;34:958&#x2013;962. doi: 10.1007/s00247-004-1285-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-004-1285-6</ArticleId><ArticleId IdType="pubmed">15372217</ArticleId></ArticleIdList></Reference><Reference><Citation>He X., Li X., Yan M., Peng H., Zhang L., Liang Y., Tang W., Li S. Cardiac function evaluation in children with spinal muscular atrophy: A case-control study. Pediatr. Int. 2024;66:e15769. doi: 10.1111/ped.15769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ped.15769</ArticleId><ArticleId IdType="pubmed">38742693</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40723072</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9067</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>Children (Basel, Switzerland)</Title><ISOAbbreviation>Children (Basel)</ISOAbbreviation></Journal><ArticleTitle>Prognosis of Pediatric Dilated Cardiomyopathy: Nomogram and Risk Score Models for Predicting Death/Heart Transplantation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">880</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/children12070880</ELocationID><Abstract><AbstractText><b>Background:</b> This study aimed to develop a predictive model to assess risk factors and prognoses in pediatric patients with dilated cardiomyopathy (DCM). <b>Methods:</b> A total of 233 pediatric patients with DCM who were hospitalized between January 2019 and June 2024 were enrolled. The children were followed up and categorized into two groups: the death/heart transplantation (D/HT) group and the non-D/HT group. Univariate and multivariate analyses identified risk factors. A nomogram model and a scoring system were developed. The performance of these models was evaluated using the H-L test, ROC analysis, and internal validation. <b>Results:</b> The results demonstrated that the age of onset, cardiac functional classification III-IV, moderate-to-severe mitral regurgitation, low voltage in limb leads on an ECG, and the need for vasoactive drugs are independent predictors of D/HT risk in children with DCM. A nomogram model was developed, achieving an AUC of 0.804 (95% CI: 0.734-0.874), a sensitivity of 80.3%, and a specificity of 66.7%. A scoring system was established: 1 point for age of onset, 10 points for cardiac functional classification III-IV, 2.5 points for moderate-to-severe mitral regurgitation, 4 points for low voltage in limb leads on an ECG, 3 points for the need for vasoactive drugs, or 0 points if none of these criteria were met. When the cumulative score was &#x2265; 13.25, the sensitivity and specificity increased to 68.9% and 73.9%, respectively. <b>Conclusions:</b> We developed both a nomogram and a scoring system model, which are capable of rapidly and accurately predicting the risk of D/HT in children with DCM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Bowen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhiyuan</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-0861-6315</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Zhenyu</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-9079-2069</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Hongfang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100034, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhen</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Zhihui</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Na</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Aihua</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Chronic Disease Management Center, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yanyan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023YFC2706202</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Children (Basel)</MedlineTA><NlmUniqueID>101648936</NlmUniqueID><ISSNLinking>2227-9067</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">death</Keyword><Keyword MajorTopicYN="N">dilated cardiomyopathy</Keyword><Keyword MajorTopicYN="N">heart transplantation</Keyword><Keyword MajorTopicYN="N">predictive model</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40723072</ArticleId><ArticleId IdType="pmc">PMC12293697</ArticleId><ArticleId IdType="doi">10.3390/children12070880</ArticleId><ArticleId IdType="pii">children12070880</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Heymans S., Lakdawala N.K., Tsch&#xf6;pe C., Klingel K. Dilated cardiomyopathy: Causes, mechanisms, and current and future treatment approaches. Lancet. 2023;402:998&#x2013;1011. doi: 10.1016/S0140-6736(23)01241-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01241-2</ArticleId><ArticleId IdType="pubmed">37716772</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershberger R.E., Hedges D.J., Morales A. Dilated cardiomyopathy: The complexity of a diverse genetic architecture. Nat. Rev. Cardiol. 2013;10:531&#x2013;547. doi: 10.1038/nrcardio.2013.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2013.105</ArticleId><ArticleId IdType="pubmed">23900355</ArticleId></ArticleIdList></Reference><Reference><Citation>Arola A., Jokinen E., Ruuskanen O., Saraste M., Pesonen E., Kuusela A.-L., Tikanoja T., Paavilainen T., Simell O. Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am. J. Epidemiol. 1997;146:385&#x2013;393. doi: 10.1093/oxfordjournals.aje.a009291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a009291</ArticleId><ArticleId IdType="pubmed">9290498</ArticleId></ArticleIdList></Reference><Reference><Citation>Japp A.G., Gulati A., Cook S.A., Cowie M.R., Prasad S.K. The Diagnosis and Evaluation of Dilated Cardiomyopathy. J. Am. Coll. Cardiol. 2016;67:2996&#x2013;3010. doi: 10.1016/j.jacc.2016.03.590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.03.590</ArticleId><ArticleId IdType="pubmed">27339497</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipshultz S.E., Sleeper L.A., Towbin J.A., Lowe A.M., Orav E.J., Cox G.F., Lurie P.R., McCoy K.L., McDonald M.A., Messere J.E., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N. Engl. J. Med. 2003;348:1647&#x2013;1655. doi: 10.1056/NEJMoa021715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa021715</ArticleId><ArticleId IdType="pubmed">12711739</ArticleId></ArticleIdList></Reference><Reference><Citation>Nugent A.W., Daubeney P.E., Chondros P., Carlin J.B., Cheung M., Wilkinson L.C., Davis A.M., Kahler S.G., Chow C., Wilkinson J.L., et al. The epidemiology of childhood cardiomyopathy in Australia. N. Engl. J. Med. 2003;348:1639&#x2013;1646. doi: 10.1056/NEJMoa021737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa021737</ArticleId><ArticleId IdType="pubmed">12711738</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziewi&#x119;cka E., Gliniak M., Winiarczyk M., Karapetyan A., Wi&#x15b;niowska-&#x15a;mia&#x142;ek S., Karabinowska A., Dziewi&#x119;cki M., Podolec P., Rubi&#x15b; P. Mortality risk in dilated cardiomyopathy: The accuracy of heart failure prognostic models and dilated cardiomyopathy-tailored prognostic model. ESC Heart Fail. 2020;7:2455&#x2013;2467. doi: 10.1002/ehf2.12809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12809</ArticleId><ArticleId IdType="pmc">PMC7524139</ArticleId><ArticleId IdType="pubmed">32853471</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannat&#xe0; A., De Angelis G., Boscutti A., Normand C., Artico J., Gentile P., Zecchin M., Heymans S., Merlo M., Sinagra G. Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction. Heart. 2020;106:656&#x2013;664. doi: 10.1136/heartjnl-2019-315942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2019-315942</ArticleId><ArticleId IdType="pubmed">31964657</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogle C., Colan S.D., Miyamoto S.D., Choudhry S., Baez-Hernandez N., Brickler M.M., Feingold B., Lal A.K., Lee T.M., Canter C.E., et al. Treatment Strategies for Cardiomyopathy in Children: A Scientific Statement from the American Heart Association. Circulation. 2023;148:174&#x2013;195. doi: 10.1161/CIR.0000000000001151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000001151</ArticleId><ArticleId IdType="pubmed">37288568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipshultz S.E., Law Y.M., Asante-Korang A., Austin E.D., Dipchand A.I., Everitt M.D., Hsu D.T., Lin K.Y., Price J.F., Wilkinson J.D., et al. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement from the American Heart Association. Circulation. 2019;140:e9&#x2013;e68. doi: 10.1161/CIR.0000000000000682.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000682</ArticleId><ArticleId IdType="pubmed">31132865</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbelo E., Protonotarios A., Gimeno J.R., Arbustini E., Barriales-Villa R., Basso C., Bezzina C.R., Biagini E., Blom N.A., de Boer R.A., et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur. Heart J. 2023;44:3503&#x2013;3626.</Citation><ArticleIdList><ArticleId IdType="pubmed">37622657</ArticleId></ArticleIdList></Reference><Reference><Citation>Colan S.D. Normal echocardiographic values for cardiovascular structures. In: Lai W.W., Mertens L.L., Cohen M.S., editors. Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult. 2nd ed. John Wiley &amp; Sons Ltd.; Hoboken, NJ, USA: 2016. pp. 883&#x2013;901.</Citation></Reference><Reference><Citation>Sluysmans T., Colan S.D. Structural measurements and adjustments for growth. In: Lai W.W., Mertens L.L., Cohen M.S., editors. Echocardiography in Pediatric and Congenital Heart Disease: From Fetus to Adult. 2nd ed. John Wiley &amp; Sons Ltd.; Hoboken, NJ, USA: 2016. pp. 61&#x2013;72.</Citation></Reference><Reference><Citation>Tromp J., Ouwerkerk W., van Veldhuisen D.J., Hillege H.L., Richards A.M., van der Meer P., Anand I.S., Lam C.S., Voors A.A. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction. JACC Heart Fail. 2022;10:73&#x2013;84. doi: 10.1016/j.jchf.2021.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.09.004</ArticleId><ArticleId IdType="pubmed">34895860</ArticleId></ArticleIdList></Reference><Reference><Citation>McMurray J.J., Packer M., Desai A.S., Gong J., Lefkowitz M.P., Rizkala A.R., Rouleau J.L., Shi V.C., Solomon S.D., Swedberg K., et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N. Engl. J. Med. 2014;371:993&#x2013;1004. doi: 10.1056/NEJMoa1409077.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1409077</ArticleId><ArticleId IdType="pubmed">25176015</ArticleId></ArticleIdList></Reference><Reference><Citation>Swedberg K., Komajda M., B&#xf6;hm M., Borer J.S., Ford I., Dubost-Brama A., Lerebours G., Tavazzi L., on behalf of the SHIFT Investigators Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet. 2010;376:875&#x2013;885. doi: 10.1016/S0140-6736(10)61198-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61198-1</ArticleId><ArticleId IdType="pubmed">20801495</ArticleId></ArticleIdList></Reference><Reference><Citation>Packer M., Anker S.D., Butler J., Filippatos G., Pocock S.J., Carson P., Januzzi J., Verma S., Tsutsui H., Brueckmann M., et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N. Engl. J. Med. 2020;383:1413&#x2013;1424. doi: 10.1056/NEJMoa2022190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2022190</ArticleId><ArticleId IdType="pubmed">32865377</ArticleId></ArticleIdList></Reference><Reference><Citation>Tromp J., Collins S.P. Dapagliflozin in heart failure: New frontiers. Eur. J. Heart Fail. 2019;21:1412&#x2013;1414. doi: 10.1002/ejhf.1633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.1633</ArticleId><ArticleId IdType="pubmed">31746109</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong P.W., Pieske B., Anstrom K.J., Ezekowitz J., Hernandez A.F., Butler J., Lam C.S.P., Ponikowski P., Voors A.A., Jia G., et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. N. Engl. J. Med. 2020;382:1883&#x2013;1893. doi: 10.1056/NEJMoa1915928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1915928</ArticleId><ArticleId IdType="pubmed">32222134</ArticleId></ArticleIdList></Reference><Reference><Citation>Teerlink J.R., Diaz R., Felker G.M., McMurray J.J., Metra M., Solomon S.D., Adams K.F., Anand I., Arias-Mendoza A., Biering-S&#xf8;rensen T., et al. Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure. N. Engl. J. Med. 2021;384:105&#x2013;116. doi: 10.1056/NEJMoa2025797.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2025797</ArticleId><ArticleId IdType="pubmed">33185990</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander P.M., Lee K., Daubeney P.E., Turner C., Robertson T., Nugent A.W., Davis A., Ramsay J., Justo R., Bharucha T., et al. Long-term outcomes of dilated cardiomyopathy diagnosed during childhood: Results from a national population-based study of childhood cardiomyopathy. Circulation. 2013;128:2039&#x2013;2046. doi: 10.1161/CIRCULATIONAHA.113.002767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.113.002767</ArticleId><ArticleId IdType="pubmed">24036608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammal Addin M.B., Young D., McCarrison S., Hunter L. Dilated cardiomyopathy in a national paediatric population. Eur. J. Pediatr. 2019;178:1229&#x2013;1235. doi: 10.1007/s00431-019-03404-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-019-03404-w</ArticleId><ArticleId IdType="pubmed">31187263</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarez J.A., Wilkinson J.D., Lipshultz S.E. Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review. Prog. Pediatr. Cardiol. 2007;23:25&#x2013;32. doi: 10.1016/j.ppedcard.2007.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ppedcard.2007.05.009</ArticleId><ArticleId IdType="pmc">PMC2729918</ArticleId><ArticleId IdType="pubmed">19701490</ArticleId></ArticleIdList></Reference><Reference><Citation>Everitt M.D., Sleeper L.A., Lu M., Canter C.E., Pahl E., Wilkinson J.D., Addonizio L.J., Towbin J.A., Rossano J., Singh R.K., et al. Recovery of echocardiographic function in children with idiopathic dilated cardiomyopathy: Results from the pediatric cardiomyopathy registry. J. Am. Coll. Cardiol. 2014;63:1405&#x2013;1413. doi: 10.1016/j.jacc.2013.11.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.11.059</ArticleId><ArticleId IdType="pmc">PMC4030008</ArticleId><ArticleId IdType="pubmed">24561146</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis A.B. Late recovery of ventricular function in children with idiopathic dilated cardiomyopathy. Pt 1Am. Heart J. 1999;138:334&#x2013;338. doi: 10.1016/S0002-8703(99)70121-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8703(99)70121-3</ArticleId><ArticleId IdType="pubmed">10426848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A. A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am. J. Cardiol. 2007;99:549&#x2013;553. doi: 10.1016/j.amjcard.2006.08.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2006.08.065</ArticleId><ArticleId IdType="pmc">PMC3129268</ArticleId><ArticleId IdType="pubmed">17293201</ArticleId></ArticleIdList></Reference><Reference><Citation>Muntwyler J., Abetel G., Gruner C., Follath F. One-year mortality among unselected outpatients with heart failure. Eur. Heart J. 2002;23:1861&#x2013;1866. doi: 10.1053/euhj.2002.3282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/euhj.2002.3282</ArticleId><ArticleId IdType="pubmed">12445535</ArticleId></ArticleIdList></Reference><Reference><Citation>Caraballo C., Desai N.R., Mulder H., Alhanti B., Wilson F.P., Fiuzat M., Felker G.M., Pi&#xf1;a I.L., O&#x2019;COnnor C.M., Lindenfeld J., et al. Clinical Implications of the New York Heart Association Classification. J. Am. Heart Assoc. 2019;8:e014240. doi: 10.1161/JAHA.119.014240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.014240</ArticleId><ArticleId IdType="pmc">PMC6912957</ArticleId><ArticleId IdType="pubmed">31771438</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels V.V., Driscoll D.J., Miller F.A., Olson T.M., Atkinson E.J., Olswold C.L., Schaid D.J. Progression of familial and non-familial dilated cardiomyopathy: Long term follow up. Heart. 2003;89:757&#x2013;761. doi: 10.1136/heart.89.7.757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heart.89.7.757</ArticleId><ArticleId IdType="pmc">PMC1767723</ArticleId><ArticleId IdType="pubmed">12807850</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin K.L., Hsiao S.H., Wu C.J., Kang P.L., Chiou K.R. Treatment strategies for acute coronary syndrome with severe mitral regurgitation and their effects on short- and long-term prognosis. Am. J. Cardiol. 2012;110:800&#x2013;806. doi: 10.1016/j.amjcard.2012.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.05.010</ArticleId><ArticleId IdType="pubmed">22640972</ArticleId></ArticleIdList></Reference><Reference><Citation>Goliasch G., Bartko P.E., Pavo N., Neuhold S., Wurm R., Mascherbauer J., Lang I.M., Strunk G., H&#xfc;lsmann M. Refining the prognostic impact of functional mitral regurgitation in chronic heart failure. Eur. Heart J. 2018;39:39&#x2013;46. doi: 10.1093/eurheartj/ehx402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehx402</ArticleId><ArticleId IdType="pubmed">29020337</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes F.P., Manlhiot C., McCrindle B.W., Mertens L., Kantor P.F., Friedberg M.K. Usefulness of mitral regurgitation as a marker of increased risk for death or cardiac transplantation in idiopathic dilated cardiomyopathy in children. Am. J. Cardiol. 2011;107:1517&#x2013;1521. doi: 10.1016/j.amjcard.2011.01.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2011.01.030</ArticleId><ArticleId IdType="pubmed">21377646</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine R.A., Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: From paradoxes to unifying concepts. Circulation. 2005;112:745&#x2013;758. doi: 10.1161/CIRCULATIONAHA.104.486720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.486720</ArticleId><ArticleId IdType="pubmed">16061756</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelliccia A., Drezner J.A., Zorzi A., Corrado D. Prevalence and clinical significance of low QRS voltages in healthy individuals, athletes, and patients with cardiomyopathy: Implications for sports pre-participation cardiovascular screening. Eur. J. Prev. Cardiol. 2024;31:1106&#x2013;1114. doi: 10.1093/eurjpc/zwae027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurjpc/zwae027</ArticleId><ArticleId IdType="pubmed">38243782</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Z.Q., Han P., Xu H.B., Yu J.M., Liu H.L. Correlation between low tube voltage in dual source CT coronary artery imaging with image quality and radiation dose. J. Huazhong Univ. Sci. Technol. Med. Sci. 2014;34:616&#x2013;620. doi: 10.1007/s11596-014-1326-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-014-1326-9</ArticleId><ArticleId IdType="pubmed">25135738</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf6;llberger C., Gerger D., Jirak P., Wegner C., Finsterer J. Evolution of electrocardiographic abnormalities in association with neuromuscular disorders and survival in left ventricular hypertrabeculation/noncompaction. Ann. Noninvasive Electrocardiol. 2014;19:567&#x2013;573. doi: 10.1111/anec.12167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anec.12167</ArticleId><ArticleId IdType="pmc">PMC6932361</ArticleId><ArticleId IdType="pubmed">24934299</ArticleId></ArticleIdList></Reference><Reference><Citation>MERIT-HF Stufy Group Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet. 1999;353:2001&#x2013;2007. doi: 10.1016/S0140-6736(99)04440-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04440-2</ArticleId><ArticleId IdType="pubmed">10376614</ArticleId></ArticleIdList></Reference><Reference><Citation>CIBIS Investigators and Committees The Cardiac Insufficiency Bisoprolol Study (CIBIS): A randomized trial of beta-blockade in heart failure. Circulation. 1994;90:1765&#x2013;1773. doi: 10.1161/01.CIR.90.4.1765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.90.4.1765</ArticleId><ArticleId IdType="pubmed">7923660</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph P., Swedberg K., Leong D.P., Yusuf S. The Evolution of &#x3b2;-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5) J. Am. Coll. Cardiol. 2019;74:672&#x2013;682. doi: 10.1016/j.jacc.2019.04.067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2019.04.067</ArticleId><ArticleId IdType="pubmed">31370960</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash A., Markham A. Metoprolol: A review of its use in chronic heart failure. Drugs. 2000;60:647&#x2013;678. doi: 10.2165/00003495-200060030-00011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-200060030-00011</ArticleId><ArticleId IdType="pubmed">11030472</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40738376</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1556-3871</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Heart rhythm</Title><ISOAbbreviation>Heart Rhythm</ISOAbbreviation></Journal><ArticleTitle>Prognostic impact of atrio-ventricular conduction abnormalities in non-ischemic cardiomyopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1547-5271(25)02721-3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.hrthm.2025.07.040</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) improves prediction of ventricular arrhythmias (VA) in non-ischemic cardiomyopathy (NICM), but risk stratification within LGE+ cases remains challenging. Atrioventricular block (AVB) has been proposed as a predictor of VA, but contemporary data are scarce.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the prognostic value of AVB in a contemporary cohort of patients with NICM studied with CMR.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cohort study including 616 patients with NICM, with assessment of AVB at electrocardiogram (ECG) and LGE at CMR. The primary arrhythmic end point included any appropriate implantable cardioverter defibrillator therapy, sustained monomorphic ventricular tachycardia, resuscitated cardiac arrest, and sudden death. The secondary heart failure (HF) end point included HF hospitalization, heart transplant, left ventricular assist device implant, and death due to end-stage HF.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">AVB was observed in 9% of patients and was associated with more severe cardiac dysfunction (left ventricular ejection fraction [LVEF] 29% vs 37%, P &lt; .001) and higher prevalence of LGE (63% vs 46%, P = .02). AVB independently predicted the combined arrhythmic end point in addition to LGE and LVEF (hazard ratio [HR], 2.7; P = .007), and was particularly impactful when present alongside LGE; among LGE+ patients, AVB significantly increased the risk of the primary end point (adjusted HR 3.4, P &lt; .001). In contrast, AV block was not a significant predictor of the HF end point at multivariate analysis (P = .11).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">AVB is a strong and independent predictor of VA and sudden death in NICM, in addition to LGE and LVEF. In addition, AVB has a significant impact on the risk stratification of LGE+ cases, identifying a small sub-group of patients with extremely high arrhythmic risk.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sana&#xfa;</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Marco</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain. Electronic address: adimarco@bellvitgehospital.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Frutos</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bermeo</LastName><ForeName>Juan Andr&#xe9;s</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez Garc&#xed;a</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nucifora</LastName><ForeName>Gaetano</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claver</LastName><ForeName>Eduard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bradley</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonzalez Lopera</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom; Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, United Kingdom; Faculty of Biology, Medicine and Health, School of Biology, Wellcome Centre for Cell-Matrix Research, University of Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jovells</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomez-Hospital</LastName><ForeName>Joan Antoni</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Com&#xed;n-Colet</LastName><ForeName>Josep</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain; Innovation, Research and Universities Department, University of Barcelona, Ger&#xe8;ncia Territorial Metropolitana Sud, Institut Catal&#xe0; de la Salut; CIBER-CV.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anguera</LastName><ForeName>Ignasi</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Bioheart-Cardiovascular Diseases Group, Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, United Kingdom; Division of Cardiovascular Sciences, School of Medical Sciences, University of Manchester, United Kingdom; Faculty of Biology, Medicine and Health, School of Biology, Wellcome Centre for Cell-Matrix Research, University of Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Heart Rhythm</MedlineTA><NlmUniqueID>101200317</NlmUniqueID><ISSNLinking>1547-5271</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrioventricular block</Keyword><Keyword MajorTopicYN="N">Cardiac magnetic resonance</Keyword><Keyword MajorTopicYN="N">Late gadolinium enhancement</Keyword><Keyword MajorTopicYN="N">Non-ischemic cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Sudden death</Keyword><Keyword MajorTopicYN="N">Ventricular arrhythmias</Keyword></KeywordList><CoiStatement>Disclosures Dr. Brown received a Fellowship salary support grant from Alliance Medical. The remaining authors have no other conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>31</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>31</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>30</Day><Hour>19</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40738376</ArticleId><ArticleId IdType="doi">10.1016/j.hrthm.2025.07.040</ArticleId><ArticleId IdType="pii">S1547-5271(25)02721-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40749517</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2772-963X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>31</Day></PubDate></JournalIssue><Title>JACC. Advances</Title><ISOAbbreviation>JACC Adv</ISOAbbreviation></Journal><ArticleTitle>Electrocardiogram-Based Artificial Intelligence to Identify Coronary Artery Disease.</ArticleTitle><Pagination><StartPage>102041</StartPage><MedlinePgn>102041</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102041</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacadv.2025.102041</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2772-963X(25)00465-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronary artery disease (CAD) results in substantial morbidity and mortality.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to develop a deep learning model to detect CAD defined using diagnostic codes ("ECG2CAD") and identify people at risk for adverse events using electrocardiograms (ECGs) in a primary care setting.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">ECG2CAD was trained on 764,670 ECGs representing 137,199 individuals at Massachusetts General Hospital (MGH). Model performance for discrimination of prevalent CAD was measured using area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPRC), and compared against model of age and sex, and Pooled Cohort Equations, in 3 test sets: MGH, Brigham and Women's Hospital (BWH), and UK Biobank. Subgroups were assessed for incident CAD-related events in a BWH primary care cohort.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">ECG2CAD was evaluated in MGH (N = 18,706 [6,051 cases], age 57 &#xb1; 16 years), BWH (N = 88,270 [27,898 cases], age 57 &#xb1; 16 years), and UK Biobank (N = 42,147 [1,509 cases], age 65 &#xb1; 8 years). ECG2CAD consistently discriminated prevalent CAD (MGH AUROC: 0.782; AUPRC: 0.639; BWH: AUROC: 0.747; AUPRC: 0.588; UK Biobank AUROC: 0.760; AUPRC: 0.155) and incrementally vs models based on age and sex or Pooled Cohort Equations (P &lt; 0.01) in MGH and BWH. In the BWH primary care subset, model performance was consistent across subgroups. Being in the highest quintile of ECG2CAD risk was associated with higher risk for adverse events compared with low-risk group (myocardial infarction HR: 5.59; 95% CI: 4.76-6.56, heart failure 10.49; 95% CI: 7.96-13.84, all-cause mortality 2.68; 95% CI: 2.32-3.10).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Artificial intelligence-enabled analysis of the ECG may facilitate identification of individuals with possible undiagnosed CAD and inform downstream testing and preventive measures.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kany</LastName><ForeName>Shinwan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Cardiology, University Heart and Vascular Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedman</LastName><ForeName>Samuel F</ForeName><Initials>SF</Initials><AffiliationInfo><Affiliation>Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Alusi</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khurshid</LastName><ForeName>Shaan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xe4;m&#xf6;</LastName><ForeName>Joel T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pipilas</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pirruccello</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Institute for Human Genetics, University of California-San Francisco, San Francisco, California, USA; Division of Cardiology, University of California-San Francisco, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeder</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philippakis</LastName><ForeName>Anthony A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Jennifer E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiology Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maddah</LastName><ForeName>Mahnaz</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Data Sciences Platform, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellinor</LastName><ForeName>Patrick T</ForeName><Initials>PT</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahed</LastName><ForeName>Akl C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Cardiovascular Disease Initiative, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: afahed@mgh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Adv</MedlineTA><NlmUniqueID>9918419284106676</NlmUniqueID><ISSNLinking>2772-963X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">electrocardiogram</Keyword><Keyword MajorTopicYN="N">prediction</Keyword></KeywordList><CoiStatement>Funding support and author disclosures Dr Kany is supported by the Walter Benjamin Fellowship from the Deutsche Forschungsgemeinschaft (521832260). Dr R&#xe4;m&#xf6; is supported by a Fellowship grant from the Sigrid Jus&#xe9;lius Foundation. Dr Ellinor is supported by grants from the National Institutes of Health (R01HL092577, 1R01HL157635, 5R01HL139731), from the American Heart Association (18SFRN34110082, 961045) and from the European Union (MAESTRIA 965286). Dr Fahed is supported by grants from the National Heart Lung and Blood Institute (K08HL161448 and R01HL164629). Dr Ho is supported by grants from the National Institutes of Health (K24 HL153669, R01 HL160003, R01 HL140224). Dr Khurshid is supported by grants from the National Heart, Lung, and Blood Institute (K23HL169839) and the American Heart Association (23CDA1050571). Dr Fahed is cofounder of Goodpath. Dr Ellinor has received sponsored research support from Bayer AG, IBM Research, Bristol Myers Squibb, Pfizer, and Novo Nordisk; and has also served on advisory boards or consulted for MyoKardia and Bayer AG. Dr Ho has received research support from Bayer AG. Dr Philippakis is a Venture Partner and employee of GV; and has received funding from Intel, IBM, Verily, Microsoft, and Bayer, all unrelated to the present work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>2</Day><Hour>10</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>18</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40749517</ArticleId><ArticleId IdType="pmc">PMC12337187</ArticleId><ArticleId IdType="doi">10.1016/j.jacadv.2025.102041</ArticleId><ArticleId IdType="pii">S2772-963X(25)00465-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics&#x2014;2023 update: a report from the American Heart Association. Circulation. 2023;147:e93&#x2013;e621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC12135016</ArticleId><ArticleId IdType="pubmed">36695182</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth G.A., Mensah G.A., Johnson C.O., et al. GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group Global Burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76:2982&#x2013;3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Enos W.F., Holmes R.H., Beyer J. Coronary disease among United States soldiers killed in action in Korea; preliminary report. J Am Med Assoc. 1953;152:1090&#x2013;1093.</Citation><ArticleIdList><ArticleId IdType="pubmed">13052433</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong J.P. Coronary atherosclerosis in soldiers: a clue to the natural history of atherosclerosis in the young. JAMA. 1986;256:2863&#x2013;2866.</Citation><ArticleIdList><ArticleId IdType="pubmed">3534337</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergstr&#xf6;m G., Persson M., Adiels M., et al. Prevalence of subclinical coronary artery atherosclerosis in the general population. Circulation. 2021;144:916&#x2013;929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8448414</ArticleId><ArticleId IdType="pubmed">34543072</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedin O. Acta Universitatis Upsaliensis; 2015. Prevalence and Prognostic Impact of Periodontal Disease and Conventional Risk Factors in Patients With Stable Coronary Heart Disease.</Citation></Reference><Reference><Citation>Figtree G.A., Vernon S.T., Harmer J.A., et al. Clinical pathway for coronary atherosclerosis in patients without conventional modifiable risk factors: JACC State-of-the-Art Review. J Am Coll Cardiol. 2023;82:1343&#x2013;1359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10522922</ArticleId><ArticleId IdType="pubmed">37730292</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgels A.P., Vos M.A., Mulleneers R., de Zwaan C., B&#xe4;r F.W., Wellens H.J. Value of the electrocardiogram in diagnosing the number of severely narrowed coronary arteries in rest angina pectoris. Am J Cardiol. 1993;72:999&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">8213601</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurshid S., Friedman S., Reeder C., et al. ECG-based deep learning and clinical risk factors to predict atrial fibrillation. Circulation. 2022;145:122&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8748400</ArticleId><ArticleId IdType="pubmed">34743566</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia Z.I., Kapa S., Lopez-Jimenez F., et al. Screening for cardiac contractile dysfunction using an artificial intelligence&#x2013;enabled electrocardiogram. Nat Med. 2019;25:70&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">30617318</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P., Haimovich J., Reeder C., et al. One clinician is all you need&#x2013;cardiac magnetic resonance imaging measurement extraction: deep learning algorithm development. JMIR Med Inform. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9526125</ArticleId><ArticleId IdType="pubmed">35960155</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurshid S., Reeder C., Harrington L.X., et al. Cohort design and natural language processing to reduce bias in electronic health records research. NPJ Digit Med. 2022;5:47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8993873</ArticleId><ArticleId IdType="pubmed">35396454</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C., Freeman C., Petkova D., et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadlowsky S., Hayward R.A., Sussman J.B., McClelland R.L., Min Y.-I., Basu S. Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann Intern Med. 2018;169:20&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">29868850</ArticleId></ArticleIdList></Reference><Reference><Citation>Goff D.C., Jr., Lloyd-Jones D.M., Bennett G., et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;63(25_Part_B):2935&#x2013;2959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4700825</ArticleId><ArticleId IdType="pubmed">24239921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P., Gifford A., Meng X., et al. Mapping ICD-10 and ICD-10-CM codes to phecodes: workflow development and initial evaluation. JMIR Med Inform. 2019;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6911227</ArticleId><ArticleId IdType="pubmed">31553307</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes J.W., Tooley J., Torres Soto J., et al. A deep learning-based electrocardiogram risk score for long term cardiovascular death and disease. NPJ Digit Med. 2023;6:169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10497604</ArticleId><ArticleId IdType="pubmed">37700032</ArticleId></ArticleIdList></Reference><Reference><Citation>Awasthi S., Sachdeva N., Gupta Y., et al. Identification and risk stratification of coronary disease by artificial intelligence-enabled ECG. EClinicalMedicine. 2023;65</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10725070</ArticleId><ArticleId IdType="pubmed">38106563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinno M.C.N., Kowalski M., Kenigsberg D.N., Krishnan S.C., Khanal S. R-wave amplitude changes measured by electrocardiography during early transmural ischemia. J Electrocardiol. 2008;41:425&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pubmed">18353345</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne P., Cullinan J., Smith S.M. Statins for primary prevention of cardiovascular disease. BMJ. 2019;367</Citation><ArticleIdList><ArticleId IdType="pubmed">31619406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40746819</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Left Ventricular Noncompaction Cardiomyopathy in an Elderly Patient: A Case Report.</ArticleTitle><Pagination><StartPage>e87020</StartPage><MedlinePgn>e87020</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e87020</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.87020</ELocationID><Abstract><AbstractText>Left ventricular noncompaction is a rare cardiomyopathy, often underrecognized in older adults, characterized by prominent myocardial trabeculations and deep intertrabecular recesses. These structural abnormalities can lead to heart failure, arrhythmias, and thromboembolic events. We report the case of an 85-year-old woman with a history of heart failure with preserved ejection fraction and atrial fibrillation who presented with chest pain and dyspnea. Her electrocardiogram (ECG) revealed new diffuse T-wave inversions. Coronary angiography showed no obstructive disease. Transthoracic echocardiography demonstrated features consistent with left ventricular noncompaction cardiomyopathy (LVNC), including a noncompacted-to-compacted ratio greater than 2:1, along with a reduced left ventricular ejection fraction (LVEF) of 25-30% (normal LVEF &gt;55%). Cardiac MRI was recommended to further characterize the myocardial structure, but the patient declined. She was managed with guideline-directed medical therapy for heart failure and anticoagulation and discharged with a wearable defibrillator. While LVNC is congenital, it may remain undiagnosed until later in life, particularly when symptoms arise due to progressive systolic dysfunction. This case illustrates the delayed diagnosis of a congenital condition rather than a late-onset disease. Greater awareness of LVNC and use of advanced imaging modalities, such as cardiac MRI, are important to improve recognition and management in older adults.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Alavi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alavi</LastName><ForeName>Reza</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hospital Corporation of America (HCA) Florida Bayonet Point Hospital, Hudson, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Armando Sanchez Garcia</LastName><ForeName>Hector</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Internal Medicine, Hospital Corporation of America (HCA) Florida Bayonet Point Hospital, Hudson, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiology, Hospital Corporation of America (HCA) Florida Bayonet Point Hospital, Hudson, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akel</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Interventional Cardiology, Hospital Corporation of America (HCA) Florida Bayonet Point Hospital, Hudson, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiomyopathy</Keyword><Keyword MajorTopicYN="N">echocardiography</Keyword><Keyword MajorTopicYN="N">left ventricular noncompaction cardiomyopathy</Keyword><Keyword MajorTopicYN="N">noncompacted-to-compacted ratio</Keyword><Keyword MajorTopicYN="N">structural heart disease</Keyword><Keyword MajorTopicYN="N">trabeculations</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>11</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>11</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>1</Day><Hour>5</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40746819</ArticleId><ArticleId IdType="pmc">PMC12310411</ArticleId><ArticleId IdType="doi">10.7759/cureus.87020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Left ventricular non-compaction: from recognition to treatment. Ganame J. Curr Pharm Des. 2015;21:484&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">25483950</ArticleId></ArticleIdList></Reference><Reference><Citation>A rare case of left ventricular non-compaction with coronary artery anomaly complicated by ST-elevation myocardial infarction and subcutaneous defibrillator implantation. Prandi FR, Illuminato F, Galluccio C, et al. Int J Environ Res Public Health. 2022;19:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8775424</ArticleId><ArticleId IdType="pubmed">35055613</ArticleId></ArticleIdList></Reference><Reference><Citation>Left ventricular non-compaction cardiomyopathy. Towbin JA, Lorts A, Jefferies JL. Lancet. 2015;386:813&#x2013;825.</Citation><ArticleIdList><ArticleId IdType="pubmed">25865865</ArticleId></ArticleIdList></Reference><Reference><Citation>European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus statement on the state of genetic testing for cardiac diseases. Wilde AA, Semsarian C, M&#xe1;rquez MF, et al. Heart Rhythm. 2022;19:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">35390533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ventricular non-compaction review. Srivastava S, Yavari M, Al-Abcha A, Banga S, Abela G. Heart Fail Rev. 2022;27:1063&#x2013;1076.</Citation><ArticleIdList><ArticleId IdType="pubmed">34232438</ArticleId></ArticleIdList></Reference><Reference><Citation>The pivotal role of cardiovascular imaging in the identification and risk stratification of non-compaction cardiomyopathy patients. Mavrogeni SI, Markousis-Mavrogenis G, Vartela V, et al. Heart Fail Rev. 2020;25:1007&#x2013;1015.</Citation><ArticleIdList><ArticleId IdType="pubmed">31784859</ArticleId></ArticleIdList></Reference><Reference><Citation>Isolated noncompaction of the left ventricular myocardium&#x2014;a review of the literature two decades after the initial case description. Engberding R, Yelbuz TM, Breithardt G. Clin Res Cardiol. 2007;96:481&#x2013;488.</Citation><ArticleIdList><ArticleId IdType="pubmed">17534568</ArticleId></ArticleIdList></Reference><Reference><Citation>Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Heart. 2001;86:666&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1730012</ArticleId><ArticleId IdType="pubmed">11711464</ArticleId></ArticleIdList></Reference><Reference><Citation>Refinement of echocardiographic criteria for left ventricular noncompaction. St&#xf6;llberger C, Gerecke B, Finsterer J, Engberding R. Int J Cardiol. 2013;165:463&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">21944384</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of cardiac magnetic resonance on the diagnosis of left ventricular noncompaction-a 15-year experience. Ojrzy&#x144;ska-Witek N, Marczak M, Mazurkiewicz &#x141;, Petryka-Mazurkiewicz J, Mi&#x142;osz B, Grzybowski J, &#x15a;piewak M. J Clin Med. 2024;13:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10889560</ArticleId><ArticleId IdType="pubmed">38398262</ArticleId></ArticleIdList></Reference><Reference><Citation>Electrocardiographic characteristics at initial diagnosis in patients with isolated left ventricular noncompaction. Steffel J, Kobza R, Oechslin E, Jenni R, Duru F. Am J Cardiol. 2009;104:984&#x2013;989.</Citation><ArticleIdList><ArticleId IdType="pubmed">19766768</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40714217</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2615</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Trends in cardiovascular medicine</Title><ISOAbbreviation>Trends Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Inflammatory cardiomyopathy: an update for clinicians.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S1050-1738(25)00095-7</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tcm.2025.07.003</ELocationID><Abstract><AbstractText>Inflammatory cardiomyopathy (CMP) is a myocardial disorder characterized by persistent inflammation leading to ventricular dysfunction and remodeling, often evolving from acute myocarditis of infectious or immune-mediated origin. Its pathogenesis is multifactorial, involving viral triggers, dysregulated immune responses, and genetic predispositions, resulting in a broad clinical spectrum-from infarct-like presentations and arrhythmias to heart failure presentations. Diagnosis requires an integrated approach using multiple diagnostic tools, integrating clinical evaluation, ECG, biomarkers, multimodality imaging, including cardiac magnetic resonance (CMR), and endomyocardial biopsy (EMB), which remains the gold standard for identifying histologic subtypes and guiding immunosuppressive therapy. Genetic testing should be included in the integrated diagnosis due to its key role in diagnosis, risk stratification, treatment decisions, and outcome prediction in complicated recurrent cases, since pathogenic variants in genes (e.g. titin, DSP, FLNC) may predispose individuals to myocardial inflammation and recurrent injury. The prognosis is influenced by initial severity, fibrosis extent, and underlying etiology. Ongoing research into precision diagnostics and immunomodulatory treatments promises to improve outcomes in this heterogeneous and potentially reversible condition.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Imazio</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Udine, Italy; Cardiothoracic Department, University Hospital Santa Maria della Misericordia, ASUFC, Udine, Italy. Electronic address: massimo.imazio@uniud.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Trends Cardiovasc Med</MedlineTA><NlmUniqueID>9108337</NlmUniqueID><ISSNLinking>1050-1738</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiac magnetic resonance</Keyword><Keyword MajorTopicYN="N">Endomyocardial biopsy</Keyword><Keyword MajorTopicYN="N">Inflammatory cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Myocarditis</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>27</Day><Hour>1</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40714217</ArticleId><ArticleId IdType="doi">10.1016/j.tcm.2025.07.003</ArticleId><ArticleId IdType="pii">S1050-1738(25)00095-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40717627</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2048-8734</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>European heart journal. Acute cardiovascular care</Title><ISOAbbreviation>Eur Heart J Acute Cardiovasc Care</ISOAbbreviation></Journal><ArticleTitle>Failure of standard contemporary ST-elevation myocardial infarction electrocardiogram criteria to reliably identify acute occlusion of the left anterior descending coronary artery.</ArticleTitle><Pagination><StartPage>403</StartPage><EndPage>411</EndPage><MedlinePgn>403-411</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjacc/zuaf037</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">ST-elevation (STE) criteria on the electrocardiogram (ECG) are poorly sensitive for acute coronary occlusion myocardial infarction (ACOMI or OMI). This study evaluates the sensitivity of STE criteria on serial ECGs for total left anterior descending (LAD) coronary artery occlusion. We compared STE criteria with expert interpretation and a validated artificial intelligence (AI) ECG model for diagnosing LAD OMI.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This is a retrospective sub-study of the DOMI-ARIGATO case-control study of OMI (808 patients, 265 with OMI). All cases of total (TIMI-0 flow) LAD occlusion were assessed for STE criteria. An OMI ECG expert blindly interpreted all serial ECGs. An AI model (PMCardio Queen of Hearts) was applied to the first available 12-lead ECG. Among the 53 cases of acute LAD OMI with TIMI-0 flow, 20 (38%) did not meet STE myocardial infarction (STEMI) criteria on any pre-angiography ECG; 16/20 had at least two ECGs before angiography. Both the expert and AI model had 100% sensitivity for diagnosing LAD OMI on the first ECG in these 20 cases. Door-to-balloon time (DBT) was significantly shorter for those meeting STEMI criteria. Infarct size, measured by ejection fraction and peak troponin, did not differ between cases with and without STEMI criteria.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The STEMI criteria missed 38% of acute total LAD occlusions on all serial ECGs. Both expert interpretation and the AI model demonstrated 100% sensitivity on the first ECG for all cases. Despite the lack of STEMI criteria, these cases had similar infarct sizes but were associated with longer DBTs.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meyers</LastName><ForeName>H Pendell</ForeName><Initials>HP</Initials><Identifier Source="ORCID">0000-0001-7484-2022</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, 1000 Blythe Blvd, Charlotte, NC 28203, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharkey</LastName><ForeName>Scott W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Minneapolis Heart Institute, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herman</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Alencar</LastName><ForeName>Jos&#xe9; Nunes</ForeName><Initials>JN</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dante Pazzanese Institute of Cardiology, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shroff</LastName><ForeName>Gautam R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Hennepin Healthcare and University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frick</LastName><ForeName>William H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, SSM Health St. Louis University Hospital, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephen W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Hennepin Healthcare and the University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Acute Cardiovasc Care</MedlineTA><NlmUniqueID>101591369</NlmUniqueID><ISSNLinking>2048-8726</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054059" MajorTopicYN="Y">Coronary Occlusion</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="Y">Coronary Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute coronary syndromes</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword><Keyword MajorTopicYN="N">LAD occlusion</Keyword><Keyword MajorTopicYN="N">OMI</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">STEMI criteria</Keyword></KeywordList><CoiStatement>Conflict of interest: H.P.M. is a consultant of Powerful Medical. R.H. is the Chief Medical Officer of Powerful Medical. H.P.M., R.H., and S.W.S. all own stock in Powerful Medical.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>18</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40717627</ArticleId><ArticleId IdType="doi">10.1093/ehjacc/zuaf037</ArticleId><ArticleId IdType="pii">8214322</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40716792</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2053-3624</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>27</Day></PubDate></JournalIssue><Title>Open heart</Title><ISOAbbreviation>Open Heart</ISOAbbreviation></Journal><ArticleTitle>Adequately identifying low-risk chest pain in emergency primary care: evaluating the performance of preHEAR(T) based on two European cohorts.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e003362</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/openhrt-2025-003362</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Differentiating cardiac from non-cardiac acute chest pain poses a diagnostic challenge, especially in primary care. The History, ECG, Age, Risk factors and Troponin level (HEART) score aid in risk stratification in hospitals, while the prehospital HEART (preHEART) score was refined for paramedics' use. However, its accuracy in emergency primary care has not been studied. This study evaluates the preHEAR(T) score, with and without high-sensitivity cardiac troponin (hs-cTn), as a tool to rule out acute myocardial infarction (MI) in emergency primary care.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective data from two European cohorts were analysed, namely the One-hoUr Troponin in a low-prevalence population of Acute Coronary Syndrome (OUT-ACS) study (1711 patients) at a Norwegian emergency primary care centre (2016-2018) and the TRiage of Acute Chest pain Evaluated in urgent primary care (TRACE) study (664 patients) at a Dutch emergency primary care centre (2017). The preHEAR (without hs-cTn) score was evaluated in both cohorts. The preHEART score was assessed in OUT-ACS only, as the TRACE study did not measure troponins. The threshold of &#x2264;3 points has previously been determined as low risk for acute MI (AMI) and optimal for rule-out purposes. The primary outcome was diagnostic performance for ruling out MI, and the secondary outcome was the composite of 90-day AMI or all-cause death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In OUT-ACS, 3.6% of patients had an AMI (median age 56 years (45-68); 47.7% female), and 3% in TRACE (median age 48 years (32-67); 56.9% female). PreHEAR identified 49.3% (OUT-ACS) and 82.7% (TRACE) as low risk, while preHEART identified 33.6% (OUT-ACS) as low risk. Sensitivity/specificity for AMI were 63.9% (95% CI 50.6 to 75.8)/49.8% (95% CI 47.3 to 52.7) (OUT-ACS) and 65% (95% CI 40.8 to 84.6)/84.2% (95% CI 81.1 to 86.9) (TRACE) for preHEAR and 93.4% (95% CI 84.1 to 98.2)/34.6% (95% CI 32.2 to 37) for preHEART. For the secondary outcome, similar diagnostic performance metrics were found. There were four missed AMI cases in the low-risk preHEART group, who were all female.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Neither the preHEAR nor preHEART scores provide sufficient rule out safety in emergency primary care and may particularly underestimate AMI risk in females.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">OUT-ACS: clinicaltrials.gov NCT02983123.</AbstractText><AbstractText Label="TRACE" NlmCategory="UNASSIGNED">Netherlands Trial Registry (NL-OMON20102); https://onderzoekmetmensen.nl/nl/trial/20102.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johannessen</LastName><ForeName>Tonje R</ForeName><Initials>TR</Initials><Identifier Source="ORCID">0000-0001-9368-1471</Identifier><AffiliationInfo><Affiliation>Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency General Practice, Oslo Accident and Emergency Outpatient Clinic, City of Oslo Health Agency, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melessen</LastName><ForeName>Indra M B</ForeName><Initials>IMB</Initials><AffiliationInfo><Affiliation>Department of General Practice, Amsterdam University Medical Centre, Amsterdam Cardiovascular Sciences Research Institute, AmstelHeart research group, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallersnes</LastName><ForeName>Odd Martin</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency General Practice, Oslo Accident and Emergency Outpatient Clinic, City of Oslo Health Agency, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manten</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Practice, Amsterdam University Medical Centre, Amsterdam Cardiovascular Sciences Research Institute, AmstelHeart research group, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halvorsen</LastName><ForeName>Sigrun</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Oslo University Hospital, Ullevaal, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atar</LastName><ForeName>Dan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-1513-8793</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Oslo University Hospital, Ullevaal, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harskamp</LastName><ForeName>Ralf E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0001-9041-0350</Identifier><AffiliationInfo><Affiliation>Department of General Practice, Amsterdam University Medical Centre, Amsterdam Cardiovascular Sciences Research Institute, AmstelHeart research group, Amsterdam, The Netherlands r.e.harskamp@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02983123</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Open Heart</MedlineTA><NlmUniqueID>101631219</NlmUniqueID><ISSNLinking>2053-3624</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014336">Troponin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="Y">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002637" MajorTopicYN="Y">Chest Pain</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="Y">Emergency Medical Services</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014336" MajorTopicYN="Y">Troponin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014218" MajorTopicYN="N">Triage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054058" MajorTopicYN="Y">Acute Coronary Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute Coronary Syndrome</Keyword><Keyword MajorTopicYN="N">Chest Pain</Keyword><Keyword MajorTopicYN="N">Myocardial Infarction</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>18</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>4</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>27</Day><Hour>20</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40716792</ArticleId><ArticleId IdType="pmc">PMC12306204</ArticleId><ArticleId IdType="doi">10.1136/openhrt-2025-003362</ArticleId><ArticleId IdType="pii">openhrt-2025-003362</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Blinkenberg J, Pahlavanyali S, Hetlevik &#xd8;, et al. General practitioners&#x2019; and out-of-hours doctors&#x2019; role as gatekeeper in emergency admissions to somatic hospitals in Norway: registry-based observational study. BMC Health Serv Res. 2019;19:568. doi: 10.1186/s12913-019-4419-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-019-4419-0</ArticleId><ArticleId IdType="pmc">PMC6693245</ArticleId><ArticleId IdType="pubmed">31412931</ArticleId></ArticleIdList></Reference><Reference><Citation>Haasenritter J, Biroga T, Keunecke C, et al. Causes of chest pain in primary care--a systematic review and meta-analysis. Croat Med J. 2015;56:422&#x2013;30. doi: 10.3325/cmj.2015.56.422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3325/cmj.2015.56.422</ArticleId><ArticleId IdType="pmc">PMC4655927</ArticleId><ArticleId IdType="pubmed">26526879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoorweg BB, Willemsen RT, Cleef LE, et al. Frequency of chest pain in primary care, diagnostic tests performed and final diagnoses. Heart. 2017;103:1727&#x2013;32. doi: 10.1136/heartjnl-2016-310905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2016-310905</ArticleId><ArticleId IdType="pubmed">28634285</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Bulk S, Manten A, Bonten TN, et al. Chest Pain in Primary Care: A Systematic Review of Risk Stratification Tools to Rule Out Acute Coronary Syndrome. Ann Fam Med. 2024;22:426&#x2013;36. doi: 10.1370/afm.3141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1370/afm.3141</ArticleId><ArticleId IdType="pmc">PMC11419710</ArticleId><ArticleId IdType="pubmed">39313342</ArticleId></ArticleIdList></Reference><Reference><Citation>Harskamp R, van Peet P, Bont J, et al. The conundrum of acute chest pain in general practice: a nationwide survey in The Netherlands. BJGP Open. 2018;2:bjgpopen18X101619. doi: 10.3399/bjgpopen18X101619.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen18X101619</ArticleId><ArticleId IdType="pmc">PMC6348327</ArticleId><ArticleId IdType="pubmed">30723804</ArticleId></ArticleIdList></Reference><Reference><Citation>Schols AMR, van Boekholt TA, Oversier LMR, et al. General practitioners&#x2019; experiences with out-of-hours cardiorespiratory consultations: a qualitative study. BMJ Open. 2016;6:e012136. doi: 10.1136/bmjopen-2016-012136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-012136</ArticleId><ArticleId IdType="pmc">PMC4985977</ArticleId><ArticleId IdType="pubmed">27519924</ArticleId></ArticleIdList></Reference><Reference><Citation>Six AJ, Backus BE, Kelder JC. Chest pain in the emergency room: value of the HEART score. Neth Heart J . 2008;16:191&#x2013;6. doi: 10.1007/BF03086144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03086144</ArticleId><ArticleId IdType="pmc">PMC2442661</ArticleId><ArticleId IdType="pubmed">18665203</ArticleId></ArticleIdList></Reference><Reference><Citation>Backus BE, Six AJ, Kelder JC, et al. A prospective validation of the HEART score for chest pain patients at the emergency department. Int J Cardiol. 2013;168:2153&#x2013;8. doi: 10.1016/j.ijcard.2013.01.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2013.01.255</ArticleId><ArticleId IdType="pubmed">23465250</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishak M, Ali D, Fokkert MJ, et al. Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score. Eur Heart J Acute Cardiovasc Care. 2018;7:102&#x2013;10. doi: 10.1177/2048872616687116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2048872616687116</ArticleId><ArticleId IdType="pubmed">28084079</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dongen DN, Fokkert MJ, Tolsma RT, et al. Value of Prehospital Troponin Assessment in Suspected Non-ST-Elevation Acute Coronary Syndrome. Am J Cardiol. 2018;122:1610&#x2013;6. doi: 10.1016/j.amjcard.2018.07.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2018.07.037</ArticleId><ArticleId IdType="pubmed">30262402</ArticleId></ArticleIdList></Reference><Reference><Citation>Backus BE, Six AJ, Kelder JC, et al. Chest pain in the emergency room: a multicenter validation of the HEART Score. Crit Pathw Cardiol. 2010;9:164&#x2013;9. doi: 10.1097/HPC.0b013e3181ec36d8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HPC.0b013e3181ec36d8</ArticleId><ArticleId IdType="pubmed">20802272</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannessen TR, Atar D, Vallersnes OM, et al. Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study. BMJ Open. 2021;11:e046024. doi: 10.1136/bmjopen-2020-046024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-046024</ArticleId><ArticleId IdType="pmc">PMC7908281</ArticleId><ArticleId IdType="pubmed">33627355</ArticleId></ArticleIdList></Reference><Reference><Citation>Khand AU, Backus B, Campbell M, et al. HEART Score Recalibration Using Higher Sensitivity Troponin T. Ann Emerg Med. 2023;82:449&#x2013;62. doi: 10.1016/j.annemergmed.2023.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2023.04.024</ArticleId><ArticleId IdType="pubmed">37306637</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahler SA, Ashburn NP, Paradee BE, et al. Safety and Effectiveness of the High-Sensitivity Cardiac Troponin HEART Pathway in Patients With Possible Acute Coronary Syndrome. Circ Cardiovasc Qual Outcomes. 2024;17:e010270. doi: 10.1161/CIRCOUTCOMES.123.010270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCOUTCOMES.123.010270</ArticleId><ArticleId IdType="pmc">PMC11697537</ArticleId><ArticleId IdType="pubmed">38328912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagel D, Vlaar PJ, van Roosmalen R, et al. Prehospital risk stratification in patients with chest pain. Emerg Med J . 2021;38:814&#x2013;9. doi: 10.1136/emermed-2020-210212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2020-210212</ArticleId><ArticleId IdType="pmc">PMC8551969</ArticleId><ArticleId IdType="pubmed">34373266</ArticleId></ArticleIdList></Reference><Reference><Citation>Smulders KRR, Demandt JPA, Vlaar PJ. Early risk assessment in patients with suspected NSTE-ACS; a retrospective cohort study. Am J Emerg Med. 2022;60:106&#x2013;15. doi: 10.1016/j.ajem.2022.07.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2022.07.053</ArticleId><ArticleId IdType="pubmed">35939854</ArticleId></ArticleIdList></Reference><Reference><Citation>Demandt JPA, Koks A, Sagel D, et al. External validation of the preHEART score and comparison with current clinical risk scores for prehospital risk assessment in patients with suspected NSTE-ACS. Emerg Med J . 2024;41:610&#x2013;6. doi: 10.1136/emermed-2023-213866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/emermed-2023-213866</ArticleId><ArticleId IdType="pubmed">39074964</ArticleId></ArticleIdList></Reference><Reference><Citation>Johannessen TR, Vallersnes OM, Halvorsen S, et al. Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study. Open Heart. 2020;7:e001296. doi: 10.1136/openhrt-2020-001296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2020-001296</ArticleId><ArticleId IdType="pmc">PMC7380862</ArticleId><ArticleId IdType="pubmed">32719074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleton M, Manten A, Smits I, et al. Performance of risk scores for coronary artery disease: a retrospective cohort study of patients with chest pain in urgent primary care. BMJ Open. 2021;11:e045387. doi: 10.1136/bmjopen-2020-045387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045387</ArticleId><ArticleId IdType="pmc">PMC8655518</ArticleId><ArticleId IdType="pubmed">34880006</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organisation . International statistical classification of diseases and related health problems 10th revision (ICD-10) 5th. Geneva, Switzerland: WHO Press; 2016. edn.</Citation></Reference><Reference><Citation>Norwegian Institute of Public Health  Norwegian cardiovascular disease registry. 2012. https://www.fhi.no/en/hn/health-registries/cardiovascular-disease-registry Available.</Citation></Reference><Reference><Citation>Manten A, Cuijpers CJJ, Rietveld R, et al. Rationale and design of a cohort study evaluating triage of acute chest pain in out-of-hours primary care in the Netherlands (TRACE) Prim Health Care Res Dev . 2020;21:e10. doi: 10.1017/S1463423620000122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1463423620000122</ArticleId><ArticleId IdType="pmc">PMC7214526</ArticleId><ArticleId IdType="pubmed">32383424</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchick MR, Setteducato ML, Revenis JJ, et al. Comparison of 3 Symptom Classification Methods to Standardize the History Component of the HEART Score. Crit Pathw Cardiol. 2017;16:102&#x2013;4. doi: 10.1097/HPC.0000000000000119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/HPC.0000000000000119</ArticleId><ArticleId IdType="pmc">PMC5880314</ArticleId><ArticleId IdType="pubmed">28742646</ArticleId></ArticleIdList></Reference><Reference><Citation>Parenti N, Lippi G, Bacchi Reggiani ML, et al. Multicenter observational study on the reliability of the HEART score. Clin Exp Emerg Med. 2019;6:212&#x2013;7. doi: 10.15441/ceem.18.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.15441/ceem.18.045</ArticleId><ArticleId IdType="pmc">PMC6774007</ArticleId><ArticleId IdType="pubmed">31571437</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254&#x2013;61. doi: 10.1373/clinchem.2009.132654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1373/clinchem.2009.132654</ArticleId><ArticleId IdType="pubmed">19959623</ArticleId></ArticleIdList></Reference><Reference><Citation>Saenger AK, Beyrau R, Braun S, et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin Chim Acta. 2011;412:748&#x2013;54. doi: 10.1016/j.cca.2010.12.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2010.12.034</ArticleId><ArticleId IdType="pubmed">21219893</ArticleId></ArticleIdList></Reference><Reference><Citation>World Organization of Family Doctors (Wonca)  International classification of primary care, 2nd edition (ICPC-2) 2005.  [12-Feb-2022]. https://www.ehelse.no/kodeverk/icpc-2e--english-version Available. Accessed.</Citation></Reference><Reference><Citation>IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB)  High-sensitivity* cardiac troponin I and T assay analytical characteristics designated by manufacturer. 2022.  [01-Sep-2022]. https://www.ifcc.org/media/479435/high-sensitivity-cardiac-troponin-i-and-t-assay-analytical-characteristics-designated-by-manufacturer-v052022.pdf Available. Accessed.</Citation></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC) Eur Heart J. 2023;44:3720&#x2013;826. doi: 10.1093/eurheartj/ehad191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad191</ArticleId><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickering JW. The Need to Improve Derivation and Description of Algorithms to Rule-Out Patients With Possible Myocardial Infarction. Circulation. 2019;139:1351&#x2013;3. doi: 10.1161/CIRCULATIONAHA.118.038418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.118.038418</ArticleId><ArticleId IdType="pubmed">30855997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ. 2015;351:h5527. doi: 10.1136/bmj.h5527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5527</ArticleId><ArticleId IdType="pmc">PMC4623764</ArticleId><ArticleId IdType="pubmed">26511519</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis BH. Spectrum bias--why clinicians need to be cautious when applying diagnostic test studies. Fam Pract. 2008;25:390&#x2013;6. doi: 10.1093/fampra/cmn051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmn051</ArticleId><ArticleId IdType="pubmed">18765409</ArticleId></ArticleIdList></Reference><Reference><Citation>Than M, Herbert M, Flaws D, et al. What is an acceptable risk of major adverse cardiac event in chest pain patients soon after discharge from the Emergency Department?: a clinical survey. Int J Cardiol. 2013;166:752&#x2013;4. doi: 10.1016/j.ijcard.2012.09.171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2012.09.171</ArticleId><ArticleId IdType="pubmed">23084108</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah ASV, Ferry AV, Mills NL. Cardiac Biomarkers and the Diagnosis of Myocardial Infarction in Women. Curr Cardiol Rep. 2017;19:40. doi: 10.1007/s11886-017-0839-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-017-0839-9</ArticleId><ArticleId IdType="pmc">PMC5385194</ArticleId><ArticleId IdType="pubmed">28391559</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobb K, Kocher M, Bullock-Palmer RP. Underrepresentation of women in cardiovascular trials- it is time to shatter this glass ceiling. Am Heart J Plus . 2022;13:100109. doi: 10.1016/j.ahjo.2022.100109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahjo.2022.100109</ArticleId><ArticleId IdType="pmc">PMC10978176</ArticleId><ArticleId IdType="pubmed">38560055</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. The Lancet. 2021;397:2385&#x2013;438. doi: 10.1016/S0140-6736(21)00684-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00684-X</ArticleId><ArticleId IdType="pubmed">34010613</ArticleId></ArticleIdList></Reference><Reference><Citation>Raber I, McCarthy CP, Januzzi JL., Jr A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings. J Am Coll Cardiol. 2021;77:1357&#x2013;67. doi: 10.1016/j.jacc.2021.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.01.011</ArticleId><ArticleId IdType="pubmed">33706879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dakshi A, Hatherley J, Collinson P, et al. Evaluation of the analytical and clinical performance of a high-sensitivity troponin I point-of-care assay in the Mersey Acute Coronary Syndrome Rule Out Study (MACROS-2) Clin Chem Lab Med . 2024 doi: 10.1515/cclm-2024-0138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2024-0138</ArticleId><ArticleId IdType="pubmed">39239902</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen L, Greenslade J, Parsonage W, et al. Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2&#x2005;h. Eur Heart J. 2024;45:2508&#x2013;15. doi: 10.1093/eurheartj/ehae343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehae343</ArticleId><ArticleId IdType="pubmed">38842324</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary. J Am Coll Cardiol. 2021;78:2218&#x2013;61. doi: 10.1016/j.jacc.2021.07.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.07.052</ArticleId><ArticleId IdType="pubmed">34756652</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman R, Meyers HP, Smith SW, et al. International evaluation of an artificial intelligence-powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. Eur Heart J Digit Health . 2024;5:123&#x2013;33. doi: 10.1093/ehjdh/ztad074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztad074</ArticleId><ArticleId IdType="pmc">PMC10944682</ArticleId><ArticleId IdType="pubmed">38505483</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmelreich JCL, Harskamp RE. Diagnostic accuracy of the PMcardio smartphone application for artificial intelligence-based interpretation of electrocardiograms in primary care (AMSTELHEART-1) Cardiovasc Digit Health J . 2023;4:80&#x2013;90. doi: 10.1016/j.cvdhj.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cvdhj.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10282008</ArticleId><ArticleId IdType="pubmed">37351331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline JA, Johnson CL, Pollack CV, Jr, et al. Pretest probability assessment derived from attribute matching. BMC Med Inform Decis Mak. 2005;5:26. doi: 10.1186/1472-6947-5-26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1472-6947-5-26</ArticleId><ArticleId IdType="pmc">PMC1201143</ArticleId><ArticleId IdType="pubmed">16095534</ArticleId></ArticleIdList></Reference><Reference><Citation>Westwood M, Ramaekers B, Grimm S, et al. High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation. Health Technol Assess. 2021;25:1&#x2013;276. doi: 10.3310/hta25330.</Citation><ArticleIdList><ArticleId IdType="doi">10.3310/hta25330</ArticleId><ArticleId IdType="pmc">PMC8200931</ArticleId><ArticleId IdType="pubmed">34061019</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40709154</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Simultaneous Myocardial Infarctions in Dual Coronary Territories Due to a Single Culprit Lesion: A Diagnostic and Management Challenge.</ArticleTitle><Pagination><StartPage>e86658</StartPage><MedlinePgn>e86658</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e86658</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.86658</ELocationID><Abstract><AbstractText>Electrocardiographic (ECG) changes in myocardial infarction (MI) typically evolve predictably over time, allowing early identification of the ischemic territory and culprit vessel. Rarely, simultaneous ischemic changes in territories supplied by two different coronary arteries are observed, complicating diagnosis and urgent management. We present a rare case of acute chest pain with concurrent hyperacute T-waves in anterior leads, suggestive of left anterior descending (LAD) artery occlusion, and ST-segment elevations in inferior leads, suggestive of right coronary artery (RCA) occlusion. Coronary angiography revealed a chronic total occlusion of the RCA with retrograde filling from the LAD&#xa0;and an acute thrombotic lesion in the mid-LAD. Emergency percutaneous intervention in the LAD restored perfusion to both coronary beds, with rapid clinical and ECG recovery. This case highlights the importance of understanding ECG evolution in MI and emphasizes early revascularization strategies when facing diagnostic dilemmas.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Singh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Nidhi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Sarvodaya Hospital, Greater Noida West, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Tushar</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Sarvodaya Hospital, Greater Noida West, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Rishika</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, Yatharth Hospital, Noida, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Amit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, King George's Medical University, Lucknow, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhandary</LastName><ForeName>Vaibhav S</ForeName><Initials>VS</Initials><AffiliationInfo><Affiliation>Department of Radiology, Srinivas Institute of Medical Sciences and Research Center, Mangaluru, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">12-lead ecg</Keyword><Keyword MajorTopicYN="N">coronary angiography</Keyword><Keyword MajorTopicYN="N">culprit lesion</Keyword><Keyword MajorTopicYN="N">percutaneous transluminal coronary angioplasty</Keyword><Keyword MajorTopicYN="N">st-elevation myocardial infarction (stemi)</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>39</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>4</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40709154</ArticleId><ArticleId IdType="pmc">PMC12288706</ArticleId><ArticleId IdType="doi">10.7759/cureus.86658</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fourth universal definition of myocardial infarction (2018) Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. Circulation. 2018;138:0&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">30571511</ArticleId></ArticleIdList></Reference><Reference><Citation>The electrocardiogram in ST elevation acute myocardial infarction: correlation with coronary anatomy and prognosis. Birnbaum Y, Drew BJ. Postgrad Med J. 2003;79:490&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1742828</ArticleId><ArticleId IdType="pubmed">13679544</ArticleId></ArticleIdList></Reference><Reference><Citation>AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. Wagner GS, Macfarlane P, Wellens H, et al. J Am Coll Cardiol. 2009;53:1003&#x2013;1011.</Citation><ArticleIdList><ArticleId IdType="pubmed">19281933</ArticleId></ArticleIdList></Reference><Reference><Citation>2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Ibanez B, James S, Agewall S, et al. Eur Heart J. 2018;39:119&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>ECG diagnosis and classification of acute coronary syndromes. Birnbaum Y, Wilson JM, Fiol M, de Luna AB, Eskola M, Nikus K. Ann Noninvasive Electrocardiol. 2014;19:4&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6931956</ArticleId><ArticleId IdType="pubmed">24382164</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7-9: "hidden" ST-segment elevations revealing acute posterior infarction. Matetzky S, Freimark D, Feinberg MS, et al.  https://www.jacc.org/doi/10.1016/S0735-1097(99)00249-1. J Am Coll Cardiol. 1999;34:748&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pubmed">10483956</ArticleId></ArticleIdList></Reference><Reference><Citation>Modern morphologic electrocardiographic interpretation--a valuable tool for rapid clinical decision making in acute ischemic coronary syndromes. Nikus KC, Eskola MJ, Niemel&#xe4; KO, Sclarovsky S. https://doi.org/10.1016/j.jelectrocard.2004.09.016. J Electrocardiol. 2005;38:4&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">15660340</ArticleId></ArticleIdList></Reference><Reference><Citation>Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Menown IB, Mackenzie G, Adgey AA. Eur Heart J. 2000;21:275&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">10653675</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results of the F.I.R.E. (efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. Atar D, Petzelbauer P, Schwitter J, et al. J Am Coll Cardiol. 2009;53:720&#x2013;729.</Citation><ArticleIdList><ArticleId IdType="pubmed">19232907</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Smith SW, Dodd KW, Henry TD, Dvorak DM, Pearce LA. Ann Emerg Med. 2012;60:766&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">22939607</ArticleId></ArticleIdList></Reference><Reference><Citation>A new electrocardiographic algorithm to locate the occlusion in left anterior descending coronary artery. Fiol M, Carrillo A, Cygankiewicz I, et al. Clin Cardiol. 2009;32:0&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6652907</ArticleId><ArticleId IdType="pubmed">19816974</ArticleId></ArticleIdList></Reference><Reference><Citation>Evolving myocardial infarction with ST elevation: ups and downs of ST in different leads identifies the culprit artery and location of the occlusion. Fiol M, Cygankiewicz I, Guindo J, et al. Ann Noninvasive Electrocardiol. 2004;9:180&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6931954</ArticleId><ArticleId IdType="pubmed">15084217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40705383</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1473-5830</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>07</Day></PubDate></JournalIssue><Title>Coronary artery disease</Title><ISOAbbreviation>Coron Artery Dis</ISOAbbreviation></Journal><ArticleTitle>AI-enhanced recognition of occlusions in acute coronary syndrome (AERO-ACS): a retrospective study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1097/MCA.0000000000001555</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Artificial intelligence (AI) augmentation of ECG assessment has significant potential to improve patient outcomes in acute coronary syndrome.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought to evaluate the performance of a novel AI device (PMCardio) in assessing angiographic occlusion myocardial infarction (OMI) and predicting clinical outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We used a 1-year retrospective cohort of angiographic data from patients presenting with ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). The device analyzed precatheterization ECGs to identify OMI, defined as a culprit vessel with thrombolysis In myocardial infarction (TIMI) 0-2 flow or TIMI 3 flow and peak cardiac troponin I&#x2005;&gt;&#x2005;10.0 ng/ml.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 217 patients were included: 72 STEMI (32%) and 145 NSTEMI (65%). Angiographic OMI was confirmed in 60 (83%) STEMI and 51 (35%) NSTEMI cases. The AI model achieved a sensitivity of 86.5%, specificity of 82.2%, and an area under the curve of 0.84. Traditional STEMI criteria had a sensitivity of 54.1% and a specificity of 88.7%. The AI model was 100% sensitive in detecting STEMI-OMI. The odds ratio for mortality in AI-detected OMI patients was 12.44 (1.56-98.98), unplanned readmissions 1.15 (0.53-2.51), and reduced ejection fraction at 1 year 0.24 (0.26-2.16).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The AI model demonstrated higher sensitivity and similar specificity compared with traditional STEMI criteria, improving OMI detection while reducing false positives. These findings suggest potential benefits in triage accuracy and resource utilization, but further prospective validation is needed to determine its clinical impact.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>James W H</ForeName><Initials>JWH</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torelli</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverman</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Sara Saravia</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Darren</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaish</LastName><ForeName>Esha</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katic</LastName><ForeName>Luka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagourney</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Zara</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robbins</LastName><ForeName>Lexi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinney</LastName><ForeName>Sean</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barman</LastName><ForeName>Nitin</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farhan</LastName><ForeName>Serdar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Northwell, Cardiovascular Institute, Lenox Hill Hospital, New Hyde Park, New York, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Coron Artery Dis</MedlineTA><NlmUniqueID>9011445</NlmUniqueID><ISSNLinking>0954-6928</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">coronary angiography</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40705383</ArticleId><ArticleId IdType="doi">10.1097/MCA.0000000000001555</ArticleId><ArticleId IdType="pii">00019501-990000000-00394</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Foo CY, Bonsu KO, Nallamothu BK, Reid CM, Dhippayom T, Reidpath DD, Chaiyakunapruk N. Coronary intervention door-to-balloon time and outcomes in ST-elevation myocardial infarction: a meta-analysis. Heart 2018; 104:1362&#x2013;1369.</Citation></Reference><Reference><Citation>de Alencar Neto JN, Scheffer MK, Correia BP, Franchini KG, Felicioni SP, De Marchi MFN. Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion. Int J Cardiol 2024; 402:131889.</Citation></Reference><Reference><Citation>Menown IB, Mackenzie G, Adgey AA. Optimizing the initial 12-lead electrocardiographic diagnosis of acute myocardial infarction. Eur Heart J 2000; 21:275&#x2013;283.</Citation></Reference><Reference><Citation>Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994; 343:311&#x2013;322.</Citation></Reference><Reference><Citation>Macfarlane PW, Browne D, Devine B, Clark E, Miller E, Seyal J, Hampton D. Modification of ACC/ESC criteria for acute myocardial infarction. J Electrocardiol 2004; 37:98&#x2013;103.</Citation></Reference><Reference><Citation>Wang TY, Zhang M, Fu Y, Armstrong PW, Newby LK, Gibson CM, et al. Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography. Am Heart J 2009; 157:716&#x2013;723.</Citation></Reference><Reference><Citation>Schmitt C, Lehmann G, Schmieder S, Karch M, Neumann FJ, Sch&#xf6;mig A. Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel: limitations of ST-segment elevation in standard and extended ECG leads. Chest 2001; 120:1540&#x2013;1546.</Citation></Reference><Reference><Citation>Pride YB, Tung P, Mohanavelu S, Zorkun C, Wiviott SD, Antman EM, et al.; TIMI Study Group. Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy. JACC Cardiovasc Interv 2010; 3:806&#x2013;811.</Citation></Reference><Reference><Citation>Khan AR, Golwala H, Tripathi A, Bin Abdulhak AA, Bavishi C, Riaz H, et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. Eur Heart J 2017; 38:3082&#x2013;3089.</Citation></Reference><Reference><Citation>Abusharekh M, Kampf J, Dykun I, Souri K, Backmann V, Al-Rashid F, et al. Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality. Eur Heart J Qual Care Clin Outcomes 2024; 10:402&#x2013;410.</Citation></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 2023; 44:3720&#x2013;3826.</Citation></Reference><Reference><Citation>Herman R, Meyers HP, Smith SW, Bertolone DT, Leone A, Bermpeis K, et al. International evaluation of an artificial intelligence-powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. Eur Heart J Digit Health 2023; 5:123&#x2013;133.</Citation></Reference><Reference><Citation>Pendell Meyers H, Bracey A, Lee D, Lichtenheld A, Li WJ, Singer DD, et al. Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction. Int J Cardiol Heart Vasc 2021; 33:100767.</Citation></Reference><Reference><Citation>Meyers HP, Bracey A, Lee D, Lichtenheld A, Li WJ, Singer DD, et al. Comparison of the ST-elevation myocardial infarction (STEMI) vs. NSTEMI and occlusion MI (OMI) vs. NOMI paradigms of acute MI. J Emerg Med 2021; 60:273&#x2013;284.</Citation></Reference><Reference><Citation>Aslanger EK, Yildirimt&#xfc;rk O, &#x15e;im&#x15f;ek B, Bozbeyo&#x11f;lu E, &#x15e;im&#x15f;ek MA, Y&#xfc;cel Karabay C, et al. DIagnostic accuracy oF electrocardiogram for acute coronary OCClUsion resuLTing in myocardial infarction (DIFOCCULT Study). Int J Cardiol Heart Vasc 2020; 30:100603.</Citation></Reference><Reference><Citation>Herman R, Smith SW, Meyers HP, Bertolone DT, Leone A, Bermpeis K, et al. Poor prognosis of total culprit artery occlusion in patients presenting with NSTEMI. Eur Heart J 2023; 44:ehad655.1536. doi: 10.1093/eurheartj/ehad655.1536.</Citation></Reference><Reference><Citation>Siontis KC, Noseworthy PA, Attia ZI, Friedman PA. Artificial intelligence-enhanced electrocardiography in cardiovascular disease management. Nat Rev Cardiol 2021; 18:465&#x2013;478.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40703870</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">0300-1652</ISSN><JournalIssue CitedMedium="Print"><Volume>66</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Season>Mar-Apr</Season></PubDate></JournalIssue><Title>Nigerian medical journal : journal of the Nigeria Medical Association</Title><ISOAbbreviation>Niger Med J</ISOAbbreviation></Journal><ArticleTitle>Pattern of electrocardiographic and echocardiographic findings amongst Nigeria national football team players.</ArticleTitle><Pagination><StartPage>457</StartPage><EndPage>467</EndPage><MedlinePgn>457-467</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.71480/nmj.v66i2.594</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Cardiac adaptations in athletes, particularly football players, often result in distinct electrocardiographic (ECG) and echocardiographic changes. This study evaluates these cardiac patterns in Nigerian national football players compared to matched non-athlete controls.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="UNASSIGNED">A case-control study was conducted from January 2022 to December 2023 during pre-participation screenings of national football teams: Super Eagles, Flying Eagles, Golden Eaglets, Super Falcons, and Falconets. Seventy-eight athletes (aged 18-32) were compared with 42 age- and sex-matched controls drawn from team officials and supporters. Inclusion criteria required active participation in professional football for athletes and absence of known cardiac disease for controls. All participants underwent detailed history, physical examination, resting ECG, and 2D echocardiography. ECGs were assessed for features suggestive of athlete's heart or hypertrophic cardiomyopathy. Echocardiograms were performed with a Hewlett-Packard Sonos 2500 using a 3.5 MHz probe to measure ventricular dimensions, wall thickness, and function.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Footballers demonstrated significant cardiac adaptations. ECGs showed lower mean heart rates, longer PR intervals, and a higher prevalence of sinus bradycardia and incomplete right bundle branch block. Additionally, footballers had higher R/S wave voltages and more frequent ST-segment elevations. Echocardiographic findings revealed larger left ventricular end-diastolic and end-systolic dimensions, as well as increased interventricular septal and posterior wall thickness, consistent with physiological, not pathological, hypertrophy.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Nigerian national football players exhibit characteristic ECG and echocardiographic patterns reflecting physiological cardiac remodeling due to intensive training. Differentiating these benign adaptations from pathological findings is essential for accurate cardiovascular assessment and safe sports participation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Nigerian Medical Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ngabea</LastName><ForeName>Murtala Audu</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Medicine, Maitama District Hospital, Abuja, Nigeria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Physiology, Faculty of Basic Medical Sciences, Baze University, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oboirien</LastName><ForeName>Isa Omokhudu</ForeName><Initials>IO</Initials><AffiliationInfo><Affiliation>Department of Acute Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Herries Road, Sheffield, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ochayi</LastName><ForeName>Okwute Michael</ForeName><Initials>OM</Initials><AffiliationInfo><Affiliation>Department of Human Physiology, Faculty of Basic Medical Sciences, Baze University, Abuja, Nigeria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Nigeria</Country><MedlineTA>Niger Med J</MedlineTA><NlmUniqueID>0315137</NlmUniqueID><ISSNLinking>0300-1652</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Athlete&#x2019;s Heart</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword><Keyword MajorTopicYN="N">Hypertrophic Cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Nigerian National Football Team</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>5</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40703870</ArticleId><ArticleId IdType="pmc">PMC12280313</ArticleId><ArticleId IdType="doi">10.71480/nmj.v66i2.594</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akinbinu B, Olabode A, Agi CE. Nigeria: Health and medical issues in elite football. In Africa&#x2019;s Elite Football. Routledge; 2019. p. 252-62.</Citation></Reference><Reference><Citation>Guglielmini C, Berlanda M, Fracassi F, Poser H, Koren S, Baron Toaldo M. Electrocardiographic and echocardiographic evaluation in dogs with hypothyroidism before and after levothyroxine supplementation: A prospective controlled study. J Vet Intern Med. 2019. Sep;33(5):1935-42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6766517</ArticleId><ArticleId IdType="pubmed">31468615</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawlins J, Carre F, Kervio G, et al. Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes. Circulation. 2010;121:1078&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">20176985</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MG, Sharma S, Carr&#xe9; F, Charron P, Richard P, O'Hanlon R, et al. Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum. Br J Sports Med. 2012. Nov 1;46(Suppl 1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3603779</ArticleId><ArticleId IdType="pubmed">23097480</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira JB, Wohlwend M, Wisl&#xf8;ff U. Exercise and cardiac health: physiological and molecular insights. Nat Metab. 2020. Sep;2(9):829-39.</Citation><ArticleIdList><ArticleId IdType="pubmed">32807982</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado D, Zorzi A, Basso C, Thiene G. 800 years of research at the University of Padua (1222&#x2013;2022): contemporary insights into Sports Cardiology.</Citation><ArticleIdList><ArticleId IdType="pubmed">35567556</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorimachi H, Obokata M, Omote K, Reddy YN, Takahashi N, Koepp KE, et al. Long-term changes in cardiac structure and function following bariatric surgery. J Am Coll Cardiol. 2022. Oct 18;80(16):1501-12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9926898</ArticleId><ArticleId IdType="pubmed">36229085</ArticleId></ArticleIdList></Reference><Reference><Citation>La Gerche A, Wasfy MM, Brosnan MJ, Claessen G, Fatkin D, Heidbuchel H, et al. The athlete&#x2019;s heart&#x2014;challenges and controversies: JACC focus seminar 4/4. J Am Coll Cardiol. 2022. Sep 5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36075838</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen D, Abreu A, Ambrosetti M, Cornelissen V, Gevaert A, Kemps H, et al. Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2022. Jan;29(1):230-45.</Citation><ArticleIdList><ArticleId IdType="pubmed">34077542</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedralli ML, Marschner RA, Kollet DP, Neto SG, Eibel B, Tanaka H, et al. Different exercise training modalities produce similar endothelial function improvements in individuals with prehypertension or hypertension: A randomized clinical trial. Sci Rep. 2020. May 6;10(1):1-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314832</ArticleId><ArticleId IdType="pubmed">32581275</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragazzoni GL, Cavigli L, Cavarretta E, Maffei S, Mandoli GE, Pastore MC, et al. How to evaluate resting ECG and imaging in children practising sport: a critical review and proposal of an algorithm for ECG interpretation. Eur J Prev Cardiol. 2022. Sep 21.</Citation><ArticleIdList><ArticleId IdType="pubmed">36130334</ArticleId></ArticleIdList></Reference><Reference><Citation>Millar RS. How to look at an ECG: ECG education. CME: Your SA J CPD. 2004. Mar 1;22(3):145-8.</Citation></Reference><Reference><Citation>Feigenbaum H. Role of M-mode technique in today's electrocardiography. J Am Soc Echocardiogr. 2010. Mar 1;23(3):240-57.</Citation><ArticleIdList><ArticleId IdType="pubmed">20206828</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SH, Shub C, Nobrega TP, Bailey KR, Seward JB. Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode electrocardiography. J Am Soc Echocardiogr. 1996. Mar 1;9(2):119-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">8849607</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawlins J, Carre F, Kervio G, Papadakis M, Chandra N, Edwards C, Whyte GP, Sharma S. Exercise Physiology.</Citation><ArticleIdList><ArticleId IdType="pubmed">20176985</ArticleId></ArticleIdList></Reference><Reference><Citation>Basavarajaiah S, Boraita A, Whyte G, et al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;51:2256&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">18534273</ArticleId></ArticleIdList></Reference><Reference><Citation>Magalski A, Maron BJ, Main ML, et al. Relation of race to electrocardiographic patterns in elite American football players. J Am Coll Cardiol. 2008;51:2250&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18534272</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadakis M, Carre F, Kervio G, et al. The prevalence, distribution and clinical outcomes of electrocardiographic repolarisation patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J. 2011;32:2304&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">21613263</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BJ, Carney KP, Lever HM, Barac I, Casey SA, Sherrid MV. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2003;41:974&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">12651044</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes. Analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">19221222</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Paolo FM, Schmied C, Zerguini YA, Junge A, Quattrini F, Culasso F, et al. The athlete's heart in adolescent Africans: an electrocardiographic and echocardiographic study. J Am Coll Cardiol. 2012. Mar 13;59(11):1029-36.</Citation><ArticleIdList><ArticleId IdType="pubmed">22402076</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosso R, Kogan E, Belhassen B, Rozovski U, Scheinman MM, Zeltser D, et al. J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. J Am Coll Cardiol. 2008. Oct 7;52(15):1231-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18926326</ArticleId></ArticleIdList></Reference><Reference><Citation>Francavilla CV, Sessa F, Salerno M, Albano GD, Villano I, Messina G, et al. Influence of football on physiological cardiac indexes in professional and young athletes. Front Physiol. 2018. Feb 28;9:153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5835836</ArticleId><ArticleId IdType="pubmed">29541036</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanti G, Stefani L, Mascherini G, Di Tante V, Toncelli L. Left ventricular remodeling and the athlete&#x2019;s heart, irrespective of quality load training. Cardiovasc Ultrasound. 2016. Dec;14:1-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5114809</ArticleId><ArticleId IdType="pubmed">27855701</ArticleId></ArticleIdList></Reference><Reference><Citation>Adeseye AA, Lookman KO. Structural and functional adaptations to exercise: Echocardiographic findings among professional footballers on routine screening among Nigerians-A view of athletes&#x2032; heart. Niger J Cardiol. 2015. Jul 1;12(2):111-4.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40703113</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2634-3916</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>4</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European heart journal. Digital health</Title><ISOAbbreviation>Eur Heart J Digit Health</ISOAbbreviation></Journal><ArticleTitle>Novel artificial intelligence model using electrocardiogram for detecting acute myocardial infarction needing revascularization.</ArticleTitle><Pagination><StartPage>608</StartPage><EndPage>618</EndPage><MedlinePgn>608-618</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjdh/ztaf049</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="UNASSIGNED">Rapid myocardial revascularization in patients with acute myocardial infarction (AMI) is essential to improve clinical outcomes. There is still room for improvement in the timely diagnosis of AMI. This study aimed to develop an artificial intelligence (AI) model using electrocardiograms (ECGs) for detecting AMI needing revascularization.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="UNASSIGNED">A total of 723 389 ECGs from 300 627 patients in the derivation cohort at a single centre between 2013 and 2020, including 5872 patients with AMI (1.95%) who underwent revascularization, were used for model training and internal testing. A transformer-based deep learning model, initially trained on about one million unlabelled ECGs through self-supervised learning, was fine-tuned for AMI detection. The model's final performance was evaluated in the internal test and the external validation set. The external validation was conducted at an independent centre between 2002 and 2020 using 261 429 ECGs from 259 454 patients, including 1095 patients with AMI (0.42%). By integrating self-supervised learning to train the AI model, we enhanced the AMI detection performance, as demonstrated by an increase in the area under the receiver operating characteristic curve (AUROC) from 0.910 (95% CI, 0.904-0.915) to 0.968 (95% CI, 0.965-0.971) in the external validation set. For ST-elevation myocardial infarction and non-ST-elevation myocardial infarction detection, the AUROCs were 0.991 (95% CI, 0.989-0.993) and 0.947 (95% CI, 0.942-0.952) in the external validation set, respectively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">This novel ECG-based AI model may be beneficial for the timely identification of patients with AMI needing revascularization.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Kyung Hoon</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Victorian Heart Institute, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Young Hoon</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>AI Research Center, VUNO Corporation, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joo</LastName><ForeName>Sunghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>AI Research Center, VUNO Corporation, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Mineok</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4569-6326</Identifier><AffiliationInfo><Affiliation>AI Research Center, VUNO Corporation, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Seok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Yongwhan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Joon Ho</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Seung Hun</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-2337-7826</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyun</LastName><ForeName>Dae Young</ForeName><Initials>DY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Namho</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Seonghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Jung Rae</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Min-Kyung</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Dong-Geum</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yeha</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>AI Research Center, VUNO Corporation, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Min Chul</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sim</LastName><ForeName>Doo Sun</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Young Joon</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ju Han</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Youngkeun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2022-9366</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Donghoon</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Hallym University Kangnam Sacred Heart Hospital, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Myung Ho</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0003-2424-810X</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Chonnam National University Hospital, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 61469, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Gwangju Veterans Hospital, 99 Cheomdanwolbong-ro, Gwangsan-gu, Gwangju 62284, Republic of Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Digit Health</MedlineTA><NlmUniqueID>101778323</NlmUniqueID><ISSNLinking>2634-3916</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Myocardial revascularization</Keyword><Keyword MajorTopicYN="N">ST-elevation myocardial infarction</Keyword><Keyword MajorTopicYN="N">Self-supervised learning</Keyword></KeywordList><CoiStatement>Conflict of interest: K.H.C. and D.H. received the institutional research grant from VUNO Corporation. Y.Lee is the co-founder and shareholder of VUNO Corporation. Y.H.J, S.J, and M.C. received salaries from VUNO Corporation.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>2</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>24</Day><Hour>5</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>5</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40703113</ArticleId><ArticleId IdType="pmc">PMC12282381</ArticleId><ArticleId IdType="doi">10.1093/ehjdh/ztaf049</ArticleId><ArticleId IdType="pii">ztaf049</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McClellan &#xa0;M, Brown &#xa0;N, Califf &#xa0;RM, Warner &#xa0;JJ. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association. Circulation &#xa0;2019;139:e44&#x2013;e54.</Citation><ArticleIdList><ArticleId IdType="pubmed">30674212</ArticleId></ArticleIdList></Reference><Reference><Citation>Nallamothu &#xa0;BK, Normand &#xa0;S-LT, Wang &#xa0;Y, Hofer &#xa0;TP, Brush &#xa0;JE &#xa0;Jr, Messenger &#xa0;JC, et al. &#xa0;Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet &#xa0;2015;385:1114&#x2013;1122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409657</ArticleId><ArticleId IdType="pubmed">25467573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho &#xa0;KH, Han &#xa0;X, Ahn &#xa0;JH, Hyun &#xa0;DY, Kim &#xa0;MC, Sim &#xa0;DS, et al. &#xa0;Long-term outcomes of patients with late presentation of ST-segment elevation myocardial infarction. J Am Coll Cardiol &#xa0;2021;77:1859&#x2013;1870.</Citation><ArticleIdList><ArticleId IdType="pubmed">33858622</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha &#xa0;JJ, Bae &#xa0;S, Park &#xa0;DW, Park &#xa0;JH, Hong &#xa0;SJ, Park &#xa0;SM, et al. &#xa0;Clinical outcomes in patients with delayed hospitalization for non-ST-segment elevation myocardial infarction. J Am Coll Cardiol &#xa0;2022;79:311&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pubmed">35086652</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu &#xa0;J, Gale &#xa0;CP, Hall &#xa0;M, Dondo &#xa0;TB, Metcalfe &#xa0;E, Oliver &#xa0;G, et al. &#xa0;Editor's choice&#x2014;impact of initial hospital diagnosis on mortality for acute myocardial infarction: a national cohort study. Eur Heart J Acute Cardiovasc Care &#xa0;2018;7:139&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7614828</ArticleId><ArticleId IdType="pubmed">27574333</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson &#xa0;M, Welch &#xa0;J, Schuur &#xa0;J, O'Laughlin &#xa0;K, Cutler &#xa0;D. Hospital and emergency department factors associated with variations in missed diagnosis and costs for patients age 65 years and older with acute myocardial infarction who present to emergency departments. Acad Emerg Med &#xa0;2014;21:1101&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4285372</ArticleId><ArticleId IdType="pubmed">25308132</ArticleId></ArticleIdList></Reference><Reference><Citation>Moy &#xa0;E, Barrett &#xa0;M, Coffey &#xa0;R, Hines &#xa0;AL, Newman-Toker &#xa0;DE. Missed diagnoses of acute myocardial infarction in the emergency department: variation by patient and facility characteristics. Diagnosis (Berl) &#xa0;2015;2:29&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">29540019</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams &#xa0;T, Savage &#xa0;L, Whitehead &#xa0;N, Orvad &#xa0;H, Cummins &#xa0;C, Faddy &#xa0;S, et al. &#xa0;Missed acute myocardial infarction (MAMI) in a rural and regional setting. Int J Cardiol Heart Vasc &#xa0;2019;22:177&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6411579</ArticleId><ArticleId IdType="pubmed">30906847</ArticleId></ArticleIdList></Reference><Reference><Citation>Elias &#xa0;P, Poterucha &#xa0;TJ, Rajaram &#xa0;V, Moller &#xa0;LM, Rodriguez &#xa0;V, Bhave &#xa0;S, et al. &#xa0;Deep learning electrocardiographic analysis for detection of left-sided valvular heart disease. J Am Coll Cardiol &#xa0;2022;80:613&#x2013;626.</Citation><ArticleIdList><ArticleId IdType="pubmed">35926935</ArticleId></ArticleIdList></Reference><Reference><Citation>Galloway &#xa0;CD, Valys &#xa0;AV, Shreibati &#xa0;JB, Treiman &#xa0;DL, Petterson &#xa0;FL, Gundotra &#xa0;VP, et al. &#xa0;Development and validation of a deep-learning model to screen for hyperkalemia from the electrocardiogram. JAMA Cardiol &#xa0;2019;4:428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537816</ArticleId><ArticleId IdType="pubmed">30942845</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi &#xa0;J, Lee &#xa0;S, Chang &#xa0;M, Lee &#xa0;Y, Oh &#xa0;GC, Lee &#xa0;HY. Deep learning of ECG waveforms for diagnosis of heart failure with a reduced left ventricular ejection fraction. Sci Rep &#xa0;2022;12:14235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9392508</ArticleId><ArticleId IdType="pubmed">35987961</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia &#xa0;ZI, Noseworthy &#xa0;PA, Lopez-Jimenez &#xa0;F, Asirvatham &#xa0;SJ, Deshmukh &#xa0;AJ, Gersh &#xa0;BJ, et al. &#xa0;An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet &#xa0;2019;394:861&#x2013;867.</Citation><ArticleIdList><ArticleId IdType="pubmed">31378392</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu &#xa0;W-C, Lin &#xa0;C-S, Tsai &#xa0;C-S, Tsao &#xa0;T-P, Cheng &#xa0;C-C, Liou &#xa0;J-T, et al. &#xa0;A deep learning algorithm for detecting acute myocardial infarction. EuroIntervention &#xa0;2021;17:765&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724911</ArticleId><ArticleId IdType="pubmed">33840640</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson &#xa0;S, Gedon &#xa0;D, Lampa &#xa0;E, Ribeiro &#xa0;AH, Holzmann &#xa0;MJ, Sch&#xf6;n &#xa0;TB, et al. &#xa0;Development and validation of deep learning ECG-based prediction of myocardial infarction in emergency department patients. Sci Rep &#xa0;2022;12:19615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9666471</ArticleId><ArticleId IdType="pubmed">36380048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee &#xa0;BT, Kwon &#xa0;J-M, Cho &#xa0;J, Bae &#xa0;W, Park &#xa0;H, Seo &#xa0;W-W, et al. &#xa0;Usefulness of deep-learning algorithm for detecting acute myocardial infarction using electrocardiogram alone in patients with chest pain at emergency department: DAMI-ECG study. J Cardiovasc Interv &#xa0;2023;2:100&#x2013;112.</Citation></Reference><Reference><Citation>Chang &#xa0;K-C, Hsieh &#xa0;P-H, Wu &#xa0;M-Y, Wang &#xa0;Y-C, Wei &#xa0;J-T, Shih &#xa0;ESC, et al. &#xa0;Usefulness of multi-labelling artificial intelligence in detecting rhythm disorders and acute ST-elevation myocardial infarction on 12-lead electrocardiogram. Eur Heart J Digit Health &#xa0;2021;2:299&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9708016</ArticleId><ArticleId IdType="pubmed">36712388</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaid &#xa0;A, Jiang &#xa0;J, Sawant &#xa0;A, Lerakis &#xa0;S, Argulian &#xa0;E, Ahuja &#xa0;Y, et al. &#xa0;A foundational vision transformer improves diagnostic performance for electrocardiograms. NPJ Digit Med &#xa0;2023;6:108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10242218</ArticleId><ArticleId IdType="pubmed">37280346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawano &#xa0;S, Kodera &#xa0;S, Setoguchi &#xa0;N, Tanabe &#xa0;K, Kushida &#xa0;S, Kanda &#xa0;J, et al. &#xa0;Applying masked autoencoder-based self-supervised learning for high-capability vision transformers of electrocardiographies. PLoS One &#xa0;2024;19:e0307978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11324121</ArticleId><ArticleId IdType="pubmed">39141600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai &#xa0;J, Tan &#xa0;H, Wang &#xa0;J, Ji &#xa0;L, Guo &#xa0;J, Han &#xa0;B, et al. &#xa0;Practical intelligent diagnostic algorithm for wearable 12-lead ECG via self-supervised learning on large-scale dataset. Nat Commun &#xa0;2023;14:3741.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10290151</ArticleId><ArticleId IdType="pubmed">37353501</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen &#xa0;K, Alpert &#xa0;JS, Jaffe &#xa0;AS, Chaitman &#xa0;BR, Bax &#xa0;JJ, Morrow &#xa0;DA, et al. &#xa0;Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol &#xa0;2018;72:2231&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">30153967</ArticleId></ArticleIdList></Reference><Reference><Citation>

Dosovitskiy &#xa0;A, Beyer &#xa0;L, Kolesnikov &#xa0;A, Weissenborn &#xa0;D, Zhai &#xa0;X, Unterthiner &#xa0;T, et al.  &#xa0;An image is worth 16&#xd7;16 words: Transformers for image recognition at scale. In: <i>9th International Conference on Learning Representations (ICLR), Virtual Conference</i>, 2021. https://openreview.net/forum?id=YicbFdNTTy.</Citation></Reference><Reference><Citation>

He &#xa0;K, Chen &#xa0;X, Xie &#xa0;S, Li &#xa0;Y, Doll&#xe1;r &#xa0;P, Girshick &#xa0;R. &#xa0;Masked autoencoders are scalable vision learners. In: <i>2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR), New Orleans, Louisiana, USA</i>, 2022, p.16000&#x2013;16009. IEEE, Piscataway, New Jersey, USA.</Citation></Reference><Reference><Citation>
World Health Organization . Cardiovascular diseases (CVDs). https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) (29 January 2024).</Citation></Reference><Reference><Citation>Hayashi &#xa0;M, Shimizu &#xa0;W, Albert &#xa0;CM. The spectrum of epidemiology underlying sudden cardiac death. Circ Res &#xa0;2015;116:1887&#x2013;1906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4929621</ArticleId><ArticleId IdType="pubmed">26044246</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne &#xa0;RA, Rossello &#xa0;X, Coughlan &#xa0;J, Barbato &#xa0;E, Berry &#xa0;C, Chieffo &#xa0;A, et al. &#xa0;2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J &#xa0;2023;44:3720&#x2013;3826.</Citation><ArticleIdList><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Canto &#xa0;JG, Shlipak &#xa0;MG, Rogers &#xa0;WJ, Malmgren &#xa0;JA, Frederick &#xa0;PD, Lambrew &#xa0;CT, et al. &#xa0;Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA &#xa0;2000;283:3223&#x2013;3229.</Citation><ArticleIdList><ArticleId IdType="pubmed">10866870</ArticleId></ArticleIdList></Reference><Reference><Citation>Han &#xa0;X, Bai &#xa0;L, Jeong &#xa0;MH, Ahn &#xa0;JH, Hyun &#xa0;DY, Cho &#xa0;KH, et al. &#xa0;Higher long-term mortality in patients with non-ST-elevation myocardial infarction than ST-elevation myocardial infarction after discharge. Yonsei Med J &#xa0;2021;62:400&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8084695</ArticleId><ArticleId IdType="pubmed">33908210</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe &#xa0;JM, Armstrong &#xa0;EJ, Ku &#xa0;I, Kulkarni &#xa0;A, Hoffmayer &#xa0;KS, Bhave &#xa0;PD, et al. &#xa0;Physician accuracy in interpreting potential ST-segment elevation myocardial infarction electrocardiograms. J Am Heart Assoc &#xa0;2013;2:e000268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835230</ArticleId><ArticleId IdType="pubmed">24096575</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho &#xa0;KH, Shin &#xa0;MH, Kim &#xa0;MC, Sim &#xa0;DS, Hong &#xa0;YJ, Kim &#xa0;JH, et al. &#xa0;Incidence, relevant patient factors, and clinical outcomes of the misdiagnosis of ST-segment-elevation myocardial infarction: results from the Korea acute myocardial infarction registry. J Am Heart Assoc &#xa0;2023;12:e029728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10356100</ArticleId><ArticleId IdType="pubmed">37345749</ArticleId></ArticleIdList></Reference><Reference><Citation>Taggart &#xa0;C, Roos &#xa0;A, Kadesjo &#xa0;E, Anand &#xa0;A, Li &#xa0;Z, Doudesis &#xa0;D, et al. &#xa0;Application of the universal definition of myocardial infarction in clinical practice in Scotland and Sweden. JAMA Netw Open &#xa0;2024;7:e245853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11002705</ArticleId><ArticleId IdType="pubmed">38587840</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin &#xa0;C, Liu &#xa0;W-T, Chang &#xa0;C-H, Lee &#xa0;C-C, Hsing &#xa0;S-C, Fang &#xa0;W-H, et al. &#xa0;Artificial intelligence&#x2013;powered rapid identification of ST-elevation myocardial infarction via electrocardiogram (ARISE)&#x2014;a pragmatic randomized controlled trial. NEJM AI &#xa0;2024;1. doi: 10.1056/AIoa2400190</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/AIoa2400190</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zaiti &#xa0;SS, Martin-Gill &#xa0;C, Zegre-Hemsey &#xa0;JK, Bouzid &#xa0;Z, Faramand &#xa0;Z, Alrawashdeh &#xa0;MO, et al. &#xa0;Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med &#xa0;2023;29:1804&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10353937</ArticleId><ArticleId IdType="pubmed">37386246</ArticleId></ArticleIdList></Reference><Reference><Citation>Rani &#xa0;V, Nabi &#xa0;ST, Kumar &#xa0;M, Mittal &#xa0;A, Kumar &#xa0;K. Self-supervised learning: a succinct review. Arch Comput Methods Eng &#xa0;2023;30:2761&#x2013;2775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9857922</ArticleId><ArticleId IdType="pubmed">36713767</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulluck &#xa0;H, Hammond-Haley &#xa0;M, Weinmann &#xa0;S, Martinez-Macias &#xa0;R, Hausenloy &#xa0;DJ. Myocardial infarct size by CMR in clinical cardioprotection studies: insights from randomized controlled trials. JACC Cardiovasc Imaging &#xa0;2017;10:230&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5348096</ArticleId><ArticleId IdType="pubmed">28279370</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40803357</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2383-4625</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2025</Year><Month>Aug</Month><Day>13</Day></PubDate></JournalIssue><Title>Clinical and experimental emergency medicine</Title><ISOAbbreviation>Clin Exp Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Comparison of Regional Wall Motion Abnormalities in STEMI(+) vs. STEMI(-) Occlusion Myocardial Infarction.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.15441/ceem.24.373</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">We aimed to determine if there are similar rates of regional wall motion abnormalities (RWMAs) in patients with acute coronary occlusion myocardial infarction (ACOMI, or OMI for short) with and without STEMI criteria on electrocardiogram (ECG).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We performed a retrospective review of a database of patients at high risk for acute coronary syndrome (ACS) with previously established outcomes for the presence of OMI in order to compare rates of RWMA in patients presenting with STEMI(+) OMI vs. STEMI(-) OMI. Furthermore, we compared how often the RWMA aligned with the anatomical territory observed on ECG.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among 808 patients, 551 underwent formal echocardiography, including 256 of 265 OMI patients and 295 of 543 patients with No Occlusion. Of the 256 OMIs that underwent formal echocardiography, only 41% (105/256) met STEMI criteria. 90% (94/105) of STEMI(+) OMI patients had RWMA compared to 82% (124/151) of STEMI(-) OMI patients (p = 0.10 [95 CI: -1.63% to 15.6%]). Both groups had greater prevalence of RWMA than the NOMI group (45%). RWMA matched the anatomic territory predicted by ECG in 92.5% of STEMI(+) OMI, 82.3% of STEMI(-) OMI, and 2.9% of the NOMI cohorts.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Location of RWMA was well-correlated with ECG findings regardless of the presence or absence of STEMI criteria. Prospective study is warranted to determine the utility of echocardiography in the detection of STEMI(-) OMI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bracey</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Albany Medical Center Hospital, Albany, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyers</LastName><ForeName>H Pendell</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Carolinas Medical Center, Charlotte, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watkins</LastName><ForeName>Caleb</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Albany Medical Center Hospital, Albany, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shroff</LastName><ForeName>Gautam R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Cardiology, Hennepin County Medical Center, University of Minnesota Medical School, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Kaiser Permanente Medical Center, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Stony Brook University Hospital, Stony Brook, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Stephen W</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Hennepin County Medical Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Korea (South)</Country><MedlineTA>Clin Exp Emerg Med</MedlineTA><NlmUniqueID>101657493</NlmUniqueID><ISSNLinking>2383-4625</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Electrocardiogram</Keyword><Keyword MajorTopicYN="N">OMI</Keyword><Keyword MajorTopicYN="N">Regional Wall Motion Abnormality</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>13</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40803357</ArticleId><ArticleId IdType="doi">10.15441/ceem.24.373</ArticleId><ArticleId IdType="pii">ceem.24.373</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40791931</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-6022</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><PubDate><Year>2025</Year><Month>Sep</Month></PubDate></JournalIssue><Title>American heart journal plus : cardiology research and practice</Title><ISOAbbreviation>Am Heart J Plus</ISOAbbreviation></Journal><ArticleTitle>Echocardiographic predictors of mortality in heart failure from Chagas cardiomyopathy: Refining risk stratification with speckle-tracking echocardiography.</ArticleTitle><Pagination><StartPage>100584</StartPage><MedlinePgn>100584</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100584</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ahjo.2025.100584</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Chagas cardiomyopathy is a major cause of mortality in endemic regions, predicted primarily by left ventricular (LV) systolic function. Speckle-tracking echocardiography (STE)-derived strain is a sensitive tool for assessing ventricular function and may enhance risk stratification. This study aimed to determine whether STE provides incremental prognostic value beyond traditional echocardiographic parameters in patients with Chagas cardiomyopathy.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients with Chagas cardiomyopathy who had evidence of heart failure were selected for the study. Clinical evaluation, electrocardiogram (ECG), and echocardiogram were performed at the time of enrollment. STE-derived global longitudinal strain (GLS) was analyzed offline. The outcome was all-cause mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 317 patients were enrolled, with a mean age was 66&#xa0;&#xb1;&#xa0;12&#xa0;years, and 133 (42&#xa0;%) were male. Over a median follow-up of 2.7&#xa0;years ([IQR] 1.96-3.50), 114 patients died (36&#xa0;%). GLS was an important predictor of death (HR 0.88; 95&#xa0;% CI 0.84 to 0.92; p&#xa0;&lt;&#xa0;0.001), adding incremental prognostic value beyond standard echocardiographic parameters, including left atrial (LA) volume, E/e' ratio, right ventricular (RV) dimension, and LV ejection fraction. The predictive model incorporating GLS demonstrated superior accuracy for mortality prediction compared to model based on conventional echocardiographic variables. Further stratification by LV ejection fraction revealed that the prognostic utility of GLS was strongest in patients with preserved or mildly reduced systolic function and decreased in those with severe LV dysfunction.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">In a cohort of patients with heart failure from Chagas cardiomyopathy residing in remote areas, GLS emerged as an independent predictor of mortality, improving risk stratification beyond standard echocardiographic parameters, particularly in patients with early stages of cardiac involvement. STE offers a valuable tool in clinical settings, improving risk assessment and providing guidance for the management of this population.</AbstractText><CopyrightInformation>&#xa9; 2025 Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maia</LastName><ForeName>Marcelo Alves</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Post-Graduation Program in Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabino</LastName><ForeName>Ester Cerdeira</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Instituto de Medicina Tropical e Departamento de Mol&#xe9;stias Infecciosas e Parasitarias da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Jose Luiz Padilha</ForeName><Initials>JLP</Initials><AffiliationInfo><Affiliation>Department of Statistics, Universidade Federal do Paran&#xe1;, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taconeli</LastName><ForeName>Cesar Augusto</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Statistics, Universidade Federal do Paran&#xe1;, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Lea Campos</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Laborat&#xf3;rio de Investiga&#xe7;&#xe3;o M&#xe9;dica (LIM03), Hospital das Clinicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos Junior</LastName><ForeName>Omar Ribeiro</ForeName><Initials>OR</Initials><AffiliationInfo><Affiliation>Post-Graduation Program in Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maia</LastName><ForeName>Ana Isabel Nobre</ForeName><Initials>AIN</Initials><AffiliationInfo><Affiliation>Health Science Program, Universidade Estadual de Montes Claros, Montes Claros, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Versiani</LastName><ForeName>Fellipe Colares P G</ForeName><Initials>FCPG</Initials><AffiliationInfo><Affiliation>Health Science Program, Universidade Estadual de Montes Claros, Montes Claros, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Ariela Mota</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Health Science Program, Universidade Estadual de Montes Claros, Montes Claros, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Antonio Luiz P</ForeName><Initials>ALP</Initials><AffiliationInfo><Affiliation>Post-Graduation Program in Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nunes</LastName><ForeName>Maria Carmo P</ForeName><Initials>MCP</Initials><AffiliationInfo><Affiliation>Post-Graduation Program in Infectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Heart J Plus</MedlineTA><NlmUniqueID>101779333</NlmUniqueID><ISSNLinking>2666-6022</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chagas cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Chagas disease</Keyword><Keyword MajorTopicYN="N">Global longitudinal strain</Keyword><Keyword MajorTopicYN="N">Risk stratification, mortality</Keyword><Keyword MajorTopicYN="N">Speckle-tracking echocardiography</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>11</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>12</Day><Hour>5</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40791931</ArticleId><ArticleId IdType="pmc">PMC12336684</ArticleId><ArticleId IdType="doi">10.1016/j.ahjo.2025.100584</ArticleId><ArticleId IdType="pii">S2666-6022(25)00087-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol. Rec. 2015;90(6):33&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">25671846</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO/PAHO . 2016. Neglected Infectious Diseases in the Americas: Success Stories and Innovation to Reach the Neediest.</Citation></Reference><Reference><Citation>Sabino E.C., Nunes M.C.P., Blum J., Molina I., Ribeiro A.L.P. Cardiac involvement in Chagas disease and African trypanosomiasis. Nat. Rev. Cardiol. 2024;(12):1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">39009679</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuani L., Bierrenbach A.L., Alencar A.P., Mendrone A., Jr., Ferreira J.E., Custer B., et al. Mortality among blood donors seropositive and seronegative for Chagas disease (1996&#x2013;2000) in S&#xe3;o Paulo, Brazil: a death certificate linkage study. PLoS Negl. Trop. Dis. 2017;11(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5436632</ArticleId><ArticleId IdType="pubmed">28545053</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucunub&#xe1; Z.M., Okuwoga O., Bas&#xe1;&#xf1;ez M.-G., Nouvellet P. Increased mortality attributed to Chagas disease: a systematic review and meta-analysis. Parasit. Vectors. 2016;9(1):42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4728795</ArticleId><ArticleId IdType="pubmed">26813568</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin-Neto J.A., Rassi A., Jr., Oliveira G.M.M., Correia L.C.L., Ramos J&#xfa;nior A.N., Luquetti A.O., et al. Diretriz da SBC sobre Diagn&#xf3;stico e Tratamento de Pacientes com Cardiomiopatia da Doen&#xe7;a de Chagas&#x2013;2023. Arq. Bras. Cardiol. 2023;120</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10344417</ArticleId><ArticleId IdType="pubmed">37377258</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes M.C.P., Bern C., Clark E.H., Teixeira A.L., Molina I. Clinical features of Chagas disease progression and severity. The Lancet Regional Health&#x2013;Americas. 2024:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11519696</ArticleId><ArticleId IdType="pubmed">39474468</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira Nunes Mdo C., Barbosa M.M., Ribeiro A.L., Amorim Fenelon L.M., Rocha M.O. Predictors of mortality in patients with dilated cardiomyopathy: relevance of chagas disease as an etiological factor. Rev. Esp. Cardiol. 2010;63(7):788&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">20609312</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes M.C., Dones W., Morillo C.A., Encina J.J., Ribeiro A.L., Council on Chagas disease of the Interamerican Society of C Chagas disease: an overview of clinical and epidemiological aspects. J. Am. Coll. Cardiol. 2013;62(9):767&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">23770163</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes M.C.P., Beaton A., Acquatella H., Bern C., Bolger A.F., Echeverria L.E., et al. Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association. Circulation. 2018;138(12):e169&#x2013;e209.</Citation><ArticleIdList><ArticleId IdType="pubmed">30354432</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes M.C.P., Badano L.P., Marin-Neto J.A., Edvardsen T., Fernandez-Golfin C., Bucciarelli-Ducci C., et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) Eur. Heart J. Cardiovasc. Imaging. 2018;19(4):459&#x2013;460. doi: 10.1093/ehjci/jex154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jex154</ArticleId><ArticleId IdType="pubmed">29029074</ArticleId></ArticleIdList></Reference><Reference><Citation>Acquatella H., Asch F.M., Barbosa M.M., Barros M., Bern C., Cavalcante J.L., et al. Recommendations for multimodality cardiac imaging in patients with Chagas disease: a report from the American Society of Echocardiography in collaboration with the InterAmerican Association of Echocardiography (ECOSIAC) and the Cardiovascular Imaging Department of the Brazilian Society of Cardiology (DIC-SBC) J. Am. Soc. Echocardiogr. 2018;31(1):3&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">29306364</ArticleId></ArticleIdList></Reference><Reference><Citation>Saraiva R.M., Mediano M.F.F., Quintana M.S., da Silva G.M.S., Costa A.R., Sousa A.S., et al. Two-dimensional strain derived parameters provide independent predictors of progression to Chagas cardiomyopathy and mortality in patients with Chagas disease. IJC Heart Vasc. 2022;38</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8826593</ArticleId><ArticleId IdType="pubmed">35169612</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa M.M., Costa Rocha M.O., Vidigal D.F., Bicalho Carneiro Rde C., Araujo R.D., Palma M.C., et al. Early detection of left ventricular contractility abnormalities by two-dimensional speckle tracking strain in Chagas&#x2019; disease. Echocardiography. 2014;31(5):623&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">25232573</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho V.T., Pinto L.H.C., Nunes M.C.P. Role of strain echocardiography in the evaluation of patients with Chagas disease. 2023;36(3)</Citation></Reference><Reference><Citation>Gomes V.A., Alves G.F., Hadlich M., Azevedo C.F., Pereira I.M., Santos C.R., et al. Analysis of regional left ventricular strain in patients with Chagas disease and normal left ventricular systolic function. J. Am. Soc. Echocardiogr. 2016;29(7):679&#x2013;688. doi: 10.1016/j.echo.2016.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2016.03.007</ArticleId><ArticleId IdType="pubmed">27086044</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos Junior O.R., Sabino E.C., Carvalho V.T., Brito BodF, Oliveira Lcd, Ferreira A.M., et al. Prevalence and factors associated with impaired left ventricular global longitudinal strain in patients with Chagas disease: SaMi-trop cohort study. Int. J. Card. Imaging. 2022;(11):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">36434344</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso C.S., Sabino E.C., Oliveira C.D.L., de Oliveira L.C., Ferreira A.M., Cunha-Neto E., et al. Longitudinal study of patients with chronic Chagas cardiomyopathy in Brazil (SaMi-Trop project): a cohort profile. BMJ Open. 2016;6(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4861110</ArticleId><ArticleId IdType="pubmed">27147390</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts E., Ludman A.J., Dworzynski K., Al-Mohammad A., Cowie M.R., McMurray J.J., et al. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting. Bmj. 2015;350</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4353288</ArticleId><ArticleId IdType="pubmed">25740799</ArticleId></ArticleIdList></Reference><Reference><Citation>Maisel A., Mueller C., Adams K., Jr., Anker S.D., Aspromonte N., Cleland J.G., et al. State of the art: using natriuretic peptide levels in clinical practice. Eur. J. Heart Fail. 2008;10(9):824&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pubmed">18760965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro A.L.P., Marcolino M.S., Prineas R.J., Lima-Costa M.F. Electrocardiographic abnormalities in elderly Chagas disease patients: 10-year follow-up of the Bambui Cohort Study of Aging. J. Am. Heart Assoc. 2014;3(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3959704</ArticleId><ArticleId IdType="pubmed">24510116</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang R.M., Badano L.P., Mor-Avi V., Afilalo J., Armstrong A., Ernande L., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Heart J. Cardiovasc. Imaging. 2015;16(3):233&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pubmed">25712077</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes M.C., Carmo A.A., Rocha M.O., Ribeiro A.L. Mortality prediction in Chagas heart disease. Expert. Rev. Cardiovasc. Ther. 2012;10(9):1173&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">23098153</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassi A., Jr., Rassi A., Rassi S.G. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007;115(9):1101&#x2013;1108.</Citation><ArticleIdList><ArticleId IdType="pubmed">17339568</ArticleId></ArticleIdList></Reference><Reference><Citation>Vizzoni A.G., Varela M.C., Sangenis L.H.C., Hasslocher-Moreno A.M., do Brasil P.E.A.A., Saraiva R.M. Ageing with Chagas disease: an overview of an urban Brazilian cohort in Rio de Janeiro. Parasit. Vectors. 2018;11(1):354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6006711</ArticleId><ArticleId IdType="pubmed">29914550</ArticleId></ArticleIdList></Reference><Reference><Citation>Marwick T.H., Shah S.J., Thomas J.D. Myocardial strain in the assessment of patients with heart failure: a review. JAMA Cardiol. 2019;4(3):287&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">30810702</ArticleId></ArticleIdList></Reference><Reference><Citation>Carluccio E., Pugliese N.R., Biagioli P., Zuchi C., Lauciello R., Mengoni A., et al. Global longitudinal strain in heart failure with reduced ejection fraction: prognostic relevance across disease severity as assessed by automated cluster analysis. Int. J. Cardiol. 2021;332:91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33713708</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon S.D., Candesartan in Heart Failure Reduction in Mortality (CHARM) Investigators Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation. 2005;112:3738&#x2013;3744.</Citation><ArticleIdList><ArticleId IdType="pubmed">16330684</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalam K., Otahal P., Marwick T.H. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014;100(21):1673&#x2013;1680.</Citation><ArticleIdList><ArticleId IdType="pubmed">24860005</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes M.C., Barbosa M.M., Ribeiro A.L., Colosimo E.A., Rocha M.O. Left atrial volume provides independent prognostic value in patients with Chagas cardiomyopathy. J. Am. Soc. Echocardiogr. 2009;22(1):82&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">19131007</ArticleId></ArticleIdList></Reference><Reference><Citation>Maria do Carmo P.N., Rocha M.O.C., Ribeiro A.L.P., Colosimo E.A., Rezende R.A., Carmo G.A.A., et al. Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas&#x2019; cardiomyopathy. Int. J. Cardiol. 2008;127(3):372&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">17689706</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes M.C.P., Acquatella H. Am Heart Assoc; 2017. Prevalence of Right Ventricular Dysfunction in Chagas Disease: Does This Depend on the Method Used? Usefulness of Cardiac Magnetic Resonance.</Citation><ArticleIdList><ArticleId IdType="pubmed">28289021</ArticleId></ArticleIdList></Reference><Reference><Citation>Maia M.A., Sabino E.C., de Oliveira L.C., Oliveira C.D.L., Cardoso C.S., Maia A.I.N., et al. Incremental prognostic value of echocardiography to brain natriuretic peptide in patients with Chagas cardiomyopathy from endemic areas. J. Am. Soc. Echocardiogr. 2022;35(9):1002&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">35605895</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Alvarez A., Sitges M., Regueiro A., Poyatos S., Jesus Pinazo M., Posada E., et al. Myocardial deformation analysis in Chagas heart disease with the use of speckle tracking echocardiography. J. Card. Fail. 2011;17(12):1028&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pubmed">22123367</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento C.A., Gomes V.A., Silva S.K., Santos C.R., Chambela M.C., Madeira F.S., et al. Left atrial and left ventricular diastolic function in chronic Chagas disease. J. Am. Soc. Echocardiogr. 2013;26(12):1424&#x2013;1433.</Citation><ArticleIdList><ArticleId IdType="pubmed">24055123</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverr&#xed;a L.E., Rojas L.Z., Rueda-Ochoa O.L., G&#xf3;mez-Ochoa S.A., Mayer M.A., Becerra-Motta L.P., et al. Longitudinal strain by speckle tracking and echocardiographic parameters as predictors of adverse cardiovascular outcomes in chronic Chagas cardiomyopathy. Int. J. Card. Imaging. 2022;38(6):1245&#x2013;1255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11143027</ArticleId><ArticleId IdType="pubmed">35028799</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Zhang L., Hu X., Gao L., Ji M., He Q., et al. Clinical usefulness of speckle-tracking echocardiography in patients with heart failure with preserved ejection fraction. Diagnostics. 2023;13(18)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10529773</ArticleId><ArticleId IdType="pubmed">37761290</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40788825</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1940-087X</ISSN><JournalIssue CitedMedium="Internet"><Issue>221</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of visualized experiments : JoVE</Title><ISOAbbreviation>J Vis Exp</ISOAbbreviation></Journal><ArticleTitle>A Minimally Invasive Double Live-Knot Technique for Myocardial Ischemia-Reperfusion Injury Modeling in Rats.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.3791/68430</ELocationID><Abstract><AbstractText>The myocardial ischemia-reperfusion injury (MI/RI) model is of great significance in exploring the pathophysiological mechanisms of myocardial infarction and facilitating the development of relevant drugs. However, among the commonly used modeling methods, the traditional polyethylene-tube-assisted coronary artery ligation method has significant drawbacks. It requires reopening the chest to untie the ligature, which is not only time-consuming but also causes substantial damage to the experimental animals and can easily lead to their death. The aim of this study is to introduce an improved model-preparation method. In this method, the Left Anterior Descending Coronary Artery (LAD) is ligated using a double live-knot coil, and the live-knot can be opened in vitro to achieve reperfusion, thus avoiding a second invasive procedure. Evaluation methods such as electrocardiogram (ECG) monitoring, M-mode echocardiography (ME) determination, Evans Blue and 2,3,5-triphenyte-trazoliumchloride staining (EB-TTC) showed that this method could induce stable MI/RI. This improved MI/RI model scheme is characterized by its simplicity and speed, and the modeling success rate is highly satisfactory. Overall, it offers practical and valuable guidance for researchers engaged in the field of MI/RI research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lei</LastName><ForeName>Ziwen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Cao</LastName><ForeName>Xinyuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>He</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiaoxiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhichao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Kaixuan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Jiaxiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Yajun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Junbo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, School of Pharmacy, Shaanxi University of Chinese Medicine; luanfeiren@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vis Exp</MedlineTA><NlmUniqueID>101313252</NlmUniqueID><ISSNLinking>1940-087X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015428" MajorTopicYN="Y">Myocardial Reperfusion Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="Y">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="N">Coronary Vessels</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008026" MajorTopicYN="N">Ligation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>18</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>18</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>13</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40788825</ArticleId><ArticleId IdType="doi">10.3791/68430</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40785860</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2223-4292</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Quantitative imaging in medicine and surgery</Title><ISOAbbreviation>Quant Imaging Med Surg</ISOAbbreviation></Journal><ArticleTitle>Prognostic significance of cold pressor test myocardial perfusion imaging in patients with ischemia and nonobstructive coronary arteries.</ArticleTitle><Pagination><StartPage>6763</StartPage><EndPage>6775</EndPage><MedlinePgn>6763-6775</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21037/qims-2025-33</ELocationID><Abstract><AbstractText Label="CORRESPONDENCE TO" NlmCategory="UNASSIGNED">Cunzhi Lu, MD. Department of Nuclear Medicine, Xuzhou Central Hospital, No. 199, Jiefangnan Road, Xuzhou 221009, China. Email: 13912045900@163.com; Yuetao Wang, MD. Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, No. 185, Juqian Street, Changzhou 213003, China; Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou, China. Email: yuetao-w@163.com.</AbstractText><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Ischemia with nonobstructive coronary arteries (INOCA) is prevalent among patients with angina, is linked to major adverse cardiovascular events (MACEs), and is often driven by endothelial dysfunction. This study aimed to assess the efficacy of the cold pressor test (CPT) in identifying individuals at elevated risk for MACEs among patients with INOCA.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 124 INOCA inpatients were included in the retrospective cohort study. Clinical data including age, gender, BMI, hypertension, hyperlipidemia, diabetes mellitus (DM), active smoking, and symptoms were collected from medical records. A positive CPT-myocardial perfusion imaging (MPI) result was considered to be the presence of a reversible perfusion defect with a summed difference score (SDS) &#x2265;2. The patients were routinely followed-up according to standard protocol. An MACE was defined as a composite endpoint including all-cause mortality, late coronary revascularization [&#x2265;3 months following single-photon emission computed tomography (SPECT)-MPI], nonfatal myocardial infarction, rehospitalization due to angina, heart failure, and stroke.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The number of positive CPT-MPI cases was 49 (39.5%) and that of negative CPT-MPI cases was 75 (60.5%). Compared with negative CPT-MPI, positive CPT-MPI group had a higher percentage of DM [16 (32.7%) <i>vs.</i> 13 (17.3%)], coronary atherosclerosis [33 (67.3%) <i>vs.</i> 32 (42.7%)], and ST-T segment changes on routine admission electrocardiogram (ECG) [37 (75.5%) <i>vs.</i> 42 (56.0%)] (all P values &lt;0.05). Univariate and multivariate logistic regression analyses indicated coronary atherosclerosis as independent risk factor for positive CPT-MPI [odds ratio (OR) 2.68, 95% confidence interval (CI): 1.22-5.90; P=0.014]. The proportion of positive CPT-MPI was higher in patients with MACEs than in patients without them [6 (32.7%) <i>vs.</i> 16 (8%); P &lt;0.05]. In the multivariate Cox proportional hazards model, only positive CPT-MPI (hazard ratio 2.97, 95% CI: 1.02-8.58; P=0.04) was significantly associated with MACE occurrence.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Among patients with INOCA &lt;39.5% had positive CPT, which was significantly related to MACE occurrence. In patients with positive CPT, the risk of MACE increased twofold. Coronary atherosclerosis was the independent risk factor of positive CPT. CPT-MPI offers valuable insights for risk stratification and treatment decision-making in patients with INOCA, particularly in identifying those at higher risk of adverse cardiovascular events.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 AME Publishing Company. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Yu</LastName><ForeName>Wenji</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fu</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Xuzhou Central Hospital, Xuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Cunzhi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nuclear Medicine, Xuzhou Central Hospital, Xuzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuetao</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-2859-8625</Identifier><AffiliationInfo><Affiliation>Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Quant Imaging Med Surg</MedlineTA><NlmUniqueID>101577942</NlmUniqueID><ISSNLinking>2223-4306</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cold pressor test (CPT)</Keyword><Keyword MajorTopicYN="N">endothelium dysfunction</Keyword><Keyword MajorTopicYN="N">ischemia and nonobstructive coronary arteries (INOCA)</Keyword><Keyword MajorTopicYN="N">myocardial perfusion imaging (MPI)</Keyword></KeywordList><CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://qims.amegroups.com/article/view/10.21037/qims-2025-33/coif). The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40785860</ArticleId><ArticleId IdType="pmc">PMC12332663</ArticleId><ArticleId IdType="doi">10.21037/qims-2025-33</ArticleId><ArticleId IdType="pii">qims-15-08-6763</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020;41:407-77. 10.1093/eurheartj/ehz425</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz425</ArticleId><ArticleId IdType="pubmed">31504439</ArticleId></ArticleIdList></Reference><Reference><Citation>Radico F, Zimarino M, Fulgenzi F, Ricci F, Di Nicola M, Jespersen L, Chang SM, Humphries KH, Marzilli M, De Caterina R. Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis. Eur Heart J 2018;39:2135-46. 10.1093/eurheartj/ehy185</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy185</ArticleId><ArticleId IdType="pubmed">29688324</ArticleId></ArticleIdList></Reference><Reference><Citation>Feenstra RGT, Boerhout CKM, Woudstra J, Vink CEM, Wittekoek ME, de Waard GA, Appelman Y, Eringa EC, Marques KMJ, de Winter RJ, Beijk MAM, van de Hoef TP, Piek JJ. Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries. Circ Cardiovasc Interv 2022;15:e012017. 10.1161/CIRCINTERVENTIONS.122.012017</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.122.012017</ArticleId><ArticleId IdType="pubmed">35904014</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol Heart Circ Physiol 2004;287:H435-46. 10.1152/ajpheart.00262.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00262.2004</ArticleId><ArticleId IdType="pubmed">15277186</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimiya K, Takahashi J, Oyama K, Matsumoto Y, Yasuda S, Shimokawa H. Mechanisms of Coronary Artery Spasm. Eur Cardiol 2023;18:e39. 10.15420/ecr.2022.55</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2022.55</ArticleId><ArticleId IdType="pmc">PMC10345984</ArticleId><ArticleId IdType="pubmed">37456775</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman H, Corcoran D, Aetesam-Ur-Rahman M, Hoole SP, Berry C, Perera D. Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory. Heart 2019;105:1536-42. 10.1136/heartjnl-2019-315042</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2019-315042</ArticleId><ArticleId IdType="pmc">PMC6774766</ArticleId><ArticleId IdType="pubmed">31366574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang HJ, Youn HJ, Lee MY, Park CS, Choi YS, Chung WB, Lee JB, Shim B. Change of coronary flow velocity during the cold pressor test is related to endothelial markers in subjects with chest pain and a normal coronary angiogram. Clin Cardiol 2012;35:119-24. 10.1002/clc.20980</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clc.20980</ArticleId><ArticleId IdType="pmc">PMC6652701</ArticleId><ArticleId IdType="pubmed">22102482</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuyama H, Odagawa Y, Katoh C, Iwado Y, Yoshinaga K, Ito Y, Noriyasu K, Mabuchi M, Kuge Y, Kobayashi K, Tamaki N. Assessment of coronary function in children with a history of Kawasaki disease using (15)O-water positron emission tomography. Circulation 2002;105:2878-84. 10.1161/01.cir.0000018652.59840.57</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.0000018652.59840.57</ArticleId><ArticleId IdType="pubmed">12070117</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicala S, Pellegrino T, Storto G, Caprio MG, Paladini R, Mainolfi C, de Leva F, Cuocolo A. Noninvasive quantification of coronary endothelial function by SPECT imaging in children with a history of Kawasaki disease. Eur J Nucl Med Mol Imaging 2010;37:2249-55. 10.1007/s00259-010-1575-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-010-1575-1</ArticleId><ArticleId IdType="pubmed">20680267</ArticleId></ArticleIdList></Reference><Reference><Citation>Pautasso E, Koretzky M, Marcon L, Borrego C, Panini J, Lerman J. Can the cold pressor test predict future cardiovascular events in patients without demonstrated ischemic heart disease by SPECT? Int J Cardiol 2014;175:226-32. 10.1016/j.ijcard.2014.04.202</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2014.04.202</ArticleId><ArticleId IdType="pubmed">24890521</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochitte CE, George RT, Chen MY, Arbab-Zadeh A, Dewey M, Miller JM, et al. Computed tomography angiography and perfusion to assess coronary artery stenosis causing perfusion defects by single photon emission computed tomography: the CORE320 study. Eur Heart J 2014;35:1120-30. 10.1093/eurheartj/eht488</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht488</ArticleId><ArticleId IdType="pmc">PMC6693293</ArticleId><ArticleId IdType="pubmed">24255127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunadian V, Chieffo A, Camici PG, Berry C, Escaned J, Maas AHEM, Prescott E, Karam N, Appelman Y, Fraccaro C, Louise Buchanan G, Manzo-Silberman S, Al-Lamee R, Regar E, Lansky A, Abbott JD, Badimon L, Duncker DJ, Mehran R, Capodanno D, Baumbach A. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology &amp; Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 2020;41:3504-20. 10.1093/eurheartj/ehaa503</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa503</ArticleId><ArticleId IdType="pmc">PMC7577516</ArticleId><ArticleId IdType="pubmed">32626906</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery); American Society of Echocardiography; American Society of Nuclear Cardiology; Heart Rhythm Society; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Vascular Surgery. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007;116:e418-99. Erratum in: Circulation 2008;118:e143-4. Erratum in: Circulation 2008;117:e154.</Citation><ArticleIdList><ArticleId IdType="pubmed">17901357</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho I, &#xd3; Hartaigh B, Gransar H, Valenti V, Lin FY, Achenbach S, et al. Prognostic implications of coronary artery calcium in the absence of coronary artery luminal narrowing. Atherosclerosis 2017;262:185-90. 10.1016/j.atherosclerosis.2016.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2016.12.006</ArticleId><ArticleId IdType="pmc">PMC5488715</ArticleId><ArticleId IdType="pubmed">28385391</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Fish M, Gerlach J, Lemley M, Berman DS, Germano G, Slomka PJ. Combined quantitative analysis of attenuation corrected and non-corrected myocardial perfusion SPECT: Method development and clinical validation. J Nucl Cardiol 2010;17:591-9. 10.1007/s12350-010-9220-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12350-010-9220-8</ArticleId><ArticleId IdType="pmc">PMC2935899</ArticleId><ArticleId IdType="pubmed">20387137</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson BD, Shaw LJ, Pepine CJ, Reis SE, Kelsey SF, Sopko G, Rogers WJ, Mankad S, Sharaf BL, Bittner V, Bairey Merz CN. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J 2006;27:1408-15. 10.1093/eurheartj/ehl040</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehl040</ArticleId><ArticleId IdType="pubmed">16720691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelmsen L, Eriksson H, Sv&#xe4;rdsudd K, Caidahl K. Improving the detection and diagnosis of congestive heart failure. Eur Heart J 1989;10 Suppl C:13-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">2806286</ArticleId></ArticleIdList></Reference><Reference><Citation>Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation 2017;135:1075-92. 10.1161/CIRCULATIONAHA.116.024534</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.024534</ArticleId><ArticleId IdType="pmc">PMC5385930</ArticleId><ArticleId IdType="pubmed">28289007</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimokawa H, Suda A, Takahashi J, Berry C, Camici PG, Crea F, et al. Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the Coronary Vasomotor Disorders International Study (COVADIS) Group. Eur Heart J 2021;42:4592-600. 10.1093/eurheartj/ehab282</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab282</ArticleId><ArticleId IdType="pmc">PMC8633728</ArticleId><ArticleId IdType="pubmed">34038937</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC, Ebong EE, Cameron SJ, Stewart AG, Weng J. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev 2021;73:924-67. 10.1124/pharmrev.120.000096</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pharmrev.120.000096</ArticleId><ArticleId IdType="pubmed">34088867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266-71. 10.1161/01.cir.94.3.266</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.94.3.266</ArticleId><ArticleId IdType="pubmed">8759065</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertrand ME, LaBlanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Carre AG, Asseman P, Berzin B, Libersa C, Laurent JM. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-306. 10.1161/01.cir.65.7.1299</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.65.7.1299</ArticleId><ArticleId IdType="pubmed">7200405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363-8. 10.1161/01.CIR.0000153339.27064.14</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000153339.27064.14</ArticleId><ArticleId IdType="pubmed">15668353</ArticleId></ArticleIdList></Reference><Reference><Citation>Picard F, Sayah N, Spagnoli V, Adjedj J, Varenne O. Vasospastic angina: A literature review of current evidence. Arch Cardiovasc Dis 2019;112:44-55. 10.1016/j.acvd.2018.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2018.08.002</ArticleId><ArticleId IdType="pubmed">30197243</ArticleId></ArticleIdList></Reference><Reference><Citation>Sara JD, Widmer RJ, Matsuzawa Y, Lennon RJ, Lerman LO, Lerman A. Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. JACC Cardiovasc Interv 2015;8:1445-53. 10.1016/j.jcin.2015.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2015.06.017</ArticleId><ArticleId IdType="pubmed">26404197</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda R, Hissen SL, Akins JD, Washio T, Hearon CM, Jr, MacNamara JP, Sarma S, Levine BD, Fadel PJ, Fu Q. Sympathetic Neural Control at Rest and During the Cold Pressor Test in Patients With Heart Failure With Preserved Ejection Fraction. Hypertension 2024;81:917-26. 10.1161/HYPERTENSIONAHA.123.21918</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.123.21918</ArticleId><ArticleId IdType="pmc">PMC10954398</ArticleId><ArticleId IdType="pubmed">38385250</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabel EG, Ganz P, Gordon JB, Alexander RW, Selwyn AP. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 1988;77:43-52. 10.1161/01.cir.77.1.43</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.77.1.43</ArticleId><ArticleId IdType="pubmed">2826047</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeiher AM, Drexler H, Wollschlaeger H, Saurbier B, Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 1989;14:1181-90. 10.1016/0735-1097(89)90414-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(89)90414-2</ArticleId><ArticleId IdType="pubmed">2808971</ArticleId></ArticleIdList></Reference><Reference><Citation>Vane JR, Angg&#xe5;rd EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36. 10.1056/NEJM199007053230106</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199007053230106</ArticleId><ArticleId IdType="pubmed">2113184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartge MM, Kintscher U, Unger T. Endothelial dysfunction and its role in diabetic vascular disease. Endocrinol Metab Clin North Am 2006;35:551-60, viii-ix. 10.1016/j.ecl.2006.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ecl.2006.06.006</ArticleId><ArticleId IdType="pubmed">16959585</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjaer A, Meyer C, Nielsen FS, Parving HH, Hesse B. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes. J Nucl Med 2003;44:19-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">12515871</ArticleId></ArticleIdList></Reference><Reference><Citation>Raizner AE, Chahine RA, Ishimori T, Verani MS, Zacca N, Jamal N, Miller RR, Luchi RJ. Provocation of coronary artery spasm by the cold pressor test. Hemodynamic, arteriographic and quantitative angiographic observations. Circulation 1980;62:925-32. 10.1161/01.cir.62.5.925</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.62.5.925</ArticleId><ArticleId IdType="pubmed">7418176</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003;23:168-75. 10.1161/01.atv.0000051384.43104.fc</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.atv.0000051384.43104.fc</ArticleId><ArticleId IdType="pubmed">12588755</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez E, Flammer AJ, Lerman LO, El&#xed;zaga J, Lerman A, Fern&#xe1;ndez-Avil&#xe9;s F. Endothelial dysfunction over the course of coronary artery disease. Eur Heart J 2013;34:3175-81. 10.1093/eurheartj/eht351</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht351</ArticleId><ArticleId IdType="pmc">PMC3814514</ArticleId><ArticleId IdType="pubmed">24014385</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan FX, Li HM, Li SX, He SH, Dai WP, Li Y, Wang TT, Shi MM, Yuan HX, Xu Z, Zhou JG, Ning DS, Mo ZW, Ou ZJ, Ou JS. The oxidized phospholipid POVPC impairs endothelial function and vasodilation via uncoupling endothelial nitric oxide synthase. J Mol Cell Cardiol 2017;112:40-8. 10.1016/j.yjmcc.2017.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2017.08.016</ArticleId><ArticleId IdType="pubmed">28870504</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;chinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906. 10.1161/01.cir.101.16.1899</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.101.16.1899</ArticleId><ArticleId IdType="pubmed">10779454</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40815543</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0844</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>European journal of heart failure</Title><ISOAbbreviation>Eur J Heart Fail</ISOAbbreviation></Journal><ArticleTitle>Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/ejhf.3780</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Dilated cardiomyopathy (DCM) has a highly variable presentation and disease course. Current stratification strategies are complex and require multimodality evaluation. Using machine learning (ML) on a large dataset obtained at first cardiological evaluation, this study aims to identify specific DCM subgroups.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">In a retrospective cohort of DCM patients, baseline clinical, genetic, and outcome data were collected. Unsupervised clustering was performed and then simplified to identify patient subgroups. The subgroups were characterized based on outcomes, including all-cause mortality/heart transplantation (HT)/left ventricular assist device implantation (LVAD), sudden cardiac death/major ventricular arrhythmias (SCD/MVA) and heart failure-related death/HT/LVAD. These findings were then validated in an external population. In the derivation cohort of 409 patients (mean age 46&#x2009;&#xb1;&#x2009;14&#x2009;years, 71% male), two cluster-subgroups were identified: CL1 (82%) and CL2 (18%), mainly differentiated by electrocardiogram (ECG) characteristics. A lower yield of pathogenic/likely pathogenic variants was found in CL2 versus CL1 (15% vs. 47%, p&#x2009;&lt;&#x2009;0.001). A simplified clustering using only three variables (QRS duration, presence of left bundle branch block, intrinsicoid deflection &gt;50&#x2009;ms) was equally effective and validated in the external cohort of 160 patients (mean age 54&#x2009;&#xb1;&#x2009;13&#x2009;years, 68% male). A lower risk for SCD/MVA events was observed for CL2 in the primary (hazard ratio 0.29, 95% confidence interval 0.13-0.67) and validation cohort (p&#x2009;=&#x2009;0.017).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Using ML, baseline ECG variables were found to effectively identify two DCM subgroups differing in disease progression and genetic background. This approach could serve as a valuable tool for improving risk stratification of DCM patients upon their initial evaluation.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). European Journal of Heart Failure published by John Wiley &amp; Sons Ltd on behalf of European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gandin</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, Department of Medicine, Surgery and Health Science, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Perotto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8252-2934</Identifier><AffiliationInfo><Affiliation>Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Paldino</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baj</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Mathematics, Informatics and Geosciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaffalon</LastName><ForeName>Denise</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Cardiology Department, Azienda Unit&#xe0; Locale Socio-Sanitaria n. 2 Marca Trevigiana, Montebelluna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pezzato</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crescenzi</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Policlinico Casilino, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romeo</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Policlinico Casilino, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Annamaria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Policlinico Casilino, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fanisio</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Policlinico Casilino, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toto</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Policlinico Casilino, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gigli</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dal Ferro</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cal&#xf2;</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Policlinico Casilino, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sinagra</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merlo</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>D70_microgrants_GANDIN-21</GrantID><Agency>MICROGRANTS</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Heart Fail</MedlineTA><NlmUniqueID>100887595</NlmUniqueID><ISSNLinking>1388-9842</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmic risk</Keyword><Keyword MajorTopicYN="N">Clustering analysis</Keyword><Keyword MajorTopicYN="N">Dilated cardiomyopathy</Keyword><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>15</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>15</Day><Hour>12</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>15</Day><Hour>11</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40815543</ArticleId><ArticleId IdType="doi">10.1002/ejhf.3780</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Paldino A, Dal Ferro M, Stolfo D, Gandin I, Medo K, Graw S, et al. Prognostic prediction of genotype vs phenotype in genetic cardiomyopathies. J Am Coll Cardiol 2022;80:1981&#x2013;1994. https://doi.org/10.1016/j.jacc.2022.08.804</Citation></Reference><Reference><Citation>Mirelis JG, Escobar&#x2010;Lopez L, Ochoa JP, Espinosa M&#xc1;, Villacorta E, Navarro M, et al. Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non&#x2010;ischaemic dilated cardiomyopathy. Eur J Heart Fail 2022;24:1183&#x2013;1196. https://doi.org/10.1002/ejhf.2514</Citation></Reference><Reference><Citation>Gigli M, Merlo M, Graw SL, Barbati G, Rowland TJ, Slavov DB, et al. Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy. J Am Coll Cardiol 2019;74:1480&#x2013;1490. https://doi.org/10.1016/j.jacc.2019.06.072</Citation></Reference><Reference><Citation>Dziewi&#x119;cka E, Gliniak M, Winiarczyk M, Karapetyan A, Wi&#x15b;niowska&#x2010;&#x15a;mia&#x142;ek S, Karabinowska A, et al. Mortality risk in dilated cardiomyopathy: The accuracy of heart failure prognostic models and dilated cardiomyopathy&#x2010;tailored prognostic model. ESC Heart Fail 2020;7:2455&#x2013;2467. https://doi.org/10.1002/ehf2.12809</Citation></Reference><Reference><Citation>Elliott PM. Personalized medicine for dilated cardiomyopathy. Eur Heart J 2021;42:175&#x2013;177. https://doi.org/10.1093/eurheartj/ehaa869</Citation></Reference><Reference><Citation>Tayal U, Verdonschot JAJ, Hazebroek MR, Howard J, Gregson J, Newsome S, et al. Precision phenotyping of dilated cardiomyopathy using multidimensional data. J Am Coll Cardiol 2022;79:2219&#x2013;2232. https://doi.org/10.1016/j.jacc.2022.03.375</Citation></Reference><Reference><Citation>Verdonschot JAJ, Wang P, Derks KWJ, Adriaens ME, Stroeks SLVM, Henkens MTHM, et al. Clustering of cardiac transcriptome profiles reveals unique: Subgroups of dilated cardiomyopathy patients. JACC Basic Transl Sci 2023;8:406&#x2013;418. https://doi.org/10.1016/j.jacbts.2022.10.010</Citation></Reference><Reference><Citation>Wouters PC, van de Leur RR, Vessies MB, van Stipdonk AMW, Ghossein MA, Hassink RJ, et al. Electrocardiogram&#x2010;based deep learning improves outcome prediction following cardiac resynchronization therapy. Eur Heart J 2023;44:680&#x2013;692. https://doi.org/10.1093/eurheartj/ehac617</Citation></Reference><Reference><Citation>Escobar&#x2010;Lopez L, Ochoa JP, Royuela A, Verdonschot JAJ, Dal Ferro M, Espinosa MA, et al. Clinical risk score to predict pathogenic genotypes in patients with dilated cardiomyopathy. J Am Coll Cardiol 2022;80:1115&#x2013;1126. https://doi.org/10.1016/j.jacc.2022.06.040</Citation></Reference><Reference><Citation>Gigli M, Stolfo D, Graw SL, Merlo M, Gregorio C, Nee Chen S, et al. Phenotypic expression, natural history, and risk stratification of cardiomyopathy caused by filamin C truncating variants. Circulation 2021;144:1600&#x2013;1611. https://doi.org/10.1161/CIRCULATIONAHA.121.053521</Citation></Reference><Reference><Citation>Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales&#x2010;Villa R, Basso C, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J 2023;44:3503&#x2013;3626. https://doi.org/10.1093/eurheartj/ehad194</Citation></Reference><Reference><Citation>Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: A position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270&#x2013;276. https://doi.org/10.1093/eurheartj/ehm342</Citation></Reference><Reference><Citation>Lang RM, Badano LP, Mor&#x2010;Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015;16:233&#x2013;270. https://doi.org/10.1093/ehjci/jev014</Citation></Reference><Reference><Citation>Dal Ferro M, Stolfo D, Altinier A, Gigli M, Perrieri M, Ramani F, et al. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart 2017;103:1704&#x2013;1710. https://doi.org/10.1136/heartjnl&#x2010;2016&#x2010;311017</Citation></Reference><Reference><Citation>Richards S, Aziz N, Bale S, Bick D, Das S, Gastier&#x2010;Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405&#x2013;424. https://doi.org/10.1038/gim.2015.30</Citation></Reference><Reference><Citation>Chavent M, Kuentz V, Labenne A, Saracco J. Multivariate analysis of mixed data. The R package PCAmixdata. Electron J Appl Stat Anal 2022;15:606&#x2013;645. https://doi.org/10.1285/i20705948v15n3p606</Citation></Reference><Reference><Citation>Rousseeuw PJ. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. J Comput Appl Math 1987;20:53&#x2013;65. https://doi.org/10.1016/0377&#x2010;0427(87)90125&#x2010;7</Citation></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Methodol 1996;58:267&#x2013;288. https://doi.org/10.1111/j.2517&#x2010;6161.1996.tb02080.x</Citation></Reference><Reference><Citation>Merlo M, Zaffalon D, Stolfo D, Altinier A, Barbati G, Zecchin M, et al. ECG in dilated cardiomyopathy: Specific findings and long&#x2010;term prognostic significance. J Cardiovasc Med (Hagerstown) 2019;20:450&#x2013;458. https://doi.org/10.2459/JCM.0000000000000804</Citation></Reference><Reference><Citation>Woolley RJ, Ceelen D, Ouwerkerk W, Tromp J, Figarska SM, Anker SD, et al. Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction. Eur J Heart Fail 2021;23:983&#x2013;991. https://doi.org/10.1002/ejhf.2144</Citation></Reference><Reference><Citation>Cikes M, Sanchez&#x2010;Martinez S, Claggett B, Duchateau N, Piella G, Butakoff C, et al. Machine learning&#x2010;based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy. Eur J Heart Fail 2019;21:74&#x2013;85. https://doi.org/10.1002/ejhf.1333</Citation></Reference><Reference><Citation>Min JK, Earls JP. Transforming data into diagnosis: Exercises for a computer to perform and a physician to interpret. J Am Coll Cardiol 2020;76:1686&#x2013;1689. https://doi.org/10.1016/j.jacc.2020.08.054</Citation></Reference><Reference><Citation>Rosenberg MA. Trusting magic: Interpretability of predictions from machine learning algorithms. Circulation 2021;143:1299&#x2013;1301. https://doi.org/10.1161/CIRCULATIONAHA.121.053733</Citation></Reference><Reference><Citation>Verdonschot JAJ, Hazebroek MR, Krapels IPC, Henkens MTHM, Raafs A, Wang P, et al. Implications of genetic testing in dilated cardiomyopathy. Circ Genom Precis Med 2020;13:476&#x2013;487. https://doi.org/10.1161/CIRCGEN.120.003031</Citation></Reference><Reference><Citation>Escobar&#x2010;Lopez L, Ochoa JP, Mirelis JG, Espinosa M&#xc1;, Navarro M, Gallego&#x2010;Delgado M, et al. Association of genetic variants with outcomes in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 2021;78:1682&#x2013;1699. https://doi.org/10.1016/j.jacc.2021.08.039</Citation></Reference><Reference><Citation>Eda Y, Nabeta T, Iikura S, Takigami Y, Fujita T, Iida Y, et al. Non&#x2010;dilated left ventricular cardiomyopathy vs. dilated cardiomyopathy: Clinical background and outcomes. ESC Heart Fail 2024;11:1463&#x2013;1471. https://doi.org/10.1002/ehf2.14711</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40810163</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2575-9108</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>08</Day></PubDate></JournalIssue><Title>ACS pharmacology &amp; translational science</Title><ISOAbbreviation>ACS Pharmacol Transl Sci</ISOAbbreviation></Journal><ArticleTitle>Cardioprotective Potential of ApoE-Derived Peptide (ApoEFrag) in Myocardial Infarction in Rats: A Mechanistic Study.</ArticleTitle><Pagination><StartPage>2431</StartPage><EndPage>2447</EndPage><MedlinePgn>2431-2447</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acsptsci.4c00759</ELocationID><Abstract><AbstractText>Cardiovascular diseases (CVDs) are the leading cause of death among non-communicable diseases globally. Myocardial infarction (MI) is one of the most significant CVDs resulting from acute or chronic myocardial ischemia, which can lead to irreversible damage. Despite the substantial burden posed by these conditions, specific treatments remain limited to symptomatic management. ApoEFrag has been shown to be protective in the CNS. However, the cardioprotective potential of ApoE-mimetic has not been investigated. Thus, this study investigates the cardioprotective potential of ApoEFrag, a novel ApoE-mimetic peptide, in an acute MI model in rats. MI was induced in rats through two doses of isoproterenol (100 mg/kg via subcutaneous injection) administered 24 h apart. ApoEFrag was given at doses of 0.5 and 1 mg/kg to ISO-treated rats. Following treatment, we measured electrocardiogram (ECG) changes and arterial and ventricular pressure functions using the PV-loop system. Plasma and heart samples were collected for biochemical assessments, including plasma injury markers, hypertrophic index parameters, inflammatory markers, gene/protein expression analysis, and histopathological studies. ISO-induced MI resulted in alterations in ECG patterns, ventricular dysfunction, increased fibrosis, and elevated hypertrophic index parameters. Additionally, ISO administration led to increased inflammatory markers and oxidative stress levels, which were reversed by the ApoEFrag treatment. Furthermore, ApoEFrag significantly ameliorated cardiac injury, inflammation, hypertrophic index parameters, ECG alterations, ventricular dysfunction, and cardiac fibrosis in ISO-induced MI models. Notably, ApoEFrag also improved mitochondrial health. This study suggests that ApoEFrag has significant cardioprotective potential in an acute myocardial infarction model.</AbstractText><CopyrightInformation>&#xa9; 2025 American Chemical Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Sakeel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali 160062 Punjab, India.</Affiliation><Identifier Source="RINGGOLD">63547</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rihan</LastName><ForeName>Mohd</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali 160062 Punjab, India.</Affiliation><Identifier Source="RINGGOLD">63547</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pande</LastName><ForeName>Abhay H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali 160062 Punjab, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Shyam Sunder</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0002-4221-4870</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Sector 67, S.A.S. Nagar, Mohali 160062 Punjab, India.</Affiliation><Identifier Source="RINGGOLD">63547</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Pharmacol Transl Sci</MedlineTA><NlmUniqueID>101721411</NlmUniqueID><ISSNLinking>2575-9108</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ApoE-mimetic peptide</Keyword><Keyword MajorTopicYN="N">apolipoprotein E</Keyword><Keyword MajorTopicYN="N">isoproterenol-induced MI</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">oxidized phospholipid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2026</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>5</Hour><Minute>34</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40810163</ArticleId><ArticleId IdType="pmc">PMC12340640</ArticleId><ArticleId IdType="doi">10.1021/acsptsci.4c00759</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kim H. C.. Epidemiology of cardiovascular disease and its risk factors in Korea. Global health &amp; medicine. 2021;3(3):134&#x2013;141. doi: 10.35772/ghm.2021.01008.</Citation><ArticleIdList><ArticleId IdType="doi">10.35772/ghm.2021.01008</ArticleId><ArticleId IdType="pmc">PMC8239378</ArticleId><ArticleId IdType="pubmed">34250288</ArticleId></ArticleIdList></Reference><Reference><Citation>Salari N., Morddarvanjoghi F., Abdolmaleki A., Rasoulpoor S., Khaleghi A. A., Hezarkhani L. A., Shohaimi S., Mohammadi M.. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc. Disord. 2023;23(1):206. doi: 10.1186/s12872-023-03231-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12872-023-03231-w</ArticleId><ArticleId IdType="pmc">PMC10122825</ArticleId><ArticleId IdType="pubmed">37087452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalogeris T., Baines C. P., Krenz M., Korthuis R. J.. Cell biology of ischemia/reperfusion injury. Int. Rev. Cell Mol. Biol. 2012;298:229&#x2013;317. doi: 10.1016/B978-0-12-394309-5.00006-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-394309-5.00006-7</ArticleId><ArticleId IdType="pmc">PMC3904795</ArticleId><ArticleId IdType="pubmed">22878108</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah H., Altaf A., Salahuddin M., Ullah Jan M., Khan A.. Cardiovascular risk factors of hypertension, smoking and obesity: Emerging concerns among Pathan and Persian young adults? Med. J. Islam. Repub. Iran. 2018;32:760&#x2013;764. doi: 10.14196/mjiri.32.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.14196/mjiri.32.129</ArticleId><ArticleId IdType="pmc">PMC6387808</ArticleId><ArticleId IdType="pubmed">30815424</ArticleId></ArticleIdList></Reference><Reference><Citation>Elahimanesh M., Shokri N., Mahdinia E., Mohammadi P., Parvaz N., Najafi M.. Differential gene expression patterns in ST-elevation Myocardial Infarction and Non-ST-elevation Myocardial Infarction. Sci. Rep. 2024;14(1):3424. doi: 10.1038/s41598-024-54086-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-54086-w</ArticleId><ArticleId IdType="pmc">PMC10858964</ArticleId><ArticleId IdType="pubmed">38341440</ArticleId></ArticleIdList></Reference><Reference><Citation>Buja L. M.. Pathobiology of Myocardial Ischemia and Reperfusion Injury: Models, Modes, Molecular Mechanisms, Modulation, and Clinical Applications. Cardiol. Rev. 2023;31(5):252&#x2013;264. doi: 10.1097/CRD.0000000000000440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CRD.0000000000000440</ArticleId><ArticleId IdType="pmc">PMC10399947</ArticleId><ArticleId IdType="pubmed">35175958</ArticleId></ArticleIdList></Reference><Reference><Citation>Heusch G.. Myocardial ischemia/reperfusion: Translational pathophysiology of ischemic heart disease. Med. 2024;5(1):10&#x2013;31. doi: 10.1016/j.medj.2023.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2023.12.007</ArticleId><ArticleId IdType="pubmed">38218174</ArticleId></ArticleIdList></Reference><Reference><Citation>Heusch G., Gersh B. J.. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur. Heart J. 2017;38(11):774&#x2013;784. doi: 10.1093/eurheartj/ehw224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw224</ArticleId><ArticleId IdType="pubmed">27354052</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbate A., Bussani R., Amin M. S., Vetrovec G. W., Baldi A.. Acute myocardial infarction and heart failure: Role of apoptosis. Int. J. Biochem. Cell Biol. 2006;38(11):1834&#x2013;1840. doi: 10.1016/j.biocel.2006.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2006.04.010</ArticleId><ArticleId IdType="pubmed">16781883</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang M., Lu Y., Xin L., Gao J., Shang C., Jiang Z., Lin H., Fang X., Qu Y., Wang Y., Shen Z., Zhao M., Cui X.. Role of Oxidative Stress in Reperfusion following Myocardial Ischemia and Its Treatments. Oxid. Med. Cell. Longevity. 2021;2021:6614009. doi: 10.1155/2021/6614009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6614009</ArticleId><ArticleId IdType="pmc">PMC8149218</ArticleId><ArticleId IdType="pubmed">34055195</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B., Wang L., Guo W., Chen S., Ma Y., Wang D.. New treatment methods for myocardial infarction. Front. Cardiovasc. Med. 2023;10:1251669. doi: 10.3389/fcvm.2023.1251669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1251669</ArticleId><ArticleId IdType="pmc">PMC10569499</ArticleId><ArticleId IdType="pubmed">37840964</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Shao C., Han C., Li P., Wang F., Wang Y., Li J.. Correlation of ApoE gene polymorphism with acute myocardial infarction and aspirin resistance after percutaneous coronary intervention. Am. J. Transl. Res. 2022;14(5):3303&#x2013;3310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9185036</ArticleId><ArticleId IdType="pubmed">35702102</ArticleId></ArticleIdList></Reference><Reference><Citation>Jofre-Monseny L., Minihane A. M., Rimbach G.. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Mol. Nutr. Food Res. 2008;52(1):131&#x2013;145. doi: 10.1002/mnfr.200700322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200700322</ArticleId><ArticleId IdType="pubmed">18203129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S., Pande A. H., Sharma S. S.. Therapeutic potential of ApoE-mimetic peptides in CNS disorders: Current perspective. Exp. Neurol. 2022;353:114051. doi: 10.1016/j.expneurol.2022.114051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2022.114051</ArticleId><ArticleId IdType="pubmed">35314147</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H., Xue H., Wang H., Ma Y., Liu J., Chen Y.. The association of apolipoprotein E (APOE) gene polymorphisms with atherosclerosis susceptibility: a meta-analysis. Minerva Cardioangiol. 2016;64(1):47&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">26005211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolska A., Reimund M., Sviridov D. O., Amar M. J., Remaley A. T.. Apolipoprotein Mimetic Peptides: Potential New Therapies for Cardiovascular Diseases. Cells. 2021;10(3):597. doi: 10.3390/cells10030597.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030597</ArticleId><ArticleId IdType="pmc">PMC8000854</ArticleId><ArticleId IdType="pubmed">33800446</ArticleId></ArticleIdList></Reference><Reference><Citation>Nankar S. A., Ahmed S., Sharma S. S., Pande A. H.. Apolipoprotein-mimetic Peptides: Current and Future Prospectives. Curr. Protein Pept. Sci. 2022;23(11):757&#x2013;772. doi: 10.2174/1389203723666221003122624.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1389203723666221003122624</ArticleId><ArticleId IdType="pubmed">36200201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S., Rihan M., Ahmed S., Pande A. H., Sharma S. S.. Immunomodulatory potential of apolipoproteins and their mimetic peptides in asthma: Current perspective. Respir Med. 2022;204:107007. doi: 10.1016/j.rmed.2022.107007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.107007</ArticleId><ArticleId IdType="pubmed">36265420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S., Tripathy R. K., Pande A. H., Sharma S. S.. Neuroprotective potential of ApoE-mimetic peptide (ApoEFrag) in stroke models: Neurobehavioural and mechanistic study. Int. J. Biol. Macromol. 2025;304:140790. doi: 10.1016/j.ijbiomac.2025.140790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2025.140790</ArticleId><ArticleId IdType="pubmed">39924027</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., Brody D. L.. Administration of COG1410 Reduces Axonal Amyloid Precursor Protein Immunoreactivity and Microglial Activation after Controlled Cortical Impact in Mice. J. Neurotrauma. 2012;29(13):2332&#x2013;2341. doi: 10.1089/neu.2012.2362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2012.2362</ArticleId><ArticleId IdType="pmc">PMC3430478</ArticleId><ArticleId IdType="pubmed">22676717</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Q., Song H., Xu J., Huang J., Hu M., Gu X., Chen J., Zheng G., Chen H., Gao X.. Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood&#x2013;Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery. Mol. Pharmaceutics. 2016;13(11):3976&#x2013;3987. doi: 10.1021/acs.molpharmaceut.6b00781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.molpharmaceut.6b00781</ArticleId><ArticleId IdType="pubmed">27700119</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskowitz D. T., Lei B., Dawson H. N., Wang H., Bellows S. T., Christensen D. J., Vitek M. P., James M. L.. The apoE-mimetic Peptide, COG1410, Improves Functional Recovery in a Murine Model of Intracerebral Hemorrhage. Neurocritical care. 2012;16(2):316&#x2013;326. doi: 10.1007/s12028-011-9641-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12028-011-9641-5</ArticleId><ArticleId IdType="pubmed">21989844</ArticleId></ArticleIdList></Reference><Reference><Citation>Rihan M., Sharma S. S.. Cardioprotective potential of compound 3K, a selective PKM2 inhibitor in isoproterenol-induced acute myocardial infarction: A mechanistic study. Toxicol. Appl. Pharmacol. 2024;485:116905. doi: 10.1016/j.taap.2024.116905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2024.116905</ArticleId><ArticleId IdType="pubmed">38521371</ArticleId></ArticleIdList></Reference><Reference><Citation>Rihan M., Sharma S. S.. Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis. Naunyn-Schmiedeberg&#x2019;s Archives of Pharmacology. 2024;397(1):145&#x2013;159. doi: 10.1007/s00210-023-02593-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-023-02593-4</ArticleId><ArticleId IdType="pubmed">37382601</ArticleId></ArticleIdList></Reference><Reference><Citation>Boarescu P. M., Chirila I., Bulboaca A. E., Bocsan I. C., Pop R. M., Gheban D., Bolboaca S. D.. Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction. Oxid. Med. Cell. Longevity. 2019;2019(1):7847142. doi: 10.1155/2019/7847142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7847142</ArticleId><ArticleId IdType="pmc">PMC6530192</ArticleId><ArticleId IdType="pubmed">31205590</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagadeesh G. S., Nagoor Meeran M. F., Selvaraj P.. Protective Effects of 7-Hydroxycoumarin on Dyslipidemia and Cardiac Hypertrophy in Isoproterenol-Induced Myocardial Infarction in Rats. J. Biochem. Mol. Toxicol. 2016;30(3):120&#x2013;127. doi: 10.1002/jbt.21770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbt.21770</ArticleId><ArticleId IdType="pubmed">26995004</ArticleId></ArticleIdList></Reference><Reference><Citation>Rihan M., Sharma S. S.. Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis. Naunyn Schmiedebergs Arch Pharmacol. 2024;397(1):145&#x2013;159. doi: 10.1007/s00210-023-02593-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-023-02593-4</ArticleId><ArticleId IdType="pubmed">37382601</ArticleId></ArticleIdList></Reference><Reference><Citation>Subin J., Kim J. H., Yim C., Lee M., Kang H., Choi D.. Therapeutic effects of a mesenchymal stem cell-based insulin-like growth factor-1/enhanced green fluorescent protein dual gene sorting system in a myocardial infarction rat model. Mol. Med. Rep. 2018;18:5563&#x2013;5571. doi: 10.3892/mmr.2018.9561.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2018.9561</ArticleId><ArticleId IdType="pmc">PMC6236284</ArticleId><ArticleId IdType="pubmed">30365087</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaidya B., Roy I., Sharma S. S.. Neuroprotective Potential of HC070, a Potent TRPC5 Channel Inhibitor in Parkinson&#x2019;s Disease Models: A Behavioral and Mechanistic Study. ACS Chem. Neurosci. 2022;13(18):2728&#x2013;2742. doi: 10.1021/acschemneuro.2c00403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.2c00403</ArticleId><ArticleId IdType="pubmed">36094343</ArticleId></ArticleIdList></Reference><Reference><Citation>Punithavathi V. R., Prince P. S. M.. Pretreatment with a combination of quercetin and &#x3b1;-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats. Life Sci. 2010;86(5):178&#x2013;184. doi: 10.1016/j.lfs.2009.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2009.11.021</ArticleId><ArticleId IdType="pubmed">19958779</ArticleId></ArticleIdList></Reference><Reference><Citation>Bains M., Kaur J., Akhtar A., Kuhad A., Sah S. P.. Anti-inflammatory effects of ellagic acid and vanillic acid against quinolinic acid-induced rat model of Huntington&#x2019;s disease by targeting IKK-NF-&#x3ba;B pathway. Eur. J. Pharmacol. 2022;934:175316. doi: 10.1016/j.ejphar.2022.175316.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2022.175316</ArticleId><ArticleId IdType="pubmed">36209926</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubattu S., Di Castro S., Schulz H., Geurts A. M., Cotugno M., Bianchi F., Maatz H., Hummel O., Falak S., Stanzione R., Marchitti S., Scarpino S., Giusti B., Kura A., Gensini G. F., Peyvandi F., Mannucci P. M., Rasura M., Sciarretta S., Dwinell M. R., Hubner N., Volpe M.. Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human Disease. J. Am. Heart Assoc. 2016;5(2):e002701. doi: 10.1161/JAHA.115.002701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.115.002701</ArticleId><ArticleId IdType="pmc">PMC4802485</ArticleId><ArticleId IdType="pubmed">26888427</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Geng Q., Yao H., Shen Z., Wu Z., Miao X., Shi P.. Protective effect of scutellarin on myocardial infarction induced by isoprenaline in rats. Iran. J. Basic Med. Sci. 2018;21(3):267&#x2013;276. doi: 10.22038/ijbms.2018.26110.6415.</Citation><ArticleIdList><ArticleId IdType="doi">10.22038/ijbms.2018.26110.6415</ArticleId><ArticleId IdType="pmc">PMC5817170</ArticleId><ArticleId IdType="pubmed">29511493</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves M. S. S., Silva E. A. P., Santos D. M., Santana I. R., Souza D. S., Araujo A. M., Heimfarth L., Vasconcelos C. M. L., Santos V. C. O., Santos M. R. V., de S S Barreto R., Quintans J&#xfa;nior L. J., Barreto A. S.. Nerolidol attenuates isoproterenol-induced acute myocardial infarction in rats. Naunyn Schmiedebergs Arch Pharmacol. 2022;395(3):353&#x2013;363. doi: 10.1007/s00210-022-02202-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-022-02202-w</ArticleId><ArticleId IdType="pubmed">35050389</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis N. G.. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 2014;11(5):255&#x2013;265. doi: 10.1038/nrcardio.2014.28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2014.28</ArticleId><ArticleId IdType="pmc">PMC4407144</ArticleId><ArticleId IdType="pubmed">24663091</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsis A., Kadoglou N. P. E., Lambadiari V., Alexiou S., Theodoropoulos K. C., Avraamides P., Kassimis G.. Prognostic role of inflammatory cytokines and novel adipokines in acute myocardial infarction: An updated and comprehensive review. Cytokine. 2022;153:155848. doi: 10.1016/j.cyto.2022.155848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.155848</ArticleId><ArticleId IdType="pubmed">35301174</ArticleId></ArticleIdList></Reference><Reference><Citation>Kibel A., Lukinac A. M., Dambic V., Juric I., Selthofer-Relatic K.. Oxidative Stress in Ischemic Heart Disease. Oxid. Med. Cell. Longevity. 2020;2020:1&#x2013;30. doi: 10.1155/2020/6627144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6627144</ArticleId><ArticleId IdType="pmc">PMC7785350</ArticleId><ArticleId IdType="pubmed">33456670</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak P. P., Firestein G. S.. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001;107(1):7&#x2013;11. doi: 10.1172/JCI11830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI11830</ArticleId><ArticleId IdType="pmc">PMC198552</ArticleId><ArticleId IdType="pubmed">11134171</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiordelisi A., Iaccarino G., Morisco C., Coscioni E., Sorriento D.. NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases. Int. J. Mol. Sci. 2019;20(7):1599. doi: 10.3390/ijms20071599.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20071599</ArticleId><ArticleId IdType="pmc">PMC6480579</ArticleId><ArticleId IdType="pubmed">30935055</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelzaher W. Y., Ahmed S. M., Welson N. N., Alsharif K. F., Batiha G. E., Labib D. A. A.. Dapsone Ameliorates Isoproterenol-Induced Myocardial Infarction via Nrf2/HO-1; TLR4/TNF-&#x3b1; Signaling Pathways and the Suppression of Oxidative Stress, Inflammation, and Apoptosis in Rats. Front. Pharmacol. 2021;12:669679. doi: 10.3389/fphar.2021.669679.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.669679</ArticleId><ArticleId IdType="pmc">PMC8170324</ArticleId><ArticleId IdType="pubmed">34093197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli C., Chio I. I. C., Tuveson D. A.. Transcriptional Regulation by Nrf2. Antioxid. Redox Signaling. 2018;29(17):1727&#x2013;1745. doi: 10.1089/ars.2017.7342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7342</ArticleId><ArticleId IdType="pmc">PMC6208165</ArticleId><ArticleId IdType="pubmed">28899199</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuberi S., Rafi H., Hussain A., Hashmi S.. Upregulation of Nrf2 in myocardial infarction and ischemia-reperfusion injury of the heart. PloS one. 2024;19(3):e0299503. doi: 10.1371/journal.pone.0299503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0299503</ArticleId><ArticleId IdType="pmc">PMC10942075</ArticleId><ArticleId IdType="pubmed">38489253</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli C., Chio I. I. C., Tuveson D. A.. Transcriptional Regulation by Nrf2. Antioxid. Redox Signaling. 2018;29(17):1727&#x2013;1745. doi: 10.1089/ars.2017.7342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7342</ArticleId><ArticleId IdType="pmc">PMC6208165</ArticleId><ArticleId IdType="pubmed">28899199</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadat S., Noureddini M., Mahjoubin-Tehran M., Nazemi S., Shojaie L., Aschner M., Maleki B., Abbasi-Kolli M., Rajabi Moghadam H., Alani B., Mirzaei H.. Pivotal Role of TGF-&#x3b2;/Smad Signaling in Cardiac Fibrosis: Non-coding RNAs as Effectual Players. Front. Cardiovasc. Med. 2021;7:588347. doi: 10.3389/fcvm.2020.588347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.588347</ArticleId><ArticleId IdType="pmc">PMC7868343</ArticleId><ArticleId IdType="pubmed">33569393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyuna L. A., Albuquerque R. P. E., Chen C.-H., Mochly-Rosen D., Ferreira J. C. B.. Targeting mitochondrial dysfunction and oxidative stress in heart failure: Challenges and opportunities. Free Radical Biol. Med. 2018;129:155&#x2013;168. doi: 10.1016/j.freeradbiomed.2018.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.09.019</ArticleId><ArticleId IdType="pmc">PMC6309415</ArticleId><ArticleId IdType="pubmed">30227272</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Zhao H., Li Y.. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduction Targeted Ther. 2023;8(1):333. doi: 10.1038/s41392-023-01547-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01547-9</ArticleId><ArticleId IdType="pmc">PMC10480456</ArticleId><ArticleId IdType="pubmed">37669960</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y., Tian Y., Jiang H., Cai L. Y., Song J., Peng R., Zhang X. M.. Mechanism of PGC-1alpha-mediated mitochondrial biogenesis in cerebral ischemia-reperfusion injury. Front. Mol. Neurosci. 2023;16:1224964. doi: 10.3389/fnmol.2023.1224964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2023.1224964</ArticleId><ArticleId IdType="pmc">PMC10363604</ArticleId><ArticleId IdType="pubmed">37492523</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth C., Brandt U., Hunte C., Zickermann V.. Structure and function of mitochondrial complex I. Biochim. Biophys. Acta, Bioenerg. 2016;1857(7):902&#x2013;914. doi: 10.1016/j.bbabio.2016.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2016.02.013</ArticleId><ArticleId IdType="pubmed">26921811</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40809899</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Transcatheter closure of perimembranous ventricular septal defects in elderly patients and risk factors of postoperative arrhythmias.</ArticleTitle><Pagination><StartPage>1580711</StartPage><MedlinePgn>1580711</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1580711</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2025.1580711</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The mid- and long-term safety and efficacy of perimembranous ventricular septal defect (pmVSD) closure and the risk factors of postoperative arrhythmias in elderly patients were not known.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">From January 2009 to June 2023, 59 pmVSD elderly patients aged over 60 years were treated through transcatheter intervention. The results and complications of the closure were evaluated by electrocardiography (ECG) and transthoracic echocardiography (TTE) immediately and 1 day after the procedure. TTE was done 1, 3, 6, 12&#x2005;m, and as a follow up annually.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Interventional closure was successful in all 59 patients. The immediate residual shunt rate was 18.6%. Postoperative arrhythmias occurred in 37 patients (62.7%, 37/59), including severe complications of complete atrioventricular block (cAVB) and implantation of permanent pacemakers in 2 patients (3.4%, 2/59). During the follow-up period, 2 deaths were recorded (due to lung cancer and acute myocardial infarction), and there were no serious complications, such as infective endocarditis, occluder embolism or valve regurgitation requiring surgical treatment. Older age (<i>P</i>&#x2009;=&#x2009;0.006, OR&#x2009;=&#x2009;1.723, 95% CI: 1.613-1.845) and the occluder size ratio (<i>d</i>-value of ventricular septal defect, dVSD/Body Surface Area, BSA) (<i>P</i>&#x2009;=&#x2009;0.002, OR&#x2009;=&#x2009;1.231, 95% CI: 1.182-1.283) were found to be independent risk factors for a high incidence of arrhythmias after occlusion.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Elderly patients with pmVSD aged over 60 years have a great risk of arrhythmias after transcatheter closure. Older age and the occluder size ratio are associated with short-term postoperative arrhythmias.</AbstractText><CopyrightInformation>&#xa9; 2025 Wang, Zhu, Geng and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianming</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Xianyang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Jingsong</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiguang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Congenital Heart Disease, General Hospital of Northern Theater Command, Shenyang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">arrhythmias</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">perimembranous ventricular septal defect</Keyword><Keyword MajorTopicYN="N">septal occluder device</Keyword><Keyword MajorTopicYN="N">transcatheter closure</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>14</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40809899</ArticleId><ArticleId IdType="pmc">PMC12343494</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2025.1580711</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rao PS. Diagnosis and management of ventricular septal defects. Rev Cardiovasc Med. (2024) 25:411. 10.31083/j.rcm2511411</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.rcm2511411</ArticleId><ArticleId IdType="pmc">PMC11607469</ArticleId><ArticleId IdType="pubmed">39618865</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J. Percutaneous transcatheter closure of congenital ventricular septal defects. Korean Circ J. (2023) 53:134&#x2013;50. 10.4070/kcj.2022.0336</Citation><ArticleIdList><ArticleId IdType="doi">10.4070/kcj.2022.0336</ArticleId><ArticleId IdType="pmc">PMC10011220</ArticleId><ArticleId IdType="pubmed">36914603</ArticleId></ArticleIdList></Reference><Reference><Citation>Santhanam H, Yang L, Chen Z, Tai BC, Rajgor DD, Quek SC. A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect. Int J Cardiol. (2018) 254:75&#x2013;83. 10.1016/j.ijcard.2017.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.12.011</ArticleId><ArticleId IdType="pubmed">29273241</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha M, Promphan W, Layangool T, Roymanee S, Wongwaitaweewong K, Prachasilchai P, et al. Feasibility and 1-year outcome of transcatheter closure of perimembranous ventricular septal defects with different devices. Catheter Cardiovasc Interv. (2019) 93:E30&#x2013;7. 10.1002/ccd.27851</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.27851</ArticleId><ArticleId IdType="pubmed">30269417</ArticleId></ArticleIdList></Reference><Reference><Citation>Maagaard M, Eckerstrom F, Boutrup N, Hjortdal VE. Functional capacity past age 40 in patients with congenital ventricular septal defects. J Am Heart Assoc. (2020) 9:e015956. 10.1161/JAHA.120.015956</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.015956</ArticleId><ArticleId IdType="pmc">PMC7792429</ArticleId><ArticleId IdType="pubmed">32962479</ArticleId></ArticleIdList></Reference><Reference><Citation>Maagaard M, Eckerstrom F, Hjortdal VE. Cardiac arrhythmias and impaired heart rate variability in older patients with ventricular septal defects. J Am Heart Assoc. (2021) 10:e020672. 10.1161/JAHA.120.020672</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.020672</ArticleId><ArticleId IdType="pmc">PMC8649231</ArticleId><ArticleId IdType="pubmed">34465126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zuo J, Yu S, Yi D, Yang X, Zhu X, et al. Effectiveness and safety of transcatheter closure of perimembranous ventricular septal defects in adults. Am J Cardiol. (2016) 117:980&#x2013;7. 10.1016/j.amjcard.2015.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2015.12.036</ArticleId><ArticleId IdType="pubmed">26796197</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao LJ, Han B, Zhang JJ, Yi YC, Jiang DD, Lyu JL. Transcatheter closure of congenital perimembranous ventricular septal defect using the amplatzer duct occluder 2. Cardiol Young. (2018) 28:447&#x2013;53. 10.1017/S1047951117002396</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951117002396</ArticleId><ArticleId IdType="pubmed">29233213</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y, Chen J, Zhao X, Liao D, Mu R, Wang S, et al. Transcatheter closure of perimembranous ventricular septal defect using a modified double-disk occluder. Am J Cardiol. (2008) 101:1781&#x2013;6. 10.1016/j.amjcard.2008.02.069</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2008.02.069</ArticleId><ArticleId IdType="pubmed">18549859</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Cao S, Li J, Yang L, Liu Y, Ren J, et al. Transcatheter closure of congenital perimembranous ventricular septal defect in children using symmetric occluders: an 8-year multiinstitutional experience. Ann Thorac Surg. (2012) 94:592&#x2013;8. 10.1016/j.athoracsur.2012.03.067</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2012.03.067</ArticleId><ArticleId IdType="pubmed">22626754</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Yang L, Wan Y, Zuo J, Zhang J, Chen W, et al. Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes. Eur Heart J. (2010) 31:2238&#x2013;45. 10.1093/eurheartj/ehq240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehq240</ArticleId><ArticleId IdType="pmc">PMC2938468</ArticleId><ArticleId IdType="pubmed">20801925</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Yang L, Yu S, Liu J, Zuo J, Chen W, et al. Transcatheter versus surgical closure of perimembranous ventricular septal defects in children: a randomized controlled trial. J Am Coll Cardiol. (2014) 63:1159&#x2013;68. 10.1016/j.jacc.2014.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2014.01.008</ArticleId><ArticleId IdType="pubmed">24509270</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert S. Current and new perspectives for interventional closure of ventricular septal defect. Kardiol Pol. (2021) 79:378&#x2013;9. 10.33963/KP.15950</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/KP.15950</ArticleId><ArticleId IdType="pubmed">33896159</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CA, Wang JK, Lin MT, Chiu HH, Hsu JY, Lin SM, et al. Exercise capacity and ventricular remodeling after transcatheter ventricular septal defect closure in asymptomatic or minimally symptomatic adolescents and adults. Circ Cardiovasc Interv. (2020) 13:e008813. 10.1161/CIRCINTERVENTIONS.119.008813</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.119.008813</ArticleId><ArticleId IdType="pubmed">32519889</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. (2021) 42:563&#x2013;645. 10.1093/eurheartj/ehaa554</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa554</ArticleId><ArticleId IdType="pubmed">32860028</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz C, Bennink G. Surgical closure of ventricular septal defects in small children in 2021: is it still the preferred therapeutical option? Eur J Cardiothorac Surg. (2021) 60:552&#x2013;3. 10.1093/ejcts/ezab188</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezab188</ArticleId><ArticleId IdType="pubmed">33895834</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian C, Ma J, Wang J, Xu G, Jiang J, Yao S, et al. Perimembranous ventricular septal defect with aneurysm: two options for transcatheter closure. Tex Heart Inst J. (2011) 38:528&#x2013;32. 10.1016/j.recesp.2011.06.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recesp.2011.06.005</ArticleId><ArticleId IdType="pmc">PMC3231530</ArticleId><ArticleId IdType="pubmed">22163127</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D, Zhang Y, Yi Y, Zhao L, Lv J, Wang J, et al. Procedural efficiencies and clinical outcomes for transcatheter device closure of perimembranous ventricular septal defects with different waist-length occluders. Circ J. (2024) 88:1372&#x2013;9. 10.1253/circj.CJ-23-0583</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-23-0583</ArticleId><ArticleId IdType="pubmed">38296536</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad RN, Saliba ZS. Comparative outcomes of two competitive devices for retrograde closure of perimembranous ventricular septal defects. Front Cardiovasc Med. (2023) 10:1215397. 10.3389/fcvm.2023.1215397</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1215397</ArticleId><ArticleId IdType="pmc">PMC10354815</ArticleId><ArticleId IdType="pubmed">37476569</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialkowski J, Szkutnik M. Complete atrioventricular block after transcatheter closure of perimembranous ventricular septal defect: a few comments based on our own experience. Kardiol Pol. (2021) 79:484&#x2013;5. 10.33963/KP.15953</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/KP.15953</ArticleId><ArticleId IdType="pubmed">33896162</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahanavaz S, Winlaw DS, Opotowsky AR. What is blocking transcatheter ventricular septal defect closure? J Am Heart Assoc. (2022) 11:e024963. 10.1161/JAHA.122.024963</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.122.024963</ArticleId><ArticleId IdType="pmc">PMC9075486</ArticleId><ArticleId IdType="pubmed">35352574</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T. Characteristics of the device and conduction disturbances in transcatheter device closure of perimembranous ventricular septal defects. Circ J. (2024) 88:1380&#x2013;2. 10.1253/circj.CJ-24-0272</Citation><ArticleIdList><ArticleId IdType="doi">10.1253/circj.CJ-24-0272</ArticleId><ArticleId IdType="pubmed">38735700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood KP, Fleming GA, Chamberlain RC. Update on transcatheter device closure of congenital septal defects. Curr Cardiol Rep. (2023) 25:1083&#x2013;93. 10.1007/s11886-023-01925-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-023-01925-3</ArticleId><ArticleId IdType="pubmed">37523002</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad RN, Houeijeh A, Odemis E, Thambo JB, Saritas T, Ece I, et al. MIOS-MFO, a multicenter international observational study of the lifetech KONAR-MF ventricular septal defect occluder in treating perimembranous ventricular septal defects. Rev Esp Cardiol. (2025):1&#x2013;10. 10.1016/j.rec.2025.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2025.02.010</ArticleId><ArticleId IdType="pubmed">40058523</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, Meng Y, Sun H, Liu X, Han B. Application of machine learning in predicting postoperative arrhythmia following transcatheter closure of perimembranous ventricular septal defects. Kardiol Pol. (2025) 83:295&#x2013;304. 10.33963/v.phj.103535</Citation><ArticleIdList><ArticleId IdType="doi">10.33963/v.phj.103535</ArticleId><ArticleId IdType="pubmed">39743914</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40832996</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1532-2092</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology</Title><ISOAbbreviation>Europace</ISOAbbreviation></Journal><ArticleTitle>Different underlying aetiologies in patients presenting with ventricular tachycardia fulfilling task force criteria for arrhythmogenic right ventricular cardiomyopathy: initial suspicion based on the 12-lead electrocardiogram.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">euaf136</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/europace/euaf136</ELocationID><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The task force criteria (TFC) for arrhythmogenic right ventricular cardiomyopathy (ARVC) are highly sensitive but lack specificity. Atypical RV involvement (aRVi) may indicate different underlying aetiologies and prognosis, requiring specific therapeutic interventions. We aimed to evaluate the role of the baseline 12-lead ECG for initial suspicion of aRVi.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From the Netherlands Heart Institute Arrhythmogenic Cardiomyopathy (NHI-ACM) registry, patients were selected who (i) fulfilled TFC for definite ARVC, (ii) presented with sustained ventricular tachycardia (VT), and (iii) underwent genetic testing. The first available ECG after VT was evaluated. PR prolongation &#x2265;220&#x2005;ms and/or a surface area of the maximum R'-wave in V1-V3 of &#x2265;1.65&#x2005;mm2 was defined as an aRVi-ECG. Patients with an ARVC-related pathogenic/likely pathogenic variant (P/LP+) were classified as 'ARVC'. Data of P/LP- were reviewed by an expert panel and classified as either 'ARVC' or 'different aetiology' based on consensus.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 159 patients were included (122 P/LP+ and 37 P/LP- patients). Nineteen patients had an aRVi-ECG [11 (9%) P/LP+ vs. 8 (22%) P/LP-, P = 0.038]. Of the P/LP- patients, 17 (46%) were classified as 'different aetiology' (e.g. myocarditis, ischaemia, sarcoidosis), including all 8 patients with an aRVi-ECG. Among the P/LP+ patients with an aRVi-ECG, 46% carried the p.Arg14del phospholamban pathogenic variant, and 64% died compared to 15 and 19% of P/LP+ patients without an aRVi-ECG, respectively (both P &lt; 0.01).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In P/LP- patients presenting with VT and fulfilling TFC, an aRVi-ECG should raise suspicion for a different underlying aetiology. In P/LP+ patients, an aRVi-ECG may identify those with poor outcome.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hoogendoorn</LastName><ForeName>Jarieke C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-8090-2447</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Willem Einthoven Center for Cardiac Arrhythmia Research and Management (WECAM), Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosman</LastName><ForeName>Laurens P</ForeName><Initials>LP</Initials><Identifier Source="ORCID">0000-0001-5037-1158</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Heijden</LastName><ForeName>Jeroen F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Haga Ziekenhuis, Den Haag, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilde</LastName><ForeName>Arthur A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-0528-0852</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Heart Centre, Amsterdam UMC Location University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart ).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Maarten P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0002-1493-2998</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yap</LastName><ForeName>Sing-Chien</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0003-4520-2725</Identifier><AffiliationInfo><Affiliation>European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart ).</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Thorax Center, Cardiovascular Institute, Erasmus Medical Center, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Tintelen</LastName><ForeName>J Peter</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0003-3854-6749</Identifier><AffiliationInfo><Affiliation>Department of Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dooijes</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-0312-5354</Identifier><AffiliationInfo><Affiliation>Department of Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Te Riele</LastName><ForeName>Anneline S J M</ForeName><Initials>ASJM</Initials><Identifier Source="ORCID">0000-0002-4694-4790</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart (ERN GUARD-Heart ).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeppenfeld</LastName><ForeName>Katja</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7034-1017</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Willem Einthoven Center for Cardiac Arrhythmia Research and Management (WECAM), Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Edwards Lifesciences</Agency><Country/></Grant><Grant><Agency>Biotronik</Agency><Country/></Grant><Grant><Agency>Medtronic</Agency><Country/></Grant><Grant><Agency>Boston Scientific</Agency><Country/></Grant><Grant><Agency>Biosense Webster</Agency><Country/></Grant><Grant><Acronym>ZONMW_</Acronym><Agency>ZonMw</Agency><Country>Netherlands</Country></Grant><Grant><GrantID>#101115536</GrantID><Agency>Horizon IMPACT</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Europace</MedlineTA><NlmUniqueID>100883649</NlmUniqueID><ISSNLinking>1099-5129</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019571" MajorTopicYN="Y">Arrhythmogenic Right Ventricular Dysplasia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017180" MajorTopicYN="Y">Tachycardia, Ventricular</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="N">Heart Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmogenic right ventricular cardiomyopathy</Keyword><Keyword MajorTopicYN="N">Cardiac sarcoidosis</Keyword><Keyword MajorTopicYN="N">Electrocardiogram</Keyword><Keyword MajorTopicYN="N">Ventricular tachycardia</Keyword></KeywordList><CoiStatement>Conflict of interest: A.A.W.: member of the scientific advisory board of Thryv Therapeutics and ARMGO. S.-C.Y. has received honoraria from Boston Scientific, Medtronic, Biotronik, Acutus Medical, and Sanofi. In addition, he has received research grants from Medtronic, Biotronik, and Boston Scientific. A.S.J.M.T.R. is a consultant for Tenaya Therapeutics, BioMarin, and Rocket Pharmaceuticals outside of the scope of the submitted work. All remaining authors have declared no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>12</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>7</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40832996</ArticleId><ArticleId IdType="pmc">PMC12365759</ArticleId><ArticleId IdType="doi">10.1093/europace/euaf136</ArticleId><ArticleId IdType="pii">8238475</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Basso &#xa0;C, Corrado &#xa0;D, Marcus &#xa0;FI, Nava &#xa0;A, Thiene &#xa0;G. Arrhythmogenic right ventricular cardiomyopathy. Lancet &#xa0;2009;373:1289&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">19362677</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus &#xa0;FI, McKenna &#xa0;WJ, Sherrill &#xa0;D, Basso &#xa0;C, Bauce &#xa0;B, Bluemke &#xa0;DA &#xa0;et al. &#xa0;Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation &#xa0;2010;121:1533&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860804</ArticleId><ArticleId IdType="pubmed">20172911</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeneweg &#xa0;JA, Bhonsale &#xa0;A, James &#xa0;CA, te Riele &#xa0;AS, Dooijes &#xa0;D, Tichnell &#xa0;C &#xa0;et al. &#xa0;Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members. Circ Cardiovasc Genet &#xa0;2015;8:437&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">25820315</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado &#xa0;D, van Tintelen &#xa0;PJ, McKenna &#xa0;WJ, Hauer &#xa0;RNW, Anastastakis &#xa0;A, Asimaki &#xa0;A &#xa0;et al. &#xa0;Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis. Eur Heart J &#xa0;2020;41:1414&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138528</ArticleId><ArticleId IdType="pubmed">31637441</ArticleId></ArticleIdList></Reference><Reference><Citation>Venlet &#xa0;J, Piers &#xa0;SR, Jongbloed &#xa0;JD, Androulakis &#xa0;AF, Naruse &#xa0;Y, den Uijl &#xa0;DW &#xa0;et al. &#xa0;Isolated subepicardial right ventricular outflow tract scar in athletes with ventricular tachycardia. J Am Coll Cardiol &#xa0;2017;69:497&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pubmed">28153106</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips &#xa0;B, Madhavan &#xa0;S, James &#xa0;CA, te Riele &#xa0;AS, Murray &#xa0;B, Tichnell &#xa0;C &#xa0;et al. &#xa0;Arrhythmogenic right ventricular dysplasia/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear. Circ Arrhythm Electrophysiol &#xa0;2014;7:230&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24585727</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogendoorn &#xa0;JC, Ninaber &#xa0;MK, Piers &#xa0;SRD, de Riva &#xa0;M, Grauss &#xa0;RW, Bogun &#xa0;FM &#xa0;et al. &#xa0;The harm of delayed diagnosis of arrhythmogenic cardiac sarcoidosis: a case series. Europace &#xa0;2020;22:1376&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7478317</ArticleId><ArticleId IdType="pubmed">32898252</ArticleId></ArticleIdList></Reference><Reference><Citation>te Riele &#xa0;AS, James &#xa0;CA, Groeneweg &#xa0;JA, Sawant &#xa0;AC, Kammers &#xa0;K, Murray &#xa0;B &#xa0;et al. &#xa0;Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. Eur Heart J &#xa0;2016;37:755&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">26314686</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogendoorn &#xa0;JC, Venlet &#xa0;J, Out &#xa0;YNJ, Man &#xa0;S, Kumar &#xa0;S, Sramko &#xa0;M &#xa0;et al. &#xa0;The precordial R&#x2019; wave: a novel discriminator between cardiac sarcoidosis and arrhythmogenic right ventricular cardiomyopathy in patients presenting with ventricular tachycardia. Heart Rhythm &#xa0;2021;18:1539&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">33957319</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosman &#xa0;LP, Verstraelen &#xa0;TE, van Lint &#xa0;FHM, Cox &#xa0;M, Groeneweg &#xa0;JA, Mast &#xa0;TP &#xa0;et al. &#xa0;The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update. Neth Heart J &#xa0;2019;27:480&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6773794</ArticleId><ArticleId IdType="pubmed">30997596</ArticleId></ArticleIdList></Reference><Reference><Citation>James &#xa0;CA, Jongbloed &#xa0;JDH, Hershberger &#xa0;RE, Morales &#xa0;A, Judge &#xa0;DP, Syrris &#xa0;P &#xa0;et al. &#xa0;International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework. Circ Genom Precis Med &#xa0;2021;14:e003273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8205996</ArticleId><ArticleId IdType="pubmed">33831308</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards &#xa0;S, Aziz &#xa0;N, Bale &#xa0;S, Bick &#xa0;D, Das &#xa0;S, Gastier-Foster &#xa0;J &#xa0;et al. &#xa0;Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med &#xa0;2015;17:405&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Surawicz &#xa0;B, Childers &#xa0;R, Deal &#xa0;BJ, Gettes &#xa0;LS, Bailey &#xa0;JJ, Gorgels &#xa0;A &#xa0;et al. &#xa0;AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol &#xa0;2009;53:976&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">19281930</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain &#xa0;R, Dalal &#xa0;D, Daly &#xa0;A, Tichnell &#xa0;C, James &#xa0;C, Evenson &#xa0;A &#xa0;et al. &#xa0;Electrocardiographic features of arrhythmogenic right ventricular dysplasia. Circulation &#xa0;2009;120:477&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2814546</ArticleId><ArticleId IdType="pubmed">19635971</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasperetti &#xa0;A, Rossi &#xa0;VA, Chiodini &#xa0;A, Casella &#xa0;M, Costa &#xa0;S, Akdis &#xa0;D &#xa0;et al. &#xa0;Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria. Heart Rhythm &#xa0;2021;18:231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">32976989</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasaiwala &#xa0;SC, Finn &#xa0;C, Delpriore &#xa0;J, Leya &#xa0;F, Gagermeier &#xa0;J, Akar &#xa0;JG &#xa0;et al. &#xa0;Prospective study of cardiac sarcoid mimicking arrhythmogenic right ventricular dysplasia. J Cardiovasc Electrophysiol &#xa0;2009;20:473&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19017339</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechering &#xa0;DG, Kochh&#xe4;user &#xa0;S, Wasmer &#xa0;K, Zellerhoff &#xa0;S, Pott &#xa0;C, K&#xf6;be &#xa0;J &#xa0;et al. &#xa0;Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm &#xa0;2013;10:158&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">23070261</ArticleId></ArticleIdList></Reference><Reference><Citation>Youden &#xa0;WJ. Index for rating diagnostic tests. Cancer &#xa0;1950;3:32&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15405679</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus &#xa0;FI, Fontaine &#xa0;GH, Guiraudon &#xa0;G, Frank &#xa0;R, Laurenceau &#xa0;JL, Malergue &#xa0;C &#xa0;et al. &#xa0;Right ventricular dysplasia: a report of 24 adult cases. Circulation &#xa0;1982;65:384&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">7053899</ArticleId></ArticleIdList></Reference><Reference><Citation>Te Riele &#xa0;AS, James &#xa0;CA, Philips &#xa0;B, Rastegar &#xa0;N, Bhonsale &#xa0;A, Groeneweg &#xa0;JA &#xa0;et al. &#xa0;Mutation-positive arrhythmogenic right ventricular dysplasia/cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol &#xa0;2013;24:1311&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3971054</ArticleId><ArticleId IdType="pubmed">23889974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar &#xa0;S, Baldinger &#xa0;SH, Kapur &#xa0;S, Romero &#xa0;J, Mehta &#xa0;NK, Mahida &#xa0;S &#xa0;et al. &#xa0;Right ventricular scar-related ventricular tachycardia in nonischemic cardiomyopathy: electrophysiological characteristics, mapping, and ablation of underlying heart disease. J Cardiovasc Electrophysiol &#xa0;2018;29:79&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">28940781</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepehrkhouy &#xa0;S, Gho &#xa0;J, van Es &#xa0;R, Harakalova &#xa0;M, de Jonge &#xa0;N, Dooijes &#xa0;D &#xa0;et al. &#xa0;Distinct fibrosis pattern in desmosomal and phospholamban mutation carriers in hereditary cardiomyopathies. Heart Rhythm &#xa0;2017;14:1024&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">28365402</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir &#xa0;K, Bomma &#xa0;C, Tandri &#xa0;H, Roguin &#xa0;A, Dalal &#xa0;D, Prakasa &#xa0;K &#xa0;et al. &#xa0;Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation &#xa0;2004;110:1527&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">15381658</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanawuttiwat &#xa0;T, Te Riele &#xa0;AS, Philips &#xa0;B, James &#xa0;CA, Murray &#xa0;B, Tichnell &#xa0;C &#xa0;et al. &#xa0;Electroanatomic correlates of depolarization abnormalities in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Cardiovasc Electrophysiol &#xa0;2016;27:443&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">26757204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloosterman &#xa0;M, Boonstra &#xa0;MJ, Roudijk &#xa0;RW, Bourfiss &#xa0;M, van der Schaaf &#xa0;I, Velthuis &#xa0;BK &#xa0;et al. &#xa0;Body surface potential mapping detects early disease onset in plakophilin-2-pathogenic variant carriers. Europace &#xa0;2023;25:euad197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10368448</ArticleId><ArticleId IdType="pubmed">37433034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zorzi &#xa0;A, Migliore &#xa0;F, Elmaghawry &#xa0;M, Silvano &#xa0;M, Marra &#xa0;MP, Niero &#xa0;A &#xa0;et al. &#xa0;Electrocardiographic predictors of electroanatomic scar size in arrhythmogenic right ventricular cardiomyopathy: implications for arrhythmic risk stratification. J Cardiovasc Electrophysiol &#xa0;2013;24:1321&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24016194</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosman &#xa0;LP, Cadrin-Tourigny &#xa0;J, Bourfiss &#xa0;M, Aliyari Ghasabeh &#xa0;M, Sharma &#xa0;A, Tichnell &#xa0;C &#xa0;et al. &#xa0;Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: clinical performance and simplified practical implementation. Europace &#xa0;2020;22:787&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7203633</ArticleId><ArticleId IdType="pubmed">32294163</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogendoorn &#xa0;JC, Sramko &#xa0;M, Venlet &#xa0;J, Siontis &#xa0;KC, Kumar &#xa0;S, Singh &#xa0;R &#xa0;et al. &#xa0;Electroanatomical voltage mapping to distinguish right-sided cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol &#xa0;2020;6:696&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pubmed">32553221</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Leur &#xa0;RR, Taha &#xa0;K, Bos &#xa0;MN, van der Heijden &#xa0;JF, Gupta &#xa0;D, Cramer &#xa0;MJ &#xa0;et al. &#xa0;Discovering and visualizing disease-specific electrocardiogram features using deep learning: proof-of-concept in phospholamban gene mutation carriers. Circ Arrhythm Electrophysiol &#xa0;2021;14:e009056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892204</ArticleId><ArticleId IdType="pubmed">33401921</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhonsale &#xa0;A, Groeneweg &#xa0;JA, James &#xa0;CA, Dooijes &#xa0;D, Tichnell &#xa0;C, Jongbloed &#xa0;JD &#xa0;et al. &#xa0;Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. Eur Heart J &#xa0;2015;36:847&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">25616645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeppenfeld &#xa0;K, Tfelt-Hansen &#xa0;J, de Riva &#xa0;M, Winkel &#xa0;BG, Behr &#xa0;ER, Blom &#xa0;NA &#xa0;et al. &#xa0;2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J &#xa0;2022;43:3997&#x2013;4126.</Citation><ArticleIdList><ArticleId IdType="pubmed">36017572</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasperetti &#xa0;A, James &#xa0;CA, Carrick &#xa0;RT, Protonotarios &#xa0;A, Te Riele &#xa0;A, Cadrin-Tourigny &#xa0;J &#xa0;et al. &#xa0;Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy. Europace &#xa0;2023;25:euad312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10674106</ArticleId><ArticleId IdType="pubmed">37935403</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40832142</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2297-055X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in cardiovascular medicine</Title><ISOAbbreviation>Front Cardiovasc Med</ISOAbbreviation></Journal><ArticleTitle>Case Report: Takotsubo cardiomyopathy caused by acute surgical pathology against the background of colorectal cancer.</ArticleTitle><Pagination><StartPage>1586353</StartPage><MedlinePgn>1586353</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1586353</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcvm.2025.1586353</ELocationID><Abstract><AbstractText>We present a case of Takotsubo cardiomyopathy (TCM) in a young woman who has developed necrosis and perforation of the sigmoid intestine with a spontaneous opening of the abscess in the abdominal cavity, which caused purulent peritonitis. The patient underwent emergency surgical intervention. The postoperative period was complicated by a clinic of acute respiratory failure and bilateral pneumonia. In five days after surgery, the patient developed laboratory and instrumental signs of acute myocardial infarction. Changes similar to myocardial infarction appeared on electrocardiogram (ECG). Echocardiography revealed akinesis of the apical segments of the left ventricle and the ejection fraction of the left ventricle was reduced (LVEF) from 63 to 31%-35%. The level of NT-proBNP has increased significantly, but the level of troponin I increased to a lesser extent. Coronary angiography demonstrated normal arteries without any obstruction. As a result, a diagnosis Takotsubo cardiomyopathy caused by acute surgical pathology was made. In the future, the patient was discharged in a stable state. Subsequent echocardiography showed normalization of the systolic function of the left ventricle, the disappearance of ECG changes, and a decrease in the level of specific cardiomarkers.</AbstractText><CopyrightInformation>&#xa9; 2025 Potievskaya, Khoronenko, Kononova, Paderina, Fashafsha and Kaprin.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Potievskaya</LastName><ForeName>Vera</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>P. Hertsen Moscow Oncology Research Institute-Branch or the Federal State Budgetary Institution "National Medical Research Radiological Centre" of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Russian Medical Academy of Postgraduate Education of Federal Scientific and Clinical Center for Specialized Medical Assistance and Medical Technologies of the Federal Medical Biological Agency, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khoronenko</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>P. Hertsen Moscow Oncology Research Institute-Branch or the Federal State Budgetary Institution "National Medical Research Radiological Centre" of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peoples' Friendship University of Russia, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kononova</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>P. Hertsen Moscow Oncology Research Institute-Branch or the Federal State Budgetary Institution "National Medical Research Radiological Centre" of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paderina</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>P. Hertsen Moscow Oncology Research Institute-Branch or the Federal State Budgetary Institution "National Medical Research Radiological Centre" of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fashafsha</LastName><ForeName>Zaki</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>P. Hertsen Moscow Oncology Research Institute-Branch or the Federal State Budgetary Institution "National Medical Research Radiological Centre" of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Personalized Cardiology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaprin</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>P. Hertsen Moscow Oncology Research Institute-Branch or the Federal State Budgetary Institution "National Medical Research Radiological Centre" of the Ministry of Health of the Russian Federation, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peoples' Friendship University of Russia, Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cardiovasc Med</MedlineTA><NlmUniqueID>101653388</NlmUniqueID><ISSNLinking>2297-055X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Takotsubo syndrome</Keyword><Keyword MajorTopicYN="N">acute heart failure</Keyword><Keyword MajorTopicYN="N">perioperative period</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword><Keyword MajorTopicYN="N">sigmoid colon cancer</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>6</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>8</Month><Day>20</Day><Hour>5</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40832142</ArticleId><ArticleId IdType="pmc">PMC12358426</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2025.1586353</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ghadri J, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. (2018) 39:2032&#x2013;46. 10.1093/eurheartj/ehy076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy076</ArticleId><ArticleId IdType="pmc">PMC5991216</ArticleId><ArticleId IdType="pubmed">29850871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurisu S, Sato H, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, et al. Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction. Am Heart J. (2002) 143(3):448&#x2013;55. 10.1067/mhj.2002.120403</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mhj.2002.120403</ArticleId><ArticleId IdType="pubmed">11868050</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavin D, Le Breton H, Daubert C. Human stress cardiomyopathy mimicking acute myocardial syndrome. Heart. (1997) 78:509&#x2013;11. 10.1136/hrt.78.5.509</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.78.5.509</ArticleId><ArticleId IdType="pmc">PMC1892287</ArticleId><ArticleId IdType="pubmed">9415014</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey SW, Shear W, Hodges M, Herzog CA. Reversible myocardial contraction abnormalities in patients with an acute noncardiac illness. Chest. (1998) 114:98&#x2013;105. 10.1378/chest.114.1.98</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.114.1.98</ArticleId><ArticleId IdType="pubmed">9674454</ArticleId></ArticleIdList></Reference><Reference><Citation>Desmet WJ, Adriaenssens BF, Dens JA. Apical ballooning of the left ventricle: first series in white patients. Heart. (2003) 89:1027&#x2013;31. 10.1136/heart.89.9.1027</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heart.89.9.1027</ArticleId><ArticleId IdType="pmc">PMC1767823</ArticleId><ArticleId IdType="pubmed">12923018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sattar Y, Siew KSW, Connerney M, Ullah W, Alraies MC. Management of Takotsubo syndrome: a comprehensive review. Cureus. (2020) 12(1):e6556. 10.7759/cureus.6556</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.6556</ArticleId><ArticleId IdType="pmc">PMC6996473</ArticleId><ArticleId IdType="pubmed">32042529</ArticleId></ArticleIdList></Reference><Reference><Citation>Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. (2015) 373(10):929&#x2013;38. 10.1056/NEJMoa1406761</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1406761</ArticleId><ArticleId IdType="pubmed">26332547</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado GA, Truesdell AG, Kirchner RM, Zuzek RW, Pomerantsev EV, Gordon PC, et al. An angiographic and intravascular ultrasound study of the left anterior descending coronary artery in takotsubo cardiomyopathy. Am J Cardiol. (2011) 108(6):888&#x2013;91. 10.1016/j.amjcard.2011.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2011.05.012</ArticleId><ArticleId IdType="pubmed">21741604</ArticleId></ArticleIdList></Reference><Reference><Citation>Naegele M, Flammer AJ, Enseleit F, Roas S, Frank M, Hirt A, et al. Endothelial function and sympathetic nervous system activity in patients with takotsubo syndrome. Int J Cardiol. (2016) 224:226&#x2013;30. 10.1016/j.ijcard.2016.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.09.008</ArticleId><ArticleId IdType="pubmed">27661411</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider B, Athanasiadis A, St&#xf6;llberger C, Pistner W, Schwab J, Gottwald U, et al. Gender differences in the manifestation of tako-tsubo cardiomyopathy. Int J Cardiol. (2013) 166(3):584&#x2013;8. 10.1016/j.ijcard.2011.11.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.11.027</ArticleId><ArticleId IdType="pubmed">22192296</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueyama T, Kasamatsu K, Hano T, Tsuruo Y, Ishikura F. Catecholamines and estrogen are involved in the pathogenesis of emotional stress-induced acute heart attack. Ann N Y Acad Sci. (2008) 1148:479&#x2013;85. 10.1196/annals.1410.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1410.079</ArticleId><ArticleId IdType="pubmed">19120144</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorn GW, 2nd. Adrenergic signaling polymorphisms and their impact on cardiovascular disease. Physiol Rev. (2010) 90(3):1013&#x2013;62. 10.1152/physrev.00001.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00001.2010</ArticleId><ArticleId IdType="pubmed">20664078</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh ET, Bickford CL. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J Am Coll Cardiol. (2009) 53(24):2231&#x2013;47. 10.1016/j.jacc.2009.02.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.02.050</ArticleId><ArticleId IdType="pubmed">19520246</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A, Noor A, Joshi S, Kim AS. Takotsubo cardiomyopathy in cancer patients. Cardio-Oncol Lond Engl. (2019) 5:7. 10.1186/s40959-019-0042-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40959-019-0042-9</ArticleId><ArticleId IdType="pmc">PMC7048040</ArticleId><ArticleId IdType="pubmed">32154014</ArticleId></ArticleIdList></Reference><Reference><Citation>Basselin C, Fontanges T, Descotes J, Chevalier P, Bui-Xuan B, Feinard G, et al. 5-fluorouracil-induced Tako-Tsubo-like syndrome. Pharmacotherapy. (2011) 31(2):226. 10.1592/phco.31.2.226</Citation><ArticleIdList><ArticleId IdType="doi">10.1592/phco.31.2.226</ArticleId><ArticleId IdType="pubmed">21275498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozturk MA, Ozveren O, Cinar V, Erdik B, Oyan B. Takotsubo syndrome: an underdiagnosed complication of 5-fluorouracil mimicking acute myocardial infarction. Blood Coagul Fibrinolysis. (2013) 24(1):90&#x2013;4. 10.1097/MBC.0b013e3283597605</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e3283597605</ArticleId><ArticleId IdType="pubmed">23249567</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco TH, Khan A, Joshi V, Thomas B. Takotsubo cardiomyopathy in two men receiving bevacizumab for metastatic cancer. Ther Clin Risk Manag. (2008) 4(6):1367&#x2013;70. 10.2147/tcrm.s3960</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/tcrm.s3960</ArticleId><ArticleId IdType="pmc">PMC2643117</ArticleId><ArticleId IdType="pubmed">19337443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis LM. Mechanisms of action of bevacizumab as a component of therapy for metastatic colorectal cancer. Semin Oncol. (2006) 33(5 Suppl 10):S1&#x2013;7. 10.1053/j.seminoncol.2006.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminoncol.2006.08.002</ArticleId><ArticleId IdType="pubmed">17145519</ArticleId></ArticleIdList></Reference><Reference><Citation>Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, et al. Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst. (2007) 99(16):1232&#x2013;9. 10.1093/jnci/djm086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djm086</ArticleId><ArticleId IdType="pubmed">17686822</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaveckait&#x117; S, &#x160;erpytis P, Pe&#x10d;i&#x16b;rait&#x117; D, Puronait&#x117; R, Valevi&#x10d;ien&#x117; N. Clinical features and three-year outcomes of takotsubo (stress) cardiomyopathy: observational data from one center. Hellenic J Cardiol. (2016) 57(6):428&#x2013;34. 10.1016/j.hjc.2016.11.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hjc.2016.11.016</ArticleId><ArticleId IdType="pubmed">28087310</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on takotsubo syndrome (part II): diagnostic workup, outcome, and management. Eur Heart J. (2018) 39(22):2047&#x2013;62. 10.1093/eurheartj/ehy077</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy077</ArticleId><ArticleId IdType="pmc">PMC5991205</ArticleId><ArticleId IdType="pubmed">29850820</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B&#xf6;hm M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. (2023) 44(37):3627&#x2013;39. 10.1093/eurheartj/ehad195</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad195</ArticleId><ArticleId IdType="pubmed">37622666</ArticleId></ArticleIdList></Reference><Reference><Citation>Medina de Chazal H, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D, et al. Stress cardiomyopathy diagnosis and treatment: jACC state-of-the-art review. J Am Coll Cardiol. (2018) 72(16):1955&#x2013;71. 10.1016/j.jacc.2018.07.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.07.072</ArticleId><ArticleId IdType="pmc">PMC7058348</ArticleId><ArticleId IdType="pubmed">30309474</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue Y, Watanabe E, Ichikawa T, Koshikawa M, Yamamoto M, Harada M, et al. Physically triggered takotsubo cardiomyopathy has a higher in-hospital mortality rate. Int J Cardiol. (2017) 235:87&#x2013;93. 10.1016/j.ijcard.2017.02.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2017.02.090</ArticleId><ArticleId IdType="pubmed">28262347</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyon AR, L&#xf3;pez-Fern&#xe1;ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC guidelines on cardio-oncology developed in collaboration with the European hematology association (EHA), the European society for therapeutic radiology and oncology (ESTRO) and the international cardio-oncology society (IC-OS). Eur Heart J. (2022) 43(41):4229&#x2013;361. 10.1093/eurheartj/ehac244</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac244</ArticleId><ArticleId IdType="pubmed">36017568</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Gil A, G&#xf3;mez-Ruiz &#xc1;J, Gil-Mart&#xed;nez J, Gil-G&#xf3;mez E, Falc&#xf3;n-Ara&#xf1;a L, Cascales-Campos PA. Tako-tsubo syndrome after intraperitoneal hyperthermic chemotherapy (HIPEC) with cisplatin: an unusual complication of cytoreductive surgery plus HIPEC. Clin Exp Metastasis. (2020) 37(3):445&#x2013;6. 10.1007/s10585-020-10034-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10585-020-10034-2</ArticleId><ArticleId IdType="pubmed">32372116</ArticleId></ArticleIdList></Reference><Reference><Citation>Coaguila-Cusicanqui L, Castillo-Atoche V, Montalvo-Suyon R, Cavero-Reyes Y, Failoc-Rojas VE. Case report: takotsubo syndrome in a postoperative patient without cardiological disease. F1000Res. (2022) 11:616. 10.12688/f1000research.122298.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.122298.2</ArticleId><ArticleId IdType="pmc">PMC11470228</ArticleId><ArticleId IdType="pubmed">39399786</ArticleId></ArticleIdList></Reference><Reference><Citation>Alta&#x15f; Y, Abdullayeva &#xdc;. case of takotsubo cardiomyopathy after surgical treatment of liver hydatid cyst: a case report. World J Clin Cases. (2023) 11(29):7187&#x2013;92. 10.12998/wjcc.v11.i29.7187</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v11.i29.7187</ArticleId><ArticleId IdType="pmc">PMC10631423</ArticleId><ArticleId IdType="pubmed">37946773</ArticleId></ArticleIdList></Reference><Reference><Citation>Badwan OZ, Abu-Shawer O, Paul A, Faulx M, Barzilai B. Postoperative apical ballooning syndrome following orthotopic liver transplantation. Cureus. (2023) 15:e34450. 10.7759/cureus.34450</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.34450</ArticleId><ArticleId IdType="pmc">PMC9980426</ArticleId><ArticleId IdType="pubmed">36874749</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishev D, Noureldine H, Ortiz F. Reverse takotsubo cardiomyopathy in the setting of small bowel obstruction: a case report. Annals of Medicine and Surgery (Lond). (2024) 86(9):5557&#x2013;60. 10.1097/MS9.0000000000002368</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MS9.0000000000002368</ArticleId><ArticleId IdType="pmc">PMC11374296</ArticleId><ArticleId IdType="pubmed">39239061</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazhev Z, Stoev H. Takotsubo cardiomyopathy after elective aortic and mitral valve replacement. Folia Medic. (2020) 62:204&#x2013;7. 10.3897/folmed.62.e47723</Citation><ArticleIdList><ArticleId IdType="doi">10.3897/folmed.62.e47723</ArticleId><ArticleId IdType="pubmed">32337907</ArticleId></ArticleIdList></Reference><Reference><Citation>Soundarrajan D, Singh R, Subramaniam M, Dhanasekararaja P, Rajkumar N, Rajasekaran S. Takotsubo syndrome after bilateral simultaneous total knee arthroplasty - A case report. J Orthop. (2024) 54:1&#x2013;4. 10.1016/j.jor.2024.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jor.2024.03.006</ArticleId><ArticleId IdType="pmc">PMC10943950</ArticleId><ArticleId IdType="pubmed">38496261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Arag&#xf3;n S, Del Pino-Camposeco J, Villanueva-Castro E, Canela-Calderon O, Arriada-Mendicoa JN, Ponce-G&#xf3;mez JA. A postoperative complication of takotsubo syndrome in the spinal surgery: a case report. Cureus. (2023) 15(12):e51034. 10.7759/cureus.51034</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.51034</ArticleId><ArticleId IdType="pmc">PMC10805121</ArticleId><ArticleId IdType="pubmed">38264385</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva M, Carrillo-Alfonso N, Amorim P. Cardiac arrest during spinal surgery: a multidisciplinary approach and management of takotsubo syndrome. Cureus. (2022) 14(12):e32404. 10.7759/cureus.32404</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.32404</ArticleId><ArticleId IdType="pmc">PMC9831275</ArticleId><ArticleId IdType="pubmed">36636538</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40677487</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>New Right Bundle Branch Block: A Benign Variant or an Ominous Sign?</ArticleTitle><Pagination><StartPage>e86103</StartPage><MedlinePgn>e86103</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e86103</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.86103</ELocationID><Abstract><AbstractText>A gentleman in his 80s presented to the hospital with several hours of ongoing, dull-aching chest pain radiating to his left arm. The initial electrocardiogram (ECG) showed atrial fibrillation (AF), bifascicular block (right bundle branch block&#xa0;(RBBB) and left anterior fascicular block), and concordant 0.5 mm ST-segment elevation in leads V1-V3. The repeated ECGs at one-hour and three-hour intervals showed similar findings. The initial high-sensitivity troponin (HS-troponin) level was 2672.7 ng/L. He was triaged as non-ST-segment elevation acute coronary syndrome&#xa0;(NSTE-ACS). However, his ECGs repeated on the next day showed AF, bifascicular block, and ST-segment elevation in leads V2-V4, I, and augmented vector left (aVL) alongside a significant troponin surge to 25,951 ng/L. The emergency coronary angiogram uncovered severe coronary artery disease that warranted percutaneous coronary intervention (PCI).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Myint Thu et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Myint Thu</LastName><ForeName>Thaw</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiology, Medway Maritime Hospital, Gillingham, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegazy</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Acute Medicine, Medway Maritime Hospital, Gillingham, GBR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dancy</LastName><ForeName>Luke</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Cardiology, Medway Maritime Hospital, Gillingham, GBR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">: acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">coronary artery angiogram</Keyword><Keyword MajorTopicYN="N">myocardial infarction type 1</Keyword><Keyword MajorTopicYN="N">non-st elevation myocardial infraction</Keyword><Keyword MajorTopicYN="N">right bundle branch block</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>5</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40677487</ArticleId><ArticleId IdType="pmc">PMC12267590</ArticleId><ArticleId IdType="doi">10.7759/cureus.86103</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Incidence of 12 common cardiovascular diseases and subsequent mortality risk in the general population. Prugger C, Perier MC, Gonzalez-Izquierdo A, Hemingway H, Denaxas S, Empana JP. Eur J Prev Cardiol. 2023;30:1715&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pubmed">37294923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortality trends after primary percutaneous coronary intervention for&#xa0;ST-segment elevation myocardial&#xa0;infarction. Thrane PG, Olesen KK, Thim T, Gyldenkerne C, Mortensen MB, Kristensen SD, Maeng M. J Am Coll Cardiol. 2023;82:999&#x2013;1010.</Citation><ArticleIdList><ArticleId IdType="pubmed">37648359</ArticleId></ArticleIdList></Reference><Reference><Citation>Correction to: 2023 ESC Guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC) Eur Heart J. 2024;45:1145.</Citation><ArticleIdList><ArticleId IdType="pubmed">38383069</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial. Wong CK, Stewart RA, Gao W, French JK, Raffel C, White HD. Eur Heart J. 2006;27:21&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">16269419</ArticleId></ArticleIdList></Reference><Reference><Citation>Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? Widimsky P, Roh&#xe1;c F, St&#xe1;sek J, et al. Eur Heart J. 2012;33:86&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3249219</ArticleId><ArticleId IdType="pubmed">21890488</ArticleId></ArticleIdList></Reference><Reference><Citation>Electrocardiographic predictors of mortality in acute anterior wall myocardial infarction with right bundle branch block and right precordial Q-waves (qRBBB) Paul A, Bhatia KS, Alex AG, Thomson VS, Mani T, Sharathbabu NM. Can J Cardiol. 2020;36:1764&#x2013;1769.</Citation><ArticleIdList><ArticleId IdType="pubmed">32610093</ArticleId></ArticleIdList></Reference><Reference><Citation>The &#x2018;qRBBB myocardial infarction&#x2019;: unwrapping an old enigma. Lanjewar CP, Shah BS, Sabnis GR, Sharma A, Kumar D. https://pmc.ncbi.nlm.nih.gov/articles/PMC10943532/ Indian Heart J. 2024;76:57&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10943532</ArticleId><ArticleId IdType="pubmed">38199561</ArticleId></ArticleIdList></Reference><Reference><Citation>Differences in presentation and clinical outcomes between left or right bundle branch block and ST segment elevation in patients with acute myocardial infarction. Meyer MR, Radovanovic D, Pedrazzini G, et al. Eur Heart J Acute Cardiovasc Care. 2020;9:848&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">32030999</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40679604</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1522-9645</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>European heart journal</Title><ISOAbbreviation>Eur Heart J</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence-enabled electrocardiography and echocardiography to track preclinical progression of transthyretin amyloid cardiomyopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">ehaf450</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurheartj/ehaf450</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIMS" NlmCategory="OBJECTIVE">The diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) requires advanced imaging, precluding large-scale preclinical testing. Artificial intelligence (AI)-enabled transthoracic echocardiography (TTE) and electrocardiography (ECG) may provide a scalable strategy for preclinical monitoring.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective analysis of individuals referred for nuclear cardiac amyloid testing at the Yale-New Haven Health System (YNHHS, internal cohort) and Houston Methodist Hospitals (HMH, external cohort). Deep learning models trained to discriminate ATTR-CM from age/sex-matched controls on TTE videos (AI-Echo) and ECG images (AI-ECG) were deployed to generate study-level ATTR-CM probabilities (0%-100%). Longitudinal trends in AI-derived probabilities were examined using age/sex-adjusted linear mixed models, and their discrimination of future disease was evaluated across preclinical stages.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 984 participants at YNHHS (median age 74 years, 44.3% female) and 806 at HMH (median age 69 years, 34.5% female), 112 (11.4%) and 174 (21.6%) tested positive for ATTR-CM, respectively. Across cohorts and modalities, AI-derived ATTR-CM probabilities from 7352 TTEs and 32 205 ECGs diverged as early as 3 years before diagnosis in cases vs controls (ptime(x)group interaction &#xa0;&#x2264; .004). Among those with both AI-Echo and AI-ECG probabilities available 1 to 3 years before nuclear testing [n = 433 (YNHHS) sand 174 (HMH)], a double-negative screen at a 0.05 threshold [164 (37.9%) and 66 (37.9%), vs all else] had 90.9% and 85.7% sensitivity (specificity of 40.3% and 41.2%), whereas a double-positive screen [78 (18.0%) and 26 (14.9%), vs all else] had 85.5% and 88.9% specificity (sensitivity of 60.6% and 42.9%).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Artificial intelligence-enabled echocardiography and electrocardiography may enable scalable risk stratification of ATTR-CM during its preclinical course.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site&#x2014;for further information please contact journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oikonomou</LastName><ForeName>Evangelos K</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0003-4362-0720</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangha</LastName><ForeName>Veer</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-8524-1203</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Engineering Science, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasisht Shankar</LastName><ForeName>Sumukh</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0005-3034-0641</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coppi</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-2046-127X</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasir</LastName><ForeName>Khurram</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Houston Methodist-Rice Digital Health Institute, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cardiovascular Computational and Precision Health, Houston Methodist DeBakey Heart &amp; Vascular Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallegos Kattan</LastName><ForeName>Cesia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mallah</LastName><ForeName>Mouaz H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Kindi</LastName><ForeName>Sadeer</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1122-7695</Identifier><AffiliationInfo><Affiliation>Houston Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital, Houston, TX, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Cardiovascular Computational and Precision Health, Houston Methodist DeBakey Heart &amp; Vascular Center, Houston, TX, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khera</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9467-6199</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiovascular Data Science (CarDS) Lab, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, 195 Church St, 6th Floor, New Haven, CT 06510, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01HL167858</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23HL153775</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1F32HL170592</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>BridgeBio</Agency><Country/></Grant><Grant><Agency>Yale University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J</MedlineTA><NlmUniqueID>8006263</NlmUniqueID><ISSNLinking>0195-668X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2025 Feb 24:2024.08.25.24312556. doi: 10.1101/2024.08.25.24312556.</RefSource><PMID Version="1">39252891</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Cardiac amyloidosis</Keyword><Keyword MajorTopicYN="N">Echocardiography</Keyword><Keyword MajorTopicYN="N">Electrocardiography</Keyword><Keyword MajorTopicYN="N">Screening</Keyword><Keyword MajorTopicYN="N">Transthyretin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>12</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40679604</ArticleId><ArticleId IdType="doi">10.1093/eurheartj/ehaf450</ArticleId><ArticleId IdType="pii">8206181</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40681967</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-227X</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC emergency medicine</Title><ISOAbbreviation>BMC Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Prehospital survival of patients with ST-elevation myocardial infarction requiring out-of-hospital cardiopulmonary resuscitation - a nationwide, real-world observational study.</ArticleTitle><Pagination><StartPage>130</StartPage><MedlinePgn>130</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">130</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12873-025-01292-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The mortality risk of patients presenting with ST-elevation myocardial infarction (STEMI) has been extensively researched. Even though STEMI can be diagnosed before hospital admission, prehospital mortality has been less frequently studied. We aimed to analyze the outcomes of patients with STEMI requiring out-of-hospital cardiopulmonary resuscitation (CPR).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From a large, nationwide prehospital case report database, we collected data from 668 patients requiring CPR because of ambulance-witnessed OHCA (out-of-hospital cardiac arrest) who were diagnosed with STEMI by ECG before cardiac arrest. Utstein-style consensus reporting guidelines were followed. The endpoint was hospital admission with spontaneous circulation. In addition to descriptive statistics, we also aimed to identify predictors of the outcome using multivariable logistic regression. Model performance was characterized by c-statistics and multiple fitting methods. Internal validation was performed using calibration intercept and slope.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Using CPR initial rhythm, age, initial heart rate, initial systolic blood pressure, and ECG localization of STEMI as predictors, we found that the constructed logistic regression model showed good discriminative ability, with a c-statistic of 0.844 (95% CI&#x2009;=&#x2009;0.8105-0.8787). The overall model fit was good, with Hosmer &amp; Lemeshow p&#x2009;=&#x2009;0.979. The value of Nagelkerke R<sup>2</sup> test of 0.445 indicated a strong relationship between predictors and outcome. The Z-value of calibration slope was relative to slope&#x2009;=&#x2009;1 (95% CI&#x2009;=&#x2009;0.85-1.16).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This model can be used to estimate the probability of hospital admission following resuscitation due to ambulance-witnessed OHCA in patients with STEMI. Further studies are needed to improve the possibility of definitive in-hospital treatment for a better survival rate.</AbstractText><AbstractText Label="CLINICAL TRIAL NUMBER" NlmCategory="BACKGROUND">Not applicable.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Szab&#xf3;</LastName><ForeName>Dominika</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Doctoral College, Semmelweis University, &#xdc;ll&#x151;i &#xfa;t. 26, Budapest, 1085, Hungary. domokos.dominika@mentok.hu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Ambulance Service, Szauter F. u. 2/A, Gy&#x151;r, 9024, Hungary. domokos.dominika@mentok.hu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szab&#xf3;</LastName><ForeName>Andr&#xe1;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Ambulance Service, Szauter F. u. 2/A, Gy&#x151;r, 9024, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sz&#xe9;kely</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oxiology and Emergency Medicine, Semmelweis University, &#xdc;ll&#x151;i &#xfa;t 26, Budapest, 1085, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Therapy, Semmelweis University, &#xdc;ll&#x151;i &#xfa;t 78, Budapest, 1082, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Emerg Med</MedlineTA><NlmUniqueID>100968543</NlmUniqueID><ISSNLinking>1471-227X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="Y">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="Y">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058687" MajorTopicYN="Y">Out-of-Hospital Cardiac Arrest</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="Y">Emergency Medical Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CPR</Keyword><Keyword MajorTopicYN="N">Initial rhythm</Keyword><Keyword MajorTopicYN="N">OHCA</Keyword><Keyword MajorTopicYN="N">Prehospital survival</Keyword><Keyword MajorTopicYN="N">STEMI</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: The use of anonymized data for this study was approved by the head of the institution and the Institutional Review Board named Regional Ethics Committee on Human Research of Semmelweis University (approval number: SE RKEB: 238/2024). The need for a consent statement was waived, as this was a retrospective analysis of a completely anonymized database, without intervention or further follow-up. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>19</Day><Hour>16</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>19</Day><Hour>16</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>23</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40681967</ArticleId><ArticleId IdType="pmc">PMC12275280</ArticleId><ArticleId IdType="doi">10.1186/s12873-025-01292-y</ArticleId><ArticleId IdType="pii">10.1186/s12873-025-01292-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hizoh I, Domokos D, Banhegyi G, et al. Mortality prediction algorithms for patients undergoing primary percutaneous coronary intervention. J Thorac Dis. 2020;12(4):1706&#x2013;20. 10.21037/jtd.2019.12.83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7212133</ArticleId><ArticleId IdType="pubmed">32395313</ArticleId></ArticleIdList></Reference><Reference><Citation>CARES 2022 Annual Report. Source: https://mycares.net/sitepages/uploads/2023/2022_flipbook/index.html queried on date: 1. Dec. 2023.</Citation></Reference><Reference><Citation>Gr&#xe4;sner JT, Herlitz J, Tjelmeland IBM, et al. European Resuscitation Council Guidelines 2021: Epidemiology of cardiac arrest in Europe. Resuscitation. 2021;161:61&#x2013;79. 10.1016/j.resuscitation.2021.02.007. Epub 2021 Mar 24.</Citation><ArticleIdList><ArticleId IdType="pubmed">33773833</ArticleId></ArticleIdList></Reference><Reference><Citation>Szab&#xf3; D, Szab&#xf3; A, et al. Success rate of out-of-hospital cardiopulmonary resuscitation in STEMI patients&#x2013;preliminary results from a nationwide database. In: EUSEM 2023 Congress. 2023:2497. https://cm.eusem.org/cmEpostersV2/#/PosterDetail/2497</Citation></Reference><Reference><Citation>Robert A, Byrne X, Rossello JJ, Coughlan, ESC Scientific Document Group, et al. 2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European society of cardiology (ESC). Eur Heart J. October 2023;44:3720&#x2013;826. 10.1093/eurheartj/ehad191.</Citation></Reference><Reference><Citation>Soar J, B&#xf6;ttiger BW, Carli P, et al. European resuscitation Council guidelines 2021: adult advanced life support. Resuscitation. 2021;161:115&#x2013;51. 10.1016/j.resuscitation.2021.02.010.</Citation><ArticleIdList><ArticleId IdType="pubmed">33773825</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldi E, Schnaubelt S, Caputo ML, et al. Association of timing of electrocardiogram acquisition after return of spontaneous circulation with coronary angiography findings in patients with Out-of-Hospital cardiac arrest. JAMA Netw Open. 2021;4(1):e2032875. 10.1001/jamanetworkopen.2020.32875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801935</ArticleId><ArticleId IdType="pubmed">33427885</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins GD, Jacobs IG, Nadkarni VM, et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update of the Utstein Resuscitation Registry Templates for Out-of-Hospital Cardiac Arrest: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association. European Resuscitation Council, Australian and New Zealand Council on Resuscitation, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, Resuscitation Council of Asia); and the American Heart Association Emergency Cardiovascular Care Committee and the Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation. Circulation. 2015;132:1286&#x2013;300. 10.1161/CIR.0000000000000144</Citation><ArticleIdList><ArticleId IdType="pubmed">25391522</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1&#x2013;73. 10.7326/M14-0698.</Citation><ArticleIdList><ArticleId IdType="pubmed">25560730</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. R: A Language and environment for statistical computing. (Version 4.4.2) [Computer software]. 2024. Retrieved from https://cran.r-project.org</Citation></Reference><Reference><Citation>The jamovi project. Jamovi. (Version 2.6) [Computer Software]. 2024. Retrieved from https://www.jamovi.org</Citation></Reference><Reference><Citation>J&#xe1;nosi A, Ferenci T, Tomcs&#xe1;nyi J, et al. Out-of-hospital cardiac arrest in patients treated for ST-elevation acute myocardial infarction: incidence, clinical features, and prognosis based on population-level data from Hungary. Resusc Plus. 2021;6:100113. 10.1016/j.resplu.2021.100113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8244239</ArticleId><ArticleId IdType="pubmed">34223373</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox KAA, FitzGerald G, Puymirat E, et al. Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score. BMJ Open. 2014;4:e004425. 10.1136/bmjopen-2013-004425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931985</ArticleId><ArticleId IdType="pubmed">24561498</ArticleId></ArticleIdList></Reference><Reference><Citation>Hizoh I, Gulyas Z, Domokos D, et al. A novel risk model including vascular access site for predicting 30-day mortality after primary PCI: the ALPHA score. Cardiovasc Revasc Med. 2016. 10.1016/j.carrev.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">28029531</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy B, P&#xe1;l-Jakab &#xc1;, Orb&#xe1;n G et al. Factors predicting mortality in the cardiac ICU during the early phase of targeted temperature management in the treatment of post-cardiac arrest syndrome&#x2013; The RAPID score, resuscitation plus, 19, 2024, 10.1016/j.resplu.2024.100732</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11378716</ArticleId><ArticleId IdType="pubmed">39246407</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapostolle F, Le Toumelin P, Agostinucci JM, et al. Basic cardiac life support providers checking the carotid pulse: performance, degree of conviction, and influencing factors. Acad Emerg Med. 2004;11:878&#x2013;80. 10.1197/j.aem.2004.02.528.</Citation><ArticleIdList><ArticleId IdType="pubmed">15289196</ArticleId></ArticleIdList></Reference><Reference><Citation>Albarran JW, Moule P, Gilchrist M, et al. Comparison of sequential and simultaneous breathing and pulse check by healthcare professionals during simulated scenarios. Resuscitation. 2006;68:243&#x2013;9. 10.1016/j.resuscitation.2005.06.010.</Citation><ArticleIdList><ArticleId IdType="pubmed">16325988</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham CA, Lewis NF. Evaluation of a new method for the carotid pulse check in cardiopulmonary resuscitation. Resuscitation. 2002;53:37&#x2013;40. 10.1016/S0300-9572(01)00487-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">11947977</ArticleId></ArticleIdList></Reference><Reference><Citation>Prosen G, Kri&#x17e;mari&#x107; M, Zavr&#x161;nik J, et al. Impact of modified treatment in echocardiographically confirmed Pseudo-Pulseless electrical activity in Out-of-Hospital cardiac arrest patients with constant End-Tidal carbon dioxide pressure during compression pauses. J Int Med Res. 2010;38(4):1458&#x2013;67. 10.1177/147323001003800428.</Citation><ArticleIdList><ArticleId IdType="pubmed">20926019</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitkreutz R, Price S, Steiger HV, Emergency Ultrasound Working Group of the Johann Wolfgang Goethe-University Hospital FaM, et al. Focused echocardiographic evaluation in life support and peri-resuscitation of emergency patients: a prospective trial. Resuscitation. 2010;81(11):1527&#x2013;33. 10.1016/j.resuscitation.2010.07.013.</Citation><ArticleIdList><ArticleId IdType="pubmed">20801576</ArticleId></ArticleIdList></Reference><Reference><Citation>Aichinger G, Zechner PM, Prause G, et al. Cardiac movement identified on prehospital echocardiography predicts outcome in cardiac arrest patients. Prehosp Emerg Care. 2012 Apr-Jun;16(2):251&#x2013;5. 10.3109/10903127.2011.640414. Epub 2012 Jan 11.</Citation><ArticleIdList><ArticleId IdType="pubmed">22235765</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40689162</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2514-2119</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>European heart journal. Case reports</Title><ISOAbbreviation>Eur Heart J Case Rep</ISOAbbreviation></Journal><ArticleTitle>de Winter electrocardiogram pattern evolving into Wellens electrocardiogram pattern in post-percutaneous coronary intervention therapy: a case report.</ArticleTitle><Pagination><StartPage>ytaf139</StartPage><MedlinePgn>ytaf139</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">ytaf139</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ehjcr/ytaf139</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The de Winter electrocardiogram (ECG) pattern and Wellens ECG pattern are rare but critical ECG findings, often considered high-risk equivalents of ST-segment elevation myocardial infarction (STEMI) associated with proximal left anterior descending coronary artery (LAD) occlusion, necessitating urgent angiography and reperfusion. Limited literature documents cases where the de Winter ECG pattern transitions into the Wellens pattern following percutaneous coronary intervention (PCI).</AbstractText><AbstractText Label="CASE SUMMARY" NlmCategory="UNASSIGNED">A 73-year-old man with a history of intermittent chest pain over 1 year presented with exacerbation lasting 3 h, leading to hospitalization for acute coronary syndrome (ACS). During chest pain, the ECG displayed the de Winter ECG pattern, prompting immediate emergency coronary angiography. Angiography revealed 90% stenosis at the proximal LAD, subsequently treated with drug-eluting stent placement. The stent expanded well, and LAD forward blood flow was at thrombolysis in myocardial infarction Level 3. Within 24&#x2005;h post-PCI, the ECG evolved into Type B Wellens pattern, accompanied by the resolution of chest pain. The patient was discharged on the seventh day post-admission.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">The de Winter ECG pattern signifies transient severe coronary stenosis during episodes of chest pain. In contrast, the Wellens ECG pattern typically occurs before PCI, with its T-wave changes often appearing during pain-free intervals, indicating spontaneous coronary artery revascularization. Post-PCI, Wellens ECG changes may suggest reperfusion injury. Timely and repeated ECG monitoring in ACS patients is crucial for identifying high-risk ECG patterns and initiating urgent reperfusion therapy. However, a Wellens ECG pattern in pre-cordial leads does not invariably signify LAD occlusion or severe stenosis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xianghong</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-9512-0432</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin Institute of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin 300211, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Mengwei</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, the Second Hospital of Tianjin Medical University, Tianjin Institute of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin 300211, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Heart J Case Rep</MedlineTA><NlmUniqueID>101730741</NlmUniqueID><ISSNLinking>2514-2119</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute coronary syndromes</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">Percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">Wellens syndrome</Keyword><Keyword MajorTopicYN="N">de Winter syndrome</Keyword></KeywordList><CoiStatement>Conflict of interest: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>21</Day><Hour>7</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40689162</ArticleId><ArticleId IdType="pmc">PMC12271725</ArticleId><ArticleId IdType="doi">10.1093/ehjcr/ytaf139</ArticleId><ArticleId IdType="pii">ytaf139</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de Winter &#xa0;RJ, Verouden &#xa0;NJ, Wellens &#xa0;HJ, Wilde &#xa0;AA. A new ECG sign of proximal LAD occlusion. N Engl J Med &#xa0;2008;359:2071&#x2013;2073.</Citation><ArticleIdList><ArticleId IdType="pubmed">18987380</ArticleId></ArticleIdList></Reference><Reference><Citation>De Zwaan &#xa0;C, B&#xe4;r &#xa0;FW, Wellens &#xa0;HJ. Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction. Am Heart J &#xa0;1982;103:730&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pubmed">6121481</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris &#xa0;NP, Body &#xa0;R. The de Winter ECG pattern: morphology and accuracy for diagnosing acute coronary occlusion: systematic review. Eur J Emerg Med &#xa0;2017;24:236&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">28362646</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinehardt &#xa0;J, Brady &#xa0;WJ, Perron &#xa0;AD, Mattu &#xa0;A. Electrocardiographic manifestations of Wellens&#x2019; syndrome. Am J Emerg Med &#xa0;2002;20:638&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">12442245</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander &#xa0;J, Rizzolo &#xa0;D. Wellens syndrome: an important consideration in patients with chest pain. JAAPA &#xa0;2023;36:25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">36701576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kloner &#xa0;RA. New observations regarding post&#x2013;ischemia/reperfusion myocardial swelling. J Am Coll Cardiol &#xa0;2015;65:324&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">25461691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu &#xa0;Y, Luo &#xa0;S, Huang &#xa0;B. Evolution of de Winter into Wellens on electrocardiogram-what happened? &#xa0;JAMA Intern Med &#xa0;2021;181:1647&#x2013;1649.</Citation><ArticleIdList><ArticleId IdType="pubmed">34633408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40697204</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1878-5409</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of cardiology cases</Title><ISOAbbreviation>J Cardiol Cases</ISOAbbreviation></Journal><ArticleTitle>SCN5A mutation-associated sick sinus syndrome revealed by atrial flutter in a pediatric patient.</ArticleTitle><Pagination><StartPage>5</StartPage><EndPage>9</EndPage><MedlinePgn>5-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jccase.2025.03.001</ELocationID><Abstract><AbstractText Label="UNLABELLED">Atrial flutter (AFL) is uncommon in children without underlying heart disease. This report details the case of a 7-year-old boy with AFL detected during school electrocardiogram (ECG) screening. He had no prior arrhythmias, congenital heart disease, or cardiomyopathy. Initial evaluations showed AFL with right bundle branch block but no structural heart abnormalities. Radiofrequency catheter ablation (RFCA) was performed, initially resolving the AFL but resulting in a 13-s sinus arrest requiring atrial pacing. Post-RFCA, the patient experienced a sinus arrest lasting up to 7&#x202f;s, leading to a diagnosis of sick sinus syndrome (SSS). A second RFCA was needed due to AFL recurrence, and post-ablation ECGs revealed saddleback-type ST-segment elevation and Brugada-type patterns, raising suspicion of Brugada syndrome (BrS). Genetic testing identified a loss-of-function (LOF) SCN5A variant (c.2678G&#x202f;&gt;&#x202f;A p.R893H) in the patient, his mother, and his sister. This case underscores that AFL in children without structural heart disease, especially when associated with SSS, may be linked to LOF SCN5A variants, which are also associated with BrS.</AbstractText><AbstractText Label="LEARNING OBJECTIVE" NlmCategory="UNASSIGNED">Atrial flutter in children without structural heart disease can be linked to genetic factors with Brugada syndrome (BrS). This case highlights the importance of thorough diagnostic evaluation, including family history and genetic testing, when rare arrhythmias are present. Early detection of BrS through detailed electrocardiographic findings and family screening can help identify at-risk individuals and guide appropriate management to prevent serious arrhythmias and sudden cardiac death.</AbstractText><CopyrightInformation>&#xa9; 2025 Japanese College of Cardiology. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>Yoshikatsu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujita</LastName><ForeName>Shuhei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yachi</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Honda</LastName><ForeName>Mariko</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwata</LastName><ForeName>Mayu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakumura</LastName><ForeName>Naoto</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueno</LastName><ForeName>Kazuyuki</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyashita</LastName><ForeName>Kengo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Futatani</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usuda</LastName><ForeName>Keisuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chikata</LastName><ForeName>Akio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usuda</LastName><ForeName>Kazuo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Toyama Prefectural Central Hospital, Toyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishida</LastName><ForeName>Keigo</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araki</LastName><ForeName>Raita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kato</LastName><ForeName>Koichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Shiga University of Medical Science, Shiga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohno</LastName><ForeName>Seiko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Genome Center, National Cerebral and Cardiovascular Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>J Cardiol Cases</MedlineTA><NlmUniqueID>101549579</NlmUniqueID><ISSNLinking>1878-5409</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atrial flutter</Keyword><Keyword MajorTopicYN="N">Brugada syndrome</Keyword><Keyword MajorTopicYN="N">Catheter ablation</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">SCN5A</Keyword><Keyword MajorTopicYN="N">Sick sinus syndrome</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>11</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>11</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>4</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40697204</ArticleId><ArticleId IdType="pmc">PMC12277622</ArticleId><ArticleId IdType="doi">10.1016/j.jccase.2025.03.001</ArticleId><ArticleId IdType="pii">S1878-5409(25)00020-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ishikawa T., Kimoto H., Mishima H., Yamagata K., Ogata S., Aizawa Y., Hayashi K., Morita H., Nakajima T., Nakano Y., Nagase S., Murakoshi N., Kowase S., Ohkubo K., Aiba T., et al. Functionally validated SCN5A variants allow interpretation of pathogenicity and prediction of lethal events in Brugada syndrome. Eur Heart J. 2021;42:2854&#x2013;2863.</Citation><ArticleIdList><ArticleId IdType="pubmed">34219138</ArticleId></ArticleIdList></Reference><Reference><Citation>Garson A., Jr., Bink-Boelkens M., Hesslein P.S., Hordof A.J., Keane J.F., Neches W.H., Porter C.J. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol. 1985;6:871&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pubmed">4031302</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieks J.-K., Backhoff D., Schneider H.E., M&#xfc;ller M.J., Krause U., Paul T. Lone atrial flutter in children and adolescents: is it really &#x201c;lone&#x201d;? Pediatr Cardiol. 2021;42:361&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907036</ArticleId><ArticleId IdType="pubmed">33165623</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Machida T., Sumitomo N., Yamamoto H., Ohkubo K., Watanabe I., Makiyama T., Fukae S., Kohno M., Harrell D.T., Ishikawa T., Tsuji Y., Nogami A., Watabe T., Oginosawa Y., et al. Sodium channelopathy underlying familial sick sinus syndrome with early onset and predominantly male characteristics. Circ Arrhythm Electrophysiol. 2014;7:511&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pubmed">24762805</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H., Li X.M., Zhang Y., Ge H.Y., Liu H.J., Li M.T. Electrophysiological characteristics and outcomes of radiofrequency catheter ablation of atrial flutter in children with or without congenital heart disease. Pediatr Cardiol. 2020;41:1509&#x2013;1514.</Citation><ArticleIdList><ArticleId IdType="pubmed">32642798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H., Sumiyoshi M., Nakazato Y., Daida H. Brugada syndrome and sinus node dysfunction. J Arrhythm. 2018;34:216&#x2013;221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6009769</ArticleId><ArticleId IdType="pubmed">29951135</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarreal-Molina T., Garc&#xed;a-Ord&#xf3;&#xf1;ez G.P., Reyes-Quintero &#xc1;.E., Dom&#xed;nguez-P&#xe9;rez M., Jacobo-Albavera L., Nava S., Carnevale A., Medeiros-Domingo A., Iturralde P. Clinical spectrum of SCN5A channelopathy in children with primary electrical disease and structurally normal hearts. Genes. 2021;13:16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8774384</ArticleId><ArticleId IdType="pubmed">35052356</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimpf R., Giustetto C., Eckardt L., Veltmann C., Wolpert C., Gaita F., Breithardt G., Borggrefe M. Prevalence of supraventricular tachyarrhythmias in a cohort of 115 patients with Brugada syndrome. Ann Noninvasive Electrocardiol. 2008;13:266&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6932135</ArticleId><ArticleId IdType="pubmed">18713327</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B., Guo C., Fang D., Guo J. Clinical observations of supraventricular arrhythmias in patients with Brugada syndrome. Int J Clin Exp Med. 2015;8:14520&#x2013;14526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4613128</ArticleId><ArticleId IdType="pubmed">26550443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohkubo K., Watanabe I., Okumura Y., Kofune M., Nagashima K., Mano H., Sonoda K., Nakai T., Kunimoto S., Kasamaki Y., Hirayama A., Sumitomo N., Nakayama T. Supraventricular tachyarrhythmia in patients with Brugada syndrome: a single-center study. J Arrhythm. 2013;29:265&#x2013;269.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="In-Process" Owner="NLM"><PMID Version="1">40696040</PMID><DateRevised><Year>2025</Year><Month>08</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2731-0590</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Nature cardiovascular research</Title><ISOAbbreviation>Nat Cardiovasc Res</ISOAbbreviation></Journal><ArticleTitle>Identification of hypertrophic cardiomyopathy on electrocardiographic images with deep learning.</ArticleTitle><Pagination><StartPage>991</StartPage><EndPage>1000</EndPage><MedlinePgn>991-1000</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s44161-025-00685-3</ELocationID><Abstract><AbstractText>Hypertrophic cardiomyopathy (HCM) is frequently underdiagnosed. Although deep learning (DL) models using raw electrocardiographic (ECG) voltage data can enhance detection, their use at the point of care is limited. Here we report the development and validation of a DL model that detects HCM from images of 12-lead ECGs across layouts. The model was developed using 124,553 ECGs from 66,987 individuals at the Yale New Haven Hospital (YNHH), with HCM features determined by concurrent imaging (cardiac magnetic resonance (CMR) or echocardiography). External validation included ECG images from MIMIC-IV, the Amsterdam University Medical Center (AUMC) and the UK Biobank (UKB), where HCM was defined by CMR (YNHH, MIMIC-IV and AUMC) and diagnosis codes (UKB). The model demonstrated robust performance across image formats and sites (areas under the receiver operating characteristic curve (AUROCs): 0.95 internal testing; 0.94 MIMIC-IV; 0.92 AUMC; 0.91 UKB). Discriminative features localized to anterior/lateral leads (V4 and V5) regardless of layout. This approach enables scalable, image-based screening for HCM across clinical settings.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sangha</LastName><ForeName>Veer</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-8524-1203</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Engineering Science, Oxford University, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dhingra</LastName><ForeName>Lovedeep Singh</ForeName><Initials>LS</Initials><Identifier Source="ORCID">0000-0002-5664-4126</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aminorroaya</LastName><ForeName>Arya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3197-2657</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Croon</LastName><ForeName>Philip M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sikand</LastName><ForeName>Nikhil V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sen</LastName><ForeName>Sounok</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Matthew W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Atlantic Health, Morristown Medical Center, Morristown, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sports Cardiology and Hypertrophic Cardiomyopathy, Morristown Medical Center, Morristown, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maron</LastName><ForeName>Martin S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>HCM Institute, Tufts Medical Center, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumholz</LastName><ForeName>Harlan M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-2046-127X</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation (CORE), Yale New Haven Hospital, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asselbergs</LastName><ForeName>Folkert W</ForeName><Initials>FW</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute for Health Research, University College London Hospitals, Biomedical Research Centre, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikonomou</LastName><ForeName>Evangelos K</ForeName><Initials>EK</Initials><Identifier Source="ORCID">0000-0003-4362-0720</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khera</LastName><ForeName>Rohan</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-9467-6199</Identifier><AffiliationInfo><Affiliation>Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA. rohan.khera@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Outcomes Research and Evaluation (CORE), Yale New Haven Hospital, New Haven, CT, USA. rohan.khera@yale.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Health Informatics, Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA. rohan.khera@yale.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23HL153775</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>R01HL167858</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant><Grant><GrantID>1F32HL170592-01</GrantID><Agency>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Cardiovasc Res</MedlineTA><NlmUniqueID>9918284280206676</NlmUniqueID><ISSNLinking>2731-0590</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2025 May 28:2023.12.23.23300490. doi: 10.1101/2023.12.23.23300490.</RefSource><PMID Version="1">38234746</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>Competing interests: V.S. and R.K. are co-inventors of US pending patent applications WO2023230345A1, &#x2018;Articles and methods for format-independent detection of hidden cardiovascular disease from printed electrocardiographic images using deep learning&#x2019;, and 63/484,426, &#x2018;Biometric contrastive learning for data-efficient deep learning from electrocardiographic images&#x2019;, filed by Yale University. These patents cover the methods of training an AI model to detect structural heart disease in a format-independent manner using varied image formats as inputs and the biocontrastive pretraining used in the present study. They are also co-founders of Ensight-AI, along with H.M.K. P.M.C. is the founder and CEO of DGTL Health BV. R.K. is an Associate Editor of JAMA. In addition to awards from the National Heart, Lung, and Blood Institute and the Doris Duke Charitable Foundation, he receives research support, through Yale University, from Bristol Myers Squibb, Novo Nordisk and BridgeBio. R.K. and E.K.O. are co-inventors of US pending patent applications 63/562,335, &#x2018;Artificial intelligence-guided screening of under-recognized cardiomyopathies adapted for point-of-care cardiac ultrasound&#x2019;; 18/813,882, &#x2018;Multimodality artificial intelligence systems to track the progression of pre-clinical amyloid cardiomyopathy&#x2019;; 63/619,241, &#x2018;A multi-modal video-based progression score for aortic stenosis using artificial intelligence&#x2019;; US20220336048A1, &#x2018;Methods for neighborhood phenomapping for clinical trials&#x2019;; 63/508,315, &#x2018;Machine learning method for adaptive trial enrichment&#x2019;; and 63/606,203, &#x2018;Methods of generating digital twin-based datasets&#x2019;, filed by Yale University and unrelated to this work. R.K. and E.K.O. are co-founders of Evidence2Health, a precision health platform to improve evidence-based cardiovascular care. E.K.O. has been a consultant for Caristo Diagnostics, Ltd. and Ensight-AI, Inc. and has received royalty fees from technology licensed through the University of Oxford. H.M.K. works under contract with the Centers for Medicare &amp; Medicaid Services to support quality measurement programs; was a recipient of a research grant from Johnson &amp; Johnson, through Yale University, to support clinical trial data sharing; was a recipient of a research agreement, through Yale University, from the Shenzhen Center for Health Information for work to advance intelligent disease prevention and health promotion; collaborates with the National Center for Cardiovascular Diseases in Beijing; receives payment from the Arnold &amp; Porter Law Firm for work related to the Sanofi clopidogrel litigation, from the Martin Baughman Law Firm for work related to the Cook Celect IVC filter litigation and from the Siegfried and Jensen Law Firm for work related to Vioxx litigation; chairs a Cardiac Scientific Advisory Board for UnitedHealth; was a member of the IBM Watson Health Life Sciences Board; is a member of the Advisory Board for Element Science, the Advisory Board for Facebook and the Physician Advisory Board for Aetna; and is the co-founder of Hugo Health, a personal health information platform, and the co-founder of Refactor Health, a healthcare AI-augmented data management company. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>11</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>11</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>22</Day><Hour>23</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40696040</ArticleId><ArticleId IdType="doi">10.1038/s44161-025-00685-3</ArticleId><ArticleId IdType="pii">10.1038/s44161-025-00685-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maron, B. J. Hypertrophic cardiomyopathy. JAMA 287, 1308&#x2013;1320 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">11886323</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron, B. J. &amp; Maron, M. S. Hypertrophic cardiomyopathy. Lancet 381, 242&#x2013;255 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">22874472</ArticleId></ArticleIdList></Reference><Reference><Citation>Semsarian, C., Ingles, J., Maron, M. S. &amp; Maron, B. J. New perspectives on the prevalence of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 65, 1249&#x2013;1254 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25814232</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabater-Molina, M., P&#xe9;rez-S&#xe1;nchez, I., Hern&#xe1;ndez del Rinc&#xf3;n, J. P. &amp; Gimeno, J. R. Genetics of hypertrophic cardiomyopathy: a review of current state. Clin. Genet. 93, 3&#x2013;14 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28369730</ArticleId></ArticleIdList></Reference><Reference><Citation>Geske, J. B., Ommen, S. R. &amp; Gersh, B. J. Hypertrophic cardiomyopathy. JACC Heart Fail. 6, 364&#x2013;375 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29655825</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron, B. J. et al. Diagnosis and evaluation of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 79, 372&#x2013;389 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35086660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ommen, S. R. et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 142, e558&#x2013;e631 (2020).</Citation></Reference><Reference><Citation>Goto, S. et al. Multinational federated learning approach to train ECG and echocardiogram models for hypertrophic cardiomyopathy detection. Circulation 146, 755&#x2013;769 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35916132</ArticleId><ArticleId IdType="pmc">9439630</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko, W.-Y. et al. Detection of hypertrophic cardiomyopathy using a convolutional neural network-enabled electrocardiogram. J. Am. Coll. Cardiol. 75, 722&#x2013;733 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32081280</ArticleId></ArticleIdList></Reference><Reference><Citation>Finocchiaro, G. et al. The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy. Heart Rhythm 17, 142&#x2013;151 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31349064</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod, C. J. et al. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J. Am. Coll. Cardiol. 54, 229&#x2013;233 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19589435</ArticleId></ArticleIdList></Reference><Reference><Citation>Siontis, K. C. et al. Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents. Int. J. Cardiol. 340, 42&#x2013;47 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34419527</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusson, P., Palm, A., Branden, E. &amp; M&#xf6;rner, S. Misclassification of hypertrophic cardiomyopathy: validation of diagnostic codes. Clin. Epidemiol. 9, 403&#x2013;410 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28848363</ArticleId><ArticleId IdType="pmc">5557115</ArticleId></ArticleIdList></Reference><Reference><Citation>Farahani, N. Z. et al. Explanatory analysis of a machine learning model to identify hypertrophic cardiomyopathy patients from EHR using diagnostic codes. Proceedings (IEEE Int. Conf. Bioinformatics Biomed.) 2020, 1932&#x2013;1937 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">34316386</ArticleId></ArticleIdList></Reference><Reference><Citation>Daskalov, I. K., Dotsinsky, I. A. &amp; Christov, I. I. Developments in ECG acquisition, preprocessing, parameter measurement, and recording. IEEE Eng. Med. Biol. Mag. 17, 50&#x2013;58 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9548081</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Velasco, M., Weng, B. &amp; Barner, K. E. ECG signal denoising and baseline wander correction based on the empirical mode decomposition. Comput. Biol. Med. 38, 1&#x2013;13 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">17669389</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangha, V. et al. Automated multilabel diagnosis on electrocardiographic images and signals. Nat. Commun. 13, 1583 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35332137</ArticleId><ArticleId IdType="pmc">8948243</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangha, V. et al. Detection of left ventricular systolic dysfunction from electrocardiographic images. Circulation 148, 765&#x2013;777 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37489538</ArticleId><ArticleId IdType="pmc">10982757</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhingra, L. S. et al. Ensemble deep learning algorithm for structural heart disease screening using electrocardiographic images: PRESENT SHD. J. Am. Coll. Cardiol. 85, 1302&#x2013;1313 (2025).</Citation><ArticleIdList><ArticleId IdType="pubmed">40139886</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, M. &amp; Le, Q V. EfficientNet: rethinking model scaling for convolutional neural networks. Proc. of the 36th International Conference on Machine Learning 97, 6105&#x2013;6114 https://proceedings.mlr.press/v97/tan19a.html (2019).</Citation></Reference><Reference><Citation>Sangha, V. et al. Biometric contrastive learning for data-efficient deep learning from electrocardiographic images. J. Am. Med. Inform. Assoc. 31, 855&#x2013;865 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38269618</ArticleId><ArticleId IdType="pmc">10990541</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvaraju, R. R. et al. Grad-CAM: visual explanations from deep networks via gradient-based localization. 2017 IEEE International Conference on Computer Vision (ICCV) 618&#x2013;626 https://doi.org/10.1109/ICCV.2017.74 (IEEE, 2017).</Citation></Reference><Reference><Citation>Gow, B. et al. MIMIC-IV-ECG: diagnostic electrocardiogram matched subset. PhysioNet https://doi.org/10.13026/4NQG-SB35 (2023).</Citation></Reference><Reference><Citation>Johnson, A., Pollard, T., Horng, S., Celi, L. A. &amp; Mark, R. MIMIC-IV-Note: deidentified free-text clinical notes. PhysioNet https://doi.org/10.13026/1N74-NE17 (2023).</Citation></Reference><Reference><Citation>Petersen, S. E. et al. Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort. J. Cardiovasc. Magn. Reson. 19, 18 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28178995</ArticleId><ArticleId IdType="pmc">5304550</ArticleId></ArticleIdList></Reference><Reference><Citation>Naderi, H. et al. Predicting left ventricular hypertrophy from the 12-lead electrocardiogram in the UK Biobank imaging study using machine learning. Eur. Heart J. Digit. Health 4, 316&#x2013;324 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37538142</ArticleId><ArticleId IdType="pmc">10393938</ArticleId></ArticleIdList></Reference><Reference><Citation>Oikonomou, E. K. et al. Artificial intelligence-enhanced risk stratification of cancer therapeutics-related cardiac dysfunction using electrocardiographic images. Circ. Cardiovasc. Qual. Outcomes 18, e011504 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">39221857</ArticleId><ArticleId IdType="pmc">11745701</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhingra, L. S. et al. Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study. Eur. Heart J. 46, 1044&#x2013;1053 (2025).</Citation><ArticleIdList><ArticleId IdType="pubmed">39804243</ArticleId></ArticleIdList></Reference><Reference><Citation>Delcr&#xe8;, S. D. L. et al. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study. Int. J. Cardiol. 167, 1038&#x2013;1045 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">22464482</ArticleId></ArticleIdList></Reference><Reference><Citation>Charron, P. et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 96, 214&#x2013;219 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9236436</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, S. et al. International recommendations for electrocardiographic interpretation in athletes. Eur. Heart J. 39, 1466&#x2013;1480 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28329355</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhingra, L. S. et al. A multicenter evaluation of the impact of therapies on deep learning-based electrocardiographic hypertrophic cardiomyopathy markers. Am. J. Cardiol. 237, 35&#x2013;40 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">39581517</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamichhane, B. &amp; Neupane, N. Improved healthcare access in low-resource regions: a review of technological solutions. Preprint at arXiv https://doi.org/10.48550/arXiv.2205.10913 (2022).</Citation></Reference><Reference><Citation>Sau, A. et al. A comparison of artificial intelligence-enhanced electrocardiography approaches for prediction of time-to-mortality using electrocardiogram images. Eur. Heart J. Digit. Health 6, 180&#x2013;189 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">40110221</ArticleId><ArticleId IdType="pmc">11914724</ArticleId></ArticleIdList></Reference><Reference><Citation>Norrish, G. et al. Yield of clinical screening for hypertrophic cardiomyopathy in child first-degree relatives. Circulation 140, 184&#x2013;192 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31006259</ArticleId><ArticleId IdType="pmc">6636798</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafreniere-Roula, M. et al. Family screening for hypertrophic cardiomyopathy: is it time to change practice guidelines? Eur. Heart J. 40, 3672&#x2013;3681 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31170284</ArticleId><ArticleId IdType="pmc">6885133</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado, D., Basso, C., Schiavon, M. &amp; Thiene, G. Screening for hypertrophic cardiomyopathy in young athletes. N. Engl. J. Med. 339, 364&#x2013;369 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9691102</ArticleId></ArticleIdList></Reference><Reference><Citation>Piro, M., Roccia, M. G., Aracena, C. J., Bianchi, M. &amp; Massimo, F. Screening program in the athlete in the suspicion of HCM. J. Integr. Cardiol. https://doi.org/10.15761/JIC.1000110 (2015).</Citation></Reference><Reference><Citation>Anderson, B. R., McElligott, S., Polsky, D. &amp; Vetter, V. L. Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death. Pediatr. Cardiol. 35, 323&#x2013;331 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24005901</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminorroaya, A. et al. Development and multinational validation of an ensemble deep learning algorithm for detecting and predicting structural heart disease using noisy single-lead electrocardiograms. Eur. Heart J. Digit. Health https://doi.org/10.1093/ehjdh/ztaf034 (2025).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjdh/ztaf034</ArticleId><ArticleId IdType="pubmed">40703117</ArticleId><ArticleId IdType="pmc">12282380</ArticleId></ArticleIdList></Reference><Reference><Citation>Albahri, A. S. et al. A systematic review of trustworthy and explainable artificial intelligence in healthcare: assessment of quality, bias risk, and data fusion. Inf. Fusion 96, 156&#x2013;191 (2023).</Citation></Reference><Reference><Citation>O&#x2019;Toole, B. I. Screening for low prevalence disorders. Aust. N. Z. J. Psychiatry 34, A39&#x2013;A46 (2000).</Citation></Reference><Reference><Citation>Basavarajaiah, S. et al. Prevalence of hypertrophic cardiomyopathy in highly trained athletes. J. Am. Coll. Cardiol. 51, 1033&#x2013;1039 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18325444</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger, A. L. et al. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation 101, E215&#x2013;E220 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10851218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, X. &amp; Xu, W. Fast implementation of DeLong&#x2019;s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Process. Lett. 21, 1389&#x2013;1393 (2014).</Citation></Reference><Reference><Citation>DeLong, E. R., DeLong, D. M. &amp; Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837&#x2013;845 (1988).</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40698226</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>The Association of Plasma Osmolarity With No-Reflow in Patients With ST-Segment Elevation Myocardial Infarction: A Retrospective Cohort Study.</ArticleTitle><Pagination><StartPage>e86521</StartPage><MedlinePgn>e86521</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e86521</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.86521</ELocationID><Abstract><AbstractText>Background The no-reflow phenomenon is a serious complication that can occur after primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI), leading to poor myocardial reperfusion and adverse outcomes. Objective This study aims to evaluate the association between admission plasma osmolarity and the occurrence of the no-reflow phenomenon in patients with STEMI undergoing primary PCI. Methods This retrospective cohort study was conducted at Shalamar Hospital, Lahore, Pakistan from February 2022 to February 2025. The study included 486 consecutive patients diagnosed with STEMI who underwent primary PCI.&#xa0;Patients aged &#x2265; 18 years, confirmed diagnosis of STEMI based on chest pain duration of more than 30 minutes, ST-segment elevation of &#x2265;1 mm in at least two contiguous ECG leads, and elevated cardiac biomarkers were included in the study. Results In this study of 486 STEMI patients undergoing primary PCI, high plasma osmolarity (&gt;295 mOsm/L) was significantly associated with an increased incidence of no-reflow (31.1%) compared to normal (13.4%) and low osmolarity groups (9.2%). The incidence of no-reflow was significantly higher in the high osmolarity group (31.1%) compared to the normal (13.4%) and low (9.2%) groups (p &lt; 0.001). High plasma osmolarity was independently associated with an increased risk of no-reflow (adjusted odds ratio 2.94; 95% CI: 1.61-5.38; p &lt; 0.001). Conclusion It is concluded that elevated plasma osmolarity is an independent predictor of the no-reflow phenomenon in STEMI patients undergoing primary PCI. Routine assessment of plasma osmolarity may offer a simple and effective method for early risk stratification, with potential implications for personalized management strategies to improve reperfusion outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Ahmad et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahmad</LastName><ForeName>Faraz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Cardiology, Shalamar Hospital, Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Usman</LastName><ForeName>Ahmad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology, Integrated Medical Care Hospital, Lahore, PAK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiology, Army Cardiac Center, Combined Military Hospital (CMH), Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afreen</LastName><ForeName>Aneela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology, Army Cardiac Center, Combined Military Hospital (CMH), Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aqeel</LastName><ForeName>Iffat</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Cardiology, Shalamar Hospital, Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farooq</LastName><ForeName>Tayyab</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cardiology, Army Cardiac Center, Combined Military Hospital (CMH), Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadeem</LastName><ForeName>Atif</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology, Army Cardiac Center, Combined Military Hospital (CMH), Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanan</LastName><ForeName>Rana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology, Shalamar Hospital, Lahore, PAK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raza</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Internal Medicine, Shalamar Hospital, Lahore, PAK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">no-reflow</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">plasma osmolarity</Keyword><Keyword MajorTopicYN="N">reperfusion</Keyword><Keyword MajorTopicYN="N">st elevation myocardial infarction</Keyword></KeywordList><CoiStatement>Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>11</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>11</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>5</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40698226</ArticleId><ArticleId IdType="pmc">PMC12281604</ArticleId><ArticleId IdType="doi">10.7759/cureus.86521</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The association of plasma osmolarity with no-reflow in patients with ST elevation myocardial infarction: a retrospective cohort study. Hamideyin &#x15e;, Arta&#xe7; &#x130;. Eurasian J Med. 2024;56:27&#x2013;34.</Citation></Reference><Reference><Citation>The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: a meta-analysis. Wang L, Huang S, Zhou Q, Dou L, Lin D. Clin Cardiol. 2024;47:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10891415</ArticleId><ArticleId IdType="pubmed">38400562</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for no-reflow in patients with ST-elevation myocardial infarction who underwent percutaneous coronary intervention: a case-control study. Yu Y, Wu Y, Wu X, Wang J, Wang C. Cardiol Res Pract. 2022;2022:3482518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8930256</ArticleId><ArticleId IdType="pubmed">35308062</ArticleId></ArticleIdList></Reference><Reference><Citation>The association between no-reflow and serum uric acid/albumin ratio in patients with acute myocardial infarction without ST elevation. Nurko&#xe7; SG, Karayi&#x11f;it O. Angiology. 2024;75:72&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">37339132</ArticleId></ArticleIdList></Reference><Reference><Citation>Novel predictors and adverse long-term outcomes of no-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Refaat H, Tantawy A, Gamal AS, Radwan H. Indian Heart J. 2021;73:35&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7961261</ArticleId><ArticleId IdType="pubmed">33714407</ArticleId></ArticleIdList></Reference><Reference><Citation>Myocardial no-reflow in humans. Niccoli G, Burzotta F, Galiuto L, Crea F. J Am Coll Cardiol. 2009;54:281&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">19608025</ArticleId></ArticleIdList></Reference><Reference><Citation>Artificial intelligence evaluation of the utility of HALP score and hematological indicators in estimating no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Rustem Y. Int J Curr Med Biol Sci. 2023;3</Citation></Reference><Reference><Citation>CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. Mirbolouk F, Gholipour M, Salari A, et al. J Cardiovasc Thorac Res. 2018;10:46&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5913693</ArticleId><ArticleId IdType="pubmed">29707178</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of atherogenic index of plasma on pre-percutaneous coronary intervention thrombolysis in myocardial infarction flow in patients with ST elevation myocardial infarction. Ayd&#x131;ny&#x131;lmaz F, &#xd6;zbeyaz NB, Guliyev &#x130;, Alg&#xfc;l E, &#x15e;ahan HF, Kalkan K. Angiology. 2024;75:841&#x2013;848.</Citation><ArticleIdList><ArticleId IdType="pubmed">37399526</ArticleId></ArticleIdList></Reference><Reference><Citation>Predictive value of elevated uric acid in Turkish patients undergoing primary angioplasty for ST elevation myocardial infarction. Akgul O, Uyarel H, Pusuroglu H, et al.  https://pmc.ncbi.nlm.nih.gov/articles/PMC4805017/ Zhonghua Minguo Xin Zang Xue Hui Za Zhi. 2014;30:119&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4805017</ArticleId><ArticleId IdType="pubmed">27122778</ArticleId></ArticleIdList></Reference><Reference><Citation>A novel and useful predictive indicator of prognosis in ST-segment elevation myocardial infarction, the prognostic nutritional index. Keskin M, Hay&#x131;ro&#x11f;lu MI, Keskin T, et al. Nutr Metab Cardiovasc Dis. 2017;27:438&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pubmed">28392077</ArticleId></ArticleIdList></Reference><Reference><Citation>The predictive value of PRECISE-DAPT score for arrhythmic complications in patients with ST-elevation myocardial infarction. Yildirim E, Turkkan C, Ozcan KS, Ceylan US, Zengin A. Coron Artery Dis. 2019;30:499&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">31567370</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of admission red cell distribution width on long-term cardiovascular events after primary percutaneous intervention: a four-year prospective study. Isik T, Kurt M, Tanboga IH, Ayhan E, Gunaydin ZY, Kaya A, Uyarel H. Cardiol J. 2016;23:281&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">26711461</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-term prognostic value of admission haemoglobin A1c (HbA1c) levels in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Pusuroglu H, Akgul O, Cakmak HA, et al. Postepy Kardiol Interwencyjnej. 2014;10:166&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4252307</ArticleId><ArticleId IdType="pubmed">25489302</ArticleId></ArticleIdList></Reference><Reference><Citation>No reflow-phenomenon: from current state of the art to future perspectives. Paradies V, Masi F, Bartolomucci F, et al. AIMS Med Sci. 2015;2:374&#x2013;395.</Citation></Reference><Reference><Citation>Reducing cardiac injury during ST-elevation myocardial infarction: a reasoned approach to a multitarget therapeutic strategy. Bellis A, Di Gioia G, Mauro C, et al. J Clin Med. 2021;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8268641</ArticleId><ArticleId IdType="pubmed">34279451</ArticleId></ArticleIdList></Reference><Reference><Citation>Evolving therapies for myocardial ischemia/reperfusion injury. Ib&#xe1;&#xf1;ez B, Heusch G, Ovize M, Van de Werf F. J Am Coll Cardiol. 2015;65:1454&#x2013;1471.</Citation><ArticleIdList><ArticleId IdType="pubmed">25857912</ArticleId></ArticleIdList></Reference><Reference><Citation>The triglyceride-glucose index and contrast-induced nephropathy in non-ST elevation myocardial infarction patients undergoing percutaneous coronary intervention. Gursoy E, Baydar O. Medicine (Baltimore) 2023;102:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9839251</ArticleId><ArticleId IdType="pubmed">36637929</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction. Baydar O, Kilic A. Cardiovasc Endocrinol Metab. 2020;9:24&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7041873</ArticleId><ArticleId IdType="pubmed">32104788</ArticleId></ArticleIdList></Reference><Reference><Citation>Elevated red cell distribution width level predicts worse postinterventional thrombolysis in myocardial infarction flow reflecting abnormal reperfusion in acute myocardial infarction treated with a primary coronary intervention. Karabulut A, Uyarel H, Uzunlar B, &#xc7;akmak M. Coron Artery Dis. 2012;23:68&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">22167053</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40700000</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0975-5764</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Annals of African medicine</Title><ISOAbbreviation>Ann Afr Med</ISOAbbreviation></Journal><ArticleTitle>Clinical and Angiographic Profile of Acute Coronary Syndrome in Adults Under 40 Years: A Cross-sectional Observational Study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.4103/aam.aam_129_25</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute coronary syndrome (ACS) in young adults presents unique clinical and diagnostic challenges, with limited data from the Indian subcontinent.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">This study aims to assess the clinical profile, risk factors, and diagnostic findings of ACS in adults aged &#x2264;40 years.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This hospital-based, cross-sectional study included 60 patients aged 18-40 with confirmed ACS. Clinical symptoms, laboratory investigations, Electrocardiography (ECG), echocardiography, and coronary angiography were analyzed. Associations were tested using the Chi-square test, with P &lt; 0.05 considered statistically significant.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The median age was 35.5 years; 96.7% were males. Breathlessness and palpitations were reported in all cases, while chest pain was present in 81.7%. Hypertension (40%), diabetes (31.7%), smoking (28.3%), and drug use (55%) were common risk factors. Single-vessel disease was the predominant angiographic finding (61.7%). Smoking correlated significantly with ECG abnormalities (P = 0.0382), and diabetes with severe coronary involvement (P = 0.0429).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ACS in young adults is more prevalent in males and often presents with nonclassical symptoms. Diabetes and smoking are significantly associated with diagnostic severity. Early risk identification and preventive strategies are essential in this population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Annals of African Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pancholi</LastName><ForeName>Tushar</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diggikar</LastName><ForeName>Pradnya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madhukar</LastName><ForeName>Madineni</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sri</LastName><ForeName>Yammanuru Bhavya</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yekkaluru</LastName><ForeName>Sreevidya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patil</LastName><ForeName>Shivraj</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aher</LastName><ForeName>Priyanka</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Prashansa</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Ann Afr Med</MedlineTA><NlmUniqueID>101231417</NlmUniqueID><ISSNLinking>0975-5764</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><OtherAbstract Type="Publisher" Language="fre"><AbstractText><b>R&#xe9;sum&#xe9;</b> <b>Contexte:</b>Le syndrome coronarien aigu (SCA) chez les jeunes adultes pr&#xe9;sente des d&#xe9;fis cliniques et diagnostiques uniques, avec des donn&#xe9;es limit&#xe9;es en provenance du sous-continent indien.<b>Objectif:</b>Cette &#xe9;tude vise &#xe0; &#xe9;valuer le profil clinique, les facteurs de risque et les r&#xe9;sultats diagnostiques du SCA chez les adultes &#xe2;g&#xe9;s de &#x2264;40 ans.<b>Mat&#xe9;riels et M&#xe9;thodes:</b>Cette &#xe9;tude transversale, men&#xe9;e en milieu hospitalier, a inclus 60 patients &#xe2;g&#xe9;s de 18 &#xe0; 40 ans avec un SCA confirm&#xe9;. Les sympt&#xf4;mes cliniques, les examens biologiques, l&#x2019;&#xe9;lectrocardiographie (ECG), l&#x2019;&#xe9;chocardiographie et la coronarographie ont &#xe9;t&#xe9; analys&#xe9;s. Les associations ont &#xe9;t&#xe9; test&#xe9;es &#xe0; l&#x2019;aide du test du Chi-carr&#xe9;, avec une valeur de P &lt; 0,05 consid&#xe9;r&#xe9;e comme statistiquement significative.<b>R&#xe9;sultats:</b>L&#x2019;&#xe2;ge m&#xe9;dian &#xe9;tait de 35,5 ans ; 96,7 % &#xe9;taient des hommes. La dyspn&#xe9;e et les palpitations ont &#xe9;t&#xe9; rapport&#xe9;es dans tous les cas, tandis que la douleur thoracique &#xe9;tait pr&#xe9;sente dans 81,7 % des cas. L&#x2019;hypertension (40 %), le diab&#xe8;te (31,7 %), le tabagisme (28,3 %) et la consommation de drogues (55 %) &#xe9;taient des facteurs de risque courants. L&#x2019;atteinte d&#x2019;un seul vaisseau &#xe9;tait la principale constatation angiographique (61,7 %). Le tabagisme &#xe9;tait significativement corr&#xe9;l&#xe9; aux anomalies de l&#x2019;ECG (P = 0,0382) et le diab&#xe8;te &#xe0; une atteinte coronarienne s&#xe9;v&#xe8;re (P = 0,0429).<b>Conclusions:</b>Le SCA chez les jeunes adultes est plus fr&#xe9;quent chez les hommes et se pr&#xe9;sente souvent avec des sympt&#xf4;mes non classiques. Le diab&#xe8;te et le tabagisme sont significativement associ&#xe9;s &#xe0; une gravit&#xe9; diagnostique accrue. L&#x2019;identification pr&#xe9;coce des risques et les strat&#xe9;gies de pr&#xe9;vention sont essentielles dans cette population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Annals of African Medicine.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiographie coronaire</Keyword><Keyword MajorTopicYN="N">Coronary angiography</Keyword><Keyword MajorTopicYN="N">ST-segment changes</Keyword><Keyword MajorTopicYN="N">anomalies des vaisseaux coronaires</Keyword><Keyword MajorTopicYN="N">coronary vessel anomalies</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">diab&#xe8;te sucr&#xe9;</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">facteurs de risque</Keyword><Keyword MajorTopicYN="N">infarctus du myocarde</Keyword><Keyword MajorTopicYN="N">jeunes hommes</Keyword><Keyword MajorTopicYN="N">modifications du segment ST</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">young male patients</Keyword><Keyword MajorTopicYN="N">&#xe9;lectrocardiographie</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>18</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>23</Day><Hour>12</Hour><Minute>33</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40700000</ArticleId><ArticleId IdType="doi">10.4103/aam.aam_129_25</ArticleId><ArticleId IdType="pii">01244624-990000000-00267</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40711415</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1866-0452</ISSN><JournalIssue CitedMedium="Internet"><Issue>Forthcoming</Issue><PubDate><Year>2025</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Deutsches Arzteblatt international</Title><ISOAbbreviation>Dtsch Arztebl Int</ISOAbbreviation></Journal><ArticleTitle>Triage of Stable Patients With Suspected Acute Myocardial Infarction and Left Bundle Branch Block: A Multicenter, Propensity Score-Matched Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">arztebl.m2025.0126</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3238/arztebl.m2025.0126</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A pragmatic immediate invasive strategy is recommended in patients with ischemic symptoms and suspected left bundle branch block acute myocardial infarction (LBBB-AMI). It is important to identify patients with LBBB-AMI who do not need to be treated with the same strategy as those with ST-segment elevation myocardial infarction (STEMI). In this study, we aimed to compare the outcome of stable but symptomatic patients with suspected LBBB-AMI with that of matched STEMI patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All consecutive patients who were referred for percutaneous coronary intervention (PCI) in a metropolitan, multicenter STEMI network in Germany were analyzed and stratified according to their ECG findings (STEMI or LBBB). Propensity score matching (PSM) and adjusted analyses were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">4563 patients were included: 4219 (92.5%) with STEMI, and 344 (7.5%) with LBBB-AMI. After the identification of stable patients and PSM (n = 187 LBBB-AMI, n = 557 STEMI), the odds ratios for LBBB-AMI patients were 1.61 (95% confidence interval, [0.78; 3.32]) for in-hospital mortality, 0.56 [0.32; 0.91] for culprit lesion, and 2.18 [1.24; 3.84] for impaired patency of infarct-related artery after PCI. The median peak creatine kinase level was 1075 U/L in the STEMI patients and 478 U/L in the LBBB-AMI patients (estimated difference: -153 U/L [-504; 196]). Approximately, 70% of the LBBB-AMI patients had a culprit lesion in combination with myocardial necrosis implying acute stenosis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Approximately, seven of ten symptomatic LBBB-AMI patients had acute culprit lesions requiring timely PCI. The findings support routine emergency coronary angiography in these patients. Future prospective trials should address more selective triage.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Macherey-Meyer</LastName><ForeName>Sascha</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Heyne</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Meertens</LastName><ForeName>Max Maria</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Finke</LastName><ForeName>Karl</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Mauri</LastName><ForeName>Victor</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Terporten</LastName><ForeName>Johannes</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Ahrens</LastName><ForeName>Ingo</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Baer</LastName><ForeName>Frank Michael</ForeName><Initials>FM</Initials></Author><Author ValidYN="Y"><LastName>Eberhardt</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Horlitz</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Sinning</LastName><ForeName>Jan-Malte</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Meissner</LastName><ForeName>Axel</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Rosswinkel</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Baldus</LastName><ForeName>Stephan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Adler</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><CollectiveName>KIM e.V.</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Dtsch Arztebl Int</MedlineTA><NlmUniqueID>101475967</NlmUniqueID><ISSNLinking>1866-0452</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>25</Day><Hour>10</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40711415</ArticleId><ArticleId IdType="doi">10.3238/arztebl.m2025.0126</ArticleId><ArticleId IdType="pii">arztebl.m2025.0126</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40662049</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Unraveling Emergency Room Patterns: Advancing Acute Care in a Newly Established Tertiary Hospital.</ArticleTitle><Pagination><StartPage>e85993</StartPage><MedlinePgn>e85993</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e85993</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.85993</ELocationID><Abstract><AbstractText>Emergency conditions are unavoidable, critical health conditions requiring immediate intervention and treatment. Emergency treatment in our country is quite unregulated and below the benchmark, which may be due to untrained medical staff, bad transportation facilities, and inadequate preparedness. Many emergency cases in our country could not even reach the hospital. In rural areas, primary and community health centers are generally not sufficient to provide adequate emergency services, considering the low ratio of staff, equipment, and lifesaving drugs. Road traffic accidents, acute myocardial infarction (AMI), and cerebrovascular accidents (CVAs) are nowadays taking many lives due to a lack of golden hour treatment.&#xa0;Cardiac arrest cases cannot survive due to a lack of knowledge about defibrillation. AMI cases are neglected in primary centers due to a lack of drugs and electrocardiography (ECG) machines, and patients are unable to survive due to delayed treatment.&#xa0;Upgrading emergency services is essential based on the type of cases visiting the emergency room. The study highlighted the primary nature of cases presented to the emergency department (ED), emphasizing the importance of a well-structured, responsive emergency care system. By identifying common trends, peak hours, and the types of emergencies coming to the hospital, this study provides valuable insights into resource allocation, staffing needs, and the development of protocols. The study's findings ensure the efficiency and effectiveness of emergency services, ultimately improving patient outcomes in the golden hour of treatment and reducing waiting times in the emergency department. Continuous surveillance and periodic evaluation of emergency case patterns will help make a resilient emergency care system.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Guru et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guru</LastName><ForeName>Rashmi Ranjan</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Hospital Administration, All India Institute of Medical Sciences, Jodhpur, Jodhpur, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathur</LastName><ForeName>Namrata</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Emergency Medicine, All India Institute of Medical Sciences, Jodhpur, Jodhpur, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Soujanya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Administration, Government Medical College, Anantapur, Anantapur, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharma</LastName><ForeName>Meenakshi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Nursing, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalai</LastName><ForeName>Swayamprava</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Biotechnology, Chandigarh University, Mohali, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitra</LastName><ForeName>Subhodip</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Administration, All India Institute of Medical Sciences, Kalyani, Kalyani, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">emergency cases</Keyword><Keyword MajorTopicYN="N">emergency patient care</Keyword><Keyword MajorTopicYN="N">management of emergency resources</Keyword><Keyword MajorTopicYN="N">patient profile</Keyword><Keyword MajorTopicYN="N">quality improvement</Keyword></KeywordList><CoiStatement>Human subjects: All authors have confirmed that this study did not involve human participants or tissue. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>5</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40662049</ArticleId><ArticleId IdType="pmc">PMC12257867</ArticleId><ArticleId IdType="doi">10.7759/cureus.85993</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Emergency care in India: a retrospective cross-sectional analysis of health management and information system and global burden of disease. Urs G, Zadey S, Kumar PK, Gangane T, Nimkar P, Staton C, Vissoci JR. medRxiv. 2024</Citation></Reference><Reference><Citation>The transformation of the Indian healthcare system. Kumar A. Cureus. 2023;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10292032</ArticleId><ArticleId IdType="pubmed">37378105</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical factors of patients who die in an emergency department: the significance of early clinical data, especially for the elderly. Serra M, Yuguero O. Signa Vitae. 2024;20:53&#x2013;59.</Citation></Reference><Reference><Citation>Considerations for service delivery for emergency care in low resource settings. Bergquist HB, Burkholder TW, Muhammad Ali OA, Omer Y, Wallis LA. Afr J Emerg Med. 2020;10:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723907</ArticleId><ArticleId IdType="pubmed">33318895</ArticleId></ArticleIdList></Reference><Reference><Citation>Emergency department operations: an overview. Joseph JW, White BA. Emerg Med Clin North Am. 2020;38:549&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pubmed">32616278</ArticleId></ArticleIdList></Reference><Reference><Citation>Emergency department resource optimisation for improved performance: a review. Ahsan KB, Alam MR, Morel DG, et al. J Ind Eng Int. 2019;15:253&#x2013;266.</Citation></Reference><Reference><Citation>Long emergency department length of stay: a concept analysis. Andersson J, Nordgren L, Cheng I, Nilsson U, Kurland L. Int Emerg Nurs. 2020;53:100930.</Citation><ArticleIdList><ArticleId IdType="pubmed">33035877</ArticleId></ArticleIdList></Reference><Reference><Citation>Quality of care. Quality of care. 2025. https://www.who.int/health-topics/quality-of-care#tab=tab_1 https://www.who.int/health-topics/quality-of-care#tab=tab_1</Citation></Reference><Reference><Citation>Emergency department design in low- and middle-income settings: lessons from a university hospital in Haiti. Marsh RH, Chalmers KD, Checkett KA, et al. Ann Glob Health. 2020;86:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6978988</ArticleId><ArticleId IdType="pubmed">31998609</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Emergency Medicine. 2020. http://www.rcem.ac.uk/ http://www.rcem.ac.uk/</Citation></Reference><Reference><Citation>Reforming New South Wales public hospitals: an assessment of the Garling inquiry. Skinner CA, Braithwaite J, Frankum B, Kerridge RK, Goulston KJ. Med J Aust. 2009;190:78&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">19236293</ArticleId></ArticleIdList></Reference><Reference><Citation>Communication skills training for emergency department senior house officers--a qualitative study. Lloyd G, Skarratts D, Robinson N, Reid C. J Accid Emerg Med. 2000;17:246&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1725398</ArticleId><ArticleId IdType="pubmed">10921809</ArticleId></ArticleIdList></Reference><Reference><Citation>Strategies for improving communication in the emergency department: mediums and messages in a noisy environment. Welch SJ, Cheung DS, Apker J, Patterson ES. Jt Comm J Qual Patient Saf. 2013;39:279&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">23789167</ArticleId></ArticleIdList></Reference><Reference><Citation>An interventional study on comprehensive emergency care and trauma registry for road traffic injuries in India: a protocol. Babu BV, Viswanathan K, Ramesh A, et al. Adv J Emerg Med. 2019;3:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6789063</ArticleId><ArticleId IdType="pubmed">31633105</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough L. http://chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://haybusaklib.am/wp-content/uploads/2021/01/Case_Studies_in_Emergency_Medicine.pdf. New York, NY: Cambridge University Press; 2010. Case Studies in Emergency Medicine.</Citation></Reference><Reference><Citation>National Accreditation Board for Hospitals and Healthcare Providers (NABH); 2025. NABH Accreditation Standards for Hospitals.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40659414</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1753-0407</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of diabetes</Title><ISOAbbreviation>J Diabetes</ISOAbbreviation></Journal><ArticleTitle>Association of Different Types of Diabetic Autonomic Neuropathy With Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes: A Cross-Sectional Study.</ArticleTitle><Pagination><StartPage>e70124</StartPage><MedlinePgn>e70124</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70124</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/1753-0407.70124</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To investigate the association between different categories of diabetic autonomic neuropathy (DAN) and left ventricular diastolic dysfunction (LVDD) in patients with type 2 diabetes mellitus (T2DM).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a cross-sectional study of 3440 participants with T2DM recruited in Diabetic Foot Care Center of West China Hospital, Sichuan University from January 2016 to February 2024. LVDD was assessed via echocardiography, defined as an average E/e' ratio&#x2009;&gt;&#x2009;14. Twenty-four hour Holter ECG, postvoid residual volume (PVR) examinations, and gastric emptying scintigraphy were employed to evaluate cardiac autonomic dysfunction, diabetic neurogenic bladder (DNB), and diabetic gastrointestinal autonomic neuropathy (DGAN), respectively. Logistic regression and propensity score matching (PSM) analyses were employed to examine the associations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Severe cardiac autonomic dysfunction (SDNN &lt;&#x2009;50&#x2009;ms) was independently associated with LVDD, with odds ratios (OR) 1.731 (95% CI: 1.103-2.719, p&#x2009;=&#x2009;0,018) after adjustment for potential confounding factors. LVDD tended to be independently associated with DNB (OR 1.356; 95% CI [0.992, 1.856]; p&#x2009;=&#x2009;0.056). PSM analysis further validated the independent associations of SDNN &lt;&#x2009;50&#x2009;ms (OR 1.587, 95% CI 1.028, 2.450, p&#x2009;=&#x2009;0.037) and DNB (OR 1.454, 95% CI 1.011, 2.090, p&#x2009;=&#x2009;0.043). However, DGAN was not independently associated with LVDD. Additionally, women had a higher risk of LVDD compared to men (OR 1.995, 95% CI 1.379, 2.885, p&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Severe (SDNN&#x2009;&lt;&#x2009;50&#x2009;ms), rather than mild-moderate, cardiac autonomic dysfunction, and DNB are independently associated with LVDD in individuals with T2DM. Additionally, women have a higher risk of LVDD than men.</AbstractText><CopyrightInformation>&#xa9; 2025 The Author(s). Journal of Diabetes published by Ruijin Hospital, Shanghai JiaoTong University School of Medicine and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Ruixue</ForeName><Initials>R</Initials><Identifier Source="ORCID">0009-0008-8685-6067</Identifier><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Donge</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Mingxin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ran</LastName><ForeName>Xingwu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Dawei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chun</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lihong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Shuang</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Sen</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9777-2650</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Endocrinology, Chengdu Eighth People's Hospital, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Murong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lei</LastName><ForeName>Zhiyi</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>West China Medical School, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7269-9741</Identifier><AffiliationInfo><Affiliation>Diabetic Foot Care Center, Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>24LCYJZD02</GrantID><Agency>Health Commission of Sichuan Province Medical Science and Technology Program</Agency><Country/></Grant><Grant><GrantID>ZYGD24005</GrantID><Agency>the 1.3.5 Project for Disciplines of Excellence, West China Hospital of Sichuan University, China</Agency><Country/></Grant><Grant><GrantID>2024NSFSC1624</GrantID><Agency>Sichuan Science and Technology Program</Agency><Country/></Grant><Grant><GrantID>GZC20241152</GrantID><Agency>Postdoctoral Fellowship Program of CPSF</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>J Diabetes</MedlineTA><NlmUniqueID>101504326</NlmUniqueID><ISSNLinking>1753-0407</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018487" MajorTopicYN="Y">Ventricular Dysfunction, Left</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003929" MajorTopicYN="Y">Diabetic Neuropathies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003971" MajorTopicYN="N">Diastole</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac autonomic dysfunction</Keyword><Keyword MajorTopicYN="N">diabetic neurogenic bladder</Keyword><Keyword MajorTopicYN="N">gastrointestinal autonomic neuropathy</Keyword><Keyword MajorTopicYN="N">left ventricular diastolic dysfunction</Keyword><Keyword MajorTopicYN="N">type 2 diabetes mellitus</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>14</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40659414</ArticleId><ArticleId IdType="pmc">PMC12259274</ArticleId><ArticleId IdType="doi">10.1111/1753-0407.70124</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dunlay S. M., Givertz M. M., Aguilar D., et&#xa0;al., &#x201c;Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This Statement Does Not Represent an Update of the 2017 ACC/AHA/HFSA Heart Failure Guideline Update,&#x201d; Circulation 140 (2019): E294&#x2013;E324.</Citation><ArticleIdList><ArticleId IdType="pubmed">31167558</ArticleId></ArticleIdList></Reference><Reference><Citation>Pop&#x2010;Busui R., Januzzi J. L., Bruemmer D., et&#xa0;al., &#x201c;Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association,&#x201d; Diabetes Care 45 (2022): 1670&#x2013;1690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9726978</ArticleId><ArticleId IdType="pubmed">35796765</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura K., Miyoshi T., Yoshida M., et&#xa0;al., &#x201c;Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients With Diabetes Mellitus,&#x201d; International Journal of Molecular Sciences 23 (2022): 3587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8999085</ArticleId><ArticleId IdType="pubmed">35408946</ArticleId></ArticleIdList></Reference><Reference><Citation>Redfield M. M., &#x201c;Heart Failure With Preserved Ejection Fraction,&#x201d; New England Journal of Medicine 375 (2016): 1868&#x2013;1877.</Citation><ArticleIdList><ArticleId IdType="pubmed">27959663</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunlay S. M., Roger V. L., and Redfield M. M., &#x201c;Epidemiology of Heart Failure With Preserved Ejection Fraction,&#x201d; Nature Reviews. Cardiology 14 (2017): 591&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">28492288</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarese G., Becher P. M., Lund L. H., Seferovic P., Rosano G. M. C., and Coats A. J. S., &#x201c;Global Burden of Heart Failure: A Comprehensive and Updated Review of Epidemiology,&#x201d; Cardiovascular Research 118 (2023): 3272&#x2013;3287.</Citation><ArticleIdList><ArticleId IdType="pubmed">35150240</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioncel O., Lainscak M., Seferovic P. M., et&#xa0;al., &#x201c;Epidemiology and One&#x2010;Year Outcomes in Patients With Chronic Heart Failure and Preserved, Mid&#x2010;Range and Reduced Ejection Fraction: An Analysis of the ESC Heart Failure Long&#x2010;Term Registry,&#x201d; European Journal of Heart Failure 19 (2017): 1574&#x2013;1585.</Citation><ArticleIdList><ArticleId IdType="pubmed">28386917</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiga T., Suzuki A., Haruta S., et&#xa0;al., &#x201c;Clinical Characteristics of Hospitalized Heart Failure Patients With Preserved, Mid&#x2010;Range, and Reduced Ejection Fractions in Japan,&#x201d; ESC Heart Failure 6 (2019): 475&#x2013;486.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487690</ArticleId><ArticleId IdType="pubmed">30829002</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters A. E., Tromp J., Shah S. J., et&#xa0;al., &#x201c;Phenomapping in Heart Failure With Preserved Ejection Fraction: Insights, Limitations, and Future Directions,&#x201d; Cardiovascular Research 119 (2023): 1096.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10153638</ArticleId><ArticleId IdType="pubmed">36680536</ArticleId></ArticleIdList></Reference><Reference><Citation>Upadhya B. and Kitzman D. W., &#x201c;Heart Failure With Preserved Ejection Fraction: New Approaches to Diagnosis and Management,&#x201d; Clinical Cardiology 43 (2020): 145&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7021648</ArticleId><ArticleId IdType="pubmed">31880340</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane G. C., Karon B. L., Mahoney D. W., et&#xa0;al., &#x201c;Progression of Left Ventricular Diastolic Dysfunction and Risk of Heart Failure,&#x201d; JAMA 306 (2011): 856&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3269764</ArticleId><ArticleId IdType="pubmed">21862747</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H., Negishi K., Wang Y., Nolan M., Saito M., and Marwick T. H., &#x201c;Echocardiographic Screening for Non&#x2010;Ischaemic Stage B Heart Failure in the Community,&#x201d; European Journal of Heart Failure 18 (2016): 1331&#x2013;1339.</Citation><ArticleIdList><ArticleId IdType="pubmed">27813300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosmala W. and Marwick T. H., &#x201c;Asymptomatic Left Ventricular Diastolic Dysfunction: Predicting Progression to Symptomatic Heart Failure,&#x201d; JACC: Cardiovascular Imaging 13 (2020): 215&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">31005530</ArticleId></ArticleIdList></Reference><Reference><Citation>Pop&#x2010;Busui R., &#x201c;Autonomic Diabetic Neuropathies: A Brief Overview,&#x201d; Diabetes Research and Clinical Practice 206, no. Suppl 1 (2023): 110762.</Citation><ArticleIdList><ArticleId IdType="pubmed">38245325</ArticleId></ArticleIdList></Reference><Reference><Citation>Pop&#x2010;Busui R., Boulton A. J. M., Feldman E. L., et&#xa0;al., &#x201c;Diabetic Neuropathy: A Position Statement by the American Diabetes Association,&#x201d; Diabetes Care 40 (2017): 136&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6977405</ArticleId><ArticleId IdType="pubmed">27999003</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti K. G. and Zimmet P. Z., &#x201c;Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus Provisional Report of a WHO Consultation,&#x201d; Diabetic Medicine 15 (1998): 539&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pubmed">9686693</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuperstein R., Hanly P., Niroumand M., and Sasson Z., &#x201c;The Importance of Age and Obesity on the Relation Between Diabetes and Left Ventricular Mass,&#x201d; Journal of the American College of Cardiology 37 (2001): 1957&#x2013;1962.</Citation><ArticleIdList><ArticleId IdType="pubmed">11401138</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagueh S. F., Smiseth O. A., Appleton C. P., et&#xa0;al., &#x201c;Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update From the American Society of Echocardiography and the European Association of Cardiovascular Imaging,&#x201d; Journal of the American Society of Echocardiography 29 (2016): 277&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pubmed">27037982</ArticleId></ArticleIdList></Reference><Reference><Citation>Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology , &#x201c;Heart Rate Variability. Standards of Measurement, Physiological Interpretation, and Clinical Use,&#x201d; European Heart Journal 17 (1996): 354&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">8737210</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan J., Batin P. D., Andrews R., et&#xa0;al., &#x201c;Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure: Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK&#x2010;Heart),&#x201d; Circulation 98 (1998): 1510&#x2013;1516.</Citation><ArticleIdList><ArticleId IdType="pubmed">9769304</ArticleId></ArticleIdList></Reference><Reference><Citation>Jn P., Cj F., and Tm K., &#x201c;Lower Urinary Tract Dysfunction in the Neurological Patient: Clinical Assessment and Management,&#x201d; Lancet Neurology 14 (2015): 720&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">26067125</ArticleId></ArticleIdList></Reference><Reference><Citation>Camilleri M., Kuo B., Nguyen L., et&#xa0;al., &#x201c;ACG Clinical Guideline: Gastroparesis,&#x201d; American Journal of Gastroenterology 117 (2022): 1197&#x2013;1220.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9373497</ArticleId><ArticleId IdType="pubmed">35926490</ArticleId></ArticleIdList></Reference><Reference><Citation>American Diabetes Association Professional Practice Committee , &#x201c;12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes&#x2010;2024,&#x201d; Diabetes Care 47 (2024): S231&#x2013;S243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10725803</ArticleId><ArticleId IdType="pubmed">38078577</ArticleId></ArticleIdList></Reference><Reference><Citation>Tesfaye S., Boulton A. J. M., Dyck P. J., et&#xa0;al., &#x201c;Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments,&#x201d; Diabetes Care 33 (2010): 2285&#x2013;2293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2945176</ArticleId><ArticleId IdType="pubmed">20876709</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai M., Chen D., Liu Y., et&#xa0;al., &#x201c;Cardiac Electrophysiology, Structure and Diastolic Function in Patients With Diabetic Foot Versus Those Without Diabetic Foot,&#x201d; Journal of Diabetes Investigation 15 (2024): 1276&#x2013;1286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11363107</ArticleId><ArticleId IdType="pubmed">38860568</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue P., Covassin N., Ran X., et&#xa0;al., &#x201c;Association of Parameters of Nocturnal Hypoxemia With Diabetic Microvascular Complications: A Cross&#x2010;Sectional Study,&#x201d; Diabetes Research and Clinical Practice 170 (2020): 108484.</Citation><ArticleIdList><ArticleId IdType="pubmed">33031843</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinh W., F&#xfc;th R., Lankisch M., et&#xa0;al., &#x201c;Cardiovascular Autonomic Neuropathy Contributes to Left Ventricular Diastolic Dysfunction in Subjects With Type 2 Diabetes and Impaired Glucose Tolerance Undergoing Coronary Angiography,&#x201d; Diabetic Medicine 28 (2011): 311&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pubmed">21204960</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Wang W., Zhu L., et&#xa0;al., &#x201c;Cardiovascular Autonomic Neuropathy Is an Independent Risk Factor for Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes,&#x201d; BioMed Research International 2017 (2017): 3270617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5468548</ArticleId><ArticleId IdType="pubmed">28638827</ArticleId></ArticleIdList></Reference><Reference><Citation>Agashe S. and Petak S., &#x201c;Cardiac Autonomic Neuropathy in Diabetes Mellitus,&#x201d; Methodist DeBakey Cardiovascular Journal 14 (2018): 251&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6369622</ArticleId><ArticleId IdType="pubmed">30788010</ArticleId></ArticleIdList></Reference><Reference><Citation>Borkar R. and Mane S., &#x201c;Association Between Left Ventricular Diastolic Dysfunction (LVDD) and Cardiac Autonomic Neuropathy (CAN) in Type 2 DM,&#x201d; Journal of the Association of Physicians of India 68 (2020): 50.</Citation><ArticleIdList><ArticleId IdType="pubmed">31979564</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata T., Inoue S., Masauji T., Miyazawa K., and Motoo Y., &#x201c;Generation and Accumulation of Various Advanced Glycation End&#x2010;Products in Cardiomyocytes May Induce Cardiovascular Disease,&#x201d; International Journal of Molecular Sciences 25 (2024): 7319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11242264</ArticleId><ArticleId IdType="pubmed">39000424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissinger A., &#x201c;Cardiac Autonomic Neuropathy: Why Should Cardiologists Care About That?,&#x201d; Journal Diabetes Research 2017 (2017): 5374176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5682059</ArticleId><ArticleId IdType="pubmed">29214181</ArticleId></ArticleIdList></Reference><Reference><Citation>Ksela J., Rupert L., Djordjevic A., Antonic M., Avbelj V., and Jug B., &#x201c;Altered Heart Rate Turbulence and Variability Parameters Predict 1&#x2010;Year Mortality in Heart Failure With Preserved Ejection Fraction,&#x201d; Journal of Cardiovascular Development and Disease 9 (2022): 213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9321795</ArticleId><ArticleId IdType="pubmed">35877575</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia G., Hill M. A., and Sowers J. R., &#x201c;Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity,&#x201d; Circulation Research 122 (2018): 624&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5819359</ArticleId><ArticleId IdType="pubmed">29449364</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacco F. and Brownlee M., &#x201c;Oxidative Stress and Diabetic Complications,&#x201d; Circulation Research 107 (2010): 1058&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996922</ArticleId><ArticleId IdType="pubmed">21030723</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D.&#x2010;R., Wang M.&#x2010;Y., Zhang C.&#x2010;L., and Wang Y., &#x201c;Endothelial Dysfunction in Vascular Complications of Diabetes: A Comprehensive Review of Mechanisms and Implications,&#x201d; Frontiers in Endocrinology 15 (2024): 1359255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11026568</ArticleId><ArticleId IdType="pubmed">38645427</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyett B., Martinez F. J., Gill B. M., et&#xa0;al., &#x201c;Delayed Radionucleotide Gastric Emptying Studies Predict Morbidity in Diabetics With Symptoms of Gastroparesis,&#x201d; Gastroenterology 137 (2009): 445&#x2013;452.</Citation><ArticleIdList><ArticleId IdType="pubmed">19410575</ArticleId></ArticleIdList></Reference><Reference><Citation>El Halabi M. and Parkman H. P., &#x201c;2023 Update on the Clinical Management of Gastroparesis,&#x201d; Expert Review of Gastroenterology &amp; Hepatology 17 (2023): 431&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">36970885</ArticleId></ArticleIdList></Reference><Reference><Citation>Choung R. S., Locke G. R., Schleck C. D., Zinsmeister A. R., Melton L. J., and Talley N. J., &#x201c;Risk of Gastroparesis in Subjects With Type 1 and 2 Diabetes in the General Population,&#x201d; American Journal of Gastroenterology 107 (2012): 82&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3280088</ArticleId><ArticleId IdType="pubmed">22085818</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J. J., &#x201c;Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes,&#x201d; Diabetes and Metabolism Journal 45 (2021): 146&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8024162</ArticleId><ArticleId IdType="pubmed">33813813</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40660572</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>104</Volume><Issue>28</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>11</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Electrocardiographic and clinical predictors for in-hospital mortality in patients with acute myocardial infarction caused by left main coronary artery occlusion.</ArticleTitle><Pagination><StartPage>e43287</StartPage><MedlinePgn>e43287</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e43287</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000043287</ELocationID><Abstract><AbstractText>The data on prediction for early mortality in patients with acute myocardial infarction (AMI) caused by total left main (LM) occlusion are limited. We aim to evaluate predictors for early mortality in these extremely high-risk patients. In this retrospective study, all consecutive patients with total occlusive LM-AMI were included between January 1997 and October 2023. The ECG and clinical data were compared between the in-hospital mortality and survival groups. The receiver operating characteristic curve (ROC) was created to identify the best predictors of in-hospital mortality. The primary endpoint was in-hospital mortality. Secondary outcomes included major adverse cardiovascular events. A total of 116 patients were included. The in-hospital mortality was 47% (54/116), and the 5-year MACE-free survival rate was 44%. ST-elevation myocardial infarction (STEMI), cardiogenic shock, STEMI plus shock, STEMI plus left anterior fascicular block (LAFB)&#x2005;+&#x2005;right bundle branch block (RBBB), post-procedural TIMI I to II flow, and collateral flow absence were associated with in-hospital death, with the area under ROC (AUC) of 0.726, 0.704, 0.782, 0.605, 0.633, and 0.671, respectively. ST-elevation in aVR and ST-elevation in aVR&#x2005;+&#x2005;aVL were more common in the survival group. STEMI plus shock showed a significantly greater AUC than the other predictors (82% specificity and 74% sensitivity, Z&#x2005;=&#x2005;1.980, P&#x2005;&lt;&#x2005;.05). STEMI plus LAFB&#x2005;+&#x2005;RBBB predicted in-hospital mortality with a specificity of 95% and a sensitivity of 26%. ECG features were associated with shock and collateral circulation. Patients with shock presented with more STEMI, LAFB&#x2005;+&#x2005;RBBB, STEMI plus LAFB&#x2005;+&#x2005;RBBB, collateral flow absence, prolonged QRS interval, and less ST-elevation in aVR (P&#x2005;&lt;&#x2005;.05). STEMI plus shock is a valuable predictor for in-hospital mortality in patients with acute total LM occlusion. STEMI plus LAFB&#x2005;+&#x2005;RBBB predicted a fatal in-hospital outcome in LM occlusion with high specificity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chunwei</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1885-5114</Identifier><AffiliationInfo><Affiliation>Department of Cardiology, Tianjin Chest Hospital, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Ultrasound, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Yuecheng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tianjin Chest Hospital, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jingxia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tianjin Chest Hospital, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cong</LastName><ForeName>Hongliang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tianjin Chest Hospital, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ximing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Tianjin Chest Hospital, Tianjin University, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="Y">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054059" MajorTopicYN="Y">Coronary Occlusion</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072657" MajorTopicYN="N">ST Elevation Myocardial Infarction</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">STEMI</Keyword><Keyword MajorTopicYN="N">electrocardiographic</Keyword><Keyword MajorTopicYN="N">in-hospital mortality</Keyword><Keyword MajorTopicYN="N">left main occlusion</Keyword><Keyword MajorTopicYN="N">shock</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40660572</ArticleId><ArticleId IdType="pmc">PMC12263001</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000043287</ArticleId><ArticleId IdType="pii">00005792-202507110-00072</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>El Nasasra A, Hochadel M, Zahn R, et al. ; ALKK-Study Group. Outcomes after left main percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock (from the German ALKK PCI Registry). Am J Cardiol. 2023;197:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">37173201</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvan-Roman F, Fernandez-Herrero I, Ariza-Sole A, et al. Prognosis of cardiogenic shock secondary to culprit left main coronary artery lesion-related myocardial infarction. ESC Heart Fail. 2023;10:111&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9871657</ArticleId><ArticleId IdType="pubmed">36151843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki O, Sasaki H. Electrocardiographic QRS findings upon admission can predict prognosis of acute myocardial infarction caused by occlusion of left main coronary artery. Cureus. 2023;15:e36435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10115561</ArticleId><ArticleId IdType="pubmed">37090322</ArticleId></ArticleIdList></Reference><Reference><Citation>Beijk MAM, Palacios-Rubio J, Grundeken MJD, Kalkman DN, De Winter RJ. Clinical outcomes after percutaneous coronary intervention for cardiogenic shock secondary to total occlusive unprotected left main coronary artery lesion-related acute myocardial infarction. J Clin Med. 2023;12:1311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9959397</ArticleId><ArticleId IdType="pubmed">36835846</ArticleId></ArticleIdList></Reference><Reference><Citation>Homorodean C, Iancu AC, Leucuta D, et al. New predictors of early and late outcomes after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and unprotected left main coronary artery culprit lesion. J Interv Cardiol. 2019;2019:8238972.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6739789</ArticleId><ArticleId IdType="pubmed">31772547</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj R, Ramasamy A, Brown JT, et al. Treatment strategies and outcomes of emergency left main percutaneous coronary intervention. Am J Cardiol. 2022;177:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">35732552</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Yang F, Hu Y, et al. Combining electrocardiographic criteria for predicting acute total left main coronary artery occlusion. Front Cardiovasc Med. 2022;9:936687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9408578</ArticleId><ArticleId IdType="pubmed">36035902</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, et al. ; ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">30165617</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzogias L, Steinberg LA, Williams AJ, et al. Electrocardiographic features and prevalence of bilateral bundle-branch delay. Circ Arrhythm Electrophysiol. 2014;7:640&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25015953</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu CW, Zhang JX, Hu YC, Wang L, Zhang YY, Cong HL. The de Winter electrocardiographic pattern evolves to ST elevation in acute total left main occlusion: a case series. Ann Noninvasive Electrocardiol. 2021;27:e12855.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8739620</ArticleId><ArticleId IdType="pubmed">34042244</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CK, Gao W, Stewart RA, et al. ; HERO-2 Investigators. aVR ST elevation: an important but neglected sign in ST elevation acute myocardial infarction. Eur Heart J. 2010;31:1845&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2913115</ArticleId><ArticleId IdType="pubmed">20513728</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamaji H, Iwasaki K, Kusachi S, et al. Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead aVR with less ST segment elevation in lead V(1). J Am Coll Cardiol. 2001;38:1348&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">11691506</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida T, Tanimura F, Takahashi K, et al. Electrocardiographic characteristics associated with in-hospital outcome in patients with left main acute coronary syndrome: for contriving a new risk stratification score. Eur Heart J Acute Cardiovasc Care. 2018;7:200&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">29027810</ArticleId></ArticleIdList></Reference><Reference><Citation>Almudarra SS, Gale CP, Baxter PD, et al. ; National Institute for Cardiovascular Outcomes Research (NICOR). Comparative outcomes after unprotected left main stem percutaneous coronary intervention: a national linked cohort study of 5,065 acute and elective cases from the BCIS Registry (British Cardiovascular Intervention Society). JACC Cardiovasc Interv. 2014;7:717&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">25060013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H, Huang YS, Zhao YT, et al. Clinical and electrocardiographic features in acute total left main coronary artery occlusion without collateral circulation. J Electrocardiol. 2023;76:79&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">36512934</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgarbossa EB, Pinski SL, Topol EJ, et al. Acute myocardial infarction and complete bundle branch block at hospital admission: clinical characteristics and outcome in the thrombolytic era. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-type plasminogen activator] for Occluded Coronary Arteries. J Am Coll Cardiol. 1998;31:105&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">9426026</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy S. Bundle branch blocks and/or hemiblocks complicating acute myocardial ischemia or infarction. J Interv Card Electrophysiol. 2018;52:287&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">30136134</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann JT, Sorensen NA, Rubsamen N, et al. Right bundle branch block in patients with suspected myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2019;8:161&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30362813</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Angelo C, Zagnoni S, Gallo P, Tortorici G, Casella G, Di Pasquale G. Electrocardiographic changes in patients with acute myocardial infarction caused by left main trunk occlusion. J Cardiovasc Med (Hagerstown). 2018;19:439&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">29889168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurisu S, Inoue I, Kawagoe T, et al. Electrocardiographic features in patients with acute myocardial infarction associated with left main coronary artery occlusion. Heart. 2004;90:1059&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1768401</ArticleId><ArticleId IdType="pubmed">15310704</ArticleId></ArticleIdList></Reference><Reference><Citation>Widimsky P, Rohac F, Stasek J, et al. Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? Eur Heart J. 2012;33:86&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3249219</ArticleId><ArticleId IdType="pubmed">21890488</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnbaum Y, Rankinen J, Jneid H, Atar D, Nikus K. The role of ECG in the diagnosis and risk stratification of acute coronary syndromes: an old but indispensable tool. Curr Cardiol Rep. 2022;24:109&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">35028816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiol M, Carrillo A, Rodriguez A, Pascual M, Bethencourt A, Bayes de Luna A. Electrocardiographic changes of ST-elevation myocardial infarction in patients with complete occlusion of the left main trunk without collateral circulation: differential diagnosis and clinical considerations. J Electrocardiol. 2012;45:487&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">22672790</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayes de Luna A, Fiol-Sala M. Where is the culprit lesion? Circulation. 2016;134:1507&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27821423</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Bravo DH, Escabi-Mendoza J. Electrocardiographic recognition of unprotected left main ST-segment elevation myocardial infarction: looking beyond aVR. JACC Case Rep. 2021;3:754&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8311158</ArticleId><ArticleId IdType="pubmed">34317620</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Barrios A, Gheorghe L, Camacho-Freire S, et al. Primary angioplasty in a catastrophic presentation: acute left main coronary total occlusion-the ATOLMA registry. J Interv Cardiol. 2020;2020:5246504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403907</ArticleId><ArticleId IdType="pubmed">32774186</ArticleId></ArticleIdList></Reference><Reference><Citation>Gharacholou SM, Ijioma NN, Lennon RJ, et al. Characteristics and long term outcomes of patients with acute coronary syndromes due to culprit left main coronary artery disease treated with percutaneous coronary intervention. Am Heart J. 2018;199:156&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">29754655</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A, Aguirre FV, Chambers J, et al. STEMI: considerations for left main culprit lesions. Curr Cardiol Rep. 2022;24:645&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">35384548</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiele H, Zeymer U, Neumann FJ, et al. ; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">22920912</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller PE, Bromfield SG, Ma Q, et al. Clinical outcomes and cost associated with an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump in patients presenting with acute myocardial infarction complicated by cardiogenic shock. JAMA Intern Med. 2022;182:926&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9295019</ArticleId><ArticleId IdType="pubmed">35849410</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap J, Singh GD, Kim JS, et al. Outcomes of primary percutaneous coronary intervention in acute myocardial infarction due to unprotected left main thrombosis: the Asia-Pacific Left Main ST-Elevation Registry (ASTER). J Interv Cardiol. 2018;31:129&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">29148142</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40662000</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Prognostic Accuracy of the HEART Score in Predicting Major Adverse Cardiac Events: A Prospective Observational Study.</ArticleTitle><Pagination><StartPage>e85966</StartPage><MedlinePgn>e85966</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e85966</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.85966</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early diagnosis and effective risk stratification of patients presenting with chest pain who are at a high risk for adverse cardiac outcomes remain priorities in emergency departments (EDs). Major adverse cardiac events (MACE) in this context include myocardial infarction, death, and urgent revascularization procedures. The HEART score, comprising History, ECG, Age, Risk factors, and Troponin, was developed to facilitate rapid and reliable risk assessment. However, shortcomings in emergency care in India, such as limited access to advanced diagnostics and variability in clinical risk assessment, underscore the need for dependable tools validated in local settings. This study aims to address these gaps by providing prospective validation of the HEART score in an Indian tertiary care ED.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The primary objective was to assess the accuracy of the HEART score in predicting MACE within 30 days among adults presenting with chest pain (excluding ST-elevation myocardial infarction). Secondary objectives included evaluating the score's diagnostic validity in guiding clinical decision-making, improving patient disposition accuracy, and optimizing resource utilization, such as reducing unnecessary admissions and invasive testing in the ED setting.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study was carried out at JSS Hospital's ED in Mysuru, India, from March to November 2022. We analyzed clinical data from 404 patients presenting to the ED with chest pain. Inter-observer variability was minimized by standardized training of clinicians performing the HEART score assessment. High-sensitivity troponin I assays (third generation) were employed to enhance reproducibility. The HEART score's predictive accuracy for MACE, defined as myocardial infarction, death, or urgent revascularization, within 30 days, was evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 404 patients, 325 (80.4%) had low HEART scores (0-3) with a MACE incidence of 0.9% (3/325; p &lt; 0.0001). Intermediate-risk patients (score 4-6) experienced MACE in 28.6% (16/56), while high-risk patients (score 7-10) had an MACE incidence of 89.2% (21/23) (p &lt; 0.0001). These findings align with prior international validations, supporting the HEART score's utility in the Indian ED context.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The HEART score enables effective, rapid risk stratification of chest pain patients, aiding clinical decision-making and potentially reducing unnecessary admissions, radiation exposure, and invasive procedures. This prospective study adds valuable evidence supporting the HEART score's applicability in Indian emergency care, addressing limitations in current risk assessment practices and resource constraints.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Reddy et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reddy</LastName><ForeName>R Hareeth</ForeName><Initials>RH</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, JSS Academy of Higher Education and Research, Mysuru, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Srinivasarangan</LastName><ForeName>Madhu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, JSS Academy of Higher Education and Research, Mysuru, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teja B</LastName><ForeName>Sai Surya</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Pinnamaneni Siddhartha Medical College, Vijayawada, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagadeesh</LastName><ForeName>Sri Harsha</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, JSS Academy of Higher Education and Research, Mysuru, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basavaraju</LastName><ForeName>Brinda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, JSS Academy of Higher Education and Research, Mysuru, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">emergency department</Keyword><Keyword MajorTopicYN="N">heart score</Keyword><Keyword MajorTopicYN="N">mace</Keyword><Keyword MajorTopicYN="N">prognostic accuracy</Keyword></KeywordList><CoiStatement>Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Institutional Ethical Committee of JSS Medical College, Mysuru issued approval JSS/MC/PG/6380/2021-22. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>15</Day><Hour>5</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40662000</ArticleId><ArticleId IdType="pmc">PMC12256709</ArticleId><ArticleId IdType="doi">10.7759/cureus.85966</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>State-of-the-art evaluation of emergency department patients presenting with potential acute coronary syndromes. Hollander JE, Than M, Mueller C. Circulation. 2016;134:547&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">27528647</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest pain in general practice: incidence, comorbidity and mortality. Ruig&#xf3;mez A, Rodr&#xed;guez LA, Wallander MA, Johansson S, Jones R. Fam Pract. 2006;23:167&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">16461444</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart disease and stroke statistics&#x2014;2020 update: a report from the American Heart Association. Virani SS, Alonso A, Benjamin EJ, et al. Circulation. 2020;141:0&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pubmed">31992061</ArticleId></ArticleIdList></Reference><Reference><Citation>A national study of the prevalence of life-threatening diagnoses in patients with chest pain. Hsia RY, Hale Z, Tabas JA. JAMA Intern Med. 2016;176:1029&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">27295579</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute coronary syndrome in the Asia-Pacific region. Chan MY, Du X, Eccleston D, et al. Int J Cardiol. 2016;202:861&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pubmed">26476044</ArticleId></ArticleIdList></Reference><Reference><Citation>Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. Roth GA, Mensah GA, Johnson CO, et al. J Am Coll Cardiol. 2020;76:2982&#x2013;3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7755038</ArticleId><ArticleId IdType="pubmed">33309175</ArticleId></ArticleIdList></Reference><Reference><Citation>Growing epidemic of coronary heart disease in low- and middle-income countries. Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Curr Probl Cardiol. 2010;35:72&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2864143</ArticleId><ArticleId IdType="pubmed">20109979</ArticleId></ArticleIdList></Reference><Reference><Citation>Heart disease in Asia. Sasayama S. Circulation. 2008;118:2669&#x2013;2671.</Citation><ArticleIdList><ArticleId IdType="pubmed">19106388</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary heart disease and risk factors in India - on the brink of an epidemic? Krishnan MN. Indian Heart J. 2012;64:364&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3860846</ArticleId><ArticleId IdType="pubmed">22929818</ArticleId></ArticleIdList></Reference><Reference><Citation>The burden of cardiovascular diseases among US states, 1990-2016. Roth GA, Johnson CO, Abate KH, et al. JAMA Cardiol. 2018;3:375&#x2013;389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6145754</ArticleId><ArticleId IdType="pubmed">29641820</ArticleId></ArticleIdList></Reference><Reference><Citation>2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Gulati M, Levy PD, Mukherjee D, et al. Circulation. 2021;144:0&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">34709879</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical consumption compared for TIMI and HEART score in chest pain patients at the emergency department: a retrospective cost analysis. Nieuwets A, Poldervaart JM, Reitsma JB, et al. BMJ Open. 2016;6:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4916625</ArticleId><ArticleId IdType="pubmed">27311905</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest pain in the emergency room: a multicenter validation of the HEART Score. Backus BE, Six AJ, Kelder JC, et al. Crit Pathw Cardiol. 2010;9:164&#x2013;169.</Citation><ArticleIdList><ArticleId IdType="pubmed">20802272</ArticleId></ArticleIdList></Reference><Reference><Citation>The HEART score for the assessment of patients with chest pain in the emergency department: a multinational validation study. Six AJ, Cullen L, Backus BE, et al. Crit Pathw Cardiol. 2013;12:121&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">23892941</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiological features of cardiovascular disease in Asia. Zhao D. JACC Asia. 2021;1:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9627928</ArticleId><ArticleId IdType="pubmed">36338365</ArticleId></ArticleIdList></Reference><Reference><Citation>Age- and sex-specific burden of cardiovascular disease attributable to five major and modifiable risk factors in 10 Asian countries of the Western Pacific region. Huxley RR, Hirakawa Y, Hussain MA, et al. Circ J. 2015;79:1662&#x2013;1674.</Citation><ArticleIdList><ArticleId IdType="pubmed">26155801</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary artery disease in South Asians. Narasimhan S, McKay K, Bainey KR. Cardiol Rev. 2012;20:304&#x2013;311.</Citation><ArticleIdList><ArticleId IdType="pubmed">22418248</ArticleId></ArticleIdList></Reference><Reference><Citation>Utility of cardiac biomarkers for the diagnosis of type V myocardial infarction after coronary artery bypass grafting: insights from serial cardiac MRI. Pegg TJ, Maunsell Z, Karamitsos TD, et al. Heart. 2011;97:810&#x2013;816.</Citation><ArticleIdList><ArticleId IdType="pubmed">21378388</ArticleId></ArticleIdList></Reference><Reference><Citation>Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Circulation. 2015;131:861&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">25587100</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease. Lindahl B, Baron T, Erlinge D, Hadziosmanovic N, Nordenskj&#xf6;ld A, Gard A, Jernberg T. Circulation. 2017;135:1481&#x2013;1489.</Citation><ArticleIdList><ArticleId IdType="pubmed">28179398</ArticleId></ArticleIdList></Reference><Reference><Citation>2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Ibanez B, James S, Agewall S, et al. Eur Heart J. 2018;39:119&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>A comprehensive review on the pharmacological prospects of Terpinen-4-ol: from nature to medicine and beyond. Prerna Prerna, Chadha J, Khullar L, Mudgil U, Harjai K. Fitoterapia. 2024;176:106051.</Citation><ArticleIdList><ArticleId IdType="pubmed">38838826</ArticleId></ArticleIdList></Reference><Reference><Citation>Non-ST-segment acute coronary syndromes. Hedayati T, Yadav N, Khanagavi J. Cardiol Clin. 2018;36:37&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">29173680</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechanisms of plaque formation and rupture. Bentzon JF, Otsuka F, Virmani R, Falk E. Circ Res. 2014;114:1852&#x2013;1866.</Citation><ArticleIdList><ArticleId IdType="pubmed">24902970</ArticleId></ArticleIdList></Reference><Reference><Citation>Contemporary NSTEMI management: the role of the hospitalist. Pollack CV, Amin A, Wang T, et al. Hosp Pract (1995) 2020;48:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">31815570</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute management of myocardial infarction with ST-segment elevation: summary of NICE guidance. Carville S, Harker M, Henderson R, Gray H. BMJ. 2013;347:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">23843545</ArticleId></ArticleIdList></Reference><Reference><Citation>Socioeconomic context in area of living and risk of myocardial infarction: results from Stockholm Heart Epidemiology Program (SHEEP) K&#xf6;leg&#xe5;rd Stj&#xe4;rne M, Diderichsen F, Reuterwall C, Hallqvist J. J Epidemiol Community Health. 2002;56:29&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1731992</ArticleId><ArticleId IdType="pubmed">11801617</ArticleId></ArticleIdList></Reference><Reference><Citation>Does this patient with chest pain have acute coronary syndrome?: the rational clinical examination systematic review. Fanaroff AC, Rymer JA, Goldstein SA, Simel DL, Newby LK. JAMA. 2015;314:1955&#x2013;1965.</Citation><ArticleIdList><ArticleId IdType="pubmed">26547467</ArticleId></ArticleIdList></Reference><Reference><Citation>Optimal cut-off value for cardiac troponin I in ruling out type 5 myocardial infarction. J&#xf8;rgensen PH, Nybo M, Jensen MK, Mortensen PE, Poulsen TS, Diederichsen AC, Mickley H. Interact Cardiovasc Thorac Surg. 2014;18:544&#x2013;550.</Citation><ArticleIdList><ArticleId IdType="pubmed">24468543</ArticleId></ArticleIdList></Reference><Reference><Citation>Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Twardella D, K&#xfc;pper-Nybelen J, Rothenbacher D, Hahmann H, W&#xfc;sten B, Brenner H. Eur Heart J. 2004;25:2101&#x2013;2108.</Citation><ArticleIdList><ArticleId IdType="pubmed">15571825</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40668529</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0291</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>Applied biochemistry and biotechnology</Title><ISOAbbreviation>Appl Biochem Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Liposomal Delivery of Allolobophora caliginosa Coelomic Fluid Attenuates Myocardial Infarction by Suppressing Oxidative Damage, Inflammation, and Apoptosis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12010-025-05340-y</ELocationID><Abstract><AbstractText>Myocardial infarction (MI) is a concerning coronary heart disease with increasing rates of death and morbidity worldwide. One potential approach to prevent MI involves exploring invertebrate supplements within the nanoliposome formulation to improve targeted delivery, thereby mitigating MI-induced heart damage. Therefore, the study aimed to evaluate the cardioprotective efficacy of liposomal delivery of Allolobophora caliginosa coelomic fluid (ACCF-liposomes) on adrenaline-induced MI in rats. Thirty male albino rats were allocated into five groups: Control, Untreated MI, MI-treated ACCF, MI-treated free liposomes, and MI-treated ACCF-liposomes. The treatment regimen spanned 21&#xa0;days. Electrocardiography (ECG), biochemical, oxidative stress, inflammatory mediators, electrolyte balance, histopathological and immunohistochemical analyses, and DNA fragmentation were evaluated. Liposomal delivery of ACCF has shown promise in regulating ECG criteria and reducing myocardial markers, particularly AST, LDH, MMP-2, creatine kinase, and troponin-I. It also improves lipid metabolism and inhibits myocardial oxidative stress. Additionally, ACCF and ACCF-liposomes treatment improves cardiomyocyte architecture and reduces DNA fragmentation in myocardial infarcted rats. Furthermore, encapsulating ACCF within liposomes statistically reduced the expression of iNOS and Beclin-1 in cardiac tissue. This suggests that liposomal delivery of ACCF enhances its effectiveness in treating myocardial infarction, potentially via its antioxidant, anti-inflammatory, and anti-apoptotic attributes.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farouk</LastName><ForeName>Asmaa E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Zoology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fahmy</LastName><ForeName>Sohair R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Zoology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soliman</LastName><ForeName>Amel M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Zoology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Sherif Abdelaziz</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Zoology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadek</LastName><ForeName>Shimaa A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0003-4093-0627</Identifier><AffiliationInfo><Affiliation>Zoology Department, Faculty of Science, Cairo University, Giza, 12613, Egypt. shsadek@sci.cu.edu.eg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Appl Biochem Biotechnol</MedlineTA><NlmUniqueID>8208561</NlmUniqueID><ISSNLinking>0273-2289</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Allolobophora caliginosa</Keyword><Keyword MajorTopicYN="N">Adrenaline</Keyword><Keyword MajorTopicYN="N">Coelomic fluid</Keyword><Keyword MajorTopicYN="N">DNA fragmentation</Keyword><Keyword MajorTopicYN="N">Liposomes</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword></KeywordList><CoiStatement>Declarations. Ethics Approval: Experimental protocols were approved by Cairo University&#x2019;s Institutional Animal Care and Use Committee (IACUC) (Egypt) (Approval No. CU/I/F/58/21), adhering to international guidelines for the care and use of laboratory animals. Consent to Participate: Informed consent is not applicable. Consent for Publication: Consent for publication is not applicable. Conflict of interest: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>16</Day><Hour>11</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40668529</ArticleId><ArticleId IdType="doi">10.1007/s12010-025-05340-y</ArticleId><ArticleId IdType="pii">10.1007/s12010-025-05340-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Di Cesare, M., McGhie, D. V., Perel, P., Mwangi, J., Taylor, S., Pervan, B., &#x2026; Pinto, F. J. (2024). The heart of the world. Global Heart, 19(1), 11. https://doi.org/10.5334/GH.1288</Citation></Reference><Reference><Citation>Kumar, D., Bardooli, F., Chen, W. J., Huang, D., Sankardas, M. A., Ahmed, W. H., &#x2026; Zhang, S. (2024). Risk factors for mortality in post-myocardial infarction patients: Insights from the improve SCA bridge study. Egyptian Heart Journal, 76(1), 1&#x2013;10. https://doi.org/10.1186/S43044-024-00505-2/TABLES/4</Citation></Reference><Reference><Citation>Mori, S., Tretter, J. T., Spicer, D. E., Bolender, D. L., &amp; Anderson, R. H. (2019). What is the real cardiac anatomy? Clinical anatomy (New York, N.Y.), 32(3), 3288&#x2013;309.</Citation></Reference><Reference><Citation>Salari, N., Morddarvanjoghi, F., Abdolmaleki, A., Rasoulpoor, S., Khaleghi, A. A., Hezarkhani, L. A., &#x2026; Mohammadi, M. (2023). The global prevalence of myocardial infarction: A systematic review and meta-analysis. BMC Cardiovascular Disorders, 23(1), 206. https://doi.org/10.1186/s12872-023-03231-w</Citation></Reference><Reference><Citation>Al-botaty, B. M., Elkhoely, A., Elsayed, E. K., &amp; Ahmed, A. A. E. (2022). Insight into the pathophysiology of myocardial infarction. Journal of Advanced Pharmacy Research, 0547(4), 223&#x2013;237. https://doi.org/10.21608/aprh.2022.155725.1188</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/aprh.2022.155725.1188</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., &#x2026; Sharifi-Rad, J. (2020). Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Frontiers in Physiology, 11(July), 1&#x2013;21. https://doi.org/10.3389/fphys.2020.00694</Citation></Reference><Reference><Citation>Song, B., Bie, Y., Feng, H., Xie, B., Liu, M., &amp; Zhao, F. (2022). Inflammatory factors driving atherosclerotic plaque progression new insights. Journal of Translational Internal Medicine, 10(1), 36&#x2013;47. https://doi.org/10.2478/jtim-2022-0012</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/jtim-2022-0012</ArticleId><ArticleId IdType="pubmed">35702179</ArticleId><ArticleId IdType="pmc">8997796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ib&#xe1;&#xf1;ez, B., Heusch, G., Ovize, M., &amp; Van de Werf, F. (2015). Evolving therapies for myocardial ischemia/reperfusion injury. Journal of the American College of Cardiology, 65(14), 1454&#x2013;1471. https://doi.org/10.1016/j.jacc.2015.02.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2015.02.032</ArticleId><ArticleId IdType="pubmed">25857912</ArticleId></ArticleIdList></Reference><Reference><Citation>Poniedzia&#x142;ek, B., Rosi&#x144;ska, J., Rzymski, P., &amp; Fio&#x142;ka, M. (2022). Polysaccharide-protein complex from coelomic fluid of Dendrobaena veneta earthworm exerts a multi-pathway antiplatelet effect without coagulopathy and cytotoxicity. Biomedicine &amp; Pharmacotherapy, 151, 113205. https://doi.org/10.1016/j.biopha.2022.113205</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113205</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, Z., Deng, X., Xie, W., Li, H., Li, Y., &amp; Deng, Z. (2024). Pharmacological effects of bioactive agents in earthworm extract: A comprehensive review. Animal Models and Experimental Medicine, 7(5), 653&#x2013;672. https://doi.org/10.1002/ame2.12465</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ame2.12465</ArticleId><ArticleId IdType="pubmed">38957072</ArticleId><ArticleId IdType="pmc">11528390</ArticleId></ArticleIdList></Reference><Reference><Citation>Omar, T., Hany, M., Abdelfattah, M., Bahaaeldine, M., Abdelnabi, H., Mohamed, E., &#x2026; Elbatran, M. (2022). Earthworm extract exhibits therapeutic effect against epinephrine-induced myocardial infarction in rats. International Journal of Pharmacology, 18, 1126&#x2013;1136. https://doi.org/10.3923/ijp.2022.1126.1136</Citation></Reference><Reference><Citation>Abdelfattah, M. A., Mohamed, A. S., Ibrahim, S. A., &amp; Fahmy, S. R. (2023). Allolobophora caliginosa coelomic fluid and extract alleviate glucocorticoid-induced osteoporosis in mice by suppressing oxidative stress and regulating osteoblastic/osteoclastic-related markers. Scientific Reports, 13(1), 2090. https://doi.org/10.1038/s41598-023-29070-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-29070-5</ArticleId><ArticleId IdType="pubmed">36746995</ArticleId><ArticleId IdType="pmc">9902447</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadek, S. A., Sayed, M. G., Fahmy, S. R., &amp; Soliman, A. M. (2022). A coelomic fluid of Allolobophora caliginosa as novel prospects for medicinal antioxidants, anti-inflammatory, antiproliferative, analgesics, and antipyretics. https://doi.org/10.33263/BRIAC133.209</Citation></Reference><Reference><Citation>Andrade, C., Oliveira, B., Guatelli, S., Martinez, P., Sim&#xf5;es, B., Bispo, C., &#x2026; Coelho, A. V. (2021). Characterization of coelomic fluid cell types in the starfish Marthasterias glacialis using a flow cytometry/imaging combined approach. Frontiers in Immunology, 12.</Citation></Reference><Reference><Citation>Sachdeva, A., Dhawan, D., Jain, G. K., Yerer, M. B., Collignon, T. E., Tewari, D., &amp; Bishayee, A. (2023). Novel strategies for the bioavailability augmentation and efficacy improvement of natural products in oral cancer. Cancers. https://doi.org/10.3390/cancers15010268</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15010268</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stefano, A. (2023). Nanotechnology in targeted drug delivery. International Journal of Molecular Sciences, 24(9), 8194.</Citation><ArticleIdList><ArticleId IdType="pubmed">37175903</ArticleId><ArticleId IdType="pmc">10179724</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman, H. S., Othman, H. H., Hammadi, N. I., Yeap, S. K., Amin, K. M., Abdul Samad, N., &amp; Alitheen, N. B. (2020). Novel drug delivery systems for loading of natural plant extracts and their biomedical applications. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s227805</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ijn.s227805</ArticleId><ArticleId IdType="pubmed">33262588</ArticleId><ArticleId IdType="pmc">7695602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hua, S., &amp; Wu, S. Y. (2013). The use of lipid-based nanocarriers for targeted pain therapies. Frontiers in Pharmacology, 4, 143.</Citation><ArticleIdList><ArticleId IdType="pubmed">24319430</ArticleId><ArticleId IdType="pmc">3836271</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteiro, N., Martins, A., Reis, R. L., &amp; Neves, N. M. (2014). Liposomes in tissue engineering and regenerative medicine. Journal of the Royal Society, Interface, 11(101), 20140459. https://doi.org/10.1098/rsif.2014.0459</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2014.0459</ArticleId><ArticleId IdType="pubmed">25401172</ArticleId><ArticleId IdType="pmc">4223894</ArticleId></ArticleIdList></Reference><Reference><Citation>Allijn, I. E., Czarny, B. M. S., Wang, X., Chong, S. Y., Weiler, M., Da Silva, A. E., &#x2026; Schiffelers, R. M. (2017). Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. Journal of Controlled Release, 247, 127&#x2013;133. https://doi.org/10.1016/j.jconrel.2016.12.042</Citation></Reference><Reference><Citation>Schriefl, C., Schoergenhofer, C., Ettl, F., Poppe, M., Clodi, C., Mueller, M., Grafeneder, J., Jilma, B., Magnet, I. A. M., Buchtele, N., Boegl, M. S., Holzer, M., Sterz, F., &amp; Schwameis, M. (2021). Change of hemoglobin levels in the early post-cardiac arrest phase is associated with outcome. Frontiers in Medicine, 8, 639803.</Citation><ArticleIdList><ArticleId IdType="pubmed">34179033</ArticleId><ArticleId IdType="pmc">8219926</ArticleId></ArticleIdList></Reference><Reference><Citation>Farouk, A. E., Fahmy, S. R., Soliman, A. M., Ibrahim, S. A., &amp; Sadek, S. A. (2023). A nano-liposomal formulation potentiates antioxidant, anti-inflammatory, and fibrinolytic activities of Allolobophora caliginosa coelomic fluid: Formulation and characterization. Bmc Biotechnology, 23(1), 28. https://doi.org/10.1186/s12896-023-00795-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12896-023-00795-5</ArticleId><ArticleId IdType="pubmed">37537554</ArticleId><ArticleId IdType="pmc">10401763</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinesh, M., Sridhar, S. N., Chandana, P., Pai, V., Geetha, K. S., &amp; Hegdge, R. N. (2013). Anticancer potentials of peptides of coelomic fluid of earthworm Eudrilus eugeniae. Biosciences, Biotechnology Research Asia, 10, 601&#x2013;606.</Citation></Reference><Reference><Citation>Chen, P.-P., Xu, H.-L., Ting-Yue, Zhuge, D.-L., Jin, B.-H., Zhu, Q.-Y., &#x2026; Li, X.-K. (2018). CoQ10-loaded liposomes combined with UTMD prevented early nephropathy of diabetic rats. Oncotarget, 9(14), 11767&#x2013;11782. https://doi.org/10.18632/oncotarget.24363</Citation></Reference><Reference><Citation>Dajem, S. B., Ali, S. B., Abdelrady, O. G., Salahaldin, N. M., Soliman, A. M., Kamal, Y. M., Abdelazim, A. Y., Mohamed, A. F., Morsy, K., Mohamed, A. S., &amp; Fahmy, S. R. (2020). Allolobophora caliginosa coelomic fluid ameliorates gentamicin-induced hepatorenal toxicity in rats. Asian Pacific Journal of Tropical Biomedicine, 10(9), 411&#x2013;6.</Citation></Reference><Reference><Citation>Guder, W. G., Narayanan, S., Wisser, H., &amp; Al, E. (1996). List of analytes&#x2014; preanalytical variables. Annex In: Samples: From the Patient to the Laboratory. Darmstadt, Germany: GIT Verlag; 1996:Annex, 24, 12&#x2013;3.</Citation></Reference><Reference><Citation>Bais, R., &amp; Philcox, M. (1994). Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 8. IFCC Method for Lactate Dehydrogenase (l-Lactate: NAD+Oxidoreductase, EC 1.1.1.27). International Federation of Clinical Chemistry (IFCC). Eur J Clin Chem Clin Biochem., 32(8), 639&#x2013;55.</Citation></Reference><Reference><Citation>Burtis, A. et al. (1999). Tietz Textbook of Clinical. Chemistry, 3rd ed.</Citation></Reference><Reference><Citation>Dobi&#xe1;sov&#xe1;, M. (2006). AIP&#x2013;aterogenn&#xed; index plazmy jako v&#xfd;znamn&#xfd; prediktor kardiovaskul&#xe1;rn&#xed;ho rizika: Od v&#xfd;zkumu do praxe [AIP&#x2013;atherogenic index of plasma as a significant predictor of cardiovascular risk: Rom research to practice]. Vnitrni lekarstvi, 52(1), 64&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">16526201</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeflmayr, J. (1979). Vergleichende photometrische Bestimmungen von Calcium mit verschiedenen Testpackungen [Comparative photometric calcium determinations with various test kits]. Therapie der Gegenwart, 118(10), 1577&#x2013;1588.</Citation><ArticleIdList><ArticleId IdType="pubmed">494121</ArticleId></ArticleIdList></Reference><Reference><Citation>Suman, S., Pandey, A., &amp; Chandna, S. (2012). An improved non-enzymatic &#x201c;DNA ladder assay&#x201d; for more sensitive and early detection of apoptosis. Cytotechnology, 64(1), 14.</Citation></Reference><Reference><Citation>Cornu, R., B&#xe9;duneau, A., &amp; Martin, H. (2020). Influence of nanoparticles on liver tissue and hepatic functions: A review. Toxicology, 430, Article 152344. https://doi.org/10.1016/j.tox.2019.152344</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2019.152344</ArticleId><ArticleId IdType="pubmed">31843632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y., Zhou, T., Qian, D., Liu, X., Xu, Y., Hong, W., &#x2026; Tang, H. (2023). Z-guggulsterone induces cell cycle arrest and apoptosis by targeting the p53/CCNB1/PLK1 pathway in triple-negative breast cancer. ACS Omega, 8(2), 2780&#x2013;2792. https://doi.org/10.1021/acsomega.2c07480</Citation></Reference><Reference><Citation>Mar&#xed;n-Royo, G., Ortega-Hern&#xe1;ndez, A., Mart&#xed;nez-Mart&#xed;nez, E., Jurado-L&#xf3;pez, R., Luaces, M., Islas, F., &#x2026; Cachofeiro, V. (2019). the impact of cardiac lipotoxicity on cardiac function and Mirnas signature in obese and non-obese rats with myocardial infarction. Scientific Reports, 9(1), 444. https://doi.org/10.1038/s41598-018-36914-y</Citation></Reference><Reference><Citation>Tamis-Holland, J. E., Jneid, H., Reynolds, H. R., Agewall, S., Brilakis, E. S., Brown, T. M., &#x2026; Beltrame, J. F. (2019). American Heart Association Interventional Cardiovascular Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; and Council on Quality of Care and Outcomes Research Conte. A Scientific Statement From the American Heart Association. Circulation, 139(18), e891&#x2013;e908.</Citation></Reference><Reference><Citation>Hu, K., Deng, W., Yang, J., Wei, Y., Wen, C., &#x2026; &amp; Li, G. (2020). Intermittent hypoxia reduces infarct size in rats with acute myocardial infarction: a systematic review and meta-analysis. BMC Cardiovascular Disorders, 20(1), 422.</Citation></Reference><Reference><Citation>Ibrahim, M. M., Khedr, M. M., Morsy, M. H., Badae, N. M., &amp; Elatrebi, S. (2022). A comparative study of the cardioprotective effect of Metformin, Sitagliptin and Dapagliflozin on Isoprenaline induced myocardial infarction in non-diabetic rats. Bulletin of the National Research Centre, 46(1), 123. https://doi.org/10.1186/s42269-022-00812-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42269-022-00812-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Muthukumar, A., Mittal, S., Choezom, T., Bhavani, K., Das, K., Joyce, N., &#x2026; Yasmin, F. (2024). Evaluation of the cardioprotective activity of summer savory (Satureja hortensis L.) extract in experimental rats with Isoproterenol-induced myocardial infarction. Journal of King Saud University - Science, 36(7), 103236. https://doi.org/10.1016/j.jksus.2024.103236</Citation></Reference><Reference><Citation>Moradi-Arzeloo, M., Farshid, A. A., Tamaddonfard, E., &amp; Siamak, A.-R. (2016). Effects of histidine and vitamin C on isoproterenol-induced acute myocardial infarction in rats. Veterinary research forum&#x202f;: An international quarterly journal, 7, 47&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">27226887</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundd, P., Gladwin, M. T., &amp; Novelli, E. M. (2019). Pathophysiology of sickle cell disease. Annual Review of Pathology: Mechanisms of Disease, 14(1), 263&#x2013;292. https://doi.org/10.1146/annurev-pathmechdis-012418-012838</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-012418-012838</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Z. H., Pan, J. H., Ma, X. P., Xu, X. Y., Yu, W. H., Fu, W. J., &#x2026; Nie, H. (2017). Cardioprotective effect of shenxiong glucose injection on acute myocardial infarction in rats via reduction in myocardial intracellular calcium ion overload. Tropical Journal of Pharmaceutical Research, 16(5), 1097&#x2013;1104. https://doi.org/10.4314/tjpr.v16i5.18</Citation></Reference><Reference><Citation>Rotariu, D., Babes, E. E., Tit, D. M., Moisi, M., Bustea, C., Stoicescu, M., Radu, A. F., Vesa, C. M., Behl, T., Bungau, A. F., &amp; Bungau, S. G. (2022). Oxidative stress &#x2013; Complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders. Biomedicine &amp; Pharmacotherapy, 152, Article 113238. https://doi.org/10.1016/j.biopha.2022.113238</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2022.113238</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng, C., Liu, C., Liu, Y., &amp; Wu, F. (2015). Oxysophoridine attenuates the injury caused by acute myocardial infarction in rats through anti-oxidative, anti-inflammatory and anti-apoptotic pathways. Molecular Medicine Reports, 11(1), 527&#x2013;532. https://doi.org/10.3892/MMR.2014.2748</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/MMR.2014.2748</ArticleId><ArticleId IdType="pubmed">25338622</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, H., Wang, H., Han, T., Huang, X., Li, S., &amp; Wang, X. (2022). Combined antioxidant formulation of ascorbic acid with resveratrol ameliorates isoproterenol-induced myocardial infarction in rats. Sains Malaysiana, 51(7), 2137&#x2013;2146. https://doi.org/10.17576/jsm-2022-5107-16</Citation><ArticleIdList><ArticleId IdType="doi">10.17576/jsm-2022-5107-16</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, S., Dawuti, A., Gong, D., Wang, R., Yuan, T., Wang, S., &#x2026; Fang, L. (2022). Puerarin-V improve mitochondrial respiration and cardiac function in a rat model of diabetic cardiomyopathy via inhibiting pyroptosis pathway through P2X7 receptors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms232113015</Citation></Reference><Reference><Citation>Zhang, Q., Wang, L., Wang, S., Cheng, H., Xu, L., Pei, G., &#x2026; Wei, Q. (2022). Signaling pathways and targeted therapy for myocardial infarction. Signal Transduction and Targeted Therapy, 7(1), 78. https://doi.org/10.1038/s41392-022-00925-z</Citation></Reference><Reference><Citation>Ali, M. A. M., Cho, W. J., Hudson, B., Kassiri, Z., Granzier, H., &amp; Schulz, R. (2010). Titin is a target of matrix metalloproteinase-2. Circulation, 122(20), 2039&#x2013;2047. https://doi.org/10.1161/CIRCULATIONAHA.109.930222</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.109.930222</ArticleId><ArticleId IdType="pubmed">21041693</ArticleId><ArticleId IdType="pmc">3057897</ArticleId></ArticleIdList></Reference><Reference><Citation>Rietz, A., &amp; Spiers, J. P. (2012). The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases. British Journal of Pharmacology, 166(4), 1225&#x2013;1243. https://doi.org/10.1111/j.1476-5381.2012.01917.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2012.01917.x</ArticleId><ArticleId IdType="pubmed">22364165</ArticleId><ArticleId IdType="pmc">3417442</ArticleId></ArticleIdList></Reference><Reference><Citation>El Ridi, R., &amp; Tallima, H. (2017). Physiological functions and pathogenic potential of uric acid: A review. Journal of Advanced Research, 8(5), 487&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">28748115</ArticleId><ArticleId IdType="pmc">5512149</ArticleId></ArticleIdList></Reference><Reference><Citation>Harzand, A., Tamariz, L., &amp; Hare, J. M. (2012). Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition. Congestive heart failure (Greenwich, Conn.), 18(3), 179&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">22587748</ArticleId></ArticleIdList></Reference><Reference><Citation>Nivethetha, M., Jayasri, J., &amp; Brindha, P. (2009). Effects of Muntingia calabura L. on isoproterenol-induced myocardial infarction. Singapore Medical Journal, 50, 300&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">19352575</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, L., Mittal, R., Ramgobin, D., Jain, R., &amp; Jain, R. (2021). Current management guidelines on hyperlipidemia: The silent killer. Journal of lipids, 2021, 9883352.</Citation><ArticleIdList><ArticleId IdType="pubmed">34394993</ArticleId><ArticleId IdType="pmc">8363437</ArticleId></ArticleIdList></Reference><Reference><Citation>Olatunji, L. K., Jimoh, A. O., Tukur, U. M., &amp; Imam, M. U. (2022). A review of the effects of policosanol on metabolic syndrome. Clinical Complementary Medicine and Pharmacology, 2(3), 100058. https://doi.org/10.1016/j.ccmp.2022.100058</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccmp.2022.100058</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahir, A., Martinez, P. J., Ahmad, F., Fisher-Hoch, S. P., McCormick, J., Gay, J. L., &#x2026; Chaudhary, S. U. (2021). An evaluation of lipid profile and pro-inflammatory cytokines as determinants of cardiovascular disease in those with diabetes: a study on a Mexican American cohort. Scientific Reports, 11(1), 2435. https://doi.org/10.1038/s41598-021-81730-6</Citation></Reference><Reference><Citation>Caselli, C., De Caterina, R., Smit, J. M., Campolo, J., El Mahdiui, M., Ragusa, R., &#x2026; SMARTool, E. (2021). Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina. Scientific Reports, 11(1), 20714. https://doi.org/10.1038/s41598-021-00020-3</Citation></Reference><Reference><Citation>Rafaqat, S., Rafaqat, S., Khurshid, H., &amp; Rafaqat, S. (2022). Electrolyte&#x2019;s imbalance role in atrial fibrillation: Pharmacological management. International Journal of Arrhythmia, 23(1), 15. https://doi.org/10.1186/s42444-022-00065-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42444-022-00065-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid, I. R., Birstow, S. M., &amp; Bolland, M. J. (2017). Calcium and cardiovascular disease. Endocrinology and metabolism (Seoul, Korea), 32(3), 339&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">28956363</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, C., Shi, Z., Ouyang, N., &amp; Ruan, X. (2021). Hyperphosphatemia and cardiovascular disease. Frontiers in Cell and Developmental Biology, 9, Article 644363. https://doi.org/10.3389/fcell.2021.644363</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.644363</ArticleId><ArticleId IdType="pubmed">33748139</ArticleId><ArticleId IdType="pmc">7970112</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Pinto, A., Ravikumar, N., Attar, R., Suinesiaputra, A., Zhao, Y., Levelt, E., &#x2026; Frangi, A. F. (2022). Predicting myocardial infarction through retinal scans and minimal personal information. Nature Machine Intelligence, 4(1), 55&#x2013;61. https://doi.org/10.1038/s42256-021-00427-7</Citation></Reference><Reference><Citation>Sheng, S., Li, J., Hu, X., &amp; Wang, Y. (2023). Regulated cell death pathways in cardiomyopathy. Acta Pharmacologica Sinica, 44(8), 1521&#x2013;1535. https://doi.org/10.1038/s41401-023-01068-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-023-01068-9</ArticleId><ArticleId IdType="pubmed">36914852</ArticleId><ArticleId IdType="pmc">10374591</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong, S. A., Lai, K. S., Hee, C. W., Loh, J. Y., Lim, S. H. E., &amp; Sathiya, M. (2022). Oxidative stress parameters as biomarkers of cardiovascular disease towards the development and progression. Antioxidants (Basel, Switzerland), 11(6), 1175.</Citation><ArticleIdList><ArticleId IdType="pubmed">35740071</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, M., Yin, Y., Ma, X., Zhang, J., Pan, W., Tan, M., &#x2026; Li, H. (2023). Glutathione system enhancement for cardiac protection: Pharmacological options against oxidative stress and ferroptosis. Cell Death &amp; Disease, 14(2), 131. https://doi.org/10.1038/s41419-023-05645-y</Citation></Reference><Reference><Citation>Demirci-&#xc7;eki&#xe7;, S., &#xd6;zkan, G., Avan, A. N., Uzunboy, S., &#xc7;apano&#x11f;lu, E., &amp; Apak, R. (2022). Biomarkers of oxidative stress and antioxidant defense. Journal of Pharmaceutical and Biomedical Analysis, 209, Article 114477. https://doi.org/10.1016/j.jpba.2021.114477</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2021.114477</ArticleId><ArticleId IdType="pubmed">34920302</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W., Zhang, T., Yang, N., Wen, R., Wang, Y., Zhang, B., Zhang, T. N., Wang, Y. J., Zhang, B. L., Yang, Y. H., Liu, C. F., &amp; Liu, C. (2023). Transcriptome-wide identification of altered RNA m6a profiles in cardiac tissue of rats with LPS-induced myocardial injury. Frontiers in Immunology, 14, 1122317.</Citation><ArticleIdList><ArticleId IdType="pubmed">37275860</ArticleId><ArticleId IdType="pmc">10237353</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanzilli, G., Arrivi, A., Placanica, A., Viceconte, N., Cammisotto, V., Nocella, C., &#x2026; Mangieri, E. (2021). Glutathione infusion before and 3 days after primary angioplasty blunts ongoing NOX2-mediated inflammatory response. Journal of the American Heart Association, 10(18), 1&#x2013;14. https://doi.org/10.1161/JAHA.120.020560</Citation></Reference><Reference><Citation>Gusti, A. M. T., Qusti, S. Y., Alshammari, E. M., Toraih, E. A., &amp; Fawzy, M. S. (2021). Antioxidants-related superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPX), glutathione-S-transferase (GST), and nitric oxide synthase (NOS) gene variants analysis in an obese population: A preliminary case-control study. Antioxidants (Basel, Switzerland), 10(4), 595.</Citation><ArticleIdList><ArticleId IdType="pubmed">33924357</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, J., Yang, Z., Lu, Y., Du, C., Cao, C., Wang, B., &#x2026; Tang, J. (2022). An antioxidant system through conjugating superoxide dismutase onto metal-organic framework for cardiac repair. Bioactive Materials, 10, 56&#x2013;67. https://doi.org/10.1016/j.bioactmat.2021.08.019</Citation></Reference><Reference><Citation>Lin, Jun, Li, Q., Jin, T., Wang, J., Gong, Y., &#x2026; Fu, G. (2022). Cardiomyocyte IL-1R2 protects heart from ischemia/reperfusion injury by attenuating IL-17RA-mediated cardiomyocyte apoptosis. Cell Death &amp; Disease, 13(1), 90. https://doi.org/10.1038/s41419-022-04533-1</Citation></Reference><Reference><Citation>Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., &amp; Bueno, H. (2018). ESC Guidelines for the management of acute myocardial infarction inpatients presenting with ST-segment elevation. European Heart Journal, 39(2), 119&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">28886621</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Y., Yan, X., Xue, J., Zheng, Y., Chen, M., Sun, Z., &#x2026; Luo, D. (2019). Connexin43 dephosphorylation at serine 282 is associated with connexin43-mediated cardiomyocyte apoptosis. Cell Death &amp; Differentiation, 26(7), 1332&#x2013;1345. https://doi.org/10.1038/s41418-019-0277-x</Citation></Reference><Reference><Citation>Cowan, J., Longman, M. R., &amp; Snabaitis, A. K. (2021). Regulation of cardiomyocyte DNA damage and cell death by the type 2A protein phosphatase regulatory protein alpha4. Scientific Reports, 11(1), 6293. https://doi.org/10.1038/s41598-021-85616-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85616-5</ArticleId><ArticleId IdType="pubmed">33737606</ArticleId><ArticleId IdType="pmc">7973735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough, C. J. R., &amp; Nolan, J. P. (2018). The role of adrenaline in cardiopulmonary resuscitation. Critical Care, 22(1), 139. https://doi.org/10.1186/s13054-018-2058-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2058-1</ArticleId><ArticleId IdType="pubmed">29843791</ArticleId><ArticleId IdType="pmc">5975505</ArticleId></ArticleIdList></Reference><Reference><Citation>Maejima, Y., Isobe, M., &amp; Sadoshima, J. (2016). Regulation of autophagy by Beclin 1 in the heart. Journal of Molecular and Cellular Cardiology, 95, 19&#x2013;25. https://doi.org/10.1016/j.yjmcc.2015.10.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2015.10.032</ArticleId><ArticleId IdType="pubmed">26546165</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, W., Sun, J., Guo, Y., Liu, N., Ding, X., Zhang, X., &#x2026; Yin, X. (2020). Calhex231 ameliorates myocardial fibrosis post myocardial infarction in rats through the autophagy-NLRP3 inflammasome pathway in macrophages. Journal of Cellular and Molecular Medicine, 24(22), 13440&#x2013;13453. https://doi.org/10.1111/jcmm.15969</Citation></Reference><Reference><Citation>Chen, J., Yang, J., Ma, L., Li, J., Shahzad, N., &amp; Kim, C. K. (2020). Structure-antioxidant activity relationship of methoxy, phenolic hydroxyl, and carboxylic acid groups of phenolic acids. Scientific Reports, 10(1), 2611. https://doi.org/10.1038/s41598-020-59451-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-59451-z</ArticleId><ArticleId IdType="pubmed">32054964</ArticleId><ArticleId IdType="pmc">7018807</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvis, M. J. M., Kaffka genaamd Dengler, S. E., Odille, C. A., Mishra, M., van der Kaaij, N. P., Doevendans, P. A., Sluijter, J. P. G., de Kleijn, D. P. V., de Jager, S. C. A., Bosch, L., &amp; van Hout, G. P. J. (2020). Damage-associated molecular patterns in myocardial infarction and heart transplantation: The road to translational success. Frontiers in Immunology, 11, Article 599511. https://doi.org/10.3389/fimmu.2020.599511</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.599511</ArticleId><ArticleId IdType="pubmed">33363540</ArticleId><ArticleId IdType="pmc">7752942</ArticleId></ArticleIdList></Reference><Reference><Citation>Soumya, R. S., &amp; Raghu, K. G. (2023). Recent advances on nanoparticle-based therapies for cardiovascular diseases. Journal of Cardiology, 81(1), 10&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">35210166</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, P. Z., Chew, N. W. S., Tay, S. H., &amp; Chang, P. (2021). The allergic myocardial infarction dilemma: Is it the anaphylaxis or the epinephrine? Journal of Thrombosis and Thrombolysis, 52(3), 941&#x2013;948. https://doi.org/10.1007/s11239-021-02389-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02389-4</ArticleId><ArticleId IdType="pubmed">33544285</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo, Y., Guo, Y., Wang, H., Yu, M., Hong, K., Li, D., &#x2026; Eugene Chen, Y. (2021). Phospholipid nanoparticles: Therapeutic potentials against atherosclerosis via reducing cholesterol crystals and inhibiting inflammation. EBioMedicine, 74, 103725.</Citation></Reference><Reference><Citation>Dewi, N. W. S., &amp; Mahendra, A. N. (2020). The in-vivo anti-inflammatory effect of red earthworm (Lumbricus rubellus) ethanolic extract from organic farmland in Bali. Indonesia. Bali Medical Journal, 9(3), 545&#x2013;548. https://doi.org/10.15562/bmj.v9i3.1788</Citation><ArticleIdList><ArticleId IdType="doi">10.15562/bmj.v9i3.1788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekhlasian, A., Eftekhar, E., Daei, S., Abbasalipourkabir, R., Nourian, A., &amp; Ziamajidi, N. (2023). The antioxidant and anti-apoptotic properties of vitamins A, C and E in heart tissue of rats exposed to zinc oxide nanoparticles. Molecular Biology Reports, 50(3), 2357&#x2013;2365. https://doi.org/10.1007/s11033-022-08103-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-08103-8</ArticleId><ArticleId IdType="pubmed">36580195</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Jingjin, Wang, T., Li, Y., Yao, W., Ji, X., &#x2026; Ni, C. (2016). Earthworm extract attenuates silica-induced pulmonary fibrosis through Nrf2-dependent mechanisms. Laboratory Investigation, 96(12), 1279&#x2013;1300. https://doi.org/10.1038/labinvest.2016.101</Citation></Reference><Reference><Citation>Guo, S., Wang, Q., Li, Z., Chen, Y., Li, H., Zhang, J., &#x2026; Zhao, M. (2023). Ecological risk of microplastic toxicity to earthworms in soil: A bibliometric analysis. Frontiers in Environmental Science, 11. https://doi.org/10.3389/fenvs.2023.1126847</Citation></Reference><Reference><Citation>Yang, W., Wang, W., Ma, Y., Yang, Q., Li, P., &amp; Du, S. (2021). Bioevaluation of Pheretima vulgaris antithrombotic extract, PvQ, and isolation, identification of six novel PvQ-derived fibrinolytic proteases. Molecules (Basel, Switzerland), 26(16), 4946.</Citation><ArticleIdList><ArticleId IdType="pubmed">34443534</ArticleId><ArticleId IdType="pmc">8402109</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, R., Ali, A., Xu, Y., Abdelrahman, H., Li, R., Lin, Y., &#x2026; Zhang, Z. (2022). Earthworms as candidates for remediation of potentially toxic elements contaminated soils and mitigating the environmental and human health risks: A review. Environment International, 158, 106924. https://doi.org/10.1016/j.envint.2021.106924</Citation></Reference><Reference><Citation>Lazzarotto-Figueir&#xf3;, J., Capelezzo, A. P., Schindler, M. S. Z., Foss&#xe1;, J. F. C., Albeny-Sim&#xf5;es, D., Zanatta, L., &#x2026; Dal Magro, J. (2021). Antioxidant activity, antibacterial and inhibitory effect of intestinal disaccharidases of extracts obtained from eugenia uniflora l. Seeds. Brazilian Journal of Biology, 81(2), 291&#x2013;300. https://doi.org/10.1590/1519-6984.224852</Citation></Reference><Reference><Citation>Abdelhalim, M. A. K., Moussa, S. A. A., Qaid, H. A. Y., &amp; Al-Ayed, M. S. (2018). Potential effects of different natural antioxidants on inflammatory damage and oxidative-mediated hepatotoxicity induced by gold nanoparticles. International Journal of Nanomedicine, 13, 7931&#x2013;7938. https://doi.org/10.2147/IJN.S171931</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S171931</ArticleId><ArticleId IdType="pubmed">30538469</ArticleId><ArticleId IdType="pmc">6260143</ArticleId></ArticleIdList></Reference><Reference><Citation>Shariare, M. H., Noor, H. B., Khan, J. H., Uddin, J., Ahamad, S. R., Altamimi, M. A., &#x2026; Kazi, M. (2021). Liposomal drug delivery of Corchorus olitorius leaf extract containing phytol using design of experiment (DoE): In-vitro anticancer and in-vivo anti-inflammatory studies. Colloids and Surfaces B: Biointerfaces, 199, 111543. https://doi.org/10.1016/j.colsurfb.2020.111543</Citation></Reference><Reference><Citation>Manna, S., Ray, A., Gautam, A., Mukherjee, S., Ray, M., &amp; Ray, S. (2022). A comparative account of coelomocyte of earthworm ecotypes with reference to its morphology, morphometry, density, phagocytosis, autofluorescence, and oxidative status. Journal of Morphology, 283, 956&#x2013;972. https://doi.org/10.1002/jmor.21483</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmor.21483</ArticleId><ArticleId IdType="pubmed">35621718</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40677457</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>The Role of Cardiac Biomarkers in Evaluating Takotsubo Cardiomyopathy: A Systematic Review.</ArticleTitle><Pagination><StartPage>e86168</StartPage><MedlinePgn>e86168</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e86168</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.86168</ELocationID><Abstract><AbstractText>Takotsubo cardiomyopathy (TTS) is an acute, reversible cardiac condition marked by transient wall motion abnormalities of the left ventricle, typically triggered by intense emotional or physical stress. Despite being first described in 1990, TTS remains relatively obscure due to limited understanding of its pathophysiology. Clinically, it mimics acute coronary syndrome (ACS), presenting with symptoms such as chest pain, shortness of breath, and ECG changes like ST-segment deviations. This resemblance often leads to initial misdiagnosis and treatment with antiplatelet and anticoagulant therapy - interventions that lack proven efficacy in managing TTS. Given the diagnostic challenges posed by the clinical overlap between TTS and ACS and the absence of disease-specific diagnostic markers, several researchers have investigated the potential role of cardiac biomarkers in distinguishing between the two conditions. This systematic review aims to explore the diagnostic utility of cardiac biomarkers in evaluating TTS. We conducted a systematic literature search using PubMed and Google Scholar, focusing on studies published between 2013 and August 10, 2023. Inclusion criteria were limited to human studies published in English with freely available full texts that evaluated the diagnostic performance of cardiac biomarkers in TTS. A total of eight studies met the criteria and were included for in-depth analysis. These studies examined a range of biomarkers, including established ones such as troponin, B-type natriuretic peptide (BNP), N-terminal proBNP, and creatine kinase-myocardial band (CK-MB), as well as emerging markers like copeptin and microRNAs (miRNAs). Collectively, the studies analyzed data from 3,602 individuals. Troponin showed limited diagnostic accuracy in differentiating TTS from ACS. In contrast, BNP exhibited stronger discriminatory ability, both alone and when used in combination with other markers. The combined use of BNP, troponin, and CK-MB enhanced diagnostic performance. Furthermore, emerging biomarkers such as copeptin and miRNAs demonstrated promising potential due to their early release patterns, association with stress-response mechanisms, and distinct expression profiles, offering new avenues for improving diagnostic accuracy. This review underscores the potential diagnostic value of both established and emerging cardiac biomarkers in identifying TTS. The findings support further research into novel biomarkers, which may ultimately lead to earlier and more accurate diagnosis, reduce inappropriate treatment, and enable more targeted and timely clinical interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Kilaru et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kilaru</LastName><ForeName>Pranavi</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine, Mamata Academy of Medical Sciences, Hyderabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kilaru</LastName><ForeName>Pranati</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, IND.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garikipaty</LastName><ForeName>Shreya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Internal Medicine, Mamata Academy of Medical Sciences, Hyderabad, IND.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">apical ballooning syndrome</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">broken heart syndrome</Keyword><Keyword MajorTopicYN="N">stress cardiomyopathy</Keyword><Keyword MajorTopicYN="N">takotsubo cardiomyopathy</Keyword></KeywordList><CoiStatement>Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>5</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40677457</ArticleId><ArticleId IdType="pmc">PMC12267605</ArticleId><ArticleId IdType="doi">10.7759/cureus.86168</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sato H, Tateishi H, Uchida T, et al. Clinical Aspect of Myocardial Injury: From Ischemia to Heart Failure. Tokyo, Japan: Kagaku Hyouronsha; 1990. Takotsubo-type cardiomyopathy due to multivessel spasm; pp. 56&#x2013;64.</Citation></Reference><Reference><Citation>SVH Heart Health. (n.d. Takotsubo cardiomyopathy. https://www.svhhearthealth.com.au/conditions/takotsubo-cardiomyopathy https://www.svhhearthealth.com.au/conditions/takotsubo-cardiomyopathy</Citation></Reference><Reference><Citation>International expert consensus document on Takotsubo syndrome (part I): clinical characteristics, diagnostic criteria, and pathophysiology. Ghadri JR, Wittstein IS, Prasad A, et al. Eur Heart J. 2018;39:2032&#x2013;2046.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991216</ArticleId><ArticleId IdType="pubmed">29850871</ArticleId></ArticleIdList></Reference><Reference><Citation>Stress cardiomyopathy diagnosis and&#xa0;treatment: JACC state-of-the-art review. Medina de Chazal H, Del Buono MG, Keyser-Marcus L, Ma L, Moeller FG, Berrocal D, Abbate A. J Am Coll Cardiol. 2018;72:1955&#x2013;1971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7058348</ArticleId><ArticleId IdType="pubmed">30309474</ArticleId></ArticleIdList></Reference><Reference><Citation>Takotsubo cardiomyopathy: review of broken heart syndrome. Boyd B, Solh T. JAAPA. 2020;33:24&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">32039951</ArticleId></ArticleIdList></Reference><Reference><Citation>International expert consensus document on Takotsubo syndrome (part II): diagnostic workup, outcome, and management. Ghadri JR, Wittstein IS, Prasad A, et al. Eur Heart J. 2018;39:2047&#x2013;2062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991205</ArticleId><ArticleId IdType="pubmed">29850820</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta A &amp; Wahed A. Clinical chemistry, immunology and laboratory quality control. https://www.sciencedirect.com/topics/medicine-and-dentistry/cardiac-marker pp. 149&#x2013;171.https://www.sciencedirect.com/topics/medicine-and-dentistry/cardiac-marker</Citation></Reference><Reference><Citation>Cardiac biomarkers: what is and what can be. Jacob R, Khan M. Indian J Cardiovasc Dis Women WINCARS. 2018;3:240&#x2013;244.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6957084</ArticleId><ArticleId IdType="pubmed">31934672</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum copeptin and copeptin/NT-proBNP ratio &#x2014; new tools to differentiate Takotsubo syndrome from acute myocardial infarction. Budnik M, Bia&#x142;ek S, Peller M, et al. Folia Med Cracov. 2020;60:5&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">32658207</ArticleId></ArticleIdList></Reference><Reference><Citation>A signature of circulating microRNAs differentiates Takotsubo cardiomyopathy from acute myocardial infarction. Jaguszewski M, Osipova J, Ghadri JR, et al. Eur Heart J. 2014;35:999&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3985061</ArticleId><ArticleId IdType="pubmed">24046434</ArticleId></ArticleIdList></Reference><Reference><Citation>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Liberati A, Altman DG, Tetzlaff J, et al. PLoS Med. 2009;6:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707010</ArticleId><ArticleId IdType="pubmed">19621070</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. Templin C, Ghadri JR, Diekmann J, et al. N Engl J Med. 2015;373:929&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pubmed">26332547</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiac biomarkers in Takotsubo cardiomyopathy. Doyen D, Moceri P, Chiche O, et al. Int J Cardiol. 2014;174:798&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">24794960</ArticleId></ArticleIdList></Reference><Reference><Citation>Value of cardiac biomarkers in the early diagnosis of Takotsubo syndrome. Dagrenat C, Von Hunolstein JJ, Matsushita K, et al. J Clin Med. 2020;9:2985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7564647</ArticleId><ArticleId IdType="pubmed">32942758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratio of high-sensitivity troponin to creatine kinase-MB in Takotsubo syndrome. Pirlet C, Pierard L, Legrand V, Gach O. Int J Cardiol. 2017;243:300&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">28595746</ArticleId></ArticleIdList></Reference><Reference><Citation>Simple markers can distinguish Takotsubo cardiomyopathy from ST segment elevation myocardial infarction. Budnik M, Kochanowski J, Piatkowski R, et al. Int J Cardiol. 2016;219:417&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">27367474</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostic utility of cardiac biomarkers in discriminating Takotsubo cardiomyopathy from acute myocardial infarction. Randhawa MS, Dhillon AS, Taylor HC, Sun Z, Desai MY. J Card Fail. 2014;20:2&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24342256</ArticleId></ArticleIdList></Reference><Reference><Citation>High-sensitive cardiac troponin T. Xu RY, Zhu XF, Yang Y, Ye P. https://pmc.ncbi.nlm.nih.gov/articles/PMC3627711/ J Geriatr Cardiol. 2013;10:102&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3627711</ArticleId><ArticleId IdType="pubmed">23610580</ArticleId></ArticleIdList></Reference><Reference><Citation>Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Weber M, Hamm C. Heart. 2006;92:843&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1860679</ArticleId><ArticleId IdType="pubmed">16698841</ArticleId></ArticleIdList></Reference><Reference><Citation>A comparative study on the diagnostic utility of creatine kinase-MB (Myocardial Band) mass estimation over its activity measurement in patients with acute myocardial infarction in a tertiary care hospital in Puducherry. Kumar NS, Rajendran S, Nanda SK, Christopher M, Kandasamy R. https://www.jebmh.com/articles/a-comparative-study-on-the-diagnostic-utility-of-creatinekinasemb-myocardial-band-mass-estimation-over-itsactivity-measu.pdf.pdf J Evid Based Med Healthc. 2021;8:2724&#x2013;2730.</Citation></Reference><Reference><Citation>Copeptin as a diagnostic and prognostic biomarker in cardiovascular diseases. Mu D, Cheng J, Qiu L, Cheng X. Front Cardiovasc Med. 2022;9:901990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9289206</ArticleId><ArticleId IdType="pubmed">35859595</ArticleId></ArticleIdList></Reference><Reference><Citation>Release patterns of copeptin and troponin in Tako-Tsubo cardiomyopathy. Burgdorf C, Schubert A, Schunkert H, Kurowski V, Radke PW. Peptides. 2012;34:389&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">22326519</ArticleId></ArticleIdList></Reference><Reference><Citation>Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. Widera C, Gupta SK, Lorenzen JM, et al. J Mol Cell Cardiol. 2011;51:872&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pubmed">21806992</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. D'Alessandra Y, Devanna P, Limana F, et al. Eur Heart J. 2010;31:2765&#x2013;2773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2980809</ArticleId><ArticleId IdType="pubmed">20534597</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40675022</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2772-963X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>16</Day></PubDate></JournalIssue><Title>JACC. Advances</Title><ISOAbbreviation>JACC Adv</ISOAbbreviation></Journal><ArticleTitle>Fully Automated Diagnosis of Acute Myocardial Infarction Using Electrocardiograms and Multimodal Deep Learning.</ArticleTitle><Pagination><StartPage>102011</StartPage><MedlinePgn>102011</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102011</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacadv.2025.102011</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2772-963X(25)00435-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Rapid detection of acute myocardial infarction (AMI) reduces morbidity and mortality. Deep learning may enhance automated electrocardiogram (ECG) interpretation.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of the study was to develop and validate a deep learning model for AMI detection using ECG data, demographics, and symptoms.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study used ECG data from 2 centers in V&#xe4;stra G&#xf6;taland County, Sweden (January 2015-June 2023), for model training and validation, with a third center for external testing. Patients with chest pain or dyspnea who received a prehospital or in-hospital ECG were included. A residual convolutional neural network was trained on ECG features, age, sex, and symptoms to predict AMI, defined by International Classification of Diseases codes at discharge. Performance was assessed using area under the receiver operating characteristic, sensitivity, and specificity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study included 104,507 individuals (208,366 ECGs), with 8.17% in the training set and 8.59% in the external set diagnosed with AMI. The model achieved AUROCs of 0.8221 &#xb1; 0.0101 (internal validation &#xb1; 95% CI) and 0.8314 &#xb1; 0.0085 (external validation). Performance was consistent across sex but slightly lower for ambulance-arriving patients (area under the receiver operating characteristic: 0.8081 &#xb1; 0.0095). Saliency maps highlighted focus on ST segments and T waves.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The deep learning model demonstrated strong AMI detection across diverse patient groups. A randomized trial is needed to compare its performance with emergency physicians.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hilgendorf</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Wallenberg Centre for Molecular and Translational Research (WCMTM), Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. Electronic address: lukas.hilgendorf@gu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petursson</LastName><ForeName>Petur</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Wallenberg Centre for Molecular and Translational Research (WCMTM), Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawshani</LastName><ForeName>Aidin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Deepak L</ForeName><Initials>DL</Initials><AffiliationInfo><Affiliation>Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>R&#xe5;munddal</LastName><ForeName>Truls</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Vibha</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Wallenberg Centre for Molecular and Translational Research (WCMTM), Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skoglund</LastName><ForeName>Kristofer</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omerovic</LastName><ForeName>Elmir</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sj&#xf6;land</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taha</LastName><ForeName>Amar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Stanford University, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundgren</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Centre for Digital Health, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawshani</LastName><ForeName>Araz</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Wallenberg Centre for Molecular and Translational Research (WCMTM), Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Adv</MedlineTA><NlmUniqueID>9918419284106676</NlmUniqueID><ISSNLinking>2772-963X</ISSNLinking></MedlineJournalInfo><CoiStatement>Funding support and author disclosures This study was funded by the Swedish Society for Medicine (Svenska L&#xe4;kars&#xe4;llskapet, grant number SLS-1000926), the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-998297), and the Wallenberg Centre for Molecular and Translational Medicine (WCMTM). Dr Bhatt discloses the following relationships: Advisory board: Angiowave, Bayer, Boehringer Ingelheim, CellProthera, Cereno Scientific, E-Star Biotech, High Enroll, Janssen, Level Ex, McKinsey, Medscape Cardiology, Merck, NirvaMed, Novo Nordisk, Stasys; Tourmaline Bio; Board of Directors: American Heart Association New York City, Angiowave (stock options), Bristol Myers Squibb (stock), DRS.LINQ (stock options), High Enroll (stock); Consultant: Broadview Ventures, Corcept Therapeutics, GlaxoSmithKline, Hims, SFJ, Summa Therapeutics, Youngene; Data Monitoring Committees: Acesion Pharma, Assistance Publique-H&#xf4;pitaux de Paris, Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute, for the PORTICO trial, funded by St. Jude Medical, now Abbott), Boston Scientific (Chair, PEITHO trial), Cleveland Clinic, Contego Medical (Chair, PERFORMANCE 2), Duke Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine (for the ENVISAGE trial, funded by Daiichi Sankyo; for the ABILITY-DM trial, funded by Concept Medical; for ALLAY-HF, funded by Alleviant Medical), Novartis, Population Health Research Institute; Rutgers University (for the NIH-funded MINT Trial); Honoraria: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org; Chair, ACC Accreditation Oversight Committee), Arnold and Porter law firm (work related to Sanofi/Bristol-Myers Squibb clopidogrel litigation), Baim Institute for Clinical Research (formerly Harvard Clinical Research Institute; AEGIS-II executive committee funded by CSL Behring), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Canadian Medical and Surgical Knowledge Translation Research Group (clinical trial steering committees), CSL Behring (AHA lecture), Cowen and Company, Duke Clinical Research Institute (clinical trial steering committees, including for the PRONOUNCE trial, funded by Ferring Pharmaceuticals), HMP Global (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Guest Editor; Associate Editor), Level Ex, Medtelligence/ReachMD (CME steering committees), MJH Life Sciences, Oakstone CME (Course Director, Comprehensive Review of Interventional Cardiology), Piper Sandler, Population Health Research Institute (for the COMPASS operations committee, publications committee, steering committee, and USA national co-leader, funded by Bayer), WebMD (CME steering committees), Wiley (steering committee); Other: Clinical Cardiology (Deputy Editor); Patent: Sotagliflozin (named on a patent for sotagliflozin assigned to Brigham and Women's Hospital who assigned to Lexicon; neither I nor Brigham and Women's Hospital receive any income from this patent); Research funding: Abbott, Acesion Pharma, Afimmune, Aker Biomarine, Alnylam, Amarin, Amgen, AstraZeneca, Bayer, Beren, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb, Cardax, CellProthera, Cereno Scientific, Chiesi, CinCor, Cleerly, CSL Behring, Faraday Pharmaceuticals, Ferring Pharmaceuticals, Fractyl, Garmin, HLS Therapeutics, Idorsia, Ironwood, Ischemix, Janssen, Javelin, Lexicon, Lilly, Medtronic, Merck, Moderna, MyoKardia, NirvaMed, Novartis, Novo Nordisk, Otsuka, Owkin, Pfizer, PhaseBio, PLx Pharma, Recardio, Regeneron, Reid Hoffman Foundation, Roche, Sanofi, Stasys, Synaptic, The Medicines Company, Youngene, 89Bio; Royalties: Elsevier (Editor, Braunwald&#x2019;s Heart Disease); Site co-investigator: Cleerly. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>1</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>1</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>17</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40675022</ArticleId><ArticleId IdType="pmc">PMC12284675</ArticleId><ArticleId IdType="doi">10.1016/j.jacadv.2025.102011</ArticleId><ArticleId IdType="pii">S2772-963X(25)00435-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guerchicoff A., Brener S.J., Maehara A., et al. Impact of delay to reperfusion on reperfusion success, infarct size, and clinical outcomes in patients with ST-segment elevation myocardial infarction: the INFUSE-AMI trial (INFUSE-Anterior myocardial infarction) JACC Cardiovasc Interv. 2014;7:733&#x2013;740.</Citation><ArticleIdList><ArticleId IdType="pubmed">25060015</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Miranda D.F., Rodin H., Bart B.A., Smith S.W., Shroff G.R. Interobserver variability among experienced electrocardiogram readers to diagnose acute thrombotic coronary occlusion in patients with out of hospital cardiac arrest: impact of metabolic milieu and angiographic culprit. Resuscitation. 2022;172:24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">35041876</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zaiti S.S., Martin-Gill C., Z&#xe8;gre-Hemsey J.K., et al. Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat. Med. 2023;29:1804&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10353937</ArticleId><ArticleId IdType="pubmed">37386246</ArticleId></ArticleIdList></Reference><Reference><Citation>McCabe J.M., Armstrong E.J., Ku I., et al. Physician accuracy in interpreting potential ST-segment elevation myocardial infarction electrocardiograms. J. Am. Heart Assoc. 2013;2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835230</ArticleId><ArticleId IdType="pubmed">24096575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes J.W., Olgin J.E., Avram R., et al. Performance of a convolutional neural network and explainability technique for 12-lead electrocardiogram interpretation. JAMA Cardiol. 2021;6:1285&#x2013;1295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340011</ArticleId><ArticleId IdType="pubmed">34347007</ArticleId></ArticleIdList></Reference><Reference><Citation>Makimoto H., H&#xf6;ckmann M., Lin T., et al. Performance of a convolutional neural network derived from an ECG database in recognizing myocardial infarction. Sci Rep. 2020;10:8445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7242480</ArticleId><ArticleId IdType="pubmed">32439873</ArticleId></ArticleIdList></Reference><Reference><Citation>Elyamani H.A., Salem M.A., Melgani F., Yhiea N.M. Deep residual 2D convolutional neural network for cardiovascular disease classification. Sci Rep. 2024;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11427665</ArticleId><ArticleId IdType="pubmed">39327440</ArticleId></ArticleIdList></Reference><Reference><Citation>Millett E.R.C., Peters S.A.E., Woodward M. Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ. 2018;363</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6364292</ArticleId><ArticleId IdType="pubmed">30404896</ArticleId></ArticleIdList></Reference><Reference><Citation>Asia Pacific Cohort Studies Collaboration The impact of cardiovascular risk factors on the age-related excess risk of coronary heart disease. Int J Epidemiol. 2006;35:1025&#x2013;1033.</Citation><ArticleIdList><ArticleId IdType="pubmed">16581818</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferry A.V., Anand A., Strachan F.E., et al. Presenting symptoms in men and women diagnosed with myocardial infarction using sex-specific criteria. J Am Heart Assoc. 2019;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6755854</ArticleId><ArticleId IdType="pubmed">31431112</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt D.L., Lopes R.D., Harrington R.A. Diagnosis and treatment of acute coronary syndromes: a review. JAMA. 2022;327:662&#x2013;675.</Citation><ArticleIdList><ArticleId IdType="pubmed">35166796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rck L., Nielsen S., Jernberg T., Zverkova-Sandstr&#xf6;m T., Giang K.W., Rosengren A. Absence of chest pain and long-term mortality in patients with acute myocardial infarction. Open Heart. 2018;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6269644</ArticleId><ArticleId IdType="pubmed">30564376</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody G., Pollard T., Moody B., et al.  WFDB software package. PhysioNet. https://physionet.org/content/wfdb/10.7.0/</Citation></Reference><Reference><Citation>Singstad B.-J., Muten E.M. Posted November 18, 2022. Assessing the impact of downsampled ECGs and alternative loss functions in multi-label classification of 12-lead ECGs. medRxiv.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.11.16.22282373</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A., Bhusnur S., Mishra S.K., Singh P. Comparative analysis of parametric B-spline and Hermite cubic spline based methods for accurate ECG signal modeling. J Electrocardiol. 2024;86</Citation><ArticleIdList><ArticleId IdType="pubmed">39213712</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul E., Hussein R., Abdulridha H., N. Hassan A. Vol. 128. 2015. pp. 97&#x2013;107. (Feature Extraction of ECG Signal using Cubic Spline Technique).</Citation></Reference><Reference><Citation>Rajput J.S., Sharma M., Tan R.S., Acharya U.R. Automated detection of severity of hypertension ECG signals using an optimal bi-orthogonal wavelet filter bank. Comput Biol Med. 2020;123</Citation><ArticleIdList><ArticleId IdType="pubmed">32768053</ArticleId></ArticleIdList></Reference><Reference><Citation>Uwaechia A.N., Ramli D.A. A comprehensive survey on ECG signals as new biometric modality for human authentication: recent advances and future challenges. IEEE Access. 2021;9:97760&#x2013;97802.</Citation></Reference><Reference><Citation>Ioffe S., Szegedy C. Batch normalization: accelerating deep network training by reducing internal covariate shift. arxiv. 2015</Citation></Reference><Reference><Citation>Hilgendorf L., Petursson P., Gupta V., et al. Predicting troponin biomarker elevation from electrocardiograms using a deep neural network. Open Heart. 2024;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11529765</ArticleId><ArticleId IdType="pubmed">39477343</ArticleId></ArticleIdList></Reference><Reference><Citation>ICD-10 version. 2019. https://icd.who.int/browse10/2019/en#/I21</Citation></Reference><Reference><Citation>ICD-10 version. 2019. https://icd.who.int/browse10/2019/en#/R06</Citation></Reference><Reference><Citation>Zang J., Wang J., Zhang Z., Zheng Y., Xue C. Improving ECG classification performance by using an optimized one-dimensional residual network model. Appl Sci. 2022;12</Citation></Reference><Reference><Citation>Jing E., Zhang H., Li Z., Liu Y., Ji Z., Ganchev I. ECG heartbeat classification based on an improved ResNet-18 model. Comput Math Methods Med. 2021;2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110414</ArticleId><ArticleId IdType="pubmed">34007306</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan F., Yu X., Yuan Z., Rehman A.U. ECG classification using 1-D convolutional deep residual neural network. PLoS One. 2023;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10128986</ArticleId><ArticleId IdType="pubmed">37098024</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangold K.E., Carter R.E., Siontis K.C., et al. Unlocking the potential of artificial intelligence in electrocardiogram biometrics: age-related changes, anomaly detection, and data authenticity in mobile health platforms. Eur Heart J Digit Health. 2024;5:314&#x2013;323.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11104462</ArticleId><ArticleId IdType="pubmed">38774362</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahn T., Jin B. Early stopping of untrained convolutional neural networks. arXiv. Posted June 6, 2024 doi: 10.48550/arXiv.2402.04610.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2402.04610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansel J., Yang E., He H., et al. Proceedings of the 29th ACM International Conference on Architectural Support for Programming Languages and Operating Systems. 2024. PyTorch 2: faster machine learning through dynamic Python bytecode transformation and graph compilation; pp. 929&#x2013;947.</Citation></Reference><Reference><Citation>Youden W.J. Index for rating diagnostic tests. Cancer. 1950;3:32&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">15405679</ArticleId></ArticleIdList></Reference><Reference><Citation>Opitz J., Burst S. Macro F1 and macro F1. arXiv. Posted February 8, 2021 doi: 10.48550/arXiv.1911.03347.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1911.03347</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott M.B.A., Zhang H., Hansen L.H., Angelotti G., Gallifant J. A closer look at AUROC and AUPRC under class imbalance. arXiv. Posted January 13, 2025 doi: 10.48550/arXiv.2401.06091.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.2401.06091</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-S&#xe1;nchez P.A., Garc&#xed;a-Isla G., Corino V.D.A., Vehkaoja A., Brukamp K., van Gils M., Mainardi L. ECG-based data-driven solutions for diagnosis and prognosis of cardiovascular diseases: a systematic review. Comput Biol Med. 2024;172</Citation><ArticleIdList><ArticleId IdType="pubmed">38460311</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawshani A., Larsson A., Gelang C., Lindqvist J., Gellerstedt M., B&#xe5;ng A., Herlitz J. Characteristics and outcome among patients who dial for the EMS due to chest pain. Int J Cardiol. 2014;176:859&#x2013;865.</Citation><ArticleIdList><ArticleId IdType="pubmed">25176629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaraman S., Sangareddi V., Periyasamy R., Joseph J., Shanmugam R.M. Modified limb lead ECG system effects on electrocardiographic wave amplitudes and frontal plane axis in sinus rhythm subjects. Anatol J Cardiol. 2017;17:46&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5324862</ArticleId><ArticleId IdType="pubmed">27443474</ArticleId></ArticleIdList></Reference><Reference><Citation>Papouchado M., Walker P.R., James M.A., Clarke L.M. Fundamental differences between the standard 12-lead electrocardiograph and the modified (Mason--Likar) exercise lead system. Eur Heart J. 1987;8:725&#x2013;733.</Citation><ArticleIdList><ArticleId IdType="pubmed">3653124</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendell Meyers H., Bracey A., Lee D., et al. Accuracy of OMI ECG findings versus STEMI criteria for diagnosis of acute coronary occlusion myocardial infarction. Int J Cardiol Heart Vasc. 2021;33</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8065286</ArticleId><ArticleId IdType="pubmed">33912650</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W.-C., Lin C.S., Tsai C.S., et al. A deep learning algorithm for detecting acute myocardial infarction. EuroIntervention. 2021;17:765&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724911</ArticleId><ArticleId IdType="pubmed">33840640</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhuang F., Qi Z., Duan K., et al. A comprehensive survey on transfer learning. arXiv. Posted June 23, 2020 doi: 10.48550/arXiv.1911.03347.</Citation><ArticleIdList><ArticleId IdType="doi">10.48550/arXiv.1911.03347</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40635597</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-7401</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>10</Day></PubDate></JournalIssue><Title>Technology and health care : official journal of the European Society for Engineering and Medicine</Title><ISOAbbreviation>Technol Health Care</ISOAbbreviation></Journal><ArticleTitle>Risk factors of acute myocardial infarction combined with First-Diagnosed atrial fibrillation.</ArticleTitle><Pagination><StartPage>9287329251355850</StartPage><MedlinePgn>9287329251355850</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09287329251355850</ELocationID><Abstract><AbstractText>BackgroundAtrial fibrillation (AF) is a common complication of acute myocardial infarction (AMI), significantly affecting patient prognosis by increasing the risk of heart failure, thromboembolic events, and mortality.ObjectiveTo explore the risk factors of AM combined with first-diagnosed AF.MethodsClinical data related to a total of 142 consecutive AMI patients admitted to Beijing Tongren Hospital from January 1, 2020 to May 1, 2020 were retrospectively analyzed, of whom 8 cases (5.6%) were divided into first-diagnosed AF group and the rest 134 cases were in non-first-diagnosed AF group according to the presence or absence of first-diagnosed AF. Clinical data, laboratory indexes, cardiac ultrasonography and coronary angiography results of the two groups were compared. Logistic regression method was used to analyze the possible risk factors offirst-diagnosed AF.ResultsComparing the various data between the two groups, the peak creatinine kinase myocardial band (CKMB), white blood cell count, left ventricular ejection fraction, and the proportion of patients with admission Killip grades 3-4 in the first-diagnosed AF group were significantly different from those in the non- first-diagnosed AF group (<i>p</i>&#x2009;&lt;&#x2009;0.05); the results of logistic multifactorial regression analysis showed that admission Killip grades 3-4 was an independent risk factor for first-diagnosed AF in patients with AMI (OR&#x2009;=&#x2009;9.549, 95% CI: 1.697-53.737, <i>p</i>&#x2009;=&#x2009;0.01).ConclusionPatients with AMI and Killip grade 3-4 face a heightened risk of developing atrial fibrillation. Close clinical observation, including ECG monitoring, is essential for early atrial fibrillation detection. Given the limitations of the current study, such as small sample size in single center, small number of AF events, the retrospective design, the validity and reliability of the research findings are constrained.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dong</LastName><ForeName>Zhimin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Xiaoxia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Caixia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Technol Health Care</MedlineTA><NlmUniqueID>9314590</NlmUniqueID><ISSNLinking>0928-7329</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Killip classification</Keyword><Keyword MajorTopicYN="N">acute myocardial infarction</Keyword><Keyword MajorTopicYN="N">first-diagnosed atrial fibrillation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40635597</ArticleId><ArticleId IdType="doi">10.1177/09287329251355850</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40636625</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>17</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Myocardial Infarction With Non-obstructive Coronary Arteries (MINOCA) in a High-Risk Young Man: A Case Report.</ArticleTitle><Pagination><StartPage>e85644</StartPage><MedlinePgn>e85644</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e85644</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.85644</ELocationID><Abstract><AbstractText>Acute coronary syndrome (ACS) in young adults with non-obstructive coronary arteries presents diagnostic and therapeutic challenges. Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a relatively uncommon but clinically significant entity, often caused by&#xa0;coronary vasospasm, microvascular dysfunction, or plaque erosion,&#xa0;requiring careful differentiation from other ischemic and non-ischemic causes. We report the case of a 27-year-old Moroccan man with a high cardiovascular risk profile, including newly diagnosed type 2 diabetes, obesity, active smoking, and a family history of coronary artery disease, who presented to the emergency department with severe, persistent chest pain and ST-segment elevation on electrocardiography (ECG). Given the ST-segment elevation MI (STEMI)-mimicking presentation and lack of immediate angiography access, fibrinolysis was administered, though symptom persistence later suggested MINOCA. An angiography was conducted, revealing no obstructive coronary lesions. Further investigation with cardiac magnetic resonance imaging (MRI) confirmed an apical transmural MI. The patient's course was managed with dual antiplatelet therapy, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and statins, with anti-anginal agents added upon the recurrence of angina. This case illustrates the diagnostic complexities of MINOCA in young adults with ACS presentations and highlights the importance of advanced imaging to confirm MI and guide treatment.&#xa0;Future research should address optimal acute management (e.g., fibrinolysis vs. conservative strategies) and the role of intracoronary imaging (intravascular ultrasound (IVUS)/optical coherence tomography (OCT)) in MINOCA.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025, Soussi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Soussi</LastName><ForeName>Oumama</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Cardiology, Ibn Sina Hospital, Ibn Sina University Hospital Center, Mohammed V University, Rabat, MAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachri</LastName><ForeName>Houda</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Cardiology, Ibn Sina Hospital, Ibn Sina University Hospital Center, Mohammed V University, Rabat, MAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bendagha</LastName><ForeName>Nesma</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiology, Ibn Sina Hospital, Ibn Sina University Hospital Center, Mohammed V University, Rabat, MAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soufiani</LastName><ForeName>Aida</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology, Ibn Sina Hospital, Ibn Sina University Hospital Center, Mohammed V University, Rabat, MAR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fellat</LastName><ForeName>Rokya</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiology, Ibn Sina Hospital, Ibn Sina University Hospital Center, Mohammed V University, Rabat, MAR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute coronary syndrome (acs)</Keyword><Keyword MajorTopicYN="N">cardiovascular risk factors (cvrf)</Keyword><Keyword MajorTopicYN="N">myocardial infarction with non-obstructive coronary arteries (minocas)</Keyword><Keyword MajorTopicYN="N">non-obstructive coronary disease</Keyword><Keyword MajorTopicYN="N">young adults&#xa0;</Keyword></KeywordList><CoiStatement>Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>10</Day><Hour>5</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40636625</ArticleId><ArticleId IdType="pmc">PMC12240548</ArticleId><ArticleId IdType="doi">10.7759/cureus.85644</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Acute myocardial infarction in young individuals. Gulati R, Behfar A, Narula J, Kanwar A, Lerman A, Cooper L, Singh M. Mayo Clin Proc. 2020;95:136&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">31902409</ArticleId></ArticleIdList></Reference><Reference><Citation>Symptomatic young adults with ST-segment elevation-acute coronary syndrome or myocarditis: the three-factor diagnostic model. Wieczorkiewicz P, Przybylak K, Supel K, Kidawa M, Zielinska M. J Clin Med. 2022;11:916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8877187</ArticleId><ArticleId IdType="pubmed">35207189</ArticleId></ArticleIdList></Reference><Reference><Citation>Atypical presentations of myocardial infarction: a systematic review of case reports. Khan IA, Karim HM, Panda CK, Ahmed G, Nayak S. Cureus. 2023;15:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10048062</ArticleId><ArticleId IdType="pubmed">36999116</ArticleId></ArticleIdList></Reference><Reference><Citation>MINOCA and INOCA: role in heart failure. Almeida AG. Curr Heart Fail Rep. 2023;20:139&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10256635</ArticleId><ArticleId IdType="pubmed">37198520</ArticleId></ArticleIdList></Reference><Reference><Citation>Myocardial infarction without obstructive coronary artery disease is not a benign condition (ANZACS-QI 10) Barr PR, Harrison W, Smyth D, Flynn C, Lee M, Kerr AJ. https://doi.org/10.1016/j.hlc.2017.02.023. Heart Lung Circ. 2018;27:165&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pubmed">28408093</ArticleId></ArticleIdList></Reference><Reference><Citation>Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO study. Safdar B, Spatz ES, Dreyer RP, et al. J Am Heart Assoc. 2018;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6064896</ArticleId><ArticleId IdType="pubmed">29954744</ArticleId></ArticleIdList></Reference><Reference><Citation>Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and meta-analysis from the MINOCA global collaboration. Pasupathy S, Lindahl B, Litwin P, et al. Circ Cardiovasc Qual Outcomes. 2021;14:0.</Citation><ArticleIdList><ArticleId IdType="pubmed">34784229</ArticleId></ArticleIdList></Reference><Reference><Citation>Contemporary diagnosis and management of&#xa0;patients with MINOCA. Parwani P, Kang N, Safaeipour M, et al. Curr Cardiol Rep. 2023;25:561&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10188585</ArticleId><ArticleId IdType="pubmed">37067753</ArticleId></ArticleIdList></Reference><Reference><Citation>Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Tamis-Holland JE, Jneid H, Reynolds HR, et al. Circulation. 2019;139:0&#x2013;908.</Citation><ArticleIdList><ArticleId IdType="pubmed">30913893</ArticleId></ArticleIdList></Reference><Reference><Citation>Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Montone RA, Niccoli G, Fracassi F, et al. Eur Heart J. 2018;39:91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">29228159</ArticleId></ArticleIdList></Reference><Reference><Citation>ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Agewall S, Beltrame JF, Reynolds HR, et al. Eur Heart J. 2017;38:143&#x2013;153.</Citation><ArticleIdList><ArticleId IdType="pubmed">28158518</ArticleId></ArticleIdList></Reference><Reference><Citation>Prognostic role of CMR and&#xa0;conventional risk factors in&#xa0;myocardial infarction with nonobstructed coronary arteries. Dastidar AG, Baritussio A, De Garate E, et al. JACC Cardiovasc Imaging. 2019;12:1973&#x2013;1982.</Citation><ArticleIdList><ArticleId IdType="pubmed">30772224</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical features and long-term outcomes in very young patients with myocardial infarction with non-obstructive coronary arteries. Juan-Salvadores P, Jim&#xe9;nez D&#xed;az VA, Rodr&#xed;guez Gonz&#xe1;lez de Araujo A, et al. J Interv Cardiol. 2022;2022:9584527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356902</ArticleId><ArticleId IdType="pubmed">35990214</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronary microvascular dysfunction. Godo S, Suda A, Takahashi J, Yasuda S, Shimokawa H. Arterioscler Thromb Vasc Biol. 2021;41:1625&#x2013;1637.</Citation><ArticleIdList><ArticleId IdType="pubmed">33761763</ArticleId></ArticleIdList></Reference><Reference><Citation>MINOCA: a pathophysiological approach of diagnosis and treatment-a narrative review. Khattab E, Karelas D, Pallas T, et al. Biomedicines. 2024;12:2457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11592352</ArticleId><ArticleId IdType="pubmed">39595023</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40642299</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-042X</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2025</Year></PubDate></JournalIssue><Title>Frontiers in physiology</Title><ISOAbbreviation>Front Physiol</ISOAbbreviation></Journal><ArticleTitle>Conduction defects and arrhythmias in <i>mdx</i> mice are not associated with a degeneration of the cardiac Purkinje network.</ArticleTitle><Pagination><StartPage>1607916</StartPage><MedlinePgn>1607916</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1607916</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fphys.2025.1607916</ELocationID><Abstract><AbstractText>Duchenne muscular dystrophy (DMD) is a severe X-chromosomal disease characterised by progressive muscle weakness and degeneration. Cardiac involvement is inevitable in DMD patients and ventricular arrhythmias are a high-risk factor for mortality in these patients. Ventricular arrhythmias are often triggered by a dysfunctional ventricular conduction system, which serves as an electrical circuit in the heart to ensure the synchronization of the heartbeat. This system includes Purkinje fibers which are susceptible to degeneration in DMD patients, leading to cardiac conduction disorders. To unravel whether a defective ventricular conduction system may account for arrhythmogenesis in a DMD mouse model, we performed a longitudinal study of the cardiac electrical activity in <i>mdx</i> mice. ECG recordings showed a progressive increase in PR interval over time and a prolonged QRS in <i>mdx</i> compared to wild-type (WT) mice. At baseline, only <i>mdx</i> mice presented premature ventricular complexes (PVC), and a greater prevalence of PVC was observed after &#x3b2;-adrenergic stimulation in these mice. These conduction defects and arrhythmias occurred while no defects in the morphology and maturation of the Purkinje fiber network were observed. However, <i>mdx</i> mice had a larger heart and showed signs of fibrosis and hypertrophy. Furthermore, conduction defects in <i>mdx</i> mice were associated with ventricular dyssynchrony and sodium current (I<sub>Na</sub>) reduction in ventricular myocytes and Purkinje fibers. Altogether, these data demonstrated that <i>mdx</i> mice develop a progressive arrhythmogenic cardiomyopathy in association with I<sub>Na</sub> loss, ventricular fibrosis but without degeneration of the ventricular conduction system.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Vahdat, Sauer, Marksteiner, Hilber and Miquerol.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vahdat</LastName><ForeName>Juliette</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Aix-Marseille Universit&#xe9;, CNRS UMR 7288, Developmental Biology Institute of Marseille, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauer</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology and Neuropharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marksteiner</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology and Neuropharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hilber</LastName><ForeName>Karlheinz</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology and Neuropharmacology, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miquerol</LastName><ForeName>Lucile</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Aix-Marseille Universit&#xe9;, CNRS UMR 7288, Developmental Biology Institute of Marseille, Marseille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Physiol</MedlineTA><NlmUniqueID>101549006</NlmUniqueID><ISSNLinking>1664-042X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DMD</Keyword><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">Purkinje fibers</Keyword><Keyword MajorTopicYN="N">conduction system anatomy</Keyword><Keyword MajorTopicYN="N">sodium current</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>11</Day><Hour>5</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40642299</ArticleId><ArticleId IdType="pmc">PMC12241033</ArticleId><ArticleId IdType="doi">10.3389/fphys.2025.1607916</ArticleId><ArticleId IdType="pii">1607916</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Amedro P., Vincenti M., De La Villeon G., Lavastre K., Barrea C., Guillaumont S., et al. (2019). Speckle-tracking echocardiography in children with duchenne muscular dystrophy: a prospective multicenter controlled cross-sectional study. J. Am. Soc. Echocardiogr. 32 (3), 412&#x2013;422. 10.1016/j.echo.2018.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2018.10.017</ArticleId><ArticleId IdType="pubmed">30679141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bies R. D., Friedman D., Roberts R., Perryman M. B., Caskey C. T. (1992). Expression and localization of dystrophin in human cardiac Purkinje fibers. Circulation 86 (1), 147&#x2013;153. 10.1161/01.cir.86.1.147</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.86.1.147</ArticleId><ArticleId IdType="pubmed">1617767</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco D. M., Wolf C. M., Sherwood M., Hammer P. E., Kang P. B., Berul C. I. (2007). Cardiac electrophysiological characteristics of the mdx (5cv) mouse model of Duchenne muscular dystrophy. J. Interv. Card. Electrophysiol. 20 (1-2), 1&#x2013;7. 10.1007/s10840-007-9168-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-007-9168-z</ArticleId><ArticleId IdType="pubmed">17940855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulfield G., Siller W. G., Wight P. A., Moore K. J. (1984). X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. U. S. A. 81 (4), 1189&#x2013;1192. 10.1073/pnas.81.4.1189</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.81.4.1189</ArticleId><ArticleId IdType="pmc">PMC344791</ArticleId><ArticleId IdType="pubmed">6583703</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenard A. A., Becane H. M., Tertrain F., de Kermadec J. M., Weiss Y. A. (1993). Ventricular arrhythmia in Duchenne muscular dystrophy: prevalence, significance and prognosis. Neuromuscul. Disord. 3 (3), 201&#x2013;206. 10.1016/0960-8966(93)90060-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0960-8966(93)90060-w</ArticleId><ArticleId IdType="pubmed">7691292</ArticleId></ArticleIdList></Reference><Reference><Citation>Choquet C., Nguyen T. H. M., Sicard P., Buttigieg E., Tran T. T., Kober F., et al. (2018). Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy. PLoS Genet. 14 (7), e1007502. 10.1371/journal.pgen.1007502</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007502</ArticleId><ArticleId IdType="pmc">PMC6051668</ArticleId><ArticleId IdType="pubmed">29979676</ArticleId></ArticleIdList></Reference><Reference><Citation>Choquet C., Sicard P., Vahdat J., Nguyen T. H. M., Kober F., Varlet I., et al. (2023). Nkx2-5 loss of function in the his-purkinje system hampers its maturation and leads to mechanical dysfunction. J. Cardiovasc Dev. Dis. 10 (5), 194. 10.3390/jcdd10050194</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd10050194</ArticleId><ArticleId IdType="pmc">PMC10219388</ArticleId><ArticleId IdType="pubmed">37233161</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu V., Otero J. M., Lopez O., Sullivan M. F., Morgan J. P., Amende I., et al. (2002). Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy. Muscle Nerve 26 (4), 513&#x2013;519. 10.1002/mus.10223</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10223</ArticleId><ArticleId IdType="pubmed">12362417</ArticleId></ArticleIdList></Reference><Reference><Citation>Colussi C., Rosati J., Straino S., Spallotta F., Berni R., Stilli D., et al. (2011). N&#x3b5;-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart. Proc. Natl. Acad. Sci. U. S. A. 108 (7), 2795&#x2013;2800. 10.1073/pnas.1013124108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1013124108</ArticleId><ArticleId IdType="pmc">PMC3041095</ArticleId><ArticleId IdType="pubmed">21282606</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebner J., Pan X., Yue Y., Sideromenos S., Marksteiner J., Koenig X., et al. (2022). Microdystrophin therapy rescues impaired Na currents in cardiac Purkinje fibers from dystrophin-deficient mdx mice. Circ. Arrhythm. Electrophysiol. 15 (8), e011161. 10.1161/CIRCEP.122.011161</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.122.011161</ArticleId><ArticleId IdType="pmc">PMC9396648</ArticleId><ArticleId IdType="pubmed">35917466</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebner J., Uhrin P., Szabo P. L., Kiss A., Podesser B. K., Todt H., et al. (2020). Reduced Na(+) current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy. Am. J. Physiol. Heart Circ. Physiol. 318 (6), H1436&#x2013;H1440. 10.1152/ajpheart.00224.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00224.2020</ArticleId><ArticleId IdType="pubmed">32383994</ArticleId></ArticleIdList></Reference><Reference><Citation>Echigoya Y., Nakamura A., Nagata T., Urasawa N., Lim K. R. Q., Trieu N., et al. (2017). Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. U. S. A. 114 (16), 4213&#x2013;4218. 10.1073/pnas.1613203114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1613203114</ArticleId><ArticleId IdType="pmc">PMC5402437</ArticleId><ArticleId IdType="pubmed">28373570</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde B., Heinen A., Godecke A., Bottermann K. (2014). Wheat germ agglutinin staining as a suitable method for detection and quantification of fibrosis in cardiac tissue after myocardial infarction. Eur. J. Histochem 58 (4), 2448. 10.4081/ejh.2014.2448</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ejh.2014.2448</ArticleId><ArticleId IdType="pmc">PMC4289847</ArticleId><ArticleId IdType="pubmed">25578975</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauconnier J., Thireau J., Reiken S., Cassan C., Richard S., Matecki S., et al. (2010). Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. U. S. A. 107 (4), 1559&#x2013;1564. 10.1073/pnas.0908540107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908540107</ArticleId><ArticleId IdType="pmc">PMC2824377</ArticleId><ArticleId IdType="pubmed">20080623</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayssoil A., Ben Yaou R., Ogna A., Chaffaut C., Leturcq F., Nardi O., et al. (2018). Left bundle branch block in Duchenne muscular dystrophy: Prevalence, genetic relationship and prognosis. PLoS One 13 (1), e0190518. 10.1371/journal.pone.0190518</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0190518</ArticleId><ArticleId IdType="pmc">PMC5755816</ArticleId><ArticleId IdType="pubmed">29304097</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavillet B., Rougier J. S., Domenighetti A. A., Behar R., Boixel C., Ruchat P., et al. (2006). Cardiac sodium channel Nav1.5 is regulated by a multiprotein complex composed of syntrophins and dystrophin. Circ. Res. 99 (4), 407&#x2013;414. 10.1161/01.RES.0000237466.13252.5e</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000237466.13252.5e</ArticleId><ArticleId IdType="pubmed">16857961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghaleh B., Barthelemy I., Sambin L., Bize A., Corboz D., Hittinger L., et al. (2023). Spatial and temporal non-uniform changes in left ventricular myocardial strain in dogs with duchenne muscular dystrophy. J. Cardiovasc Dev. Dis. 10 (5), 217. 10.3390/jcdd10050217</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd10050217</ArticleId><ArticleId IdType="pmc">PMC10219152</ArticleId><ArticleId IdType="pubmed">37233184</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez J. P., Ramachandran J., Xie L. H., Contreras J. E., Fraidenraich D. (2015). Selective Connexin43 inhibition prevents isoproterenol-induced arrhythmias and lethality in muscular dystrophy mice. Sci. Rep. 5, 13490. 10.1038/srep13490</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13490</ArticleId><ArticleId IdType="pmc">PMC4550874</ArticleId><ArticleId IdType="pubmed">26311238</ArticleId></ArticleIdList></Reference><Reference><Citation>Gros D. B., Jongsma H. J. (1996). Connexins in mammalian heart function. Bioessays 18 (9), 719&#x2013;730. 10.1002/bies.950180907</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.950180907</ArticleId><ArticleId IdType="pubmed">8831288</ArticleId></ArticleIdList></Reference><Reference><Citation>Himelman E., Lillo M. A., Nouet J., Gonzalez J. P., Zhao Q., Xie L. H., et al. (2020). Prevention of connexin-43 remodeling protects against Duchenne muscular dystrophy cardiomyopathy. J. Clin. Invest. 130 (4), 1713&#x2013;1727. 10.1172/JCI128190</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI128190</ArticleId><ArticleId IdType="pmc">PMC7108916</ArticleId><ArticleId IdType="pubmed">31910160</ArticleId></ArticleIdList></Reference><Reference><Citation>Jearawiriyapaisarn N., Moulton H. M., Sazani P., Kole R., Willis M. S. (2010). Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers. Cardiovasc Res. 85 (3), 444&#x2013;453. 10.1093/cvr/cvp335</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvp335</ArticleId><ArticleId IdType="pmc">PMC2802205</ArticleId><ArticleId IdType="pubmed">19815563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamdar F., Garry D. J. (2016). Dystrophin-deficient cardiomyopathy. J. Am. Coll. Cardiol. 67 (21), 2533&#x2013;2546. 10.1016/j.jacc.2016.02.081</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.02.081</ArticleId><ArticleId IdType="pubmed">27230049</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig X., Dysek S., Kimbacher S., Mike A. K., Cervenka R., Lukacs P., et al. (2011). Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart. PLoS One 6 (5), e20300. 10.1371/journal.pone.0020300</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020300</ArticleId><ArticleId IdType="pmc">PMC3100353</ArticleId><ArticleId IdType="pubmed">21677768</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig X., Rubi L., Obermair G. J., Cervenka R., Dang X. B., Lukacs P., et al. (2014). Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart. Am. J. Physiol. Heart Circ. Physiol. 306 (4), H564&#x2013;H573. 10.1152/ajpheart.00441.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00441.2013</ArticleId><ArticleId IdType="pmc">PMC4892346</ArticleId><ArticleId IdType="pubmed">24337461</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo M. A., Himelman E., Shirokova N., Xie L. H., Fraidenraich D., Contreras J. E. (2019). S-nitrosylation of connexin43 hemichannels elicits cardiac stress-induced arrhythmias in Duchenne muscular dystrophy mice. JCI Insight 4 (24), e130091. 10.1172/jci.insight.130091</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.130091</ArticleId><ArticleId IdType="pmc">PMC6975272</ArticleId><ArticleId IdType="pubmed">31751316</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchal G. A., van Putten M., Verkerk A. O., Casini S., Putker K., van Amersfoorth S. C. M., et al. (2021). Low human dystrophin levels prevent cardiac electrophysiological and structural remodelling in a Duchenne mouse model. Sci. Rep. 11 (1), 9779. 10.1038/s41598-021-89208-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89208-1</ArticleId><ArticleId IdType="pmc">PMC8105358</ArticleId><ArticleId IdType="pubmed">33963238</ArticleId></ArticleIdList></Reference><Reference><Citation>Megeney L. A., Kablar B., Perry R. L., Ying C., May L., Rudnicki M. A. (1999). Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc. Natl. Acad. Sci. U. S. A. 96 (1), 220&#x2013;225. 10.1073/pnas.96.1.220</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.1.220</ArticleId><ArticleId IdType="pmc">PMC15120</ArticleId><ArticleId IdType="pubmed">9874799</ArticleId></ArticleIdList></Reference><Reference><Citation>Meysen S., Marger L., Hewett K. W., Jarry-Guichard T., Agarkova I., Chauvin J. P., et al. (2007). Nkx2.5 cell-autonomous gene function is required for the postnatal formation of the peripheral ventricular conduction system. Dev. Biol. 303 (2), 740&#x2013;753. 10.1016/j.ydbio.2006.12.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2006.12.044</ArticleId><ArticleId IdType="pubmed">17250822</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquerol L., Meysen S., Mangoni M., Bois P., van Rijen H. V., Abran P., et al. (2004). Architectural and functional asymmetry of the His-Purkinje system of the murine heart. Cardiovasc Res. 63 (1), 77&#x2013;86. 10.1016/j.cardiores.2004.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2004.03.007</ArticleId><ArticleId IdType="pubmed">15194464</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigro G., Comi L. I., Politano L., Bain R. J. (1990). The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int. J. Cardiol. 26 (3), 271&#x2013;277. 10.1016/0167-5273(90)90082-g</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-5273(90)90082-g</ArticleId><ArticleId IdType="pubmed">2312196</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura H., Hizawa K. (1982). Histopathological study of the conduction system of the heart in Duchenne progressive muscular dystrophy. Acta Pathol. Jpn. 32 (6), 1027&#x2013;1033. 10.1111/j.1440-1827.1982.tb02082.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1827.1982.tb02082.x</ArticleId><ArticleId IdType="pubmed">7158338</ArticleId></ArticleIdList></Reference><Reference><Citation>Oebel S., Dinov B., Arya A., Hilbert S., Sommer P., Bollmann A., et al. (2017). ECG morphology of premature ventricular contractions predicts the presence of myocardial fibrotic substrate on cardiac magnetic resonance imaging in patients undergoing ablation. J. Cardiovasc Electrophysiol. 28 (11), 1316&#x2013;1323. 10.1111/jce.13309</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.13309</ArticleId><ArticleId IdType="pubmed">28791747</ArticleId></ArticleIdList></Reference><Reference><Citation>Olejnickova V., Kocka M., Kvasilova A., Kolesova H., Dziacky A., Gidor T., et al. (2021). Gap junctional communication via Connexin43 between Purkinje fibers and working myocytes explains the epicardial activation pattern in the postnatal mouse left ventricle. Int. J. Mol. Sci. 22 (5), 2475. 10.3390/ijms22052475</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052475</ArticleId><ArticleId IdType="pmc">PMC7957598</ArticleId><ArticleId IdType="pubmed">33804428</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono N., Yamaguchi T., Ishikawa H., Arakawa M., Takahashi N., Saikawa T., et al. (2009). Morphological varieties of the Purkinje fiber network in mammalian hearts, as revealed by light and electron microscopy. Arch. Histol. Cytol. 72 (3), 139&#x2013;149. 10.1679/aohc.72.139</Citation><ArticleIdList><ArticleId IdType="doi">10.1679/aohc.72.139</ArticleId><ArticleId IdType="pubmed">20513977</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallante B. A., Giovannone S., Fang-Yu L., Zhang J., Liu N., Kang G., et al. (2010). Contactin-2 expression in the cardiac Purkinje fiber network. Circ. Arrhythm. Electrophysiol. 3 (2), 186&#x2013;194. 10.1161/CIRCEP.109.928820</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.109.928820</ArticleId><ArticleId IdType="pmc">PMC3068837</ArticleId><ArticleId IdType="pubmed">20110552</ArticleId></ArticleIdList></Reference><Reference><Citation>Perloff J. K. (1984). Cardiac rhythm and conduction in Duchenne's muscular dystrophy: a prospective study of 20 patients. J. Am. Coll. Cardiol. 3 (5), 1263&#x2013;1268. 10.1016/s0735-1097(84)80186-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(84)80186-2</ArticleId><ArticleId IdType="pubmed">6707378</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan J. G., Hahn H. S., Wong B. L., Lorenz J. N., Wenisch A. S., Levin L. S. (2004). Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul. Disord. 14 (8-9), 491&#x2013;496. 10.1016/j.nmd.2004.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2004.04.007</ArticleId><ArticleId IdType="pubmed">15336690</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer J., Marksteiner J., Lilliu E., Hackl B., Todt H., Kubista H., et al. (2024). Empagliflozin treatment rescues abnormally reduced Na(+) currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice. Am. J. Physiol. Heart Circ. Physiol. 326 (2), H418&#x2013;H425. 10.1152/ajpheart.00729.2023</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00729.2023</ArticleId><ArticleId IdType="pmc">PMC11219046</ArticleId><ArticleId IdType="pubmed">38099845</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirokova N., Niggli E. (2013). Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies. J. Mol. Cell Cardiol. 58, 217&#x2013;224. 10.1016/j.yjmcc.2012.12.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2012.12.009</ArticleId><ArticleId IdType="pmc">PMC3615054</ArticleId><ArticleId IdType="pubmed">23261966</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikkel M. B., Francis D. P., Howard J., Gordon F., Rowlands C., Peters N. S., et al. (2017). Hierarchical statistical techniques are necessary to draw reliable conclusions from analysis of isolated cardiomyocyte studies. Cardiovasc Res. 113 (14), 1743&#x2013;1752. 10.1093/cvr/cvx151</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvx151</ArticleId><ArticleId IdType="pmc">PMC5852514</ArticleId><ArticleId IdType="pubmed">29016722</ArticleId></ArticleIdList></Reference><Reference><Citation>Souidi M., Resta J., Dridi H., Sleiman Y., Reiken S., Formoso K., et al. (2024). Ryanodine receptor dysfunction causes senescence and fibrosis in Duchenne dilated cardiomyopathy. J. Cachexia Sarcopenia Muscle 15 (2), 536&#x2013;551. 10.1002/jcsm.13411</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcsm.13411</ArticleId><ArticleId IdType="pmc">PMC10995256</ArticleId><ArticleId IdType="pubmed">38221511</ArticleId></ArticleIdList></Reference><Reference><Citation>Spurney C. F. (2011). Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve 44 (1), 8&#x2013;19. 10.1002/mus.22097</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22097</ArticleId><ArticleId IdType="pubmed">21674516</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuda T., Fitzgerald K. K. (2017). Dystrophic cardiomyopathy: complex pathobiological processes to generate clinical phenotype. J. Cardiovasc Dev. Dis. 4 (3), 14. 10.3390/jcdd4030014</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd4030014</ArticleId><ArticleId IdType="pmc">PMC5715712</ArticleId><ArticleId IdType="pubmed">29367543</ArticleId></ArticleIdList></Reference><Reference><Citation>Urasawa N., Wada M. R., Machida N., Yuasa K., Shimatsu Y., Wakao Y., et al. (2008). Selective vacuolar degeneration in dystrophin-deficient canine Purkinje fibers despite preservation of dystrophin-associated proteins with overexpression of Dp71. Circulation 117 (19), 2437&#x2013;2448. 10.1161/CIRCULATIONAHA.107.739326</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.739326</ArticleId><ArticleId IdType="pubmed">18458171</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Quick A. P., Cao S., Reynolds J., Chiang D. Y., Beavers D., et al. (2018). Oxidized CaMKII (Ca(2+)/calmodulin-dependent protein kinase II) is essential for ventricular arrhythmia in a mouse model of duchenne muscular dystrophy. Circ. Arrhythm. Electrophysiol. 11 (4), e005682. 10.1161/CIRCEP.117.005682</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.117.005682</ArticleId><ArticleId IdType="pmc">PMC5903581</ArticleId><ArticleId IdType="pubmed">29654126</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40627818</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2291-5222</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2025</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>JMIR mHealth and uHealth</Title><ISOAbbreviation>JMIR Mhealth Uhealth</ISOAbbreviation></Journal><ArticleTitle>Exploring the Barriers and Facilitators to Implementing a Smartphone App for Physicians to Improve the Management of Acute Myocardial Infarctions: Multicenter, Mixed Methods, Observational Study.</ArticleTitle><Pagination><StartPage>e60173</StartPage><MedlinePgn>e60173</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e60173</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2196/60173</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Timely and appropriate care is critical for patients with ST-elevation myocardial infarction (STEMI). Effective communication and prompt sharing of test results, particularly electrocardiograms (ECGs), between the referring emergency medicine (EM) physician or emergency medical service (EMS) paramedic and the interventional cardiologist (IC) are essential. This exchange relies on fax or SMS text messages. The SmartAMI-ACS (Strategic Management of Acute Reperfusion and Therapies in Acute Myocardial Infarction) App was developed to streamline communication. It is user friendly and privacy compliant, and enables rapid, secure ECG sharing to support faster, informed clinical decision-making.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This paper details the results of targeted preimplementation surveys to establish barriers and enablers of using a smartphone app to transmit ECG images among ICs, EM physicians, and EMS paramedics to help tailor implementation interventions.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">To assess the proposed acceptability and uptake of the app, preimplementation surveys were disseminated to ICs, EM physicians, and EMS paramedics in one region of Ontario, Canada. Questions were generated based on selected components of the Consolidated Framework for Implementation Research, results from a pilot study carried out at a regional hospital where the SmartAMI-ACS app was previously implemented, and predicted barriers based on expert guidance. The preimplementation surveys consisted of 7-point Likert scale questions (1=strongly disagree and 7=strongly agree) and open-ended questions. Open-ended data were extracted verbatim and analyzed using an inductive qualitative approach, with transcripts coded into descriptive qualitative codes and then collapsed into themes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Survey uptake was acceptable, with 9 of the invited 10 ICs, 51 of the invited 223 EM physicians, and 93 of the invited 1138 EMS paramedics responding. All groups recognized that current practices for sharing ECGs allowed room for improvement, accepting that fax can be inconvenient and SMS text messages may not be secure. When asked whether there was a need for a smartphone app to transmit ECGs, ICs (mean 6.67, SD 0.5), EM physicians (mean 5.57, SD 1.3), and EMS paramedics (mean 5.79, SD 1.45) consistently agreed. Commonly reported barriers were concerns over technological challenges, privacy issues, and cell phone reception strength. Through the identification of the barriers in each stakeholder group, implementation strategies were developed that facilitated the scale-up of this system-change intervention.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Results from the 3 web-based preimplementation surveys to identify key barriers and enablers to the implementation of the app helped inform the selection of tailored implementation strategies to support the rollout of the app across the health region. The surveys identified key barriers around technology, privacy, and access to required Wi-Fi that needed to be addressed during app implementation to facilitate uptake and use. Results from the surveys, and ongoing evaluation of effectiveness, are informing the expansion of the app intervention to local ambulance services and other health regions.</AbstractText><CopyrightInformation>&#xa9; Katelyn J Cullen, Hassan Mir, Madhu K Natarajan, Marija Corovic, Karen Mosleh, Jacob Crawshaw, Mathew Mercuri, Hassan Masoom, JD Schwalm. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Cullen</LastName><ForeName>Katelyn J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0003-3589-8159</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamilton Health Sciences Knowledge Centre, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Mir</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7486-8123</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, Ottawa Heart Institute Research Corporation, University of Ottawa Heart Institute, 40 Ruskin St, Ottawa, ON, K1Y 4W7, Canada, 1 613-696-7406.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Natarajan</LastName><ForeName>Madhu K</ForeName><Initials>MK</Initials><Identifier Source="ORCID">0000-0001-6372-1348</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamilton Health Sciences Knowledge Centre, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corovic</LastName><ForeName>Marija</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6310-2376</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamilton Health Sciences Knowledge Centre, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosleh</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9009-3452</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamilton Health Sciences Knowledge Centre, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crawshaw</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-6302-1496</Identifier><AffiliationInfo><Affiliation>Centre for Implementation Research, Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercuri</LastName><ForeName>Mathew</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8070-9615</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Philosophy of Epidemiology, Medicine and Public Health, Department of Philosophy, University of Johannesburg, Auckland Park, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Philosophy, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masoom</LastName><ForeName>Hassan</ForeName><Initials>H</Initials><Identifier Source="ORCID">0009-0006-1702-8132</Identifier><AffiliationInfo><Affiliation>Division of Cardiology, William Osler Health System, Brampton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schwalm</LastName><ForeName>J D</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0003-2516-4952</Identifier><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hamilton Health Sciences Knowledge Centre, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Research Institute, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>JMIR Mhealth Uhealth</MedlineTA><NlmUniqueID>101624439</NlmUniqueID><ISSNLinking>2291-5222</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063731" MajorTopicYN="Y">Mobile Applications</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010820" MajorTopicYN="Y">Physicians</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="Y">Myocardial Infarction</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009864" MajorTopicYN="N" Type="Geographic">Ontario</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068997" MajorTopicYN="N">Smartphone</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Canada</Keyword><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">Ontario</Keyword><Keyword MajorTopicYN="N">ST-elevation myocardial infarction</Keyword><Keyword MajorTopicYN="N">app</Keyword><Keyword MajorTopicYN="N">application</Keyword><Keyword MajorTopicYN="N">barriers and enablers</Keyword><Keyword MajorTopicYN="N">cardiology</Keyword><Keyword MajorTopicYN="N">decision</Keyword><Keyword MajorTopicYN="N">decision support</Keyword><Keyword MajorTopicYN="N">decision-making</Keyword><Keyword MajorTopicYN="N">digital health</Keyword><Keyword MajorTopicYN="N">emergency medicine</Keyword><Keyword MajorTopicYN="N">interprofessional communication</Keyword><Keyword MajorTopicYN="N">intervention</Keyword><Keyword MajorTopicYN="N">mHealth</Keyword><Keyword MajorTopicYN="N">myocardial</Keyword><Keyword MajorTopicYN="N">myocardial infarctions</Keyword><Keyword MajorTopicYN="N">paramedics</Keyword><Keyword MajorTopicYN="N">privacy</Keyword><Keyword MajorTopicYN="N">survey</Keyword></KeywordList><CoiStatement><b>Conflicts of Interest:</b> HM is an inventor and sole owner of the background intellectual property of the smartphone app used in this study. There is no specific financial conflict of interest to declare as the tool is being used for research. However, it may be commercialized in the future. None of the other authors have a relevant conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>18</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>16</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40627818</ArticleId><ArticleId IdType="pmc">PMC12262926</ArticleId><ArticleId IdType="doi">10.2196/60173</ArticleId><ArticleId IdType="pii">v13i1e60173</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Training bulletin STEMI hospital bypass 118. Ministry of Long-Term Care. Jan, 2016.  [02-06-2025]. https://www.health.gov.on.ca/en/pro/programs/emergency_health/docs/ehs_training_blltn118_en.pdf URL. Accessed.</Citation></Reference><Reference><Citation>Wong GC, Welsford M, Ainsworth C, et al. 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology guidelines on the acute management of ST-elevation myocardial infarction: focused update on regionalization and reperfusion. Can J Cardiol. 2019 Feb;35(2):107&#x2013;132. doi: 10.1016/j.cjca.2018.11.031. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2018.11.031</ArticleId><ArticleId IdType="pubmed">30760415</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiac, stroke &amp; vascular centres. CorHealth Ontario.  [02-06-2025]. https://www.corhealthontario.ca/cardiac-stroke-&amp;-vascular-centres URL. Accessed.</Citation></Reference><Reference><Citation>Lambert L, Brown K, Segal E, Brophy J, Rodes-Cabau J, Bogaty P. Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction. JAMA. 2010 Jun 2;303(21):2148&#x2013;2155. doi: 10.1001/jama.2010.712. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.712</ArticleId><ArticleId IdType="pubmed">20516415</ArticleId></ArticleIdList></Reference><Reference><Citation>McNamara RL, Wang Y, Herrin J, et al. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2006 Jun 6;47(11):2180&#x2013;2186. doi: 10.1016/j.jacc.2005.12.072. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.12.072</ArticleId><ArticleId IdType="pubmed">16750682</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodie BR, Gersh BJ, Stuckey T, et al. When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. J Am Coll Cardiol. 2010 Jul 27;56(5):407&#x2013;413. doi: 10.1016/j.jacc.2010.04.020. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2010.04.020</ArticleId><ArticleId IdType="pubmed">20650362</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharing best practices: timely access to reperfusion therapy for STEMI in Ontario. CorHealth Ontario. Jan, 2018.  [02-06-2025]. https://www.corhealthontario.ca/Sharing-Best-Practices.pdf URL. Accessed.</Citation></Reference><Reference><Citation>Mir H, Syed T, Schwalm J, et al. Smartphone application for STEMI activation: a pilot study. Can J Cardiol. 2021 Oct;37(10):S8. doi: 10.1016/j.cjca.2021.07.032. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2021.07.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JJ, Yoon CH, Suh JW, et al. Reduction of ischemic time for transferred STEMI patients using a smartphone social network system. J Am Coll Cardiol. 2016 Sep 27;68(13):1490&#x2013;1492. doi: 10.1016/j.jacc.2016.07.733. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.07.733</ArticleId><ArticleId IdType="pubmed">27659471</ArticleId></ArticleIdList></Reference><Reference><Citation>Astarcioglu MA, Sen T, Kilit C, et al. Time-to-reperfusion in STEMI undergoing interhospital transfer using smartphone and WhatsApp messenger. Am J Emerg Med. 2015 Oct;33(10):1382&#x2013;1384. doi: 10.1016/j.ajem.2015.07.029. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2015.07.029</ArticleId><ArticleId IdType="pubmed">26299691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley PR, Durej MT, Gessner AE, et al. Smartphone application for transmission of ECG images in pre-hospital STEMI treatment. 2012 IEEE Systems and Information Engineering Design Symposium (SIEDS); Apr 27, 2012; Charlottesville, VA, USA. pp. 118&#x2013;123. Presented at. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/SIEDS.2012.6215144</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CC, Chen YC, Shih CM, et al. Smartphone transmission of electrocardiography images to reduce time of cardiac catheterization laboratory activation. J Chin Med Assoc. 2018 Jun;81(6):505&#x2013;510. doi: 10.1016/j.jcma.2017.11.009. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcma.2017.11.009</ArticleId><ArticleId IdType="pubmed">29287703</ArticleId></ArticleIdList></Reference><Reference><Citation>Studencan M, Alusik D, Plachy L, et al. Significant benefits of new communication technology for time delay management in STEMI patients. PLOS ONE. 2018;13(11):e0205832. doi: 10.1371/journal.pone.0205832. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0205832</ArticleId><ArticleId IdType="pmc">PMC6214513</ArticleId><ArticleId IdType="pubmed">30388116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir H, Cullen KJ, Mosleh K, et al. Smartphone app for prehospital ECG transmission in ST-elevation myocardial infarction activation: protocol for a mixed methods study. JMIR Res Protoc. 2024;13:e55506. doi: 10.2196/55506. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/55506</ArticleId><ArticleId IdType="pmc">PMC11415716</ArticleId><ArticleId IdType="pubmed">39240681</ArticleId></ArticleIdList></Reference><Reference><Citation>Census Profile, 2021 Census of Population: profile table. Statistics Canada.  [02-06-2025]. https://www12.statcan.gc.ca/census-recensement/2021/dp-pd/prof/details/page.cfm?Lang=E&amp;GENDERlist=1,2,3&amp;STATISTIClist=1,4&amp;HEADERlist=0&amp;DGUIDlist=2021A00053520005&amp;SearchText=toronto URL. Accessed.</Citation></Reference><Reference><Citation>Census Profile, 2016 Census: Hamilton Niagara Haldimand Brant, [Health region, December 2017], Ontario and Ontario [Province] Statistics Canada.  [02-06-2025]. https://www12.statcan.gc.ca/census-recensement/2016/dp-pd/prof/details/page.cfm?Lang=E&amp;Geo1=HR&amp;Code1=3504&amp;Geo2=PR&amp;Code2=35&amp;SearchText=Hamilton%20Niagara%20Haldimand%20Brant&amp;SearchType=Begins&amp;SearchPR=01&amp;B1=All&amp;GeoLevel=PR&amp;GeoCode=3504&amp;TABID=1&amp;type=0 URL. Accessed.</Citation></Reference><Reference><Citation>Hamilton Niagara Haldimand Brant LHIN: 2017-2018 annual report. Ontario Local Health Integration Network. 2018.  [2-6-2025]. https://healthcareathome.ca/wp-content/uploads/2022/11/04-2017-18-HNHBLHIN-AR-EN.pdf URL. Accessed.</Citation></Reference><Reference><Citation>Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4(1):50. doi: 10.1186/1748-5908-4-50. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1748-5908-4-50</ArticleId><ArticleId IdType="pmc">PMC2736161</ArticleId><ArticleId IdType="pubmed">19664226</ArticleId></ArticleIdList></Reference><Reference><Citation>Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci. 2022 Oct 29;17(1):75. doi: 10.1186/s13012-022-01245-0. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-022-01245-0</ArticleId><ArticleId IdType="pmc">PMC9617234</ArticleId><ArticleId IdType="pubmed">36309746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirk MA, Kelley C, Yankey N, Birken SA, Abadie B, Damschroder L. A systematic review of the use of the Consolidated Framework for Implementation Research. Implement Sci. 2016 May 17;11(1):72. doi: 10.1186/s13012-016-0437-z. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13012-016-0437-z</ArticleId><ArticleId IdType="pmc">PMC4869309</ArticleId><ArticleId IdType="pubmed">27189233</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul Malik MA, Mustapha MF, Mohamad Sobri N, et al. Optimal reliability and validity of measurement model in confirmatory factor analysis: different Likert point scale experiment. J Contemp Issues Thought. 2021 Jul;11:105&#x2013;112. doi: 10.37134/jcit.vol11.9.2021. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.37134/jcit.vol11.9.2021</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbagelata A, Bethea CF, Severance HW, et al. Smartphone ECG for evaluation of ST-segment elevation myocardial infarction (STEMI): design of the ST LEUIS international multicenter study. J Electrocardiol. 2018;51(2):260&#x2013;264. doi: 10.1016/j.jelectrocard.2017.10.011. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jelectrocard.2017.10.011</ArticleId><ArticleId IdType="pubmed">29174099</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan S, Garg S, Sharma R, et al. Smartphone based 12 lead ECG as decision support in STEMI: a prospective, cross sectional study, non-randomised, single blinded and single-center study. Int J Community Med Public Health. 2023 Mar;10(4):1410&#x2013;1414. doi: 10.18203/2394-6040.ijcmph20230916. doi.</Citation><ArticleIdList><ArticleId IdType="doi">10.18203/2394-6040.ijcmph20230916</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges do Nascimento IJ, Abdulazeem H, Vasanthan LT, et al. Barriers and facilitators to utilizing digital health technologies by healthcare professionals. NPJ Digit Med. 2023 Sep 18;6(1):161. doi: 10.1038/s41746-023-00899-4. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41746-023-00899-4</ArticleId><ArticleId IdType="pmc">PMC10507089</ArticleId><ArticleId IdType="pubmed">37723240</ArticleId></ArticleIdList></Reference><Reference><Citation>Nezamdoust S, Abdekhoda M, Rahmani A. Determinant factors in adopting mobile health application in healthcare by nurses. BMC Med Inform Decis Mak. 2022 Feb 22;22(1):47. doi: 10.1186/s12911-022-01784-y. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-022-01784-y</ArticleId><ArticleId IdType="pmc">PMC8862523</ArticleId><ArticleId IdType="pubmed">35193552</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Zaiti SS, Martin-Gill C, Z&#xe8;gre-Hemsey JK, et al. Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med. 2023 Jul;29(7):1804&#x2013;1813. doi: 10.1038/s41591-023-02396-3. doi. Medline.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02396-3</ArticleId><ArticleId IdType="pmc">PMC10353937</ArticleId><ArticleId IdType="pubmed">37386246</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40623042</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Cardiac alterations induced by Trypanosoma cruzi extracellular vesicles and immune complexes.</ArticleTitle><Pagination><StartPage>e0013273</StartPage><MedlinePgn>e0013273</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0013273</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0013273</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Trypanosoma cruzi is a protozoan parasite responsible for American trypanosomiasis or Chagas disease (CD). This disease is characterized by the presence of cardiac or gastrointestinal symptoms in many patients during the chronic phase, with cardiac symptoms being the most common and severe, affecting approximately 30% of all patients. Although the origin of these pathologies remains unclear, several mechanisms have been proposed, involving factors related to T. cruzi and the host immune response. Extracellular vesicles (EVs) have been studied for their role in parasite-host cell communication, in modulating the host's immune response and more recently as diagnostic tools.</AbstractText><AbstractText Label="METHODOLOGY AND MAIN FINDINGS" NlmCategory="RESULTS">In this study, we describe the role of EVs released by trypomastigotes and the immune complexes (ICs) they form with anti-T. cruzi IgGs (EVs-IgG) in the development of cardiac symptoms compatible with Chagas cardiomyopathy in mice. Autoantibodies detection, electrocardiographic, histopathological, and immunological analyses in mice's hearts were performed. The studies carried out revealed that, while the inoculation of EVs and ICs (seven intravenous injections of 2 &#xb5;g of EVs and ICs over 21 days) did not elicit the appearance of autoantibodies, it led to ECG alterations (heart rate and PR interval), changes in heart cavity areas and wall thickness, and reduced expression of crucial proteins for heart function (connexin 43, tubulin, and dynein), as well as VCAM-1 and altered the cytokine expression profile in the heart. Finally, both EVs-inoculated and ICs-inoculated mice showed an increased presence of B-type natriuretic peptide (BNP) in serum, suggesting that EVs or ICs may participate in the onset of cardiac damage.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our results confirm the ability of EVs shed by the infective forms of T. cruzi and the immune complexes they form with IgG to induce cardiac alterations in mice similar to those described in the literature, in T. cruzi-infected mice as well as in Chagas disease patients. This study highlights the role of EVs in the pathogenicity of Chagas disease and reinforces the importance of considering them as virulence factors in the development of Chagas disease.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2025 Cornet-Gomez et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cornet-Gomez</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9378-8594</Identifier><AffiliationInfo><Affiliation>Department of Parasitology, Biochemical and Molecular Parasitology Group CTS-183, and Institute of Biotechnology, University of Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Valle</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, School of Medicine, University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biopathology and Regenerative Medicine Institute (IBIMER), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrido</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Surgical Specialties, School of Medicine, University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Human Anatomy and Embryology, University of Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serrano</LastName><ForeName>Fernando Rodr&#xed;guez</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biopathology and Regenerative Medicine Institute (IBIMER), University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica, Universidad de Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nieto</LastName><ForeName>Ana I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica, Universidad de Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osuna</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3818-1471</Identifier><AffiliationInfo><Affiliation>Department of Parasitology, Biochemical and Molecular Parasitology Group CTS-183, and Institute of Biotechnology, University of Granada, Granada, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000936">Antigen-Antibody Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000913">Antibodies, Protozoan</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014349" MajorTopicYN="Y">Trypanosoma cruzi</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067128" MajorTopicYN="Y">Extracellular Vesicles</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000936" MajorTopicYN="Y">Antigen-Antibody Complex</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002598" MajorTopicYN="Y">Chagas Cardiomyopathy</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000913" MajorTopicYN="N">Antibodies, Protozoan</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="Y">Heart</DescriptorName><QualifierName UI="Q000469" MajorTopicYN="N">parasitology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014355" MajorTopicYN="Y">Chagas Disease</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>11</Day><Hour>18</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>7</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>7</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40623042</ArticleId><ArticleId IdType="pmc">PMC12251207</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0013273</ArticleId><ArticleId IdType="pii">PNTD-D-25-00548</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gonzalez-Sanz M, Crespillo-And&#xfa;jar C, Chamorro-Tojeiro S, Monge-Maillo B, Perez-Molina JA, Norman FF. Chagas Disease in Europe. Trop Med Infect Dis. 2023;8(12):513. doi: 10.3390/tropicalmed8120513</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed8120513</ArticleId><ArticleId IdType="pmc">PMC10747626</ArticleId><ArticleId IdType="pubmed">38133445</ArticleId></ArticleIdList></Reference><Reference><Citation>Navarro M, Reguero L, Subir&#xe0; C, Bl&#xe1;zquez-P&#xe9;rez A, Requena-M&#xe9;ndez A. Estimating chagas disease prevalence and number of underdiagnosed, and undertreated individuals in Spain. Travel Med Infect Dis. 2022;47:102284. doi: 10.1016/j.tmaid.2022.102284</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2022.102284</ArticleId><ArticleId IdType="pubmed">35245657</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Chagas disease (also known as American trypanosomiasis). 2022.  [cited 14 Jul 2022]. https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)</Citation></Reference><Reference><Citation>Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the Burden of Chagas Disease in the United States. PLoS Negl Trop Dis. 2016;10(11):e0005033. doi: 10.1371/journal.pntd.0005033</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005033</ArticleId><ArticleId IdType="pmc">PMC5098725</ArticleId><ArticleId IdType="pubmed">27820837</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverr&#xed;a LE, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation. 2018;138(12):e169&#x2013;209. doi: 10.1161/CIR.0000000000000599</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0000000000000599</ArticleId><ArticleId IdType="pubmed">30354432</ArticleId></ArticleIdList></Reference><Reference><Citation>Medical Considerations before International Travel. N Engl J Med. 2016;375(15):e32. doi: 10.1056/nejmc1610671</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmc1610671</ArticleId><ArticleId IdType="pubmed">27732814</ArticleId></ArticleIdList></Reference><Reference><Citation>Coura JR, Dias JCP. Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery. Mem Inst Oswaldo Cruz. 2009;104 Suppl 1:31&#x2013;40. doi: 10.1590/s0074-02762009000900006</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0074-02762009000900006</ArticleId><ArticleId IdType="pubmed">19753455</ArticleId></ArticleIdList></Reference><Reference><Citation>Moncayo A, Silveira AC. Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy. Mem Inst Oswaldo Cruz. 2009;104 Suppl 1:17&#x2013;30. doi: 10.1590/s0074-02762009000900005</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0074-02762009000900005</ArticleId><ArticleId IdType="pubmed">19753454</ArticleId></ArticleIdList></Reference><Reference><Citation>Apt W, Zulantay I, Arnello M, Odd&#xf3; D, Gonz&#xe1;lez S, Rodr&#xed;guez J, et al. Congenital infection by Trypanosoma cruzi in an endemic area of Chile: a multidisciplinary study. Trans R Soc Trop Med Hyg. 2013;107(2):98&#x2013;104. doi: 10.1093/trstmh/trs013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trs013</ArticleId><ArticleId IdType="pubmed">23222947</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sousa AS, Vermeij D, Ramos AN Jr, Luquetti AO. Chagas disease. Lancet. 2023;403(10422):203&#x2013;18. doi: 10.1016/S0140-6736(23)01787-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01787-7</ArticleId><ArticleId IdType="pubmed">38071985</ArticleId></ArticleIdList></Reference><Reference><Citation>Coura JR. Chagas disease: what is known and what is needed--a background article. Mem Inst Oswaldo Cruz. 2007;102 Suppl 1:113&#x2013;22. doi: 10.1590/s0074-02762007000900018</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0074-02762007000900018</ArticleId><ArticleId IdType="pubmed">17992371</ArticleId></ArticleIdList></Reference><Reference><Citation>Parada H, Carrasco HA, A&#xf1;ez N, Fuenmayor C, Inglessis I. Cardiac involvement is a constant finding in acute Chagas&#x2019; disease: a clinical, parasitological and histopathological study. Int J Cardiol. 1997;60(1):49&#x2013;54. doi: 10.1016/s0167-5273(97)02952-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0167-5273(97)02952-5</ArticleId><ArticleId IdType="pubmed">9209939</ArticleId></ArticleIdList></Reference><Reference><Citation>Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1(2):92&#x2013;100. doi: 10.1016/S1473-3099(01)00065-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(01)00065-2</ArticleId><ArticleId IdType="pubmed">11871482</ArticleId></ArticleIdList></Reference><Reference><Citation>Bern C. Chagas disease in the immunosuppressed host. Curr Opin Infect Dis. 2012;25(4):450&#x2013;7. doi: 10.1097/QCO.0b013e328354f179</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0b013e328354f179</ArticleId><ArticleId IdType="pubmed">22614520</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassi A Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (Chagas disease). Infect Dis Clin North Am. 2012;26(2):275&#x2013;91. doi: 10.1016/j.idc.2012.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2012.03.002</ArticleId><ArticleId IdType="pubmed">22632639</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristov&#xe3;o-Silva AC, Brelaz-de-Castro MCA, Hernandes MZ, Pereira VRA. Chagas disease: Immunology of the disease at a glance. Cytokine Growth Factor Rev. 2021;62:15&#x2013;22. doi: 10.1016/j.cytogfr.2021.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.10.001</ArticleId><ArticleId IdType="pubmed">34696979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestetti RB, Muccillo G. Clinical course of Chagas&#x2019; heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol. 1997;60(2):187&#x2013;93. doi: 10.1016/s0167-5273(97)00083-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0167-5273(97)00083-1</ArticleId><ArticleId IdType="pubmed">9226290</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira PC. Pathogenesis of Chagas disease cardiomyopathy. WJCID. 2012;2(3):39. doi: 10.5495/wjcid.v2.i3.39</Citation><ArticleIdList><ArticleId IdType="doi">10.5495/wjcid.v2.i3.39</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha MOC, Ribeiro ALP, Teixeira MM. Clinical management of chronic Chagas cardiomyopathy. Front Biosci. 2003;8:e44-54. doi: 10.2741/926</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/926</ArticleId><ArticleId IdType="pubmed">12456332</ArticleId></ArticleIdList></Reference><Reference><Citation>de Andrade JP, Marin Neto JA, de Paola AAV, Vilas-Boas F, Oliveira GMM, Bacal F, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas&#x2019; heart disease: executive summary. Arq Bras Cardiol. 2011;96(6):434&#x2013;42. doi: 10.1590/s0066-782x2011000600002</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0066-782x2011000600002</ArticleId><ArticleId IdType="pubmed">21789345</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Alvarez A, Sitges M, Pinazo M-J, Regueiro-Cueva A, Posada E, Poyatos S, et al. Chagas cardiomyopathy: the potential of diastolic dysfunction and brain natriuretic peptide in the early identification of cardiac damage. PLoS Negl Trop Dis. 2010;4(9):e826. doi: 10.1371/journal.pntd.0000826</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000826</ArticleId><ArticleId IdType="pmc">PMC2943653</ArticleId><ArticleId IdType="pubmed">20877635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro ALP, dos Reis AM, Barros MVL, de Sousa MR, Rocha ALL, Perez AA, et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas&#x2019; disease. Lancet. 2002;360(9331):461&#x2013;2. doi: 10.1016/S0140-6736(02)09638-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)09638-1</ArticleId><ArticleId IdType="pubmed">12241721</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron&#xe8;s N, Fresno M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?. Trends Parasitol. 2003;19(1):19&#x2013;22. doi: 10.1016/s1471-4922(02)00006-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1471-4922(02)00006-5</ArticleId><ArticleId IdType="pubmed">12488221</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira ARL, Hecht MM, Guimaro MC, Sousa AO, Nitz N. Pathogenesis of chagas&#x2019; disease: parasite persistence and autoimmunity. Clin Microbiol Rev. 2011;24(3):592&#x2013;630. doi: 10.1128/CMR.00063-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00063-10</ArticleId><ArticleId IdType="pmc">PMC3131057</ArticleId><ArticleId IdType="pubmed">21734249</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bona E, Lidani KCF, Bavia L, Omidian Z, Gremski LH, Sandri TL, et al. Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?. Front Immunol. 2018;9:1842. doi: 10.3389/fimmu.2018.01842</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01842</ArticleId><ArticleId IdType="pmc">PMC6088212</ArticleId><ArticleId IdType="pubmed">30127792</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda CH, Figueiredo AB, Maciel BC, Marin-Neto JA, Sim&#xf5;es MV. Sustained ventricular tachycardia is associated with regional myocardial sympathetic denervation assessed with 123I-metaiodobenzylguanidine in chronic Chagas cardiomyopathy. J Nucl Med. 2011;52(4):504&#x2013;10. doi: 10.2967/jnumed.110.082032</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.110.082032</ArticleId><ArticleId IdType="pubmed">21441532</ArticleId></ArticleIdList></Reference><Reference><Citation>Macaluso G, Grippi F, Di Bella S, Blanda V, Gucciardi F, Torina A, et al. A Review on the Immunological Response against Trypanosoma cruzi. Pathogens. 2023;12(2):282. doi: 10.3390/pathogens12020282</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12020282</ArticleId><ArticleId IdType="pmc">PMC9964664</ArticleId><ArticleId IdType="pubmed">36839554</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg. 1993;48(3):348&#x2013;57. doi: 10.4269/ajtmh.1993.48.348</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1993.48.348</ArticleId><ArticleId IdType="pubmed">8470772</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarleton RL. Chagas disease: a role for autoimmunity?. Trends Parasitol. 2003;19(10):447&#x2013;51. doi: 10.1016/j.pt.2003.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pt.2003.08.008</ArticleId><ArticleId IdType="pubmed">14519582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonney KM, Taylor JM, Daniels MD, Epting CL, Engman DM. Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity. PLoS One. 2011;6(1):e14571. doi: 10.1371/journal.pone.0014571</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014571</ArticleId><ArticleId IdType="pmc">PMC3024973</ArticleId><ArticleId IdType="pubmed">21283741</ArticleId></ArticleIdList></Reference><Reference><Citation>Daliry A, Pereira IR, Pereira-Junior PP, Ramos IP, Vilar-Pereira G, Silvares RR, et al. Levels of circulating anti-muscarinic and anti-adrenergic antibodies and their effect on cardiac arrhythmias and dysautonomia in murine models of Chagas disease. Parasitology. 2014;141(13):1769&#x2013;78. doi: 10.1017/S0031182014001097</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0031182014001097</ArticleId><ArticleId IdType="pubmed">25093253</ArticleId></ArticleIdList></Reference><Reference><Citation>Florea F, Bernards C, Caproni M, Kleindienst J, Hashimoto T, Koch M, et al. Ex vivo pathogenicity of anti-laminin &#x3b3;1 autoantibodies. Am J Pathol. 2014;184(2):494&#x2013;506. doi: 10.1016/j.ajpath.2013.10.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2013.10.019</ArticleId><ArticleId IdType="pubmed">24300951</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordanengo L, Gea S, Barbieri G, Rabinovich GA. Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas&#x2019; disease. Clin Exp Immunol. 2002;124(2):266&#x2013;73. doi: 10.1046/j.1365-2249.2001.01512.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2001.01512.x</ArticleId><ArticleId IdType="pmc">PMC1906055</ArticleId><ArticleId IdType="pubmed">11422204</ArticleId></ArticleIdList></Reference><Reference><Citation>Smulski CR, Longhi SA, Ayub MJ, Edreira MM, Simonetti L, G&#xf3;mez KA, et al. Interaction map of the Trypanosoma cruzi ribosomal P protein complex (stalk) and the elongation factor 2. J Mol Recognit. 2011;24(2):359&#x2013;70. doi: 10.1002/jmr.1089</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmr.1089</ArticleId><ArticleId IdType="pubmed">21360618</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez Bergami P, Scaglione J, Levin MJ. Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J. 2001;15(14):2602&#x2013;12. doi: 10.1096/fj.01-0132com</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.01-0132com</ArticleId><ArticleId IdType="pubmed">11726536</ArticleId></ArticleIdList></Reference><Reference><Citation>Longhi SA, Atienza A, Perez Prados G, Buying A, Balouz V, Buscaglia CA, et al. Cytokine production but lack of proliferation in peripheral blood mononuclear cells from chronic Chagas&#x2019; disease cardiomyopathy patients in response to T. cruzi ribosomal P proteins. PLoS Negl Trop Dis. 2014;8(6):e2906. doi: 10.1371/journal.pntd.0002906</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002906</ArticleId><ArticleId IdType="pmc">PMC4046937</ArticleId><ArticleId IdType="pubmed">24901991</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutra WO, Martins-Filho OA, Can&#xe7;ado JR, Pinto-Dias JC, Brener Z, Freeman J&#xfa;nior GL, et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas&#x2019; disease. Int Immunol. 1994;6(4):499&#x2013;506. doi: 10.1093/intimm/6.4.499</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/6.4.499</ArticleId><ArticleId IdType="pubmed">8018591</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierszenbaum F. Chagas&#x2019; disease and the autoimmunity hypothesis. Clin Microbiol Rev. 1999;12(2):210&#x2013;23. doi: 10.1128/CMR.12.2.210</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.12.2.210</ArticleId><ArticleId IdType="pmc">PMC88915</ArticleId><ArticleId IdType="pubmed">10194457</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes JAS, Bahia-Oliveira LMG, Rocha MOC, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R. Evidence that development of severe cardiomyopathy in human Chagas&#x2019; disease is due to a Th1-specific immune response. Infect Immun. 2003;71(3):1185&#x2013;93. doi: 10.1128/IAI.71.3.1185-1193.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.71.3.1185-1193.2003</ArticleId><ArticleId IdType="pmc">PMC148818</ArticleId><ArticleId IdType="pubmed">12595431</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Angulo H, Marques J, Mendoza I, Villegas M, Mijares A, Giron&#xe8;s N, et al. Differential cytokine profiling in Chagasic patients according to their arrhythmogenic-status. BMC Infect Dis. 2017;17(1):221. doi: 10.1186/s12879-017-2324-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2324-x</ArticleId><ArticleId IdType="pmc">PMC5361844</ArticleId><ArticleId IdType="pubmed">28327099</ArticleId></ArticleIdList></Reference><Reference><Citation>da Matta Guedes PM, Gutierrez FRS, Maia FL, Milanezi CM, Silva GK, Pavanelli WR, et al. IL-17 produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis. PLoS Negl Trop Dis. 2010;4(2):e604. doi: 10.1371/journal.pntd.0000604</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000604</ArticleId><ArticleId IdType="pmc">PMC2821906</ArticleId><ArticleId IdType="pubmed">20169058</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silveira JF, Abrahamsohn PA, Colli W. Plasma membrane vesicles isolated from epimastigote forms of Trypanosoma cruzi. Biochim Biophys Acta. 1979;550(2):222&#x2013;32. doi: 10.1016/0005-2736(79)90209-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0005-2736(79)90209-8</ArticleId><ArticleId IdType="pubmed">365244</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Pol E, B&#xf6;ing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64(3):676&#x2013;705. doi: 10.1124/pr.112.005983</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.112.005983</ArticleId><ArticleId IdType="pubmed">22722893</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza-Schorey C, Di Vizio D. A class of large cell-like extracellular vesicles. Nat Cell Biol. 2025;27(3):372&#x2013;4. doi: 10.1038/s41556-025-01611-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-025-01611-2</ArticleId><ArticleId IdType="pmc">PMC12147561</ArticleId><ArticleId IdType="pubmed">39984652</ArticleId></ArticleIdList></Reference><Reference><Citation>Th&#xe9;ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750. doi: 10.1080/20013078.2018.1535750</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20013078.2018.1535750</ArticleId><ArticleId IdType="pmc">PMC6322352</ArticleId><ArticleId IdType="pubmed">30637094</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro AAS, Torrecilhas AC, Souza BS de F, Cruz FF, Guedes HL de M, Ramos TD, et al. Potential of extracellular vesicles in the pathogenesis, diagnosis and therapy for parasitic diseases. J Extracell Vesicles. 2024;13(8):e12496. doi: 10.1002/jev2.12496</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12496</ArticleId><ArticleId IdType="pmc">PMC11306921</ArticleId><ArticleId IdType="pubmed">39113589</ArticleId></ArticleIdList></Reference><Reference><Citation>Buzas EI. The roles of extracellular vesicles in the immune system. Nat Rev Immunol. 2023;23(4):236&#x2013;50. doi: 10.1038/s41577-022-00763-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00763-8</ArticleId><ArticleId IdType="pmc">PMC9361922</ArticleId><ArticleId IdType="pubmed">35927511</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuevas IC, Cazzulo JJ, S&#xe1;nchez DO. gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection. Infect Immun. 2003;71(10):5739&#x2013;49. doi: 10.1128/IAI.71.10.5739-5749.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.71.10.5739-5749.2003</ArticleId><ArticleId IdType="pmc">PMC201075</ArticleId><ArticleId IdType="pubmed">14500495</ArticleId></ArticleIdList></Reference><Reference><Citation>Retana Moreira L, Prescilla-Ledezma A, Cornet-Gomez A, Linares F, J&#xf3;dar-Reyes AB, Fernandez J, et al. Biophysical and Biochemical Comparison of Extracellular Vesicles Produced by Infective and Non-Infective Stages of Trypanosoma cruzi. Int J Mol Sci. 2021;22(10):5183. doi: 10.3390/ijms22105183</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22105183</ArticleId><ArticleId IdType="pmc">PMC8153575</ArticleId><ArticleId IdType="pubmed">34068436</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan S-Y, Tian H-M, Zhu Y, Gu W-J, Zou H, Wu X-Q, et al. Cardiac damage in autoimmune diseases: Target organ involvement that cannot be ignored. Front Immunol. 2022;13:1056400. doi: 10.3389/fimmu.2022.1056400</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1056400</ArticleId><ArticleId IdType="pmc">PMC9722763</ArticleId><ArticleId IdType="pubmed">36483559</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumori A. Myocarditis and autoimmunity. Expert Rev Cardiovasc Ther. 2023;21(6):437&#x2013;51. doi: 10.1080/14779072.2023.2219895</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14779072.2023.2219895</ArticleId><ArticleId IdType="pubmed">37243585</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. 2009;62(7):584&#x2013;92. doi: 10.1136/jcp.2009.064311</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2009.064311</ArticleId><ArticleId IdType="pubmed">19561227</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyer A, Silberbach M. Infective Endocarditis. Pediatrics In Review. 2005;26(11):394&#x2013;400. doi: 10.1542/pir.26.11.394</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/pir.26.11.394</ArticleId><ArticleId IdType="pubmed">16264027</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnanm&#xe4;ki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993;87(4):1130&#x2013;4. doi: 10.1161/01.cir.87.4.1130</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.87.4.1130</ArticleId><ArticleId IdType="pubmed">8484830</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer AS, Theofilopoulos AN, Eisenberg R, Dixon FJ, Guze LB. Circulating immune complexes in infective endocarditis. N Engl J Med. 1976;295(27):1500&#x2013;5. doi: 10.1056/NEJM197612302952703</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197612302952703</ArticleId><ArticleId IdType="pubmed">995157</ArticleId></ArticleIdList></Reference><Reference><Citation>Messias-Reason IJ, Hayashi SY, Nisihara RM, Kirschfink M. Complement activation in infective endocarditis: correlation with extracardiac manifestations and prognosis. Clin Exp Immunol. 2002;127(2):310&#x2013;5. doi: 10.1046/j.1365-2249.2002.01772.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2249.2002.01772.x</ArticleId><ArticleId IdType="pmc">PMC1906352</ArticleId><ArticleId IdType="pubmed">11876755</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xed;az Lozano IM, De Pablos LM, Longhi SA, Zago MP, Schijman AG, Osuna A. Immune complexes in chronic Chagas disease patients are formed by exovesicles from Trypanosoma cruzi carrying the conserved MASP N-terminal region. Sci Rep. 2017;7:44451. doi: 10.1038/srep44451</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep44451</ArticleId><ArticleId IdType="pmc">PMC5353755</ArticleId><ArticleId IdType="pubmed">28294160</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano N, Prescilla-Ledezma A, Calabuig E, Trelis M, Arce JMS, L&#xf3;pez Hontangas JL, et al. Circulating extracellular vesicles in sera of chronic patients as a method for determining active parasitism in Chagas disease. PLoS Negl Trop Dis. 2024;18(11):e0012356. doi: 10.1371/journal.pntd.0012356</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0012356</ArticleId><ArticleId IdType="pmc">PMC11616892</ArticleId><ArticleId IdType="pubmed">39565824</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano N, Samblas MG, Calabuig E, Gim&#xe9;nez Mart&#xed; MJ, G&#xf3;mez Ruiz MD, Arce JMS, et al. Use of sera cell free DNA (cfDNA) and exovesicle-DNA for the molecular diagnosis of chronic Chagas disease. PLoS One. 2023;18(9):e0282814. doi: 10.1371/journal.pone.0282814</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0282814</ArticleId><ArticleId IdType="pmc">PMC10490946</ArticleId><ArticleId IdType="pubmed">37682970</ArticleId></ArticleIdList></Reference><Reference><Citation>Trocoli Torrecilhas AC, Tonelli RR, Pavanelli WR, da Silva JS, Schumacher RI, de Souza W, et al. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect. 2009;11(1):29&#x2013;39. doi: 10.1016/j.micinf.2008.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2008.10.003</ArticleId><ArticleId IdType="pubmed">19028594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cestari I, Ansa-Addo E, Deolindo P, Inal JM, Ramirez MI. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. J Immunol. 2012;188(4):1942&#x2013;52. doi: 10.4049/jimmunol.1102053</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1102053</ArticleId><ArticleId IdType="pubmed">22262654</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronemberger-Andrade A, Xander P, Soares RP, Pessoa NL, Campos MA, Ellis CC, et al. Trypanosoma cruzi-Infected Human Macrophages Shed Proinflammatory Extracellular Vesicles That Enhance Host-Cell Invasion via Toll-Like Receptor 2. Front Cell Infect Microbiol. 2020;10:99. doi: 10.3389/fcimb.2020.00099</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00099</ArticleId><ArticleId IdType="pmc">PMC7098991</ArticleId><ArticleId IdType="pubmed">32266161</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutra WO, Menezes CAS, Magalh&#xe3;es LMD, Gollob KJ. Immunoregulatory networks in human Chagas disease. Parasite Immunol. 2014;36(8):377&#x2013;87. doi: 10.1111/pim.12107</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pim.12107</ArticleId><ArticleId IdType="pmc">PMC4143493</ArticleId><ArticleId IdType="pubmed">24611805</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira BL, Ferreira &#xc9;R, de Brito MV, Salu BR, Oliva MLV, Mortara RA, et al. BALB/c and C57BL/6 Mice Cytokine Responses to Trypanosoma cruzi Infection Are Independent of Parasite Strain Infectivity. Front Microbiol. 2018;9:553. doi: 10.3389/fmicb.2018.00553</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00553</ArticleId><ArticleId IdType="pmc">PMC5890190</ArticleId><ArticleId IdType="pubmed">29662478</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovo-Martins MI, Malvezi AD, Zanluqui NG, Lucchetti BFC, Tatakihara VLH, M&#xf6;rking PA, et al. Extracellular Vesicles Shed By Trypanosoma cruzi Potentiate Infection and Elicit Lipid Body Formation and PGE2 Production in Murine Macrophages. Front Immunol. 2018;9:896. doi: 10.3389/fimmu.2018.00896</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00896</ArticleId><ArticleId IdType="pmc">PMC5934475</ArticleId><ArticleId IdType="pubmed">29755471</ArticleId></ArticleIdList></Reference><Reference><Citation>Nogueira PM, Ribeiro K, Silveira ACO, Campos JH, Martins-Filho OA, Bela SR, et al. Vesicles from different <i>Trypanosoma cruzi</i> strains trigger differential innate and chronic immune responses. J Extracell Vesicles. 2015;4:28734. doi: 10.3402/jev.v4.28734

</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v4.28734</ArticleId><ArticleId IdType="pmc">PMC4662668</ArticleId><ArticleId IdType="pubmed">26613751</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues MM, Oliveira AC, Bellio M. The Immune Response to Trypanosoma cruzi: Role of Toll-Like Receptors and Perspectives for Vaccine Development. J Parasitol Res. 2012;2012:507874. doi: 10.1155/2012/507874</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/507874</ArticleId><ArticleId IdType="pmc">PMC3306967</ArticleId><ArticleId IdType="pubmed">22496959</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa GR, Gomes JAS, Fares RCG, Dam&#xe1;sio MP de S, Chaves AT, Ferreira KS, et al. Plasma cytokine expression is associated with cardiac morbidity in chagas disease. PLoS One. 2014;9(3):e87082. doi: 10.1371/journal.pone.0087082</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087082</ArticleId><ArticleId IdType="pmc">PMC3945957</ArticleId><ArticleId IdType="pubmed">24603474</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornet-Gomez A, Moreira LR, Gomez-Sambl&#xe1;s M, Osuna A. Extracellular vesicles of Trypanosoma cruzi and immune complexes they form with sialylated and non-sialylated IgGs increase small peritoneal macrophage subpopulation and elicit different cytokines profiles. Front Immunol. 2023;14:1215913. doi: 10.3389/fimmu.2023.1215913</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1215913</ArticleId><ArticleId IdType="pmc">PMC10434529</ArticleId><ArticleId IdType="pubmed">37600828</ArticleId></ArticleIdList></Reference><Reference><Citation>Retana Moreira L, Rodr&#xed;guez Serrano F, Osuna A. Extracellular vesicles of Trypanosoma cruzi tissue-culture cell-derived trypomastigotes: Induction of physiological changes in non-parasitized culture cells. PLoS Negl Trop Dis. 2019;13(2):e0007163. doi: 10.1371/journal.pntd.0007163</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007163</ArticleId><ArticleId IdType="pmc">PMC6383987</ArticleId><ArticleId IdType="pubmed">30789912</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornet-Gomez A, Retana Moreira L, Kronenberger T, Osuna A. Extracellular vesicles of trypomastigotes of Trypanosoma cruzi induce changes in ubiquitin-related processes, cell-signaling pathways and apoptosis. Sci Rep. 2023;13(1):7618. doi: 10.1038/s41598-023-34820-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-34820-6</ArticleId><ArticleId IdType="pmc">PMC10171165</ArticleId><ArticleId IdType="pubmed">37165081</ArticleId></ArticleIdList></Reference><Reference><Citation>Colby LA, Nowland MH, Kennedy LH. Clinical Laboratory Animal Medicine: An Introduction. 2019.</Citation></Reference><Reference><Citation>De Pablos LM, D&#xed;az Lozano IM, Jercic MI, Quinzada M, Gim&#xe9;nez MJ, Calabuig E, et al. The C-terminal region of Trypanosoma cruzi MASPs is antigenic and secreted via exovesicles. Sci Rep. 2016;6:27293. doi: 10.1038/srep27293</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep27293</ArticleId><ArticleId IdType="pmc">PMC4897614</ArticleId><ArticleId IdType="pubmed">27270330</ArticleId></ArticleIdList></Reference><Reference><Citation>Cura CI, Duffy T, Lucero RH, Bisio M, P&#xe9;neau J, Jimenez-Coello M, et al. Multiplex Real-Time PCR Assay Using TaqMan Probes for the Identification of Trypanosoma cruzi DTUs in Biological and Clinical Samples. PLoS Negl Trop Dis. 2015;9(5):e0003765. doi: 10.1371/journal.pntd.0003765</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003765</ArticleId><ArticleId IdType="pmc">PMC4437652</ArticleId><ArticleId IdType="pubmed">25993316</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayer-Santos E, Aguilar-Bonavides C, Rodrigues SP, Cordero EM, Marques AF, Varela-Ramirez A, et al. Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins. J Proteome Res. 2013;12(2):883&#x2013;97. doi: 10.1021/pr300947g</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr300947g</ArticleId><ArticleId IdType="pubmed">23214914</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicenzetto C, Giordani AS, Menghi C, Baritussio A, Peloso Cattini MG, Pontara E, et al. The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review. Biomedicines. 2024;12(6):1156. doi: 10.3390/biomedicines12061156</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12061156</ArticleId><ArticleId IdType="pmc">PMC11200507</ArticleId><ArticleId IdType="pubmed">38927363</ArticleId></ArticleIdList></Reference><Reference><Citation>Cestari I, Ramirez MI. Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells. PLoS One. 2010;5(3):e9721. doi: 10.1371/journal.pone.0009721</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009721</ArticleId><ArticleId IdType="pmc">PMC2838796</ArticleId><ArticleId IdType="pubmed">20300530</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyllie MP, Ramirez MI. Microvesicles released during the interaction between Trypanosoma cruzi TcI and TcII strains and host blood cells inhibit complement system and increase the infectivity of metacyclic forms of host cells in a strain-independent process. Pathog Dis. 2017;75(7):10.1093/femspd/ftx077. doi: 10.1093/femspd/ftx077</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femspd/ftx077</ArticleId><ArticleId IdType="pubmed">28859399</ArticleId></ArticleIdList></Reference><Reference><Citation>Auber M, Svenningsen P. An estimate of extracellular vesicle secretion rates of human blood cells. J Extracell Biol. 2022;1(6):e46. doi: 10.1002/jex2.46</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jex2.46</ArticleId><ArticleId IdType="pmc">PMC11080926</ArticleId><ArticleId IdType="pubmed">38938292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M, Jordan V, Blenkiron C, Chamley LW. Biodistribution of extracellular vesicles following administration into animals: A systematic review. J Extracell Vesicles. 2021;10(8):e12085. doi: 10.1002/jev2.12085</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jev2.12085</ArticleId><ArticleId IdType="pmc">PMC8224174</ArticleId><ArticleId IdType="pubmed">34194679</ArticleId></ArticleIdList></Reference><Reference><Citation>Rank A, Nieuwland R, Crispin A, Gr&#xfc;tzner S, Iberer M, Toth B, et al. Clearance of platelet microparticles in vivo. Platelets. 2011;22(2):111&#x2013;6. doi: 10.3109/09537104.2010.520373</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537104.2010.520373</ArticleId><ArticleId IdType="pubmed">21231854</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai T, Takahashi Y, Nishikawa M, Kato K, Morishita M, Yamashita T, et al. Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice. J Extracell Vesicles. 2015;4:26238. doi: 10.3402/jev.v4.26238</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v4.26238</ArticleId><ArticleId IdType="pmc">PMC4323410</ArticleId><ArticleId IdType="pubmed">25669322</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista AM, Alvarado-Arnez LE, Alves SM, Melo G, Pereira IR, Ruivo LA de S, et al. Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas&#x2019; Heart Disease: Antagonistic Participation of CCR1+ and CCR5+ Cells in Chronic Chagasic Cardiomyopathy. Front Immunol. 2018;9:615. doi: 10.3389/fimmu.2018.00615</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00615</ArticleId><ArticleId IdType="pmc">PMC5904358</ArticleId><ArticleId IdType="pubmed">29696014</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DN, Begg LR, Filiano AJ. Unique aspects of IFN-&#x3b3;/STAT1 signaling in neurons. Immunol Rev. 2022;311(1):187&#x2013;204. doi: 10.1111/imr.13092</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.13092</ArticleId><ArticleId IdType="pmc">PMC10120860</ArticleId><ArticleId IdType="pubmed">35656941</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagman S, M&#xe4;kinen A, Yl&#xe4;-Outinen L, Huhtala H, Elovaara I, Narkilahti S. Effects of inflammatory cytokines IFN-&#x3b3;, TNF-&#x3b1; and IL-6 on the viability and functionality of human pluripotent stem cell-derived neural cells. J Neuroimmunol. 2019;331:36&#x2013;45. doi: 10.1016/j.jneuroim.2018.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2018.07.010</ArticleId><ArticleId IdType="pubmed">30195439</ArticleId></ArticleIdList></Reference><Reference><Citation>Pongratz G, Straub RH. The sympathetic nervous response in inflammation. Arthritis Res Ther. 2014;16(6):504. doi: 10.1186/s13075-014-0504-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-014-0504-2</ArticleId><ArticleId IdType="pmc">PMC4396833</ArticleId><ArticleId IdType="pubmed">25789375</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#xe1;vila DF, Inglessis G, Mazzei de D&#xe1;vila CA. Chagas&#x2019; heart disease and the autonomic nervous system. Int J Cardiol. 1998;66(2):123&#x2013;7. doi: 10.1016/s0167-5273(98)00212-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0167-5273(98)00212-5</ArticleId><ArticleId IdType="pubmed">9829322</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibaldi D, Vilar-Pereira G, Pereira IR, Silva AA, Barrios LC, Ramos IP, et al. CCL3/Macrophage Inflammatory Protein-1&#x3b1; Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFN&#x3b3;-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy. Front Immunol. 2020;11:306. doi: 10.3389/fimmu.2020.00306</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00306</ArticleId><ArticleId IdType="pmc">PMC7063958</ArticleId><ArticleId IdType="pubmed">32194558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Capecchi PL, Laghi-Pasini F. Long QT Syndrome: An Emerging Role for Inflammation and Immunity. Front Cardiovasc Med. 2015;2:26. doi: 10.3389/fcvm.2015.00026</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2015.00026</ArticleId><ArticleId IdType="pmc">PMC4712633</ArticleId><ArticleId IdType="pubmed">26798623</ArticleId></ArticleIdList></Reference><Reference><Citation>Salles G, Xavier S, Sousa A, Hasslocher-Moreno A, Cardoso C. Prognostic value of QT interval parameters for mortality risk stratification in Chagas&#x2019; disease: results of a long-term follow-up study. Circulation. 2003;108(3):305&#x2013;12. doi: 10.1161/01.CIR.0000079174.13444.9C</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000079174.13444.9C</ArticleId><ArticleId IdType="pubmed">12835217</ArticleId></ArticleIdList></Reference><Reference><Citation>Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A. Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy. J Am Coll Cardiol. 2007;49(16):1684&#x2013;92. doi: 10.1016/j.jacc.2006.11.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2006.11.051</ArticleId><ArticleId IdType="pubmed">17448369</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavine KJ, Pinto AR, Epelman S, Kopecky BJ, Clemente-Casares X, Godwin J, et al. The Macrophage in Cardiac Homeostasis and Disease: JACC Macrophage in CVD Series (Part 4). J Am Coll Cardiol. 2018;72(18):2213&#x2013;30. doi: 10.1016/j.jacc.2018.08.2149</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.2149</ArticleId><ArticleId IdType="pmc">PMC6209119</ArticleId><ArticleId IdType="pubmed">30360829</ArticleId></ArticleIdList></Reference><Reference><Citation>Epelman S, Lavine KJ, Randolph GJ. Origin and functions of tissue macrophages. Immunity. 2014;41(1):21&#x2013;35. doi: 10.1016/j.immuni.2014.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.06.013</ArticleId><ArticleId IdType="pmc">PMC4470379</ArticleId><ArticleId IdType="pubmed">25035951</ArticleId></ArticleIdList></Reference><Reference><Citation>Heidt T, Courties G, Dutta P, Sager HB, Sebas M, Iwamoto Y, et al. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res. 2014;115(2):284&#x2013;95. doi: 10.1161/CIRCRESAHA.115.303567</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.303567</ArticleId><ArticleId IdType="pmc">PMC4082439</ArticleId><ArticleId IdType="pubmed">24786973</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafuse WP, Wozniak DJ, Rajaram MVS. Role of Cardiac Macrophages on Cardiac Inflammation, Fibrosis and Tissue Repair. Cells. 2020;10(1):51. doi: 10.3390/cells10010051</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010051</ArticleId><ArticleId IdType="pmc">PMC7824389</ArticleId><ArticleId IdType="pubmed">33396359</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Qian N, Xu J, Wang Y. The Roles of Macrophages in Heart Regeneration and Repair After Injury. Front Cardiovasc Med. 2021;8:744615. doi: 10.3389/fcvm.2021.744615</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.744615</ArticleId><ArticleId IdType="pmc">PMC8575035</ArticleId><ArticleId IdType="pubmed">34760943</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodjakovic D, Salm L, Beldi G. Function of Connexin-43 in Macrophages. Int J Mol Sci. 2021;22(3):1412. doi: 10.3390/ijms22031412</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22031412</ArticleId><ArticleId IdType="pmc">PMC7866802</ArticleId><ArticleId IdType="pubmed">33573367</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Li X, Wang S, Yu L, Tang J, Zhou S. The Role of Cardiac Macrophage and Cytokines on Ventricular Arrhythmias. Front Physiol. 2020;11:1113. doi: 10.3389/fphys.2020.01113</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.01113</ArticleId><ArticleId IdType="pmc">PMC7540080</ArticleId><ArticleId IdType="pubmed">33071805</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Lou L, Chen W, Qiang X, Zhu C, Wang H. Connexin 43 and Pannexin 1 hemichannels as endogenous regulators of innate immunity in sepsis. Front Immunol. 2024;15:1523306. doi: 10.3389/fimmu.2024.1523306</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1523306</ArticleId><ArticleId IdType="pmc">PMC11701031</ArticleId><ArticleId IdType="pubmed">39763679</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Gao Y, Wang J, Tan X, Liang Y, Yu W, et al. Connexin 43 Deficiency Confers Resistance to Immunotherapy in Lung Cancer via Inhibition of the Cyclic GMP-AMP Synthase-Stimulator of Interferon Genes Pathway. J Cell Mol Med. 2024;28(22):e70211. doi: 10.1111/jcmm.70211</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.70211</ArticleId><ArticleId IdType="pmc">PMC11598135</ArticleId><ArticleId IdType="pubmed">39592436</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulsmans M, Clauss S, Xiao L, Aguirre AD, King KR, Hanley A, et al. Macrophages Facilitate Electrical Conduction in the Heart. Cell. 2017;169(3):510-522.e20. doi: 10.1016/j.cell.2017.03.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.03.050</ArticleId><ArticleId IdType="pmc">PMC5474950</ArticleId><ArticleId IdType="pubmed">28431249</ArticleId></ArticleIdList></Reference><Reference><Citation>Adesse D, Garzoni LR, Huang H, Tanowitz HB, de Nazareth Meirelles M, Spray DC. Trypanosoma cruzi induces changes in cardiac connexin43 expression. Microbes Infect. 2008;10(1):21&#x2013;8. doi: 10.1016/j.micinf.2007.09.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2007.09.017</ArticleId><ArticleId IdType="pmc">PMC2651827</ArticleId><ArticleId IdType="pubmed">18068391</ArticleId></ArticleIdList></Reference><Reference><Citation>Barreto BC, das Neves MVG, Cardoso CMA, Meira CS, Daltro PS, Figueira CP, et al. The effects of inflammation on connexin 43 in chronic Chagas disease cardiomyopathy. Front Immunol. 2024;15:1440662. doi: 10.3389/fimmu.2024.1440662</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2024.1440662</ArticleId><ArticleId IdType="pmc">PMC11317259</ArticleId><ArticleId IdType="pubmed">39136016</ArticleId></ArticleIdList></Reference><Reference><Citation>Padget RL, Zeitz MJ, Blair GA, Wu X, North MD, Tanenbaum MT, et al. Acute Adenoviral Infection Elicits an Arrhythmogenic Substrate Prior to Myocarditis. Circ Res. 2024;134(7):892&#x2013;912. doi: 10.1161/CIRCRESAHA.122.322437</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.122.322437</ArticleId><ArticleId IdType="pmc">PMC11003857</ArticleId><ArticleId IdType="pubmed">38415360</ArticleId></ArticleIdList></Reference><Reference><Citation>Calhoun PJ, Phan AV, Taylor JD, James CC, Padget RL, Zeitz MJ, et al. Adenovirus targets transcriptional and posttranslational mechanisms to limit gap junction function. FASEB J. 2020;34(7):9694&#x2013;712. doi: 10.1096/fj.202000667R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000667R</ArticleId><ArticleId IdType="pmc">PMC7501180</ArticleId><ArticleId IdType="pubmed">32485054</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghavan S, Kenchappa DB, Leo MD. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity. Front Cardiovasc Med. 2021;8:687783. doi: 10.3389/fcvm.2021.687783</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.687783</ArticleId><ArticleId IdType="pmc">PMC8225996</ArticleId><ArticleId IdType="pubmed">34179146</ArticleId></ArticleIdList></Reference><Reference><Citation>Prieto-Villalobos J, Lucero CM, Rovegno M, G&#xf3;mez GI, Retamal MA, Orellana JA. SARS-CoV-2 spike protein S1 activates Cx43 hemichannels and disturbs intracellular Ca2+ dynamics. Biol Res. 2023;56(1):56. doi: 10.1186/s40659-023-00468-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40659-023-00468-9</ArticleId><ArticleId IdType="pmc">PMC10598968</ArticleId><ArticleId IdType="pubmed">37876016</ArticleId></ArticleIdList></Reference><Reference><Citation>Westphalen K, Gusarova GA, Islam MN, Subramanian M, Cohen TS, Prince AS, et al. Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature. 2014;506(7489):503&#x2013;6. doi: 10.1038/nature12902</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12902</ArticleId><ArticleId IdType="pmc">PMC4117212</ArticleId><ArticleId IdType="pubmed">24463523</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao C-K, Wang S-M, Chen Y-L, Wang H-S, Wu J-C. Lipopolysaccharide-induced inhibition of connexin43 gap junction communication in astrocytes is mediated by downregulation of caveolin-3. Int J Biochem Cell Biol. 2010;42(5):762&#x2013;70. doi: 10.1016/j.biocel.2010.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2010.01.016</ArticleId><ArticleId IdType="pubmed">20093193</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox CB, Castro M, Brown TL, Bigley NJ. IL-10 and TGF-&#x3b2; Increase Connexin-43 Expression and Membrane Potential of HL-1 Cardiomyocytes Coupled with RAW 264.7 Macrophages. Immunohorizons. 2022;6(6):334&#x2013;43. doi: 10.4049/immunohorizons.2100104</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/immunohorizons.2100104</ArticleId><ArticleId IdType="pubmed">35697477</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinrich M, Oberbach A, Schlichting N, Stolzenburg J-U, Neuhaus J. Cytokine effects on gap junction communication and connexin expression in human bladder smooth muscle cells and suburothelial myofibroblasts. PLoS One. 2011;6(6):e20792. doi: 10.1371/journal.pone.0020792</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020792</ArticleId><ArticleId IdType="pmc">PMC3107230</ArticleId><ArticleId IdType="pubmed">21674053</ArticleId></ArticleIdList></Reference><Reference><Citation>Roger E, Chadjichristos CE, Kavvadas P, Price GW, Cliff CL, Hadjadj S, et al. Connexin-43 hemichannels orchestrate NOD-like receptor protein-3 (NLRP3) inflammasome activation and sterile inflammation in tubular injury. Cell Commun Signal. 2023;21(1):263. doi: 10.1186/s12964-023-01245-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12964-023-01245-7</ArticleId><ArticleId IdType="pmc">PMC10536814</ArticleId><ArticleId IdType="pubmed">37770948</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosch M, Zindel J, Jebbawi F, Melin N, Sanchez-Taltavull D, Stroka D, et al. Connexin-43-dependent ATP release mediates macrophage activation during sepsis. Elife. 2019;8:e42670. doi: 10.7554/eLife.42670</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.42670</ArticleId><ArticleId IdType="pmc">PMC6415938</ArticleId><ArticleId IdType="pubmed">30735126</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira A-C, de Alencar BC, Tzelepis F, Klezewsky W, da Silva RN, Neves FS, et al. Impaired innate immunity in Tlr4(-/-) mice but preserved CD8+ T cell responses against Trypanosoma cruzi in Tlr4-, Tlr2-, Tlr9- or Myd88-deficient mice. PLoS Pathog. 2010;6(4):e1000870. doi: 10.1371/journal.ppat.1000870</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000870</ArticleId><ArticleId IdType="pmc">PMC2861687</ArticleId><ArticleId IdType="pubmed">20442858</ArticleId></ArticleIdList></Reference><Reference><Citation>Severs NJ. Pathophysiology of gap junctions in heart disease. J Cardiovasc Electrophysiol. 1994;5(5):462&#x2013;75. doi: 10.1111/j.1540-8167.1994.tb01185.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.1994.tb01185.x</ArticleId><ArticleId IdType="pubmed">7519952</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponsaerts R, D&#x2019;hondt C, Hertens F, Parys JB, Leybaert L, Vereecke J, et al. RhoA GTPase switch controls Cx43-hemichannel activity through the contractile system. PLoS One. 2012;7(7):e42074. doi: 10.1371/journal.pone.0042074</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042074</ArticleId><ArticleId IdType="pmc">PMC3408431</ArticleId><ArticleId IdType="pubmed">22860057</ArticleId></ArticleIdList></Reference><Reference><Citation>Michela P, Velia V, Aldo P, Ada P. Role of connexin 43 in cardiovascular diseases. Eur J Pharmacol. 2015;768:71&#x2013;6. doi: 10.1016/j.ejphar.2015.10.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2015.10.030</ArticleId><ArticleId IdType="pubmed">26499977</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak JM, Silva TA, Thomas D, Siqueira-Neto JL, McKerrow JH, Gonzalez DJ, et al. Molecular dissection of Chagas induced cardiomyopathy reveals central disease associated and druggable signaling pathways. PLoS Negl Trop Dis. 2020;14(5):e0007980. doi: 10.1371/journal.pntd.0007980</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007980</ArticleId><ArticleId IdType="pmc">PMC7279607</ArticleId><ArticleId IdType="pubmed">32433643</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito BO de F, Ribeiro ALP. Electrocardiogram in Chagas disease. Rev Soc Bras Med Trop. 2018;51(5):570&#x2013;7. doi: 10.1590/0037-8682-0184-2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0184-2018</ArticleId><ArticleId IdType="pubmed">30304260</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster CA. VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders. J Allergy Clin Immunol. 1996;98(6 Pt 2):S270-7. doi: 10.1016/s0091-6749(96)70075-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0091-6749(96)70075-1</ArticleId><ArticleId IdType="pubmed">8977536</ArticleId></ArticleIdList></Reference><Reference><Citation>Grabmaier U, Kania G, Kreiner J, Grabmeier J, Uhl A, Huber BC, et al. Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as a Biomarker in the Mouse Model of Experimental Autoimmune Myocarditis (EAM). PLoS One. 2016;11(8):e0158299. doi: 10.1371/journal.pone.0158299</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0158299</ArticleId><ArticleId IdType="pmc">PMC4976901</ArticleId><ArticleId IdType="pubmed">27501319</ArticleId></ArticleIdList></Reference><Reference><Citation>Keating SM, Deng X, Fernandes F, Cunha-Neto E, Ribeiro AL, Adesina B, et al. Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease. Int J Cardiol. 2015;199:451&#x2013;9. doi: 10.1016/j.ijcard.2015.07.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.07.040</ArticleId><ArticleId IdType="pmc">PMC4868386</ArticleId><ArticleId IdType="pubmed">26277551</ArticleId></ArticleIdList></Reference><Reference><Citation>Troncoso MF, Ortiz-Quintero J, Garrido-Moreno V, Sanhueza-Olivares F, Guerrero-Moncayo A, Chiong M, et al. VCAM-1 as a predictor biomarker in cardiovascular disease. Biochim Biophys Acta Mol Basis Dis. 2021;1867(9):166170. doi: 10.1016/j.bbadis.2021.166170</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2021.166170</ArticleId><ArticleId IdType="pubmed">34000374</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaitkevicius-Ant&#xe3;o V, Silva BA, Barros M da S, da Costa-Oliveira CN, Torre&#xe3;o B de C, da Silva AC, et al. Profile of soluble cell adhesion molecules as potential biomarkers in the cardiac stages of chronic Chagas disease. Front Immunol. 2025;16:1541860. doi: 10.3389/fimmu.2025.1541860</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2025.1541860</ArticleId><ArticleId IdType="pmc">PMC11926430</ArticleId><ArticleId IdType="pubmed">40124363</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Calderon TM, Berman JW, Braunstein VL, Weiss LM, Wittner M, et al. Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect Immun. 1999;67(10):5434&#x2013;40. doi: 10.1128/IAI.67.10.5434-5440.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.67.10.5434-5440.1999</ArticleId><ArticleId IdType="pmc">PMC96901</ArticleId><ArticleId IdType="pubmed">10496926</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso B. Modulation of immune response in experimental Chagas disease. World J Exp Med. 2013;3(1):1&#x2013;10. doi: 10.5493/wjem.v3.i1.1</Citation><ArticleIdList><ArticleId IdType="doi">10.5493/wjem.v3.i1.1</ArticleId><ArticleId IdType="pmc">PMC3905588</ArticleId><ArticleId IdType="pubmed">24520540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Wang Y, Liu J, Guan X, Chang X, Liu Z, et al. Microtubules and cardiovascular diseases: insights into pathology and therapeutic strategies. Int J Biochem Cell Biol. 2024;175:106650. doi: 10.1016/j.biocel.2024.106650</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2024.106650</ArticleId><ArticleId IdType="pubmed">39237031</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporizzo MA, Chen CY, Prosser BL. Cardiac microtubules in health and heart disease. Exp Biol Med (Maywood). 2019;244(15):1255&#x2013;72. doi: 10.1177/1535370219868960</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370219868960</ArticleId><ArticleId IdType="pmc">PMC6880149</ArticleId><ArticleId IdType="pubmed">31398994</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein I. Colchicine stimulates the rate of contraction of heart cells in culture. Cardiovasc Res. 1983;17(8):459&#x2013;65. doi: 10.1093/cvr/17.8.459</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/17.8.459</ArticleId><ArticleId IdType="pubmed">6616518</ArticleId></ArticleIdList></Reference><Reference><Citation>Giepmans BN, Verlaan I, Hengeveld T, Janssen H, Calafat J, Falk MM, et al. Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol. 2001;11(17):1364&#x2013;8. doi: 10.1016/s0960-9822(01)00424-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0960-9822(01)00424-9</ArticleId><ArticleId IdType="pubmed">11553331</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez-Sinovas A, S&#xe1;nchez JA, Valls-Lacalle L, Consegal M, Ferreira-Gonz&#xe1;lez I. Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease. Int J Mol Sci. 2021;22(9):4413. doi: 10.3390/ijms22094413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094413</ArticleId><ArticleId IdType="pmc">PMC8122935</ArticleId><ArticleId IdType="pubmed">33922534</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele DF, Fedida D. Cytoskeletal roles in cardiac ion channel expression. Biochim Biophys Acta. 2014;1838(2):665&#x2013;73. doi: 10.1016/j.bbamem.2013.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2013.05.001</ArticleId><ArticleId IdType="pubmed">23680626</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens U, Cerbai E. Role of potassium currents in cardiac arrhythmias. Europace. 2008;10(10):1133&#x2013;7. doi: 10.1093/europace/eun193</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/europace/eun193</ArticleId><ArticleId IdType="pubmed">18653669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sica DA, Struthers AD, Cushman WC, Wood M, Banas JS Jr, Epstein M. Importance of potassium in cardiovascular disease. J Clin Hypertens (Greenwich). 2002;4(3):198&#x2013;206. doi: 10.1111/j.1524-6175.2002.01728.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-6175.2002.01728.x</ArticleId><ArticleId IdType="pmc">PMC8101903</ArticleId><ArticleId IdType="pubmed">12045369</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazzerini PE, Laghi-Pasini F, Boutjdir M, Capecchi PL. Cardioimmunology of arrhythmias: the role of autoimmune and inflammatory cardiac channelopathies. Nat Rev Immunol. 2019;19: 63&#x2013;4. doi: 10.1038/s41577-018-0098-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0098-z</ArticleId><ArticleId IdType="pubmed">30552387</ArticleId></ArticleIdList></Reference><Reference><Citation>Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol. 2018;18(12):733&#x2013;44. doi: 10.1038/s41577-018-0065-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0065-8</ArticleId><ArticleId IdType="pubmed">30228378</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;ger E, Murthy S, Schmidt C, Hahn M, Strobel S, Peters A, et al. Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis. Nat Commun. 2020;11(1):4243. doi: 10.1038/s41467-020-17749-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17749-6</ArticleId><ArticleId IdType="pmc">PMC7447633</ArticleId><ArticleId IdType="pubmed">32843625</ArticleId></ArticleIdList></Reference><Reference><Citation>Monnerat G, Alarc&#xf3;n ML, Vasconcellos LR, Hochman-Mendez C, Brasil G, Bassani RA, et al. Macrophage-dependent IL-1&#x3b2; production induces cardiac arrhythmias in diabetic mice. Nat Commun. 2016;7:13344. doi: 10.1038/ncomms13344</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13344</ArticleId><ArticleId IdType="pmc">PMC5123037</ArticleId><ArticleId IdType="pubmed">27882934</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wang H, Zhang Y, Gao H, Nattel S, Wang Z. Impairment of HERG K(+) channel function by tumor necrosis factor-alpha: role of reactive oxygen species as a mediator. J Biol Chem. 2004;279(14):13289&#x2013;92. doi: 10.1074/jbc.C400025200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.C400025200</ArticleId><ArticleId IdType="pubmed">14973143</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawaya SE, Rajawat YS, Rami TG, Szalai G, Price RL, Sivasubramanian N, et al. Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am J Physiol Heart Circ Physiol. 2007;292(3):H1561-7. doi: 10.1152/ajpheart.00285.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00285.2006</ArticleId><ArticleId IdType="pubmed">17122196</ArticleId></ArticleIdList></Reference><Reference><Citation>Aromolaran AS, Srivastava U, Al&#xed; A, Chahine M, Lazaro D, El-Sherif N, et al. Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation. PLoS One. 2018;13(12):e0208321. doi: 10.1371/journal.pone.0208321</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208321</ArticleId><ArticleId IdType="pmc">PMC6283635</ArticleId><ArticleId IdType="pubmed">30521586</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi MA, Gon&#xe7;alves S, Ribeiro-dos-Santos R. Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis. Am J Pathol. 1984;114(2):209&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1900336</ArticleId><ArticleId IdType="pubmed">6230012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilate AMB, Salemi VMC, Ramires FJA, de Brito T, Silva AM, Umezawa ES, et al. The Syrian hamster as a model for the dilated cardiomyopathy of Chagas&#x2019; disease: a quantitative echocardiographical and histopathological analysis. Microbes Infect. 2003;5(12):1116&#x2013;24. doi: 10.1016/j.micinf.2003.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2003.07.001</ArticleId><ArticleId IdType="pubmed">14554253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S, Belbin TJ, Spray DC, Iacobas DA, Weiss LM, Kitsis RN, et al. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res. 2003;91(3):187&#x2013;96. doi: 10.1007/s00436-003-0937-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00436-003-0937-z</ArticleId><ArticleId IdType="pubmed">12910413</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S, Nagajyothi F, Mukhopadhyay A, Machado FS, Belbin TJ, Campos de Carvalho A, et al. Alterations in myocardial gene expression associated with experimental Trypanosoma cruzi infection. Genomics. 2008;91(5):423&#x2013;32. doi: 10.1016/j.ygeno.2008.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ygeno.2008.01.008</ArticleId><ArticleId IdType="pmc">PMC2386515</ArticleId><ArticleId IdType="pubmed">18343633</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowie MR, Mendez GF. BNP and congestive heart failure. Prog Cardiovasc Dis. 2002;44(4):293&#x2013;321. doi: 10.1053/pcad.2002.24599</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/pcad.2002.24599</ArticleId><ArticleId IdType="pubmed">12007084</ArticleId></ArticleIdList></Reference><Reference><Citation>James KB, Troughton RW, Feldschuh J, Soltis D, Thomas D, Fouad-Tarazi F. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study. Am Heart J. 2005;150(5):984. doi: 10.1016/j.ahj.2005.07.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2005.07.031</ArticleId><ArticleId IdType="pubmed">16290978</ArticleId></ArticleIdList></Reference><Reference><Citation>Pino-Mar&#xed;n A, Medina-Rinc&#xf3;n GJ, Gallo-Bernal S, Duran-Crane A, Arango Duque &#xc1;I, Rodr&#xed;guez MJ, et al. Chagas Cardiomyopathy: From Roma&#xf1;a Sign to Heart Failure and Sudden Cardiac Death. Pathogens. 2021;10(5):505. doi: 10.3390/pathogens10050505</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10050505</ArticleId><ArticleId IdType="pmc">PMC8145478</ArticleId><ArticleId IdType="pubmed">33922366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, Higuchi ML, et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas&#x2019; disease cardiomyopathy. Am J Pathol. 2005;167(2):305&#x2013;13. doi: 10.1016/S0002-9440(10)62976-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)62976-8</ArticleId><ArticleId IdType="pmc">PMC1603558</ArticleId><ArticleId IdType="pubmed">16049318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ba X, Gupta S, Davidson M, Garg NJ. Trypanosoma cruzi induces the reactive oxygen species-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes. J Biol Chem. 2010;285(15):11596&#x2013;606. doi: 10.1074/jbc.M109.076984</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.076984</ArticleId><ArticleId IdType="pmc">PMC2857037</ArticleId><ArticleId IdType="pubmed">20145242</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, et al. Chronic Chagas&#x2019; disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun. 2001;17(1):99&#x2013;107. doi: 10.1006/jaut.2001.0523</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jaut.2001.0523</ArticleId><ArticleId IdType="pubmed">11488642</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyagi T, Matsui T. The Cardiomyocyte as a Source of Cytokines in Cardiac Injury. J Cell Sci Ther. 2012;2012(S5):003. doi: 10.4172/2157-7013.s5-003</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2157-7013.s5-003</ArticleId><ArticleId IdType="pmc">PMC3594870</ArticleId><ArticleId IdType="pubmed">23493668</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitas LM, dos Santos SL, Rodrigues-Luiz GF, Mendes TAO, Rodrigues TS, Gazzinelli RT, et al. Genomic analyses, gene expression and antigenic profile of the trans-sialidase superfamily of Trypanosoma cruzi reveal an undetected level of complexity. PLoS One. 2011;6(10):e25914. doi: 10.1371/journal.pone.0025914</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0025914</ArticleId><ArticleId IdType="pmc">PMC3198458</ArticleId><ArticleId IdType="pubmed">22039427</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler CE, de Carvalho TMU, Grisard EC, Field RA, Tyler KM. Trans-sialidase stimulates eat me response from epithelial cells. Traffic. 2013;14(7):853&#x2013;69. doi: 10.1111/tra.12078</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12078</ArticleId><ArticleId IdType="pmc">PMC3770925</ArticleId><ArticleId IdType="pubmed">23601193</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalak KP, Michalak AZ. Understanding chronic inflammation: couplings between cytokines, ROS, NO, Cai2+, HIF-1&#x3b1;, Nrf2 and autophagy. Front Immunol. 2025;16:1558263. doi: 10.3389/fimmu.2025.1558263</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2025.1558263</ArticleId><ArticleId IdType="pmc">PMC12012389</ArticleId><ArticleId IdType="pubmed">40264757</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias WB, Fajardo FD, Gra&#xe7;a-Souza AV, Freire-de-Lima L, Vieira F, Girard MF, et al. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi. Cell Microbiol. 2008;10(1):88&#x2013;99. doi: 10.1111/j.1462-5822.2007.01017.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2007.01017.x</ArticleId><ArticleId IdType="pubmed">17672865</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao W, Pereira MA. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton&#x2019;s tyrosine kinase. Eur J Immunol. 2001;31(5):1503&#x2013;12. doi: 10.1002/1521-4141(200105)31:5&lt;1503::aid-immu1503&gt;3.0.co;2-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1521-4141(200105)31:5&lt;1503::aid-immu1503&gt;3.0.co;2-w</ArticleId><ArticleId IdType="pubmed">11465107</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo DA, Jackson SW, Gorosito-Serran M, Acosta-Rodriguez EV, Amezcua-Vesely MC, Sather BD, et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors ROR&#x3b3;t and Ahr that leads to IL-17 production by activated B cells. Nat Immunol. 2013;14(5):514&#x2013;22. doi: 10.1038/ni.2569</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2569</ArticleId><ArticleId IdType="pmc">PMC3631452</ArticleId><ArticleId IdType="pubmed">23563688</ArticleId></ArticleIdList></Reference><Reference><Citation>Coggins M, Rosenzweig A. The fire within: cardiac inflammatory signaling in health and disease. Circ Res. 2012;110(1):116&#x2013;25. doi: 10.1161/CIRCRESAHA.111.243196</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.111.243196</ArticleId><ArticleId IdType="pubmed">22223209</ArticleId></ArticleIdList></Reference><Reference><Citation>Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, et al. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest. 1999;104(3):271&#x2013;80. doi: 10.1172/JCI6709</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI6709</ArticleId><ArticleId IdType="pmc">PMC408420</ArticleId><ArticleId IdType="pubmed">10430608</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Zhao H, Graveline AR, Buys ES, Schmidt U, Bloch KD, et al. MyD88 and NOS2 are essential for toll-like receptor 4-mediated survival effect in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2006;291(4):H1900-9. doi: 10.1152/ajpheart.00112.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00112.2006</ArticleId><ArticleId IdType="pubmed">16648192</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res. 2006;72(3):384&#x2013;93. doi: 10.1016/j.cardiores.2006.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2006.09.011</ArticleId><ArticleId IdType="pubmed">17054926</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Cobo M, Gingalewski C, Drujan D, De Maio A. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine. 1999;11(3):216&#x2013;24. doi: 10.1006/cyto.1998.0422</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cyto.1998.0422</ArticleId><ArticleId IdType="pubmed">10209069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Ikegawa M, Ori D, Akira S. Decoding Toll-like receptors: Recent insights and perspectives in innate immunity. Immunity. 2024;57(4):649&#x2013;73. doi: 10.1016/j.immuni.2024.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2024.03.004</ArticleId><ArticleId IdType="pubmed">38599164</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado FS, Martins GA, Aliberti JC, Mestriner FL, Cunha FQ, Silva JS. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation. 2000;102(24):3003&#x2013;8. doi: 10.1161/01.cir.102.24.3003</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.cir.102.24.3003</ArticleId><ArticleId IdType="pubmed">11113053</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho CME, Silverio JC, da Silva AA, Pereira IR, Coelho JMC, Britto CC, et al. Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury. PLoS Negl Trop Dis. 2012;6(5):e1644. doi: 10.1371/journal.pntd.0001644</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001644</ArticleId><ArticleId IdType="pmc">PMC3348164</ArticleId><ArticleId IdType="pubmed">22590660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha-Neto E, Nogueira LG, Teixeira PC, Ramasawmy R, Drigo SA, Goldberg AC, et al. Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz. 2009;104 Suppl 1:252&#x2013;8. doi: 10.1590/s0074-02762009000900032</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/s0074-02762009000900032</ArticleId><ArticleId IdType="pubmed">19753481</ArticleId></ArticleIdList></Reference><Reference><Citation>Michailowsky V, Silva NM, Rocha CD, Vieira LQ, Lannes-Vieira J, Gazzinelli RT. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection. Am J Pathol. 2001;159(5):1723&#x2013;33. doi: 10.1016/s0002-9440(10)63019-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-9440(10)63019-2</ArticleId><ArticleId IdType="pmc">PMC3277321</ArticleId><ArticleId IdType="pubmed">11696433</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti E, Basso B, Cervetta L, Brigada A, Barbieri G. Patterns of cytokines and soluble cellular receptors in the sera of children with acute chagas&#x2019; disease. Clin Diagn Lab Immunol. 2002;9(6):1324&#x2013;7. doi: 10.1128/cdli.9.6.1324-1327.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cdli.9.6.1324-1327.2002</ArticleId><ArticleId IdType="pmc">PMC130093</ArticleId><ArticleId IdType="pubmed">12414768</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Liu M-F, Huang J-N, Li J-M, Jiang J, Wang J-A. Role of interleukin-15 in cardiovascular diseases. J Cell Mol Med. 2020;24(13):7094&#x2013;101. doi: 10.1111/jcmm.15296</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15296</ArticleId><ArticleId IdType="pmc">PMC7339208</ArticleId><ArticleId IdType="pubmed">32406586</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth JW, Hong T-T, Gao D, Vogan JM, Jensen BC, Fong TS, et al. Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. J Clin Invest. 2010;120(1):266&#x2013;79. doi: 10.1172/JCI39740</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI39740</ArticleId><ArticleId IdType="pmc">PMC2798685</ArticleId><ArticleId IdType="pubmed">20038810</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40618029</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2261</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>05</Day></PubDate></JournalIssue><Title>BMC cardiovascular disorders</Title><ISOAbbreviation>BMC Cardiovasc Disord</ISOAbbreviation></Journal><ArticleTitle>Exploring sex-specific clinical features in Chinese patients with Takotsubo syndrome.</ArticleTitle><Pagination><StartPage>490</StartPage><MedlinePgn>490</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">490</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12872-025-04788-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Takotsubo syndrome (TTS) is considered as a transient acute heart failure syndrome predominant in females. However, data on Chinese TTS patients are limited. Therefore, this study aimed to investigate the clinical characteristics of Chinese TTS patients, identify prognostic markers.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 258 TTS patients were enrolled. Data on clinical characteristics and in-hospital major adverse cardiovascular events (MACE) were collected and analyzed. The latter included severe heart failure, shock, malignant arrhythmia, and death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The average age of TTS patients was 59.3&#x2009;&#xb1;&#x2009;19.2&#xa0;years. Female patients accounted for 68.9%. MACE occurred in 41.4% of patients during hospitalization. Compared with males, female TTS patients were older, had more emotional causes, higher proportion of typical apical ballooning type, higher LVEF, more prolonged QTc, as well as lower early repolarization (ER) and MACE ratio (35.6% vs. 53.8%, P&#x2009;=&#x2009;0.006). Compared to female patients with emotional triggers, those female patients with physical triggers are younger, have a lower proportion of chest pain and abnormal ECG, but are more prone to experiencing MACE. Physical triggers, CKMB, LVEF, non-apical ballooning, ER pattern and premature ventricular beats were independent predictors of in-hospital MACE, whereas age, physical triggers and platelet count were specifically independent predictors for female TTS cases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Chinese TTS patients demonstrate unique clinical characteristics and in-hospital outcomes. Apart from the well-known fact that male with TTS has high-risk phenotype, our study newly identifies that TTS females with younger age or physical triggers also have worse prognosis, which warrants close attention and follow-up.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName><ForeName>Hong-Yi</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ling-Lin</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Ling-Chun</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Lishui Central Hospital and the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Zhen-Hua</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>Lishui Central Hospital and the Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Xiao-Ping</ForeName><Initials>XP</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zheng-Yang</ForeName><Initials>ZY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Guo-Hua</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Xin-Hong</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Chang-Wu</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Ultrasonography, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jin-Ling</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Ultrasonography, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Hong-Ning</ForeName><Initials>HN</Initials><AffiliationInfo><Affiliation>Department of Ultrasonography, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Stem Cell Research and Application, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jin-Qiu</ForeName><Initials>JQ</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barajas-Martinez</LastName><ForeName>Hector</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Lankenau Institute for Medical Research, and Lankenau Heart Institute, Wynnwood, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antzelevitch</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lankenau Institute for Medical Research, and Lankenau Heart Institute, Wynnwood, PA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Washington University in St. Louis, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Dan</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-0994-8434</Identifier><AffiliationInfo><Affiliation>Department of Cardiology and Cardiovascular Research Institute, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. hudan0716@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubei Key Laboratory of Cardiology, Wuhan, Hubei, China. hudan0716@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2023YFE0118300</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>82270332</GrantID><Agency>National Natural Science Foundation Project of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Cardiovasc Disord</MedlineTA><NlmUniqueID>100968539</NlmUniqueID><ISSNLinking>1471-2261</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Population" UI="C000724312">Chinese people</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054549" MajorTopicYN="Y">Takotsubo Cardiomyopathy</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054624" MajorTopicYN="Y">Health Status Disparities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004644" MajorTopicYN="N">Emotions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N">East Asian People</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arrhythmia</Keyword><Keyword MajorTopicYN="N">Heart failure</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Takotsubo syndrome</Keyword><Keyword MajorTopicYN="N">Triggers</Keyword><Keyword MajorTopicYN="N">Women</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: All investigative procedures were conducted in accordance with the principles of the Declaration of Helsinki and the study received approval from the ethics committee of Renmin Hospital of Wuhan University (Ethics Approval No: WDRY2024-K136). Consent for publication: All patients provided informed consent for the use of their records for research purpose. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>5</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40618029</ArticleId><ArticleId IdType="pmc">PMC12229039</ArticleId><ArticleId IdType="doi">10.1186/s12872-025-04788-4</ArticleId><ArticleId IdType="pii">10.1186/s12872-025-04788-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on takotsubo syndrome (part i): Clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39:2032&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991216</ArticleId><ArticleId IdType="pubmed">29850871</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, Yoshikawa T, Maekawa Y, Ueda T, Isogai T, Sakata K, et al. Gender differences in patients with takotsubo cardiomyopathy: Multi-center registry from tokyo ccu network. PLoS ONE. 2015;10: e0136655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552760</ArticleId><ArticleId IdType="pubmed">26317750</ArticleId></ArticleIdList></Reference><Reference><Citation>Imori Y, Kato K, Cammann VL, Szawan KA, Wischnewsky M, Dreiding S, et al. Ethnic comparison in takotsubo syndrome: Novel insights from the international takotsubo registry. Clin Res Cardiol. 2022;111:186&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8816760</ArticleId><ArticleId IdType="pubmed">34013386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JW, Kim JY, Youn YJ, Sung JK, Lee NS, Lee KH, et al. Clinical characteristics and prognostic factors of stress-induced cardiomyopathy. Korean circulation journal. 2010;40:277&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2893368</ArticleId><ArticleId IdType="pubmed">20589200</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow K, Watson TJ, Foo D, Ho HH. Clinical characteristics and outcomes of south-east asian patients with takotsubo (stress-induced) cardiomyopathy. International journal of cardiology: heart &amp; vasculature. 2018;21:29&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6154765</ArticleId><ArticleId IdType="pubmed">30258979</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro F, Costantino MD, Guastafierro F, Triggiani G, Ferraretti A, Tarantino N, et al. Inflammatory patterns in takotsubo cardiomyopathy and acute coronary syndrome: A propensity score matched analysis. Atherosclerosis. 2018;274:157&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">29783063</ArticleId></ArticleIdList></Reference><Reference><Citation>Couch LS, Thomas KE, Marin F, Terentes-Printzios D, Kotronias RA, Chai J, et al. The role of coronary blood flow and myocardial edema in the pathophysiology of takotsubo syndrome. JACC Cardiovasc Imaging. 2024;17:835&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">38573286</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong F, Yin L, Sisakian H, Hakobyan T, Jeong LS, Joshi H, et al. Takotsubo syndrome is a coronary microvascular disease: Experimental evidence. Eur Heart J. 2023;44:2244&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10290875</ArticleId><ArticleId IdType="pubmed">37170610</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong TK, Chen J, Lyu L, Wei Y, Liu Y, Wu L, et al. Clinical characteristics and outcome correlates of chinese patients with takotsubo syndrome: Results from the first chinese takotsubo syndrome registry. Int J Cardiol. 2023;387:131129.</Citation><ArticleIdList><ArticleId IdType="pubmed">37355242</ArticleId></ArticleIdList></Reference><Reference><Citation>Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373:929&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">26332547</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro F, N&#xfa;&#xf1;ez Gil IJ, Stiermaier T, El-Battrawy I, Guerra F, Novo G, et al. Assessment of the german and italian stress cardiomyopathy score for risk stratification for in-hospital complications in patients with takotsubo syndrome. JAMA cardiology. 2019;4:892&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6686773</ArticleId><ArticleId IdType="pubmed">31389988</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami T, Yoshikawa T, Maekawa Y, Ueda T, Isogai T, Konishi Y, et al. Characterization of predictors of in-hospital cardiac complications of takotsubo cardiomyopathy: Multi-center registry from tokyo ccu network. J Cardiol. 2014;63:269&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">24139869</ArticleId></ArticleIdList></Reference><Reference><Citation>Song BG, Hahn JY, Cho SJ, Park YH, Choi SM, Park JH, et al. Clinical characteristics, ballooning pattern, and long-term prognosis of transient left ventricular ballooning syndrome. Heart lung. 2010;39(3):188&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">20457338</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcari L, N&#xfa;&#xf1;ez Gil IJ, Stiermaier T, El-Battrawy I, Guerra F, Novo G, et al. Gender differences in takotsubo syndrome. J Am Coll Cardiol. 2022;79:2085&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8972425</ArticleId><ArticleId IdType="pubmed">35618345</ArticleId></ArticleIdList></Reference><Reference><Citation>Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: A study of the national inpatient sample 2008 to 2009. Am Heart J. 2012;164:215&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">22877807</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue Y, Watanabe E, Ichikawa T, Koshikawa M, Yamamoto M, Harada M, et al. Physically triggered takotsubo cardiomyopathy has a higher in-hospital mortality rate. Int J Cardiol. 2017;235:87&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">28262347</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Castellanos A, Mart&#xed;nez-Sell&#xe9;s M, Mej&#xed;a-Renter&#xed;a H, Andr&#xe9;s M, Sionis A, Almendro-Delia M, et al. Tako-tsubo syndrome in men: Rare, but with poor prognosis. Rev Esp Cardiol (English ed). 2018;71:703&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">29122513</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider B, Athanasiadis A, St&#xf6;llberger C, Pistner W, Schwab J, Gottwald U, et al. Gender differences in the manifestation of tako-tsubo cardiomyopathy. Int J Cardiol. 2013;166:584&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22192296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, Li P, Teng C, Cai P, Wang B. Anemia is associated with poor clinical outcomes in hospitalized patients with takotsubo cardiomyopathy. Angiology. 2021;72:842&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33685245</ArticleId></ArticleIdList></Reference><Reference><Citation>Gili S, Cammann VL, Schlossbauer SA, Kato K, D&#x2019;Ascenzo F, Di Vece D, et al. Cardiac arrest in takotsubo syndrome: Results from the intertak registry. Eur Heart J. 2019;40:2142&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6612368</ArticleId><ArticleId IdType="pubmed">31098611</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang A, Wang YG, Jayanna MB, Wu X, Cadaret LM, Liu K. Mortality correlates in patients with takotsubo syndrome during the covid-19 pandemic. Mayo Clin Proc Innov Qual Outcomes. 2021;5(6):1050&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8479536</ArticleId><ArticleId IdType="pubmed">34604705</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Battrawy I, Santoro F, Stiermaier T, M&#xf6;ller C, Guastafierro F, Novo G, et al. Prevalence, management, and outcome of adverse rhythm disorders in takotsubo syndrome: Insights from the international multicenter geist registry. Heart Fail Rev. 2020;25:505&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">31713085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikkanen JT, Anttonen O, Junttila MJ, Aro AL, Kerola T, Rissanen HA, et al. Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med. 2009;361:2529&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">19917913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha&#xef;ssaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L, et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med. 2008;358:2016&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">18463377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Barajas-Mart&#xed;nez H, Xia H, Zhang Z, Chen G, Yang B, et al. Clinical and functional genetic characterization of the role of cardiac calcium channel variants in the early repolarization syndrome. Frontiers in cardiovascular medicine. 2021;8: 680819.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8249565</ArticleId><ArticleId IdType="pubmed">34222376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu D, Barajas-Mart&#xed;nez H, Pfeiffer R, Dezi F, Pfeiffer J, Buch T, et al. Mutations in scn10a are responsible for a large fraction of cases of brugada syndrome. J Am Coll Cardiol. 2014;64:66&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4116276</ArticleId><ArticleId IdType="pubmed">24998131</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng B, Zhang X, Schimpf R, Powers A, Glikson M, Antzelevitch C, et al. Functional identification of hot-spot mutations in cardiac calcium channel genes associated with the J wave syndromes. Philosophical transactions of the royal society B-biological sciences. 2023;378:20220286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10150203</ArticleId><ArticleId IdType="pubmed">37122210</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang ZH, Barajas-Mart&#xed;nez H, Xia H, Li B, Capra JA, Clatot J, et al. Distinct features of probands with early repolarization and brugada syndromes carrying scn5a pathogenic variants. J Am Coll Cardiol. 2021;78:1603&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9272763</ArticleId><ArticleId IdType="pubmed">34649698</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International expert consensus document on takotsubo syndrome (part ii): Diagnostic workup, outcome, and management. Eur Heart J. 2018;39:2047&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5991205</ArticleId><ArticleId IdType="pubmed">29850820</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchert T, H&#xfc;bscher D, Guessoum CI, Lam TD, Ghadri JR, Schellinger IN, et al. Catecholamine-dependent &#x3b2;-adrenergic signaling in a pluripotent stem cell model of takotsubo cardiomyopathy. J Am Coll Cardiol. 2017;70:975&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">28818208</ArticleId></ArticleIdList></Reference><Reference><Citation>Komesaroff PA, Esler MD, Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J Clin Endocrinol Metab. 1999;84:606&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">10022424</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung BH, Ching M, Izzo JL Jr, Dandona P, Wilson MF. Estrogen improves abnormal norepinephrine-induced vasoconstriction in postmenopausal women. J Hypertens. 1999;17:523&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10404954</ArticleId></ArticleIdList></Reference><Reference><Citation>Aweimer A, Dietrich JW, Santoro F, F&#xe0;bregas MC, M&#xfc;gge A, N&#xfa;&#xf1;ez-Gil IJ, et al. Takotsubo syndrome outcomes predicted by thyroid hormone signature: Insights from cluster analysis of a multicentre registry. EBioMedicine. 2024;102: 105063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10963195</ArticleId><ArticleId IdType="pubmed">38502972</ArticleId></ArticleIdList></Reference><Reference><Citation>Santoro F, Ferraretti A, Ieva R, Musaico F, Fanelli M, Tarantino N, et al. Renal impairment and outcome in patients with takotsubo cardiomyopathy. Am J Emerg Med. 2016;34:548&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">26806176</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazirani R, Delia MA, Blanco-Ponce E, Mart&#xed;n-Garc&#xed;a AC, Fern&#xe1;ndez-Cord&#xf3;n C, Uribarri A, et al. Renal impairment and outcome in takotsubo syndrome: Insights from a national multicentric cohort. Int J Cardiol. 2024;405: 131971.</Citation><ArticleIdList><ArticleId IdType="pubmed">38490270</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40616932</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2772-963X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>04</Day></PubDate></JournalIssue><Title>JACC. Advances</Title><ISOAbbreviation>JACC Adv</ISOAbbreviation></Journal><ArticleTitle>A Novel Electrocardiographic Approach for Accurate Diagnosis of Prior Inferior Myocardial Infarction.</ArticleTitle><Pagination><StartPage>101968</StartPage><MedlinePgn>101968</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101968</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacadv.2025.101968</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2772-963X(25)00390-4</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The accuracy of diagnosing prior inferior wall myocardial infarction (IMI) on the 12-lead electrocardiogram (ECG) remains limited.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of the study was to use predictive model building to select the optimal ECG criteria specific to the diagnoses of true-IMI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From an ongoing health system-based cohort study (n = 382,121), all consecutive subjects with ECG-based diagnoses of prior IMI (n = 9,676; 2019-2023) were assessed. Subjects with at least 1 cardiac imaging test performed were identified (n = 5,924). Discovery (2019-2022, n = 329) and validation (2023, n = 185) subgroups were identified by random sampling. Subjects with true- vs pseudo-IMI were identified from a combination of ECG and imaging. Logistic regression was used in the discovery cohort to identify ECG parameters associated with true-IMI, and optimal cutoff values were determined using the Youden Index.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the discovery sample, 209 subjects (63.5%) were identified as pseudo-IMI. A combination of lead II Q-wave duration &gt;20 ms and/or amplitude ratio &gt;0.2, derived from logistic regression and selected to optimize diagnostic performance while minimizing false negatives, improved sensitivity and specificity to 100.0% and 96.7%. The positive and negative predictive values were 94.5% and 100.0%, respectively. Findings were consistent in the validation cohort.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Using the prevailing definition for electrocardiographic diagnosis of prior IMI had a significantly high rate of pseudo-IMI. Refinement using simple ECG lead II criteria substantially improved the accuracy of the ECG-based diagnosis. These findings have potential implications for clinical practice and highlight the need for large, multicenter studies to further define the optimal criteria for the ECG diagnosis of structural heart disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hailei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA; Division of Cardiology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tri Tai Truyen</LastName><ForeName>Thien Tan</ForeName><Initials>TT</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chugh</LastName><ForeName>Harpriya</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinier</LastName><ForeName>Kyndaron</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehdaie</LastName><ForeName>Ashkan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cingolani</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramireddy</LastName><ForeName>Archana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braunstein</LastName><ForeName>Eric D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shehata</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xunzhang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA. Electronic address: xunzhang.wang@cshs.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chugh</LastName><ForeName>Sumeet S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California, USA. Electronic address: sumeet.chugh@csmc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Adv</MedlineTA><NlmUniqueID>9918419284106676</NlmUniqueID><ISSNLinking>2772-963X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">inferior myocardial infarction</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword></KeywordList><CoiStatement>Funding support and author disclosures This study is funded by the Pauline and Harold Price Chair in Cardiac Electrophysiology Research at Cedars-Sinai, Los Angeles (Holder: Dr S. S. Chugh). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>5</Day><Hour>18</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40616932</ArticleId><ArticleId IdType="pmc">PMC12272430</ArticleId><ArticleId IdType="doi">10.1016/j.jacadv.2025.101968</ArticleId><ArticleId IdType="pii">S2772-963X(25)00390-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>GBD 2021 Causes of Death Collaborators Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global burden of disease study 2021. Lancet. 2024;403:2100&#x2013;2132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11126520</ArticleId><ArticleId IdType="pubmed">38582094</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess D.C., Hunt D., Li L., et al. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Eur Heart J. 2010;31:92&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">19797259</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbier C.E., Themudo R., Bjerner T., Johansson L., Lind L., Ahlstr&#xf6;m H. Long-term prognosis of unrecognized myocardial infarction detected with cardiovascular magnetic resonance in an elderly population. J Cardiovasc Magn Reson. 2016;18:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4950686</ArticleId><ArticleId IdType="pubmed">27430315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannel W.B., Abbott R.D. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med. 1984;311:1144&#x2013;1147.</Citation><ArticleIdList><ArticleId IdType="pubmed">6482932</ArticleId></ArticleIdList></Reference><Reference><Citation>de Torbal A., Boersma E., Kors J.A., et al. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: the Rotterdam Study. Eur Heart J. 2006;27:729&#x2013;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">16478749</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., Alpert J.S., Jaffe A.S., et al. Fourth universal definition of myocardial infarction (2018) J Am Coll Cardiol. 2018;72:2231&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pubmed">30153967</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobeek M., Badings E., Lenssen M., et al. Diagnostic value of the electrocardiogram in the assessment of prior myocardial infarction. Neth Heart J. 2021;29:142&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7904994</ArticleId><ArticleId IdType="pubmed">33197002</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadour W., Doyle M., Williams R.B., et al. Does the presence of Q waves on the EKG accurately predict prior myocardial infarction when compared to cardiac magnetic resonance using late gadolinium enhancement? A cross-population study of noninfarct vs infarct patients. Heart Rhythm. 2014;11:2018&#x2013;2026.</Citation><ArticleIdList><ArticleId IdType="pubmed">25063692</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnbaum Y., Fiol M., Nikus K., et al. A counterpoint paper: comments on the electrocardiographic part of the 2018 Fourth Universal definition of myocardial infarction endorsed by the International society of electrocardiology and the International society for holter and noninvasive electrocardiology. Ann Noninvasive Electrocardiol. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507065</ArticleId><ArticleId IdType="pubmed">32638432</ArticleId></ArticleIdList></Reference><Reference><Citation>Horan L.G., Flowers N.C., Johnson J.C. Significance of the diagnostic Q wave of myocardial infarction. Circulation. 1971;43:428&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">5544988</ArticleId></ArticleIdList></Reference><Reference><Citation>Asch F.M., Shah S., Rattin C., Swaminathan S., Fuisz A., Lindsay J. Lack of sensitivity of the electrocardiogram for detection of old myocardial infarction: a cardiac magnetic resonance imaging study. Am Heart J. 2006;152:742&#x2013;748.</Citation><ArticleIdList><ArticleId IdType="pubmed">16996851</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner R.A., Hill N.E. Optimized electrocardiographic criteria for prior inferior and anterior myocardial infarction. J Electrocardiol. 2012;45:209&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">22217365</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammar K.A., Kors J.A., Yawn B.P., Rodeheffer R.J. Defining unrecognized myocardial infarction: a call for standardized electrocardiographic diagnostic criteria. Am Heart J. 2004;148:277&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pubmed">15308997</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation. 2007;116:2634&#x2013;2653.</Citation><ArticleIdList><ArticleId IdType="pubmed">17951284</ArticleId></ArticleIdList></Reference><Reference><Citation>Krittayaphong R., Maneesai A., Chaithiraphan V., Saiviroonporn P., Chaiphet O., Udompunturak S. Comparison of diagnostic and prognostic value of different electrocardiographic criteria to delayed-enhancement magnetic resonance imaging for healed myocardial infarction. Am J Cardiol. 2009;103:464&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pubmed">19195503</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurd H.P., 2nd, Starling M.R., Crawford M.H., Dlabal P.W., O'Rourke R.A. Comparative accuracy of electrocardiographic and vectorcardiographic criteria for inferior myocardial infarction. Circulation. 1981;63:1025&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">7471360</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner R., Hill N.E., Sheehe P.R., Mookherjee S., Fruehan C.T., Smulyan H. Improved electrocardiographic criteria for the diagnosis of inferior myocardial infarction. Circulation. 1982;66:422&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">7094249</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen J.K., &#xd8;vrehus K., M&#xf8;ldrup M., Mickley H., H&#xf8;ilund-Carlsen P.F. Redefinition of the Q wave -- is there a clinical problem? Am J Cardiol. 2006;97:974&#x2013;976.</Citation><ArticleIdList><ArticleId IdType="pubmed">16563898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosum P., Theerasuwipakorn N., Srisuwanwattana W., et al. Diagnostic values of inferior Q-waves for myocardial scar identification detected by 3.0 T cardiac MRI. Sci Rep. 2024;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11271564</ArticleId><ArticleId IdType="pubmed">39030234</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma C., Bekkers S.C., Haidari Z., et al. Comparison of different electrocardiographic scoring systems for detection of any previous myocardial infarction as assessed with cardiovascular magnetic resonance imaging. Am J Cardiol. 2013;112:1069&#x2013;1074.</Citation><ArticleIdList><ArticleId IdType="pubmed">23827406</ArticleId></ArticleIdList></Reference><Reference><Citation>Cag&#xe1;n S., Kuch&#xe1;rov&#xe1; L. Hodnotenie kmitu Q vo zvodoch II, III, aVF. I. Devi&#xe1;cia elektrickej osi srdca, ischemicka choroba srdca [Evaluation of the Q wave in leads II, III, and aVF. I. Deviation of the electrical axis of the heart, ischemic heart disease] Vnitr Lek. 1989;35:743&#x2013;751.</Citation><ArticleIdList><ArticleId IdType="pubmed">2800381</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogossian H., Ninios I., Frommeyer G., et al. Q wave in the inferior leads: there is more than scar. Ann Noninvasive Electrocardiol. 2015;20:609&#x2013;611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6931544</ArticleId><ArticleId IdType="pubmed">25631624</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger A.L. Normal and noninfarct Q waves. Cardiol Clin. 1987;5:357&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pubmed">3319161</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B., Kheiwa A., Swamy P., et al. Clinical significance of coronary arterial dominance: a review of the literature. J Am Heart Assoc. 2024;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11179863</ArticleId><ArticleId IdType="pubmed">38639360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-P&#xe9;rez J.T., Rodr&#xed;guez J., Meyers S.N., Lee D.C., Davidson C., Wu E. Correspondence between the 17-segment model and coronary arterial anatomy using contrast-enhanced cardiac magnetic resonance imaging. JACC Cardiovasc Imaging. 2008;1:282&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">19356440</ArticleId></ArticleIdList></Reference><Reference><Citation>Toma A., Diller G.P., Lawler P.R. Deep learning in medicine. JACC Adv. 2022;1</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11198249</ArticleId><ArticleId IdType="pubmed">38939084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40628684</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1757-790X</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2025</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>BMJ case reports</Title><ISOAbbreviation>BMJ Case Rep</ISOAbbreviation></Journal><ArticleTitle>Non-bacterial thrombotic endocarditis leading to the diagnosis of pancreatic adenocarcinoma.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e266289</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bcr-2025-266289</ELocationID><Abstract><AbstractText>Non-bacterial thrombotic endocarditis (NBTE) is a rare, non-infective endocarditis affecting cardiac structures, often associated with underlying conditions and is frequently overlooked or misdiagnosed.We present the case of a man in his 50s who initially presented with symptoms concerning for myocardial ischaemia, and laboratory and ECG findings raised suspicion for a subacute non-ST-elevation myocardial infarction. Coronary angiography showed coronary sclerosis without significant stenoses and a dilated left ventricle with reduced systolic function. Transthoracic echocardiography revealed vegetations on a bicuspid aortic valve, while blood cultures were negative. Subsequent imaging identified a mass in the pancreatic head with liver metastases, confirmed as an adenocarcinoma by biopsy. The diagnosis of NBTE was established based on the presence of a malignancy, persistent negative blood cultures and the absence of laboratory signs of infection. Antibiotics were discontinued, and heparin therapy was initiated, emphasising NBTE as a paraneoplastic syndrome with a prothrombotic state without criteria for infectious endocarditis.</AbstractText><CopyrightInformation>&#xa9; BMJ Publishing Group Limited 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Velco</LastName><ForeName>Aron</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3926-4279</Identifier><AffiliationInfo><Affiliation>Internal Medicine, University Hospital Zurich, Z&#xfc;rich, Switzerland aronvelco@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>N&#xe4;gele</LastName><ForeName>Matthias Philip</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Cardiology, University Hospital Zurich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jurisic</LastName><ForeName>Stjepan</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-3126-8555</Identifier><AffiliationInfo><Affiliation>Cardiology, University Hospital Zurich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guffi</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0009-5129-2158</Identifier><AffiliationInfo><Affiliation>Internal Medicine, University Hospital Zurich, Z&#xfc;rich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Case Rep</MedlineTA><NlmUniqueID>101526291</NlmUniqueID><ISSNLinking>1757-790X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010190" MajorTopicYN="Y">Pancreatic Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059905" MajorTopicYN="Y">Endocarditis, Non-Infective</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="Y">Adenocarcinoma</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010257" MajorTopicYN="Y">Paraneoplastic Syndromes</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="N">Coronary Angiography</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Pancreatic cancer</Keyword><Keyword MajorTopicYN="N">Thrombosis</Keyword><Keyword MajorTopicYN="N">Valvar diseases</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>9</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>9</Day><Hour>0</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>8</Day><Hour>22</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40628684</ArticleId><ArticleId IdType="doi">10.1136/bcr-2025-266289</ArticleId><ArticleId IdType="pii">18/7/e266289</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40615329</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Artificial intelligence for electrocardiographic diagnosis of perioperative myocardial ischaemia: a scoping review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(25)00353-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2025.05.037</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Perioperative electrocardiographic monitoring can offer immediate detection of myocardial ischaemia, yet its application in perioperative and remote monitoring settings is hampered by frequent false alarms and signal contamination. We performed a scoping review for the current state of artificial intelligence (AI) in perioperative ECG interpretation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A literature search in Ovid MEDLINE, EMBASE, Compendex, and CINAHL databases was performed from inception to May 10, 2023. All original research of ECG monitoring for myocardial ischaemia, myocardial infarction, or both was included.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 182 original research articles published between 1991 and 2023 were included. Most studies (n=132) used a pre-existing ECG database to develop AI algorithms retrospectively, and the rest did not specify their sources. Processing filters were used in 58% of the studies to remove ECG noises/artifacts before AI algorithm development. Amongst the AI technologies used, ResNet demonstrated the highest median sensitivity, precision, and specificity at 98.4%, 99.8%, and 99.1%, respectively. There are only five studies with intermittent prospective ECG collection on ST-segment elevation myocardial infarction. No studies prospectively collected continuous ECG perioperatively, with frequent false alarms and signal contamination.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">AI technology can achieve high diagnostic accuracy for myocardial ischaemia detection in clean intermittent electrocardiograms. However, almost all these algorithms were developed from a few open-source clean ECG databases without testing on 'noisy data', which limited their clinical applicability in the perioperative setting where signal contamination is frequent. AI algorithms on perioperative electrocardiography, tested in a noisy perioperative and remote monitoring environment, including wearable devices, are needed.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatterjee</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iansavitchene</LastName><ForeName>Alla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>London Health Science Centre, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komeili</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Adrian D C</ForeName><Initials>ADC</Initials><AffiliationInfo><Affiliation>Department of Systems and Computer Engineering, Carleton University, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Homer</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, University of Western Ontario, London, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chui</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia &amp; Perioperative Medicine, University of Western Ontario, London, ON, Canada. Electronic address: Jason.chui@lhsc.on.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ECG</Keyword><Keyword MajorTopicYN="N">artificial intelligence</Keyword><Keyword MajorTopicYN="N">electrocardiography</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">monitoring</Keyword><Keyword MajorTopicYN="N">myocardial infarction</Keyword><Keyword MajorTopicYN="N">myocardial ischaemia</Keyword><Keyword MajorTopicYN="N">remote home monitoring</Keyword></KeywordList><CoiStatement>Declaration of interest The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>5</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>5</Day><Hour>0</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>4</Day><Hour>22</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40615329</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2025.05.037</ArticleId><ArticleId IdType="pii">S0007-0912(25)00353-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40612172</PMID><DateRevised><Year>2025</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">3050-2225</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2025</Year><Season>Jan-Dec</Season></PubDate></JournalIssue><Title>Sage open pediatrics</Title><ISOAbbreviation>Sage Open Pediatr</ISOAbbreviation></Journal><ArticleTitle>Incessant Ventricular Tachycardia in Infant With Structurally Normal Heart: Is it Truly Benign or a Old Wives' Tale.</ArticleTitle><Pagination><StartPage>30502225251319869</StartPage><MedlinePgn>30502225251319869</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">30502225251319869</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/30502225251319869</ELocationID><Abstract><AbstractText>Idiopathic ventricular tachycardia (VT) is a rare form of arrhythmia in neonates that can be life-threatening prompting its timely diagnosis and importance of treatment to avoid serious complications, that is; heart failure. We describe a neonate with an incessant idiopathic ventricular tachycardia presented with heart failure and severe left ventricular dysfunction. This infant presented with poor feeding, irritability, increase work of breathing, and heartbeat of 260/min. The electrocardiogram (ECG) showed wide complex tachycardia and the echocardiogram showed a structurally normal heart with dilated cardiomyopathy. The clinical signs and chest X-ray changes were consistent with cardiac failure but preserved peripheral perfusion. This presentation, the sustained VT and the global cardiac failure makes the treatment challenging; therefore, early diagnosis of incessant VT in neonate is important for better prognosis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2025.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohsin</LastName><ForeName>Muhammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>National institute of cardiovascular diseases, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangi</LastName><ForeName>Rumana</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-0160-7133</Identifier><AffiliationInfo><Affiliation>Aga Khan University Hospital, Karachi Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheikh</LastName><ForeName>Abdul Sattar</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>National institute of cardiovascular diseases, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Sage Open Pediatr</MedlineTA><NlmUniqueID>9919052035406676</NlmUniqueID><ISSNLinking>3050-2225</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Idiopathic ventricular tachycardia</Keyword><Keyword MajorTopicYN="N">heart failure</Keyword><Keyword MajorTopicYN="N">neonate</Keyword><Keyword MajorTopicYN="N">normal heart</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>4</Day><Hour>4</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40612172</ArticleId><ArticleId IdType="pmc">PMC12220836</ArticleId><ArticleId IdType="doi">10.1177/30502225251319869</ArticleId><ArticleId IdType="pii">10.1177_30502225251319869</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ban JE. Neonatal arrhythmias: diagnosis, treatment, and clinical outcome. Korean J Pediatr. 2017;60(11):344-352. doi: 10.3345/kjp.2017.60.11.344</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2017.60.11.344</ArticleId><ArticleId IdType="pmc">PMC5725339</ArticleId><ArticleId IdType="pubmed">29234357</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rosa G, Butera G, Chessa M, et al. Outcome of newborns with asymptomatic monomorphic ventricular arrhythmia. Arch Dis Child Fetal Neonatal Ed. 2006;91(6):F419-F422. doi: 10.1136/adc.2005.092932</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.2005.092932</ArticleId><ArticleId IdType="pmc">PMC2672755</ArticleId><ArticleId IdType="pubmed">16820390</ArticleId></ArticleIdList></Reference><Reference><Citation>Levin MD, Stephens P, Tanel RE, Vetter VL, Rhodes LA. Ventricular tachycardia in infants with structurally normal heart: a benign disorder. Cardiol Young. 2010;20(6):641-647. doi: 10.1017/S1047951110000867</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951110000867</ArticleId><ArticleId IdType="pmc">PMC3751393</ArticleId><ArticleId IdType="pubmed">20723269</ArticleId></ArticleIdList></Reference><Reference><Citation>El Joueid N, Touma Boulos M, Abou Jaoude S, Daou L. Ventricular tachycardia in an infant without congenital anomaly: a case report. Cardiol Res. 2020;11(1):61-65. doi: 10.14740/cr1005</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/cr1005</ArticleId><ArticleId IdType="pmc">PMC7011923</ArticleId><ArticleId IdType="pubmed">32095198</ArticleId></ArticleIdList></Reference><Reference><Citation>Crosson JE, Callans DJ, Bradley DJ, et al. PACES/HRS expert consensus statement on the evaluation and management of ventricular arrhythmias in the child with a structurally normal heart. Heart Rhythm. 2014;11(9):e55-e78. doi: 10.1016/j.hrthm.2014.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2014.05.010</ArticleId><ArticleId IdType="pubmed">24814375</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H, Raman D, Dean C, Salvo R, Achamallah N. Incessant ventricular tachycardia in the setting of septic shock treated with bilateral stellate ganglion block. J Am Coll Cardiol. 2019;73(9):2464. doi: 10.1016/S0735-1097(19)33070-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(19)33070-0</ArticleId></ArticleIdList></Reference><Reference><Citation>
Vetter VL.
Ventricular arrhythmias in patients with congenital heart disease. In: Greenspon AJ, Waxman HL, eds. Contemporary management of ventricular arrhythmias. Cardiovasc Clin. 1992;22(1):255-273. https://pubmed.ncbi.nlm.nih.gov/1728429/
</Citation><ArticleIdList><ArticleId IdType="pubmed">1728429</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch D. Pediatric arrhythmias. J Pediatr Nurs. 2001;16(5):351-362. doi: 10.1053/jpdn.2001.26571</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jpdn.2001.26571</ArticleId><ArticleId IdType="pubmed">11598867</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry JC. Ventricular tachycardia in neonates. Pacing Clin Electrophysiol. 1997;20(8):2061-2064. doi: 10.1111/j.1540-8159.1997.tb03628.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.1997.tb03628.x</ArticleId><ArticleId IdType="pubmed">9272509</ArticleId></ArticleIdList></Reference><Reference><Citation>Case CL, Gillette PC, Crawford FA. Cardiac rhabdomyomas causing supraventricular and lethal ventricnlar arrhythmias in an infant. Am Heart J. 1991;122(5):1484-1486. doi: 10.1016/0002-8703(91)90600-m</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-8703(91)90600-m</ArticleId><ArticleId IdType="pubmed">1951021</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen NM, Azam M, Dunne KP, Walsh KP. Idiopathic ventricular tachycardia in a newborn: immediate response to lidocaine. Pediatr Cardiol. 2011;32(5):706-707. doi: 10.1007/s00246-011-9947-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-011-9947-2</ArticleId><ArticleId IdType="pubmed">21547492</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis AM, Gow RM, McCrindle BW, Hamilton RM. Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children. Am Heart J. 1996;131(1):186-191. doi: 10.1016/s0002-8703(96)90068-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0002-8703(96)90068-x</ArticleId><ArticleId IdType="pubmed">8554007</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfammatter JP, Paul T. Working Group on Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology. Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. J Am Coll Cardiol. 1999;33(7):2067-2072. doi: 10.1016/s0735-1097(99)00105-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0735-1097(99)00105-9</ArticleId><ArticleId IdType="pubmed">10362215</ArticleId></ArticleIdList></Reference><Reference><Citation>Escudero CA, Tan RBM, Beach CM, Dalal AS, LaPage MJ, Hill AC. Approach to wide complex tachycardia in paediatric patients. CJC Pediatr Congenit Heart Dis. 2022;1(2):60-73. doi: 10.1016/j.cjcpc.2022.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjcpc.2022.02.003</ArticleId><ArticleId IdType="pmc">PMC10642107</ArticleId><ArticleId IdType="pubmed">37969244</ArticleId></ArticleIdList></Reference><Reference><Citation>Maghrabi K, Uzun O, Kirsh JA, Balaji S, Von Bergen NH, Sanatani S. Cardiovascular collapse with intravenous amiodarone in children: a multi-center retrospectivecohort study. Pediatr Cardiol. 2019;40(5):925-933. doi: 10.1007/s00246-019-02090-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00246-019-02090-7</ArticleId><ArticleId IdType="pubmed">30929065</ArticleId></ArticleIdList></Reference><Reference><Citation>Saul JP, Scott WA, Brown S, et al. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation. 2005;29(22):3470-3477. doi: 10.1161/CIRCULATIONAHA.105.534149</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.105.534149</ArticleId><ArticleId IdType="pubmed">16316969</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasdemir C, Yuksel A, Camli D, et al. Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias. Pacing Clin Electrophysiol. 2012;35(4):465-470.</Citation><ArticleIdList><ArticleId IdType="pubmed">22303908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu SN, Wu WL, Lu CW, et al. Primary ventricular tachycardia in paediatric population in a tertiary centre. Arch Dis Child. 2017;102(12):1137-1142. doi: 10.1136/archdischild-2016-312418</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2016-312418</ArticleId><ArticleId IdType="pubmed">28821499</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>